BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 656439 COc1ccc(NC(=O)[C@@H]2CCCN2C(=O)c2cc(C)ccc2-n2nccn2)c(N)c1 InChI=1S/C22H24N6O3/c1-14-5-8-19(28-24-9-10-25-28)16(12-14)22(30)27-11-3-4-20(27)21(29)26-18-7-6-15(31-2)13-17(18)23/h5-10,12-13,20H,3-4,11,23H2,1-2H3,(H,26,29)/t20-/m0/s1 LOBRQAJIMHKKSD-FQEVSTJZSA-N 334389 (5-Methyl-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(4-nitro-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US9732075, Example 1.1 Orexin/Hypocretin receptor type 1 Homo sapiens 1500 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334389 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334389&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127483 384986549 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656440 COc1ccc(NC(=O)[C@@H]2CCCN2C(=O)c2cc(C)ccc2-n2nccn2)c(N)c1 InChI=1S/C22H24N6O3/c1-14-5-8-19(28-24-9-10-25-28)16(12-14)22(30)27-11-3-4-20(27)21(29)26-18-7-6-15(31-2)13-17(18)23/h5-10,12-13,20H,3-4,11,23H2,1-2H3,(H,26,29)/t20-/m0/s1 LOBRQAJIMHKKSD-FQEVSTJZSA-N 334389 (5-Methyl-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(4-nitro-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US9732075, Example 1.1 Orexin receptor type 2 Homo sapiens 108 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334389 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334389&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127483 384986549 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656441 Cc1nc(C(=O)N2CCC[C@H]2c2nc3cc(Cl)ccc3[nH]2)c(s1)-c1cccc(Cl)c1 InChI=1S/C22H18Cl2N4OS/c1-12-25-19(20(30-12)13-4-2-5-14(23)10-13)22(29)28-9-3-6-18(28)21-26-16-8-7-15(24)11-17(16)27-21/h2,4-5,7-8,10-11,18H,3,6,9H2,1H3,(H,26,27)/t18-/m0/s1 LUERQCUTYHGMCP-SFHVURJKSA-N 334390 US11040966, Example 1.10::US9732075, Example 1.10::[(S)-2-(5-Chloro-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 98.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334390 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334390&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102412 384986550 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656442 Cc1nc(C(=O)N2CCC[C@H]2c2nc3cc(Cl)ccc3[nH]2)c(s1)-c1cccc(Cl)c1 InChI=1S/C22H18Cl2N4OS/c1-12-25-19(20(30-12)13-4-2-5-14(23)10-13)22(29)28-9-3-6-18(28)21-26-16-8-7-15(24)11-17(16)27-21/h2,4-5,7-8,10-11,18H,3,6,9H2,1H3,(H,26,27)/t18-/m0/s1 LUERQCUTYHGMCP-SFHVURJKSA-N 334390 US11040966, Example 1.10::US9732075, Example 1.10::[(S)-2-(5-Chloro-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 248 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334390 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334390&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102412 384986550 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656443 Cc1nc(C(=O)N2CCCC2c2nc3c(Cl)cc(cc3[nH]2)C(F)(F)F)c(s1)-c1cccc(Cl)c1 334391 US11040966, Example 1.100::US9732075, Example 1.100::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(4-chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 27.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334391 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334391&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127507 384986551 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656444 Cc1nc(C(=O)N2CCCC2c2nc3c(Cl)cc(cc3[nH]2)C(F)(F)F)c(s1)-c1cccc(Cl)c1 334391 US11040966, Example 1.100::US9732075, Example 1.100::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(4-chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 104 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334391 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334391&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127507 384986551 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656445 Cc1nc(C(=O)N2CCCC2c2nc3cc(Cl)c(C)cc3[nH]2)c(s1)-c1cccc(Cl)c1 334392 US11040966, Example 1.101::US9732075, Example 1.101::rac-[2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 21.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334392 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334392&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694279 384986552 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656446 Cc1nc(C(=O)N2CCCC2c2nc3cc(Cl)c(C)cc3[nH]2)c(s1)-c1cccc(Cl)c1 334392 US11040966, Example 1.101::US9732075, Example 1.101::rac-[2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 50.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334392 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334392&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694279 384986552 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656447 Cc1nc(C(=O)N2CCCC2c2nc3c(C)cc(C)cc3[nH]2)c(s1)-c1cccc(Cl)c1 334393 US11040966, Example 1.102::US9732075, Example 1.102::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(4,6-dimethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 17.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334393 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334393&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695494 384986553 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656448 Cc1nc(C(=O)N2CCCC2c2nc3c(C)cc(C)cc3[nH]2)c(s1)-c1cccc(Cl)c1 334393 US11040966, Example 1.102::US9732075, Example 1.102::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(4,6-dimethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 17.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334393 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334393&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695494 384986553 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656449 Cc1nc(C(=O)N2CCCC2c2nc3c(CO)cccc3[nH]2)c(s1)-c1cccc(Cl)c1 334394 US11040966, Example 1.103::US9732075, Example 1.103::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(4-hydroxymethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 364 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334394 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334394&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127322 384986554 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656450 Cc1nc(C(=O)N2CCCC2c2nc3c(CO)cccc3[nH]2)c(s1)-c1cccc(Cl)c1 334394 US11040966, Example 1.103::US9732075, Example 1.103::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(4-hydroxymethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 112 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334394 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334394&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127322 384986554 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656451 Cc1nc(C(=O)N2CCCC2c2nc3c(F)cccc3[nH]2)c(s1)-c1cccc(Cl)c1 334395 US11040966, Example 1.104::US9732075, Example 1.104::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(4-fluoro-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 657 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334395 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334395&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102439 384986555 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656452 Cc1nc(C(=O)N2CCCC2c2nc3c(F)cccc3[nH]2)c(s1)-c1cccc(Cl)c1 334395 US11040966, Example 1.104::US9732075, Example 1.104::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(4-fluoro-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 769 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334395 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334395&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102439 384986555 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656453 Cc1nc(C(=O)N2CCCC2c2nc3c(cccc3[nH]2)C(F)(F)F)c(s1)-c1cccc(Cl)c1 334396 US11040966, Example 1.105::US9732075, Example 1.105::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 45.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334396 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334396&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127959 384986556 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656454 Cc1nc(C(=O)N2CCCC2c2nc3c(cccc3[nH]2)C(F)(F)F)c(s1)-c1cccc(Cl)c1 334396 US11040966, Example 1.105::US9732075, Example 1.105::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 89.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334396 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334396&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127959 384986556 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656455 Cc1nc(C(=O)N2CCCC2c2nc3c(Br)cccc3[nH]2)c(s1)-c1cccc(Cl)c1 334397 US11040966, Example 1.106::US9732075, Example 1.106::rac-[2-(4-Bromo-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 17.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334397 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334397&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695492 384986557 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656456 Cc1nc(C(=O)N2CCCC2c2nc3c(Br)cccc3[nH]2)c(s1)-c1cccc(Cl)c1 334397 US11040966, Example 1.106::US9732075, Example 1.106::rac-[2-(4-Bromo-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 31.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334397 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334397&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695492 384986557 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656457 Cc1nc(C(=O)N2CCCC2c2nc3cc(Br)cc(C)c3[nH]2)c(s1)-c1cccc(Cl)c1 334398 US11040966, Example 1.107::US9732075, Example 1.107::rac-[2-(5-Bromo-7-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 28.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334398 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334398&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695493 384986558 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656458 Cc1nc(C(=O)N2CCCC2c2nc3cc(Br)cc(C)c3[nH]2)c(s1)-c1cccc(Cl)c1 334398 US11040966, Example 1.107::US9732075, Example 1.107::rac-[2-(5-Bromo-7-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 58.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334398 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334398&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695493 384986558 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656459 Cc1nc(C(=O)N2CCCC2c2nc3cc(OC(F)(F)F)ccc3[nH]2)c(s1)-c1cccc(Cl)c1 334399 US11040966, Example 1.108::US9732075, Example 1.108::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 171 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334399 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334399&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127949 384986559 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656460 Cc1nc(C(=O)N2CCCC2c2nc3cc(OC(F)(F)F)ccc3[nH]2)c(s1)-c1cccc(Cl)c1 334399 US11040966, Example 1.108::US9732075, Example 1.108::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 835 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334399 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334399&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127949 384986559 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656461 Cc1nc(C(=O)N2CCCC2c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1cccc(Cl)c1 334400 US11040966, Example 1.109::US9732075, Example 1.109::rac-[2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334400 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334400&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694280 384986560 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656462 Cc1nc(C(=O)N2CCCC2c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1cccc(Cl)c1 334400 US11040966, Example 1.109::US9732075, Example 1.109::rac-[2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 10.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334400 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334400&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694280 384986560 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656463 COc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C23H21ClN4O2S/c1-13-25-20(21(31-13)14-6-3-7-15(24)12-14)23(29)28-11-5-9-17(28)22-26-16-8-4-10-18(30-2)19(16)27-22/h3-4,6-8,10,12,17H,5,9,11H2,1-2H3,(H,26,27)/t17-/m0/s1 URWCYOFMLJYDCT-KRWDZBQOSA-N 334401 US11040966, Example 1.11::US9732075, Example 1.11::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 110 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334401 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334401&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102330 384986561 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656464 COc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C23H21ClN4O2S/c1-13-25-20(21(31-13)14-6-3-7-15(24)12-14)23(29)28-11-5-9-17(28)22-26-16-8-4-10-18(30-2)19(16)27-22/h3-4,6-8,10,12,17H,5,9,11H2,1-2H3,(H,26,27)/t17-/m0/s1 URWCYOFMLJYDCT-KRWDZBQOSA-N 334401 US11040966, Example 1.11::US9732075, Example 1.11::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 54.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334401 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334401&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102330 384986561 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656465 COc1cc2nc([nH]c2cc1OC)C1CCCN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1 334402 US11040966, Example 1.110::US9732075, Example 1.110::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(5,6-dimethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 164 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334402 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334402&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102298 384986562 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656466 COc1cc2nc([nH]c2cc1OC)C1CCCN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1 334402 US11040966, Example 1.110::US9732075, Example 1.110::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(5,6-dimethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 46.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334402 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334402&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102298 384986562 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656467 Cc1nc(C(=O)N2CCCC2c2nc3cc(c(F)cc3[nH]2)C(F)(F)F)c(s1)-c1cccc(Cl)c1 334403 US11040966, Example 1.111::US9732075, Example 1.111::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(6-fluoro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 32.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334403 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334403&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128141 384986563 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656468 Cc1nc(C(=O)N2CCCC2c2nc3cc(c(F)cc3[nH]2)C(F)(F)F)c(s1)-c1cccc(Cl)c1 334403 US11040966, Example 1.111::US9732075, Example 1.111::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(6-fluoro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 243 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334403 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334403&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128141 384986563 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656469 Cc1nc(C(=O)N2CCCC2c2nc3cc(F)c(Br)cc3[nH]2)c(s1)-c1cccc(Cl)c1 334404 US11040966, Example 1.112::US9732075, Example 1.112::rac-[2-(6-Bromo-5-fluoro-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 69.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334404 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334404&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128115 384986564 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656470 Cc1nc(C(=O)N2CCCC2c2nc3cc(F)c(Br)cc3[nH]2)c(s1)-c1cccc(Cl)c1 334404 US11040966, Example 1.112::US9732075, Example 1.112::rac-[2-(6-Bromo-5-fluoro-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 289 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334404 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334404&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128115 384986564 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656471 Cc1nc(C(=O)N2CCCC2c2nc3cc(c(Cl)cc3[nH]2)C(F)(F)F)c(s1)-c1cccc(Cl)c1 334405 US11040966, Example 1.113::US9732075, Example 1.113::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(6-chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334405 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334405&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694278 384986565 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656472 Cc1nc(C(=O)N2CCCC2c2nc3cc(c(Cl)cc3[nH]2)C(F)(F)F)c(s1)-c1cccc(Cl)c1 334405 US11040966, Example 1.113::US9732075, Example 1.113::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(6-chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 58.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334405 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334405&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694278 384986565 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656473 Cc1nc(C(=O)N2CCCC2c2nc3c(Br)cc(F)cc3[nH]2)c(s1)-c1cccc(Cl)c1 334406 US11040966, Example 1.114::US9732075, Example 1.114::rac-[2-(4-Bromo-6-fluoro-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 30.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334406 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334406&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694277 384986566 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656474 Cc1nc(C(=O)N2CCCC2c2nc3c(Br)cc(F)cc3[nH]2)c(s1)-c1cccc(Cl)c1 334406 US11040966, Example 1.114::US9732075, Example 1.114::rac-[2-(4-Bromo-6-fluoro-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 74.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334406 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334406&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694277 384986566 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656475 Cc1nc(C(=O)N2CCCC2c2nc3c(C)c(C)ccc3[nH]2)c(s1)-c1cccc(Cl)c1 334407 US11040966, Example 1.115::US9732075, Example 1.115::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(4,5-dimethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 37.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334407 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334407&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694281 384986567 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656476 Cc1nc(C(=O)N2CCCC2c2nc3c(C)c(C)ccc3[nH]2)c(s1)-c1cccc(Cl)c1 334407 US11040966, Example 1.115::US9732075, Example 1.115::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(4,5-dimethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 19.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334407 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334407&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694281 384986567 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656477 CC(C)c1cccc2[nH]c(nc12)C1CCCN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1 334408 US11040966, Example 1.116::US9732075, Example 1.116::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(4-isopropyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 86.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334408 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334408&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102444 384986568 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656478 CC(C)c1cccc2[nH]c(nc12)C1CCCN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1 334408 US11040966, Example 1.116::US9732075, Example 1.116::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(4-isopropyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 248 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334408 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334408&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102444 384986568 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656479 Cc1nc(C(=O)N2CCCC2c2nc3c4OCCOc4ccc3[nH]2)c(s1)-c1cccc(Cl)c1 334409 US11040966, Example 1.117::US9732075, Example 1.117::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(7,8-dihydro-3H-6,9-dioxa-1,3-diaza-cyclopenta[a]naphthalen-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 136 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334409 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334409&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102419 384986569 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656480 Cc1nc(C(=O)N2CCCC2c2nc3c4OCCOc4ccc3[nH]2)c(s1)-c1cccc(Cl)c1 334409 US11040966, Example 1.117::US9732075, Example 1.117::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(7,8-dihydro-3H-6,9-dioxa-1,3-diaza-cyclopenta[a]naphthalen-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 56.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334409 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334409&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102419 384986569 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656481 Cc1nc(C(=O)N2CCCC2c2nc3c(cc(cc3[nH]2)C(F)(F)F)C(F)(F)F)c(s1)-c1ccccc1 334410 US11040966, Example 1.118::US9732075, Example 1.118::rac-[2-(4,6-Bis-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 191 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334410 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334410&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102250 384986570 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656482 Cc1nc(C(=O)N2CCCC2c2nc3c(cc(cc3[nH]2)C(F)(F)F)C(F)(F)F)c(s1)-c1ccccc1 334410 US11040966, Example 1.118::US9732075, Example 1.118::rac-[2-(4,6-Bis-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 364 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334410 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334410&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102250 384986570 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656483 Cc1nc(C(=O)N2CCCC2c2nc3cc(Cl)c(Cl)cc3[nH]2)c(s1)-c1ccccc1 334411 US11040966, Example 1.119::US9732075, Example 1.119::rac-[2-(5,6-Dichloro-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 27.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334411 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334411&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127004 384986571 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656484 Cc1nc(C(=O)N2CCCC2c2nc3cc(Cl)c(Cl)cc3[nH]2)c(s1)-c1ccccc1 334411 US11040966, Example 1.119::US9732075, Example 1.119::rac-[2-(5,6-Dichloro-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 77.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334411 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334411&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127004 384986571 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656485 Cc1nc(C(=O)N2CCC[C@H]2c2nc3c(O)cccc3[nH]2)c(s1)-c1cccc(Cl)c1 InChI=1S/C22H19ClN4O2S/c1-12-24-19(20(30-12)13-5-2-6-14(23)11-13)22(29)27-10-4-8-16(27)21-25-15-7-3-9-17(28)18(15)26-21/h2-3,5-7,9,11,16,28H,4,8,10H2,1H3,(H,25,26)/t16-/m0/s1 XRFCLOSGRBWXBX-INIZCTEOSA-N 334412 US11040966, Example 1.12::US9732075, Example 1.12::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(4-hydroxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 273 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334412 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334412&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102263 384986572 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656486 Cc1nc(C(=O)N2CCC[C@H]2c2nc3c(O)cccc3[nH]2)c(s1)-c1cccc(Cl)c1 InChI=1S/C22H19ClN4O2S/c1-12-24-19(20(30-12)13-5-2-6-14(23)11-13)22(29)27-10-4-8-16(27)21-25-15-7-3-9-17(28)18(15)26-21/h2-3,5-7,9,11,16,28H,4,8,10H2,1H3,(H,25,26)/t16-/m0/s1 XRFCLOSGRBWXBX-INIZCTEOSA-N 334412 US11040966, Example 1.12::US9732075, Example 1.12::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(4-hydroxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 344 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334412 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334412&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102263 384986572 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656487 Cc1nc(C(=O)N2CCCC2c2nc3cc(Br)ccc3[nH]2)c(s1)-c1ccccc1 334413 US11040966, Example 1.120::US9732075, Example 1.120::rac-[2-(5-Bromo-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 147 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334413 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334413&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127730 384986573 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656488 Cc1nc(C(=O)N2CCCC2c2nc3cc(Br)ccc3[nH]2)c(s1)-c1ccccc1 334413 US11040966, Example 1.120::US9732075, Example 1.120::rac-[2-(5-Bromo-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 557 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334413 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334413&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127730 384986573 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656489 Cc1nc(C(=O)N2CCCC2c2nc3cc(ccc3[nH]2)C(F)(F)F)c(s1)-c1ccccc1 334414 US11040966, Example 1.121::US9732075, Example 1.121::rac-(2-Methyl-5-phenyl-thiazol-4-yl)-[2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 76.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334414 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334414&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102470 384986574 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656490 Cc1nc(C(=O)N2CCCC2c2nc3cc(ccc3[nH]2)C(F)(F)F)c(s1)-c1ccccc1 334414 US11040966, Example 1.121::US9732075, Example 1.121::rac-(2-Methyl-5-phenyl-thiazol-4-yl)-[2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 287 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334414 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334414&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102470 384986574 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656491 Cc1nc(C(=O)N2CCCC2c2nc3cc(C)c(C)cc3[nH]2)c(s1)-c1ccccc1 334415 US11040966, Example 1.122::US9732075, Example 1.122::rac-[2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 55.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334415 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334415&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102316 384986575 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656492 Cc1nc(C(=O)N2CCCC2c2nc3cc(C)c(C)cc3[nH]2)c(s1)-c1ccccc1 334415 US11040966, Example 1.122::US9732075, Example 1.122::rac-[2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 45.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334415 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334415&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102316 384986575 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656493 Cc1nc(C(=O)N2CCCC2c2nc3c(C)cccc3[nH]2)c(s1)-c1ccccc1 334416 US11040966, Example 1.123::US9732075, Example 1.123::rac-[2-(4-Methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 147 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334416 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334416&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127045 384986576 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656494 Cc1nc(C(=O)N2CCCC2c2nc3c(C)cccc3[nH]2)c(s1)-c1ccccc1 334416 US11040966, Example 1.123::US9732075, Example 1.123::rac-[2-(4-Methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 70.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334416 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334416&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127045 384986576 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656495 Cc1nc(C(=O)N2CCCC2c2nc3cc(ccc3[nH]2)C(C)(C)C)c(s1)-c1ccccc1 334417 US11040966, Example 1.124::US9732075, Example 1.124::rac-[2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 119 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334417 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334417&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102243 384986577 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656496 Cc1nc(C(=O)N2CCCC2c2nc3cc(ccc3[nH]2)C(C)(C)C)c(s1)-c1ccccc1 334417 US11040966, Example 1.124::US9732075, Example 1.124::rac-[2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 42.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334417 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334417&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102243 384986577 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656497 Cc1nc(C(=O)N2CCCC2c2nc3c(Cl)cc(cc3[nH]2)C(F)(F)F)c(s1)-c1ccccc1 334418 US11040966, Example 1.125::US9732075, Example 1.125::rac-[2-(4-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 39.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334418 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334418&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127593 384986578 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656498 Cc1nc(C(=O)N2CCCC2c2nc3c(Cl)cc(cc3[nH]2)C(F)(F)F)c(s1)-c1ccccc1 334418 US11040966, Example 1.125::US9732075, Example 1.125::rac-[2-(4-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 73.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334418 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334418&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127593 384986578 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656499 Cc1nc(C(=O)N2CCCC2c2nc3cc(Cl)c(C)cc3[nH]2)c(s1)-c1ccccc1 334419 US11040966, Example 1.126::US9732075, Example 1.126::rac-[2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 18.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334419 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334419&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128139 384986579 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656500 Cc1nc(C(=O)N2CCCC2c2nc3cc(Cl)c(C)cc3[nH]2)c(s1)-c1ccccc1 334419 US11040966, Example 1.126::US9732075, Example 1.126::rac-[2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 24.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334419 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334419&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128139 384986579 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656501 Cc1nc(C(=O)N2CCCC2c2nc3c(C)cc(C)cc3[nH]2)c(s1)-c1ccccc1 334421 US11040966, Example 1.127::US9732075, Example 1.127::rac-[2-(4,6-Dimethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 33.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334421 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334421&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694282 384986581 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656502 Cc1nc(C(=O)N2CCCC2c2nc3c(C)cc(C)cc3[nH]2)c(s1)-c1ccccc1 334421 US11040966, Example 1.127::US9732075, Example 1.127::rac-[2-(4,6-Dimethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 22.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334421 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334421&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694282 384986581 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656503 Cc1nc(C(=O)N2CCCC2c2nc3c(CO)cccc3[nH]2)c(s1)-c1ccccc1 334422 US11040966, Example 1.128::US9732075, Example 1.128::rac-[2-(4-Hydroxymethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 1480 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334422 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334422&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102390 384986582 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656504 Cc1nc(C(=O)N2CCCC2c2nc3c(CO)cccc3[nH]2)c(s1)-c1ccccc1 334422 US11040966, Example 1.128::US9732075, Example 1.128::rac-[2-(4-Hydroxymethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 331 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334422 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334422&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102390 384986582 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656505 Cc1nc(C(=O)N2CCCC2c2nc3c(cccc3[nH]2)C(F)(F)F)c(s1)-c1ccccc1 334424 US11040966, Example 1.129::US9732075, Example 1.129::rac-(2-Methyl-5-phenyl-thiazol-4-yl)-[2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 93.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334424 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334424&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102272 384986584 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656506 Cc1nc(C(=O)N2CCCC2c2nc3c(cccc3[nH]2)C(F)(F)F)c(s1)-c1ccccc1 334424 US11040966, Example 1.129::US9732075, Example 1.129::rac-(2-Methyl-5-phenyl-thiazol-4-yl)-[2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 124 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334424 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334424&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102272 384986584 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656507 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C23H21ClN4OS2/c1-13-25-20(21(31-13)14-6-3-7-15(24)12-14)23(29)28-11-5-9-17(28)22-26-16-8-4-10-18(30-2)19(16)27-22/h3-4,6-8,10,12,17H,5,9,11H2,1-2H3,(H,26,27)/t17-/m0/s1 JEKKUDBUJRJBFO-KRWDZBQOSA-N 334425 US11040966, Example 1.13::US9732075, Example 1.13::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 15.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334425 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334425&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694482 384986585 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656508 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C23H21ClN4OS2/c1-13-25-20(21(31-13)14-6-3-7-15(24)12-14)23(29)28-11-5-9-17(28)22-26-16-8-4-10-18(30-2)19(16)27-22/h3-4,6-8,10,12,17H,5,9,11H2,1-2H3,(H,26,27)/t17-/m0/s1 JEKKUDBUJRJBFO-KRWDZBQOSA-N 334425 US11040966, Example 1.13::US9732075, Example 1.13::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 24.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334425 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334425&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694482 384986585 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656509 Cc1nc(C(=O)N2CCCC2c2nc3c(Br)cccc3[nH]2)c(s1)-c1ccccc1 334426 US11040966, Example 1.130::US9732075, Example 1.130::rac-[2-(4-Bromo-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 113 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334426 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334426&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128296 384986586 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656510 Cc1nc(C(=O)N2CCCC2c2nc3c(Br)cccc3[nH]2)c(s1)-c1ccccc1 334426 US11040966, Example 1.130::US9732075, Example 1.130::rac-[2-(4-Bromo-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 75.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334426 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334426&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128296 384986586 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656511 Cc1nc(C(=O)N2CCCC2c2nc3cc(Br)cc(C)c3[nH]2)c(s1)-c1ccccc1 334427 US11040966, Example 1.131::US9732075, Example 1.131::rac-[2-(5-Bromo-7-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 37.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334427 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334427&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128217 384986587 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656512 Cc1nc(C(=O)N2CCCC2c2nc3cc(Br)cc(C)c3[nH]2)c(s1)-c1ccccc1 334427 US11040966, Example 1.131::US9732075, Example 1.131::rac-[2-(5-Bromo-7-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 48.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334427 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334427&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128217 384986587 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656513 Cc1nc(C(=O)N2CCCC2c2nc3cc(OC(F)(F)F)ccc3[nH]2)c(s1)-c1ccccc1 334428 US11040966, Example 1.132::US9732075, Example 1.132::rac-(2-Methyl-5-phenyl-thiazol-4-yl)-[2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 90.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334428 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334428&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102279 384986588 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656514 Cc1nc(C(=O)N2CCCC2c2nc3cc(OC(F)(F)F)ccc3[nH]2)c(s1)-c1ccccc1 334428 US11040966, Example 1.132::US9732075, Example 1.132::rac-(2-Methyl-5-phenyl-thiazol-4-yl)-[2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 614 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334428 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334428&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102279 384986588 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656515 Cc1nc(C(=O)N2CCCC2c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccccc1 334429 US11040966, Example 1.133::US9732075, Example 1.133::rac-[2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334429 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334429&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127683 384986589 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656516 Cc1nc(C(=O)N2CCCC2c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccccc1 334429 US11040966, Example 1.133::US9732075, Example 1.133::rac-[2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 11.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334429 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334429&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127683 384986589 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656517 COc1cc2nc([nH]c2cc1OC)C1CCCN1C(=O)c1nc(C)sc1-c1ccccc1 334430 US11040966, Example 1.134::US9732075, Example 1.134::rac-[2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 116 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334430 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334430&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127020 384986590 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656518 COc1cc2nc([nH]c2cc1OC)C1CCCN1C(=O)c1nc(C)sc1-c1ccccc1 334430 US11040966, Example 1.134::US9732075, Example 1.134::rac-[2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 26.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334430 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334430&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127020 384986590 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656519 Cc1nc(C(=O)N2CCCC2c2nc3cc(c(F)cc3[nH]2)C(F)(F)F)c(s1)-c1ccccc1 334431 US11040966, Example 1.135::US9732075, Example 1.135::rac-[2-(6-Fluoro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 32.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334431 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334431&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127055 384986591 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656520 Cc1nc(C(=O)N2CCCC2c2nc3cc(c(F)cc3[nH]2)C(F)(F)F)c(s1)-c1ccccc1 334431 US11040966, Example 1.135::US9732075, Example 1.135::rac-[2-(6-Fluoro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 194 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334431 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334431&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127055 384986591 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656521 Cc1nc(C(=O)N2CCCC2c2nc3cc(F)c(Br)cc3[nH]2)c(s1)-c1ccccc1 334432 US11040966, Example 1.136::US9732075, Example 1.136::rac-[2-(6-Bromo-5-fluoro-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 81.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334432 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334432&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102508 384986592 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656522 Cc1nc(C(=O)N2CCCC2c2nc3cc(F)c(Br)cc3[nH]2)c(s1)-c1ccccc1 334432 US11040966, Example 1.136::US9732075, Example 1.136::rac-[2-(6-Bromo-5-fluoro-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 278 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334432 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334432&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102508 384986592 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656523 Cc1nc(C(=O)N2CCCC2c2nc3cc(c(Cl)cc3[nH]2)C(F)(F)F)c(s1)-c1ccccc1 334433 US11040966, Example 1.137::US9732075, Example 1.137::rac-[2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334433 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334433&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127120 384986593 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656524 Cc1nc(C(=O)N2CCCC2c2nc3cc(c(Cl)cc3[nH]2)C(F)(F)F)c(s1)-c1ccccc1 334433 US11040966, Example 1.137::US9732075, Example 1.137::rac-[2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 33.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334433 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334433&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127120 384986593 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656525 Cc1nc(C(=O)N2CCCC2c2nc3c(Br)cc(F)cc3[nH]2)c(s1)-c1ccccc1 334434 US11040966, Example 1.138::US9732075, Example 1.138::rac-[2-(4-Bromo-6-fluoro-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 35.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334434 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334434&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102375 384986594 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656526 Cc1nc(C(=O)N2CCCC2c2nc3c(Br)cc(F)cc3[nH]2)c(s1)-c1ccccc1 334434 US11040966, Example 1.138::US9732075, Example 1.138::rac-[2-(4-Bromo-6-fluoro-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 109 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334434 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334434&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102375 384986594 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656527 Cc1nc(C(=O)N2CCCC2c2nc3c(C)c(C)ccc3[nH]2)c(s1)-c1ccccc1 334435 US11040966, Example 1.139::US9732075, Example 1.139::rac-[2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 103 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334435 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334435&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118126987 384986595 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656528 Cc1nc(C(=O)N2CCCC2c2nc3c(C)c(C)ccc3[nH]2)c(s1)-c1ccccc1 334435 US11040966, Example 1.139::US9732075, Example 1.139::rac-[2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 26.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334435 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334435&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118126987 384986595 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656529 Cc1nc(C(=O)N2CCC[C@H]2c2nc3cccc(Cl)c3[nH]2)c(s1)-c1cccc(Cl)c1 InChI=1S/C22H18Cl2N4OS/c1-12-25-19(20(30-12)13-5-2-6-14(23)11-13)22(29)28-10-4-9-17(28)21-26-16-8-3-7-15(24)18(16)27-21/h2-3,5-8,11,17H,4,9-10H2,1H3,(H,26,27)/t17-/m0/s1 YVJOHZJBIIZGQO-KRWDZBQOSA-N 334436 US11040966, Example 1.14::US9732075, Example 1.14::[(S)-2-(7-Chloro-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 34.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334436 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334436&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102325 384986596 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656530 Cc1nc(C(=O)N2CCC[C@H]2c2nc3cccc(Cl)c3[nH]2)c(s1)-c1cccc(Cl)c1 InChI=1S/C22H18Cl2N4OS/c1-12-25-19(20(30-12)13-5-2-6-14(23)11-13)22(29)28-10-4-9-17(28)21-26-16-8-3-7-15(24)18(16)27-21/h2-3,5-8,11,17H,4,9-10H2,1H3,(H,26,27)/t17-/m0/s1 YVJOHZJBIIZGQO-KRWDZBQOSA-N 334436 US11040966, Example 1.14::US9732075, Example 1.14::[(S)-2-(7-Chloro-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 32.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334436 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334436&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102325 384986596 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656531 Cc1nc(C(=O)N2CCCC2c2nc3c4OCCOc4ccc3[nH]2)c(s1)-c1ccccc1 334437 US11040966, Example 1.140::US9732075, Example 1.140::rac-[2-(7,8-Dihydro-3H-6,9-dioxa-1,3-diaza-cyclopenta[a]naphthalen-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 192 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334437 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334437&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127936 384986597 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656532 Cc1nc(C(=O)N2CCCC2c2nc3c4OCCOc4ccc3[nH]2)c(s1)-c1ccccc1 334437 US11040966, Example 1.140::US9732075, Example 1.140::rac-[2-(7,8-Dihydro-3H-6,9-dioxa-1,3-diaza-cyclopenta[a]naphthalen-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 46.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334437 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334437&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127936 384986597 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656533 COc1ccc2[nH]c(nc2c1)C1CCCN1C(=O)c1cc(C)ccc1-n1nccn1 334438 US11040966, Example 1.141::US9732075, Example 1.141::rac-[2-(5-Methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 507 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334438 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334438&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127223 384986598 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656534 COc1ccc2[nH]c(nc2c1)C1CCCN1C(=O)c1cc(C)ccc1-n1nccn1 334438 US11040966, Example 1.141::US9732075, Example 1.141::rac-[2-(5-Methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334438 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334438&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127223 384986598 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656535 Cc1nc(C(=O)N2CCC[C@H]2c2nc3c(C)cc(C)cc3[nH]2)c(s1)-c1ccccc1 InChI=1S/C24H24N4OS/c1-14-12-15(2)20-18(13-14)26-23(27-20)19-10-7-11-28(19)24(29)21-22(30-16(3)25-21)17-8-5-4-6-9-17/h4-6,8-9,12-13,19H,7,10-11H2,1-3H3,(H,26,27)/t19-/m0/s1 PJCUVMSXYIPLOH-IBGZPJMESA-N 334439 US11040966, Example 1.142::US9732075, Example 1.142::[(S)-2-(4,6-Dimethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 24.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334439 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334439&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128321 384986599 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656536 Cc1nc(C(=O)N2CCC[C@H]2c2nc3c(C)cc(C)cc3[nH]2)c(s1)-c1ccccc1 InChI=1S/C24H24N4OS/c1-14-12-15(2)20-18(13-14)26-23(27-20)19-10-7-11-28(19)24(29)21-22(30-16(3)25-21)17-8-5-4-6-9-17/h4-6,8-9,12-13,19H,7,10-11H2,1-3H3,(H,26,27)/t19-/m0/s1 PJCUVMSXYIPLOH-IBGZPJMESA-N 334439 US11040966, Example 1.142::US9732075, Example 1.142::[(S)-2-(4,6-Dimethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334439 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334439&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128321 384986599 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656537 Cc1nc(C(=O)N2CCC[C@H]2c2nc3cc(Cl)c(C)cc3[nH]2)c(s1)-c1ccccc1 InChI=1S/C23H21ClN4OS/c1-13-11-17-18(12-16(13)24)27-22(26-17)19-9-6-10-28(19)23(29)20-21(30-14(2)25-20)15-7-4-3-5-8-15/h3-5,7-8,11-12,19H,6,9-10H2,1-2H3,(H,26,27)/t19-/m0/s1 GUENCDINPQGRNS-IBGZPJMESA-N 334440 US11040966, Example 1.143::US9732075, Example 1.143::[(S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 14.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334440 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334440&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128135 384986600 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656538 Cc1nc(C(=O)N2CCC[C@H]2c2nc3cc(Cl)c(C)cc3[nH]2)c(s1)-c1ccccc1 InChI=1S/C23H21ClN4OS/c1-13-11-17-18(12-16(13)24)27-22(26-17)19-9-6-10-28(19)23(29)20-21(30-14(2)25-20)15-7-4-3-5-8-15/h3-5,7-8,11-12,19H,6,9-10H2,1-2H3,(H,26,27)/t19-/m0/s1 GUENCDINPQGRNS-IBGZPJMESA-N 334440 US11040966, Example 1.143::US9732075, Example 1.143::[(S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 16.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334440 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334440&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128135 384986600 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656539 Cc1nc(C(=O)N2CCC[C@H]2c2nc3c(C)cc(Br)cc3[nH]2)c(s1)-c1ccccc1 InChI=1S/C23H21BrN4OS/c1-13-11-16(24)12-17-19(13)27-22(26-17)18-9-6-10-28(18)23(29)20-21(30-14(2)25-20)15-7-4-3-5-8-15/h3-5,7-8,11-12,18H,6,9-10H2,1-2H3,(H,26,27)/t18-/m0/s1 WLDSIKXAQBODNH-SFHVURJKSA-N 334441 US11040966, Example 1.144::US9732075, Example 1.144::[(S)-2-(6-Bromo-4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 33.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334441 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334441&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128215 384986601 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656540 Cc1nc(C(=O)N2CCC[C@H]2c2nc3c(C)cc(Br)cc3[nH]2)c(s1)-c1ccccc1 InChI=1S/C23H21BrN4OS/c1-13-11-16(24)12-17-19(13)27-22(26-17)18-9-6-10-28(18)23(29)20-21(30-14(2)25-20)15-7-4-3-5-8-15/h3-5,7-8,11-12,18H,6,9-10H2,1-2H3,(H,26,27)/t18-/m0/s1 WLDSIKXAQBODNH-SFHVURJKSA-N 334441 US11040966, Example 1.144::US9732075, Example 1.144::[(S)-2-(6-Bromo-4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 27.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334441 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334441&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128215 384986601 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656541 Cc1nc(C(=O)N2CCC[C@H]2c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccccc1 InChI=1S/C23H21ClN4OS/c1-13-16(24)10-11-17-19(13)27-22(26-17)18-9-6-12-28(18)23(29)20-21(30-14(2)25-20)15-7-4-3-5-8-15/h3-5,7-8,10-11,18H,6,9,12H2,1-2H3,(H,26,27)/t18-/m0/s1 RKLPQCPZHKBFPB-SFHVURJKSA-N 334442 US11040966, Example 1.145::US9732075, Example 1.145::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334442 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334442&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127680 384986602 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656542 Cc1nc(C(=O)N2CCC[C@H]2c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccccc1 InChI=1S/C23H21ClN4OS/c1-13-16(24)10-11-17-19(13)27-22(26-17)18-9-6-12-28(18)23(29)20-21(30-14(2)25-20)15-7-4-3-5-8-15/h3-5,7-8,10-11,18H,6,9,12H2,1-2H3,(H,26,27)/t18-/m0/s1 RKLPQCPZHKBFPB-SFHVURJKSA-N 334442 US11040966, Example 1.145::US9732075, Example 1.145::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334442 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334442&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127680 384986602 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656543 Cc1nc(C(=O)N2CCC[C@H]2c2nc3cc(Cl)c(cc3[nH]2)C(F)(F)F)c(s1)-c1ccccc1 InChI=1S/C23H18ClF3N4OS/c1-12-28-19(20(33-12)13-6-3-2-4-7-13)22(32)31-9-5-8-18(31)21-29-16-10-14(23(25,26)27)15(24)11-17(16)30-21/h2-4,6-7,10-11,18H,5,8-9H2,1H3,(H,29,30)/t18-/m0/s1 VXKUPARUVUBAQK-SFHVURJKSA-N 334443 US11040966, Example 1.146::US9732075, Example 1.146::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334443 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334443&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127324 384986603 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656544 Cc1nc(C(=O)N2CCC[C@H]2c2nc3cc(Cl)c(cc3[nH]2)C(F)(F)F)c(s1)-c1ccccc1 InChI=1S/C23H18ClF3N4OS/c1-12-28-19(20(33-12)13-6-3-2-4-7-13)22(32)31-9-5-8-18(31)21-29-16-10-14(23(25,26)27)15(24)11-17(16)30-21/h2-4,6-7,10-11,18H,5,8-9H2,1H3,(H,29,30)/t18-/m0/s1 VXKUPARUVUBAQK-SFHVURJKSA-N 334443 US11040966, Example 1.146::US9732075, Example 1.146::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 23.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334443 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334443&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127324 384986603 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656545 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cc(F)ccc1-n1nccn1 InChI=1S/C21H19FN6OS/c1-30-14-5-6-16-17(12-14)26-20(25-16)19-3-2-10-27(19)21(29)15-11-13(22)4-7-18(15)28-23-8-9-24-28/h4-9,11-12,19H,2-3,10H2,1H3,(H,25,26)/t19-/m0/s1 DNSFJNRAJZVNBD-IBGZPJMESA-N 334444 (5-Fluoro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.147::US9732075, Example 1.147 Orexin/Hypocretin receptor type 1 Homo sapiens 685 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334444 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334444&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127917 384986604 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656546 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cc(F)ccc1-n1nccn1 InChI=1S/C21H19FN6OS/c1-30-14-5-6-16-17(12-14)26-20(25-16)19-3-2-10-27(19)21(29)15-11-13(22)4-7-18(15)28-23-8-9-24-28/h4-9,11-12,19H,2-3,10H2,1H3,(H,25,26)/t19-/m0/s1 DNSFJNRAJZVNBD-IBGZPJMESA-N 334444 (5-Fluoro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.147::US9732075, Example 1.147 Orexin receptor type 2 Homo sapiens 24.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334444 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334444&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127917 384986604 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656547 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1c(F)cccc1-n1nccn1 InChI=1S/C21H19FN6OS/c1-30-13-7-8-15-16(12-13)26-20(25-15)18-6-3-11-27(18)21(29)19-14(22)4-2-5-17(19)28-23-9-10-24-28/h2,4-5,7-10,12,18H,3,6,11H2,1H3,(H,25,26)/t18-/m0/s1 KXIFHLBOLVUPFH-SFHVURJKSA-N 334445 (2-Fluoro-6-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.148::US9732075, Example 1.148 Orexin/Hypocretin receptor type 1 Homo sapiens 1170 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334445 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334445&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102432 384986605 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656548 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1c(F)cccc1-n1nccn1 InChI=1S/C21H19FN6OS/c1-30-13-7-8-15-16(12-13)26-20(25-15)18-6-3-11-27(18)21(29)19-14(22)4-2-5-17(19)28-23-9-10-24-28/h2,4-5,7-10,12,18H,3,6,11H2,1H3,(H,25,26)/t18-/m0/s1 KXIFHLBOLVUPFH-SFHVURJKSA-N 334445 (2-Fluoro-6-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.148::US9732075, Example 1.148 Orexin receptor type 2 Homo sapiens 44.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334445 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334445&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102432 384986605 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656549 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C21H19ClN6OS/c1-30-14-5-6-16-17(12-14)26-20(25-16)19-3-2-10-27(19)21(29)15-11-13(22)4-7-18(15)28-23-8-9-24-28/h4-9,11-12,19H,2-3,10H2,1H3,(H,25,26)/t19-/m0/s1 CMXCVYYBAAJBDT-IBGZPJMESA-N 334446 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.149::US9732075, Example 1.149 Orexin/Hypocretin receptor type 1 Homo sapiens 143 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334446 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334446&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127512 384986606 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656550 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C21H19ClN6OS/c1-30-14-5-6-16-17(12-14)26-20(25-16)19-3-2-10-27(19)21(29)15-11-13(22)4-7-18(15)28-23-8-9-24-28/h4-9,11-12,19H,2-3,10H2,1H3,(H,25,26)/t19-/m0/s1 CMXCVYYBAAJBDT-IBGZPJMESA-N 334446 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.149::US9732075, Example 1.149 Orexin receptor type 2 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334446 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334446&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127512 384986606 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656551 CSc1ccc2[nH]c(nc2c1)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C23H21ClN4OS2/c1-13-25-20(21(31-13)14-5-3-6-15(24)11-14)23(29)28-10-4-7-19(28)22-26-17-9-8-16(30-2)12-18(17)27-22/h3,5-6,8-9,11-12,19H,4,7,10H2,1-2H3,(H,26,27)/t19-/m0/s1 IDVVUIGVQPYRPK-IBGZPJMESA-N 334447 US11040966, Example 1.15::US9732075, Example 1.15::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(5-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 67.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334447 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334447&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127799 384986607 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656552 CSc1ccc2[nH]c(nc2c1)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C23H21ClN4OS2/c1-13-25-20(21(31-13)14-5-3-6-15(24)11-14)23(29)28-10-4-7-19(28)22-26-17-9-8-16(30-2)12-18(17)27-22/h3,5-6,8-9,11-12,19H,4,7,10H2,1-2H3,(H,26,27)/t19-/m0/s1 IDVVUIGVQPYRPK-IBGZPJMESA-N 334447 US11040966, Example 1.15::US9732075, Example 1.15::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(5-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 45.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334447 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334447&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127799 384986607 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656553 COc1ccc(c(c1)C(=O)N1CCC[C@H]1c1nc2ccc(SC)cc2[nH]1)-n1nccn1 InChI=1S/C22H22N6O2S/c1-30-14-5-8-19(28-23-9-10-24-28)16(12-14)22(29)27-11-3-4-20(27)21-25-17-7-6-15(31-2)13-18(17)26-21/h5-10,12-13,20H,3-4,11H2,1-2H3,(H,25,26)/t20-/m0/s1 WKRVZQZEZOQODG-FQEVSTJZSA-N 334448 (5-Methoxy-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.150::US9732075, Example 1.150 Orexin/Hypocretin receptor type 1 Homo sapiens 301 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334448 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334448&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127555 384986608 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656554 COc1ccc(c(c1)C(=O)N1CCC[C@H]1c1nc2ccc(SC)cc2[nH]1)-n1nccn1 InChI=1S/C22H22N6O2S/c1-30-14-5-8-19(28-23-9-10-24-28)16(12-14)22(29)27-11-3-4-20(27)21-25-17-7-6-15(31-2)13-18(17)26-21/h5-10,12-13,20H,3-4,11H2,1-2H3,(H,25,26)/t20-/m0/s1 WKRVZQZEZOQODG-FQEVSTJZSA-N 334448 (5-Methoxy-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.150::US9732075, Example 1.150 Orexin receptor type 2 Homo sapiens 11.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334448 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334448&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127555 384986608 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656555 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cc(ccc1-n1nccn1)C(F)(F)F InChI=1S/C22H19F3N6OS/c1-33-14-5-6-16-17(12-14)29-20(28-16)19-3-2-10-30(19)21(32)15-11-13(22(23,24)25)4-7-18(15)31-26-8-9-27-31/h4-9,11-12,19H,2-3,10H2,1H3,(H,28,29)/t19-/m0/s1 APGFFSBHRCPRCL-IBGZPJMESA-N 334449 US11040966, Example 1.151::US9732075, Example 1.151::[(S)-2-(6-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoromethyl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 763 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334449 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334449&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127038 384986609 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656556 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cc(ccc1-n1nccn1)C(F)(F)F InChI=1S/C22H19F3N6OS/c1-33-14-5-6-16-17(12-14)29-20(28-16)19-3-2-10-30(19)21(32)15-11-13(22(23,24)25)4-7-18(15)31-26-8-9-27-31/h4-9,11-12,19H,2-3,10H2,1H3,(H,28,29)/t19-/m0/s1 APGFFSBHRCPRCL-IBGZPJMESA-N 334449 US11040966, Example 1.151::US9732075, Example 1.151::[(S)-2-(6-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoromethyl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 110 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334449 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334449&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127038 384986609 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656557 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cc(ccc1-n1nccn1)C#N InChI=1S/C22H19N7OS/c1-31-15-5-6-17-18(12-15)27-21(26-17)20-3-2-10-28(20)22(30)16-11-14(13-23)4-7-19(16)29-24-8-9-25-29/h4-9,11-12,20H,2-3,10H2,1H3,(H,26,27)/t20-/m0/s1 BSTYLUWFYYEONL-FQEVSTJZSA-N 334451 3-[(S)-2-(6-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidine-1-carbonyl]-4-[1,2,3]triazol-2-yl-benzonitrile::US11040966, Example 1.152::US9732075, Example 1.152 Orexin/Hypocretin receptor type 1 Homo sapiens 282 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334451 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334451&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128082 384986611 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656558 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cc(ccc1-n1nccn1)C#N InChI=1S/C22H19N7OS/c1-31-15-5-6-17-18(12-15)27-21(26-17)20-3-2-10-28(20)22(30)16-11-14(13-23)4-7-19(16)29-24-8-9-25-29/h4-9,11-12,20H,2-3,10H2,1H3,(H,26,27)/t20-/m0/s1 BSTYLUWFYYEONL-FQEVSTJZSA-N 334451 3-[(S)-2-(6-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidine-1-carbonyl]-4-[1,2,3]triazol-2-yl-benzonitrile::US11040966, Example 1.152::US9732075, Example 1.152 Orexin receptor type 2 Homo sapiens 23.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334451 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334451&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128082 384986611 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656559 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1ccc(C)cc1-n1nccn1 InChI=1S/C22H22N6OS/c1-14-5-7-16(20(12-14)28-23-9-10-24-28)22(29)27-11-3-4-19(27)21-25-17-8-6-15(30-2)13-18(17)26-21/h5-10,12-13,19H,3-4,11H2,1-2H3,(H,25,26)/t19-/m0/s1 SWLCSGMANMQWLF-IBGZPJMESA-N 334452 US11040966, Example 1.153::US9732075, Example 1.153::[(S)-2-(6-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 40.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334452 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334452&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127106 384986612 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656560 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1ccc(C)cc1-n1nccn1 InChI=1S/C22H22N6OS/c1-14-5-7-16(20(12-14)28-23-9-10-24-28)22(29)27-11-3-4-19(27)21-25-17-8-6-15(30-2)13-18(17)26-21/h5-10,12-13,19H,3-4,11H2,1-2H3,(H,25,26)/t19-/m0/s1 SWLCSGMANMQWLF-IBGZPJMESA-N 334452 US11040966, Example 1.153::US9732075, Example 1.153::[(S)-2-(6-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334452 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334452&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127106 384986612 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656561 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1c(C)cccc1-n1nccn1 InChI=1S/C22H22N6OS/c1-14-5-3-6-18(28-23-10-11-24-28)20(14)22(29)27-12-4-7-19(27)21-25-16-9-8-15(30-2)13-17(16)26-21/h3,5-6,8-11,13,19H,4,7,12H2,1-2H3,(H,25,26)/t19-/m0/s1 RRJQSPOXPXGJRM-IBGZPJMESA-N 334453 US11040966, Example 1.154::US9732075, Example 1.154::[(S)-2-(6-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 483 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334453 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334453&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127336 384986613 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656562 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1c(C)cccc1-n1nccn1 InChI=1S/C22H22N6OS/c1-14-5-3-6-18(28-23-10-11-24-28)20(14)22(29)27-12-4-7-19(27)21-25-16-9-8-15(30-2)13-17(16)26-21/h3,5-6,8-11,13,19H,4,7,12H2,1-2H3,(H,25,26)/t19-/m0/s1 RRJQSPOXPXGJRM-IBGZPJMESA-N 334453 US11040966, Example 1.154::US9732075, Example 1.154::[(S)-2-(6-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 21.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334453 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334453&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127336 384986613 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656563 COc1cc(C(=O)N2CCC[C@H]2c2nc3ccc(SC)cc3[nH]2)c(cc1OC)-n1nccn1 InChI=1S/C23H24N6O3S/c1-31-20-12-15(19(13-21(20)32-2)29-24-8-9-25-29)23(30)28-10-4-5-18(28)22-26-16-7-6-14(33-3)11-17(16)27-22/h6-9,11-13,18H,4-5,10H2,1-3H3,(H,26,27)/t18-/m0/s1 WEPRLIOQRWPBID-SFHVURJKSA-N 334454 (4,5-Dimethoxy-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.155::US9732075, Example 1.155 Orexin/Hypocretin receptor type 1 Homo sapiens 36.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334454 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334454&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127652 384986614 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656564 COc1cc(C(=O)N2CCC[C@H]2c2nc3ccc(SC)cc3[nH]2)c(cc1OC)-n1nccn1 InChI=1S/C23H24N6O3S/c1-31-20-12-15(19(13-21(20)32-2)29-24-8-9-25-29)23(30)28-10-4-5-18(28)22-26-16-7-6-14(33-3)11-17(16)27-22/h6-9,11-13,18H,4-5,10H2,1-3H3,(H,26,27)/t18-/m0/s1 WEPRLIOQRWPBID-SFHVURJKSA-N 334454 (4,5-Dimethoxy-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.155::US9732075, Example 1.155 Orexin receptor type 2 Homo sapiens 16.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334454 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334454&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127652 384986614 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656565 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cc(F)ccc1-n1nccn1 InChI=1S/C21H19FN6O2/c1-30-14-5-6-16-17(12-14)26-20(25-16)19-3-2-10-27(19)21(29)15-11-13(22)4-7-18(15)28-23-8-9-24-28/h4-9,11-12,19H,2-3,10H2,1H3,(H,25,26)/t19-/m0/s1 SQAVLXQVQKUDRK-IBGZPJMESA-N 334455 (5-Fluoro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.156::US9732075, Example 1.156 Orexin/Hypocretin receptor type 1 Homo sapiens 1810 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334455 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334455&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127141 384986615 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656566 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cc(F)ccc1-n1nccn1 InChI=1S/C21H19FN6O2/c1-30-14-5-6-16-17(12-14)26-20(25-16)19-3-2-10-27(19)21(29)15-11-13(22)4-7-18(15)28-23-8-9-24-28/h4-9,11-12,19H,2-3,10H2,1H3,(H,25,26)/t19-/m0/s1 SQAVLXQVQKUDRK-IBGZPJMESA-N 334455 (5-Fluoro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.156::US9732075, Example 1.156 Orexin receptor type 2 Homo sapiens 29.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334455 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334455&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127141 384986615 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656567 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C21H19ClN6O2/c1-30-14-5-6-16-17(12-14)26-20(25-16)19-3-2-10-27(19)21(29)15-11-13(22)4-7-18(15)28-23-8-9-24-28/h4-9,11-12,19H,2-3,10H2,1H3,(H,25,26)/t19-/m0/s1 NWSIYQIYKFBOKG-IBGZPJMESA-N 334456 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.157::US9732075, Example 1.157 Orexin/Hypocretin receptor type 1 Homo sapiens 419 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334456 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334456&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127909 384986616 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656568 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C21H19ClN6O2/c1-30-14-5-6-16-17(12-14)26-20(25-16)19-3-2-10-27(19)21(29)15-11-13(22)4-7-18(15)28-23-8-9-24-28/h4-9,11-12,19H,2-3,10H2,1H3,(H,25,26)/t19-/m0/s1 NWSIYQIYKFBOKG-IBGZPJMESA-N 334456 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.157::US9732075, Example 1.157 Orexin receptor type 2 Homo sapiens 10.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334456 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334456&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127909 384986616 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656569 COc1ccc(c(c1)C(=O)N1CCC[C@H]1c1nc2ccc(OC)cc2[nH]1)-n1nccn1 InChI=1S/C22H22N6O3/c1-30-14-6-8-19(28-23-9-10-24-28)16(12-14)22(29)27-11-3-4-20(27)21-25-17-7-5-15(31-2)13-18(17)26-21/h5-10,12-13,20H,3-4,11H2,1-2H3,(H,25,26)/t20-/m0/s1 YUCDKMBLAKJJRH-FQEVSTJZSA-N 334457 US11040966, Example 1.158::US9732075, Example 1.158::[(S)-2-(6-Methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 538 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334457 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334457&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127697 384986617 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656570 COc1ccc(c(c1)C(=O)N1CCC[C@H]1c1nc2ccc(OC)cc2[nH]1)-n1nccn1 InChI=1S/C22H22N6O3/c1-30-14-6-8-19(28-23-9-10-24-28)16(12-14)22(29)27-11-3-4-20(27)21-25-17-7-5-15(31-2)13-18(17)26-21/h5-10,12-13,20H,3-4,11H2,1-2H3,(H,25,26)/t20-/m0/s1 YUCDKMBLAKJJRH-FQEVSTJZSA-N 334457 US11040966, Example 1.158::US9732075, Example 1.158::[(S)-2-(6-Methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 20.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334457 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334457&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127697 384986617 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656571 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cc(ccc1-n1nccn1)C#N InChI=1S/C22H19N7O2/c1-31-15-5-6-17-18(12-15)27-21(26-17)20-3-2-10-28(20)22(30)16-11-14(13-23)4-7-19(16)29-24-8-9-25-29/h4-9,11-12,20H,2-3,10H2,1H3,(H,26,27)/t20-/m0/s1 PJOAEEJOPNAJAV-FQEVSTJZSA-N 334459 3-[(S)-2-(6-Methoxy-1H-benzoimidazol-2-yl)-pyrrolidine-1-carbonyl]-4-[1,2,3]triazol-2-yl-benzonitrile::US11040966, Example 1.159::US9732075, Example 1.159 Orexin/Hypocretin receptor type 1 Homo sapiens 903 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334459 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334459&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127911 384986619 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656572 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cc(ccc1-n1nccn1)C#N InChI=1S/C22H19N7O2/c1-31-15-5-6-17-18(12-15)27-21(26-17)20-3-2-10-28(20)22(30)16-11-14(13-23)4-7-19(16)29-24-8-9-25-29/h4-9,11-12,20H,2-3,10H2,1H3,(H,26,27)/t20-/m0/s1 PJOAEEJOPNAJAV-FQEVSTJZSA-N 334459 3-[(S)-2-(6-Methoxy-1H-benzoimidazol-2-yl)-pyrrolidine-1-carbonyl]-4-[1,2,3]triazol-2-yl-benzonitrile::US11040966, Example 1.159::US9732075, Example 1.159 Orexin receptor type 2 Homo sapiens 23.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334459 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334459&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127911 384986619 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656573 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C22H22N6O2/c1-14-5-8-19(28-23-9-10-24-28)16(12-14)22(29)27-11-3-4-20(27)21-25-17-7-6-15(30-2)13-18(17)26-21/h5-10,12-13,20H,3-4,11H2,1-2H3,(H,25,26)/t20-/m0/s1 UNGLNTQVFSBZDT-FQEVSTJZSA-N 334460 US11040966, Example 1.16::US9732075, Example 1.16::[(S)-2-(6-Methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 245 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334460 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334460&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695491 384986620 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656574 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C22H22N6O2/c1-14-5-8-19(28-23-9-10-24-28)16(12-14)22(29)27-11-3-4-20(27)21-25-17-7-6-15(30-2)13-18(17)26-21/h5-10,12-13,20H,3-4,11H2,1-2H3,(H,25,26)/t20-/m0/s1 UNGLNTQVFSBZDT-FQEVSTJZSA-N 334460 US11040966, Example 1.16::US9732075, Example 1.16::[(S)-2-(6-Methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334460 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334460&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695491 384986620 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656575 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1ccc(C)cc1-n1nccn1 InChI=1S/C22H22N6O2/c1-14-5-7-16(20(12-14)28-23-9-10-24-28)22(29)27-11-3-4-19(27)21-25-17-8-6-15(30-2)13-18(17)26-21/h5-10,12-13,19H,3-4,11H2,1-2H3,(H,25,26)/t19-/m0/s1 FLGVYSUUVCYPOP-IBGZPJMESA-N 334461 US11040966, Example 1.160::US9732075, Example 1.160::[(S)-2-(6-Methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 245 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334461 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334461&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127488 384986621 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656576 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1ccc(C)cc1-n1nccn1 InChI=1S/C22H22N6O2/c1-14-5-7-16(20(12-14)28-23-9-10-24-28)22(29)27-11-3-4-19(27)21-25-17-8-6-15(30-2)13-18(17)26-21/h5-10,12-13,19H,3-4,11H2,1-2H3,(H,25,26)/t19-/m0/s1 FLGVYSUUVCYPOP-IBGZPJMESA-N 334461 US11040966, Example 1.160::US9732075, Example 1.160::[(S)-2-(6-Methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334461 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334461&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127488 384986621 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656577 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1c(C)cccc1-n1nccn1 InChI=1S/C22H22N6O2/c1-14-5-3-6-18(28-23-10-11-24-28)20(14)22(29)27-12-4-7-19(27)21-25-16-9-8-15(30-2)13-17(16)26-21/h3,5-6,8-11,13,19H,4,7,12H2,1-2H3,(H,25,26)/t19-/m0/s1 NJLZSDMGHQMASB-IBGZPJMESA-N 334462 US11040966, Example 1.161::US9732075, Example 1.161::[(S)-2-(6-Methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 1450 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334462 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334462&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127267 384986622 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656578 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1c(C)cccc1-n1nccn1 InChI=1S/C22H22N6O2/c1-14-5-3-6-18(28-23-10-11-24-28)20(14)22(29)27-12-4-7-19(27)21-25-16-9-8-15(30-2)13-17(16)26-21/h3,5-6,8-11,13,19H,4,7,12H2,1-2H3,(H,25,26)/t19-/m0/s1 NJLZSDMGHQMASB-IBGZPJMESA-N 334462 US11040966, Example 1.161::US9732075, Example 1.161::[(S)-2-(6-Methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 22.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334462 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334462&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127267 384986622 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656579 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cc(OC)c(OC)cc1-n1nccn1 InChI=1S/C23H24N6O4/c1-31-14-6-7-16-17(11-14)27-22(26-16)18-5-4-10-28(18)23(30)15-12-20(32-2)21(33-3)13-19(15)29-24-8-9-25-29/h6-9,11-13,18H,4-5,10H2,1-3H3,(H,26,27)/t18-/m0/s1 RDAMAPFWMBIFEO-SFHVURJKSA-N 334463 (4,5-Dimethoxy-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.162::US9732075, Example 1.162 Orexin/Hypocretin receptor type 1 Homo sapiens 458 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334463 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334463&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128282 384986623 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656580 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cc(OC)c(OC)cc1-n1nccn1 InChI=1S/C23H24N6O4/c1-31-14-6-7-16-17(11-14)27-22(26-16)18-5-4-10-28(18)23(30)15-12-20(32-2)21(33-3)13-19(15)29-24-8-9-25-29/h6-9,11-13,18H,4-5,10H2,1-3H3,(H,26,27)/t18-/m0/s1 RDAMAPFWMBIFEO-SFHVURJKSA-N 334463 (4,5-Dimethoxy-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.162::US9732075, Example 1.162 Orexin receptor type 2 Homo sapiens 27.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334463 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334463&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128282 384986623 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656581 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cc(F)ccc1-n1nccn1 InChI=1S/C21H19FN6OS/c1-30-18-6-2-4-15-19(18)26-20(25-15)17-5-3-11-27(17)21(29)14-12-13(22)7-8-16(14)28-23-9-10-24-28/h2,4,6-10,12,17H,3,5,11H2,1H3,(H,25,26)/t17-/m0/s1 NQUUNNOWFUILKQ-KRWDZBQOSA-N 334464 (5-Fluoro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.163::US9732075, Example 1.163 Orexin/Hypocretin receptor type 1 Homo sapiens 167 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334464 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334464&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127886 384986624 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656582 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cc(F)ccc1-n1nccn1 InChI=1S/C21H19FN6OS/c1-30-18-6-2-4-15-19(18)26-20(25-15)17-5-3-11-27(17)21(29)14-12-13(22)7-8-16(14)28-23-9-10-24-28/h2,4,6-10,12,17H,3,5,11H2,1H3,(H,25,26)/t17-/m0/s1 NQUUNNOWFUILKQ-KRWDZBQOSA-N 334464 (5-Fluoro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.163::US9732075, Example 1.163 Orexin receptor type 2 Homo sapiens 17.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334464 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334464&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127886 384986624 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656583 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1c(F)cccc1-n1nccn1 InChI=1S/C21H19FN6OS/c1-30-17-9-3-6-14-19(17)26-20(25-14)16-8-4-12-27(16)21(29)18-13(22)5-2-7-15(18)28-23-10-11-24-28/h2-3,5-7,9-11,16H,4,8,12H2,1H3,(H,25,26)/t16-/m0/s1 RJAFEVRSJGTCNJ-INIZCTEOSA-N 334465 (2-Fluoro-6-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.164::US9732075, Example 1.164 Orexin/Hypocretin receptor type 1 Homo sapiens 217 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334465 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334465&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128039 384986625 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656584 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1c(F)cccc1-n1nccn1 InChI=1S/C21H19FN6OS/c1-30-17-9-3-6-14-19(17)26-20(25-14)16-8-4-12-27(16)21(29)18-13(22)5-2-7-15(18)28-23-10-11-24-28/h2-3,5-7,9-11,16H,4,8,12H2,1H3,(H,25,26)/t16-/m0/s1 RJAFEVRSJGTCNJ-INIZCTEOSA-N 334465 (2-Fluoro-6-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.164::US9732075, Example 1.164 Orexin receptor type 2 Homo sapiens 24.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334465 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334465&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128039 384986625 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656585 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C21H19ClN6OS/c1-30-18-6-2-4-15-19(18)26-20(25-15)17-5-3-11-27(17)21(29)14-12-13(22)7-8-16(14)28-23-9-10-24-28/h2,4,6-10,12,17H,3,5,11H2,1H3,(H,25,26)/t17-/m0/s1 SBLAGNNIUXMGLT-KRWDZBQOSA-N 334467 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.165::US9732075, Example 1.165 Orexin/Hypocretin receptor type 1 Homo sapiens 76.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334467 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334467&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127117 384986627 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656586 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C21H19ClN6OS/c1-30-18-6-2-4-15-19(18)26-20(25-15)17-5-3-11-27(17)21(29)14-12-13(22)7-8-16(14)28-23-9-10-24-28/h2,4,6-10,12,17H,3,5,11H2,1H3,(H,25,26)/t17-/m0/s1 SBLAGNNIUXMGLT-KRWDZBQOSA-N 334467 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.165::US9732075, Example 1.165 Orexin receptor type 2 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334467 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334467&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127117 384986627 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656587 COc1ccc(c(c1)C(=O)N1CCC[C@H]1c1nc2cccc(SC)c2[nH]1)-n1nccn1 InChI=1S/C22H22N6O2S/c1-30-14-8-9-17(28-23-10-11-24-28)15(13-14)22(29)27-12-4-6-18(27)21-25-16-5-3-7-19(31-2)20(16)26-21/h3,5,7-11,13,18H,4,6,12H2,1-2H3,(H,25,26)/t18-/m0/s1 OJMSPEQYPWFIGB-SFHVURJKSA-N 334469 (5-Methoxy-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.166::US9732075, Example 1.166 Orexin/Hypocretin receptor type 1 Homo sapiens 45.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334469 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334469&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127584 384986629 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656588 COc1ccc(c(c1)C(=O)N1CCC[C@H]1c1nc2cccc(SC)c2[nH]1)-n1nccn1 InChI=1S/C22H22N6O2S/c1-30-14-8-9-17(28-23-10-11-24-28)15(13-14)22(29)27-12-4-6-18(27)21-25-16-5-3-7-19(31-2)20(16)26-21/h3,5,7-11,13,18H,4,6,12H2,1-2H3,(H,25,26)/t18-/m0/s1 OJMSPEQYPWFIGB-SFHVURJKSA-N 334469 (5-Methoxy-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.166::US9732075, Example 1.166 Orexin receptor type 2 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334469 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334469&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127584 384986629 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656589 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cc(ccc1-n1nccn1)C#N InChI=1S/C22H19N7OS/c1-31-19-6-2-4-16-20(19)27-21(26-16)18-5-3-11-28(18)22(30)15-12-14(13-23)7-8-17(15)29-24-9-10-25-29/h2,4,6-10,12,18H,3,5,11H2,1H3,(H,26,27)/t18-/m0/s1 ZABUBUMIZCFPBH-SFHVURJKSA-N 334470 3-[(S)-2-(7-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidine-1-carbonyl]-4-[1,2,3]triazol-2-yl-benzonitrile::US11040966, Example 1.167::US9732075, Example 1.167 Orexin/Hypocretin receptor type 1 Homo sapiens 97.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334470 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334470&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127809 384986630 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656590 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cc(ccc1-n1nccn1)C#N InChI=1S/C22H19N7OS/c1-31-19-6-2-4-16-20(19)27-21(26-16)18-5-3-11-28(18)22(30)15-12-14(13-23)7-8-17(15)29-24-9-10-25-29/h2,4,6-10,12,18H,3,5,11H2,1H3,(H,26,27)/t18-/m0/s1 ZABUBUMIZCFPBH-SFHVURJKSA-N 334470 3-[(S)-2-(7-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidine-1-carbonyl]-4-[1,2,3]triazol-2-yl-benzonitrile::US11040966, Example 1.167::US9732075, Example 1.167 Orexin receptor type 2 Homo sapiens 15.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334470 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334470&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127809 384986630 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656591 COc1ccc(c(C(=O)N2CCC[C@H]2c2nc3cccc(SC)c3[nH]2)c1F)-n1nccn1 InChI=1S/C22H21FN6O2S/c1-31-16-9-8-14(29-24-10-11-25-29)18(19(16)23)22(30)28-12-4-6-15(28)21-26-13-5-3-7-17(32-2)20(13)27-21/h3,5,7-11,15H,4,6,12H2,1-2H3,(H,26,27)/t15-/m0/s1 QQFXTVOWWSECQV-HNNXBMFYSA-N 334471 (2-Fluoro-3-methoxy-6-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.168::US9732075, Example 1.168 Orexin/Hypocretin receptor type 1 Homo sapiens 20.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334471 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334471&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127332 384986631 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656592 COc1ccc(c(C(=O)N2CCC[C@H]2c2nc3cccc(SC)c3[nH]2)c1F)-n1nccn1 InChI=1S/C22H21FN6O2S/c1-31-16-9-8-14(29-24-10-11-25-29)18(19(16)23)22(30)28-12-4-6-15(28)21-26-13-5-3-7-17(32-2)20(13)27-21/h3,5,7-11,15H,4,6,12H2,1-2H3,(H,26,27)/t15-/m0/s1 QQFXTVOWWSECQV-HNNXBMFYSA-N 334471 (2-Fluoro-3-methoxy-6-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.168::US9732075, Example 1.168 Orexin receptor type 2 Homo sapiens 57.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334471 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334471&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127332 384986631 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656593 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1ccc(C)cc1-n1nccn1 InChI=1S/C22H22N6OS/c1-14-8-9-15(18(13-14)28-23-10-11-24-28)22(29)27-12-4-6-17(27)21-25-16-5-3-7-19(30-2)20(16)26-21/h3,5,7-11,13,17H,4,6,12H2,1-2H3,(H,25,26)/t17-/m0/s1 YFRANIJCEMWOCV-KRWDZBQOSA-N 334472 US11040966, Example 1.169::US9732075, Example 1.169::[(S)-2-(7-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 37.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334472 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334472&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127402 384986632 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656594 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1ccc(C)cc1-n1nccn1 InChI=1S/C22H22N6OS/c1-14-8-9-15(18(13-14)28-23-10-11-24-28)22(29)27-12-4-6-17(27)21-25-16-5-3-7-19(30-2)20(16)26-21/h3,5,7-11,13,17H,4,6,12H2,1-2H3,(H,25,26)/t17-/m0/s1 YFRANIJCEMWOCV-KRWDZBQOSA-N 334472 US11040966, Example 1.169::US9732075, Example 1.169::[(S)-2-(7-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334472 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334472&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127402 384986632 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656595 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C22H22N6OS/c1-14-5-8-19(28-23-9-10-24-28)16(12-14)22(29)27-11-3-4-20(27)21-25-17-7-6-15(30-2)13-18(17)26-21/h5-10,12-13,20H,3-4,11H2,1-2H3,(H,25,26)/t20-/m0/s1 XXLHLBBZFMWPEJ-FQEVSTJZSA-N 334473 US11040966, Example 1.17::US9732075, Example 1.17::[(S)-2-(6-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 97.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334473 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334473&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127311 384986633 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656596 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C22H22N6OS/c1-14-5-8-19(28-23-9-10-24-28)16(12-14)22(29)27-11-3-4-20(27)21-25-17-7-6-15(30-2)13-18(17)26-21/h5-10,12-13,20H,3-4,11H2,1-2H3,(H,25,26)/t20-/m0/s1 XXLHLBBZFMWPEJ-FQEVSTJZSA-N 334473 US11040966, Example 1.17::US9732075, Example 1.17::[(S)-2-(6-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334473 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334473&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127311 384986633 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656597 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1c(C)cccc1-n1nccn1 InChI=1S/C22H22N6OS/c1-14-6-3-8-16(28-23-11-12-24-28)19(14)22(29)27-13-5-9-17(27)21-25-15-7-4-10-18(30-2)20(15)26-21/h3-4,6-8,10-12,17H,5,9,13H2,1-2H3,(H,25,26)/t17-/m0/s1 QZFZYEFZWPDLSB-KRWDZBQOSA-N 334474 US11040966, Example 1.170::US9732075, Example 1.170::[(S)-2-(7-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 258 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334474 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334474&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127776 384986634 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656598 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1c(C)cccc1-n1nccn1 InChI=1S/C22H22N6OS/c1-14-6-3-8-16(28-23-11-12-24-28)19(14)22(29)27-13-5-9-17(27)21-25-15-7-4-10-18(30-2)20(15)26-21/h3-4,6-8,10-12,17H,5,9,13H2,1-2H3,(H,25,26)/t17-/m0/s1 QZFZYEFZWPDLSB-KRWDZBQOSA-N 334474 US11040966, Example 1.170::US9732075, Example 1.170::[(S)-2-(7-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 20.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334474 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334474&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127776 384986634 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656599 COc1ccc2[nH]c(nc2c1)[C@@H]1CCCN1C(=O)c1cc(C)ccc1-n1cccn1 InChI=1S/C23H23N5O2/c1-15-6-9-20(28-12-4-10-24-28)17(13-15)23(29)27-11-3-5-21(27)22-25-18-8-7-16(30-2)14-19(18)26-22/h4,6-10,12-14,21H,3,5,11H2,1-2H3,(H,25,26)/t21-/m0/s1 VLOOXXGKDWHGCX-NRFANRHFSA-N 334475 US11040966, Example 1.171::US9732075, Example 1.171::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2210 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334475 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334475&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102346 384986635 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656600 COc1ccc2[nH]c(nc2c1)[C@@H]1CCCN1C(=O)c1cc(C)ccc1-n1cccn1 InChI=1S/C23H23N5O2/c1-15-6-9-20(28-12-4-10-24-28)17(13-15)23(29)27-11-3-5-21(27)22-25-18-8-7-16(30-2)14-19(18)26-22/h4,6-10,12-14,21H,3,5,11H2,1-2H3,(H,25,26)/t21-/m0/s1 VLOOXXGKDWHGCX-NRFANRHFSA-N 334475 US11040966, Example 1.171::US9732075, Example 1.171::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 36.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334475 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334475&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102346 384986635 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656601 COc1ccc2[nH]c(nc2c1)[C@@H]1CCCN1C(=O)c1c(F)c(C)ccc1-n1nccn1 InChI=1S/C22H21FN6O2/c1-13-5-8-17(29-24-9-10-25-29)19(20(13)23)22(30)28-11-3-4-18(28)21-26-15-7-6-14(31-2)12-16(15)27-21/h5-10,12,18H,3-4,11H2,1-2H3,(H,26,27)/t18-/m0/s1 ILQINAUBJAOEPE-SFHVURJKSA-N 334476 (2-Fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.172::US9732075, Example 1.172 Orexin/Hypocretin receptor type 1 Homo sapiens 1160 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334476 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334476&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127349 384986636 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656602 COc1ccc2[nH]c(nc2c1)[C@@H]1CCCN1C(=O)c1c(F)c(C)ccc1-n1nccn1 InChI=1S/C22H21FN6O2/c1-13-5-8-17(29-24-9-10-25-29)19(20(13)23)22(30)28-11-3-4-18(28)21-26-15-7-6-14(31-2)12-16(15)27-21/h5-10,12,18H,3-4,11H2,1-2H3,(H,26,27)/t18-/m0/s1 ILQINAUBJAOEPE-SFHVURJKSA-N 334476 (2-Fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.172::US9732075, Example 1.172 Orexin receptor type 2 Homo sapiens 19.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334476 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334476&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127349 384986636 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656603 COc1ccc2[nH]c(nc2c1)[C@@H]1CCCN1C(=O)c1nc(C)ccc1-n1nccn1 InChI=1S/C21H21N7O2/c1-13-5-8-17(28-22-9-10-23-28)19(24-13)21(29)27-11-3-4-18(27)20-25-15-7-6-14(30-2)12-16(15)26-20/h5-10,12,18H,3-4,11H2,1-2H3,(H,25,26)/t18-/m0/s1 SPIFPFNGTMVCLR-SFHVURJKSA-N 334477 US11040966, Example 1.173::US9732075, Example 1.173::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 3930 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334477 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334477&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102392 384986637 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656604 COc1ccc2[nH]c(nc2c1)[C@@H]1CCCN1C(=O)c1nc(C)ccc1-n1nccn1 InChI=1S/C21H21N7O2/c1-13-5-8-17(28-22-9-10-23-28)19(24-13)21(29)27-11-3-4-18(27)20-25-15-7-6-14(30-2)12-16(15)26-20/h5-10,12,18H,3-4,11H2,1-2H3,(H,25,26)/t18-/m0/s1 SPIFPFNGTMVCLR-SFHVURJKSA-N 334477 US11040966, Example 1.173::US9732075, Example 1.173::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone Orexin receptor type 2 Homo sapiens 54.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334477 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334477&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102392 384986637 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656605 CSc1cccc2[nH]c(nc12)[C@@H]1CCCN1C(=O)c1c(F)c(C)ccc1-n1nccn1 InChI=1S/C22H21FN6OS/c1-13-8-9-15(29-24-10-11-25-29)18(19(13)23)22(30)28-12-4-6-16(28)21-26-14-5-3-7-17(31-2)20(14)27-21/h3,5,7-11,16H,4,6,12H2,1-2H3,(H,26,27)/t16-/m0/s1 XTRYPPJYLFTXGP-INIZCTEOSA-N 334478 (2-Fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(4-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.174::US9732075, Example 1.174 Orexin/Hypocretin receptor type 1 Homo sapiens 68.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334478 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334478&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127975 384986638 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656606 CSc1cccc2[nH]c(nc12)[C@@H]1CCCN1C(=O)c1c(F)c(C)ccc1-n1nccn1 InChI=1S/C22H21FN6OS/c1-13-8-9-15(29-24-10-11-25-29)18(19(13)23)22(30)28-12-4-6-16(28)21-26-14-5-3-7-17(31-2)20(14)27-21/h3,5,7-11,16H,4,6,12H2,1-2H3,(H,26,27)/t16-/m0/s1 XTRYPPJYLFTXGP-INIZCTEOSA-N 334478 (2-Fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(4-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.174::US9732075, Example 1.174 Orexin receptor type 2 Homo sapiens 87.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334478 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334478&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127975 384986638 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656607 CSc1cccc2[nH]c(nc12)[C@@H]1CCCN1C(=O)c1nc(C)ccc1-n1nccn1 InChI=1S/C21H21N7OS/c1-13-8-9-15(28-22-10-11-23-28)19(24-13)21(29)27-12-4-6-16(27)20-25-14-5-3-7-17(30-2)18(14)26-20/h3,5,7-11,16H,4,6,12H2,1-2H3,(H,25,26)/t16-/m0/s1 JVQJEZPXXARTGW-INIZCTEOSA-N 334480 US11040966, Example 1.175::US9732075, Example 1.175::[(S)-2-(4-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 528 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334480 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334480&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127766 384986640 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656608 CSc1cccc2[nH]c(nc12)[C@@H]1CCCN1C(=O)c1nc(C)ccc1-n1nccn1 InChI=1S/C21H21N7OS/c1-13-8-9-15(28-22-10-11-23-28)19(24-13)21(29)27-12-4-6-16(27)20-25-14-5-3-7-17(30-2)18(14)26-20/h3,5,7-11,16H,4,6,12H2,1-2H3,(H,25,26)/t16-/m0/s1 JVQJEZPXXARTGW-INIZCTEOSA-N 334480 US11040966, Example 1.175::US9732075, Example 1.175::[(S)-2-(4-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone Orexin receptor type 2 Homo sapiens 76.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334480 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334480&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127766 384986640 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656609 CSc1ccc2[nH]c(nc2c1)[C@@H]1CCCN1C(=O)c1ccccc1-n1cccn1 InChI=1S/C22H21N5OS/c1-29-15-9-10-17-18(14-15)25-21(24-17)20-8-4-12-26(20)22(28)16-6-2-3-7-19(16)27-13-5-11-23-27/h2-3,5-7,9-11,13-14,20H,4,8,12H2,1H3,(H,24,25)/t20-/m0/s1 FFXNWTQBSXEVPF-FQEVSTJZSA-N 334481 US11040966, Example 1.176::US9732075, Example 1.176::[(S)-2-(5-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-pyrazol-1-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2190 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334481 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334481&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127893 384986641 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656610 CSc1ccc2[nH]c(nc2c1)[C@@H]1CCCN1C(=O)c1ccccc1-n1cccn1 InChI=1S/C22H21N5OS/c1-29-15-9-10-17-18(14-15)25-21(24-17)20-8-4-12-26(20)22(28)16-6-2-3-7-19(16)27-13-5-11-23-27/h2-3,5-7,9-11,13-14,20H,4,8,12H2,1H3,(H,24,25)/t20-/m0/s1 FFXNWTQBSXEVPF-FQEVSTJZSA-N 334481 US11040966, Example 1.176::US9732075, Example 1.176::[(S)-2-(5-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-pyrazol-1-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 99.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334481 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334481&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127893 384986641 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656611 CSc1ccc2[nH]c(nc2c1)[C@@H]1CCCN1C(=O)c1cc(C)ccc1-n1cccn1 InChI=1S/C23H23N5OS/c1-15-6-9-20(28-12-4-10-24-28)17(13-15)23(29)27-11-3-5-21(27)22-25-18-8-7-16(30-2)14-19(18)26-22/h4,6-10,12-14,21H,3,5,11H2,1-2H3,(H,25,26)/t21-/m0/s1 GVKIGOCNOPXQGV-NRFANRHFSA-N 334482 (5-Methyl-2-pyrazol-1-yl-phenyl)-[(S)-2-(5-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.177::US9732075, Example 1.177 Orexin/Hypocretin receptor type 1 Homo sapiens 842 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334482 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334482&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127329 384986642 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656612 CSc1ccc2[nH]c(nc2c1)[C@@H]1CCCN1C(=O)c1cc(C)ccc1-n1cccn1 InChI=1S/C23H23N5OS/c1-15-6-9-20(28-12-4-10-24-28)17(13-15)23(29)27-11-3-5-21(27)22-25-18-8-7-16(30-2)14-19(18)26-22/h4,6-10,12-14,21H,3,5,11H2,1-2H3,(H,25,26)/t21-/m0/s1 GVKIGOCNOPXQGV-NRFANRHFSA-N 334482 (5-Methyl-2-pyrazol-1-yl-phenyl)-[(S)-2-(5-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.177::US9732075, Example 1.177 Orexin receptor type 2 Homo sapiens 30.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334482 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334482&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127329 384986642 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656613 CSc1ccc2[nH]c(nc2c1)[C@@H]1CCCN1C(=O)c1nc(C)ccc1-n1cccn1 InChI=1S/C22H22N6OS/c1-14-6-9-18(28-12-4-10-23-28)20(24-14)22(29)27-11-3-5-19(27)21-25-16-8-7-15(30-2)13-17(16)26-21/h4,6-10,12-13,19H,3,5,11H2,1-2H3,(H,25,26)/t19-/m0/s1 MXVCPQMIWOKSFK-IBGZPJMESA-N 334483 (6-Methyl-3-pyrazol-1-yl-pyridin-2-yl)-[(S)-2-(5-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.178::US9732075, Example 1.178 Orexin/Hypocretin receptor type 1 Homo sapiens 2680 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334483 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334483&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102453 384986643 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656614 CSc1ccc2[nH]c(nc2c1)[C@@H]1CCCN1C(=O)c1nc(C)ccc1-n1cccn1 InChI=1S/C22H22N6OS/c1-14-6-9-18(28-12-4-10-23-28)20(24-14)22(29)27-11-3-5-19(27)21-25-16-8-7-15(30-2)13-17(16)26-21/h4,6-10,12-13,19H,3,5,11H2,1-2H3,(H,25,26)/t19-/m0/s1 MXVCPQMIWOKSFK-IBGZPJMESA-N 334483 (6-Methyl-3-pyrazol-1-yl-pyridin-2-yl)-[(S)-2-(5-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.178::US9732075, Example 1.178 Orexin receptor type 2 Homo sapiens 96.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334483 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334483&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102453 384986643 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656615 CSc1ccc2[nH]c(nc2c1)[C@@H]1CCCN1C(=O)c1c(F)c(C)ccc1-n1nccn1 InChI=1S/C22H21FN6OS/c1-13-5-8-17(29-24-9-10-25-29)19(20(13)23)22(30)28-11-3-4-18(28)21-26-15-7-6-14(31-2)12-16(15)27-21/h5-10,12,18H,3-4,11H2,1-2H3,(H,26,27)/t18-/m0/s1 QLHDVTDZPSQBBI-SFHVURJKSA-N 334484 (2-Fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(5-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.179::US9732075, Example 1.179 Orexin/Hypocretin receptor type 1 Homo sapiens 486 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334484&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127149 384986644 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656616 CSc1ccc2[nH]c(nc2c1)[C@@H]1CCCN1C(=O)c1c(F)c(C)ccc1-n1nccn1 InChI=1S/C22H21FN6OS/c1-13-5-8-17(29-24-9-10-25-29)19(20(13)23)22(30)28-11-3-4-18(28)21-26-15-7-6-14(31-2)12-16(15)27-21/h5-10,12,18H,3-4,11H2,1-2H3,(H,26,27)/t18-/m0/s1 QLHDVTDZPSQBBI-SFHVURJKSA-N 334484 (2-Fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(5-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.179::US9732075, Example 1.179 Orexin receptor type 2 Homo sapiens 28.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334484&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127149 384986644 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656617 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1ccc(Br)cc1 InChI=1S/C23H21BrN4O2S/c1-13-25-20(21(31-13)14-5-7-15(24)8-6-14)23(29)28-11-3-4-19(28)22-26-17-10-9-16(30-2)12-18(17)27-22/h5-10,12,19H,3-4,11H2,1-2H3,(H,26,27)/t19-/m0/s1 MGZRVDRTWXIIFM-IBGZPJMESA-N 334485 US11040966, Example 1.18::US9732075, Example 1.18::[5-(4-Bromo-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 935 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334485&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102334 384986645 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656618 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1ccc(Br)cc1 InChI=1S/C23H21BrN4O2S/c1-13-25-20(21(31-13)14-5-7-15(24)8-6-14)23(29)28-11-3-4-19(28)22-26-17-10-9-16(30-2)12-18(17)27-22/h5-10,12,19H,3-4,11H2,1-2H3,(H,26,27)/t19-/m0/s1 MGZRVDRTWXIIFM-IBGZPJMESA-N 334485 US11040966, Example 1.18::US9732075, Example 1.18::[5-(4-Bromo-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 153 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334485&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102334 384986645 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656619 CSc1ccc2[nH]c(nc2c1)[C@@H]1CCCN1C(=O)c1nc(C)ccc1-n1nccn1 InChI=1S/C21H21N7OS/c1-13-5-8-17(28-22-9-10-23-28)19(24-13)21(29)27-11-3-4-18(27)20-25-15-7-6-14(30-2)12-16(15)26-20/h5-10,12,18H,3-4,11H2,1-2H3,(H,25,26)/t18-/m0/s1 UXEIIHQOUJKGML-SFHVURJKSA-N 334486 US11040966, Example 1.180::US9732075, Example 1.180::[(S)-2-(5-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 1490 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334486 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334486&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128150 384986646 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656620 CSc1ccc2[nH]c(nc2c1)[C@@H]1CCCN1C(=O)c1nc(C)ccc1-n1nccn1 InChI=1S/C21H21N7OS/c1-13-5-8-17(28-22-9-10-23-28)19(24-13)21(29)27-11-3-4-18(27)20-25-15-7-6-14(30-2)12-16(15)26-20/h5-10,12,18H,3-4,11H2,1-2H3,(H,25,26)/t18-/m0/s1 UXEIIHQOUJKGML-SFHVURJKSA-N 334486 US11040966, Example 1.180::US9732075, Example 1.180::[(S)-2-(5-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone Orexin receptor type 2 Homo sapiens 50.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334486 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334486&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128150 384986646 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656621 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1Cl InChI=1S/C23H20Cl2N4O2S/c1-12-26-20(21(32-12)14-5-3-6-15(24)19(14)25)23(30)29-10-4-7-18(29)22-27-16-9-8-13(31-2)11-17(16)28-22/h3,5-6,8-9,11,18H,4,7,10H2,1-2H3,(H,27,28)/t18-/m0/s1 NSTXIYYXGQYSCJ-SFHVURJKSA-N 334487 US11040966, Example 1.19::US9732075, Example 1.19::[5-(2,3-Dichloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 660 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334487 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334487&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102445 384986647 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656622 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1Cl InChI=1S/C23H20Cl2N4O2S/c1-12-26-20(21(32-12)14-5-3-6-15(24)19(14)25)23(30)29-10-4-7-18(29)22-27-16-9-8-13(31-2)11-17(16)28-22/h3,5-6,8-9,11,18H,4,7,10H2,1-2H3,(H,27,28)/t18-/m0/s1 NSTXIYYXGQYSCJ-SFHVURJKSA-N 334487 US11040966, Example 1.19::US9732075, Example 1.19::[5-(2,3-Dichloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 76.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334487 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334487&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102445 384986647 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656623 COc1ccc2[nH]c(nc2c1)[C@@H]1CCCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C22H22N6O2/c1-14-5-8-19(28-23-9-10-24-28)16(12-14)22(29)27-11-3-4-20(27)21-25-17-7-6-15(30-2)13-18(17)26-21/h5-10,12-13,20H,3-4,11H2,1-2H3,(H,25,26)/t20-/m0/s1 UNGLNTQVFSBZDT-FQEVSTJZSA-N 334488 US11040966, Example 1.2::US9732075, Example 1.2::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 349 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334488 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334488&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695491 384986648 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656624 COc1ccc2[nH]c(nc2c1)[C@@H]1CCCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C22H22N6O2/c1-14-5-8-19(28-23-9-10-24-28)16(12-14)22(29)27-11-3-4-20(27)21-25-17-7-6-15(30-2)13-18(17)26-21/h5-10,12-13,20H,3-4,11H2,1-2H3,(H,25,26)/t20-/m0/s1 UNGLNTQVFSBZDT-FQEVSTJZSA-N 334488 US11040966, Example 1.2::US9732075, Example 1.2::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334488 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334488&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695491 384986648 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656625 COc1cccc(c1)-c1sc(C)nc1C(=O)N1CCC[C@H]1c1nc2ccc(OC)cc2[nH]1 InChI=1S/C24H24N4O3S/c1-14-25-21(22(32-14)15-6-4-7-16(12-15)30-2)24(29)28-11-5-8-20(28)23-26-18-10-9-17(31-3)13-19(18)27-23/h4,6-7,9-10,12-13,20H,5,8,11H2,1-3H3,(H,26,27)/t20-/m0/s1 ZWTIXHWPWDSNPN-FQEVSTJZSA-N 334489 US11040966, Example 1.20::US9732075, Example 1.20::[(S)-2-(6-Methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-[5-(3-methoxy-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 692 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334489 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334489&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102240 384986649 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656626 COc1cccc(c1)-c1sc(C)nc1C(=O)N1CCC[C@H]1c1nc2ccc(OC)cc2[nH]1 InChI=1S/C24H24N4O3S/c1-14-25-21(22(32-14)15-6-4-7-16(12-15)30-2)24(29)28-11-5-8-20(28)23-26-18-10-9-17(31-3)13-19(18)27-23/h4,6-7,9-10,12-13,20H,5,8,11H2,1-3H3,(H,26,27)/t20-/m0/s1 ZWTIXHWPWDSNPN-FQEVSTJZSA-N 334489 US11040966, Example 1.20::US9732075, Example 1.20::[(S)-2-(6-Methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-[5-(3-methoxy-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 121 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334489 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334489&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102240 384986649 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656627 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1cccc(F)c1 InChI=1S/C23H21FN4O2S/c1-13-25-20(21(31-13)14-5-3-6-15(24)11-14)23(29)28-10-4-7-19(28)22-26-17-9-8-16(30-2)12-18(17)27-22/h3,5-6,8-9,11-12,19H,4,7,10H2,1-2H3,(H,26,27)/t19-/m0/s1 AYHCZBLXCBLRRG-IBGZPJMESA-N 334490 US11040966, Example 1.21::US9732075, Example 1.21::[5-(3-Fluoro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 1180 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334490 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334490&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102355 384986650 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656628 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1cccc(F)c1 InChI=1S/C23H21FN4O2S/c1-13-25-20(21(31-13)14-5-3-6-15(24)11-14)23(29)28-10-4-7-19(28)22-26-17-9-8-16(30-2)12-18(17)27-22/h3,5-6,8-9,11-12,19H,4,7,10H2,1-2H3,(H,26,27)/t19-/m0/s1 AYHCZBLXCBLRRG-IBGZPJMESA-N 334490 US11040966, Example 1.21::US9732075, Example 1.21::[5-(3-Fluoro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 149 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334490 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334490&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102355 384986650 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656629 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1ccc(C)cc1 InChI=1S/C24H24N4O2S/c1-14-6-8-16(9-7-14)22-21(25-15(2)31-22)24(29)28-12-4-5-20(28)23-26-18-11-10-17(30-3)13-19(18)27-23/h6-11,13,20H,4-5,12H2,1-3H3,(H,26,27)/t20-/m0/s1 RUHSTWPONTYGMW-FQEVSTJZSA-N 334491 US11040966, Example 1.22::US9732075, Example 1.22::[(S)-2-(6-Methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-p-tolyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 415 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334491 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334491&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127358 384986651 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656630 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1ccc(C)cc1 InChI=1S/C24H24N4O2S/c1-14-6-8-16(9-7-14)22-21(25-15(2)31-22)24(29)28-12-4-5-20(28)23-26-18-11-10-17(30-3)13-19(18)27-23/h6-11,13,20H,4-5,12H2,1-3H3,(H,26,27)/t20-/m0/s1 RUHSTWPONTYGMW-FQEVSTJZSA-N 334491 US11040966, Example 1.22::US9732075, Example 1.22::[(S)-2-(6-Methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-p-tolyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 52.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334491 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334491&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127358 384986651 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656631 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1nc(sc1-c1ccc(C)cc1)C1CC1 InChI=1S/C26H26N4O2S/c1-15-5-7-16(8-6-15)23-22(29-25(33-23)17-9-10-17)26(31)30-13-3-4-21(30)24-27-19-12-11-18(32-2)14-20(19)28-24/h5-8,11-12,14,17,21H,3-4,9-10,13H2,1-2H3,(H,27,28)/t21-/m0/s1 QKGIQQBUMYDMDC-NRFANRHFSA-N 334492 (2-Cyclopropyl-5-p-tolyl-thiazol-4-yl)-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.23::US9732075, Example 1.23 Orexin/Hypocretin receptor type 1 Homo sapiens 523 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334492 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334492&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102247 384986652 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656632 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1nc(sc1-c1ccc(C)cc1)C1CC1 InChI=1S/C26H26N4O2S/c1-15-5-7-16(8-6-15)23-22(29-25(33-23)17-9-10-17)26(31)30-13-3-4-21(30)24-27-19-12-11-18(32-2)14-20(19)28-24/h5-8,11-12,14,17,21H,3-4,9-10,13H2,1-2H3,(H,27,28)/t21-/m0/s1 QKGIQQBUMYDMDC-NRFANRHFSA-N 334492 (2-Cyclopropyl-5-p-tolyl-thiazol-4-yl)-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.23::US9732075, Example 1.23 Orexin receptor type 2 Homo sapiens 212 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334492 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334492&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102247 384986652 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656633 CCc1ccc(cc1)-c1sc(C)nc1C(=O)N1CCC[C@H]1c1nc2ccc(OC)cc2[nH]1 InChI=1S/C25H26N4O2S/c1-4-16-7-9-17(10-8-16)23-22(26-15(2)32-23)25(30)29-13-5-6-21(29)24-27-19-12-11-18(31-3)14-20(19)28-24/h7-12,14,21H,4-6,13H2,1-3H3,(H,27,28)/t21-/m0/s1 MYECXQQMURIEKE-NRFANRHFSA-N 334493 US11040966, Example 1.24::US9732075, Example 1.24::[5-(4-Ethyl-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 850 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334493 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334493&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102430 384986653 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656634 CCc1ccc(cc1)-c1sc(C)nc1C(=O)N1CCC[C@H]1c1nc2ccc(OC)cc2[nH]1 InChI=1S/C25H26N4O2S/c1-4-16-7-9-17(10-8-16)23-22(26-15(2)32-23)25(30)29-13-5-6-21(29)24-27-19-12-11-18(31-3)14-20(19)28-24/h7-12,14,21H,4-6,13H2,1-3H3,(H,27,28)/t21-/m0/s1 MYECXQQMURIEKE-NRFANRHFSA-N 334493 US11040966, Example 1.24::US9732075, Example 1.24::[5-(4-Ethyl-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 81.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334493 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334493&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102430 384986653 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656635 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C23H21ClN4O2S/c1-13-25-20(21(31-13)14-5-3-6-15(24)11-14)23(29)28-10-4-7-19(28)22-26-17-9-8-16(30-2)12-18(17)27-22/h3,5-6,8-9,11-12,19H,4,7,10H2,1-2H3,(H,26,27)/t19-/m0/s1 XYVPOQGVLHKCMJ-IBGZPJMESA-N 334494 US11040966, Example 1.25::US9732075, Example 1.25::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 364 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334494 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334494&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102356 384986654 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656636 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C23H21ClN4O2S/c1-13-25-20(21(31-13)14-5-3-6-15(24)11-14)23(29)28-10-4-7-19(28)22-26-17-9-8-16(30-2)12-18(17)27-22/h3,5-6,8-9,11-12,19H,4,7,10H2,1-2H3,(H,26,27)/t19-/m0/s1 XYVPOQGVLHKCMJ-IBGZPJMESA-N 334494 US11040966, Example 1.25::US9732075, Example 1.25::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 90.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334494 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334494&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102356 384986654 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656637 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1ccccc1-c1ccc(C)c(C)c1 InChI=1S/C27H27N3O2/c1-17-10-11-19(15-18(17)2)21-7-4-5-8-22(21)27(31)30-14-6-9-25(30)26-28-23-13-12-20(32-3)16-24(23)29-26/h4-5,7-8,10-13,15-16,25H,6,9,14H2,1-3H3,(H,28,29)/t25-/m0/s1 AHUOSCJPKJIMFN-VWLOTQADSA-N 334495 (3',4'-Dimethyl-biphenyl-2-yl)-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.26::US9732075, Example 1.26 Orexin/Hypocretin receptor type 1 Homo sapiens 125 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334495 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334495&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128144 384986655 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656638 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1ccccc1-c1ccc(C)c(C)c1 InChI=1S/C27H27N3O2/c1-17-10-11-19(15-18(17)2)21-7-4-5-8-22(21)27(31)30-14-6-9-25(30)26-28-23-13-12-20(32-3)16-24(23)29-26/h4-5,7-8,10-13,15-16,25H,6,9,14H2,1-3H3,(H,28,29)/t25-/m0/s1 AHUOSCJPKJIMFN-VWLOTQADSA-N 334495 (3',4'-Dimethyl-biphenyl-2-yl)-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.26::US9732075, Example 1.26 Orexin receptor type 2 Homo sapiens 22.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334495 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334495&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128144 384986655 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656639 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1ccccc1-n1nccn1 InChI=1S/C21H20N6O2/c1-29-14-8-9-16-17(13-14)25-20(24-16)19-7-4-12-26(19)21(28)15-5-2-3-6-18(15)27-22-10-11-23-27/h2-3,5-6,8-11,13,19H,4,7,12H2,1H3,(H,24,25)/t19-/m0/s1 PDLCEAWBFLORCP-IBGZPJMESA-N 334496 US11040966, Example 1.27::US9732075, Example 1.27::[(S)-2-(6-Methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 1040 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334496 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334496&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127273 384986656 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656640 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1ccccc1-n1nccn1 InChI=1S/C21H20N6O2/c1-29-14-8-9-16-17(13-14)25-20(24-16)19-7-4-12-26(19)21(28)15-5-2-3-6-18(15)27-22-10-11-23-27/h2-3,5-6,8-11,13,19H,4,7,12H2,1H3,(H,24,25)/t19-/m0/s1 PDLCEAWBFLORCP-IBGZPJMESA-N 334496 US11040966, Example 1.27::US9732075, Example 1.27::[(S)-2-(6-Methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 35.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334496 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334496&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127273 384986656 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656641 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1ccc(Cl)c(Cl)c1 InChI=1S/C24H21Cl2N5O2/c1-13-27-12-16(22(28-13)14-5-7-17(25)18(26)10-14)24(32)31-9-3-4-21(31)23-29-19-8-6-15(33-2)11-20(19)30-23/h5-8,10-12,21H,3-4,9H2,1-2H3,(H,29,30)/t21-/m0/s1 SYZGHXVDDCVFOA-NRFANRHFSA-N 334497 US11040966, Example 1.28::US9732075, Example 1.28::[4-(3,4-Dichloro-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 114 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334497 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334497&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127392 384986657 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656642 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1ccc(Cl)c(Cl)c1 InChI=1S/C24H21Cl2N5O2/c1-13-27-12-16(22(28-13)14-5-7-17(25)18(26)10-14)24(32)31-9-3-4-21(31)23-29-19-8-6-15(33-2)11-20(19)30-23/h5-8,10-12,21H,3-4,9H2,1-2H3,(H,29,30)/t21-/m0/s1 SYZGHXVDDCVFOA-NRFANRHFSA-N 334497 US11040966, Example 1.28::US9732075, Example 1.28::[4-(3,4-Dichloro-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 110 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334497 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334497&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127392 384986657 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656643 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1cccc(Cl)c1 InChI=1S/C24H22ClN5O2/c1-14-26-13-18(22(27-14)15-5-3-6-16(25)11-15)24(31)30-10-4-7-21(30)23-28-19-9-8-17(32-2)12-20(19)29-23/h3,5-6,8-9,11-13,21H,4,7,10H2,1-2H3,(H,28,29)/t21-/m0/s1 UUPVTEWSICLUSQ-NRFANRHFSA-N 334498 US11040966, Example 1.29::US9732075, Example 1.29::[4-(3-Chloro-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 369 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334498 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334498&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102303 384986658 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656644 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1cccc(Cl)c1 InChI=1S/C24H22ClN5O2/c1-14-26-13-18(22(27-14)15-5-3-6-16(25)11-15)24(31)30-10-4-7-21(30)23-28-19-9-8-17(32-2)12-20(19)29-23/h3,5-6,8-9,11-13,21H,4,7,10H2,1-2H3,(H,28,29)/t21-/m0/s1 UUPVTEWSICLUSQ-NRFANRHFSA-N 334498 US11040966, Example 1.29::US9732075, Example 1.29::[4-(3-Chloro-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 182 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334498 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334498&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102303 384986658 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656645 Cc1ccc(c(c1)C(=O)N1CCC[C@H]1c1nc2cc(Cl)ccc2[nH]1)-n1nccn1 InChI=1S/C21H19ClN6O/c1-13-4-7-18(28-23-8-9-24-28)15(11-13)21(29)27-10-2-3-19(27)20-25-16-6-5-14(22)12-17(16)26-20/h4-9,11-12,19H,2-3,10H2,1H3,(H,25,26)/t19-/m0/s1 WKHRJTLJTFGOAC-IBGZPJMESA-N 334499 US11040966, Example 1.3::US9732075, Example 1.3::[(S)-2-(5-Chloro-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 265 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334499 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334499&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102426 384986659 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656646 Cc1ccc(c(c1)C(=O)N1CCC[C@H]1c1nc2cc(Cl)ccc2[nH]1)-n1nccn1 InChI=1S/C21H19ClN6O/c1-13-4-7-18(28-23-8-9-24-28)15(11-13)21(29)27-10-2-3-19(27)20-25-16-6-5-14(22)12-17(16)26-20/h4-9,11-12,19H,2-3,10H2,1H3,(H,25,26)/t19-/m0/s1 WKHRJTLJTFGOAC-IBGZPJMESA-N 334499 US11040966, Example 1.3::US9732075, Example 1.3::[(S)-2-(5-Chloro-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 51.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334499 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334499&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102426 384986659 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656647 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cncnc1-c1ccc(Br)c(Cl)c1 InChI=1S/C23H19BrClN5O2/c1-32-14-5-7-18-19(10-14)29-22(28-18)20-3-2-8-30(20)23(31)15-11-26-12-27-21(15)13-4-6-16(24)17(25)9-13/h4-7,9-12,20H,2-3,8H2,1H3,(H,28,29)/t20-/m0/s1 YGIGTNINTALUAH-FQEVSTJZSA-N 334500 US11040966, Example 1.30::US9732075, Example 1.30::[4-(4-Bromo-3-chloro-phenyl)-pyrimidin-5-yl]-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 624 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334500 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334500&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102309 384986660 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656648 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cncnc1-c1ccc(Br)c(Cl)c1 InChI=1S/C23H19BrClN5O2/c1-32-14-5-7-18-19(10-14)29-22(28-18)20-3-2-8-30(20)23(31)15-11-26-12-27-21(15)13-4-6-16(24)17(25)9-13/h4-7,9-12,20H,2-3,8H2,1H3,(H,28,29)/t20-/m0/s1 YGIGTNINTALUAH-FQEVSTJZSA-N 334500 US11040966, Example 1.30::US9732075, Example 1.30::[4-(4-Bromo-3-chloro-phenyl)-pyrimidin-5-yl]-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 147 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334500 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334500&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102309 384986660 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656649 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1ccc(C)c(C)c1 InChI=1S/C26H27N5O2/c1-15-7-8-18(12-16(15)2)24-20(14-27-17(3)28-24)26(32)31-11-5-6-23(31)25-29-21-10-9-19(33-4)13-22(21)30-25/h7-10,12-14,23H,5-6,11H2,1-4H3,(H,29,30)/t23-/m0/s1 YWRJJLQJSAZOLG-QHCPKHFHSA-N 334501 US11040966, Example 1.31::US9732075, Example 1.31::[4-(3,4-Dimethyl-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 195 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334501 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334501&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128107 384986661 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656650 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1ccc(C)c(C)c1 InChI=1S/C26H27N5O2/c1-15-7-8-18(12-16(15)2)24-20(14-27-17(3)28-24)26(32)31-11-5-6-23(31)25-29-21-10-9-19(33-4)13-22(21)30-25/h7-10,12-14,23H,5-6,11H2,1-4H3,(H,29,30)/t23-/m0/s1 YWRJJLQJSAZOLG-QHCPKHFHSA-N 334501 US11040966, Example 1.31::US9732075, Example 1.31::[4-(3,4-Dimethyl-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 78.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334501 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334501&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128107 384986661 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656651 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1ccccc1 InChI=1S/C24H23N5O2/c1-15-25-14-18(22(26-15)16-7-4-3-5-8-16)24(30)29-12-6-9-21(29)23-27-19-11-10-17(31-2)13-20(19)28-23/h3-5,7-8,10-11,13-14,21H,6,9,12H2,1-2H3,(H,27,28)/t21-/m0/s1 ZAQVZCUFUNEOHE-NRFANRHFSA-N 334502 US11040966, Example 1.32::US9732075, Example 1.32::[(S)-2-(6-Methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-4-phenyl-pyrimidin-5-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 347 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334502 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334502&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102450 384986662 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656652 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1ccccc1 InChI=1S/C24H23N5O2/c1-15-25-14-18(22(26-15)16-7-4-3-5-8-16)24(30)29-12-6-9-21(29)23-27-19-11-10-17(31-2)13-20(19)28-23/h3-5,7-8,10-11,13-14,21H,6,9,12H2,1-2H3,(H,27,28)/t21-/m0/s1 ZAQVZCUFUNEOHE-NRFANRHFSA-N 334502 US11040966, Example 1.32::US9732075, Example 1.32::[(S)-2-(6-Methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-4-phenyl-pyrimidin-5-yl)-methanone Orexin receptor type 2 Homo sapiens 139 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334502 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334502&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102450 384986662 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656653 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1ccc(Br)c(Cl)c1 InChI=1S/C24H21BrClN5O2/c1-13-27-12-16(22(28-13)14-5-7-17(25)18(26)10-14)24(32)31-9-3-4-21(31)23-29-19-8-6-15(33-2)11-20(19)30-23/h5-8,10-12,21H,3-4,9H2,1-2H3,(H,29,30)/t21-/m0/s1 NLAVETTWGINANC-NRFANRHFSA-N 334503 US11040966, Example 1.33::US9732075, Example 1.33::[4-(4-Bromo-3-chloro-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 76.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334503 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334503&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127500 384986663 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656654 COc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1ccc(Br)c(Cl)c1 InChI=1S/C24H21BrClN5O2/c1-13-27-12-16(22(28-13)14-5-7-17(25)18(26)10-14)24(32)31-9-3-4-21(31)23-29-19-8-6-15(33-2)11-20(19)30-23/h5-8,10-12,21H,3-4,9H2,1-2H3,(H,29,30)/t21-/m0/s1 NLAVETTWGINANC-NRFANRHFSA-N 334503 US11040966, Example 1.33::US9732075, Example 1.33::[4-(4-Bromo-3-chloro-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 48.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334503 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334503&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127500 384986663 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656655 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1ccc(Br)cc1 InChI=1S/C23H21BrN4OS2/c1-13-25-20(21(31-13)14-5-7-15(24)8-6-14)23(29)28-11-3-4-19(28)22-26-17-10-9-16(30-2)12-18(17)27-22/h5-10,12,19H,3-4,11H2,1-2H3,(H,26,27)/t19-/m0/s1 UPJJCCHGXYHSIW-IBGZPJMESA-N 334504 US11040966, Example 1.34::US9732075, Example 1.34::[5-(4-Bromo-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 124 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334504 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334504&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127600 384986664 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656656 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1ccc(Br)cc1 InChI=1S/C23H21BrN4OS2/c1-13-25-20(21(31-13)14-5-7-15(24)8-6-14)23(29)28-11-3-4-19(28)22-26-17-10-9-16(30-2)12-18(17)27-22/h5-10,12,19H,3-4,11H2,1-2H3,(H,26,27)/t19-/m0/s1 UPJJCCHGXYHSIW-IBGZPJMESA-N 334504 US11040966, Example 1.34::US9732075, Example 1.34::[5-(4-Bromo-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 56.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334504 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334504&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127600 384986664 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656657 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1nc(sc1-c1ccccc1)C1CC1 InChI=1S/C25H24N4OS2/c1-31-17-11-12-18-19(14-17)27-23(26-18)20-8-5-13-29(20)25(30)21-22(15-6-3-2-4-7-15)32-24(28-21)16-9-10-16/h2-4,6-7,11-12,14,16,20H,5,8-10,13H2,1H3,(H,26,27)/t20-/m0/s1 LLSWLKWSTDTWCA-FQEVSTJZSA-N 334505 (2-Cyclopropyl-5-phenyl-thiazol-4-yl)-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.35::US9732075, Example 1.35 Orexin/Hypocretin receptor type 1 Homo sapiens 117 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334505 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334505&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102310 384986665 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656658 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1nc(sc1-c1ccccc1)C1CC1 InChI=1S/C25H24N4OS2/c1-31-17-11-12-18-19(14-17)27-23(26-18)20-8-5-13-29(20)25(30)21-22(15-6-3-2-4-7-15)32-24(28-21)16-9-10-16/h2-4,6-7,11-12,14,16,20H,5,8-10,13H2,1H3,(H,26,27)/t20-/m0/s1 LLSWLKWSTDTWCA-FQEVSTJZSA-N 334505 (2-Cyclopropyl-5-phenyl-thiazol-4-yl)-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.35::US9732075, Example 1.35 Orexin receptor type 2 Homo sapiens 99.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334505 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334505&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102310 384986665 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656659 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1Cl InChI=1S/C23H20Cl2N4OS2/c1-12-26-20(21(32-12)14-5-3-6-15(24)19(14)25)23(30)29-10-4-7-18(29)22-27-16-9-8-13(31-2)11-17(16)28-22/h3,5-6,8-9,11,18H,4,7,10H2,1-2H3,(H,27,28)/t18-/m0/s1 GLIKJIRHPALZSN-SFHVURJKSA-N 334506 US11040966, Example 1.36::US9732075, Example 1.36::[5-(2,3-Dichloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 109 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334506 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334506&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127574 384986666 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656660 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1Cl InChI=1S/C23H20Cl2N4OS2/c1-12-26-20(21(32-12)14-5-3-6-15(24)19(14)25)23(30)29-10-4-7-18(29)22-27-16-9-8-13(31-2)11-17(16)28-22/h3,5-6,8-9,11,18H,4,7,10H2,1-2H3,(H,27,28)/t18-/m0/s1 GLIKJIRHPALZSN-SFHVURJKSA-N 334506 US11040966, Example 1.36::US9732075, Example 1.36::[5-(2,3-Dichloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 27.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334506 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334506&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127574 384986666 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656661 COc1cccc(c1)-c1sc(C)nc1C(=O)N1CCC[C@H]1c1nc2ccc(SC)cc2[nH]1 InChI=1S/C24H24N4O2S2/c1-14-25-21(22(32-14)15-6-4-7-16(12-15)30-2)24(29)28-11-5-8-20(28)23-26-18-10-9-17(31-3)13-19(18)27-23/h4,6-7,9-10,12-13,20H,5,8,11H2,1-3H3,(H,26,27)/t20-/m0/s1 HCILMPCKBIOOGY-FQEVSTJZSA-N 334507 US11040966, Example 1.37::US9732075, Example 1.37::[5-(3-Methoxy-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 154 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334507 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334507&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128224 384986667 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656662 COc1cccc(c1)-c1sc(C)nc1C(=O)N1CCC[C@H]1c1nc2ccc(SC)cc2[nH]1 InChI=1S/C24H24N4O2S2/c1-14-25-21(22(32-14)15-6-4-7-16(12-15)30-2)24(29)28-11-5-8-20(28)23-26-18-10-9-17(31-3)13-19(18)27-23/h4,6-7,9-10,12-13,20H,5,8,11H2,1-3H3,(H,26,27)/t20-/m0/s1 HCILMPCKBIOOGY-FQEVSTJZSA-N 334507 US11040966, Example 1.37::US9732075, Example 1.37::[5-(3-Methoxy-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 62.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334507 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334507&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128224 384986667 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656663 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1cccc(c1)C(F)(F)F InChI=1S/C24H21F3N4OS2/c1-13-28-20(21(34-13)14-5-3-6-15(11-14)24(25,26)27)23(32)31-10-4-7-19(31)22-29-17-9-8-16(33-2)12-18(17)30-22/h3,5-6,8-9,11-12,19H,4,7,10H2,1-2H3,(H,29,30)/t19-/m0/s1 ISRBQEWKZZNOTP-IBGZPJMESA-N 334508 US11040966, Example 1.38::US9732075, Example 1.38::[(S)-2-(6-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-[2-methyl-5-(3-trifluoromethyl-phenyl)-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 360 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334508 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334508&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127880 384986668 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656664 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1cccc(c1)C(F)(F)F InChI=1S/C24H21F3N4OS2/c1-13-28-20(21(34-13)14-5-3-6-15(11-14)24(25,26)27)23(32)31-10-4-7-19(31)22-29-17-9-8-16(33-2)12-18(17)30-22/h3,5-6,8-9,11-12,19H,4,7,10H2,1-2H3,(H,29,30)/t19-/m0/s1 ISRBQEWKZZNOTP-IBGZPJMESA-N 334508 US11040966, Example 1.38::US9732075, Example 1.38::[(S)-2-(6-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-[2-methyl-5-(3-trifluoromethyl-phenyl)-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 110 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334508 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334508&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127880 384986668 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656665 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1cccc(F)c1 InChI=1S/C23H21FN4OS2/c1-13-25-20(21(31-13)14-5-3-6-15(24)11-14)23(29)28-10-4-7-19(28)22-26-17-9-8-16(30-2)12-18(17)27-22/h3,5-6,8-9,11-12,19H,4,7,10H2,1-2H3,(H,26,27)/t19-/m0/s1 UMIQMJCEWICALV-IBGZPJMESA-N 334509 US11040966, Example 1.39::US9732075, Example 1.39::[5-(3-Fluoro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 157 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334509 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334509&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127658 384986669 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656666 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1cccc(F)c1 InChI=1S/C23H21FN4OS2/c1-13-25-20(21(31-13)14-5-3-6-15(24)11-14)23(29)28-10-4-7-19(28)22-26-17-9-8-16(30-2)12-18(17)27-22/h3,5-6,8-9,11-12,19H,4,7,10H2,1-2H3,(H,26,27)/t19-/m0/s1 UMIQMJCEWICALV-IBGZPJMESA-N 334509 US11040966, Example 1.39::US9732075, Example 1.39::[5-(3-Fluoro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 73.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334509 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334509&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127658 384986669 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656667 COc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C22H22N6O2/c1-14-8-9-17(28-23-10-11-24-28)15(13-14)22(29)27-12-4-6-18(27)21-25-16-5-3-7-19(30-2)20(16)26-21/h3,5,7-11,13,18H,4,6,12H2,1-2H3,(H,25,26)/t18-/m0/s1 XKVBESXDOTURKM-SFHVURJKSA-N 334510 US11040966, Example 1.4::US9732075, Example 1.4::[(S)-2-(7-Methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 241 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334510 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334510&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128247 384986670 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656668 COc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C22H22N6O2/c1-14-8-9-17(28-23-10-11-24-28)15(13-14)22(29)27-12-4-6-18(27)21-25-16-5-3-7-19(30-2)20(16)26-21/h3,5,7-11,13,18H,4,6,12H2,1-2H3,(H,25,26)/t18-/m0/s1 XKVBESXDOTURKM-SFHVURJKSA-N 334510 US11040966, Example 1.4::US9732075, Example 1.4::[(S)-2-(7-Methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 30.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334510 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334510&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128247 384986670 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656669 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1ccc(C)cc1 InChI=1S/C24H24N4OS2/c1-14-6-8-16(9-7-14)22-21(25-15(2)31-22)24(29)28-12-4-5-20(28)23-26-18-11-10-17(30-3)13-19(18)27-23/h6-11,13,20H,4-5,12H2,1-3H3,(H,26,27)/t20-/m0/s1 SVGPNOYFYXRDQB-FQEVSTJZSA-N 334511 US11040966, Example 1.40::US9732075, Example 1.40::[(S)-2-(6-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-p-tolyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 74.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334511 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334511&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694481 384986671 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656670 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1ccc(C)cc1 InChI=1S/C24H24N4OS2/c1-14-6-8-16(9-7-14)22-21(25-15(2)31-22)24(29)28-12-4-5-20(28)23-26-18-11-10-17(30-3)13-19(18)27-23/h6-11,13,20H,4-5,12H2,1-3H3,(H,26,27)/t20-/m0/s1 SVGPNOYFYXRDQB-FQEVSTJZSA-N 334511 US11040966, Example 1.40::US9732075, Example 1.40::[(S)-2-(6-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-p-tolyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 23.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334511 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334511&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694481 384986671 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656671 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1nc(sc1-c1ccc(C)cc1)C1CC1 InChI=1S/C26H26N4OS2/c1-15-5-7-16(8-6-15)23-22(29-25(33-23)17-9-10-17)26(31)30-13-3-4-21(30)24-27-19-12-11-18(32-2)14-20(19)28-24/h5-8,11-12,14,17,21H,3-4,9-10,13H2,1-2H3,(H,27,28)/t21-/m0/s1 NRBQXWKHMFPQTC-NRFANRHFSA-N 334512 (2-Cyclopropyl-5-p-tolyl-thiazol-4-yl)-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.41::US9732075, Example 1.41 Orexin/Hypocretin receptor type 1 Homo sapiens 115 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334512 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334512&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102423 384986672 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656672 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1nc(sc1-c1ccc(C)cc1)C1CC1 InChI=1S/C26H26N4OS2/c1-15-5-7-16(8-6-15)23-22(29-25(33-23)17-9-10-17)26(31)30-13-3-4-21(30)24-27-19-12-11-18(32-2)14-20(19)28-24/h5-8,11-12,14,17,21H,3-4,9-10,13H2,1-2H3,(H,27,28)/t21-/m0/s1 NRBQXWKHMFPQTC-NRFANRHFSA-N 334512 (2-Cyclopropyl-5-p-tolyl-thiazol-4-yl)-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.41::US9732075, Example 1.41 Orexin receptor type 2 Homo sapiens 64.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334512 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334512&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102423 384986672 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656673 CCc1ccc(cc1)-c1sc(C)nc1C(=O)N1CCC[C@H]1c1nc2ccc(SC)cc2[nH]1 InChI=1S/C25H26N4OS2/c1-4-16-7-9-17(10-8-16)23-22(26-15(2)32-23)25(30)29-13-5-6-21(29)24-27-19-12-11-18(31-3)14-20(19)28-24/h7-12,14,21H,4-6,13H2,1-3H3,(H,27,28)/t21-/m0/s1 VQFWFLHWQSETLZ-NRFANRHFSA-N 334513 US11040966, Example 1.42::US9732075, Example 1.42::[5-(4-Ethyl-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 263 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334513 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334513&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118126989 384986673 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656674 CCc1ccc(cc1)-c1sc(C)nc1C(=O)N1CCC[C@H]1c1nc2ccc(SC)cc2[nH]1 InChI=1S/C25H26N4OS2/c1-4-16-7-9-17(10-8-16)23-22(26-15(2)32-23)25(30)29-13-5-6-21(29)24-27-19-12-11-18(31-3)14-20(19)28-24/h7-12,14,21H,4-6,13H2,1-3H3,(H,27,28)/t21-/m0/s1 VQFWFLHWQSETLZ-NRFANRHFSA-N 334513 US11040966, Example 1.42::US9732075, Example 1.42::[5-(4-Ethyl-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 65.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334513 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334513&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118126989 384986673 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656675 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C23H21ClN4OS2/c1-13-25-20(21(31-13)14-5-3-6-15(24)11-14)23(29)28-10-4-7-19(28)22-26-17-9-8-16(30-2)12-18(17)27-22/h3,5-6,8-9,11-12,19H,4,7,10H2,1-2H3,(H,26,27)/t19-/m0/s1 IDVVUIGVQPYRPK-IBGZPJMESA-N 334514 US11040966, Example 1.43::US9732075, Example 1.43::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 97.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334514 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334514&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127799 384986674 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656676 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C23H21ClN4OS2/c1-13-25-20(21(31-13)14-5-3-6-15(24)11-14)23(29)28-10-4-7-19(28)22-26-17-9-8-16(30-2)12-18(17)27-22/h3,5-6,8-9,11-12,19H,4,7,10H2,1-2H3,(H,26,27)/t19-/m0/s1 IDVVUIGVQPYRPK-IBGZPJMESA-N 334514 US11040966, Example 1.43::US9732075, Example 1.43::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 58.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334514 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334514&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127799 384986674 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656677 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1cc(F)cc(F)c1 InChI=1S/C23H20F2N4OS2/c1-12-26-20(21(32-12)13-8-14(24)10-15(25)9-13)23(30)29-7-3-4-19(29)22-27-17-6-5-16(31-2)11-18(17)28-22/h5-6,8-11,19H,3-4,7H2,1-2H3,(H,27,28)/t19-/m0/s1 WXVZNXYEWPKXDR-IBGZPJMESA-N 334515 US11040966, Example 1.44::US9732075, Example 1.44::[5-(3,5-Difluoro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 404 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334515 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334515&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127972 384986675 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656678 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1cc(F)cc(F)c1 InChI=1S/C23H20F2N4OS2/c1-12-26-20(21(32-12)13-8-14(24)10-15(25)9-13)23(30)29-7-3-4-19(29)22-27-17-6-5-16(31-2)11-18(17)28-22/h5-6,8-11,19H,3-4,7H2,1-2H3,(H,27,28)/t19-/m0/s1 WXVZNXYEWPKXDR-IBGZPJMESA-N 334515 US11040966, Example 1.44::US9732075, Example 1.44::[5-(3,5-Difluoro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 120 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334515 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334515&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127972 384986675 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656679 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1nccnc1-c1cc(C)cc(F)c1 InChI=1S/C24H22FN5OS/c1-14-10-15(12-16(25)11-14)21-22(27-8-7-26-21)24(31)30-9-3-4-20(30)23-28-18-6-5-17(32-2)13-19(18)29-23/h5-8,10-13,20H,3-4,9H2,1-2H3,(H,28,29)/t20-/m0/s1 ZYVZIIXUTPMZRW-FQEVSTJZSA-N 334516 US11040966, Example 1.45::US9732075, Example 1.45::[3-(3-Fluoro-5-methyl-phenyl)-pyrazin-2-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 501 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334516 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334516&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127938 384986676 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656680 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1nccnc1-c1cc(C)cc(F)c1 InChI=1S/C24H22FN5OS/c1-14-10-15(12-16(25)11-14)21-22(27-8-7-26-21)24(31)30-9-3-4-20(30)23-28-18-6-5-17(32-2)13-19(18)29-23/h5-8,10-13,20H,3-4,9H2,1-2H3,(H,28,29)/t20-/m0/s1 ZYVZIIXUTPMZRW-FQEVSTJZSA-N 334516 US11040966, Example 1.45::US9732075, Example 1.45::[3-(3-Fluoro-5-methyl-phenyl)-pyrazin-2-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 109 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334516 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334516&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127938 384986676 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656681 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1ccccc1-c1ccc(C)c(C)c1 InChI=1S/C27H27N3OS/c1-17-10-11-19(15-18(17)2)21-7-4-5-8-22(21)27(31)30-14-6-9-25(30)26-28-23-13-12-20(32-3)16-24(23)29-26/h4-5,7-8,10-13,15-16,25H,6,9,14H2,1-3H3,(H,28,29)/t25-/m0/s1 HHJGRMWOTILCFK-VWLOTQADSA-N 334517 (3',4'-Dimethyl-biphenyl-2-yl)-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.46::US9732075, Example 1.46 Orexin/Hypocretin receptor type 1 Homo sapiens 128 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334517 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334517&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128136 384986677 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656682 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1ccccc1-c1ccc(C)c(C)c1 InChI=1S/C27H27N3OS/c1-17-10-11-19(15-18(17)2)21-7-4-5-8-22(21)27(31)30-14-6-9-25(30)26-28-23-13-12-20(32-3)16-24(23)29-26/h4-5,7-8,10-13,15-16,25H,6,9,14H2,1-3H3,(H,28,29)/t25-/m0/s1 HHJGRMWOTILCFK-VWLOTQADSA-N 334517 (3',4'-Dimethyl-biphenyl-2-yl)-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.46::US9732075, Example 1.46 Orexin receptor type 2 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334517 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334517&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128136 384986677 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656683 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1ccccc1-n1nccn1 InChI=1S/C21H20N6OS/c1-29-14-8-9-16-17(13-14)25-20(24-16)19-7-4-12-26(19)21(28)15-5-2-3-6-18(15)27-22-10-11-23-27/h2-3,5-6,8-11,13,19H,4,7,12H2,1H3,(H,24,25)/t19-/m0/s1 QOYPTLJJBIQBPJ-IBGZPJMESA-N 334518 US11040966, Example 1.47::US9732075, Example 1.47::[(S)-2-(6-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 446 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334518 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334518&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127793 384986678 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656684 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1ccccc1-n1nccn1 InChI=1S/C21H20N6OS/c1-29-14-8-9-16-17(13-14)25-20(24-16)19-7-4-12-26(19)21(28)15-5-2-3-6-18(15)27-22-10-11-23-27/h2-3,5-6,8-11,13,19H,4,7,12H2,1H3,(H,24,25)/t19-/m0/s1 QOYPTLJJBIQBPJ-IBGZPJMESA-N 334518 US11040966, Example 1.47::US9732075, Example 1.47::[(S)-2-(6-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334518 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334518&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127793 384986678 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656685 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1ccc(Cl)c(Cl)c1 InChI=1S/C24H21Cl2N5OS/c1-13-27-12-16(22(28-13)14-5-7-17(25)18(26)10-14)24(32)31-9-3-4-21(31)23-29-19-8-6-15(33-2)11-20(19)30-23/h5-8,10-12,21H,3-4,9H2,1-2H3,(H,29,30)/t21-/m0/s1 IDWUVVAPAGGUJX-NRFANRHFSA-N 334519 US11040966, Example 1.49::US9732075, Example 1.49::[4-(3,4-Dichloro-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 32.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334519 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334519&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127848 384986679 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656686 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1ccc(Cl)c(Cl)c1 InChI=1S/C24H21Cl2N5OS/c1-13-27-12-16(22(28-13)14-5-7-17(25)18(26)10-14)24(32)31-9-3-4-21(31)23-29-19-8-6-15(33-2)11-20(19)30-23/h5-8,10-12,21H,3-4,9H2,1-2H3,(H,29,30)/t21-/m0/s1 IDWUVVAPAGGUJX-NRFANRHFSA-N 334519 US11040966, Example 1.49::US9732075, Example 1.49::[4-(3,4-Dichloro-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 42.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334519 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334519&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127848 384986679 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656687 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C22H22N6OS/c1-14-8-9-17(28-23-10-11-24-28)15(13-14)22(29)27-12-4-6-18(27)21-25-16-5-3-7-19(30-2)20(16)26-21/h3,5,7-11,13,18H,4,6,12H2,1-2H3,(H,25,26)/t18-/m0/s1 HTLSPVCAEDMMOW-SFHVURJKSA-N 334520 US11040966, Example 1.5::US9732075, Example 1.5::[(S)-2-(7-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 56.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334520 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334520&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694483 384986680 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656688 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C22H22N6OS/c1-14-8-9-17(28-23-10-11-24-28)15(13-14)22(29)27-12-4-6-18(27)21-25-16-5-3-7-19(30-2)20(16)26-21/h3,5,7-11,13,18H,4,6,12H2,1-2H3,(H,25,26)/t18-/m0/s1 HTLSPVCAEDMMOW-SFHVURJKSA-N 334520 US11040966, Example 1.5::US9732075, Example 1.5::[(S)-2-(7-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 23.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334520 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334520&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694483 384986680 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656689 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1ccc(F)cc1 InChI=1S/C24H22FN5OS/c1-14-26-13-18(22(27-14)15-5-7-16(25)8-6-15)24(31)30-11-3-4-21(30)23-28-19-10-9-17(32-2)12-20(19)29-23/h5-10,12-13,21H,3-4,11H2,1-2H3,(H,28,29)/t21-/m0/s1 ATKSNTOBTLXHCR-NRFANRHFSA-N 334521 US11040966, Example 1.50::US9732075, Example 1.50::[4-(4-Fluoro-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 394 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334521 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334521&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127923 384986681 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656690 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1ccc(F)cc1 InChI=1S/C24H22FN5OS/c1-14-26-13-18(22(27-14)15-5-7-16(25)8-6-15)24(31)30-11-3-4-21(30)23-28-19-10-9-17(32-2)12-20(19)29-23/h5-10,12-13,21H,3-4,11H2,1-2H3,(H,28,29)/t21-/m0/s1 ATKSNTOBTLXHCR-NRFANRHFSA-N 334521 US11040966, Example 1.50::US9732075, Example 1.50::[4-(4-Fluoro-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 107 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334521 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334521&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127923 384986681 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656691 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1cccc(Cl)c1 InChI=1S/C24H22ClN5OS/c1-14-26-13-18(22(27-14)15-5-3-6-16(25)11-15)24(31)30-10-4-7-21(30)23-28-19-9-8-17(32-2)12-20(19)29-23/h3,5-6,8-9,11-13,21H,4,7,10H2,1-2H3,(H,28,29)/t21-/m0/s1 MIMICLWIYMZNDS-NRFANRHFSA-N 334522 US11040966, Example 1.51::US9732075, Example 1.51::[4-(3-Chloro-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 66.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334522 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334522&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694382 384986682 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656692 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1cccc(Cl)c1 InChI=1S/C24H22ClN5OS/c1-14-26-13-18(22(27-14)15-5-3-6-16(25)11-15)24(31)30-10-4-7-21(30)23-28-19-9-8-17(32-2)12-20(19)29-23/h3,5-6,8-9,11-13,21H,4,7,10H2,1-2H3,(H,28,29)/t21-/m0/s1 MIMICLWIYMZNDS-NRFANRHFSA-N 334522 US11040966, Example 1.51::US9732075, Example 1.51::[4-(3-Chloro-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 21.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334522 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334522&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694382 384986682 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656693 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cncnc1-c1ccc(Cl)c(Cl)c1 InChI=1S/C23H19Cl2N5OS/c1-32-14-5-7-18-19(10-14)29-22(28-18)20-3-2-8-30(20)23(31)15-11-26-12-27-21(15)13-4-6-16(24)17(25)9-13/h4-7,9-12,20H,2-3,8H2,1H3,(H,28,29)/t20-/m0/s1 XUOISZVUPNLVJJ-FQEVSTJZSA-N 334523 US11040966, Example 1.52::US9732075, Example 1.52::[4-(3,4-Dichloro-phenyl)-pyrimidin-5-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 737 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334523 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334523&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102249 384986683 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656694 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cncnc1-c1ccc(Cl)c(Cl)c1 InChI=1S/C23H19Cl2N5OS/c1-32-14-5-7-18-19(10-14)29-22(28-18)20-3-2-8-30(20)23(31)15-11-26-12-27-21(15)13-4-6-16(24)17(25)9-13/h4-7,9-12,20H,2-3,8H2,1H3,(H,28,29)/t20-/m0/s1 XUOISZVUPNLVJJ-FQEVSTJZSA-N 334523 US11040966, Example 1.52::US9732075, Example 1.52::[4-(3,4-Dichloro-phenyl)-pyrimidin-5-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 121 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334523 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334523&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102249 384986683 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656695 CSc1ccc2nc([nH]c2c1)[C@@H]1CC(CN1C=O)c1cnc(nc1)-c1ccc(C)c(C)c1 InChI=1S/C25H25N5OS/c1-15-4-5-17(8-16(15)2)24-26-11-19(12-27-24)18-9-23(30(13-18)14-31)25-28-21-7-6-20(32-3)10-22(21)29-25/h4-8,10-12,14,18,23H,9,13H2,1-3H3,(H,28,29)/t18?,23-/m0/s1 WYHNXAWURUTZMU-IMMUGOHXSA-N 334524 4-[(3,4-Dimethyl-phenyl)-pyrimidin-5-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.53::US9732075, Example 1.53 Orexin/Hypocretin receptor type 1 Homo sapiens 616 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334524 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334524&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 138752656 384986684 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656696 CSc1ccc2nc([nH]c2c1)[C@@H]1CC(CN1C=O)c1cnc(nc1)-c1ccc(C)c(C)c1 InChI=1S/C25H25N5OS/c1-15-4-5-17(8-16(15)2)24-26-11-19(12-27-24)18-9-23(30(13-18)14-31)25-28-21-7-6-20(32-3)10-22(21)29-25/h4-8,10-12,14,18,23H,9,13H2,1-3H3,(H,28,29)/t18?,23-/m0/s1 WYHNXAWURUTZMU-IMMUGOHXSA-N 334524 4-[(3,4-Dimethyl-phenyl)-pyrimidin-5-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.53::US9732075, Example 1.53 Orexin receptor type 2 Homo sapiens 90.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334524 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334524&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 138752656 384986684 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656697 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cncnc1-c1ccc(Br)c(Cl)c1 InChI=1S/C23H19BrClN5OS/c1-32-14-5-7-18-19(10-14)29-22(28-18)20-3-2-8-30(20)23(31)15-11-26-12-27-21(15)13-4-6-16(24)17(25)9-13/h4-7,9-12,20H,2-3,8H2,1H3,(H,28,29)/t20-/m0/s1 WSQQINOREKVQOT-FQEVSTJZSA-N 334525 US9732075, Example 1.54::[4-(4-Bromo-3-chloro-phenyl)-pyrimidin-5-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 726 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334525 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334525&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127086 384986685 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656698 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cncnc1-c1ccc(Br)c(Cl)c1 InChI=1S/C23H19BrClN5OS/c1-32-14-5-7-18-19(10-14)29-22(28-18)20-3-2-8-30(20)23(31)15-11-26-12-27-21(15)13-4-6-16(24)17(25)9-13/h4-7,9-12,20H,2-3,8H2,1H3,(H,28,29)/t20-/m0/s1 WSQQINOREKVQOT-FQEVSTJZSA-N 334525 US9732075, Example 1.54::[4-(4-Bromo-3-chloro-phenyl)-pyrimidin-5-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 80.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334525 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334525&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127086 384986685 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656699 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1ccc(C)c(C)c1 InChI=1S/C26H27N5OS/c1-15-7-8-18(12-16(15)2)24-20(14-27-17(3)28-24)26(32)31-11-5-6-23(31)25-29-21-10-9-19(33-4)13-22(21)30-25/h7-10,12-14,23H,5-6,11H2,1-4H3,(H,29,30)/t23-/m0/s1 QYHBKIAEOCKXHX-QHCPKHFHSA-N 334526 US11040966, Example 1.55::US9732075, Example 1.55::[4-(3,4-Dimethyl-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 35.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334526 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334526&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694381 384986686 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656700 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1ccc(C)c(C)c1 InChI=1S/C26H27N5OS/c1-15-7-8-18(12-16(15)2)24-20(14-27-17(3)28-24)26(32)31-11-5-6-23(31)25-29-21-10-9-19(33-4)13-22(21)30-25/h7-10,12-14,23H,5-6,11H2,1-4H3,(H,29,30)/t23-/m0/s1 QYHBKIAEOCKXHX-QHCPKHFHSA-N 334526 US11040966, Example 1.55::US9732075, Example 1.55::[4-(3,4-Dimethyl-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 10.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334526 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334526&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694381 384986686 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656701 COc1cccc(c1)-c1nc(C)ncc1C(=O)N1CCC[C@H]1c1nc2ccc(SC)cc2[nH]1 InChI=1S/C25H25N5O2S/c1-15-26-14-19(23(27-15)16-6-4-7-17(12-16)32-2)25(31)30-11-5-8-22(30)24-28-20-10-9-18(33-3)13-21(20)29-24/h4,6-7,9-10,12-14,22H,5,8,11H2,1-3H3,(H,28,29)/t22-/m0/s1 HLQQODKXSJTUAD-QFIPXVFZSA-N 334527 US11040966, Example 1.56::US9732075, Example 1.56::[4-(3-Methoxy-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 252 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334527 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334527&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127601 384986687 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656702 COc1cccc(c1)-c1nc(C)ncc1C(=O)N1CCC[C@H]1c1nc2ccc(SC)cc2[nH]1 InChI=1S/C25H25N5O2S/c1-15-26-14-19(23(27-15)16-6-4-7-17(12-16)32-2)25(31)30-11-5-8-22(30)24-28-20-10-9-18(33-3)13-21(20)29-24/h4,6-7,9-10,12-14,22H,5,8,11H2,1-3H3,(H,28,29)/t22-/m0/s1 HLQQODKXSJTUAD-QFIPXVFZSA-N 334527 US11040966, Example 1.56::US9732075, Example 1.56::[4-(3-Methoxy-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 88.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334527 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334527&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127601 384986687 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656703 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1ccccc1 InChI=1S/C24H23N5OS/c1-15-25-14-18(22(26-15)16-7-4-3-5-8-16)24(30)29-12-6-9-21(29)23-27-19-11-10-17(31-2)13-20(19)28-23/h3-5,7-8,10-11,13-14,21H,6,9,12H2,1-2H3,(H,27,28)/t21-/m0/s1 BBLBGHPIWOBLLO-NRFANRHFSA-N 334528 (2-Methyl-4-phenyl-pyrimidin-5-yl)-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.57::US9732075, Example 1.57 Orexin/Hypocretin receptor type 1 Homo sapiens 76.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334528 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334528&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694384 384986688 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656704 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1ccccc1 InChI=1S/C24H23N5OS/c1-15-25-14-18(22(26-15)16-7-4-3-5-8-16)24(30)29-12-6-9-21(29)23-27-19-11-10-17(31-2)13-20(19)28-23/h3-5,7-8,10-11,13-14,21H,6,9,12H2,1-2H3,(H,27,28)/t21-/m0/s1 BBLBGHPIWOBLLO-NRFANRHFSA-N 334528 (2-Methyl-4-phenyl-pyrimidin-5-yl)-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.57::US9732075, Example 1.57 Orexin receptor type 2 Homo sapiens 22.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334528 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334528&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694384 384986688 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656705 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1ccc(Br)c(Cl)c1 InChI=1S/C24H21BrClN5OS/c1-13-27-12-16(22(28-13)14-5-7-17(25)18(26)10-14)24(32)31-9-3-4-21(31)23-29-19-8-6-15(33-2)11-20(19)30-23/h5-8,10-12,21H,3-4,9H2,1-2H3,(H,29,30)/t21-/m0/s1 KIZGIMPAXLDJCB-NRFANRHFSA-N 334529 US11040966, Example 1.58::US9732075, Example 1.58::[4-(4-Bromo-3-chloro-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 32.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334529 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334529&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694383 384986689 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656706 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1ccc(Br)c(Cl)c1 InChI=1S/C24H21BrClN5OS/c1-13-27-12-16(22(28-13)14-5-7-17(25)18(26)10-14)24(32)31-9-3-4-21(31)23-29-19-8-6-15(33-2)11-20(19)30-23/h5-8,10-12,21H,3-4,9H2,1-2H3,(H,29,30)/t21-/m0/s1 KIZGIMPAXLDJCB-NRFANRHFSA-N 334529 US11040966, Example 1.58::US9732075, Example 1.58::[4-(4-Bromo-3-chloro-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 24.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334529 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334529&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694383 384986689 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656707 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1cc(Cl)cc(Cl)c1 InChI=1S/C24H21Cl2N5OS/c1-13-27-12-18(22(28-13)14-8-15(25)10-16(26)9-14)24(32)31-7-3-4-21(31)23-29-19-6-5-17(33-2)11-20(19)30-23/h5-6,8-12,21H,3-4,7H2,1-2H3,(H,29,30)/t21-/m0/s1 MZOVFNNJIFCVRX-NRFANRHFSA-N 334530 US11040966, Example 1.59::US9732075, Example 1.59::[4-(3,5-Dichloro-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 77.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334530 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334530&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127016 384986690 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656708 CSc1ccc2nc([nH]c2c1)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1cc(Cl)cc(Cl)c1 InChI=1S/C24H21Cl2N5OS/c1-13-27-12-18(22(28-13)14-8-15(25)10-16(26)9-14)24(32)31-7-3-4-21(31)23-29-19-6-5-17(33-2)11-20(19)30-23/h5-6,8-12,21H,3-4,7H2,1-2H3,(H,29,30)/t21-/m0/s1 MZOVFNNJIFCVRX-NRFANRHFSA-N 334530 US11040966, Example 1.59::US9732075, Example 1.59::[4-(3,5-Dichloro-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(6-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 252 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334530 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334530&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127016 384986690 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656709 Cc1ccc(c(c1)C(=O)N1CCC[C@H]1c1nc2cccc(Cl)c2[nH]1)-n1nccn1 InChI=1S/C21H19ClN6O/c1-13-7-8-17(28-23-9-10-24-28)14(12-13)21(29)27-11-3-6-18(27)20-25-16-5-2-4-15(22)19(16)26-20/h2,4-5,7-10,12,18H,3,6,11H2,1H3,(H,25,26)/t18-/m0/s1 VEDWHDKEAFEZES-SFHVURJKSA-N 334531 US11040966, Example 1.6::US9732075, Example 1.6::[(S)-2-(7-Chloro-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 202 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334531 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334531&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102422 384986691 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656710 Cc1ccc(c(c1)C(=O)N1CCC[C@H]1c1nc2cccc(Cl)c2[nH]1)-n1nccn1 InChI=1S/C21H19ClN6O/c1-13-7-8-17(28-23-9-10-24-28)14(12-13)21(29)27-11-3-6-18(27)20-25-16-5-2-4-15(22)19(16)26-20/h2,4-5,7-10,12,18H,3,6,11H2,1H3,(H,25,26)/t18-/m0/s1 VEDWHDKEAFEZES-SFHVURJKSA-N 334531 US11040966, Example 1.6::US9732075, Example 1.6::[(S)-2-(7-Chloro-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 46.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334531 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334531&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102422 384986691 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656711 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1ccc(Br)cc1 InChI=1S/C23H21BrN4OS2/c1-13-25-20(21(31-13)14-8-10-15(24)11-9-14)23(29)28-12-4-6-17(28)22-26-16-5-3-7-18(30-2)19(16)27-22/h3,5,7-11,17H,4,6,12H2,1-2H3,(H,26,27)/t17-/m0/s1 DQGWQJYLINXYQR-KRWDZBQOSA-N 334532 US11040966, Example 1.60::US9732075, Example 1.60::[5-(4-Bromo-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 61.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334532 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334532&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118126988 384986692 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656712 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1ccc(Br)cc1 InChI=1S/C23H21BrN4OS2/c1-13-25-20(21(31-13)14-8-10-15(24)11-9-14)23(29)28-12-4-6-17(28)22-26-16-5-3-7-18(30-2)19(16)27-22/h3,5,7-11,17H,4,6,12H2,1-2H3,(H,26,27)/t17-/m0/s1 DQGWQJYLINXYQR-KRWDZBQOSA-N 334532 US11040966, Example 1.60::US9732075, Example 1.60::[5-(4-Bromo-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 48.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334532 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334532&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118126988 384986692 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656713 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1nc(sc1-c1ccccc1)C1CC1 InChI=1S/C25H24N4OS2/c1-31-19-11-5-9-17-20(19)27-23(26-17)18-10-6-14-29(18)25(30)21-22(15-7-3-2-4-8-15)32-24(28-21)16-12-13-16/h2-5,7-9,11,16,18H,6,10,12-14H2,1H3,(H,26,27)/t18-/m0/s1 WKZGTCAKQUKKCC-SFHVURJKSA-N 334533 (2-Cyclopropyl-5-phenyl-thiazol-4-yl)-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.61::US9732075, Example 1.61 Orexin/Hypocretin receptor type 1 Homo sapiens 21.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334533 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334533&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694386 384986693 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656714 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1nc(sc1-c1ccccc1)C1CC1 InChI=1S/C25H24N4OS2/c1-31-19-11-5-9-17-20(19)27-23(26-17)18-10-6-14-29(18)25(30)21-22(15-7-3-2-4-8-15)32-24(28-21)16-12-13-16/h2-5,7-9,11,16,18H,6,10,12-14H2,1H3,(H,26,27)/t18-/m0/s1 WKZGTCAKQUKKCC-SFHVURJKSA-N 334533 (2-Cyclopropyl-5-phenyl-thiazol-4-yl)-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.61::US9732075, Example 1.61 Orexin receptor type 2 Homo sapiens 21.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334533 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334533&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694386 384986693 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656715 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1Cl InChI=1S/C23H20Cl2N4OS2/c1-12-26-20(21(32-12)13-6-3-7-14(24)18(13)25)23(30)29-11-5-9-16(29)22-27-15-8-4-10-17(31-2)19(15)28-22/h3-4,6-8,10,16H,5,9,11H2,1-2H3,(H,27,28)/t16-/m0/s1 JZAKQDTYKYIGSJ-INIZCTEOSA-N 334534 US11040966, Example 1.62::US9732075, Example 1.62::[5-(2,3-Dichloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 128 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334534 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334534&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127929 384986694 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656716 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1Cl InChI=1S/C23H20Cl2N4OS2/c1-12-26-20(21(32-12)13-6-3-7-14(24)18(13)25)23(30)29-11-5-9-16(29)22-27-15-8-4-10-17(31-2)19(15)28-22/h3-4,6-8,10,16H,5,9,11H2,1-2H3,(H,27,28)/t16-/m0/s1 JZAKQDTYKYIGSJ-INIZCTEOSA-N 334534 US11040966, Example 1.62::US9732075, Example 1.62::[5-(2,3-Dichloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 197 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334534 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334534&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127929 384986694 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656717 COc1cccc(c1)-c1sc(C)nc1C(=O)N1CCC[C@H]1c1nc2cccc(SC)c2[nH]1 InChI=1S/C24H24N4O2S2/c1-14-25-21(22(32-14)15-7-4-8-16(13-15)30-2)24(29)28-12-6-10-18(28)23-26-17-9-5-11-19(31-3)20(17)27-23/h4-5,7-9,11,13,18H,6,10,12H2,1-3H3,(H,26,27)/t18-/m0/s1 UXQVMIROINZUOC-SFHVURJKSA-N 334535 US11040966, Example 1.63::US9732075, Example 1.63::[5-(3-Methoxy-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 12.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334535 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334535&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694385 384986695 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656718 COc1cccc(c1)-c1sc(C)nc1C(=O)N1CCC[C@H]1c1nc2cccc(SC)c2[nH]1 InChI=1S/C24H24N4O2S2/c1-14-25-21(22(32-14)15-7-4-8-16(13-15)30-2)24(29)28-12-6-10-18(28)23-26-17-9-5-11-19(31-3)20(17)27-23/h4-5,7-9,11,13,18H,6,10,12H2,1-3H3,(H,26,27)/t18-/m0/s1 UXQVMIROINZUOC-SFHVURJKSA-N 334535 US11040966, Example 1.63::US9732075, Example 1.63::[5-(3-Methoxy-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334535 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334535&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694385 384986695 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656719 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1cccc(c1)C(F)(F)F InChI=1S/C24H21F3N4OS2/c1-13-28-20(21(34-13)14-6-3-7-15(12-14)24(25,26)27)23(32)31-11-5-9-17(31)22-29-16-8-4-10-18(33-2)19(16)30-22/h3-4,6-8,10,12,17H,5,9,11H2,1-2H3,(H,29,30)/t17-/m0/s1 KGKZRTMWKKDPKH-KRWDZBQOSA-N 334536 US11040966, Example 1.64::US9732075, Example 1.64::[(S)-2-(7-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-[2-methyl-5-(3-trifluoromethyl-phenyl)-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 12.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334536 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334536&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694787 384986696 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656720 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1cccc(c1)C(F)(F)F InChI=1S/C24H21F3N4OS2/c1-13-28-20(21(34-13)14-6-3-7-15(12-14)24(25,26)27)23(32)31-11-5-9-17(31)22-29-16-8-4-10-18(33-2)19(16)30-22/h3-4,6-8,10,12,17H,5,9,11H2,1-2H3,(H,29,30)/t17-/m0/s1 KGKZRTMWKKDPKH-KRWDZBQOSA-N 334536 US11040966, Example 1.64::US9732075, Example 1.64::[(S)-2-(7-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-[2-methyl-5-(3-trifluoromethyl-phenyl)-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 18.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334536 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334536&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694787 384986696 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656721 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1cccc(F)c1 InChI=1S/C23H21FN4OS2/c1-13-25-20(21(31-13)14-6-3-7-15(24)12-14)23(29)28-11-5-9-17(28)22-26-16-8-4-10-18(30-2)19(16)27-22/h3-4,6-8,10,12,17H,5,9,11H2,1-2H3,(H,26,27)/t17-/m0/s1 RLPJGRHMTOSUBD-KRWDZBQOSA-N 334538 US11040966, Example 1.65::US9732075, Example 1.65::[5-(3-Fluoro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 63.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334538 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334538&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128086 384986698 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656722 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1cccc(F)c1 InChI=1S/C23H21FN4OS2/c1-13-25-20(21(31-13)14-6-3-7-15(24)12-14)23(29)28-11-5-9-17(28)22-26-16-8-4-10-18(30-2)19(16)27-22/h3-4,6-8,10,12,17H,5,9,11H2,1-2H3,(H,26,27)/t17-/m0/s1 RLPJGRHMTOSUBD-KRWDZBQOSA-N 334538 US11040966, Example 1.65::US9732075, Example 1.65::[5-(3-Fluoro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 147 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334538 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334538&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128086 384986698 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656723 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1ccc(C)cc1 InChI=1S/C24H24N4OS2/c1-14-9-11-16(12-10-14)22-21(25-15(2)31-22)24(29)28-13-5-7-18(28)23-26-17-6-4-8-19(30-3)20(17)27-23/h4,6,8-12,18H,5,7,13H2,1-3H3,(H,26,27)/t18-/m0/s1 AHBLJDKOKSEQJP-SFHVURJKSA-N 334539 US11040966, Example 1.66::US9732075, Example 1.66::[(S)-2-(7-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-p-tolyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 20.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334539 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334539&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694789 384986699 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656724 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1ccc(C)cc1 InChI=1S/C24H24N4OS2/c1-14-9-11-16(12-10-14)22-21(25-15(2)31-22)24(29)28-13-5-7-18(28)23-26-17-6-4-8-19(30-3)20(17)27-23/h4,6,8-12,18H,5,7,13H2,1-3H3,(H,26,27)/t18-/m0/s1 AHBLJDKOKSEQJP-SFHVURJKSA-N 334539 US11040966, Example 1.66::US9732075, Example 1.66::[(S)-2-(7-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-p-tolyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 47.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334539 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334539&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694789 384986699 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656725 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1ccc(F)c(F)c1 InChI=1S/C23H20F2N4OS2/c1-12-26-20(21(32-12)13-8-9-14(24)15(25)11-13)23(30)29-10-4-6-17(29)22-27-16-5-3-7-18(31-2)19(16)28-22/h3,5,7-9,11,17H,4,6,10H2,1-2H3,(H,27,28)/t17-/m0/s1 VDTLZABOPPLAPJ-KRWDZBQOSA-N 334540 US11040966, Example 1.67::US9732075, Example 1.67::[5-(3,4-Difluoro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 127 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334540 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334540&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127857 384986700 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656726 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1ccc(F)c(F)c1 InChI=1S/C23H20F2N4OS2/c1-12-26-20(21(32-12)13-8-9-14(24)15(25)11-13)23(30)29-10-4-6-17(29)22-27-16-5-3-7-18(31-2)19(16)28-22/h3,5,7-9,11,17H,4,6,10H2,1-2H3,(H,27,28)/t17-/m0/s1 VDTLZABOPPLAPJ-KRWDZBQOSA-N 334540 US11040966, Example 1.67::US9732075, Example 1.67::[5-(3,4-Difluoro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 84.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334540 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334540&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127857 384986700 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656727 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1nc(sc1-c1ccc(C)cc1)C1CC1 InChI=1S/C26H26N4OS2/c1-15-8-10-16(11-9-15)23-22(29-25(33-23)17-12-13-17)26(31)30-14-4-6-19(30)24-27-18-5-3-7-20(32-2)21(18)28-24/h3,5,7-11,17,19H,4,6,12-14H2,1-2H3,(H,27,28)/t19-/m0/s1 SFAGJJKDFXHLIE-IBGZPJMESA-N 334541 (2-Cyclopropyl-5-p-tolyl-thiazol-4-yl)-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.68::US9732075, Example 1.68 Orexin/Hypocretin receptor type 1 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334541 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334541&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694480 384986701 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656728 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1nc(sc1-c1ccc(C)cc1)C1CC1 InChI=1S/C26H26N4OS2/c1-15-8-10-16(11-9-15)23-22(29-25(33-23)17-12-13-17)26(31)30-14-4-6-19(30)24-27-18-5-3-7-20(32-2)21(18)28-24/h3,5,7-11,17,19H,4,6,12-14H2,1-2H3,(H,27,28)/t19-/m0/s1 SFAGJJKDFXHLIE-IBGZPJMESA-N 334541 (2-Cyclopropyl-5-p-tolyl-thiazol-4-yl)-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.68::US9732075, Example 1.68 Orexin receptor type 2 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334541 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334541&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694480 384986701 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656729 CCc1ccc(cc1)-c1sc(C)nc1C(=O)N1CCC[C@H]1c1nc2cccc(SC)c2[nH]1 InChI=1S/C25H26N4OS2/c1-4-16-10-12-17(13-11-16)23-22(26-15(2)32-23)25(30)29-14-6-8-19(29)24-27-18-7-5-9-20(31-3)21(18)28-24/h5,7,9-13,19H,4,6,8,14H2,1-3H3,(H,27,28)/t19-/m0/s1 ZBHWTBYZUJXGJA-IBGZPJMESA-N 334542 US11040966, Example 1.69::US9732075, Example 1.69::[5-(4-Ethyl-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 37.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334542 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334542&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127226 384986702 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656730 CCc1ccc(cc1)-c1sc(C)nc1C(=O)N1CCC[C@H]1c1nc2cccc(SC)c2[nH]1 InChI=1S/C25H26N4OS2/c1-4-16-10-12-17(13-11-16)23-22(26-15(2)32-23)25(30)29-14-6-8-19(29)24-27-18-7-5-9-20(31-3)21(18)28-24/h5,7,9-13,19H,4,6,8,14H2,1-3H3,(H,27,28)/t19-/m0/s1 ZBHWTBYZUJXGJA-IBGZPJMESA-N 334542 US11040966, Example 1.69::US9732075, Example 1.69::[5-(4-Ethyl-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 31.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334542 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334542&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127226 384986702 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656731 CSc1ccc2[nH]c(nc2c1)[C@@H]1CCCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C22H22N6OS/c1-14-5-8-19(28-23-9-10-24-28)16(12-14)22(29)27-11-3-4-20(27)21-25-17-7-6-15(30-2)13-18(17)26-21/h5-10,12-13,20H,3-4,11H2,1-2H3,(H,25,26)/t20-/m0/s1 XXLHLBBZFMWPEJ-FQEVSTJZSA-N 334543 US11040966, Example 1.7::US9732075, Example 1.7::[(S)-2-(5-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 93.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334543 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334543&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127311 384986703 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656732 CSc1ccc2[nH]c(nc2c1)[C@@H]1CCCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C22H22N6OS/c1-14-5-8-19(28-23-9-10-24-28)16(12-14)22(29)27-11-3-4-20(27)21-25-17-7-6-15(30-2)13-18(17)26-21/h5-10,12-13,20H,3-4,11H2,1-2H3,(H,25,26)/t20-/m0/s1 XXLHLBBZFMWPEJ-FQEVSTJZSA-N 334543 US11040966, Example 1.7::US9732075, Example 1.7::[(S)-2-(5-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334543 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334543&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127311 384986703 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656733 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1nc(sc1-c1ccc(F)cc1)C1CC1 InChI=1S/C25H23FN4OS2/c1-32-19-6-2-4-17-20(19)28-23(27-17)18-5-3-13-30(18)25(31)21-22(14-9-11-16(26)12-10-14)33-24(29-21)15-7-8-15/h2,4,6,9-12,15,18H,3,5,7-8,13H2,1H3,(H,27,28)/t18-/m0/s1 SUWOLYQPXZMIAS-SFHVURJKSA-N 334544 US11040966, Example 1.70::US9732075, Example 1.70::[2-Cyclopropyl-5-(4-fluoro-phenyl)-thiazol-4-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 26.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334544 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334544&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694479 384986704 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656734 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1nc(sc1-c1ccc(F)cc1)C1CC1 InChI=1S/C25H23FN4OS2/c1-32-19-6-2-4-17-20(19)28-23(27-17)18-5-3-13-30(18)25(31)21-22(14-9-11-16(26)12-10-14)33-24(29-21)15-7-8-15/h2,4,6,9-12,15,18H,3,5,7-8,13H2,1H3,(H,27,28)/t18-/m0/s1 SUWOLYQPXZMIAS-SFHVURJKSA-N 334544 US11040966, Example 1.70::US9732075, Example 1.70::[2-Cyclopropyl-5-(4-fluoro-phenyl)-thiazol-4-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 26.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334544 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334544&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694479 384986704 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656735 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1cc(F)cc(F)c1 InChI=1S/C23H20F2N4OS2/c1-12-26-20(21(32-12)13-9-14(24)11-15(25)10-13)23(30)29-8-4-6-17(29)22-27-16-5-3-7-18(31-2)19(16)28-22/h3,5,7,9-11,17H,4,6,8H2,1-2H3,(H,27,28)/t17-/m0/s1 WCZVADLDLKLJEI-KRWDZBQOSA-N 334545 US11040966, Example 1.71::US9732075, Example 1.71::[5-(3,5-Difluoro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 95.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334545 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334545&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127822 384986705 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656736 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1cc(F)cc(F)c1 InChI=1S/C23H20F2N4OS2/c1-12-26-20(21(32-12)13-9-14(24)11-15(25)10-13)23(30)29-8-4-6-17(29)22-27-16-5-3-7-18(31-2)19(16)28-22/h3,5,7,9-11,17H,4,6,8H2,1-2H3,(H,27,28)/t17-/m0/s1 WCZVADLDLKLJEI-KRWDZBQOSA-N 334545 US11040966, Example 1.71::US9732075, Example 1.71::[5-(3,5-Difluoro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 162 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334545 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334545&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127822 384986705 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656737 COc1ccc(cc1)-c1nccnc1C(=O)N1CCC[C@H]1c1nc2cccc(SC)c2[nH]1 InChI=1S/C24H23N5O2S/c1-31-16-10-8-15(9-11-16)20-22(26-13-12-25-20)24(30)29-14-4-6-18(29)23-27-17-5-3-7-19(32-2)21(17)28-23/h3,5,7-13,18H,4,6,14H2,1-2H3,(H,27,28)/t18-/m0/s1 PTBDDWQJLAMOIB-SFHVURJKSA-N 334546 US11040966, Example 1.72::US9732075, Example 1.72::[3-(4-Methoxy-phenyl)-pyrazin-2-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 112 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334546 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334546&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102258 384986706 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656738 COc1ccc(cc1)-c1nccnc1C(=O)N1CCC[C@H]1c1nc2cccc(SC)c2[nH]1 InChI=1S/C24H23N5O2S/c1-31-16-10-8-15(9-11-16)20-22(26-13-12-25-20)24(30)29-14-4-6-18(29)23-27-17-5-3-7-19(32-2)21(17)28-23/h3,5,7-13,18H,4,6,14H2,1-2H3,(H,27,28)/t18-/m0/s1 PTBDDWQJLAMOIB-SFHVURJKSA-N 334546 US11040966, Example 1.72::US9732075, Example 1.72::[3-(4-Methoxy-phenyl)-pyrazin-2-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 180 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334546 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334546&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102258 384986706 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656739 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1nccnc1-c1cccc(c1)C(F)(F)F InChI=1S/C24H20F3N5OS/c1-34-18-9-3-7-16-20(18)31-22(30-16)17-8-4-12-32(17)23(33)21-19(28-10-11-29-21)14-5-2-6-15(13-14)24(25,26)27/h2-3,5-7,9-11,13,17H,4,8,12H2,1H3,(H,30,31)/t17-/m0/s1 NZQJGWVKJLZJIZ-KRWDZBQOSA-N 334547 US11040966, Example 1.73::US9732075, Example 1.73::[(S)-2-(7-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-[3-(3-trifluoromethyl-phenyl)-pyrazin-2-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 136 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334547 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334547&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127787 384986707 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656740 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1nccnc1-c1cccc(c1)C(F)(F)F InChI=1S/C24H20F3N5OS/c1-34-18-9-3-7-16-20(18)31-22(30-16)17-8-4-12-32(17)23(33)21-19(28-10-11-29-21)14-5-2-6-15(13-14)24(25,26)27/h2-3,5-7,9-11,13,17H,4,8,12H2,1H3,(H,30,31)/t17-/m0/s1 NZQJGWVKJLZJIZ-KRWDZBQOSA-N 334547 US11040966, Example 1.73::US9732075, Example 1.73::[(S)-2-(7-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-[3-(3-trifluoromethyl-phenyl)-pyrazin-2-yl]-methanone Orexin receptor type 2 Homo sapiens 282 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334547 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334547&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127787 384986707 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656741 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1nccnc1-c1cc(C)cc(F)c1 InChI=1S/C24H22FN5OS/c1-14-11-15(13-16(25)12-14)20-22(27-9-8-26-20)24(31)30-10-4-6-18(30)23-28-17-5-3-7-19(32-2)21(17)29-23/h3,5,7-9,11-13,18H,4,6,10H2,1-2H3,(H,28,29)/t18-/m0/s1 NIWYQVCOUJVVGA-SFHVURJKSA-N 334548 US11040966, Example 1.74::US9732075, Example 1.74::[3-(3-Fluoro-5-methyl-phenyl)-pyrazin-2-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 52.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334548 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334548&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127069 384986708 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656742 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1nccnc1-c1cc(C)cc(F)c1 InChI=1S/C24H22FN5OS/c1-14-11-15(13-16(25)12-14)20-22(27-9-8-26-20)24(31)30-10-4-6-18(30)23-28-17-5-3-7-19(32-2)21(17)29-23/h3,5,7-9,11-13,18H,4,6,10H2,1-2H3,(H,28,29)/t18-/m0/s1 NIWYQVCOUJVVGA-SFHVURJKSA-N 334548 US11040966, Example 1.74::US9732075, Example 1.74::[3-(3-Fluoro-5-methyl-phenyl)-pyrazin-2-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 100.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334548 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334548&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127069 384986708 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656743 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1ccccc1-c1ccc(C)c(C)c1 InChI=1S/C27H27N3OS/c1-17-13-14-19(16-18(17)2)20-8-4-5-9-21(20)27(31)30-15-7-11-23(30)26-28-22-10-6-12-24(32-3)25(22)29-26/h4-6,8-10,12-14,16,23H,7,11,15H2,1-3H3,(H,28,29)/t23-/m0/s1 KJYLFYSLBZATDX-QHCPKHFHSA-N 334549 (3',4'-Dimethyl-biphenyl-2-yl)-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.75::US9732075, Example 1.75 Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334549 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334549&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694890 384986709 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656744 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1ccccc1-c1ccc(C)c(C)c1 InChI=1S/C27H27N3OS/c1-17-13-14-19(16-18(17)2)20-8-4-5-9-21(20)27(31)30-15-7-11-23(30)26-28-22-10-6-12-24(32-3)25(22)29-26/h4-6,8-10,12-14,16,23H,7,11,15H2,1-3H3,(H,28,29)/t23-/m0/s1 KJYLFYSLBZATDX-QHCPKHFHSA-N 334549 (3',4'-Dimethyl-biphenyl-2-yl)-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.75::US9732075, Example 1.75 Orexin receptor type 2 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334549 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334549&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694890 384986709 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656745 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1ccccc1-n1nccn1 InChI=1S/C21H20N6OS/c1-29-18-10-4-7-15-19(18)25-20(24-15)17-9-5-13-26(17)21(28)14-6-2-3-8-16(14)27-22-11-12-23-27/h2-4,6-8,10-12,17H,5,9,13H2,1H3,(H,24,25)/t17-/m0/s1 GLJRTAQBJNCMEO-KRWDZBQOSA-N 334550 US11040966, Example 1.76::US9732075, Example 1.76::[(S)-2-(7-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 279 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334550 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334550&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127157 384986710 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656746 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1ccccc1-n1nccn1 InChI=1S/C21H20N6OS/c1-29-18-10-4-7-15-19(18)25-20(24-15)17-9-5-13-26(17)21(28)14-6-2-3-8-16(14)27-22-11-12-23-27/h2-4,6-8,10-12,17H,5,9,13H2,1H3,(H,24,25)/t17-/m0/s1 GLJRTAQBJNCMEO-KRWDZBQOSA-N 334550 US11040966, Example 1.76::US9732075, Example 1.76::[(S)-2-(7-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 17.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334550 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334550&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127157 384986710 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656747 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cncnc1-c1ccc(C)cc1 InChI=1S/C24H23N5OS/c1-15-8-10-16(11-9-15)21-17(13-25-14-26-21)24(30)29-12-4-6-19(29)23-27-18-5-3-7-20(31-2)22(18)28-23/h3,5,7-11,13-14,19H,4,6,12H2,1-2H3,(H,27,28)/t19-/m0/s1 NQOHGZWMOAPCBQ-IBGZPJMESA-N 334551 US11040966, Example 1.78::US9732075, Example 1.78::[(S)-2-(7-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(4-p-tolyl-pyrimidin-5-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 102 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334551 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334551&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127901 384986711 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656748 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cncnc1-c1ccc(C)cc1 InChI=1S/C24H23N5OS/c1-15-8-10-16(11-9-15)21-17(13-25-14-26-21)24(30)29-12-4-6-19(29)23-27-18-5-3-7-20(31-2)22(18)28-23/h3,5,7-11,13-14,19H,4,6,12H2,1-2H3,(H,27,28)/t19-/m0/s1 NQOHGZWMOAPCBQ-IBGZPJMESA-N 334551 US11040966, Example 1.78::US9732075, Example 1.78::[(S)-2-(7-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(4-p-tolyl-pyrimidin-5-yl)-methanone Orexin receptor type 2 Homo sapiens 408 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334551 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334551&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127901 384986711 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656749 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1ccc(Cl)c(Cl)c1 InChI=1S/C24H21Cl2N5OS/c1-13-27-12-15(21(28-13)14-8-9-16(25)17(26)11-14)24(32)31-10-4-6-19(31)23-29-18-5-3-7-20(33-2)22(18)30-23/h3,5,7-9,11-12,19H,4,6,10H2,1-2H3,(H,29,30)/t19-/m0/s1 GIEGFRBKZPFXTI-IBGZPJMESA-N 334552 US11040966, Example 1.79::US9732075, Example 1.79::[4-(3,4-Dichloro-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334552 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334552&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694791 384986712 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656750 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1ccc(Cl)c(Cl)c1 InChI=1S/C24H21Cl2N5OS/c1-13-27-12-15(21(28-13)14-8-9-16(25)17(26)11-14)24(32)31-10-4-6-19(31)23-29-18-5-3-7-20(33-2)22(18)30-23/h3,5,7-9,11-12,19H,4,6,10H2,1-2H3,(H,29,30)/t19-/m0/s1 GIEGFRBKZPFXTI-IBGZPJMESA-N 334552 US11040966, Example 1.79::US9732075, Example 1.79::[4-(3,4-Dichloro-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 46.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334552 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334552&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694791 384986712 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656751 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1ccc(F)cc1 InChI=1S/C24H22FN5OS/c1-14-26-13-17(21(27-14)15-8-10-16(25)11-9-15)24(31)30-12-4-6-19(30)23-28-18-5-3-7-20(32-2)22(18)29-23/h3,5,7-11,13,19H,4,6,12H2,1-2H3,(H,28,29)/t19-/m0/s1 YCCKINOOUOQIAP-IBGZPJMESA-N 334553 US11040966, Example 1.80::US9732075, Example 1.80::[4-(4-Fluoro-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 41.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334553 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334553&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127955 384986713 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656752 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1ccc(F)cc1 InChI=1S/C24H22FN5OS/c1-14-26-13-17(21(27-14)15-8-10-16(25)11-9-15)24(31)30-12-4-6-19(30)23-28-18-5-3-7-20(32-2)22(18)29-23/h3,5,7-11,13,19H,4,6,12H2,1-2H3,(H,28,29)/t19-/m0/s1 YCCKINOOUOQIAP-IBGZPJMESA-N 334553 US11040966, Example 1.80::US9732075, Example 1.80::[4-(4-Fluoro-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 564 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334553 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334553&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127955 384986713 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656753 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1cccc(Cl)c1 InChI=1S/C24H22ClN5OS/c1-14-26-13-17(21(27-14)15-6-3-7-16(25)12-15)24(31)30-11-5-9-19(30)23-28-18-8-4-10-20(32-2)22(18)29-23/h3-4,6-8,10,12-13,19H,5,9,11H2,1-2H3,(H,28,29)/t19-/m0/s1 DYOVNQRKFGSZFM-IBGZPJMESA-N 334554 US11040966, Example 1.81::US9732075, Example 1.81::[4-(3-Chloro-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 20.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334554 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334554&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127731 384986714 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656754 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1cccc(Cl)c1 InChI=1S/C24H22ClN5OS/c1-14-26-13-17(21(27-14)15-6-3-7-16(25)12-15)24(31)30-11-5-9-19(30)23-28-18-8-4-10-20(32-2)22(18)29-23/h3-4,6-8,10,12-13,19H,5,9,11H2,1-2H3,(H,28,29)/t19-/m0/s1 DYOVNQRKFGSZFM-IBGZPJMESA-N 334554 US11040966, Example 1.81::US9732075, Example 1.81::[4-(3-Chloro-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 116 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334554 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334554&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127731 384986714 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656755 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cncnc1-c1ccc(Cl)c(Cl)c1 InChI=1S/C23H19Cl2N5OS/c1-32-19-6-2-4-17-21(19)29-22(28-17)18-5-3-9-30(18)23(31)14-11-26-12-27-20(14)13-7-8-15(24)16(25)10-13/h2,4,6-8,10-12,18H,3,5,9H2,1H3,(H,28,29)/t18-/m0/s1 GUUSAHRICWMQQR-SFHVURJKSA-N 334555 US11040966, Example 1.82::US9732075, Example 1.82::[4-(3,4-Dichloro-phenyl)-pyrimidin-5-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334555 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334555&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694792 384986715 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656756 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cncnc1-c1ccc(Cl)c(Cl)c1 InChI=1S/C23H19Cl2N5OS/c1-32-19-6-2-4-17-21(19)29-22(28-17)18-5-3-9-30(18)23(31)14-11-26-12-27-20(14)13-7-8-15(24)16(25)10-13/h2,4,6-8,10-12,18H,3,5,9H2,1H3,(H,28,29)/t18-/m0/s1 GUUSAHRICWMQQR-SFHVURJKSA-N 334555 US11040966, Example 1.82::US9732075, Example 1.82::[4-(3,4-Dichloro-phenyl)-pyrimidin-5-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 17.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334555 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334555&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694792 384986715 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656757 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cncnc1-c1ccc(C)c(C)c1 InChI=1S/C25H25N5OS/c1-15-9-10-17(12-16(15)2)22-18(13-26-14-27-22)25(31)30-11-5-7-20(30)24-28-19-6-4-8-21(32-3)23(19)29-24/h4,6,8-10,12-14,20H,5,7,11H2,1-3H3,(H,28,29)/t20-/m0/s1 KJVXCGISSSJMBC-FQEVSTJZSA-N 334556 US11040966, Example 1.83::US9732075, Example 1.83::[4-(3,4-Dimethyl-phenyl)-pyrimidin-5-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 17.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334556 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334556&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694788 384986716 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656758 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cncnc1-c1ccc(C)c(C)c1 InChI=1S/C25H25N5OS/c1-15-9-10-17(12-16(15)2)22-18(13-26-14-27-22)25(31)30-11-5-7-20(30)24-28-19-6-4-8-21(32-3)23(19)29-24/h4,6,8-10,12-14,20H,5,7,11H2,1-3H3,(H,28,29)/t20-/m0/s1 KJVXCGISSSJMBC-FQEVSTJZSA-N 334556 US11040966, Example 1.83::US9732075, Example 1.83::[4-(3,4-Dimethyl-phenyl)-pyrimidin-5-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 36.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334556 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334556&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694788 384986716 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656759 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cncnc1-c1ccc(Br)c(Cl)c1 InChI=1S/C23H19BrClN5OS/c1-32-19-6-2-4-17-21(19)29-22(28-17)18-5-3-9-30(18)23(31)14-11-26-12-27-20(14)13-7-8-15(24)16(25)10-13/h2,4,6-8,10-12,18H,3,5,9H2,1H3,(H,28,29)/t18-/m0/s1 AYKFNFLKUZRBJY-SFHVURJKSA-N 334557 US11040966, Example 1.84::US9732075, Example 1.84::[4-(4-Bromo-3-chloro-phenyl)-pyrimidin-5-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 14.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334557 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334557&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128255 384986717 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656760 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cncnc1-c1ccc(Br)c(Cl)c1 InChI=1S/C23H19BrClN5OS/c1-32-19-6-2-4-17-21(19)29-22(28-17)18-5-3-9-30(18)23(31)14-11-26-12-27-20(14)13-7-8-15(24)16(25)10-13/h2,4,6-8,10-12,18H,3,5,9H2,1H3,(H,28,29)/t18-/m0/s1 AYKFNFLKUZRBJY-SFHVURJKSA-N 334557 US11040966, Example 1.84::US9732075, Example 1.84::[4-(4-Bromo-3-chloro-phenyl)-pyrimidin-5-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 20.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334557 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334557&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128255 384986717 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656761 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1ccc(C)c(C)c1 InChI=1S/C26H27N5OS/c1-15-10-11-18(13-16(15)2)23-19(14-27-17(3)28-23)26(32)31-12-6-8-21(31)25-29-20-7-5-9-22(33-4)24(20)30-25/h5,7,9-11,13-14,21H,6,8,12H2,1-4H3,(H,29,30)/t21-/m0/s1 KZGNSIZLRYQTAO-NRFANRHFSA-N 334558 US11040966, Example 1.85::US9732075, Example 1.85::[4-(3,4-Dimethyl-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334558 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334558&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127092 384986718 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656762 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1ccc(C)c(C)c1 InChI=1S/C26H27N5OS/c1-15-10-11-18(13-16(15)2)23-19(14-27-17(3)28-23)26(32)31-12-6-8-21(31)25-29-20-7-5-9-22(33-4)24(20)30-25/h5,7,9-11,13-14,21H,6,8,12H2,1-4H3,(H,29,30)/t21-/m0/s1 KZGNSIZLRYQTAO-NRFANRHFSA-N 334558 US11040966, Example 1.85::US9732075, Example 1.85::[4-(3,4-Dimethyl-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 23.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334558 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334558&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127092 384986718 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656763 COc1cccc(c1)-c1nc(C)ncc1C(=O)N1CCC[C@H]1c1nc2cccc(SC)c2[nH]1 InChI=1S/C25H25N5O2S/c1-15-26-14-18(22(27-15)16-7-4-8-17(13-16)32-2)25(31)30-12-6-10-20(30)24-28-19-9-5-11-21(33-3)23(19)29-24/h4-5,7-9,11,13-14,20H,6,10,12H2,1-3H3,(H,28,29)/t20-/m0/s1 DXIWHEXINQSCME-FQEVSTJZSA-N 334559 US11040966, Example 1.86::US9732075, Example 1.86::[4-(3-Methoxy-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 56.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334559 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334559&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127818 384986719 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656764 COc1cccc(c1)-c1nc(C)ncc1C(=O)N1CCC[C@H]1c1nc2cccc(SC)c2[nH]1 InChI=1S/C25H25N5O2S/c1-15-26-14-18(22(27-15)16-7-4-8-17(13-16)32-2)25(31)30-12-6-10-20(30)24-28-19-9-5-11-21(33-3)23(19)29-24/h4-5,7-9,11,13-14,20H,6,10,12H2,1-3H3,(H,28,29)/t20-/m0/s1 DXIWHEXINQSCME-FQEVSTJZSA-N 334559 US11040966, Example 1.86::US9732075, Example 1.86::[4-(3-Methoxy-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 118 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334559 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334559&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127818 384986719 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656765 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1ccccc1 InChI=1S/C24H23N5OS/c1-15-25-14-17(21(26-15)16-8-4-3-5-9-16)24(30)29-13-7-11-19(29)23-27-18-10-6-12-20(31-2)22(18)28-23/h3-6,8-10,12,14,19H,7,11,13H2,1-2H3,(H,27,28)/t19-/m0/s1 IRSJOZHEKVEDAO-IBGZPJMESA-N 334560 (2-Methyl-4-phenyl-pyrimidin-5-yl)-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.87::US9732075, Example 1.87 Orexin/Hypocretin receptor type 1 Homo sapiens 30.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334560 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334560&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128078 384986720 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656766 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1ccccc1 InChI=1S/C24H23N5OS/c1-15-25-14-17(21(26-15)16-8-4-3-5-9-16)24(30)29-13-7-11-19(29)23-27-18-10-6-12-20(31-2)22(18)28-23/h3-6,8-10,12,14,19H,7,11,13H2,1-2H3,(H,27,28)/t19-/m0/s1 IRSJOZHEKVEDAO-IBGZPJMESA-N 334560 (2-Methyl-4-phenyl-pyrimidin-5-yl)-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 1.87::US9732075, Example 1.87 Orexin receptor type 2 Homo sapiens 77.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334560 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334560&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128078 384986720 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656767 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cncnc1-c1cccc(C)c1 InChI=1S/C24H23N5OS/c1-15-6-3-7-16(12-15)21-17(13-25-14-26-21)24(30)29-11-5-9-19(29)23-27-18-8-4-10-20(31-2)22(18)28-23/h3-4,6-8,10,12-14,19H,5,9,11H2,1-2H3,(H,27,28)/t19-/m0/s1 HMNFIRZAYPGZOY-IBGZPJMESA-N 334561 US11040966, Example 1.88::US9732075, Example 1.88::[(S)-2-(7-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(4-m-tolyl-pyrimidin-5-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 102 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334561 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334561&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127001 384986721 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656768 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cncnc1-c1cccc(C)c1 InChI=1S/C24H23N5OS/c1-15-6-3-7-16(12-15)21-17(13-25-14-26-21)24(30)29-11-5-9-19(29)23-27-18-8-4-10-20(31-2)22(18)28-23/h3-4,6-8,10,12-14,19H,5,9,11H2,1-2H3,(H,27,28)/t19-/m0/s1 HMNFIRZAYPGZOY-IBGZPJMESA-N 334561 US11040966, Example 1.88::US9732075, Example 1.88::[(S)-2-(7-Methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(4-m-tolyl-pyrimidin-5-yl)-methanone Orexin receptor type 2 Homo sapiens 109 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334561 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334561&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127001 384986721 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656769 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cncnc1-c1cc(Cl)cc(Cl)c1 InChI=1S/C23H19Cl2N5OS/c1-32-19-6-2-4-17-21(19)29-22(28-17)18-5-3-7-30(18)23(31)16-11-26-12-27-20(16)13-8-14(24)10-15(25)9-13/h2,4,6,8-12,18H,3,5,7H2,1H3,(H,28,29)/t18-/m0/s1 XHCXDOFHOCEXRV-SFHVURJKSA-N 334562 US11040966, Example 1.89::US9732075, Example 1.89::[4-(3,5-Dichloro-phenyl)-pyrimidin-5-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 39.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334562 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334562&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102300 384986722 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656770 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cncnc1-c1cc(Cl)cc(Cl)c1 InChI=1S/C23H19Cl2N5OS/c1-32-19-6-2-4-17-21(19)29-22(28-17)18-5-3-7-30(18)23(31)16-11-26-12-27-20(16)13-8-14(24)10-15(25)9-13/h2,4,6,8-12,18H,3,5,7H2,1H3,(H,28,29)/t18-/m0/s1 XHCXDOFHOCEXRV-SFHVURJKSA-N 334562 US11040966, Example 1.89::US9732075, Example 1.89::[4-(3,5-Dichloro-phenyl)-pyrimidin-5-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 180 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334562 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334562&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102300 384986722 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656771 COc1ccc2[nH]c(nc2c1)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C23H21ClN4O2S/c1-13-25-20(21(31-13)14-5-3-6-15(24)11-14)23(29)28-10-4-7-19(28)22-26-17-9-8-16(30-2)12-18(17)27-22/h3,5-6,8-9,11-12,19H,4,7,10H2,1-2H3,(H,26,27)/t19-/m0/s1 XYVPOQGVLHKCMJ-IBGZPJMESA-N 334563 US11040966, Example 1.9::US9732075, Example 1.9::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 337 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334563 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334563&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102356 384986723 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656772 COc1ccc2[nH]c(nc2c1)[C@@H]1CCCN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C23H21ClN4O2S/c1-13-25-20(21(31-13)14-5-3-6-15(24)11-14)23(29)28-10-4-7-19(28)22-26-17-9-8-16(30-2)12-18(17)27-22/h3,5-6,8-9,11-12,19H,4,7,10H2,1-2H3,(H,26,27)/t19-/m0/s1 XYVPOQGVLHKCMJ-IBGZPJMESA-N 334563 US11040966, Example 1.9::US9732075, Example 1.9::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 69.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334563 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334563&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102356 384986723 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656773 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1ccc(Br)c(Cl)c1 InChI=1S/C24H21BrClN5OS/c1-13-27-12-15(21(28-13)14-8-9-16(25)17(26)11-14)24(32)31-10-4-6-19(31)23-29-18-5-3-7-20(33-2)22(18)30-23/h3,5,7-9,11-12,19H,4,6,10H2,1-2H3,(H,29,30)/t19-/m0/s1 TZVRPQFYZBQRPK-IBGZPJMESA-N 334564 US11040966, Example 1.90::US9732075, Example 1.90::[4-(4-Bromo-3-chloro-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334564 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334564&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694790 384986724 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656774 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1ccc(Br)c(Cl)c1 InChI=1S/C24H21BrClN5OS/c1-13-27-12-15(21(28-13)14-8-9-16(25)17(26)11-14)24(32)31-10-4-6-19(31)23-29-18-5-3-7-20(33-2)22(18)30-23/h3,5,7-9,11-12,19H,4,6,10H2,1-2H3,(H,29,30)/t19-/m0/s1 TZVRPQFYZBQRPK-IBGZPJMESA-N 334564 US11040966, Example 1.90::US9732075, Example 1.90::[4-(4-Bromo-3-chloro-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 14.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334564 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334564&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694790 384986724 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656775 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1cc(Cl)cc(Cl)c1 InChI=1S/C24H21Cl2N5OS/c1-13-27-12-17(21(28-13)14-9-15(25)11-16(26)10-14)24(32)31-8-4-6-19(31)23-29-18-5-3-7-20(33-2)22(18)30-23/h3,5,7,9-12,19H,4,6,8H2,1-2H3,(H,29,30)/t19-/m0/s1 RMLYCAIXKBFYSV-IBGZPJMESA-N 334565 US11040966, Example 1.91::US9732075, Example 1.91::[4-(3,5-Dichloro-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334565 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334565&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694889 384986725 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656776 CSc1cccc2nc([nH]c12)[C@@H]1CCCN1C(=O)c1cnc(C)nc1-c1cc(Cl)cc(Cl)c1 InChI=1S/C24H21Cl2N5OS/c1-13-27-12-17(21(28-13)14-9-15(25)11-16(26)10-14)24(32)31-8-4-6-19(31)23-29-18-5-3-7-20(33-2)22(18)30-23/h3,5,7,9-12,19H,4,6,8H2,1-2H3,(H,29,30)/t19-/m0/s1 RMLYCAIXKBFYSV-IBGZPJMESA-N 334565 US11040966, Example 1.91::US9732075, Example 1.91::[4-(3,5-Dichloro-phenyl)-2-methyl-pyrimidin-5-yl]-[(S)-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 25.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334565 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334565&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694889 384986725 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656777 Cc1nc(C(=O)N2CCCC2c2nc3cc(Cl)c(Cl)cc3[nH]2)c(s1)-c1cccc(Cl)c1 334566 US11040966, Example 1.92::US9732075, Example 1.92::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(5,6-dichloro-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 23.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334566 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334566&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128092 384986726 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656778 Cc1nc(C(=O)N2CCCC2c2nc3cc(Cl)c(Cl)cc3[nH]2)c(s1)-c1cccc(Cl)c1 334566 US11040966, Example 1.92::US9732075, Example 1.92::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(5,6-dichloro-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 69.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334566 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334566&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128092 384986726 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656779 Cc1nc(C(=O)N2CCCC2c2nc3cc(Br)ccc3[nH]2)c(s1)-c1cccc(Cl)c1 334567 US11040966, Example 1.93::US9732075, Example 1.93::rac-[2-(5-Bromo-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 102 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334567 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334567&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102486 384986727 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656780 Cc1nc(C(=O)N2CCCC2c2nc3cc(Br)ccc3[nH]2)c(s1)-c1cccc(Cl)c1 334567 US11040966, Example 1.93::US9732075, Example 1.93::rac-[2-(5-Bromo-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 458 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334567 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334567&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102486 384986727 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656781 Cc1nc(C(=O)N2CCCC2c2nc3cc(ccc3[nH]2)C(F)(F)F)c(s1)-c1cccc(Cl)c1 334568 US11040966, Example 1.94::US9732075, Example 1.94::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 42.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334568 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334568&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127127 384986728 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656782 Cc1nc(C(=O)N2CCCC2c2nc3cc(ccc3[nH]2)C(F)(F)F)c(s1)-c1cccc(Cl)c1 334568 US11040966, Example 1.94::US9732075, Example 1.94::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 414 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334568 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334568&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127127 384986728 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656783 Cc1nc(C(=O)N2CCCC2c2nc3cc(C)c(C)cc3[nH]2)c(s1)-c1cccc(Cl)c1 334569 US11040966, Example 1.95::US9732075, Example 1.95::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(5,6-dimethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 18.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334569 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334569&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128160 384986729 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656784 Cc1nc(C(=O)N2CCCC2c2nc3cc(C)c(C)cc3[nH]2)c(s1)-c1cccc(Cl)c1 334569 US11040966, Example 1.95::US9732075, Example 1.95::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(5,6-dimethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 15.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334569 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334569&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128160 384986729 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656785 Cc1nc(C(=O)N2CCCC2c2nc3c(C)cccc3[nH]2)c(s1)-c1cccc(Cl)c1 334570 US11040966, Example 1.96::US9732075, Example 1.96::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 54.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334570 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334570&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102482 384986730 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656786 Cc1nc(C(=O)N2CCCC2c2nc3c(C)cccc3[nH]2)c(s1)-c1cccc(Cl)c1 334570 US11040966, Example 1.96::US9732075, Example 1.96::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 43.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334570 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334570&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102482 384986730 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656787 Cc1nc(C(=O)N2CCCC2c2nc3cc(Cl)ccc3[nH]2)c(s1)-c1cccc(Cl)c1 334571 US11040966, Example 1.97::US9732075, Example 1.97::rac-[2-(5-Chloro-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 95.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334571 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334571&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102274 384986731 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656788 Cc1nc(C(=O)N2CCCC2c2nc3cc(Cl)ccc3[nH]2)c(s1)-c1cccc(Cl)c1 334571 US11040966, Example 1.97::US9732075, Example 1.97::rac-[2-(5-Chloro-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 314 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334571 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334571&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102274 384986731 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656789 Cc1nc(C(=O)N2CCCC2c2nc3cc(F)c(Cl)cc3[nH]2)c(s1)-c1cccc(Cl)c1 334572 US11040966, Example 1.98::US9732075, Example 1.98::rac-[2-(6-Chloro-5-fluoro-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 105 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334572 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334572&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127836 384986732 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656790 Cc1nc(C(=O)N2CCCC2c2nc3cc(F)c(Cl)cc3[nH]2)c(s1)-c1cccc(Cl)c1 334572 US11040966, Example 1.98::US9732075, Example 1.98::rac-[2-(6-Chloro-5-fluoro-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 387 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334572 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334572&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127836 384986732 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656791 Cc1nc(C(=O)N2CCCC2c2nc3cc(ccc3[nH]2)C(C)(C)C)c(s1)-c1cccc(Cl)c1 334573 US11040966, Example 1.99::US9732075, Example 1.99::rac-[2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 58.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334573 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334573&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102416 384986733 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656792 Cc1nc(C(=O)N2CCCC2c2nc3cc(ccc3[nH]2)C(C)(C)C)c(s1)-c1cccc(Cl)c1 334573 US11040966, Example 1.99::US9732075, Example 1.99::rac-[2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 50.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334573 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334573&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102416 384986733 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656793 Cc1ccc(c(c1)C(=O)N1C[C@@H](F)C[C@H]1c1nc2ccc(Cl)c(C)c2[nH]1)-n1nccn1 334574 US9732075, Example 2.1::[(2S,4S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-fluoro-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 56.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334574 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334574&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127928 384986734 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656794 Cc1ccc(c(c1)C(=O)N1C[C@@H](F)C[C@H]1c1nc2ccc(Cl)c(C)c2[nH]1)-n1nccn1 334574 US9732075, Example 2.1::[(2S,4S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-fluoro-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 53.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334574 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334574&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127928 384986734 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656795 Cc1nc(C(=O)N2C[C@H](F)C[C@H]2c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1cccc(Cl)c1 InChI=1S/C23H19Cl2FN4OS/c1-11-16(25)6-7-17-19(11)29-22(28-17)18-9-15(26)10-30(18)23(31)20-21(32-12(2)27-20)13-4-3-5-14(24)8-13/h3-8,15,18H,9-10H2,1-2H3,(H,28,29)/t15-,18+/m1/s1 IHYJKQRSDCOXKV-QAPCUYQASA-N 334575 US11040966, Example 2.10::US9732075, Example 2.10::[(2S,4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-fluoro-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334575 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334575&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127307 384986735 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656796 Cc1nc(C(=O)N2C[C@H](F)C[C@H]2c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1cccc(Cl)c1 InChI=1S/C23H19Cl2FN4OS/c1-11-16(25)6-7-17-19(11)29-22(28-17)18-9-15(26)10-30(18)23(31)20-21(32-12(2)27-20)13-4-3-5-14(24)8-13/h3-8,15,18H,9-10H2,1-2H3,(H,28,29)/t15-,18+/m1/s1 IHYJKQRSDCOXKV-QAPCUYQASA-N 334575 US11040966, Example 2.10::US9732075, Example 2.10::[(2S,4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-fluoro-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334575 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334575&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127307 384986735 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656797 Cc1ccc(c(c1)C(=O)N1C[C@H](F)C[C@H]1c1nc2c(C)cccc2[nH]1)-n1nccn1 InChI=1S/C22H21FN6O/c1-13-6-7-18(29-24-8-9-25-29)16(10-13)22(30)28-12-15(23)11-19(28)21-26-17-5-3-4-14(2)20(17)27-21/h3-10,15,19H,11-12H2,1-2H3,(H,26,27)/t15-,19+/m1/s1 CQTHPUWNUCKVCN-BEFAXECRSA-N 334576 US11040966, Example 2.11::US9732075, Example 2.11::[(2S,4R)-4-Fluoro-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 69.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334576 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334576&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127476 384986736 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656798 Cc1ccc(c(c1)C(=O)N1C[C@H](F)C[C@H]1c1nc2c(C)cccc2[nH]1)-n1nccn1 InChI=1S/C22H21FN6O/c1-13-6-7-18(29-24-8-9-25-29)16(10-13)22(30)28-12-15(23)11-19(28)21-26-17-5-3-4-14(2)20(17)27-21/h3-10,15,19H,11-12H2,1-2H3,(H,26,27)/t15-,19+/m1/s1 CQTHPUWNUCKVCN-BEFAXECRSA-N 334576 US11040966, Example 2.11::US9732075, Example 2.11::[(2S,4R)-4-Fluoro-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 124 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334576 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334576&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127476 384986736 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656799 Cc1nc(C(=O)N2C[C@@H](F)C[C@H]2c2nc3c(C)cccc3[nH]2)c(s1)-c1ccccc1 InChI=1S/C23H21FN4OS/c1-13-7-6-10-17-19(13)27-22(26-17)18-11-16(24)12-28(18)23(29)20-21(30-14(2)25-20)15-8-4-3-5-9-15/h3-10,16,18H,11-12H2,1-2H3,(H,26,27)/t16-,18-/m0/s1 LIHQBVPBOMOTFN-WMZOPIPTSA-N 334577 US11040966, Example 2.2::US9732075, Example 2.2::[(2S,4S)-4-Fluoro-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 1300 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334577 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334577&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127360 384986737 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656800 Cc1nc(C(=O)N2C[C@@H](F)C[C@H]2c2nc3c(C)cccc3[nH]2)c(s1)-c1ccccc1 InChI=1S/C23H21FN4OS/c1-13-7-6-10-17-19(13)27-22(26-17)18-11-16(24)12-28(18)23(29)20-21(30-14(2)25-20)15-8-4-3-5-9-15/h3-10,16,18H,11-12H2,1-2H3,(H,26,27)/t16-,18-/m0/s1 LIHQBVPBOMOTFN-WMZOPIPTSA-N 334577 US11040966, Example 2.2::US9732075, Example 2.2::[(2S,4S)-4-Fluoro-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 317 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334577 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334577&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127360 384986737 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656801 Cc1nc(C(=O)N2C[C@H](F)C[C@H]2c2nc3c(C)cccc3[nH]2)c(s1)-c1ccccc1 InChI=1S/C23H21FN4OS/c1-13-7-6-10-17-19(13)27-22(26-17)18-11-16(24)12-28(18)23(29)20-21(30-14(2)25-20)15-8-4-3-5-9-15/h3-10,16,18H,11-12H2,1-2H3,(H,26,27)/t16-,18+/m1/s1 LIHQBVPBOMOTFN-AEFFLSMTSA-N 334578 US11040966, Example 2.3::US9732075, Example 2.3::[(2S,4R)-4-Fluoro-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 67.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334578 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334578&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127330 384986738 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656802 Cc1nc(C(=O)N2C[C@H](F)C[C@H]2c2nc3c(C)cccc3[nH]2)c(s1)-c1ccccc1 InChI=1S/C23H21FN4OS/c1-13-7-6-10-17-19(13)27-22(26-17)18-11-16(24)12-28(18)23(29)20-21(30-14(2)25-20)15-8-4-3-5-9-15/h3-10,16,18H,11-12H2,1-2H3,(H,26,27)/t16-,18+/m1/s1 LIHQBVPBOMOTFN-AEFFLSMTSA-N 334578 US11040966, Example 2.3::US9732075, Example 2.3::[(2S,4R)-4-Fluoro-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 61.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334578 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334578&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127330 384986738 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656803 Cc1nc(C(=O)N2CC(F)(F)C[C@H]2c2nc3c(C)cccc3[nH]2)c(s1)-c1ccccc1 InChI=1S/C23H20F2N4OS/c1-13-7-6-10-16-18(13)28-21(27-16)17-11-23(24,25)12-29(17)22(30)19-20(31-14(2)26-19)15-8-4-3-5-9-15/h3-10,17H,11-12H2,1-2H3,(H,27,28)/t17-/m0/s1 AAMPWGKWKFWRDR-KRWDZBQOSA-N 334579 US11040966, Example 2.4::US9732075, Example 2.4::[(S)-4,4-Difluoro-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 425 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334579 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334579&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102313 384986739 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656804 Cc1nc(C(=O)N2CC(F)(F)C[C@H]2c2nc3c(C)cccc3[nH]2)c(s1)-c1ccccc1 InChI=1S/C23H20F2N4OS/c1-13-7-6-10-16-18(13)28-21(27-16)17-11-23(24,25)12-29(17)22(30)19-20(31-14(2)26-19)15-8-4-3-5-9-15/h3-10,17H,11-12H2,1-2H3,(H,27,28)/t17-/m0/s1 AAMPWGKWKFWRDR-KRWDZBQOSA-N 334579 US11040966, Example 2.4::US9732075, Example 2.4::[(S)-4,4-Difluoro-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 131 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334579 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334579&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102313 384986739 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656805 Cc1ccc(c(c1)C(=O)N1C[C@H](F)C[C@H]1c1nc2c(C)c(Cl)ccc2[nH]1)-n1nccn1 InChI=1S/C22H20ClFN6O/c1-12-3-6-18(30-25-7-8-26-30)15(9-12)22(31)29-11-14(24)10-19(29)21-27-17-5-4-16(23)13(2)20(17)28-21/h3-9,14,19H,10-11H2,1-2H3,(H,27,28)/t14-,19+/m1/s1 BHKUHYOMYDNXGE-KUHUBIRLSA-N 334580 US11040966, Example 2.5::US9732075, Example 2.5::[(2S,4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-fluoro-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334580 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334580&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127211 384986740 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656806 Cc1ccc(c(c1)C(=O)N1C[C@H](F)C[C@H]1c1nc2c(C)c(Cl)ccc2[nH]1)-n1nccn1 InChI=1S/C22H20ClFN6O/c1-12-3-6-18(30-25-7-8-26-30)15(9-12)22(31)29-11-14(24)10-19(29)21-27-17-5-4-16(23)13(2)20(17)28-21/h3-9,14,19H,10-11H2,1-2H3,(H,27,28)/t14-,19+/m1/s1 BHKUHYOMYDNXGE-KUHUBIRLSA-N 334580 US11040966, Example 2.5::US9732075, Example 2.5::[(2S,4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-fluoro-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 12.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334580 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334580&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127211 384986740 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656807 Cc1ccc(c(c1)C(=O)N1CC(F)(F)C[C@H]1c1nc2c(C)c(Cl)ccc2[nH]1)-n1nccn1 InChI=1S/C22H19ClF2N6O/c1-12-3-6-17(31-26-7-8-27-31)14(9-12)21(32)30-11-22(24,25)10-18(30)20-28-16-5-4-15(23)13(2)19(16)29-20/h3-9,18H,10-11H2,1-2H3,(H,28,29)/t18-/m0/s1 VGVZIDIZUHVJLK-SFHVURJKSA-N 334581 US11040966, Example 2.6::US9732075, Example 2.6::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4,4-difluoro-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 52.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334581 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334581&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128132 384986741 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656808 Cc1ccc(c(c1)C(=O)N1CC(F)(F)C[C@H]1c1nc2c(C)c(Cl)ccc2[nH]1)-n1nccn1 InChI=1S/C22H19ClF2N6O/c1-12-3-6-17(31-26-7-8-27-31)14(9-12)21(32)30-11-22(24,25)10-18(30)20-28-16-5-4-15(23)13(2)19(16)29-20/h3-9,18H,10-11H2,1-2H3,(H,28,29)/t18-/m0/s1 VGVZIDIZUHVJLK-SFHVURJKSA-N 334581 US11040966, Example 2.6::US9732075, Example 2.6::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4,4-difluoro-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 59.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334581 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334581&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128132 384986741 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656809 Cc1nc(C(=O)N2C[C@@H](F)C[C@H]2c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccccc1 InChI=1S/C23H20ClFN4OS/c1-12-16(24)8-9-17-19(12)28-22(27-17)18-10-15(25)11-29(18)23(30)20-21(31-13(2)26-20)14-6-4-3-5-7-14/h3-9,15,18H,10-11H2,1-2H3,(H,27,28)/t15-,18-/m0/s1 SEMOTBSBKOXCEV-YJBOKZPZSA-N 334582 US11040966, Example 2.7::US9732075, Example 2.7::[(2S,4S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-fluoro-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 66.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334582 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334582&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127948 384986742 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656810 Cc1nc(C(=O)N2C[C@@H](F)C[C@H]2c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccccc1 InChI=1S/C23H20ClFN4OS/c1-12-16(24)8-9-17-19(12)28-22(27-17)18-10-15(25)11-29(18)23(30)20-21(31-13(2)26-20)14-6-4-3-5-7-14/h3-9,15,18H,10-11H2,1-2H3,(H,27,28)/t15-,18-/m0/s1 SEMOTBSBKOXCEV-YJBOKZPZSA-N 334582 US11040966, Example 2.7::US9732075, Example 2.7::[(2S,4S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-fluoro-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 42.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334582 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334582&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127948 384986742 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656811 Cc1nc(C(=O)N2CC(F)(F)C[C@H]2c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccccc1 InChI=1S/C23H19ClF2N4OS/c1-12-15(24)8-9-16-18(12)29-21(28-16)17-10-23(25,26)11-30(17)22(31)19-20(32-13(2)27-19)14-6-4-3-5-7-14/h3-9,17H,10-11H2,1-2H3,(H,28,29)/t17-/m0/s1 RVNZOLZTRBRTRZ-KRWDZBQOSA-N 334583 US11040966, Example 2.9::US9732075, Example 2.8::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4,4-difluoro-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 70.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334583 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334583&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127436 384986743 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656812 Cc1nc(C(=O)N2CC(F)(F)C[C@H]2c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccccc1 InChI=1S/C23H19ClF2N4OS/c1-12-15(24)8-9-16-18(12)29-21(28-16)17-10-23(25,26)11-30(17)22(31)19-20(32-13(2)27-19)14-6-4-3-5-7-14/h3-9,17H,10-11H2,1-2H3,(H,28,29)/t17-/m0/s1 RVNZOLZTRBRTRZ-KRWDZBQOSA-N 334583 US11040966, Example 2.9::US9732075, Example 2.8::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4,4-difluoro-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 51.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334583 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334583&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127436 384986743 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656813 Cc1nc(C(=O)N2C[C@H](F)C[C@H]2c2nc3c(C)cccc3[nH]2)c(s1)-c1cccc(Cl)c1 InChI=1S/C23H20ClFN4OS/c1-12-5-3-8-17-19(12)28-22(27-17)18-10-16(25)11-29(18)23(30)20-21(31-13(2)26-20)14-6-4-7-15(24)9-14/h3-9,16,18H,10-11H2,1-2H3,(H,27,28)/t16-,18+/m1/s1 WAQLGFJYQJXXHE-AEFFLSMTSA-N 334584 US9732075, Example 2.9::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,4R)-4-fluoro-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 17.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334584 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334584&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694684 384986744 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656814 Cc1nc(C(=O)N2C[C@H](F)C[C@H]2c2nc3c(C)cccc3[nH]2)c(s1)-c1cccc(Cl)c1 InChI=1S/C23H20ClFN4OS/c1-12-5-3-8-17-19(12)28-22(27-17)18-10-16(25)11-29(18)23(30)20-21(31-13(2)26-20)14-6-4-7-15(24)9-14/h3-9,16,18H,10-11H2,1-2H3,(H,27,28)/t16-,18+/m1/s1 WAQLGFJYQJXXHE-AEFFLSMTSA-N 334584 US9732075, Example 2.9::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,4R)-4-fluoro-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 18.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334584 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334584&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694684 384986744 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656815 CO[C@H]1C[C@H](N(C1)C(=O)c1cc(C)ccc1-n1nccn1)c1nc2ccc(Cl)c(C)c2[nH]1 334585 US9732075, Example 3.1::[(2S,4S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 102 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334585 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334585&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127373 384986745 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656816 CO[C@H]1C[C@H](N(C1)C(=O)c1cc(C)ccc1-n1nccn1)c1nc2ccc(Cl)c(C)c2[nH]1 334585 US9732075, Example 3.1::[(2S,4S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 69.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334585 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334585&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127373 384986745 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656817 CO[C@@H]1C[C@H](N(C1)C(=O)c1cc(Cl)ccc1-n1nccn1)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C22H20Cl2N6O2/c1-12-16(24)4-5-17-20(12)28-21(27-17)19-10-14(32-2)11-29(19)22(31)15-9-13(23)3-6-18(15)30-25-7-8-26-30/h3-9,14,19H,10-11H2,1-2H3,(H,27,28)/t14-,19+/m1/s1 OULMOZIVKGPEQO-KUHUBIRLSA-N 334586 US11040966, Example 3.10::US9732075, Example 3.10::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(5-chloro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 45.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334586 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334586&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127765 384986746 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656818 CO[C@@H]1C[C@H](N(C1)C(=O)c1cc(Cl)ccc1-n1nccn1)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C22H20Cl2N6O2/c1-12-16(24)4-5-17-20(12)28-21(27-17)19-10-14(32-2)11-29(19)22(31)15-9-13(23)3-6-18(15)30-25-7-8-26-30/h3-9,14,19H,10-11H2,1-2H3,(H,27,28)/t14-,19+/m1/s1 OULMOZIVKGPEQO-KUHUBIRLSA-N 334586 US11040966, Example 3.10::US9732075, Example 3.10::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(5-chloro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334586 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334586&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127765 384986746 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656819 CO[C@@H]1C[C@H](N(C1)C(=O)c1c(F)c(OC)ccc1-n1nccn1)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C23H22ClFN6O3/c1-12-14(24)4-5-15-21(12)29-22(28-15)17-10-13(33-2)11-30(17)23(32)19-16(31-26-8-9-27-31)6-7-18(34-3)20(19)25/h4-9,13,17H,10-11H2,1-3H3,(H,28,29)/t13-,17+/m1/s1 WEMWBUGVPBYHDK-DYVFJYSZSA-N 334587 US11040966, Example 3.11::US9732075, Example 3.11::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(2-fluoro-3-methoxy-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334587 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334587&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127019 384986747 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656820 CO[C@@H]1C[C@H](N(C1)C(=O)c1c(F)c(OC)ccc1-n1nccn1)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C23H22ClFN6O3/c1-12-14(24)4-5-15-21(12)29-22(28-15)17-10-13(33-2)11-30(17)23(32)19-16(31-26-8-9-27-31)6-7-18(34-3)20(19)25/h4-9,13,17H,10-11H2,1-3H3,(H,28,29)/t13-,17+/m1/s1 WEMWBUGVPBYHDK-DYVFJYSZSA-N 334587 US11040966, Example 3.11::US9732075, Example 3.11::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(2-fluoro-3-methoxy-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334587 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334587&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127019 384986747 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656821 CO[C@@H]1C[C@H](N(C1)C(=O)c1cc(OC)ccc1-n1nccn1)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C23H23ClN6O3/c1-13-17(24)5-6-18-21(13)28-22(27-18)20-11-15(33-3)12-29(20)23(31)16-10-14(32-2)4-7-19(16)30-25-8-9-26-30/h4-10,15,20H,11-12H2,1-3H3,(H,27,28)/t15-,20+/m1/s1 GOVDVCACXWVVDU-QRWLVFNGSA-N 334588 US11040966, Example 3.12::US9732075, Example 3.12::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334588 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334588&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127503 384986748 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656822 CO[C@@H]1C[C@H](N(C1)C(=O)c1cc(OC)ccc1-n1nccn1)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C23H23ClN6O3/c1-13-17(24)5-6-18-21(13)28-22(27-18)20-11-15(33-3)12-29(20)23(31)16-10-14(32-2)4-7-19(16)30-25-8-9-26-30/h4-10,15,20H,11-12H2,1-3H3,(H,27,28)/t15-,20+/m1/s1 GOVDVCACXWVVDU-QRWLVFNGSA-N 334588 US11040966, Example 3.12::US9732075, Example 3.12::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334588 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334588&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127503 384986748 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656823 CO[C@@H]1C[C@H](N(C1)C(=O)c1c(F)c(C)ccc1-n1nccn1)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C23H22ClFN6O2/c1-12-4-7-17(31-26-8-9-27-31)19(20(12)25)23(32)30-11-14(33-3)10-18(30)22-28-16-6-5-15(24)13(2)21(16)29-22/h4-9,14,18H,10-11H2,1-3H3,(H,28,29)/t14-,18+/m1/s1 OHDRBNXNNCSTBA-KDOFPFPSSA-N 334589 US11040966, Example 3.13::US9732075, Example 3.13::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 16.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334589 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334589&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127609 384986749 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656824 CO[C@@H]1C[C@H](N(C1)C(=O)c1c(F)c(C)ccc1-n1nccn1)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C23H22ClFN6O2/c1-12-4-7-17(31-26-8-9-27-31)19(20(12)25)23(32)30-11-14(33-3)10-18(30)22-28-16-6-5-15(24)13(2)21(16)29-22/h4-9,14,18H,10-11H2,1-3H3,(H,28,29)/t14-,18+/m1/s1 OHDRBNXNNCSTBA-KDOFPFPSSA-N 334589 US11040966, Example 3.13::US9732075, Example 3.13::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334589 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334589&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127609 384986749 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656825 CO[C@@H]1C[C@H](N(C1)C(=O)c1c(C)cccc1-n1nccn1)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C23H23ClN6O2/c1-13-5-4-6-18(30-25-9-10-26-30)20(13)23(31)29-12-15(32-3)11-19(29)22-27-17-8-7-16(24)14(2)21(17)28-22/h4-10,15,19H,11-12H2,1-3H3,(H,27,28)/t15-,19+/m1/s1 HDVXWRGMXYXHTH-BEFAXECRSA-N 334590 US11040966, Example 3.14::US9732075, Example 3.14::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(2-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 674 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334590 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334590&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128164 384986750 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656826 CO[C@@H]1C[C@H](N(C1)C(=O)c1c(C)cccc1-n1nccn1)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C23H23ClN6O2/c1-13-5-4-6-18(30-25-9-10-26-30)20(13)23(31)29-12-15(32-3)11-19(29)22-27-17-8-7-16(24)14(2)21(17)28-22/h4-10,15,19H,11-12H2,1-3H3,(H,27,28)/t15-,19+/m1/s1 HDVXWRGMXYXHTH-BEFAXECRSA-N 334590 US11040966, Example 3.14::US9732075, Example 3.14::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(2-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 23.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334590 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334590&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128164 384986750 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656827 CO[C@@H]1C[C@H](N(C1)C(=O)c1ccc(C)cc1-n1nccn1)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C23H23ClN6O2/c1-13-4-5-16(19(10-13)30-25-8-9-26-30)23(31)29-12-15(32-3)11-20(29)22-27-18-7-6-17(24)14(2)21(18)28-22/h4-10,15,20H,11-12H2,1-3H3,(H,27,28)/t15-,20+/m1/s1 GHMQNTLYTUGDHC-QRWLVFNGSA-N 334591 US11040966, Example 3.15::US9732075, Example 3.15::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 96.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334591 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334591&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127142 384986751 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656828 CO[C@@H]1C[C@H](N(C1)C(=O)c1ccc(C)cc1-n1nccn1)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C23H23ClN6O2/c1-13-4-5-16(19(10-13)30-25-8-9-26-30)23(31)29-12-15(32-3)11-20(29)22-27-18-7-6-17(24)14(2)21(18)28-22/h4-10,15,20H,11-12H2,1-3H3,(H,27,28)/t15-,20+/m1/s1 GHMQNTLYTUGDHC-QRWLVFNGSA-N 334591 US11040966, Example 3.15::US9732075, Example 3.15::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334591 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334591&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127142 384986751 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656829 CO[C@@H]1C[C@H](N(C1)C(=O)c1cc(C)c(C)cc1-n1nccn1)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C24H25ClN6O2/c1-13-9-17(20(10-14(13)2)31-26-7-8-27-31)24(32)30-12-16(33-4)11-21(30)23-28-19-6-5-18(25)15(3)22(19)29-23/h5-10,16,21H,11-12H2,1-4H3,(H,28,29)/t16-,21+/m1/s1 UVNZNIABJSNWOQ-IERDGZPVSA-N 334592 US11040966, Example 3.16::US9732075, Example 3.16::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(4,5-dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 24.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334592 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334592&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127024 384986752 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656830 CO[C@@H]1C[C@H](N(C1)C(=O)c1cc(C)c(C)cc1-n1nccn1)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C24H25ClN6O2/c1-13-9-17(20(10-14(13)2)31-26-7-8-27-31)24(32)30-12-16(33-4)11-21(30)23-28-19-6-5-18(25)15(3)22(19)29-23/h5-10,16,21H,11-12H2,1-4H3,(H,28,29)/t16-,21+/m1/s1 UVNZNIABJSNWOQ-IERDGZPVSA-N 334592 US11040966, Example 3.16::US9732075, Example 3.16::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(4,5-dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334592 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334592&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127024 384986752 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656831 CO[C@@H]1C[C@H](N(C1)C(=O)c1cc(ccc1-n1nccn1)C(F)(F)F)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C23H20ClF3N6O2/c1-12-16(24)4-5-17-20(12)31-21(30-17)19-10-14(35-2)11-32(19)22(34)15-9-13(23(25,26)27)3-6-18(15)33-28-7-8-29-33/h3-9,14,19H,10-11H2,1-2H3,(H,30,31)/t14-,19+/m1/s1 JYAPWUDTYSCHPQ-KUHUBIRLSA-N 334593 US11040966, Example 3.17::US9732075, Example 3.17::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoro-methyl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 368 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334593 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334593&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127863 384986753 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656832 CO[C@@H]1C[C@H](N(C1)C(=O)c1cc(ccc1-n1nccn1)C(F)(F)F)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C23H20ClF3N6O2/c1-12-16(24)4-5-17-20(12)31-21(30-17)19-10-14(35-2)11-32(19)22(34)15-9-13(23(25,26)27)3-6-18(15)33-28-7-8-29-33/h3-9,14,19H,10-11H2,1-2H3,(H,30,31)/t14-,19+/m1/s1 JYAPWUDTYSCHPQ-KUHUBIRLSA-N 334593 US11040966, Example 3.17::US9732075, Example 3.17::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoro-methyl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 51.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334593 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334593&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127863 384986753 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656833 CO[C@@H]1C[C@H](N(C1)C(=O)c1cc(F)ccc1-n1nccn1)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C22H20ClFN6O2/c1-12-16(23)4-5-17-20(12)28-21(27-17)19-10-14(32-2)11-29(19)22(31)15-9-13(24)3-6-18(15)30-25-7-8-26-30/h3-9,14,19H,10-11H2,1-2H3,(H,27,28)/t14-,19+/m1/s1 REULCEXUVQPBTK-KUHUBIRLSA-N 334594 US11040966, Example 3.18::US9732075, Example 3.18::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(5-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 97.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334594 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334594&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128140 384986754 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656834 CO[C@@H]1C[C@H](N(C1)C(=O)c1cc(F)ccc1-n1nccn1)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C22H20ClFN6O2/c1-12-16(23)4-5-17-20(12)28-21(27-17)19-10-14(32-2)11-29(19)22(31)15-9-13(24)3-6-18(15)30-25-7-8-26-30/h3-9,14,19H,10-11H2,1-2H3,(H,27,28)/t14-,19+/m1/s1 REULCEXUVQPBTK-KUHUBIRLSA-N 334594 US11040966, Example 3.18::US9732075, Example 3.18::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(5-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334594 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334594&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128140 384986754 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656835 CO[C@@H]1C[C@H](N(C1)C(=O)c1cc(Cl)ccc1-n1nccn1)c1nc2ccc(OC)cc2[nH]1 InChI=1S/C22H21ClN6O3/c1-31-14-4-5-17-18(10-14)27-21(26-17)20-11-15(32-2)12-28(20)22(30)16-9-13(23)3-6-19(16)29-24-7-8-25-29/h3-10,15,20H,11-12H2,1-2H3,(H,26,27)/t15-,20+/m1/s1 QJVUASSVXGUFQP-QRWLVFNGSA-N 334595 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(2S,4R)-4-methoxy-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 3.19::US9732075, Example 3.19 Orexin/Hypocretin receptor type 1 Homo sapiens 1930 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334595 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334595&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127333 384986755 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656836 CO[C@@H]1C[C@H](N(C1)C(=O)c1cc(Cl)ccc1-n1nccn1)c1nc2ccc(OC)cc2[nH]1 InChI=1S/C22H21ClN6O3/c1-31-14-4-5-17-18(10-14)27-21(26-17)20-11-15(32-2)12-28(20)22(30)16-9-13(23)3-6-19(16)29-24-7-8-25-29/h3-10,15,20H,11-12H2,1-2H3,(H,26,27)/t15-,20+/m1/s1 QJVUASSVXGUFQP-QRWLVFNGSA-N 334595 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(2S,4R)-4-methoxy-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 3.19::US9732075, Example 3.19 Orexin receptor type 2 Homo sapiens 21.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334595 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334595&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127333 384986755 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656837 CO[C@@H]1C[C@H](N(C1)C(=O)c1cc(C)ccc1-n1nccn1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C23H23ClN6O2/c1-13-4-7-19(30-25-8-9-26-30)16(10-13)23(31)29-12-15(32-3)11-20(29)22-27-18-6-5-17(24)14(2)21(18)28-22/h4-10,15,20H,11-12H2,1-3H3,(H,27,28)/t15-,20+/m1/s1 VHWGLBVUOHRYHN-QRWLVFNGSA-N 334596 US11040966, Example 3.2::US9732075, Example 3.2::[(2S,4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334596 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334596&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127939 384986756 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656838 CO[C@@H]1C[C@H](N(C1)C(=O)c1cc(C)ccc1-n1nccn1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C23H23ClN6O2/c1-13-4-7-19(30-25-8-9-26-30)16(10-13)23(31)29-12-15(32-3)11-20(29)22-27-18-6-5-17(24)14(2)21(18)28-22/h4-10,15,20H,11-12H2,1-3H3,(H,27,28)/t15-,20+/m1/s1 VHWGLBVUOHRYHN-QRWLVFNGSA-N 334596 US11040966, Example 3.2::US9732075, Example 3.2::[(2S,4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334596 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334596&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127939 384986756 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656839 CO[C@@H]1C[C@H](N(C1)C(=O)c1cc(OC)ccc1-n1nccn1)c1nc2ccc(OC)cc2[nH]1 InChI=1S/C23H24N6O4/c1-31-14-5-7-20(29-24-8-9-25-29)17(10-14)23(30)28-13-16(33-3)12-21(28)22-26-18-6-4-15(32-2)11-19(18)27-22/h4-11,16,21H,12-13H2,1-3H3,(H,26,27)/t16-,21+/m1/s1 HLQOROPPQGKJGZ-IERDGZPVSA-N 334597 US11040966, Example 3.20::US9732075, Example 3.20::[(2S,4R)-4-Methoxy-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 1860 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334597 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334597&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127954 384986757 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656840 CO[C@@H]1C[C@H](N(C1)C(=O)c1cc(OC)ccc1-n1nccn1)c1nc2ccc(OC)cc2[nH]1 InChI=1S/C23H24N6O4/c1-31-14-5-7-20(29-24-8-9-25-29)17(10-14)23(30)28-13-16(33-3)12-21(28)22-26-18-6-4-15(32-2)11-19(18)27-22/h4-11,16,21H,12-13H2,1-3H3,(H,26,27)/t16-,21+/m1/s1 HLQOROPPQGKJGZ-IERDGZPVSA-N 334597 US11040966, Example 3.20::US9732075, Example 3.20::[(2S,4R)-4-Methoxy-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 40.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334597 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334597&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127954 384986757 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656841 CO[C@@H]1C[C@H](N(C1)C(=O)c1ccc(C)cc1-n1nccn1)c1nc2ccc(OC)cc2[nH]1 InChI=1S/C23H24N6O3/c1-14-4-6-17(20(10-14)29-24-8-9-25-29)23(30)28-13-16(32-3)12-21(28)22-26-18-7-5-15(31-2)11-19(18)27-22/h4-11,16,21H,12-13H2,1-3H3,(H,26,27)/t16-,21+/m1/s1 GSULCIGCVPFXKF-IERDGZPVSA-N 334598 US11040966, Example 3.21::US9732075, Example 3.21::[(2S,4R)-4-Methoxy-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2510 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334598 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334598&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128291 384986758 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656842 CO[C@@H]1C[C@H](N(C1)C(=O)c1ccc(C)cc1-n1nccn1)c1nc2ccc(OC)cc2[nH]1 InChI=1S/C23H24N6O3/c1-14-4-6-17(20(10-14)29-24-8-9-25-29)23(30)28-13-16(32-3)12-21(28)22-26-18-7-5-15(31-2)11-19(18)27-22/h4-11,16,21H,12-13H2,1-3H3,(H,26,27)/t16-,21+/m1/s1 GSULCIGCVPFXKF-IERDGZPVSA-N 334598 US11040966, Example 3.21::US9732075, Example 3.21::[(2S,4R)-4-Methoxy-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 33.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334598 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334598&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128291 384986758 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656843 CO[C@@H]1C[C@H](N(C1)C(=O)c1cc(C)c(C)cc1-n1nccn1)c1nc2ccc(OC)cc2[nH]1 InChI=1S/C24H26N6O3/c1-14-9-18(21(10-15(14)2)30-25-7-8-26-30)24(31)29-13-17(33-4)12-22(29)23-27-19-6-5-16(32-3)11-20(19)28-23/h5-11,17,22H,12-13H2,1-4H3,(H,27,28)/t17-,22+/m1/s1 XIGZWKRYYRXUPJ-VGSWGCGISA-N 334599 (4,5-Dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-[(2S,4R)-4-methoxy-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 3.22::US9732075, Example 3.22 Orexin/Hypocretin receptor type 1 Homo sapiens 576 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334599 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334599&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127964 384986759 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656844 CO[C@@H]1C[C@H](N(C1)C(=O)c1cc(C)c(C)cc1-n1nccn1)c1nc2ccc(OC)cc2[nH]1 InChI=1S/C24H26N6O3/c1-14-9-18(21(10-15(14)2)30-25-7-8-26-30)24(31)29-13-17(33-4)12-22(29)23-27-19-6-5-16(32-3)11-20(19)28-23/h5-11,17,22H,12-13H2,1-4H3,(H,27,28)/t17-,22+/m1/s1 XIGZWKRYYRXUPJ-VGSWGCGISA-N 334599 (4,5-Dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-[(2S,4R)-4-methoxy-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 3.22::US9732075, Example 3.22 Orexin receptor type 2 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334599 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334599&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127964 384986759 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656845 CO[C@@H]1C[C@H](N(C1)C(=O)c1cc(F)ccc1-n1nccn1)c1nc2ccc(OC)cc2[nH]1 InChI=1S/C22H21FN6O3/c1-31-14-4-5-17-18(10-14)27-21(26-17)20-11-15(32-2)12-28(20)22(30)16-9-13(23)3-6-19(16)29-24-7-8-25-29/h3-10,15,20H,11-12H2,1-2H3,(H,26,27)/t15-,20+/m1/s1 LDHQVBJHTWBOLS-QRWLVFNGSA-N 334600 (5-Fluoro-2-[1,2,3]triazol-2-yl-phenyl)-[(2S,4R)-4-methoxy-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 3.23::US9732075, Example 3.23 Orexin/Hypocretin receptor type 1 Homo sapiens 3890 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334600 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334600&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127205 384986760 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656846 CO[C@@H]1C[C@H](N(C1)C(=O)c1cc(F)ccc1-n1nccn1)c1nc2ccc(OC)cc2[nH]1 InChI=1S/C22H21FN6O3/c1-31-14-4-5-17-18(10-14)27-21(26-17)20-11-15(32-2)12-28(20)22(30)16-9-13(23)3-6-19(16)29-24-7-8-25-29/h3-10,15,20H,11-12H2,1-2H3,(H,26,27)/t15-,20+/m1/s1 LDHQVBJHTWBOLS-QRWLVFNGSA-N 334600 (5-Fluoro-2-[1,2,3]triazol-2-yl-phenyl)-[(2S,4R)-4-methoxy-2-(6-methoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 3.23::US9732075, Example 3.23 Orexin receptor type 2 Homo sapiens 67.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334600 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334600&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127205 384986760 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656847 CO[C@H]1CN(C(=O)c2nc(C)sc2-c2ccccc2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C25H25ClN4O2S/c1-14-18(26)10-11-19-20(14)29-24(28-19)25(3)12-17(32-4)13-30(25)23(31)21-22(33-15(2)27-21)16-8-6-5-7-9-16/h5-11,17H,12-13H2,1-4H3,(H,28,29)/t17-,25?/m1/s1 BPTCIKAHEBIJHG-SMFUYQKNSA-N 334601 US11040966, Example 3.24::US9732075, Example 3.24::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334601 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334601&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127511 384986761 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656848 CO[C@H]1CN(C(=O)c2nc(C)sc2-c2ccccc2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C25H25ClN4O2S/c1-14-18(26)10-11-19-20(14)29-24(28-19)25(3)12-17(32-4)13-30(25)23(31)21-22(33-15(2)27-21)16-8-6-5-7-9-16/h5-11,17H,12-13H2,1-4H3,(H,28,29)/t17-,25?/m1/s1 BPTCIKAHEBIJHG-SMFUYQKNSA-N 334601 US11040966, Example 3.24::US9732075, Example 3.24::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 12.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334601 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334601&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127511 384986761 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656849 CO[C@H]1CN(C(=O)c2cc(C)ccc2-n2nccn2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C24H25ClN6O2/c1-14-5-8-20(31-26-9-10-27-31)17(11-14)22(32)30-13-16(33-4)12-24(30,3)23-28-19-7-6-18(25)15(2)21(19)29-23/h5-11,16H,12-13H2,1-4H3,(H,28,29)/t16-,24?/m1/s1 SMWYFICPEVRFOB-YAOANENCSA-N 334602 US11040966, Example 3.25::US9732075, Example 3.25::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334602 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334602&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127082 384986762 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656850 CO[C@H]1CN(C(=O)c2cc(C)ccc2-n2nccn2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C24H25ClN6O2/c1-14-5-8-20(31-26-9-10-27-31)17(11-14)22(32)30-13-16(33-4)12-24(30,3)23-28-19-7-6-18(25)15(2)21(19)29-23/h5-11,16H,12-13H2,1-4H3,(H,28,29)/t16-,24?/m1/s1 SMWYFICPEVRFOB-YAOANENCSA-N 334602 US11040966, Example 3.25::US9732075, Example 3.25::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334602 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334602&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127082 384986762 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656851 CO[C@H]1CN(C(=O)c2cc(C)ccc2-n2nccn2)C(C)(C1)c1nc2c(C)cccc2[nH]1 InChI=1S/C24H26N6O2/c1-15-8-9-20(30-25-10-11-26-30)18(12-15)22(31)29-14-17(32-4)13-24(29,3)23-27-19-7-5-6-16(2)21(19)28-23/h5-12,17H,13-14H2,1-4H3,(H,27,28)/t17-,24?/m1/s1 JSLVFYIEPZHFIQ-BPNWFJGMSA-N 334603 US11040966, Example 3.26::US9732075, Example 3.26::[(2RS)-(4R)-4-Methoxy-2-methyl-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 50.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334603 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334603&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127287 384986763 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656852 CO[C@H]1CN(C(=O)c2cc(C)ccc2-n2nccn2)C(C)(C1)c1nc2c(C)cccc2[nH]1 InChI=1S/C24H26N6O2/c1-15-8-9-20(30-25-10-11-26-30)18(12-15)22(31)29-14-17(32-4)13-24(29,3)23-27-19-7-5-6-16(2)21(19)28-23/h5-12,17H,13-14H2,1-4H3,(H,27,28)/t17-,24?/m1/s1 JSLVFYIEPZHFIQ-BPNWFJGMSA-N 334603 US11040966, Example 3.26::US9732075, Example 3.26::[(2RS)-(4R)-4-Methoxy-2-methyl-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 66.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334603 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334603&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127287 384986763 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656853 CO[C@H]1CN(C(=O)c2nc(C)sc2-c2cccc(Cl)c2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C25H24Cl2N4O2S/c1-13-18(27)8-9-19-20(13)30-24(29-19)25(3)11-17(33-4)12-31(25)23(32)21-22(34-14(2)28-21)15-6-5-7-16(26)10-15/h5-10,17H,11-12H2,1-4H3,(H,29,30)/t17-,25?/m1/s1 BWIVUNXAJXPBFO-SMFUYQKNSA-N 334604 US11040966, Example 3.27::US9732075, Example 3.27::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334604 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334604&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127246 384986764 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656854 CO[C@H]1CN(C(=O)c2nc(C)sc2-c2cccc(Cl)c2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C25H24Cl2N4O2S/c1-13-18(27)8-9-19-20(13)30-24(29-19)25(3)11-17(33-4)12-31(25)23(32)21-22(34-14(2)28-21)15-6-5-7-16(26)10-15/h5-10,17H,11-12H2,1-4H3,(H,29,30)/t17-,25?/m1/s1 BWIVUNXAJXPBFO-SMFUYQKNSA-N 334604 US11040966, Example 3.27::US9732075, Example 3.27::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 16.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334604 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334604&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127246 384986764 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656855 CO[C@H]1CN(C(=O)c2nc(C)sc2-c2cccc(Cl)c2)C(C)(C1)c1nc2c(C)cccc2[nH]1 InChI=1S/C25H25ClN4O2S/c1-14-7-5-10-19-20(14)29-24(28-19)25(3)12-18(32-4)13-30(25)23(31)21-22(33-15(2)27-21)16-8-6-9-17(26)11-16/h5-11,18H,12-13H2,1-4H3,(H,28,29)/t18-,25?/m1/s1 UKIOGYCAAMEJKJ-YDONVPIESA-N 334605 US11040966, Example 3.28::US9732075, Example 3.28::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2RS)-(4R)-4-methoxy-2-methyl-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 10.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334605 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334605&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127568 384986765 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656856 CO[C@H]1CN(C(=O)c2nc(C)sc2-c2cccc(Cl)c2)C(C)(C1)c1nc2c(C)cccc2[nH]1 InChI=1S/C25H25ClN4O2S/c1-14-7-5-10-19-20(14)29-24(28-19)25(3)12-18(32-4)13-30(25)23(31)21-22(33-15(2)27-21)16-8-6-9-17(26)11-16/h5-11,18H,12-13H2,1-4H3,(H,28,29)/t18-,25?/m1/s1 UKIOGYCAAMEJKJ-YDONVPIESA-N 334605 US11040966, Example 3.28::US9732075, Example 3.28::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2RS)-(4R)-4-methoxy-2-methyl-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 19.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334605 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334605&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127568 384986765 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656857 CO[C@H]1CN(C(=O)c2nc(C)sc2-c2ccccc2)C(C)(C1)c1nc2c(C)cccc2[nH]1 InChI=1S/C25H26N4O2S/c1-15-9-8-12-19-20(15)28-24(27-19)25(3)13-18(31-4)14-29(25)23(30)21-22(32-16(2)26-21)17-10-6-5-7-11-17/h5-12,18H,13-14H2,1-4H3,(H,27,28)/t18-,25?/m1/s1 YKAQTQOSDXXGMZ-YDONVPIESA-N 334606 US11040966, Example 3.29::US9732075, Example 3.29::[(2RS)-(4R)-4-Methoxy-2-methyl-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 28.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334606 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334606&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127805 384986766 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656858 CO[C@H]1CN(C(=O)c2nc(C)sc2-c2ccccc2)C(C)(C1)c1nc2c(C)cccc2[nH]1 InChI=1S/C25H26N4O2S/c1-15-9-8-12-19-20(15)28-24(27-19)25(3)13-18(31-4)14-29(25)23(30)21-22(32-16(2)26-21)17-10-6-5-7-11-17/h5-12,18H,13-14H2,1-4H3,(H,27,28)/t18-,25?/m1/s1 YKAQTQOSDXXGMZ-YDONVPIESA-N 334606 US11040966, Example 3.29::US9732075, Example 3.29::[(2RS)-(4R)-4-Methoxy-2-methyl-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 20.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334606 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334606&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127805 384986766 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656859 CO[C@H]1C[C@H](N(C1)C(=O)c1nc(C)sc1-c1ccccc1)c1nc2c(C)cccc2[nH]1 InChI=1S/C24H24N4O2S/c1-14-8-7-11-18-20(14)27-23(26-18)19-12-17(30-3)13-28(19)24(29)21-22(31-15(2)25-21)16-9-5-4-6-10-16/h4-11,17,19H,12-13H2,1-3H3,(H,26,27)/t17-,19-/m0/s1 OPQYIHNPNRVKLM-HKUYNNGSSA-N 334607 US11040966, Example 3.3::US9732075, Example 3.3::[(2S,4S)-4-Methoxy-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 1290 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334607 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334607&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127811 384986767 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656860 CO[C@H]1C[C@H](N(C1)C(=O)c1nc(C)sc1-c1ccccc1)c1nc2c(C)cccc2[nH]1 InChI=1S/C24H24N4O2S/c1-14-8-7-11-18-20(14)27-23(26-18)19-12-17(30-3)13-28(19)24(29)21-22(31-15(2)25-21)16-9-5-4-6-10-16/h4-11,17,19H,12-13H2,1-3H3,(H,26,27)/t17-,19-/m0/s1 OPQYIHNPNRVKLM-HKUYNNGSSA-N 334607 US11040966, Example 3.3::US9732075, Example 3.3::[(2S,4S)-4-Methoxy-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 255 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334607 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334607&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127811 384986767 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656861 CO[C@H]1CN(C(=O)c2cc(C)ccc2-n2nccn2)[C@@](C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C24H25ClN6O2/c1-14-5-8-20(31-26-9-10-27-31)17(11-14)22(32)30-13-16(33-4)12-24(30,3)23-28-19-7-6-18(25)15(2)21(19)29-23/h5-11,16H,12-13H2,1-4H3,(H,28,29)/t16-,24+/m1/s1 SMWYFICPEVRFOB-GYCJOSAFSA-N 334608 US11040966, Example 3.30::US9732075, Example 3.30::[(2S,4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334608 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334608&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127589 384986768 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656862 CO[C@H]1CN(C(=O)c2cc(C)ccc2-n2nccn2)[C@@](C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C24H25ClN6O2/c1-14-5-8-20(31-26-9-10-27-31)17(11-14)22(32)30-13-16(33-4)12-24(30,3)23-28-19-7-6-18(25)15(2)21(19)29-23/h5-11,16H,12-13H2,1-4H3,(H,28,29)/t16-,24+/m1/s1 SMWYFICPEVRFOB-GYCJOSAFSA-N 334608 US11040966, Example 3.30::US9732075, Example 3.30::[(2S,4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334608 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334608&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127589 384986768 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656863 CO[C@H]1CN(C(=O)c2nc(C)sc2-c2cccc(Cl)c2)[C@@](C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C25H24Cl2N4O2S/c1-13-18(27)8-9-19-20(13)30-24(29-19)25(3)11-17(33-4)12-31(25)23(32)21-22(34-14(2)28-21)15-6-5-7-16(26)10-15/h5-10,17H,11-12H2,1-4H3,(H,29,30)/t17-,25+/m1/s1 BWIVUNXAJXPBFO-NSYGIPOTSA-N 334609 US11040966, Example 3.31::US9732075, Example 3.31::[(2S,4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334609 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334609&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127351 384986769 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656864 CO[C@H]1CN(C(=O)c2nc(C)sc2-c2cccc(Cl)c2)[C@@](C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C25H24Cl2N4O2S/c1-13-18(27)8-9-19-20(13)30-24(29-19)25(3)11-17(33-4)12-31(25)23(32)21-22(34-14(2)28-21)15-6-5-7-16(26)10-15/h5-10,17H,11-12H2,1-4H3,(H,29,30)/t17-,25+/m1/s1 BWIVUNXAJXPBFO-NSYGIPOTSA-N 334609 US11040966, Example 3.31::US9732075, Example 3.31::[(2S,4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334609 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334609&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127351 384986769 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656865 CO[C@@H]1C[C@H](N(C1)C(=O)c1nc(C)sc1-c1cccc(C)c1)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C25H25ClN4O2S/c1-13-6-5-7-16(10-13)23-22(27-15(3)33-23)25(31)30-12-17(32-4)11-20(30)24-28-19-9-8-18(26)14(2)21(19)29-24/h5-10,17,20H,11-12H2,1-4H3,(H,28,29)/t17-,20+/m1/s1 BIYHTTUWIYFGHN-XLIONFOSSA-N 334610 US11040966, Example 3.32::US9732075, Example 3.32::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(2-methyl-5-m-tolyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 0.900 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334610 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334610&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127343 384986770 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656866 CO[C@@H]1C[C@H](N(C1)C(=O)c1nc(C)sc1-c1cccc(C)c1)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C25H25ClN4O2S/c1-13-6-5-7-16(10-13)23-22(27-15(3)33-23)25(31)30-12-17(32-4)11-20(30)24-28-19-9-8-18(26)14(2)21(19)29-24/h5-10,17,20H,11-12H2,1-4H3,(H,28,29)/t17-,20+/m1/s1 BIYHTTUWIYFGHN-XLIONFOSSA-N 334610 US11040966, Example 3.32::US9732075, Example 3.32::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(2-methyl-5-m-tolyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334610 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334610&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127343 384986770 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656867 CO[C@@H]1C[C@H](N(C1)C(=O)c1nc(sc1-c1ccc(C)c(C)c1)N(C)C)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C27H30ClN5O2S/c1-14-7-8-17(11-15(14)2)24-23(31-27(36-24)32(4)5)26(34)33-13-18(35-6)12-21(33)25-29-20-10-9-19(28)16(3)22(20)30-25/h7-11,18,21H,12-13H2,1-6H3,(H,29,30)/t18-,21+/m1/s1 BRMIJZHNESDJJS-NQIIRXRSSA-N 334611 US11040966, Example 3.33::US9732075, Example 3.33::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-[2-dimethylamino-5-(3,4-dimethyl-phenyl)-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 0.800 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334611 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334611&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127535 384986771 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656868 CO[C@@H]1C[C@H](N(C1)C(=O)c1nc(sc1-c1ccc(C)c(C)c1)N(C)C)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C27H30ClN5O2S/c1-14-7-8-17(11-15(14)2)24-23(31-27(36-24)32(4)5)26(34)33-13-18(35-6)12-21(33)25-29-20-10-9-19(28)16(3)22(20)30-25/h7-11,18,21H,12-13H2,1-6H3,(H,29,30)/t18-,21+/m1/s1 BRMIJZHNESDJJS-NQIIRXRSSA-N 334611 US11040966, Example 3.33::US9732075, Example 3.33::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-[2-dimethylamino-5-(3,4-dimethyl-phenyl)-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 10.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334611 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334611&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127535 384986771 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656869 CO[C@@H]1C[C@H](N(C1)C(=O)c1nc(C)sc1-c1ccc(C)c(C)c1)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C26H27ClN4O2S/c1-13-6-7-17(10-14(13)2)24-23(28-16(4)34-24)26(32)31-12-18(33-5)11-21(31)25-29-20-9-8-19(27)15(3)22(20)30-25/h6-10,18,21H,11-12H2,1-5H3,(H,29,30)/t18-,21+/m1/s1 ZKDXPQCTBSYECW-NQIIRXRSSA-N 334612 US11040966, Example 3.34::US9732075, Example 3.34::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-[5-(3,4-dimethyl-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 0.900 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334612 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334612&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127480 384986772 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656870 CO[C@@H]1C[C@H](N(C1)C(=O)c1nc(C)sc1-c1ccc(C)c(C)c1)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C26H27ClN4O2S/c1-13-6-7-17(10-14(13)2)24-23(28-16(4)34-24)26(32)31-12-18(33-5)11-21(31)25-29-20-9-8-19(27)15(3)22(20)30-25/h6-10,18,21H,11-12H2,1-5H3,(H,29,30)/t18-,21+/m1/s1 ZKDXPQCTBSYECW-NQIIRXRSSA-N 334612 US11040966, Example 3.34::US9732075, Example 3.34::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-[5-(3,4-dimethyl-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334612 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334612&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127480 384986772 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656871 CO[C@@H]1C[C@H](N(C1)C(=O)c1nc(C)sc1-c1ccc(Cl)cc1)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C24H22Cl2N4O2S/c1-12-17(26)8-9-18-20(12)29-23(28-18)19-10-16(32-3)11-30(19)24(31)21-22(33-13(2)27-21)14-4-6-15(25)7-5-14/h4-9,16,19H,10-11H2,1-3H3,(H,28,29)/t16-,19+/m1/s1 YEDDEIUNRODXSF-APWZRJJASA-N 334613 US11040966, Example 3.35::US9732075, Example 3.35::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-[5-(4-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334613 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334613&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127335 384986773 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656872 CO[C@@H]1C[C@H](N(C1)C(=O)c1nc(C)sc1-c1ccc(Cl)cc1)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C24H22Cl2N4O2S/c1-12-17(26)8-9-18-20(12)29-23(28-18)19-10-16(32-3)11-30(19)24(31)21-22(33-13(2)27-21)14-4-6-15(25)7-5-14/h4-9,16,19H,10-11H2,1-3H3,(H,28,29)/t16-,19+/m1/s1 YEDDEIUNRODXSF-APWZRJJASA-N 334613 US11040966, Example 3.35::US9732075, Example 3.35::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-[5-(4-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334613 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334613&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127335 384986773 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656873 CO[C@@H]1C[C@H](N(C1)C(=O)c1nc(C)sc1-c1ccc(C)cc1)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C25H25ClN4O2S/c1-13-5-7-16(8-6-13)23-22(27-15(3)33-23)25(31)30-12-17(32-4)11-20(30)24-28-19-10-9-18(26)14(2)21(19)29-24/h5-10,17,20H,11-12H2,1-4H3,(H,28,29)/t17-,20+/m1/s1 KKQHPVFNBRPWMH-XLIONFOSSA-N 334614 US11040966, Example 3.36::US9732075, Example 3.36::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(2-methyl-5-p-tolyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334614 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334614&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127462 384986774 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656874 CO[C@@H]1C[C@H](N(C1)C(=O)c1nc(C)sc1-c1ccc(C)cc1)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C25H25ClN4O2S/c1-13-5-7-16(8-6-13)23-22(27-15(3)33-23)25(31)30-12-17(32-4)11-20(30)24-28-19-10-9-18(26)14(2)21(19)29-24/h5-10,17,20H,11-12H2,1-4H3,(H,28,29)/t17-,20+/m1/s1 KKQHPVFNBRPWMH-XLIONFOSSA-N 334614 US11040966, Example 3.36::US9732075, Example 3.36::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(2-methyl-5-p-tolyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334614 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334614&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127462 384986774 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656875 CO[C@@H]1C[C@H](N(C1)C(=O)c1nc(C)sc1-c1ccc(OC)cc1)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C25H25ClN4O3S/c1-13-18(26)9-10-19-21(13)29-24(28-19)20-11-17(33-4)12-30(20)25(31)22-23(34-14(2)27-22)15-5-7-16(32-3)8-6-15/h5-10,17,20H,11-12H2,1-4H3,(H,28,29)/t17-,20+/m1/s1 PRRYQDOHJUDXJF-XLIONFOSSA-N 334615 US11040966, Example 3.37::US9732075, Example 3.37::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-[5-(4-methoxy-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334615 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334615&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127112 384986775 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656876 CO[C@@H]1C[C@H](N(C1)C(=O)c1nc(C)sc1-c1ccc(OC)cc1)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C25H25ClN4O3S/c1-13-18(26)9-10-19-21(13)29-24(28-19)20-11-17(33-4)12-30(20)25(31)22-23(34-14(2)27-22)15-5-7-16(32-3)8-6-15/h5-10,17,20H,11-12H2,1-4H3,(H,28,29)/t17-,20+/m1/s1 PRRYQDOHJUDXJF-XLIONFOSSA-N 334615 US11040966, Example 3.37::US9732075, Example 3.37::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-[5-(4-methoxy-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334615 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334615&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127112 384986775 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656877 CO[C@@H]1C[C@H](N(C1)C(=O)c1ccccc1-c1ccc(C)c(C)c1)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C28H28ClN3O2/c1-16-9-10-19(13-17(16)2)21-7-5-6-8-22(21)28(33)32-15-20(34-4)14-25(32)27-30-24-12-11-23(29)18(3)26(24)31-27/h5-13,20,25H,14-15H2,1-4H3,(H,30,31)/t20-,25+/m1/s1 VRWZOKFNMBQHMA-NLFFAJNJSA-N 334616 US11040966, Example 3.38::US9732075, Example 3.38::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(3',4'-dimethyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334616 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334616&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127282 384986776 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656878 CO[C@@H]1C[C@H](N(C1)C(=O)c1ccccc1-c1ccc(C)c(C)c1)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C28H28ClN3O2/c1-16-9-10-19(13-17(16)2)21-7-5-6-8-22(21)28(33)32-15-20(34-4)14-25(32)27-30-24-12-11-23(29)18(3)26(24)31-27/h5-13,20,25H,14-15H2,1-4H3,(H,30,31)/t20-,25+/m1/s1 VRWZOKFNMBQHMA-NLFFAJNJSA-N 334616 US11040966, Example 3.38::US9732075, Example 3.38::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(3',4'-dimethyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334616 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334616&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127282 384986776 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656879 CO[C@@H]1C[C@H](N(C1)C(=O)c1ccccc1-c1ccccc1)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C26H24ClN3O2/c1-16-21(27)12-13-22-24(16)29-25(28-22)23-14-18(32-2)15-30(23)26(31)20-11-7-6-10-19(20)17-8-4-3-5-9-17/h3-13,18,23H,14-15H2,1-2H3,(H,28,29)/t18-,23+/m1/s1 HKYUAAMXDHDSMG-JPYJTQIMSA-N 334617 Biphenyl-2-yl-[(2S,4R)-2-(6-chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-methanone::US11040966, Example 3.39::US9732075, Example 3.39 Orexin/Hypocretin receptor type 1 Homo sapiens 74.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334617 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334617&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102465 384986777 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656880 CO[C@@H]1C[C@H](N(C1)C(=O)c1ccccc1-c1ccccc1)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C26H24ClN3O2/c1-16-21(27)12-13-22-24(16)29-25(28-22)23-14-18(32-2)15-30(23)26(31)20-11-7-6-10-19(20)17-8-4-3-5-9-17/h3-13,18,23H,14-15H2,1-2H3,(H,28,29)/t18-,23+/m1/s1 HKYUAAMXDHDSMG-JPYJTQIMSA-N 334617 Biphenyl-2-yl-[(2S,4R)-2-(6-chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-methanone::US11040966, Example 3.39::US9732075, Example 3.39 Orexin receptor type 2 Homo sapiens 57.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334617 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334617&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102465 384986777 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656881 CO[C@@H]1C[C@H](N(C1)C(=O)c1nc(C)sc1-c1ccccc1)c1nc2c(C)cccc2[nH]1 InChI=1S/C24H24N4O2S/c1-14-8-7-11-18-20(14)27-23(26-18)19-12-17(30-3)13-28(19)24(29)21-22(31-15(2)25-21)16-9-5-4-6-10-16/h4-11,17,19H,12-13H2,1-3H3,(H,26,27)/t17-,19+/m1/s1 OPQYIHNPNRVKLM-MJGOQNOKSA-N 334618 US11040966, Example 3.4::US9732075, Example 3.4::[(2S,4R)-4-Methoxy-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 44.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334618 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334618&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128134 384986778 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656882 CO[C@@H]1C[C@H](N(C1)C(=O)c1nc(C)sc1-c1ccccc1)c1nc2c(C)cccc2[nH]1 InChI=1S/C24H24N4O2S/c1-14-8-7-11-18-20(14)27-23(26-18)19-12-17(30-3)13-28(19)24(29)21-22(31-15(2)25-21)16-9-5-4-6-10-16/h4-11,17,19H,12-13H2,1-3H3,(H,26,27)/t17-,19+/m1/s1 OPQYIHNPNRVKLM-MJGOQNOKSA-N 334618 US11040966, Example 3.4::US9732075, Example 3.4::[(2S,4R)-4-Methoxy-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 14.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334618 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334618&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128134 384986778 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656883 CO[C@@H]1C[C@H](N(C1)C(=O)c1ccccc1-c1ccc(F)c(C)c1)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C27H25ClFN3O2/c1-15-12-17(8-10-22(15)29)19-6-4-5-7-20(19)27(33)32-14-18(34-3)13-24(32)26-30-23-11-9-21(28)16(2)25(23)31-26/h4-12,18,24H,13-14H2,1-3H3,(H,30,31)/t18-,24+/m1/s1 WURLOVAITMAHFC-KOSHJBKYSA-N 334619 US11040966, Example 3.40::US9732075, Example 3.40::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(4'-fluoro-3'-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334619 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334619&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118126997 384986779 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656884 CO[C@@H]1C[C@H](N(C1)C(=O)c1ccccc1-c1ccc(F)c(C)c1)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C27H25ClFN3O2/c1-15-12-17(8-10-22(15)29)19-6-4-5-7-20(19)27(33)32-14-18(34-3)13-24(32)26-30-23-11-9-21(28)16(2)25(23)31-26/h4-12,18,24H,13-14H2,1-3H3,(H,30,31)/t18-,24+/m1/s1 WURLOVAITMAHFC-KOSHJBKYSA-N 334619 US11040966, Example 3.40::US9732075, Example 3.40::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(4'-fluoro-3'-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334619 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334619&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118126997 384986779 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656885 CO[C@@H]1C[C@H](N(C1)C(=O)c1nc(sc1-c1cccc(Cl)c1)N(C)C)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C25H25Cl2N5O2S/c1-13-17(27)8-9-18-20(13)29-23(28-18)19-11-16(34-4)12-32(19)24(33)21-22(35-25(30-21)31(2)3)14-6-5-7-15(26)10-14/h5-10,16,19H,11-12H2,1-4H3,(H,28,29)/t16-,19+/m1/s1 FEJNEXSKTFURIP-APWZRJJASA-N 334620 US11040966, Example 3.41::US9732075, Example 3.41::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-dimethylamino-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 0.700 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334620 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334620&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127423 384986780 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656886 CO[C@@H]1C[C@H](N(C1)C(=O)c1nc(sc1-c1cccc(Cl)c1)N(C)C)c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C25H25Cl2N5O2S/c1-13-17(27)8-9-18-20(13)29-23(28-18)19-11-16(34-4)12-32(19)24(33)21-22(35-25(30-21)31(2)3)14-6-5-7-15(26)10-14/h5-10,16,19H,11-12H2,1-4H3,(H,28,29)/t16-,19+/m1/s1 FEJNEXSKTFURIP-APWZRJJASA-N 334620 US11040966, Example 3.41::US9732075, Example 3.41::[(2S,4R)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-dimethylamino-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334620 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334620&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127423 384986780 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656887 CO[C@H]1CN(C(=O)c2c(F)cccc2-n2nccn2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C23H22ClFN6O2/c1-13-15(24)7-8-17-20(13)29-22(28-17)23(2)11-14(33-3)12-30(23)21(32)19-16(25)5-4-6-18(19)31-26-9-10-27-31/h4-10,14H,11-12H2,1-3H3,(H,28,29)/t14-,23?/m1/s1 DVBLWCSCSNQUJD-PDNQZYNLSA-N 334621 US11040966, Example 3.42::US9732075, Example 3.42::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(2-fluoro-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 193 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334621 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334621&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127404 384986781 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656888 CO[C@H]1CN(C(=O)c2c(F)cccc2-n2nccn2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C23H22ClFN6O2/c1-13-15(24)7-8-17-20(13)29-22(28-17)23(2)11-14(33-3)12-30(23)21(32)19-16(25)5-4-6-18(19)31-26-9-10-27-31/h4-10,14H,11-12H2,1-3H3,(H,28,29)/t14-,23?/m1/s1 DVBLWCSCSNQUJD-PDNQZYNLSA-N 334621 US11040966, Example 3.42::US9732075, Example 3.42::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(2-fluoro-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 395 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334621 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334621&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127404 384986781 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656889 CO[C@H]1CN(C(=O)c2cc(F)ccc2-n2nccn2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C23H22ClFN6O2/c1-13-17(24)5-6-18-20(13)29-22(28-18)23(2)11-15(33-3)12-30(23)21(32)16-10-14(25)4-7-19(16)31-26-8-9-27-31/h4-10,15H,11-12H2,1-3H3,(H,28,29)/t15-,23?/m1/s1 ZIFGMOLIBCAVCD-NKTHEXPSSA-N 334622 US11040966, Example 3.43::US9732075, Example 3.43::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(5-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 10.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334622 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334622&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127982 384986782 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656890 CO[C@H]1CN(C(=O)c2cc(F)ccc2-n2nccn2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C23H22ClFN6O2/c1-13-17(24)5-6-18-20(13)29-22(28-18)23(2)11-15(33-3)12-30(23)21(32)16-10-14(25)4-7-19(16)31-26-8-9-27-31/h4-10,15H,11-12H2,1-3H3,(H,28,29)/t15-,23?/m1/s1 ZIFGMOLIBCAVCD-NKTHEXPSSA-N 334622 US11040966, Example 3.43::US9732075, Example 3.43::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(5-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334622 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334622&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127982 384986782 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656891 CO[C@H]1CN(C(=O)c2cc(Cl)ccc2-n2nccn2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C23H22Cl2N6O2/c1-13-17(25)5-6-18-20(13)29-22(28-18)23(2)11-15(33-3)12-30(23)21(32)16-10-14(24)4-7-19(16)31-26-8-9-27-31/h4-10,15H,11-12H2,1-3H3,(H,28,29)/t15-,23?/m1/s1 VKJYSIARVKDYIT-NKTHEXPSSA-N 334623 US11040966, Example 3.44::US9732075, Example 3.44::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(5-chloro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334623 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334623&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127260 384986783 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656892 CO[C@H]1CN(C(=O)c2cc(Cl)ccc2-n2nccn2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C23H22Cl2N6O2/c1-13-17(25)5-6-18-20(13)29-22(28-18)23(2)11-15(33-3)12-30(23)21(32)16-10-14(24)4-7-19(16)31-26-8-9-27-31/h4-10,15H,11-12H2,1-3H3,(H,28,29)/t15-,23?/m1/s1 VKJYSIARVKDYIT-NKTHEXPSSA-N 334623 US11040966, Example 3.44::US9732075, Example 3.44::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(5-chloro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334623 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334623&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127260 384986783 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656893 CO[C@H]1CN(C(=O)c2ccccc2-n2nccn2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C23H23ClN6O2/c1-14-17(24)8-9-18-20(14)28-22(27-18)23(2)12-15(32-3)13-29(23)21(31)16-6-4-5-7-19(16)30-25-10-11-26-30/h4-11,15H,12-13H2,1-3H3,(H,27,28)/t15-,23?/m1/s1 MERASXPSAAHTHI-NKTHEXPSSA-N 334624 US11040966, Example 3.45::US9732075, Example 3.45::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 16.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334624 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334624&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127862 384986784 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656894 CO[C@H]1CN(C(=O)c2ccccc2-n2nccn2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C23H23ClN6O2/c1-14-17(24)8-9-18-20(14)28-22(27-18)23(2)12-15(32-3)13-29(23)21(31)16-6-4-5-7-19(16)30-25-10-11-26-30/h4-11,15H,12-13H2,1-3H3,(H,27,28)/t15-,23?/m1/s1 MERASXPSAAHTHI-NKTHEXPSSA-N 334624 US11040966, Example 3.45::US9732075, Example 3.45::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 19.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334624 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334624&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127862 384986784 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656895 CO[C@H]1CN(C(=O)c2c(F)c(OC)ccc2-n2nccn2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C24H24ClFN6O3/c1-13-15(25)5-6-16-21(13)30-23(29-16)24(2)11-14(34-3)12-31(24)22(33)19-17(32-27-9-10-28-32)7-8-18(35-4)20(19)26/h5-10,14H,11-12H2,1-4H3,(H,29,30)/t14-,24?/m1/s1 ZSVQXJJVUCRVNX-GMBBYQRISA-N 334625 US11040966, Example 3.46::US9732075, Example 3.46::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methoxy-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 223 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334625 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334625&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128210 384986785 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656896 CO[C@H]1CN(C(=O)c2c(F)c(OC)ccc2-n2nccn2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C24H24ClFN6O3/c1-13-15(25)5-6-16-21(13)30-23(29-16)24(2)11-14(34-3)12-31(24)22(33)19-17(32-27-9-10-28-32)7-8-18(35-4)20(19)26/h5-10,14H,11-12H2,1-4H3,(H,29,30)/t14-,24?/m1/s1 ZSVQXJJVUCRVNX-GMBBYQRISA-N 334625 US11040966, Example 3.46::US9732075, Example 3.46::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methoxy-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 288 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334625 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334625&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128210 384986785 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656897 CO[C@H]1CN(C(=O)c2c(F)c(C)ccc2-n2nccn2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C24H24ClFN6O2/c1-13-5-8-18(32-27-9-10-28-32)19(20(13)26)22(33)31-12-15(34-4)11-24(31,3)23-29-17-7-6-16(25)14(2)21(17)30-23/h5-10,15H,11-12H2,1-4H3,(H,29,30)/t15-,24?/m1/s1 GISRWMARXJTKDS-GZAIGYLVSA-N 334626 US11040966, Example 3.47::US9732075, Example 3.47::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 225 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334626 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334626&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127647 384986786 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656898 CO[C@H]1CN(C(=O)c2c(F)c(C)ccc2-n2nccn2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C24H24ClFN6O2/c1-13-5-8-18(32-27-9-10-28-32)19(20(13)26)22(33)31-12-15(34-4)11-24(31,3)23-29-17-7-6-16(25)14(2)21(17)30-23/h5-10,15H,11-12H2,1-4H3,(H,29,30)/t15-,24?/m1/s1 GISRWMARXJTKDS-GZAIGYLVSA-N 334626 US11040966, Example 3.47::US9732075, Example 3.47::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 471 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334626 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334626&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127647 384986786 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656899 CO[C@H]1CN(C(=O)c2cc(C)c(C)cc2-n2nccn2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C25H27ClN6O2/c1-14-10-18(21(11-15(14)2)32-27-8-9-28-32)23(33)31-13-17(34-5)12-25(31,4)24-29-20-7-6-19(26)16(3)22(20)30-24/h6-11,17H,12-13H2,1-5H3,(H,29,30)/t17-,25?/m1/s1 QGANVXHHDNOJNO-SMFUYQKNSA-N 334627 US11040966, Example 3.48::US9732075, Example 3.48::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(4,5-dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334627 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334627&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127794 384986787 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656900 CO[C@H]1CN(C(=O)c2cc(C)c(C)cc2-n2nccn2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C25H27ClN6O2/c1-14-10-18(21(11-15(14)2)32-27-8-9-28-32)23(33)31-13-17(34-5)12-25(31,4)24-29-20-7-6-19(26)16(3)22(20)30-24/h6-11,17H,12-13H2,1-5H3,(H,29,30)/t17-,25?/m1/s1 QGANVXHHDNOJNO-SMFUYQKNSA-N 334627 US11040966, Example 3.48::US9732075, Example 3.48::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(4,5-dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334627 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334627&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127794 384986787 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656901 CO[C@H]1CN(C(=O)c2ccc(C)cc2-n2nccn2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C24H25ClN6O2/c1-14-5-6-17(20(11-14)31-26-9-10-27-31)22(32)30-13-16(33-4)12-24(30,3)23-28-19-8-7-18(25)15(2)21(19)29-23/h5-11,16H,12-13H2,1-4H3,(H,28,29)/t16-,24?/m1/s1 CGJSCCIUIHOISZ-YAOANENCSA-N 334628 US11040966, Example 3.49::US9732075, Example 3.49::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334628 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334628&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127520 384986788 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656902 CO[C@H]1CN(C(=O)c2ccc(C)cc2-n2nccn2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C24H25ClN6O2/c1-14-5-6-17(20(11-14)31-26-9-10-27-31)22(32)30-13-16(33-4)12-24(30,3)23-28-19-8-7-18(25)15(2)21(19)29-23/h5-11,16H,12-13H2,1-4H3,(H,28,29)/t16-,24?/m1/s1 CGJSCCIUIHOISZ-YAOANENCSA-N 334628 US11040966, Example 3.49::US9732075, Example 3.49::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 18.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334628 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334628&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127520 384986788 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656903 CO[C@H]1C[C@H](N(C1)C(=O)c1nc(C)sc1-c1ccccc1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C24H23ClN4O2S/c1-13-17(25)9-10-18-20(13)28-23(27-18)19-11-16(31-3)12-29(19)24(30)21-22(32-14(2)26-21)15-7-5-4-6-8-15/h4-10,16,19H,11-12H2,1-3H3,(H,27,28)/t16-,19-/m0/s1 IZHDGARJKYGHMR-LPHOPBHVSA-N 334629 US11040966, Example 3.5::US9732075, Example 3.5::[(2S,4S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 109 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334629 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334629&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128212 384986789 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656904 CO[C@H]1C[C@H](N(C1)C(=O)c1nc(C)sc1-c1ccccc1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C24H23ClN4O2S/c1-13-17(25)9-10-18-20(13)28-23(27-18)19-11-16(31-3)12-29(19)24(30)21-22(32-14(2)26-21)15-7-5-4-6-8-15/h4-10,16,19H,11-12H2,1-3H3,(H,27,28)/t16-,19-/m0/s1 IZHDGARJKYGHMR-LPHOPBHVSA-N 334629 US11040966, Example 3.5::US9732075, Example 3.5::[(2S,4S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 74.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334629 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334629&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128212 384986789 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656905 CO[C@H]1CN(C(=O)c2cc(ccc2-n2nccn2)C(F)(F)F)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C24H22ClF3N6O2/c1-13-17(25)5-6-18-20(13)32-22(31-18)23(2)11-15(36-3)12-33(23)21(35)16-10-14(24(26,27)28)4-7-19(16)34-29-8-9-30-34/h4-10,15H,11-12H2,1-3H3,(H,31,32)/t15-,23?/m1/s1 RGCNNXGDSILIIC-NKTHEXPSSA-N 334630 US11040966, Example 3.50::US9732075, Example 3.50::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoromethyl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 232 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334630 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334630&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127264 384986790 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656906 CO[C@H]1CN(C(=O)c2cc(ccc2-n2nccn2)C(F)(F)F)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C24H22ClF3N6O2/c1-13-17(25)5-6-18-20(13)32-22(31-18)23(2)11-15(36-3)12-33(23)21(35)16-10-14(24(26,27)28)4-7-19(16)34-29-8-9-30-34/h4-10,15H,11-12H2,1-3H3,(H,31,32)/t15-,23?/m1/s1 RGCNNXGDSILIIC-NKTHEXPSSA-N 334630 US11040966, Example 3.50::US9732075, Example 3.50::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoromethyl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 252 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334630 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334630&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127264 384986790 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656907 CO[C@H]1CN(C(=O)c2cc(OC(F)(F)F)ccc2-n2nccn2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C24H22ClF3N6O3/c1-13-17(25)5-6-18-20(13)32-22(31-18)23(2)11-15(36-3)12-33(23)21(35)16-10-14(37-24(26,27)28)4-7-19(16)34-29-8-9-30-34/h4-10,15H,11-12H2,1-3H3,(H,31,32)/t15-,23?/m1/s1 JKAQEFIPJYJNQX-NKTHEXPSSA-N 334631 US11040966, Example 3.51::US9732075, Example 3.51::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoromethoxy-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 94.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334631 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334631&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127048 384986791 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656908 CO[C@H]1CN(C(=O)c2cc(OC(F)(F)F)ccc2-n2nccn2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C24H22ClF3N6O3/c1-13-17(25)5-6-18-20(13)32-22(31-18)23(2)11-15(36-3)12-33(23)21(35)16-10-14(37-24(26,27)28)4-7-19(16)34-29-8-9-30-34/h4-10,15H,11-12H2,1-3H3,(H,31,32)/t15-,23?/m1/s1 JKAQEFIPJYJNQX-NKTHEXPSSA-N 334631 US11040966, Example 3.51::US9732075, Example 3.51::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoromethoxy-phenyl)-methanone Orexin receptor type 2 Homo sapiens 44.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334631 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334631&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127048 384986791 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656909 CO[C@H]1CN(C(=O)c2cc(OC)c(OC)cc2-n2nccn2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C25H27ClN6O4/c1-14-17(26)6-7-18-22(14)30-24(29-18)25(2)12-15(34-3)13-31(25)23(33)16-10-20(35-4)21(36-5)11-19(16)32-27-8-9-28-32/h6-11,15H,12-13H2,1-5H3,(H,29,30)/t15-,25?/m1/s1 MPRWPJCJVOKAIE-FXBVVIMESA-N 334632 US11040966, Example 3.52::US9732075, Example 3.52::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(4,5-dimethoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 28.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334632 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334632&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127705 384986792 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656910 CO[C@H]1CN(C(=O)c2cc(OC)c(OC)cc2-n2nccn2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C25H27ClN6O4/c1-14-17(26)6-7-18-22(14)30-24(29-18)25(2)12-15(34-3)13-31(25)23(33)16-10-20(35-4)21(36-5)11-19(16)32-27-8-9-28-32/h6-11,15H,12-13H2,1-5H3,(H,29,30)/t15-,25?/m1/s1 MPRWPJCJVOKAIE-FXBVVIMESA-N 334632 US11040966, Example 3.52::US9732075, Example 3.52::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(4,5-dimethoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 27.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334632 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334632&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127705 384986792 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656911 CO[C@H]1CN(C(=O)c2cc(C)ccc2-n2cccn2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C25H26ClN5O2/c1-15-6-9-21(31-11-5-10-27-31)18(12-15)23(32)30-14-17(33-4)13-25(30,3)24-28-20-8-7-19(26)16(2)22(20)29-24/h5-12,17H,13-14H2,1-4H3,(H,28,29)/t17-,25?/m1/s1 IRVBQUVNVDYHKL-SMFUYQKNSA-N 334633 US11040966, Example 3.53::US9732075, Example 3.53::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 10.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334633 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334633&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127443 384986793 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656912 CO[C@H]1CN(C(=O)c2cc(C)ccc2-n2cccn2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C25H26ClN5O2/c1-15-6-9-21(31-11-5-10-27-31)18(12-15)23(32)30-14-17(33-4)13-25(30,3)24-28-20-8-7-19(26)16(2)22(20)29-24/h5-12,17H,13-14H2,1-4H3,(H,28,29)/t17-,25?/m1/s1 IRVBQUVNVDYHKL-SMFUYQKNSA-N 334633 US11040966, Example 3.53::US9732075, Example 3.53::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 20.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334633 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334633&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127443 384986793 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656913 CO[C@H]1CN(C(=O)c2ccccc2-n2cccn2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C24H24ClN5O2/c1-15-18(25)9-10-19-21(15)28-23(27-19)24(2)13-16(32-3)14-29(24)22(31)17-7-4-5-8-20(17)30-12-6-11-26-30/h4-12,16H,13-14H2,1-3H3,(H,27,28)/t16-,24?/m1/s1 PBCMUHCDRZUMPJ-YAOANENCSA-N 334634 US11040966, Example 3.54::US9732075, Example 3.54::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(2-pyrazol-1-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 52.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334634 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334634&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128108 384986794 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656914 CO[C@H]1CN(C(=O)c2ccccc2-n2cccn2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C24H24ClN5O2/c1-15-18(25)9-10-19-21(15)28-23(27-19)24(2)13-16(32-3)14-29(24)22(31)17-7-4-5-8-20(17)30-12-6-11-26-30/h4-12,16H,13-14H2,1-3H3,(H,27,28)/t16-,24?/m1/s1 PBCMUHCDRZUMPJ-YAOANENCSA-N 334634 US11040966, Example 3.54::US9732075, Example 3.54::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(2-pyrazol-1-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 44.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334634 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334634&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128108 384986794 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656915 CO[C@H]1CN(C(=O)c2nc(C)ccc2-n2cccn2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C24H25ClN6O2/c1-14-6-9-19(31-11-5-10-26-31)21(27-14)22(32)30-13-16(33-4)12-24(30,3)23-28-18-8-7-17(25)15(2)20(18)29-23/h5-11,16H,12-13H2,1-4H3,(H,28,29)/t16-,24?/m1/s1 SQVIODFPIKXIQL-YAOANENCSA-N 334635 US11040966, Example 3.55::US9732075, Example 3.55::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(6-methyl-3-pyrazol-1-yl-pyridin-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 18.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334635 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334635&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127570 384986795 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656916 CO[C@H]1CN(C(=O)c2nc(C)ccc2-n2cccn2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C24H25ClN6O2/c1-14-6-9-19(31-11-5-10-26-31)21(27-14)22(32)30-13-16(33-4)12-24(30,3)23-28-18-8-7-17(25)15(2)20(18)29-23/h5-11,16H,12-13H2,1-4H3,(H,28,29)/t16-,24?/m1/s1 SQVIODFPIKXIQL-YAOANENCSA-N 334635 US11040966, Example 3.55::US9732075, Example 3.55::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(6-methyl-3-pyrazol-1-yl-pyridin-2-yl)-methanone Orexin receptor type 2 Homo sapiens 45.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334635 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334635&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127570 384986795 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656917 CO[C@H]1CN(C(=O)c2nc(C)ccc2-n2nccn2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C23H24ClN7O2/c1-13-5-8-18(31-25-9-10-26-31)20(27-13)21(32)30-12-15(33-4)11-23(30,3)22-28-17-7-6-16(24)14(2)19(17)29-22/h5-10,15H,11-12H2,1-4H3,(H,28,29)/t15-,23?/m1/s1 COPUKJYYNMUOMZ-NKTHEXPSSA-N 334636 US11040966, Example 3.56::US9732075, Example 3.56::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 18.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334636 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334636&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127831 384986796 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656918 CO[C@H]1CN(C(=O)c2nc(C)ccc2-n2nccn2)C(C)(C1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C23H24ClN7O2/c1-13-5-8-18(31-25-9-10-26-31)20(27-13)21(32)30-12-15(33-4)11-23(30,3)22-28-17-7-6-16(24)14(2)19(17)29-22/h5-10,15H,11-12H2,1-4H3,(H,28,29)/t15-,23?/m1/s1 COPUKJYYNMUOMZ-NKTHEXPSSA-N 334636 US11040966, Example 3.56::US9732075, Example 3.56::[(2RS)-(4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-2-methyl-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone Orexin receptor type 2 Homo sapiens 37.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334636 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334636&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127831 384986796 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656919 CO[C@@H]1C[C@H](N(C1)C(=O)c1nc(C)sc1-c1ccccc1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C24H23ClN4O2S/c1-13-17(25)9-10-18-20(13)28-23(27-18)19-11-16(31-3)12-29(19)24(30)21-22(32-14(2)26-21)15-7-5-4-6-8-15/h4-10,16,19H,11-12H2,1-3H3,(H,27,28)/t16-,19+/m1/s1 IZHDGARJKYGHMR-APWZRJJASA-N 334637 US11040966, Example 3.6::US9732075, Example 3.6::[(2S,4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334637 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334637&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127221 384986797 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656920 CO[C@@H]1C[C@H](N(C1)C(=O)c1nc(C)sc1-c1ccccc1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C24H23ClN4O2S/c1-13-17(25)9-10-18-20(13)28-23(27-18)19-11-16(31-3)12-29(19)24(30)21-22(32-14(2)26-21)15-7-5-4-6-8-15/h4-10,16,19H,11-12H2,1-3H3,(H,27,28)/t16-,19+/m1/s1 IZHDGARJKYGHMR-APWZRJJASA-N 334637 US11040966, Example 3.6::US9732075, Example 3.6::[(2S,4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334637 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334637&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127221 384986797 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656921 CO[C@@H]1C[C@H](N(C1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1)c1nc2c(C)cccc2[nH]1 InChI=1S/C24H23ClN4O2S/c1-13-6-4-9-18-20(13)28-23(27-18)19-11-17(31-3)12-29(19)24(30)21-22(32-14(2)26-21)15-7-5-8-16(25)10-15/h4-10,17,19H,11-12H2,1-3H3,(H,27,28)/t17-,19+/m1/s1 YTAFXZOJDKCAFY-MJGOQNOKSA-N 334638 US11040966, Example 3.7::US9732075, Example 3.7::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,4R)-4-methoxy-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334638 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334638&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128061 384986798 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656922 CO[C@@H]1C[C@H](N(C1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1)c1nc2c(C)cccc2[nH]1 InChI=1S/C24H23ClN4O2S/c1-13-6-4-9-18-20(13)28-23(27-18)19-11-17(31-3)12-29(19)24(30)21-22(32-14(2)26-21)15-7-5-8-16(25)10-15/h4-10,17,19H,11-12H2,1-3H3,(H,27,28)/t17-,19+/m1/s1 YTAFXZOJDKCAFY-MJGOQNOKSA-N 334638 US11040966, Example 3.7::US9732075, Example 3.7::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,4R)-4-methoxy-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334638 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334638&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128061 384986798 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656923 CO[C@H]1C[C@H](N(C1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C24H22Cl2N4O2S/c1-12-17(26)7-8-18-20(12)29-23(28-18)19-10-16(32-3)11-30(19)24(31)21-22(33-13(2)27-21)14-5-4-6-15(25)9-14/h4-9,16,19H,10-11H2,1-3H3,(H,28,29)/t16-,19-/m0/s1 ORXQOPADZCARMN-LPHOPBHVSA-N 334639 US11040966, Example 3.8::US9732075, Example 3.8::[(2S,4S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 22.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334639 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334639&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127263 384986799 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656924 CO[C@H]1C[C@H](N(C1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C24H22Cl2N4O2S/c1-12-17(26)7-8-18-20(12)29-23(28-18)19-10-16(32-3)11-30(19)24(31)21-22(33-13(2)27-21)14-5-4-6-15(25)9-14/h4-9,16,19H,10-11H2,1-3H3,(H,28,29)/t16-,19-/m0/s1 ORXQOPADZCARMN-LPHOPBHVSA-N 334639 US11040966, Example 3.8::US9732075, Example 3.8::[(2S,4S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 12.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334639 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334639&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127263 384986799 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656925 CO[C@@H]1C[C@H](N(C1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C24H22Cl2N4O2S/c1-12-17(26)7-8-18-20(12)29-23(28-18)19-10-16(32-3)11-30(19)24(31)21-22(33-13(2)27-21)14-5-4-6-15(25)9-14/h4-9,16,19H,10-11H2,1-3H3,(H,28,29)/t16-,19+/m1/s1 ORXQOPADZCARMN-APWZRJJASA-N 334640 US11040966, Example 3.9::US9732075, Example 3.9::[(2S,4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334640 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334640&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118126993 384986800 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656926 CO[C@@H]1C[C@H](N(C1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C24H22Cl2N4O2S/c1-12-17(26)7-8-18-20(12)29-23(28-18)19-10-16(32-3)11-30(19)24(31)21-22(33-13(2)27-21)14-5-4-6-15(25)9-14/h4-9,16,19H,10-11H2,1-3H3,(H,28,29)/t16-,19+/m1/s1 ORXQOPADZCARMN-APWZRJJASA-N 334640 US11040966, Example 3.9::US9732075, Example 3.9::[(2S,4R)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334640 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334640&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118126993 384986800 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656927 C[C@H]1CCN([C@@H]1c1nc2cccc(C)c2[nH]1)C(=O)c1cc(C)ccc1-n1nccn1 334641 US9732075, Example 4.1::[(2S,3S)-3-Methyl-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 29.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334641 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334641&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127605 384986801 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656928 C[C@H]1CCN([C@@H]1c1nc2cccc(C)c2[nH]1)C(=O)c1cc(C)ccc1-n1nccn1 334641 US9732075, Example 4.1::[(2S,3S)-3-Methyl-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 778 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334641 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334641&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127605 384986801 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656929 C[C@H]1CCN([C@@H]1c1nc2cc(C)c(C)cc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C25H25ClN4OS/c1-13-8-9-30(22(13)24-28-19-10-14(2)15(3)11-20(19)29-24)25(31)21-23(32-16(4)27-21)17-6-5-7-18(26)12-17/h5-7,10-13,22H,8-9H2,1-4H3,(H,28,29)/t13-,22-/m0/s1 BHYJNXZXWCRENL-XMHCIUCPSA-N 334642 US9732075, Example 4.10::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-2-(5,6-dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334642 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334642&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128053 384986802 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656930 C[C@H]1CCN([C@@H]1c1nc2cc(C)c(C)cc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C25H25ClN4OS/c1-13-8-9-30(22(13)24-28-19-10-14(2)15(3)11-20(19)29-24)25(31)21-23(32-16(4)27-21)17-6-5-7-18(26)12-17/h5-7,10-13,22H,8-9H2,1-4H3,(H,28,29)/t13-,22-/m0/s1 BHYJNXZXWCRENL-XMHCIUCPSA-N 334642 US9732075, Example 4.10::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-2-(5,6-dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 833 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334642 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334642&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128053 384986802 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656931 C[C@H]1CCN([C@@H]1c1nc2c(C)cc(Cl)cc2[nH]1)C(=O)c1nc(C)sc1-c1ccc(F)cc1 InChI=1S/C24H22ClFN4OS/c1-12-8-9-30(21(12)23-28-18-11-16(25)10-13(2)19(18)29-23)24(31)20-22(32-14(3)27-20)15-4-6-17(26)7-5-15/h4-7,10-12,21H,8-9H2,1-3H3,(H,28,29)/t12-,21-/m0/s1 MYRVFLCZPBNRHL-QKVFXAPYSA-N 334643 US11040966, Example 4.100::US9732075, Example 4.100::[(2S,3S)-2-(6-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334643 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334643&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127581 384986803 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656932 C[C@H]1CCN([C@@H]1c1nc2c(C)cc(Cl)cc2[nH]1)C(=O)c1nc(C)sc1-c1ccc(F)cc1 InChI=1S/C24H22ClFN4OS/c1-12-8-9-30(21(12)23-28-18-11-16(25)10-13(2)19(18)29-23)24(31)20-22(32-14(3)27-20)15-4-6-17(26)7-5-15/h4-7,10-12,21H,8-9H2,1-3H3,(H,28,29)/t12-,21-/m0/s1 MYRVFLCZPBNRHL-QKVFXAPYSA-N 334643 US11040966, Example 4.100::US9732075, Example 4.100::[(2S,3S)-2-(6-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 1280 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334643 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334643&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127581 384986803 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656933 C[C@H]1CCN([C@@H]1c1nc2c(C)cc(Cl)cc2[nH]1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H21ClN6O/c1-13-7-10-28(20(13)21-26-17-12-15(23)11-14(2)19(17)27-21)22(30)16-5-3-4-6-18(16)29-24-8-9-25-29/h3-6,8-9,11-13,20H,7,10H2,1-2H3,(H,26,27)/t13-,20-/m0/s1 SXIGUDRSURDTOY-RBZFPXEDSA-N 334644 US11040966, Example 4.101::US9732075, Example 4.101::[(2S,3S)-2-(6-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 18.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334644 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334644&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127403 384986804 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656934 C[C@H]1CCN([C@@H]1c1nc2c(C)cc(Cl)cc2[nH]1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H21ClN6O/c1-13-7-10-28(20(13)21-26-17-12-15(23)11-14(2)19(17)27-21)22(30)16-5-3-4-6-18(16)29-24-8-9-25-29/h3-6,8-9,11-13,20H,7,10H2,1-2H3,(H,26,27)/t13-,20-/m0/s1 SXIGUDRSURDTOY-RBZFPXEDSA-N 334644 US11040966, Example 4.101::US9732075, Example 4.101::[(2S,3S)-2-(6-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 183 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334644 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334644&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127403 384986804 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656935 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)ccc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C23H20Cl2N4OS/c1-12-8-9-29(20(12)22-27-17-7-6-16(25)11-18(17)28-22)23(30)19-21(31-13(2)26-19)14-4-3-5-15(24)10-14/h3-7,10-12,20H,8-9H2,1-2H3,(H,27,28)/t12-,20-/m0/s1 CTYPDKHVOJCDKL-YUNKPMOVSA-N 334645 US11040966, Example 4.11::US9732075, Example 4.11::[(2S,3S)-2-(5-Chloro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 10.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334645 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334645&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127262 384986805 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656936 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)ccc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C23H20Cl2N4OS/c1-12-8-9-29(20(12)22-27-17-7-6-16(25)11-18(17)28-22)23(30)19-21(31-13(2)26-19)14-4-3-5-15(24)10-14/h3-7,10-12,20H,8-9H2,1-2H3,(H,27,28)/t12-,20-/m0/s1 CTYPDKHVOJCDKL-YUNKPMOVSA-N 334645 US11040966, Example 4.11::US9732075, Example 4.11::[(2S,3S)-2-(5-Chloro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 4060 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334645 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334645&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127262 384986805 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656937 C[C@H]1CCN([C@@H]1c1nc2cc(F)c(F)cc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C23H19ClF2N4OS/c1-11-6-7-30(20(11)22-28-17-9-15(25)16(26)10-18(17)29-22)23(31)19-21(32-12(2)27-19)13-4-3-5-14(24)8-13/h3-5,8-11,20H,6-7H2,1-2H3,(H,28,29)/t11-,20-/m0/s1 JESCMWIZIVINDZ-YBTHPKLGSA-N 334646 US11040966, Example 4.12::US9732075, Example 4.12::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-2-(5,6-difluoro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 23.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334646 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334646&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127275 384986806 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656938 C[C@H]1CCN([C@@H]1c1nc2cc(F)c(F)cc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C23H19ClF2N4OS/c1-11-6-7-30(20(11)22-28-17-9-15(25)16(26)10-18(17)29-22)23(31)19-21(32-12(2)27-19)13-4-3-5-14(24)8-13/h3-5,8-11,20H,6-7H2,1-2H3,(H,28,29)/t11-,20-/m0/s1 JESCMWIZIVINDZ-YBTHPKLGSA-N 334646 US11040966, Example 4.12::US9732075, Example 4.12::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-2-(5,6-difluoro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 4870 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334646 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334646&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127275 384986806 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656939 COC(=O)c1cccc2[nH]c(nc12)[C@@H]1[C@@H](C)CCN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C25H23ClN4O3S/c1-13-10-11-30(21(13)23-28-18-9-5-8-17(19(18)29-23)25(32)33-3)24(31)20-22(34-14(2)27-20)15-6-4-7-16(26)12-15/h4-9,12-13,21H,10-11H2,1-3H3,(H,28,29)/t13-,21-/m0/s1 RJMSGCLXLQOAFX-ZSEKCTLFSA-N 334647 2-{(2S,3S)-1-[5-(3-Chloro-phenyl)-2-methyl-thiazole-4-carbon-yl]-3-methyl-pyrrolidin-2-yl}-1H-benzoimidazole-4-carboxylicacid methyl ester::US11040966, Example 4.13::US9732075, Example 4.13 Orexin/Hypocretin receptor type 1 Homo sapiens 26.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334647 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334647&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127155 384986807 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656940 COC(=O)c1cccc2[nH]c(nc12)[C@@H]1[C@@H](C)CCN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C25H23ClN4O3S/c1-13-10-11-30(21(13)23-28-18-9-5-8-17(19(18)29-23)25(32)33-3)24(31)20-22(34-14(2)27-20)15-6-4-7-16(26)12-15/h4-9,12-13,21H,10-11H2,1-3H3,(H,28,29)/t13-,21-/m0/s1 RJMSGCLXLQOAFX-ZSEKCTLFSA-N 334647 2-{(2S,3S)-1-[5-(3-Chloro-phenyl)-2-methyl-thiazole-4-carbon-yl]-3-methyl-pyrrolidin-2-yl}-1H-benzoimidazole-4-carboxylicacid methyl ester::US11040966, Example 4.13::US9732075, Example 4.13 Orexin receptor type 2 Homo sapiens 4910 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334647 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334647&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127155 384986807 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656941 COc1cccc2[nH]c(nc12)[C@@H]1[C@@H](C)CCN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C24H23ClN4O2S/c1-13-10-11-29(21(13)23-27-17-8-5-9-18(31-3)19(17)28-23)24(30)20-22(32-14(2)26-20)15-6-4-7-16(25)12-15/h4-9,12-13,21H,10-11H2,1-3H3,(H,27,28)/t13-,21-/m0/s1 HGVKAWCWIWNEEJ-ZSEKCTLFSA-N 334648 US11040966, Example 4.14::US9732075, Example 4.14::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-2-(4-methoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 15.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334648 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334648&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118126999 384986808 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656942 COc1cccc2[nH]c(nc12)[C@@H]1[C@@H](C)CCN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C24H23ClN4O2S/c1-13-10-11-29(21(13)23-27-17-8-5-9-18(31-3)19(17)28-23)24(30)20-22(32-14(2)26-20)15-6-4-7-16(25)12-15/h4-9,12-13,21H,10-11H2,1-3H3,(H,27,28)/t13-,21-/m0/s1 HGVKAWCWIWNEEJ-ZSEKCTLFSA-N 334648 US11040966, Example 4.14::US9732075, Example 4.14::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-2-(4-methoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 4030 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334648 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334648&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118126999 384986808 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656943 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C24H22Cl2N4OS/c1-12-7-8-30(21(12)23-28-18-9-13(2)17(26)11-19(18)29-23)24(31)20-22(32-14(3)27-20)15-5-4-6-16(25)10-15/h4-6,9-12,21H,7-8H2,1-3H3,(H,28,29)/t12-,21-/m0/s1 UNNYKAHMVYXHRC-QKVFXAPYSA-N 334649 US11040966, Example 4.15::US9732075, Example 4.15::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334649 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334649&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127204 384986809 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656944 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C24H22Cl2N4OS/c1-12-7-8-30(21(12)23-28-18-9-13(2)17(26)11-19(18)29-23)24(31)20-22(32-14(3)27-20)15-5-4-6-16(25)10-15/h4-6,9-12,21H,7-8H2,1-3H3,(H,28,29)/t12-,21-/m0/s1 UNNYKAHMVYXHRC-QKVFXAPYSA-N 334649 US11040966, Example 4.15::US9732075, Example 4.15::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 670 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334649 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334649&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127204 384986809 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656945 C[C@H]1CCN([C@@H]1c1nc2c(C)cc(C)cc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C25H25ClN4OS/c1-13-10-15(3)20-19(11-13)28-24(29-20)22-14(2)8-9-30(22)25(31)21-23(32-16(4)27-21)17-6-5-7-18(26)12-17/h5-7,10-12,14,22H,8-9H2,1-4H3,(H,28,29)/t14-,22-/m0/s1 CSNOPSKKXVIYCS-FPTDNZKUSA-N 334650 US11040966, Example 4.16::US9732075, Example 4.16::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-2-(4,6-dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334650 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334650&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128044 384986810 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656946 C[C@H]1CCN([C@@H]1c1nc2c(C)cc(C)cc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C25H25ClN4OS/c1-13-10-15(3)20-19(11-13)28-24(29-20)22-14(2)8-9-30(22)25(31)21-23(32-16(4)27-21)17-6-5-7-18(26)12-17/h5-7,10-12,14,22H,8-9H2,1-4H3,(H,28,29)/t14-,22-/m0/s1 CSNOPSKKXVIYCS-FPTDNZKUSA-N 334650 US11040966, Example 4.16::US9732075, Example 4.16::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-2-(4,6-dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 250 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334650 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334650&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128044 384986810 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656947 C[C@H]1CCN([C@@H]1c1nc2c(CO)cccc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C24H23ClN4O2S/c1-13-9-10-29(21(13)23-27-18-8-4-6-16(12-30)19(18)28-23)24(31)20-22(32-14(2)26-20)15-5-3-7-17(25)11-15/h3-8,11,13,21,30H,9-10,12H2,1-2H3,(H,27,28)/t13-,21-/m0/s1 FLWHQIWSJMUHII-ZSEKCTLFSA-N 334651 US11040966, Example 4.17::US9732075, Example 4.17::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-2-(4-hydroxymethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 14.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334651 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334651&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127224 384986811 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656948 C[C@H]1CCN([C@@H]1c1nc2c(CO)cccc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C24H23ClN4O2S/c1-13-9-10-29(21(13)23-27-18-8-4-6-16(12-30)19(18)28-23)24(31)20-22(32-14(2)26-20)15-5-3-7-17(25)11-15/h3-8,11,13,21,30H,9-10,12H2,1-2H3,(H,27,28)/t13-,21-/m0/s1 FLWHQIWSJMUHII-ZSEKCTLFSA-N 334651 US11040966, Example 4.17::US9732075, Example 4.17::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-2-(4-hydroxymethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 1670 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334651 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334651&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127224 384986811 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656949 C[C@H]1CCN([C@@H]1c1nc2c(F)cccc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C23H20ClFN4OS/c1-12-9-10-29(20(12)22-27-17-8-4-7-16(25)18(17)28-22)23(30)19-21(31-13(2)26-19)14-5-3-6-15(24)11-14/h3-8,11-12,20H,9-10H2,1-2H3,(H,27,28)/t12-,20-/m0/s1 RBQATKBBNQFBRZ-YUNKPMOVSA-N 334652 US11040966, Example 4.18::US9732075, Example 4.18::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-2-(4-fluoro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 43.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334652 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334652&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127800 384986812 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656950 C[C@H]1CCN([C@@H]1c1nc2c(F)cccc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C23H20ClFN4OS/c1-12-9-10-29(20(12)22-27-17-8-4-7-16(25)18(17)28-22)23(30)19-21(31-13(2)26-19)14-5-3-6-15(24)11-14/h3-8,11-12,20H,9-10H2,1-2H3,(H,27,28)/t12-,20-/m0/s1 RBQATKBBNQFBRZ-YUNKPMOVSA-N 334652 US11040966, Example 4.18::US9732075, Example 4.18::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-2-(4-fluoro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 2930 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334652 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334652&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127800 384986812 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656951 C[C@H]1CCN([C@@H]1c1nc2c(cccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C24H20ClF3N4OS/c1-12-9-10-32(20(12)22-30-17-8-4-7-16(18(17)31-22)24(26,27)28)23(33)19-21(34-13(2)29-19)14-5-3-6-15(25)11-14/h3-8,11-12,20H,9-10H2,1-2H3,(H,30,31)/t12-,20-/m0/s1 GNDUVCYFKUIFPJ-YUNKPMOVSA-N 334653 US11040966, Example 4.19::US9732075, Example 4.19::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334653 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334653&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127160 384986813 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656952 C[C@H]1CCN([C@@H]1c1nc2c(cccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C24H20ClF3N4OS/c1-12-9-10-32(20(12)22-30-17-8-4-7-16(18(17)31-22)24(26,27)28)23(33)19-21(34-13(2)29-19)14-5-3-6-15(25)11-14/h3-8,11-12,20H,9-10H2,1-2H3,(H,30,31)/t12-,20-/m0/s1 GNDUVCYFKUIFPJ-YUNKPMOVSA-N 334653 US11040966, Example 4.19::US9732075, Example 4.19::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 422 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334653 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334653&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127160 384986813 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656953 C[C@H]1CCN([C@@H]1c1nc2cc(C)ccc2[nH]1)C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C23H24N6O/c1-14-5-7-20(29-24-9-10-25-29)17(12-14)23(30)28-11-8-16(3)21(28)22-26-18-6-4-15(2)13-19(18)27-22/h4-7,9-10,12-13,16,21H,8,11H2,1-3H3,(H,26,27)/t16-,21-/m0/s1 DZTLPLUNBIYKBB-KKSFZXQISA-N 334654 US11040966, Example 4.2::US9732075, Example 4.2::[(2S,3S)-3-Methyl-2-(5-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 132 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334654 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334654&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128173 384986814 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656954 C[C@H]1CCN([C@@H]1c1nc2cc(C)ccc2[nH]1)C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C23H24N6O/c1-14-5-7-20(29-24-9-10-25-29)17(12-14)23(30)28-11-8-16(3)21(28)22-26-18-6-4-15(2)13-19(18)27-22/h4-7,9-10,12-13,16,21H,8,11H2,1-3H3,(H,26,27)/t16-,21-/m0/s1 DZTLPLUNBIYKBB-KKSFZXQISA-N 334654 US11040966, Example 4.2::US9732075, Example 4.2::[(2S,3S)-3-Methyl-2-(5-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 669 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334654 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334654&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128173 384986814 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656955 C[C@H]1CCN([C@@H]1c1nc2cc(F)ccc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C23H20ClFN4OS/c1-12-8-9-29(20(12)22-27-17-7-6-16(25)11-18(17)28-22)23(30)19-21(31-13(2)26-19)14-4-3-5-15(24)10-14/h3-7,10-12,20H,8-9H2,1-2H3,(H,27,28)/t12-,20-/m0/s1 IVHGJUDWMSGLHT-YUNKPMOVSA-N 334655 US11040966, Example 4.20::US9732075, Example 4.20::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-2-(5-fluoro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 28.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334655 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334655&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127522 384986815 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656956 C[C@H]1CCN([C@@H]1c1nc2cc(F)ccc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C23H20ClFN4OS/c1-12-8-9-29(20(12)22-27-17-7-6-16(25)11-18(17)28-22)23(30)19-21(31-13(2)26-19)14-4-3-5-15(24)10-14/h3-7,10-12,20H,8-9H2,1-2H3,(H,27,28)/t12-,20-/m0/s1 IVHGJUDWMSGLHT-YUNKPMOVSA-N 334655 US11040966, Example 4.20::US9732075, Example 4.20::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-2-(5-fluoro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 2450 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334655 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334655&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127522 384986815 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656957 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C24H22Cl2N4OS/c1-12-9-10-30(21(12)23-28-18-8-7-17(26)13(2)19(18)29-23)24(31)20-22(32-14(3)27-20)15-5-4-6-16(25)11-15/h4-8,11-12,21H,9-10H2,1-3H3,(H,28,29)/t12-,21-/m0/s1 CNZCWXXEJIVJJI-QKVFXAPYSA-N 334656 US11040966, Example 4.21::US9732075, Example 4.21::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334656 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334656&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127071 384986816 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656958 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C24H22Cl2N4OS/c1-12-9-10-30(21(12)23-28-18-8-7-17(26)13(2)19(18)29-23)24(31)20-22(32-14(3)27-20)15-5-4-6-16(25)11-15/h4-8,11-12,21H,9-10H2,1-3H3,(H,28,29)/t12-,21-/m0/s1 CNZCWXXEJIVJJI-QKVFXAPYSA-N 334656 US11040966, Example 4.21::US9732075, Example 4.21::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 133 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334656 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334656&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127071 384986816 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656959 C[C@H]1CCN([C@@H]1c1nc2c(Cl)cccc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C23H20Cl2N4OS/c1-12-9-10-29(20(12)22-27-17-8-4-7-16(25)18(17)28-22)23(30)19-21(31-13(2)26-19)14-5-3-6-15(24)11-14/h3-8,11-12,20H,9-10H2,1-2H3,(H,27,28)/t12-,20-/m0/s1 TWJUXJGFNPSWDO-YUNKPMOVSA-N 334657 US11040966, Example 4.22::US9732075, Example 4.22::[(2S,3S)-2-(4-Chloro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334657 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334657&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127566 384986817 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656960 C[C@H]1CCN([C@@H]1c1nc2c(Cl)cccc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C23H20Cl2N4OS/c1-12-9-10-29(20(12)22-27-17-8-4-7-16(25)18(17)28-22)23(30)19-21(31-13(2)26-19)14-5-3-6-15(24)11-14/h3-8,11-12,20H,9-10H2,1-2H3,(H,27,28)/t12-,20-/m0/s1 TWJUXJGFNPSWDO-YUNKPMOVSA-N 334657 US11040966, Example 4.22::US9732075, Example 4.22::[(2S,3S)-2-(4-Chloro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 1075 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334657 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334657&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127566 384986817 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656961 C[C@H]1CCN([C@@H]1c1nc2c(F)c(F)ccc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C23H19ClF2N4OS/c1-11-8-9-30(20(11)22-28-16-7-6-15(25)17(26)18(16)29-22)23(31)19-21(32-12(2)27-19)13-4-3-5-14(24)10-13/h3-7,10-11,20H,8-9H2,1-2H3,(H,28,29)/t11-,20-/m0/s1 WHSRGEHJSZRZHM-YBTHPKLGSA-N 334658 US11040966, Example 4.23::US9732075, Example 4.23::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-2-(4,5-difluoro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334658 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334658&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127002 384986818 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656962 C[C@H]1CCN([C@@H]1c1nc2c(F)c(F)ccc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C23H19ClF2N4OS/c1-11-8-9-30(20(11)22-28-16-7-6-15(25)17(26)18(16)29-22)23(31)19-21(32-12(2)27-19)13-4-3-5-14(24)10-13/h3-7,10-11,20H,8-9H2,1-2H3,(H,28,29)/t11-,20-/m0/s1 WHSRGEHJSZRZHM-YBTHPKLGSA-N 334658 US11040966, Example 4.23::US9732075, Example 4.23::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-2-(4,5-difluoro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 1940 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334658 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334658&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127002 384986818 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656963 C[C@H]1CCN([C@@H]1c1nc2c(C)c(C)ccc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C25H25ClN4OS/c1-13-8-9-19-20(15(13)3)29-24(28-19)22-14(2)10-11-30(22)25(31)21-23(32-16(4)27-21)17-6-5-7-18(26)12-17/h5-9,12,14,22H,10-11H2,1-4H3,(H,28,29)/t14-,22-/m0/s1 WNICTQLZNYNDDE-FPTDNZKUSA-N 334659 US11040966, Example 4.24::US9732075, Example 4.24::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-2-(4,5-dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334659 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334659&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127180 384986819 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656964 C[C@H]1CCN([C@@H]1c1nc2c(C)c(C)ccc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C25H25ClN4OS/c1-13-8-9-19-20(15(13)3)29-24(28-19)22-14(2)10-11-30(22)25(31)21-23(32-16(4)27-21)17-6-5-7-18(26)12-17/h5-9,12,14,22H,10-11H2,1-4H3,(H,28,29)/t14-,22-/m0/s1 WNICTQLZNYNDDE-FPTDNZKUSA-N 334659 US11040966, Example 4.24::US9732075, Example 4.24::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-2-(4,5-dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 367 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334659 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334659&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127180 384986819 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656965 CC(C)c1cccc2[nH]c(nc12)[C@@H]1[C@@H](C)CCN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C26H27ClN4OS/c1-14(2)19-9-6-10-20-21(19)30-25(29-20)23-15(3)11-12-31(23)26(32)22-24(33-16(4)28-22)17-7-5-8-18(27)13-17/h5-10,13-15,23H,11-12H2,1-4H3,(H,29,30)/t15-,23-/m0/s1 CILYBMUJEDXLPI-WNSKOXEYSA-N 334660 US11040966, Example 4.25::US9732075, Example 4.25::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-2-(4-isopropyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334660 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334660&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127455 384986820 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656966 CC(C)c1cccc2[nH]c(nc12)[C@@H]1[C@@H](C)CCN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C26H27ClN4OS/c1-14(2)19-9-6-10-20-21(19)30-25(29-20)23-15(3)11-12-31(23)26(32)22-24(33-16(4)28-22)17-7-5-8-18(27)13-17/h5-10,13-15,23H,11-12H2,1-4H3,(H,29,30)/t15-,23-/m0/s1 CILYBMUJEDXLPI-WNSKOXEYSA-N 334660 US11040966, Example 4.25::US9732075, Example 4.25::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-2-(4-isopropyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 441 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334660 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334660&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127455 384986820 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656967 COc1ccc2[nH]c(nc2c1)[C@@H]1[C@@H](C)CCN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C24H23ClN4O2S/c1-13-9-10-29(21(13)23-27-18-8-7-17(31-3)12-19(18)28-23)24(30)20-22(32-14(2)26-20)15-5-4-6-16(25)11-15/h4-8,11-13,21H,9-10H2,1-3H3,(H,27,28)/t13-,21-/m0/s1 VEQGEAAKPDUZJF-ZSEKCTLFSA-N 334661 US11040966, Example 4.26::US9732075, Example 4.26::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 17.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334661 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334661&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127304 384986821 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656968 COc1ccc2[nH]c(nc2c1)[C@@H]1[C@@H](C)CCN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C24H23ClN4O2S/c1-13-9-10-29(21(13)23-27-18-8-7-17(31-3)12-19(18)28-23)24(30)20-22(32-14(2)26-20)15-5-4-6-16(25)11-15/h4-8,11-13,21H,9-10H2,1-3H3,(H,27,28)/t13-,21-/m0/s1 VEQGEAAKPDUZJF-ZSEKCTLFSA-N 334661 US11040966, Example 4.26::US9732075, Example 4.26::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 2280 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334661 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334661&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127304 384986821 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656969 C[C@H]1CCN([C@@H]1c1nc2cc(CO)ccc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C24H23ClN4O2S/c1-13-8-9-29(21(13)23-27-18-7-6-15(12-30)10-19(18)28-23)24(31)20-22(32-14(2)26-20)16-4-3-5-17(25)11-16/h3-7,10-11,13,21,30H,8-9,12H2,1-2H3,(H,27,28)/t13-,21-/m0/s1 BOKHYOWAELVLPN-ZSEKCTLFSA-N 334662 US11040966, Example 4.27::US9732075, Example 4.27::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-2-(5-hydroxymethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 59.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334662 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334662&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118126994 384986822 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656970 C[C@H]1CCN([C@@H]1c1nc2cc(CO)ccc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C24H23ClN4O2S/c1-13-8-9-29(21(13)23-27-18-7-6-15(12-30)10-19(18)28-23)24(31)20-22(32-14(2)26-20)16-4-3-5-17(25)11-16/h3-7,10-11,13,21,30H,8-9,12H2,1-2H3,(H,27,28)/t13-,21-/m0/s1 BOKHYOWAELVLPN-ZSEKCTLFSA-N 334662 US11040966, Example 4.27::US9732075, Example 4.27::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-2-(5-hydroxymethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 5590 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334662 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334662&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118126994 384986822 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656971 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)cc(C)c2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C24H22Cl2N4OS/c1-12-7-8-30(21(12)23-28-18-11-17(26)9-13(2)19(18)29-23)24(31)20-22(32-14(3)27-20)15-5-4-6-16(25)10-15/h4-6,9-12,21H,7-8H2,1-3H3,(H,28,29)/t12-,21-/m0/s1 ZTNQZEPNQJBTRM-QKVFXAPYSA-N 334663 US11040966, Example 4.28::US9732075, Example 4.28::[(2S,3S)-2-(5-Chloro-7-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334663 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334663&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127755 384986823 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656972 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)cc(C)c2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C24H22Cl2N4OS/c1-12-7-8-30(21(12)23-28-18-11-17(26)9-13(2)19(18)29-23)24(31)20-22(32-14(3)27-20)15-5-4-6-16(25)10-15/h4-6,9-12,21H,7-8H2,1-3H3,(H,28,29)/t12-,21-/m0/s1 ZTNQZEPNQJBTRM-QKVFXAPYSA-N 334663 US11040966, Example 4.28::US9732075, Example 4.28::[(2S,3S)-2-(5-Chloro-7-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 486 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334663 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334663&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127755 384986823 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656973 C[C@H]1CCN([C@@H]1c1nc2cc(ccc2[nH]1)C(F)(F)F)C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C23H21F3N6O/c1-13-3-6-19(32-27-8-9-28-32)16(11-13)22(33)31-10-7-14(2)20(31)21-29-17-5-4-15(23(24,25)26)12-18(17)30-21/h3-6,8-9,11-12,14,20H,7,10H2,1-2H3,(H,29,30)/t14-,20-/m0/s1 KCZDSYOSWXMAHE-XOBRGWDASA-N 334664 (5-Methyl-2-[1,2,3]triazol-2-yl-phenyl)-[(2S,3S)-3-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 4.29::US9732075, Example 4.29 Orexin/Hypocretin receptor type 1 Homo sapiens 30.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334664 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334664&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127433 384986824 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656974 C[C@H]1CCN([C@@H]1c1nc2cc(ccc2[nH]1)C(F)(F)F)C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C23H21F3N6O/c1-13-3-6-19(32-27-8-9-28-32)16(11-13)22(33)31-10-7-14(2)20(31)21-29-17-5-4-15(23(24,25)26)12-18(17)30-21/h3-6,8-9,11-12,14,20H,7,10H2,1-2H3,(H,29,30)/t14-,20-/m0/s1 KCZDSYOSWXMAHE-XOBRGWDASA-N 334664 (5-Methyl-2-[1,2,3]triazol-2-yl-phenyl)-[(2S,3S)-3-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 4.29::US9732075, Example 4.29 Orexin receptor type 2 Homo sapiens 353 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334664 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334664&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127433 384986824 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656975 C[C@H]1CCN([C@@H]1c1nc2cc(C)ccc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C24H23ClN4OS/c1-13-7-8-18-19(11-13)28-23(27-18)21-14(2)9-10-29(21)24(30)20-22(31-15(3)26-20)16-5-4-6-17(25)12-16/h4-8,11-12,14,21H,9-10H2,1-3H3,(H,27,28)/t14-,21-/m0/s1 JCKMPXFAFQBRQV-QKKBWIMNSA-N 334665 US11040966, Example 4.3::US9732075, Example 4.3::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(5-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334665 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334665&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127461 384986825 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656976 C[C@H]1CCN([C@@H]1c1nc2cc(C)ccc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C24H23ClN4OS/c1-13-7-8-18-19(11-13)28-23(27-18)21-14(2)9-10-29(21)24(30)20-22(31-15(3)26-20)16-5-4-6-17(25)12-16/h4-8,11-12,14,21H,9-10H2,1-3H3,(H,27,28)/t14-,21-/m0/s1 JCKMPXFAFQBRQV-QKKBWIMNSA-N 334665 US11040966, Example 4.3::US9732075, Example 4.3::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(5-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 1350 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334665 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334665&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127461 384986825 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656977 C[C@H]1CCN([C@@H]1c1nc2cc(C)c(C)cc2[nH]1)C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C24H26N6O/c1-14-5-6-21(30-25-8-9-26-30)18(11-14)24(31)29-10-7-15(2)22(29)23-27-19-12-16(3)17(4)13-20(19)28-23/h5-6,8-9,11-13,15,22H,7,10H2,1-4H3,(H,27,28)/t15-,22-/m0/s1 CPZDWSPKSZMENA-NYHFZMIOSA-N 334666 US11040966, Example 4.30::US9732075, Example 4.30::[(2S,3S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 12.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334666 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334666&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127009 384986826 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656978 C[C@H]1CCN([C@@H]1c1nc2cc(C)c(C)cc2[nH]1)C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C24H26N6O/c1-14-5-6-21(30-25-8-9-26-30)18(11-14)24(31)29-10-7-15(2)22(29)23-27-19-12-16(3)17(4)13-20(19)28-23/h5-6,8-9,11-13,15,22H,7,10H2,1-4H3,(H,27,28)/t15-,22-/m0/s1 CPZDWSPKSZMENA-NYHFZMIOSA-N 334666 US11040966, Example 4.30::US9732075, Example 4.30::[(2S,3S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 155 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334666 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334666&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127009 384986826 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656979 COc1cccc2[nH]c(nc12)[C@@H]1[C@@H](C)CCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C23H24N6O2/c1-14-7-8-18(29-24-10-11-25-29)16(13-14)23(30)28-12-9-15(2)21(28)22-26-17-5-4-6-19(31-3)20(17)27-22/h4-8,10-11,13,15,21H,9,12H2,1-3H3,(H,26,27)/t15-,21-/m0/s1 RPHPRSUZYJFVIH-BTYIYWSLSA-N 334667 US11040966, Example 4.31::US9732075, Example 4.31::[(2S,3S)-2-(4-Methoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 77.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334667 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334667&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127983 384986827 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656980 COc1cccc2[nH]c(nc12)[C@@H]1[C@@H](C)CCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C23H24N6O2/c1-14-7-8-18(29-24-10-11-25-29)16(13-14)23(30)28-12-9-15(2)21(28)22-26-17-5-4-6-19(31-3)20(17)27-22/h4-8,10-11,13,15,21H,9,12H2,1-3H3,(H,26,27)/t15-,21-/m0/s1 RPHPRSUZYJFVIH-BTYIYWSLSA-N 334667 US11040966, Example 4.31::US9732075, Example 4.31::[(2S,3S)-2-(4-Methoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 774 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334667 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334667&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127983 384986827 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656981 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C23H23ClN6O/c1-13-4-5-20(30-25-7-8-26-30)16(10-13)23(31)29-9-6-14(2)21(29)22-27-18-11-15(3)17(24)12-19(18)28-22/h4-5,7-8,10-12,14,21H,6,9H2,1-3H3,(H,27,28)/t14-,21-/m0/s1 HSTYJYQZIWUHCL-QKKBWIMNSA-N 334668 US11040966, Example 4.32::US9732075, Example 4.32::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334668 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334668&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127844 384986828 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656982 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C23H23ClN6O/c1-13-4-5-20(30-25-7-8-26-30)16(10-13)23(31)29-9-6-14(2)21(29)22-27-18-11-15(3)17(24)12-19(18)28-22/h4-5,7-8,10-12,14,21H,6,9H2,1-3H3,(H,27,28)/t14-,21-/m0/s1 HSTYJYQZIWUHCL-QKKBWIMNSA-N 334668 US11040966, Example 4.32::US9732075, Example 4.32::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 156 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334668 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334668&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127844 384986828 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656983 C[C@H]1CCN([C@@H]1c1nc2c(C)cc(C)cc2[nH]1)C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C24H26N6O/c1-14-5-6-20(30-25-8-9-26-30)18(12-14)24(31)29-10-7-16(3)22(29)23-27-19-13-15(2)11-17(4)21(19)28-23/h5-6,8-9,11-13,16,22H,7,10H2,1-4H3,(H,27,28)/t16-,22-/m0/s1 AEVIXBKPFHDELL-AOMKIAJQSA-N 334669 US11040966, Example 4.33::US9732075, Example 4.33::[(2S,3S)-2-(4,6-Dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334669 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334669&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127266 384986829 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656984 C[C@H]1CCN([C@@H]1c1nc2c(C)cc(C)cc2[nH]1)C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C24H26N6O/c1-14-5-6-20(30-25-8-9-26-30)18(12-14)24(31)29-10-7-16(3)22(29)23-27-19-13-15(2)11-17(4)21(19)28-23/h5-6,8-9,11-13,16,22H,7,10H2,1-4H3,(H,27,28)/t16-,22-/m0/s1 AEVIXBKPFHDELL-AOMKIAJQSA-N 334669 US11040966, Example 4.33::US9732075, Example 4.33::[(2S,3S)-2-(4,6-Dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 294 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334669 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334669&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127266 384986829 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656985 C[C@H]1CCN([C@@H]1c1nc2c(cccc2[nH]1)C(F)(F)F)C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C23H21F3N6O/c1-13-6-7-18(32-27-9-10-28-32)15(12-13)22(33)31-11-8-14(2)20(31)21-29-17-5-3-4-16(19(17)30-21)23(24,25)26/h3-7,9-10,12,14,20H,8,11H2,1-2H3,(H,29,30)/t14-,20-/m0/s1 RBWNMKPVERQASZ-XOBRGWDASA-N 334670 (5-Methyl-2-[1,2,3]triazol-2-yl-phenyl)-[(2S,3S)-3-methyl-2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 4.34::US9732075, Example 4.34 Orexin/Hypocretin receptor type 1 Homo sapiens 37.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334670 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334670&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127283 384986830 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656986 C[C@H]1CCN([C@@H]1c1nc2c(cccc2[nH]1)C(F)(F)F)C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C23H21F3N6O/c1-13-6-7-18(32-27-9-10-28-32)15(12-13)22(33)31-11-8-14(2)20(31)21-29-17-5-3-4-16(19(17)30-21)23(24,25)26/h3-7,9-10,12,14,20H,8,11H2,1-2H3,(H,29,30)/t14-,20-/m0/s1 RBWNMKPVERQASZ-XOBRGWDASA-N 334670 (5-Methyl-2-[1,2,3]triazol-2-yl-phenyl)-[(2S,3S)-3-methyl-2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 4.34::US9732075, Example 4.34 Orexin receptor type 2 Homo sapiens 1880 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334670 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334670&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127283 384986830 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656987 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C23H23ClN6O/c1-13-4-7-19(30-25-9-10-26-30)16(12-13)23(31)29-11-8-14(2)21(29)22-27-18-6-5-17(24)15(3)20(18)28-22/h4-7,9-10,12,14,21H,8,11H2,1-3H3,(H,27,28)/t14-,21-/m0/s1 FIIIFGLLUUQWSJ-QKKBWIMNSA-N 334671 US11040966, Example 4.35::US9732075, Example 4.35::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334671 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334671&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127821 384986831 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656988 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C23H23ClN6O/c1-13-4-7-19(30-25-9-10-26-30)16(12-13)23(31)29-11-8-14(2)21(29)22-27-18-6-5-17(24)15(3)20(18)28-22/h4-7,9-10,12,14,21H,8,11H2,1-3H3,(H,27,28)/t14-,21-/m0/s1 FIIIFGLLUUQWSJ-QKKBWIMNSA-N 334671 US11040966, Example 4.35::US9732075, Example 4.35::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 193 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334671 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334671&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127821 384986831 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656989 C[C@H]1CCN([C@@H]1c1nc2c(Cl)cccc2[nH]1)C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C22H21ClN6O/c1-13-6-7-18(29-24-9-10-25-29)15(12-13)22(30)28-11-8-14(2)20(28)21-26-17-5-3-4-16(23)19(17)27-21/h3-7,9-10,12,14,20H,8,11H2,1-2H3,(H,26,27)/t14-,20-/m0/s1 OSOPKEWTXOKDSB-XOBRGWDASA-N 334672 US11040966, Example 4.36::US9732075, Example 4.36::[(2S,3S)-2-(4-Chloro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 70.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334672 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334672&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127798 384986832 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656990 C[C@H]1CCN([C@@H]1c1nc2c(Cl)cccc2[nH]1)C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C22H21ClN6O/c1-13-6-7-18(29-24-9-10-25-29)15(12-13)22(30)28-11-8-14(2)20(28)21-26-17-5-3-4-16(23)19(17)27-21/h3-7,9-10,12,14,20H,8,11H2,1-2H3,(H,26,27)/t14-,20-/m0/s1 OSOPKEWTXOKDSB-XOBRGWDASA-N 334672 US11040966, Example 4.36::US9732075, Example 4.36::[(2S,3S)-2-(4-Chloro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 2740 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334672 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334672&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127798 384986832 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656991 C[C@H]1CCN([C@@H]1c1nc2c(C)c(C)ccc2[nH]1)C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C24H26N6O/c1-14-5-8-20(30-25-10-11-26-30)18(13-14)24(31)29-12-9-16(3)22(29)23-27-19-7-6-15(2)17(4)21(19)28-23/h5-8,10-11,13,16,22H,9,12H2,1-4H3,(H,27,28)/t16-,22-/m0/s1 KCFDBTAICDQZSQ-AOMKIAJQSA-N 334675 US11040966, Example 4.37::US9732075, Example 4.37::[(2S,3S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 24.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334675 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334675&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127162 384986835 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656992 C[C@H]1CCN([C@@H]1c1nc2c(C)c(C)ccc2[nH]1)C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C24H26N6O/c1-14-5-8-20(30-25-10-11-26-30)18(13-14)24(31)29-12-9-16(3)22(29)23-27-19-7-6-15(2)17(4)21(19)28-23/h5-8,10-11,13,16,22H,9,12H2,1-4H3,(H,27,28)/t16-,22-/m0/s1 KCFDBTAICDQZSQ-AOMKIAJQSA-N 334675 US11040966, Example 4.37::US9732075, Example 4.37::[(2S,3S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 988 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334675 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334675&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127162 384986835 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656993 CC(C)c1cccc2[nH]c(nc12)[C@@H]1[C@@H](C)CCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C25H28N6O/c1-15(2)18-6-5-7-20-22(18)29-24(28-20)23-17(4)10-13-30(23)25(32)19-14-16(3)8-9-21(19)31-26-11-12-27-31/h5-9,11-12,14-15,17,23H,10,13H2,1-4H3,(H,28,29)/t17-,23-/m0/s1 HLPZUZPVFLIJDJ-SBUREZEXSA-N 334676 US11040966, Example 4.38::US9732075, Example 4.38::[(2S,3S)-2-(4-Isopropyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 55.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334676 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334676&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127418 384986836 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656994 CC(C)c1cccc2[nH]c(nc12)[C@@H]1[C@@H](C)CCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C25H28N6O/c1-15(2)18-6-5-7-20-22(18)29-24(28-20)23-17(4)10-13-30(23)25(32)19-14-16(3)8-9-21(19)31-26-11-12-27-31/h5-9,11-12,14-15,17,23H,10,13H2,1-4H3,(H,28,29)/t17-,23-/m0/s1 HLPZUZPVFLIJDJ-SBUREZEXSA-N 334676 US11040966, Example 4.38::US9732075, Example 4.38::[(2S,3S)-2-(4-Isopropyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 756 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334676 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334676&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127418 384986836 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656995 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)cc(C)c2[nH]1)C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C23H23ClN6O/c1-13-4-5-19(30-25-7-8-26-30)17(10-13)23(31)29-9-6-14(2)21(29)22-27-18-12-16(24)11-15(3)20(18)28-22/h4-5,7-8,10-12,14,21H,6,9H2,1-3H3,(H,27,28)/t14-,21-/m0/s1 NHCUEWIUUDFYKZ-QKKBWIMNSA-N 334677 US11040966, Example 4.39::US9732075, Example 4.39::[(2S,3S)-2-(5-Chloro-7-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 14.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334677 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334677&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127179 384986837 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656996 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)cc(C)c2[nH]1)C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C23H23ClN6O/c1-13-4-5-19(30-25-7-8-26-30)17(10-13)23(31)29-9-6-14(2)21(29)22-27-18-12-16(24)11-15(3)20(18)28-22/h4-5,7-8,10-12,14,21H,6,9H2,1-3H3,(H,27,28)/t14-,21-/m0/s1 NHCUEWIUUDFYKZ-QKKBWIMNSA-N 334677 US11040966, Example 4.39::US9732075, Example 4.39::[(2S,3S)-2-(5-Chloro-7-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 315 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334677 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334677&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127179 384986837 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656997 C[C@H]1CCN([C@@H]1c1nc2c(C)cccc2[nH]1)C(=O)c1nc(C)sc1-c1ccccc1 InChI=1S/C24H24N4OS/c1-14-8-7-11-18-19(14)27-23(26-18)21-15(2)12-13-28(21)24(29)20-22(30-16(3)25-20)17-9-5-4-6-10-17/h4-11,15,21H,12-13H2,1-3H3,(H,26,27)/t15-,21-/m0/s1 YSLSWVOZNJHVAZ-BTYIYWSLSA-N 334678 US11040966, Example 4.4::US9732075, Example 4.4::[(2S,3S)-3-Methyl-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 11.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334678 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334678&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128249 384986838 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 656998 C[C@H]1CCN([C@@H]1c1nc2c(C)cccc2[nH]1)C(=O)c1nc(C)sc1-c1ccccc1 InChI=1S/C24H24N4OS/c1-14-8-7-11-18-19(14)27-23(26-18)21-15(2)12-13-28(21)24(29)20-22(30-16(3)25-20)17-9-5-4-6-10-17/h4-11,15,21H,12-13H2,1-3H3,(H,26,27)/t15-,21-/m0/s1 YSLSWVOZNJHVAZ-BTYIYWSLSA-N 334678 US11040966, Example 4.4::US9732075, Example 4.4::[(2S,3S)-3-Methyl-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 1170 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334678 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334678&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128249 384986838 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 656999 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C23H23ClN6O3/c1-13-6-9-29(23(31)15-10-14(24)4-5-18(15)30-25-7-8-26-30)21(13)22-27-16-11-19(32-2)20(33-3)12-17(16)28-22/h4-5,7-8,10-13,21H,6,9H2,1-3H3,(H,27,28)/t13-,21-/m0/s1 VWOGVLLNWDSHRU-ZSEKCTLFSA-N 334679 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(2S,3S)-2-(5,6-dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone::US11040966, Example 4.40::US9732075, Example 4.40 Orexin/Hypocretin receptor type 1 Homo sapiens 21.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334679 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334679&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127958 384986839 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657000 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C23H23ClN6O3/c1-13-6-9-29(23(31)15-10-14(24)4-5-18(15)30-25-7-8-26-30)21(13)22-27-16-11-19(32-2)20(33-3)12-17(16)28-22/h4-5,7-8,10-13,21H,6,9H2,1-3H3,(H,27,28)/t13-,21-/m0/s1 VWOGVLLNWDSHRU-ZSEKCTLFSA-N 334679 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(2S,3S)-2-(5,6-dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone::US11040966, Example 4.40::US9732075, Example 4.40 Orexin receptor type 2 Homo sapiens 28.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334679 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334679&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127958 384986839 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657001 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1cc(F)ccc1-n1nccn1 InChI=1S/C23H23FN6O3/c1-13-6-9-29(23(31)15-10-14(24)4-5-18(15)30-25-7-8-26-30)21(13)22-27-16-11-19(32-2)20(33-3)12-17(16)28-22/h4-5,7-8,10-13,21H,6,9H2,1-3H3,(H,27,28)/t13-,21-/m0/s1 RRKTZLOQAMJSPX-ZSEKCTLFSA-N 334680 US11040966, Example 4.41::US9732075, Example 4.41::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 182 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334680 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334680&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128121 384986840 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657002 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1cc(F)ccc1-n1nccn1 InChI=1S/C23H23FN6O3/c1-13-6-9-29(23(31)15-10-14(24)4-5-18(15)30-25-7-8-26-30)21(13)22-27-16-11-19(32-2)20(33-3)12-17(16)28-22/h4-5,7-8,10-13,21H,6,9H2,1-3H3,(H,27,28)/t13-,21-/m0/s1 RRKTZLOQAMJSPX-ZSEKCTLFSA-N 334680 US11040966, Example 4.41::US9732075, Example 4.41::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 248 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334680 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334680&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128121 384986840 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657003 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1c(F)cccc1-n1nccn1 InChI=1S/C23H23FN6O3/c1-13-7-10-29(23(31)20-14(24)5-4-6-17(20)30-25-8-9-26-30)21(13)22-27-15-11-18(32-2)19(33-3)12-16(15)28-22/h4-6,8-9,11-13,21H,7,10H2,1-3H3,(H,27,28)/t13-,21-/m0/s1 HBAPITZROIODQQ-ZSEKCTLFSA-N 334681 US11040966, Example 4.42::US9732075, Example 4.42::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-fluoro-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 365 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334681 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334681&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127058 384986841 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657004 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1c(F)cccc1-n1nccn1 InChI=1S/C23H23FN6O3/c1-13-7-10-29(23(31)20-14(24)5-4-6-17(20)30-25-8-9-26-30)21(13)22-27-15-11-18(32-2)19(33-3)12-16(15)28-22/h4-6,8-9,11-13,21H,7,10H2,1-3H3,(H,27,28)/t13-,21-/m0/s1 HBAPITZROIODQQ-ZSEKCTLFSA-N 334681 US11040966, Example 4.42::US9732075, Example 4.42::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-fluoro-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 1130 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334681 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334681&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127058 384986841 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657005 COc1ccc(c(c1)C(=O)N1CC[C@H](C)[C@H]1c1nc2cc(OC)c(OC)cc2[nH]1)-n1nccn1 InChI=1S/C24H26N6O4/c1-14-7-10-29(22(14)23-27-17-12-20(33-3)21(34-4)13-18(17)28-23)24(31)16-11-15(32-2)5-6-19(16)30-25-8-9-26-30/h5-6,8-9,11-14,22H,7,10H2,1-4H3,(H,27,28)/t14-,22-/m0/s1 KZGAEZTZSNQHKN-FPTDNZKUSA-N 334682 US11040966, Example 4.43::US9732075, Example 4.43::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 39.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334682 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334682&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127813 384986842 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657006 COc1ccc(c(c1)C(=O)N1CC[C@H](C)[C@H]1c1nc2cc(OC)c(OC)cc2[nH]1)-n1nccn1 InChI=1S/C24H26N6O4/c1-14-7-10-29(22(14)23-27-17-12-20(33-3)21(34-4)13-18(17)28-23)24(31)16-11-15(32-2)5-6-19(16)30-25-8-9-26-30/h5-6,8-9,11-14,22H,7,10H2,1-4H3,(H,27,28)/t14-,22-/m0/s1 KZGAEZTZSNQHKN-FPTDNZKUSA-N 334682 US11040966, Example 4.43::US9732075, Example 4.43::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 97.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334682 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334682&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127813 384986842 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657007 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1c(F)c(C)ccc1-n1nccn1 InChI=1S/C24H25FN6O3/c1-13-5-6-17(31-26-8-9-27-31)20(21(13)25)24(32)30-10-7-14(2)22(30)23-28-15-11-18(33-3)19(34-4)12-16(15)29-23/h5-6,8-9,11-12,14,22H,7,10H2,1-4H3,(H,28,29)/t14-,22-/m0/s1 GQHCGXFQAPFLMZ-FPTDNZKUSA-N 334683 US11040966, Example 4.44::US9732075, Example 4.44::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 38.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334683 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334683&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128046 384986843 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657008 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1c(F)c(C)ccc1-n1nccn1 InChI=1S/C24H25FN6O3/c1-13-5-6-17(31-26-8-9-27-31)20(21(13)25)24(32)30-10-7-14(2)22(30)23-28-15-11-18(33-3)19(34-4)12-16(15)29-23/h5-6,8-9,11-12,14,22H,7,10H2,1-4H3,(H,28,29)/t14-,22-/m0/s1 GQHCGXFQAPFLMZ-FPTDNZKUSA-N 334683 US11040966, Example 4.44::US9732075, Example 4.44::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 246 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334683 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334683&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128046 384986843 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657009 COc1ccc(c(C(=O)N2CC[C@H](C)[C@H]2c2nc3cc(OC)c(OC)cc3[nH]2)c1F)-n1nccn1 InChI=1S/C24H25FN6O4/c1-13-7-10-30(22(13)23-28-14-11-18(34-3)19(35-4)12-15(14)29-23)24(32)20-16(31-26-8-9-27-31)5-6-17(33-2)21(20)25/h5-6,8-9,11-13,22H,7,10H2,1-4H3,(H,28,29)/t13-,22-/m0/s1 GRTCPKUAJWENQU-XMHCIUCPSA-N 334684 US11040966, Example 4.45::US9732075, Example 4.45::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methoxy-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 124 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334684 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334684&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127025 384986844 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657010 COc1ccc(c(C(=O)N2CC[C@H](C)[C@H]2c2nc3cc(OC)c(OC)cc3[nH]2)c1F)-n1nccn1 InChI=1S/C24H25FN6O4/c1-13-7-10-30(22(13)23-28-14-11-18(34-3)19(35-4)12-15(14)29-23)24(32)20-16(31-26-8-9-27-31)5-6-17(33-2)21(20)25/h5-6,8-9,11-13,22H,7,10H2,1-4H3,(H,28,29)/t13-,22-/m0/s1 GRTCPKUAJWENQU-XMHCIUCPSA-N 334684 US11040966, Example 4.45::US9732075, Example 4.45::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methoxy-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 5780 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334684 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334684&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127025 384986844 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657011 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1ccc(C)cc1-n1nccn1 InChI=1S/C24H26N6O3/c1-14-5-6-16(19(11-14)30-25-8-9-26-30)24(31)29-10-7-15(2)22(29)23-27-17-12-20(32-3)21(33-4)13-18(17)28-23/h5-6,8-9,11-13,15,22H,7,10H2,1-4H3,(H,27,28)/t15-,22-/m0/s1 IJSLVODBWIHVSM-NYHFZMIOSA-N 334685 US11040966, Example 4.46::US9732075, Example 4.46::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 14.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334685 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334685&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127796 384986845 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657012 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1ccc(C)cc1-n1nccn1 InChI=1S/C24H26N6O3/c1-14-5-6-16(19(11-14)30-25-8-9-26-30)24(31)29-10-7-15(2)22(29)23-27-17-12-20(32-3)21(33-4)13-18(17)28-23/h5-6,8-9,11-13,15,22H,7,10H2,1-4H3,(H,27,28)/t15-,22-/m0/s1 IJSLVODBWIHVSM-NYHFZMIOSA-N 334685 US11040966, Example 4.46::US9732075, Example 4.46::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 51.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334685 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334685&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127796 384986845 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657013 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1cc(ccc1-n1nccn1)C(F)(F)F InChI=1S/C24H23F3N6O3/c1-13-6-9-32(21(13)22-30-16-11-19(35-2)20(36-3)12-17(16)31-22)23(34)15-10-14(24(25,26)27)4-5-18(15)33-28-7-8-29-33/h4-5,7-8,10-13,21H,6,9H2,1-3H3,(H,30,31)/t13-,21-/m0/s1 KMMYNAWBITWGII-ZSEKCTLFSA-N 334686 US11040966, Example 4.47::US9732075, Example 4.47::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoromethyl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 176 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334686 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334686&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128103 384986846 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657014 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1cc(ccc1-n1nccn1)C(F)(F)F InChI=1S/C24H23F3N6O3/c1-13-6-9-32(21(13)22-30-16-11-19(35-2)20(36-3)12-17(16)31-22)23(34)15-10-14(24(25,26)27)4-5-18(15)33-28-7-8-29-33/h4-5,7-8,10-13,21H,6,9H2,1-3H3,(H,30,31)/t13-,21-/m0/s1 KMMYNAWBITWGII-ZSEKCTLFSA-N 334686 US11040966, Example 4.47::US9732075, Example 4.47::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoromethyl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 281 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334686 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334686&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128103 384986846 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657015 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1c(C)cccc1-n1nccn1 InChI=1S/C24H26N6O3/c1-14-6-5-7-18(30-25-9-10-26-30)21(14)24(31)29-11-8-15(2)22(29)23-27-16-12-19(32-3)20(33-4)13-17(16)28-23/h5-7,9-10,12-13,15,22H,8,11H2,1-4H3,(H,27,28)/t15-,22-/m0/s1 FQFZOPJCFCIAJI-NYHFZMIOSA-N 334687 US11040966, Example 4.48::US9732075, Example 4.48::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 391 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334687 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334687&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127328 384986847 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657016 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1c(C)cccc1-n1nccn1 InChI=1S/C24H26N6O3/c1-14-6-5-7-18(30-25-9-10-26-30)21(14)24(31)29-11-8-15(2)22(29)23-27-16-12-19(32-3)20(33-4)13-17(16)28-23/h5-7,9-10,12-13,15,22H,8,11H2,1-4H3,(H,27,28)/t15-,22-/m0/s1 FQFZOPJCFCIAJI-NYHFZMIOSA-N 334687 US11040966, Example 4.48::US9732075, Example 4.48::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 1320 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334687 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334687&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127328 384986847 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657017 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1ccccc1-n1nccn1 InChI=1S/C23H24N6O3/c1-14-8-11-28(23(30)15-6-4-5-7-18(15)29-24-9-10-25-29)21(14)22-26-16-12-19(31-2)20(32-3)13-17(16)27-22/h4-7,9-10,12-14,21H,8,11H2,1-3H3,(H,26,27)/t14-,21-/m0/s1 JBFGAYMWVJPKLU-QKKBWIMNSA-N 334688 US11040966, Example 4.49::US9732075, Example 4.49::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 221 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334688 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334688&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127586 384986848 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657018 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1ccccc1-n1nccn1 InChI=1S/C23H24N6O3/c1-14-8-11-28(23(30)15-6-4-5-7-18(15)29-24-9-10-25-29)21(14)22-26-16-12-19(31-2)20(32-3)13-17(16)27-22/h4-7,9-10,12-14,21H,8,11H2,1-3H3,(H,26,27)/t14-,21-/m0/s1 JBFGAYMWVJPKLU-QKKBWIMNSA-N 334688 US11040966, Example 4.49::US9732075, Example 4.49::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 533 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334688 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334688&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127586 384986848 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657019 C[C@H]1CCN([C@@H]1c1nc2cc(C)ccc2[nH]1)C(=O)c1nc(C)sc1-c1ccccc1 InChI=1S/C24H24N4OS/c1-14-9-10-18-19(13-14)27-23(26-18)21-15(2)11-12-28(21)24(29)20-22(30-16(3)25-20)17-7-5-4-6-8-17/h4-10,13,15,21H,11-12H2,1-3H3,(H,26,27)/t15-,21-/m0/s1 BVZBUBSILYCIEC-BTYIYWSLSA-N 334689 US11040966, Example 4.5::US9732075, Example 4.5::[(2S,3S)-3-Methyl-2-(5-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 29.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334689 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334689&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128011 384986849 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657020 C[C@H]1CCN([C@@H]1c1nc2cc(C)ccc2[nH]1)C(=O)c1nc(C)sc1-c1ccccc1 InChI=1S/C24H24N4OS/c1-14-9-10-18-19(13-14)27-23(26-18)21-15(2)11-12-28(21)24(29)20-22(30-16(3)25-20)17-7-5-4-6-8-17/h4-10,13,15,21H,11-12H2,1-3H3,(H,26,27)/t15-,21-/m0/s1 BVZBUBSILYCIEC-BTYIYWSLSA-N 334689 US11040966, Example 4.5::US9732075, Example 4.5::[(2S,3S)-3-Methyl-2-(5-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 3190 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334689 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334689&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128011 384986849 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657021 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1nc(C)sc1-c1ccc(cc1)C(F)(F)F InChI=1S/C26H25F3N4O3S/c1-13-9-10-33(22(13)24-31-17-11-19(35-3)20(36-4)12-18(17)32-24)25(34)21-23(37-14(2)30-21)15-5-7-16(8-6-15)26(27,28)29/h5-8,11-13,22H,9-10H2,1-4H3,(H,31,32)/t13-,22-/m0/s1 LJONLIZPONZRBL-XMHCIUCPSA-N 334690 US11040966, Example 4.50::US9732075, Example 4.50::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[2-methyl-5-(4-trifluoromethyl-phenyl)-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 373 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334690 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334690&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127490 384986850 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657022 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1nc(C)sc1-c1ccc(cc1)C(F)(F)F InChI=1S/C26H25F3N4O3S/c1-13-9-10-33(22(13)24-31-17-11-19(35-3)20(36-4)12-18(17)32-24)25(34)21-23(37-14(2)30-21)15-5-7-16(8-6-15)26(27,28)29/h5-8,11-13,22H,9-10H2,1-4H3,(H,31,32)/t13-,22-/m0/s1 LJONLIZPONZRBL-XMHCIUCPSA-N 334690 US11040966, Example 4.50::US9732075, Example 4.50::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[2-methyl-5-(4-trifluoromethyl-phenyl)-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 4220 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334690 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334690&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127490 384986850 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657023 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1sc(C)nc1-c1ccc(C)cc1 InChI=1S/C26H28N4O3S/c1-14-6-8-17(9-7-14)22-24(34-16(3)27-22)26(31)30-11-10-15(2)23(30)25-28-18-12-20(32-4)21(33-5)13-19(18)29-25/h6-9,12-13,15,23H,10-11H2,1-5H3,(H,28,29)/t15-,23-/m0/s1 HZSOVPVAPYQHAM-WNSKOXEYSA-N 334691 US11040966, Example 4.51::US9732075, Example 4.51::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-methyl-4-p-tolyl-thiazol-5-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 99.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334691 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334691&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127779 384986851 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657024 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1sc(C)nc1-c1ccc(C)cc1 InChI=1S/C26H28N4O3S/c1-14-6-8-17(9-7-14)22-24(34-16(3)27-22)26(31)30-11-10-15(2)23(30)25-28-18-12-20(32-4)21(33-5)13-19(18)29-25/h6-9,12-13,15,23H,10-11H2,1-5H3,(H,28,29)/t15-,23-/m0/s1 HZSOVPVAPYQHAM-WNSKOXEYSA-N 334691 US11040966, Example 4.51::US9732075, Example 4.51::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-methyl-4-p-tolyl-thiazol-5-yl)-methanone Orexin receptor type 2 Homo sapiens 677 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334691 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334691&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127779 384986851 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657025 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1nc(C)sc1-c1cc(F)cc(F)c1 InChI=1S/C25H24F2N4O3S/c1-12-5-6-31(22(12)24-29-17-10-19(33-3)20(34-4)11-18(17)30-24)25(32)21-23(35-13(2)28-21)14-7-15(26)9-16(27)8-14/h7-12,22H,5-6H2,1-4H3,(H,29,30)/t12-,22-/m0/s1 QXKAILWURPAHCV-YTEVENLXSA-N 334692 US11040966, Example 4.52::US9732075, Example 4.52::[5-(3,5-Difluoro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-2-(5,6-dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 19.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334692 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334692&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128006 384986852 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657026 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1nc(C)sc1-c1cc(F)cc(F)c1 InChI=1S/C25H24F2N4O3S/c1-12-5-6-31(22(12)24-29-17-10-19(33-3)20(34-4)11-18(17)30-24)25(32)21-23(35-13(2)28-21)14-7-15(26)9-16(27)8-14/h7-12,22H,5-6H2,1-4H3,(H,29,30)/t12-,22-/m0/s1 QXKAILWURPAHCV-YTEVENLXSA-N 334692 US11040966, Example 4.52::US9732075, Example 4.52::[5-(3,5-Difluoro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-2-(5,6-dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 1067 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334692 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334692&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128006 384986852 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657027 COc1ccc(cn1)-c1sc(C)nc1C(=O)N1CC[C@H](C)[C@H]1c1nc2cc(OC)c(OC)cc2[nH]1 InChI=1S/C25H27N5O4S/c1-13-8-9-30(22(13)24-28-16-10-18(32-3)19(33-4)11-17(16)29-24)25(31)21-23(35-14(2)27-21)15-6-7-20(34-5)26-12-15/h6-7,10-13,22H,8-9H2,1-5H3,(H,28,29)/t13-,22-/m0/s1 GUVQKKARBJNPKF-XMHCIUCPSA-N 334693 US11040966, Example 4.53::US9732075, Example 4.53::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(6-methoxy-pyridin-3-yl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 111 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334693 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334693&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127385 384986853 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657028 COc1ccc(cn1)-c1sc(C)nc1C(=O)N1CC[C@H](C)[C@H]1c1nc2cc(OC)c(OC)cc2[nH]1 InChI=1S/C25H27N5O4S/c1-13-8-9-30(22(13)24-28-16-10-18(32-3)19(33-4)11-17(16)29-24)25(31)21-23(35-14(2)27-21)15-6-7-20(34-5)26-12-15/h6-7,10-13,22H,8-9H2,1-5H3,(H,28,29)/t13-,22-/m0/s1 GUVQKKARBJNPKF-XMHCIUCPSA-N 334693 US11040966, Example 4.53::US9732075, Example 4.53::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(6-methoxy-pyridin-3-yl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 4440 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334693 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334693&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127385 384986853 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657029 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1nc(C)sc1-c1ccc(F)cc1 InChI=1S/C25H25FN4O3S/c1-13-9-10-30(22(13)24-28-17-11-19(32-3)20(33-4)12-18(17)29-24)25(31)21-23(34-14(2)27-21)15-5-7-16(26)8-6-15/h5-8,11-13,22H,9-10H2,1-4H3,(H,28,29)/t13-,22-/m0/s1 DQVWALDJSFVAOC-XMHCIUCPSA-N 334694 US11040966, Example 4.54::US9732075, Example 4.54::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 21.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334694 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334694&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127618 384986854 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657030 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1nc(C)sc1-c1ccc(F)cc1 InChI=1S/C25H25FN4O3S/c1-13-9-10-30(22(13)24-28-17-11-19(32-3)20(33-4)12-18(17)29-24)25(31)21-23(34-14(2)27-21)15-5-7-16(26)8-6-15/h5-8,11-13,22H,9-10H2,1-4H3,(H,28,29)/t13-,22-/m0/s1 DQVWALDJSFVAOC-XMHCIUCPSA-N 334694 US11040966, Example 4.54::US9732075, Example 4.54::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 2322 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334694 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334694&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127618 384986854 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657031 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1ncsc1-c1cccc(Cl)c1 InChI=1S/C24H23ClN4O3S/c1-13-7-8-29(24(30)20-22(33-12-26-20)14-5-4-6-15(25)9-14)21(13)23-27-16-10-18(31-2)19(32-3)11-17(16)28-23/h4-6,9-13,21H,7-8H2,1-3H3,(H,27,28)/t13-,21-/m0/s1 HZQSENHXBOFDRH-ZSEKCTLFSA-N 334695 US11040966, Example 4.55::US9732075, Example 4.55::[5-(3-Chloro-phenyl)-thiazol-4-yl]-[(2S,3S)-2-(5,6-dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 167 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334695 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334695&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127883 384986855 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657032 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1ncsc1-c1cccc(Cl)c1 InChI=1S/C24H23ClN4O3S/c1-13-7-8-29(24(30)20-22(33-12-26-20)14-5-4-6-15(25)9-14)21(13)23-27-16-10-18(31-2)19(32-3)11-17(16)28-23/h4-6,9-13,21H,7-8H2,1-3H3,(H,27,28)/t13-,21-/m0/s1 HZQSENHXBOFDRH-ZSEKCTLFSA-N 334695 US11040966, Example 4.55::US9732075, Example 4.55::[5-(3-Chloro-phenyl)-thiazol-4-yl]-[(2S,3S)-2-(5,6-dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 7970 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334695 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334695&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127883 384986855 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657033 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1ccccc1-n1cccn1 InChI=1S/C24H25N5O3/c1-15-9-12-28(24(30)16-7-4-5-8-19(16)29-11-6-10-25-29)22(15)23-26-17-13-20(31-2)21(32-3)14-18(17)27-23/h4-8,10-11,13-15,22H,9,12H2,1-3H3,(H,26,27)/t15-,22-/m0/s1 HKKKQFHDCURWGF-NYHFZMIOSA-N 334696 US11040966, Example 4.56::US9732075, Example 4.56::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-pyrazol-1-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 283 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334696 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334696&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102264 384986856 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657034 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1ccccc1-n1cccn1 InChI=1S/C24H25N5O3/c1-15-9-12-28(24(30)16-7-4-5-8-19(16)29-11-6-10-25-29)22(15)23-26-17-13-20(31-2)21(32-3)14-18(17)27-23/h4-8,10-11,13-15,22H,9,12H2,1-3H3,(H,26,27)/t15-,22-/m0/s1 HKKKQFHDCURWGF-NYHFZMIOSA-N 334696 US11040966, Example 4.56::US9732075, Example 4.56::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-pyrazol-1-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 2620 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334696 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334696&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102264 384986856 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657035 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1cc(C)ccc1-n1cccn1 InChI=1S/C25H27N5O3/c1-15-6-7-20(30-10-5-9-26-30)17(12-15)25(31)29-11-8-16(2)23(29)24-27-18-13-21(32-3)22(33-4)14-19(18)28-24/h5-7,9-10,12-14,16,23H,8,11H2,1-4H3,(H,27,28)/t16-,23-/m0/s1 SXXAPAAJFNKYAK-HJPURHCSSA-N 334697 US11040966, Example 4.57::US9732075, Example 4.57::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 59.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334697 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334697&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127746 384986857 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657036 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1cc(C)ccc1-n1cccn1 InChI=1S/C25H27N5O3/c1-15-6-7-20(30-10-5-9-26-30)17(12-15)25(31)29-11-8-16(2)23(29)24-27-18-13-21(32-3)22(33-4)14-19(18)28-24/h5-7,9-10,12-14,16,23H,8,11H2,1-4H3,(H,27,28)/t16-,23-/m0/s1 SXXAPAAJFNKYAK-HJPURHCSSA-N 334697 US11040966, Example 4.57::US9732075, Example 4.57::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 250 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334697 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334697&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127746 384986857 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657037 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1ccccc1-c1ccc(C)cc1 InChI=1S/C28H29N3O3/c1-17-9-11-19(12-10-17)20-7-5-6-8-21(20)28(32)31-14-13-18(2)26(31)27-29-22-15-24(33-3)25(34-4)16-23(22)30-27/h5-12,15-16,18,26H,13-14H2,1-4H3,(H,29,30)/t18-,26-/m0/s1 PPRICUOOSYRJNP-QYBDOPJKSA-N 334698 US11040966, Example 4.58::US9732075, Example 4.58::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4'-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 66.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334698 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334698&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102495 384986858 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657038 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1ccccc1-c1ccc(C)cc1 InChI=1S/C28H29N3O3/c1-17-9-11-19(12-10-17)20-7-5-6-8-21(20)28(32)31-14-13-18(2)26(31)27-29-22-15-24(33-3)25(34-4)16-23(22)30-27/h5-12,15-16,18,26H,13-14H2,1-4H3,(H,29,30)/t18-,26-/m0/s1 PPRICUOOSYRJNP-QYBDOPJKSA-N 334698 US11040966, Example 4.58::US9732075, Example 4.58::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4'-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 2170 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334698 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334698&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102495 384986858 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657039 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H21ClN6O/c1-13-9-12-28(20(13)21-26-17-8-7-16(23)14(2)19(17)27-21)22(30)15-5-3-4-6-18(15)29-24-10-11-25-29/h3-8,10-11,13,20H,9,12H2,1-2H3,(H,26,27)/t13-,20-/m0/s1 AFEOPHKUWYDQAM-RBZFPXEDSA-N 334699 US11040966, Example 4.59::US9732075, Example 4.59::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334699 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334699&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128145 384986859 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657040 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H21ClN6O/c1-13-9-12-28(20(13)21-26-17-8-7-16(23)14(2)19(17)27-21)22(30)15-5-3-4-6-18(15)29-24-10-11-25-29/h3-8,10-11,13,20H,9,12H2,1-2H3,(H,26,27)/t13-,20-/m0/s1 AFEOPHKUWYDQAM-RBZFPXEDSA-N 334699 US11040966, Example 4.59::US9732075, Example 4.59::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 67.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334699 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334699&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128145 384986859 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657041 C[C@H]1CCN([C@@H]1c1nc2ccccc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C23H21ClN4OS/c1-13-10-11-28(20(13)22-26-17-8-3-4-9-18(17)27-22)23(29)19-21(30-14(2)25-19)15-6-5-7-16(24)12-15/h3-9,12-13,20H,10-11H2,1-2H3,(H,26,27)/t13-,20-/m0/s1 ZGVJYVAUTAWQIE-RBZFPXEDSA-N 334700 US11040966, Example 4.6::US9732075, Example 4.6::[(2S,3S)-2-(1H-Benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 29.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334700 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334700&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127231 384986860 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657042 C[C@H]1CCN([C@@H]1c1nc2ccccc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C23H21ClN4OS/c1-13-10-11-28(20(13)22-26-17-8-3-4-9-18(17)27-22)23(29)19-21(30-14(2)25-19)15-6-5-7-16(24)12-15/h3-9,12-13,20H,10-11H2,1-2H3,(H,26,27)/t13-,20-/m0/s1 ZGVJYVAUTAWQIE-RBZFPXEDSA-N 334700 US11040966, Example 4.6::US9732075, Example 4.6::[(2S,3S)-2-(1H-Benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 3890 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334700 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334700&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127231 384986860 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657043 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C22H20Cl2N6O/c1-12-7-10-29(20(12)21-27-17-5-4-16(24)13(2)19(17)28-21)22(31)15-11-14(23)3-6-18(15)30-25-8-9-26-30/h3-6,8-9,11-12,20H,7,10H2,1-2H3,(H,27,28)/t12-,20-/m0/s1 LUOZKRPVGIKIME-YUNKPMOVSA-N 334701 US11040966, Example 4.60::US9732075, Example 4.60::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-chloro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334701 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334701&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128088 384986861 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657044 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C22H20Cl2N6O/c1-12-7-10-29(20(12)21-27-17-5-4-16(24)13(2)19(17)28-21)22(31)15-11-14(23)3-6-18(15)30-25-8-9-26-30/h3-6,8-9,11-12,20H,7,10H2,1-2H3,(H,27,28)/t12-,20-/m0/s1 LUOZKRPVGIKIME-YUNKPMOVSA-N 334701 US11040966, Example 4.60::US9732075, Example 4.60::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-chloro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 65.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334701 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334701&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128088 384986861 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657045 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1ccccc1-c1ccc(C)cc1 InChI=1S/C27H26ClN3O/c1-16-8-10-19(11-9-16)20-6-4-5-7-21(20)27(32)31-15-14-17(2)25(31)26-29-23-13-12-22(28)18(3)24(23)30-26/h4-13,17,25H,14-15H2,1-3H3,(H,29,30)/t17-,25-/m0/s1 FKHQMNLZLWPYFA-GKVSMKOHSA-N 334702 US11040966, Example 4.61::US9732075, Example 4.61::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4'-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 0.900 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334702 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334702&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127018 384986862 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657046 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1ccccc1-c1ccc(C)cc1 InChI=1S/C27H26ClN3O/c1-16-8-10-19(11-9-16)20-6-4-5-7-21(20)27(32)31-15-14-17(2)25(31)26-29-23-13-12-22(28)18(3)24(23)30-26/h4-13,17,25H,14-15H2,1-3H3,(H,29,30)/t17-,25-/m0/s1 FKHQMNLZLWPYFA-GKVSMKOHSA-N 334702 US11040966, Example 4.61::US9732075, Example 4.61::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4'-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 72.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334702 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334702&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127018 384986862 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657047 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1ccc(C)cc1-n1nccn1 InChI=1S/C23H23ClN6O/c1-13-4-5-16(19(12-13)30-25-9-10-26-30)23(31)29-11-8-14(2)21(29)22-27-18-7-6-17(24)15(3)20(18)28-22/h4-7,9-10,12,14,21H,8,11H2,1-3H3,(H,27,28)/t14-,21-/m0/s1 XTIOBAAREREBIF-QKKBWIMNSA-N 334703 US11040966, Example 4.62::US9732075, Example 4.62::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334703 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334703&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128057 384986863 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657048 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1ccc(C)cc1-n1nccn1 InChI=1S/C23H23ClN6O/c1-13-4-5-16(19(12-13)30-25-9-10-26-30)23(31)29-11-8-14(2)21(29)22-27-18-7-6-17(24)15(3)20(18)28-22/h4-7,9-10,12,14,21H,8,11H2,1-3H3,(H,27,28)/t14-,21-/m0/s1 XTIOBAAREREBIF-QKKBWIMNSA-N 334703 US11040966, Example 4.62::US9732075, Example 4.62::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 19.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334703 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334703&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128057 384986863 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657049 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1nc(C)sc1-c1ccc(Cl)cc1 InChI=1S/C24H22Cl2N4OS/c1-12-10-11-30(21(12)23-28-18-9-8-17(26)13(2)19(18)29-23)24(31)20-22(32-14(3)27-20)15-4-6-16(25)7-5-15/h4-9,12,21H,10-11H2,1-3H3,(H,28,29)/t12-,21-/m0/s1 HOHXELLMHKNVOC-QKVFXAPYSA-N 334704 US11040966, Example 4.63::US9732075, Example 4.63::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(4-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 0.800 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334704 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334704&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127906 384986864 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657050 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1nc(C)sc1-c1ccc(Cl)cc1 InChI=1S/C24H22Cl2N4OS/c1-12-10-11-30(21(12)23-28-18-9-8-17(26)13(2)19(18)29-23)24(31)20-22(32-14(3)27-20)15-4-6-16(25)7-5-15/h4-9,12,21H,10-11H2,1-3H3,(H,28,29)/t12-,21-/m0/s1 HOHXELLMHKNVOC-QKVFXAPYSA-N 334704 US11040966, Example 4.63::US9732075, Example 4.63::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(4-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 122 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334704 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334704&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127906 384986864 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657051 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1cc(C)ccc1-n1cccn1 InChI=1S/C24H24ClN5O/c1-14-5-8-20(30-11-4-10-26-30)17(13-14)24(31)29-12-9-15(2)22(29)23-27-19-7-6-18(25)16(3)21(19)28-23/h4-8,10-11,13,15,22H,9,12H2,1-3H3,(H,27,28)/t15-,22-/m0/s1 MUPOKYOVVTXJKM-NYHFZMIOSA-N 334705 US11040966, Example 4.64::US9732075, Example 4.64::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334705 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334705&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127650 384986865 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657052 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1cc(C)ccc1-n1cccn1 InChI=1S/C24H24ClN5O/c1-14-5-8-20(30-11-4-10-26-30)17(13-14)24(31)29-12-9-15(2)22(29)23-27-19-7-6-18(25)16(3)21(19)28-23/h4-8,10-11,13,15,22H,9,12H2,1-3H3,(H,27,28)/t15-,22-/m0/s1 MUPOKYOVVTXJKM-NYHFZMIOSA-N 334705 US11040966, Example 4.64::US9732075, Example 4.64::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 800 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334705 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334705&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127650 384986865 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657053 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1sc(C)nc1-c1ccc(C)cc1 InChI=1S/C25H25ClN4OS/c1-13-5-7-17(8-6-13)21-23(32-16(4)27-21)25(31)30-12-11-14(2)22(30)24-28-19-10-9-18(26)15(3)20(19)29-24/h5-10,14,22H,11-12H2,1-4H3,(H,28,29)/t14-,22-/m0/s1 VWQIEYGDQSSVAB-FPTDNZKUSA-N 334706 US11040966, Example 4.65::US9732075, Example 4.65::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-methyl-4-p-tolyl-thiazol-5-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334706 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334706&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127804 384986866 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657054 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1sc(C)nc1-c1ccc(C)cc1 InChI=1S/C25H25ClN4OS/c1-13-5-7-17(8-6-13)21-23(32-16(4)27-21)25(31)30-12-11-14(2)22(30)24-28-19-10-9-18(26)15(3)20(19)29-24/h5-10,14,22H,11-12H2,1-4H3,(H,28,29)/t14-,22-/m0/s1 VWQIEYGDQSSVAB-FPTDNZKUSA-N 334706 US11040966, Example 4.65::US9732075, Example 4.65::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-methyl-4-p-tolyl-thiazol-5-yl)-methanone Orexin receptor type 2 Homo sapiens 207 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334706 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334706&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127804 384986866 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657055 COc1ccc(c(c1)C(=O)N1CC[C@H](C)[C@H]1c1nc2c(C)c(Cl)ccc2[nH]1)-n1nccn1 InChI=1S/C23H23ClN6O2/c1-13-8-11-29(21(13)22-27-18-6-5-17(24)14(2)20(18)28-22)23(31)16-12-15(32-3)4-7-19(16)30-25-9-10-26-30/h4-7,9-10,12-13,21H,8,11H2,1-3H3,(H,27,28)/t13-,21-/m0/s1 HFYYHVKYLPJNOE-ZSEKCTLFSA-N 334707 US11040966, Example 4.66::US9732075, Example 4.66::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334707 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334707&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127820 384986867 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657056 COc1ccc(c(c1)C(=O)N1CC[C@H](C)[C@H]1c1nc2c(C)c(Cl)ccc2[nH]1)-n1nccn1 InChI=1S/C23H23ClN6O2/c1-13-8-11-29(21(13)22-27-18-6-5-17(24)14(2)20(18)28-22)23(31)16-12-15(32-3)4-7-19(16)30-25-9-10-26-30/h4-7,9-10,12-13,21H,8,11H2,1-3H3,(H,27,28)/t13-,21-/m0/s1 HFYYHVKYLPJNOE-ZSEKCTLFSA-N 334707 US11040966, Example 4.66::US9732075, Example 4.66::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 23.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334707 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334707&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127820 384986867 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657057 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1nc(C)sc1-c1cc(F)cc(F)c1 InChI=1S/C24H21ClF2N4OS/c1-11-6-7-31(21(11)23-29-18-5-4-17(25)12(2)19(18)30-23)24(32)20-22(33-13(3)28-20)14-8-15(26)10-16(27)9-14/h4-5,8-11,21H,6-7H2,1-3H3,(H,29,30)/t11-,21-/m0/s1 FDXRERSZBCJENM-MQJDWESPSA-N 334708 US11040966, Example 4.67::US9732075, Example 4.67::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(3,5-difluoro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 0.900 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334708 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334708&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127378 384986868 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657058 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1nc(C)sc1-c1cc(F)cc(F)c1 InChI=1S/C24H21ClF2N4OS/c1-11-6-7-31(21(11)23-29-18-5-4-17(25)12(2)19(18)30-23)24(32)20-22(33-13(3)28-20)14-8-15(26)10-16(27)9-14/h4-5,8-11,21H,6-7H2,1-3H3,(H,29,30)/t11-,21-/m0/s1 FDXRERSZBCJENM-MQJDWESPSA-N 334708 US11040966, Example 4.67::US9732075, Example 4.67::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(3,5-difluoro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 251 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334708 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334708&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127378 384986868 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657059 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1c(F)c(C)ccc1-n1nccn1 InChI=1S/C23H22ClFN6O/c1-12-4-7-17(31-26-9-10-27-31)18(19(12)25)23(32)30-11-8-13(2)21(30)22-28-16-6-5-15(24)14(3)20(16)29-22/h4-7,9-10,13,21H,8,11H2,1-3H3,(H,28,29)/t13-,21-/m0/s1 XWVOVQAMOXFSHM-ZSEKCTLFSA-N 334709 US11040966, Example 4.68::US9732075, Example 4.68::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334709 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334709&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127105 384986869 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657060 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1c(F)c(C)ccc1-n1nccn1 InChI=1S/C23H22ClFN6O/c1-12-4-7-17(31-26-9-10-27-31)18(19(12)25)23(32)30-11-8-13(2)21(30)22-28-16-6-5-15(24)14(3)20(16)29-22/h4-7,9-10,13,21H,8,11H2,1-3H3,(H,28,29)/t13-,21-/m0/s1 XWVOVQAMOXFSHM-ZSEKCTLFSA-N 334709 US11040966, Example 4.68::US9732075, Example 4.68::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 400 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334709 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334709&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127105 384986869 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657061 COc1ccc(cn1)-c1sc(C)nc1C(=O)N1CC[C@H](C)[C@H]1c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C24H24ClN5O2S/c1-12-9-10-30(21(12)23-28-17-7-6-16(25)13(2)19(17)29-23)24(31)20-22(33-14(3)27-20)15-5-8-18(32-4)26-11-15/h5-8,11-12,21H,9-10H2,1-4H3,(H,28,29)/t12-,21-/m0/s1 YNQCYKPXLIMHBV-QKVFXAPYSA-N 334710 US11040966, Example 4.69::US9732075, Example 4.69::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(6-methoxy-pyridin-3-yl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334710 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334710&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128068 384986870 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657062 COc1ccc(cn1)-c1sc(C)nc1C(=O)N1CC[C@H](C)[C@H]1c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C24H24ClN5O2S/c1-12-9-10-30(21(12)23-28-17-7-6-16(25)13(2)19(17)29-23)24(31)20-22(33-14(3)27-20)15-5-8-18(32-4)26-11-15/h5-8,11-12,21H,9-10H2,1-4H3,(H,28,29)/t12-,21-/m0/s1 YNQCYKPXLIMHBV-QKVFXAPYSA-N 334710 US11040966, Example 4.69::US9732075, Example 4.69::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(6-methoxy-pyridin-3-yl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 191 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334710 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334710&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128068 384986870 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657063 C[C@H]1CCN([C@@H]1c1nc2c(C)cccc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C24H23ClN4OS/c1-13-6-4-9-18-19(13)28-23(27-18)21-14(2)10-11-29(21)24(30)20-22(31-15(3)26-20)16-7-5-8-17(25)12-16/h4-9,12,14,21H,10-11H2,1-3H3,(H,27,28)/t14-,21-/m0/s1 JAKBTQVRVCJFGZ-QKKBWIMNSA-N 334711 US11040966, Example 4.7::US9732075, Example 4.7::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334711 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334711&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127531 384986871 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657064 C[C@H]1CCN([C@@H]1c1nc2c(C)cccc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C24H23ClN4OS/c1-13-6-4-9-18-19(13)28-23(27-18)21-14(2)10-11-29(21)24(30)20-22(31-15(3)26-20)16-7-5-8-17(25)12-16/h4-9,12,14,21H,10-11H2,1-3H3,(H,27,28)/t14-,21-/m0/s1 JAKBTQVRVCJFGZ-QKKBWIMNSA-N 334711 US11040966, Example 4.7::US9732075, Example 4.7::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 603 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334711 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334711&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127531 384986871 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657065 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1nc(C)sc1-c1ccc(F)cc1 InChI=1S/C24H22ClFN4OS/c1-12-10-11-30(21(12)23-28-18-9-8-17(25)13(2)19(18)29-23)24(31)20-22(32-14(3)27-20)15-4-6-16(26)7-5-15/h4-9,12,21H,10-11H2,1-3H3,(H,28,29)/t12-,21-/m0/s1 JJALNSGVCOGWGJ-QKVFXAPYSA-N 334712 US11040966, Example 4.70::US9732075, Example 4.70::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 0.600 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334712 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334712&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127643 384986872 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657066 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1nc(C)sc1-c1ccc(F)cc1 InChI=1S/C24H22ClFN4OS/c1-12-10-11-30(21(12)23-28-18-9-8-17(25)13(2)19(18)29-23)24(31)20-22(32-14(3)27-20)15-4-6-16(26)7-5-15/h4-9,12,21H,10-11H2,1-3H3,(H,28,29)/t12-,21-/m0/s1 JJALNSGVCOGWGJ-QKVFXAPYSA-N 334712 US11040966, Example 4.70::US9732075, Example 4.70::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 404 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334712 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334712&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127643 384986872 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657067 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C22H20Cl2N6O/c1-12-5-8-29(20(12)21-27-17-9-13(2)16(24)11-18(17)28-21)22(31)15-10-14(23)3-4-19(15)30-25-6-7-26-30/h3-4,6-7,9-12,20H,5,8H2,1-2H3,(H,27,28)/t12-,20-/m0/s1 KNPKLOPHGBSXHO-YUNKPMOVSA-N 334713 US11040966, Example 4.71::US9732075, Example 4.71::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-chloro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334713 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334713&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127327 384986873 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657068 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C22H20Cl2N6O/c1-12-5-8-29(20(12)21-27-17-9-13(2)16(24)11-18(17)28-21)22(31)15-10-14(23)3-4-19(15)30-25-6-7-26-30/h3-4,6-7,9-12,20H,5,8H2,1-2H3,(H,27,28)/t12-,20-/m0/s1 KNPKLOPHGBSXHO-YUNKPMOVSA-N 334713 US11040966, Example 4.71::US9732075, Example 4.71::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-chloro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 133 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334713 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334713&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127327 384986873 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657069 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1ccc(C)cc1-n1nccn1 InChI=1S/C23H23ClN6O/c1-13-4-5-16(20(10-13)30-25-7-8-26-30)23(31)29-9-6-14(2)21(29)22-27-18-11-15(3)17(24)12-19(18)28-22/h4-5,7-8,10-12,14,21H,6,9H2,1-3H3,(H,27,28)/t14-,21-/m0/s1 ORWFLSUKJBCAEL-QKKBWIMNSA-N 334714 US11040966, Example 4.72::US9732075, Example 4.72::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334714 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334714&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127516 384986874 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657070 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1ccc(C)cc1-n1nccn1 InChI=1S/C23H23ClN6O/c1-13-4-5-16(20(10-13)30-25-7-8-26-30)23(31)29-9-6-14(2)21(29)22-27-18-11-15(3)17(24)12-19(18)28-22/h4-5,7-8,10-12,14,21H,6,9H2,1-3H3,(H,27,28)/t14-,21-/m0/s1 ORWFLSUKJBCAEL-QKKBWIMNSA-N 334714 US11040966, Example 4.72::US9732075, Example 4.72::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 51.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334714 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334714&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127516 384986874 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657071 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1cc(C)ccc1-n1cccn1 InChI=1S/C24H24ClN5O/c1-14-5-6-21(30-9-4-8-26-30)17(11-14)24(31)29-10-7-15(2)22(29)23-27-19-12-16(3)18(25)13-20(19)28-23/h4-6,8-9,11-13,15,22H,7,10H2,1-3H3,(H,27,28)/t15-,22-/m0/s1 NHYKKPMJTBFKRC-NYHFZMIOSA-N 334715 US11040966, Example 4.73::US9732075, Example 4.73::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 17.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334715 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334715&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128066 384986875 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657072 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1cc(C)ccc1-n1cccn1 InChI=1S/C24H24ClN5O/c1-14-5-6-21(30-9-4-8-26-30)17(11-14)24(31)29-10-7-15(2)22(29)23-27-19-12-16(3)18(25)13-20(19)28-23/h4-6,8-9,11-13,15,22H,7,10H2,1-3H3,(H,27,28)/t15-,22-/m0/s1 NHYKKPMJTBFKRC-NYHFZMIOSA-N 334715 US11040966, Example 4.73::US9732075, Example 4.73::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 1290 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334715 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334715&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128066 384986875 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657073 COc1ccc(c(c1)C(=O)N1CC[C@H](C)[C@H]1c1nc2cc(Cl)c(C)cc2[nH]1)-n1nccn1 InChI=1S/C23H23ClN6O2/c1-13-6-9-29(21(13)22-27-18-10-14(2)17(24)12-19(18)28-22)23(31)16-11-15(32-3)4-5-20(16)30-25-7-8-26-30/h4-5,7-8,10-13,21H,6,9H2,1-3H3,(H,27,28)/t13-,21-/m0/s1 CNCDUEDPGAHZTP-ZSEKCTLFSA-N 334716 US11040966, Example 4.74::US9732075, Example 4.74::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334716 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334716&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127272 384986876 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657074 COc1ccc(c(c1)C(=O)N1CC[C@H](C)[C@H]1c1nc2cc(Cl)c(C)cc2[nH]1)-n1nccn1 InChI=1S/C23H23ClN6O2/c1-13-6-9-29(21(13)22-27-18-10-14(2)17(24)12-19(18)28-22)23(31)16-11-15(32-3)4-5-20(16)30-25-7-8-26-30/h4-5,7-8,10-13,21H,6,9H2,1-3H3,(H,27,28)/t13-,21-/m0/s1 CNCDUEDPGAHZTP-ZSEKCTLFSA-N 334716 US11040966, Example 4.74::US9732075, Example 4.74::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 78.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334716 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334716&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127272 384986876 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657075 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1c(F)c(C)ccc1-n1nccn1 InChI=1S/C23H22ClFN6O/c1-12-4-5-18(31-26-7-8-27-31)19(20(12)25)23(32)30-9-6-13(2)21(30)22-28-16-10-14(3)15(24)11-17(16)29-22/h4-5,7-8,10-11,13,21H,6,9H2,1-3H3,(H,28,29)/t13-,21-/m0/s1 DUXJDJUOXIYMEC-ZSEKCTLFSA-N 334717 US11040966, Example 4.75::US9732075, Example 4.75::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334717 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334717&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127438 384986877 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657076 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1c(F)c(C)ccc1-n1nccn1 InChI=1S/C23H22ClFN6O/c1-12-4-5-18(31-26-7-8-27-31)19(20(12)25)23(32)30-9-6-13(2)21(30)22-28-16-10-14(3)15(24)11-17(16)29-22/h4-5,7-8,10-11,13,21H,6,9H2,1-3H3,(H,28,29)/t13-,21-/m0/s1 DUXJDJUOXIYMEC-ZSEKCTLFSA-N 334717 US11040966, Example 4.75::US9732075, Example 4.75::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 636 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334717 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334717&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127438 384986877 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657077 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H21ClN6O/c1-13-7-10-28(20(13)21-26-17-11-14(2)16(23)12-18(17)27-21)22(30)15-5-3-4-6-19(15)29-24-8-9-25-29/h3-6,8-9,11-13,20H,7,10H2,1-2H3,(H,26,27)/t13-,20-/m0/s1 WLWILFYLLZUFNF-RBZFPXEDSA-N 334718 US11040966, Example 4.76::US9732075, Example 4.76::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334718 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334718&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127993 384986878 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657078 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H21ClN6O/c1-13-7-10-28(20(13)21-26-17-11-14(2)16(23)12-18(17)27-21)22(30)15-5-3-4-6-19(15)29-24-8-9-25-29/h3-6,8-9,11-13,20H,7,10H2,1-2H3,(H,26,27)/t13-,20-/m0/s1 WLWILFYLLZUFNF-RBZFPXEDSA-N 334718 US11040966, Example 4.76::US9732075, Example 4.76::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 113 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334718 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334718&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127993 384986878 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657079 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1ccccc1-c1ccc(C)cc1 InChI=1S/C27H26ClN3O/c1-16-8-10-19(11-9-16)20-6-4-5-7-21(20)27(32)31-13-12-17(2)25(31)26-29-23-14-18(3)22(28)15-24(23)30-26/h4-11,14-15,17,25H,12-13H2,1-3H3,(H,29,30)/t17-,25-/m0/s1 FVSDPGVQXOJCRW-GKVSMKOHSA-N 334719 US11040966, Example 4.77::US9732075, Example 4.77::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4'-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334719 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334719&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127486 384986879 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657080 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1ccccc1-c1ccc(C)cc1 InChI=1S/C27H26ClN3O/c1-16-8-10-19(11-9-16)20-6-4-5-7-21(20)27(32)31-13-12-17(2)25(31)26-29-23-14-18(3)22(28)15-24(23)30-26/h4-11,14-15,17,25H,12-13H2,1-3H3,(H,29,30)/t17-,25-/m0/s1 FVSDPGVQXOJCRW-GKVSMKOHSA-N 334719 US11040966, Example 4.77::US9732075, Example 4.77::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4'-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 790 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334719 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334719&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127486 384986879 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657081 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1nc(C)sc1-c1ccc(Cl)cc1 InChI=1S/C24H22Cl2N4OS/c1-12-8-9-30(21(12)23-28-18-10-13(2)17(26)11-19(18)29-23)24(31)20-22(32-14(3)27-20)15-4-6-16(25)7-5-15/h4-7,10-12,21H,8-9H2,1-3H3,(H,28,29)/t12-,21-/m0/s1 VMTXFIPTHBQSRT-QKVFXAPYSA-N 334720 US11040966, Example 4.78::US9732075, Example 4.78::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(4-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334720 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334720&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127569 384986880 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657082 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1nc(C)sc1-c1ccc(Cl)cc1 InChI=1S/C24H22Cl2N4OS/c1-12-8-9-30(21(12)23-28-18-10-13(2)17(26)11-19(18)29-23)24(31)20-22(32-14(3)27-20)15-4-6-16(25)7-5-15/h4-7,10-12,21H,8-9H2,1-3H3,(H,28,29)/t12-,21-/m0/s1 VMTXFIPTHBQSRT-QKVFXAPYSA-N 334720 US11040966, Example 4.78::US9732075, Example 4.78::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(4-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 1630 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334720 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334720&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127569 384986880 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657083 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1sc(C)nc1-c1ccc(C)cc1 InChI=1S/C25H25ClN4OS/c1-13-5-7-17(8-6-13)21-23(32-16(4)27-21)25(31)30-10-9-14(2)22(30)24-28-19-11-15(3)18(26)12-20(19)29-24/h5-8,11-12,14,22H,9-10H2,1-4H3,(H,28,29)/t14-,22-/m0/s1 XMRLZYQSRYUEOY-FPTDNZKUSA-N 334721 US11040966, Example 4.79::US9732075, Example 4.79::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-methyl-4-p-tolyl-thiazol-5-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 18.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334721 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334721&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127616 384986881 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657084 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1sc(C)nc1-c1ccc(C)cc1 InChI=1S/C25H25ClN4OS/c1-13-5-7-17(8-6-13)21-23(32-16(4)27-21)25(31)30-10-9-14(2)22(30)24-28-19-11-15(3)18(26)12-20(19)29-24/h5-8,11-12,14,22H,9-10H2,1-4H3,(H,28,29)/t14-,22-/m0/s1 XMRLZYQSRYUEOY-FPTDNZKUSA-N 334721 US11040966, Example 4.79::US9732075, Example 4.79::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-methyl-4-p-tolyl-thiazol-5-yl)-methanone Orexin receptor type 2 Homo sapiens 541 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334721 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334721&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127616 384986881 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657085 C[C@H]1CCN([C@@H]1c1nc2cc(ccc2[nH]1)C#N)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C24H20ClN5OS/c1-13-8-9-30(21(13)23-28-18-7-6-15(12-26)10-19(18)29-23)24(31)20-22(32-14(2)27-20)16-4-3-5-17(25)11-16/h3-7,10-11,13,21H,8-9H2,1-2H3,(H,28,29)/t13-,21-/m0/s1 PZHYRUNAUPAIGR-ZSEKCTLFSA-N 334722 2-{(2S,3S)-1-[5-(3-Chloro-phenyl)-2-methyl-thiazole-4-carbonyl]-3-methyl-pyrrolidin-2-yl}-1H-benzoimidazole-5-carbonitrile::US11040966, Example 4.8::US9732075, Example 4.8 Orexin/Hypocretin receptor type 1 Homo sapiens 68.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334722 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334722&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128260 384986882 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657086 C[C@H]1CCN([C@@H]1c1nc2cc(ccc2[nH]1)C#N)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C24H20ClN5OS/c1-13-8-9-30(21(13)23-28-18-7-6-15(12-26)10-19(18)29-23)24(31)20-22(32-14(2)27-20)16-4-3-5-17(25)11-16/h3-7,10-11,13,21H,8-9H2,1-2H3,(H,28,29)/t13-,21-/m0/s1 PZHYRUNAUPAIGR-ZSEKCTLFSA-N 334722 2-{(2S,3S)-1-[5-(3-Chloro-phenyl)-2-methyl-thiazole-4-carbonyl]-3-methyl-pyrrolidin-2-yl}-1H-benzoimidazole-5-carbonitrile::US11040966, Example 4.8::US9732075, Example 4.8 Orexin receptor type 2 Homo sapiens 9930 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334722 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334722&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128260 384986882 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657087 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1nc(C)sc1-c1cc(F)cc(F)c1 InChI=1S/C24H21ClF2N4OS/c1-11-4-5-31(21(11)23-29-18-6-12(2)17(25)10-19(18)30-23)24(32)20-22(33-13(3)28-20)14-7-15(26)9-16(27)8-14/h6-11,21H,4-5H2,1-3H3,(H,29,30)/t11-,21-/m0/s1 GKGAVHIEIUAYHG-MQJDWESPSA-N 334723 US11040966, Example 4.80::US9732075, Example 4.80::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(3,5-difluoro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334723 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334723&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127608 384986883 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657088 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1nc(C)sc1-c1cc(F)cc(F)c1 InChI=1S/C24H21ClF2N4OS/c1-11-4-5-31(21(11)23-29-18-6-12(2)17(25)10-19(18)30-23)24(32)20-22(33-13(3)28-20)14-7-15(26)9-16(27)8-14/h6-11,21H,4-5H2,1-3H3,(H,29,30)/t11-,21-/m0/s1 GKGAVHIEIUAYHG-MQJDWESPSA-N 334723 US11040966, Example 4.80::US9732075, Example 4.80::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(3,5-difluoro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 2020 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334723 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334723&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127608 384986883 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657089 C[C@H]1CCN([C@@H]1c1nc2cc(C)c(C)cc2[nH]1)C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C23H23ClN6O/c1-13-6-9-29(21(13)22-27-18-10-14(2)15(3)11-19(18)28-22)23(31)17-12-16(24)4-5-20(17)30-25-7-8-26-30/h4-5,7-8,10-13,21H,6,9H2,1-3H3,(H,27,28)/t13-,21-/m0/s1 OJVPFTHFYQCMAZ-ZSEKCTLFSA-N 334724 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(2S,3S)-2-(5,6-dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone::US11040966, Example 4.81::US9732075, Example 4.81 Orexin/Hypocretin receptor type 1 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334724 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334724&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127241 384986884 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657090 C[C@H]1CCN([C@@H]1c1nc2cc(C)c(C)cc2[nH]1)C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C23H23ClN6O/c1-13-6-9-29(21(13)22-27-18-10-14(2)15(3)11-19(18)28-22)23(31)17-12-16(24)4-5-20(17)30-25-7-8-26-30/h4-5,7-8,10-13,21H,6,9H2,1-3H3,(H,27,28)/t13-,21-/m0/s1 OJVPFTHFYQCMAZ-ZSEKCTLFSA-N 334724 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(2S,3S)-2-(5,6-dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone::US11040966, Example 4.81::US9732075, Example 4.81 Orexin receptor type 2 Homo sapiens 79.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334724 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334724&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127241 384986884 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657091 C[C@H]1CCN([C@@H]1c1nc2cc(C)c(C)cc2[nH]1)C(=O)c1ccc(C)cc1-n1nccn1 InChI=1S/C24H26N6O/c1-14-5-6-18(21(11-14)30-25-8-9-26-30)24(31)29-10-7-15(2)22(29)23-27-19-12-16(3)17(4)13-20(19)28-23/h5-6,8-9,11-13,15,22H,7,10H2,1-4H3,(H,27,28)/t15-,22-/m0/s1 YRDYMMSFSGXWLF-NYHFZMIOSA-N 334725 US11040966, Example 4.82::US9732075, Example 4.82::[(2S,3S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334725 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334725&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127146 384986885 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657092 C[C@H]1CCN([C@@H]1c1nc2cc(C)c(C)cc2[nH]1)C(=O)c1ccc(C)cc1-n1nccn1 InChI=1S/C24H26N6O/c1-14-5-6-18(21(11-14)30-25-8-9-26-30)24(31)29-10-7-15(2)22(29)23-27-19-12-16(3)17(4)13-20(19)28-23/h5-6,8-9,11-13,15,22H,7,10H2,1-4H3,(H,27,28)/t15-,22-/m0/s1 YRDYMMSFSGXWLF-NYHFZMIOSA-N 334725 US11040966, Example 4.82::US9732075, Example 4.82::[(2S,3S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 32.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334725 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334725&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127146 384986885 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657093 C[C@H]1CCN([C@@H]1c1nc2cc(C)c(C)cc2[nH]1)C(=O)c1cc(C)ccc1-n1cccn1 InChI=1S/C25H27N5O/c1-15-6-7-22(30-10-5-9-26-30)19(12-15)25(31)29-11-8-16(2)23(29)24-27-20-13-17(3)18(4)14-21(20)28-24/h5-7,9-10,12-14,16,23H,8,11H2,1-4H3,(H,27,28)/t16-,23-/m0/s1 RMCDGZFEOXSGFK-HJPURHCSSA-N 334726 US11040966, Example 4.83::US9732075, Example 4.83::[(2S,3S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 159 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334726 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334726&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127381 384986886 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657094 C[C@H]1CCN([C@@H]1c1nc2cc(C)c(C)cc2[nH]1)C(=O)c1cc(C)ccc1-n1cccn1 InChI=1S/C25H27N5O/c1-15-6-7-22(30-10-5-9-26-30)19(12-15)25(31)29-11-8-16(2)23(29)24-27-20-13-17(3)18(4)14-21(20)28-24/h5-7,9-10,12-14,16,23H,8,11H2,1-4H3,(H,27,28)/t16-,23-/m0/s1 RMCDGZFEOXSGFK-HJPURHCSSA-N 334726 US11040966, Example 4.83::US9732075, Example 4.83::[(2S,3S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 2322 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334726 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334726&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127381 384986886 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657095 COc1ccc(c(c1)C(=O)N1CC[C@H](C)[C@H]1c1nc2cc(C)c(C)cc2[nH]1)-n1nccn1 InChI=1S/C24H26N6O2/c1-14-7-10-29(22(14)23-27-19-11-15(2)16(3)12-20(19)28-23)24(31)18-13-17(32-4)5-6-21(18)30-25-8-9-26-30/h5-6,8-9,11-14,22H,7,10H2,1-4H3,(H,27,28)/t14-,22-/m0/s1 NGVMELDKDAWMQT-FPTDNZKUSA-N 334727 US11040966, Example 4.84::US9732075, Example 4.84::[(2S,3S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334727 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334727&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127770 384986887 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657096 COc1ccc(c(c1)C(=O)N1CC[C@H](C)[C@H]1c1nc2cc(C)c(C)cc2[nH]1)-n1nccn1 InChI=1S/C24H26N6O2/c1-14-7-10-29(22(14)23-27-19-11-15(2)16(3)12-20(19)28-23)24(31)18-13-17(32-4)5-6-21(18)30-25-8-9-26-30/h5-6,8-9,11-14,22H,7,10H2,1-4H3,(H,27,28)/t14-,22-/m0/s1 NGVMELDKDAWMQT-FPTDNZKUSA-N 334727 US11040966, Example 4.84::US9732075, Example 4.84::[(2S,3S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 58.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334727 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334727&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127770 384986887 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657097 C[C@H]1CCN([C@@H]1c1nc2cc(C)c(C)cc2[nH]1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C23H24N6O/c1-14-8-11-28(21(14)22-26-18-12-15(2)16(3)13-19(18)27-22)23(30)17-6-4-5-7-20(17)29-24-9-10-25-29/h4-7,9-10,12-14,21H,8,11H2,1-3H3,(H,26,27)/t14-,21-/m0/s1 QBUJVLVFFUUXFF-QKKBWIMNSA-N 334728 US11040966, Example 4.85::US9732075, Example 4.85::[(2S,3S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334728 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334728&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128257 384986888 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657098 C[C@H]1CCN([C@@H]1c1nc2cc(C)c(C)cc2[nH]1)C(=O)c1ccccc1-n1nccn1 InChI=1S/C23H24N6O/c1-14-8-11-28(21(14)22-26-18-12-15(2)16(3)13-19(18)27-22)23(30)17-6-4-5-7-20(17)29-24-9-10-25-29/h4-7,9-10,12-14,21H,8,11H2,1-3H3,(H,26,27)/t14-,21-/m0/s1 QBUJVLVFFUUXFF-QKKBWIMNSA-N 334728 US11040966, Example 4.85::US9732075, Example 4.85::[(2S,3S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 43.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334728 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334728&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128257 384986888 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657099 C[C@H]1CCN([C@@H]1c1nc2cc(C)c(C)cc2[nH]1)C(=O)c1ccccc1-c1ccc(C)cc1 InChI=1S/C28H29N3O/c1-17-9-11-21(12-10-17)22-7-5-6-8-23(22)28(32)31-14-13-18(2)26(31)27-29-24-15-19(3)20(4)16-25(24)30-27/h5-12,15-16,18,26H,13-14H2,1-4H3,(H,29,30)/t18-,26-/m0/s1 QOTCEKFAJMFSKR-QYBDOPJKSA-N 334729 US11040966, Example 4.86::US9732075, Example 4.86::[(2S,3S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4'-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334729 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334729&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127034 384986889 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657100 C[C@H]1CCN([C@@H]1c1nc2cc(C)c(C)cc2[nH]1)C(=O)c1ccccc1-c1ccc(C)cc1 InChI=1S/C28H29N3O/c1-17-9-11-21(12-10-17)22-7-5-6-8-23(22)28(32)31-14-13-18(2)26(31)27-29-24-15-19(3)20(4)16-25(24)30-27/h5-12,15-16,18,26H,13-14H2,1-4H3,(H,29,30)/t18-,26-/m0/s1 QOTCEKFAJMFSKR-QYBDOPJKSA-N 334729 US11040966, Example 4.86::US9732075, Example 4.86::[(2S,3S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4'-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 352 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334729 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334729&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127034 384986889 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657101 C[C@H]1CCN([C@@H]1c1nc2cc(C)c(C)cc2[nH]1)C(=O)c1nc(C)sc1-c1ccc(Cl)cc1 InChI=1S/C25H25ClN4OS/c1-13-9-10-30(22(13)24-28-19-11-14(2)15(3)12-20(19)29-24)25(31)21-23(32-16(4)27-21)17-5-7-18(26)8-6-17/h5-8,11-13,22H,9-10H2,1-4H3,(H,28,29)/t13-,22-/m0/s1 GTSMUBXJQHGVEY-XMHCIUCPSA-N 334730 US11040966, Example 4.87::US9732075, Example 4.87::[5-(4-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-2-(5,6-dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334730 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334730&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127639 384986890 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657102 C[C@H]1CCN([C@@H]1c1nc2cc(C)c(C)cc2[nH]1)C(=O)c1nc(C)sc1-c1ccc(Cl)cc1 InChI=1S/C25H25ClN4OS/c1-13-9-10-30(22(13)24-28-19-11-14(2)15(3)12-20(19)29-24)25(31)21-23(32-16(4)27-21)17-5-7-18(26)8-6-17/h5-8,11-13,22H,9-10H2,1-4H3,(H,28,29)/t13-,22-/m0/s1 GTSMUBXJQHGVEY-XMHCIUCPSA-N 334730 US11040966, Example 4.87::US9732075, Example 4.87::[5-(4-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-2-(5,6-dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 2076 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334730 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334730&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127639 384986890 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657103 C[C@H]1CCN([C@@H]1c1nc2cc(C)c(C)cc2[nH]1)C(=O)c1sc(C)nc1-c1ccc(C)cc1 InChI=1S/C26H28N4OS/c1-14-6-8-19(9-7-14)22-24(32-18(5)27-22)26(31)30-11-10-15(2)23(30)25-28-20-12-16(3)17(4)13-21(20)29-25/h6-9,12-13,15,23H,10-11H2,1-5H3,(H,28,29)/t15-,23-/m0/s1 MARGZNYZJKEULD-WNSKOXEYSA-N 334731 US11040966, Example 4.88::US9732075, Example 4.88::[(2S,3S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-methyl-4-p-tolyl-thiazol-5-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 11.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334731 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334731&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127061 384986891 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657104 C[C@H]1CCN([C@@H]1c1nc2cc(C)c(C)cc2[nH]1)C(=O)c1sc(C)nc1-c1ccc(C)cc1 InChI=1S/C26H28N4OS/c1-14-6-8-19(9-7-14)22-24(32-18(5)27-22)26(31)30-11-10-15(2)23(30)25-28-20-12-16(3)17(4)13-21(20)29-25/h6-9,12-13,15,23H,10-11H2,1-5H3,(H,28,29)/t15-,23-/m0/s1 MARGZNYZJKEULD-WNSKOXEYSA-N 334731 US11040966, Example 4.88::US9732075, Example 4.88::[(2S,3S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-methyl-4-p-tolyl-thiazol-5-yl)-methanone Orexin receptor type 2 Homo sapiens 182 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334731 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334731&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127061 384986891 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657105 C[C@H]1CCN([C@@H]1c1nc2cc(C)c(C)cc2[nH]1)C(=O)c1nc(C)sc1-c1cc(F)cc(F)c1 InChI=1S/C25H24F2N4OS/c1-12-5-6-31(22(12)24-29-19-7-13(2)14(3)8-20(19)30-24)25(32)21-23(33-15(4)28-21)16-9-17(26)11-18(27)10-16/h7-12,22H,5-6H2,1-4H3,(H,29,30)/t12-,22-/m0/s1 RKDYDLNYKPFOQV-YTEVENLXSA-N 334732 US11040966, Example 4.89::US9732075, Example 4.89::[5-(3,5-Difluoro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-2-(5,6-dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334732 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334732&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127489 384986892 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657106 C[C@H]1CCN([C@@H]1c1nc2cc(C)c(C)cc2[nH]1)C(=O)c1nc(C)sc1-c1cc(F)cc(F)c1 InChI=1S/C25H24F2N4OS/c1-12-5-6-31(22(12)24-29-19-7-13(2)14(3)8-20(19)30-24)25(32)21-23(33-15(4)28-21)16-9-17(26)11-18(27)10-16/h7-12,22H,5-6H2,1-4H3,(H,29,30)/t12-,22-/m0/s1 RKDYDLNYKPFOQV-YTEVENLXSA-N 334732 US11040966, Example 4.89::US9732075, Example 4.89::[5-(3,5-Difluoro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-2-(5,6-dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 2170 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334732 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334732&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127489 384986892 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657107 C[C@H]1CCN([C@@H]1c1nc2cc(ccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C24H20ClF3N4OS/c1-12-8-9-32(20(12)22-30-17-7-6-15(24(26,27)28)11-18(17)31-22)23(33)19-21(34-13(2)29-19)14-4-3-5-16(25)10-14/h3-7,10-12,20H,8-9H2,1-2H3,(H,30,31)/t12-,20-/m0/s1 NCYAPGCCXVOJBV-YUNKPMOVSA-N 334733 US11040966, Example 4.9::US9732075, Example 4.9::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334733 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334733&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127679 384986893 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657108 C[C@H]1CCN([C@@H]1c1nc2cc(ccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C24H20ClF3N4OS/c1-12-8-9-32(20(12)22-30-17-7-6-15(24(26,27)28)11-18(17)31-22)23(33)19-21(34-13(2)29-19)14-4-3-5-16(25)10-14/h3-7,10-12,20H,8-9H2,1-2H3,(H,30,31)/t12-,20-/m0/s1 NCYAPGCCXVOJBV-YUNKPMOVSA-N 334733 US11040966, Example 4.9::US9732075, Example 4.9::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 2780 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334733 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334733&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127679 384986893 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657109 C[C@H]1CCN([C@@H]1c1nc2cc(C)c(C)cc2[nH]1)C(=O)c1nc(C)sc1-c1ccc(F)cc1 InChI=1S/C25H25FN4OS/c1-13-9-10-30(22(13)24-28-19-11-14(2)15(3)12-20(19)29-24)25(31)21-23(32-16(4)27-21)17-5-7-18(26)8-6-17/h5-8,11-13,22H,9-10H2,1-4H3,(H,28,29)/t13-,22-/m0/s1 HFVBVYUFLNJLFO-XMHCIUCPSA-N 334734 US11040966, Example 4.90::US9732075, Example 4.90::[(2S,3S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334734 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334734&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127817 384986894 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657110 C[C@H]1CCN([C@@H]1c1nc2cc(C)c(C)cc2[nH]1)C(=O)c1nc(C)sc1-c1ccc(F)cc1 InChI=1S/C25H25FN4OS/c1-13-9-10-30(22(13)24-28-19-11-14(2)15(3)12-20(19)29-24)25(31)21-23(32-16(4)27-21)17-5-7-18(26)8-6-17/h5-8,11-13,22H,9-10H2,1-4H3,(H,28,29)/t13-,22-/m0/s1 HFVBVYUFLNJLFO-XMHCIUCPSA-N 334734 US11040966, Example 4.90::US9732075, Example 4.90::[(2S,3S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 2350 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334734 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334734&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127817 384986894 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657111 C[C@H]1CCN([C@@H]1c1nc2c(C)cc(Cl)cc2[nH]1)C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C22H20Cl2N6O/c1-12-5-8-29(20(12)21-27-17-11-15(24)9-13(2)19(17)28-21)22(31)16-10-14(23)3-4-18(16)30-25-6-7-26-30/h3-4,6-7,9-12,20H,5,8H2,1-2H3,(H,27,28)/t12-,20-/m0/s1 OPXBETVFJQNNKZ-YUNKPMOVSA-N 334735 US11040966, Example 4.91::US9732075, Example 4.91::[(2S,3S)-2-(6-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-chloro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 17.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334735 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334735&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127005 384986895 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657112 C[C@H]1CCN([C@@H]1c1nc2c(C)cc(Cl)cc2[nH]1)C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C22H20Cl2N6O/c1-12-5-8-29(20(12)21-27-17-11-15(24)9-13(2)19(17)28-21)22(31)16-10-14(23)3-4-18(16)30-25-6-7-26-30/h3-4,6-7,9-12,20H,5,8H2,1-2H3,(H,27,28)/t12-,20-/m0/s1 OPXBETVFJQNNKZ-YUNKPMOVSA-N 334735 US11040966, Example 4.91::US9732075, Example 4.91::[(2S,3S)-2-(6-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-chloro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 183 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334735 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334735&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127005 384986895 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657113 C[C@H]1CCN([C@@H]1c1nc2c(C)cc(Cl)cc2[nH]1)C(=O)c1ccccc1-c1ccc(C)cc1 InChI=1S/C27H26ClN3O/c1-16-8-10-19(11-9-16)21-6-4-5-7-22(21)27(32)31-13-12-17(2)25(31)26-29-23-15-20(28)14-18(3)24(23)30-26/h4-11,14-15,17,25H,12-13H2,1-3H3,(H,29,30)/t17-,25-/m0/s1 DYGMNLMPFFDBNB-GKVSMKOHSA-N 334736 US11040966, Example 4.92::US9732075, Example 4.92::[(2S,3S)-2-(6-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4'-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334736 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334736&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127220 384986896 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657114 C[C@H]1CCN([C@@H]1c1nc2c(C)cc(Cl)cc2[nH]1)C(=O)c1ccccc1-c1ccc(C)cc1 InChI=1S/C27H26ClN3O/c1-16-8-10-19(11-9-16)21-6-4-5-7-22(21)27(32)31-13-12-17(2)25(31)26-29-23-15-20(28)14-18(3)24(23)30-26/h4-11,14-15,17,25H,12-13H2,1-3H3,(H,29,30)/t17-,25-/m0/s1 DYGMNLMPFFDBNB-GKVSMKOHSA-N 334736 US11040966, Example 4.92::US9732075, Example 4.92::[(2S,3S)-2-(6-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4'-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 212 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334736 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334736&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127220 384986896 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657115 C[C@H]1CCN([C@@H]1c1nc2c(C)cc(Cl)cc2[nH]1)C(=O)c1ccc(C)cc1-n1nccn1 InChI=1S/C23H23ClN6O/c1-13-4-5-17(19(10-13)30-25-7-8-26-30)23(31)29-9-6-14(2)21(29)22-27-18-12-16(24)11-15(3)20(18)28-22/h4-5,7-8,10-12,14,21H,6,9H2,1-3H3,(H,27,28)/t14-,21-/m0/s1 LZTASGJPADXFHY-QKKBWIMNSA-N 334737 US11040966, Example 4.93::US9732075, Example 4.93::[(2S,3S)-2-(6-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334737 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334737&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127136 384986897 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657116 C[C@H]1CCN([C@@H]1c1nc2c(C)cc(Cl)cc2[nH]1)C(=O)c1ccc(C)cc1-n1nccn1 InChI=1S/C23H23ClN6O/c1-13-4-5-17(19(10-13)30-25-7-8-26-30)23(31)29-9-6-14(2)21(29)22-27-18-12-16(24)11-15(3)20(18)28-22/h4-5,7-8,10-12,14,21H,6,9H2,1-3H3,(H,27,28)/t14-,21-/m0/s1 LZTASGJPADXFHY-QKKBWIMNSA-N 334737 US11040966, Example 4.93::US9732075, Example 4.93::[(2S,3S)-2-(6-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 74.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334737 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334737&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127136 384986897 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657117 C[C@H]1CCN([C@@H]1c1nc2c(C)cc(Cl)cc2[nH]1)C(=O)c1nc(C)sc1-c1ccc(Cl)cc1 InChI=1S/C24H22Cl2N4OS/c1-12-8-9-30(21(12)23-28-18-11-17(26)10-13(2)19(18)29-23)24(31)20-22(32-14(3)27-20)15-4-6-16(25)7-5-15/h4-7,10-12,21H,8-9H2,1-3H3,(H,28,29)/t12-,21-/m0/s1 NZBAPJBYGIRLSE-QKVFXAPYSA-N 334738 US11040966, Example 4.94::US9732075, Example 4.94::[(2S,3S)-2-(6-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(4-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334738 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334738&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127190 384986898 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657118 C[C@H]1CCN([C@@H]1c1nc2c(C)cc(Cl)cc2[nH]1)C(=O)c1nc(C)sc1-c1ccc(Cl)cc1 InChI=1S/C24H22Cl2N4OS/c1-12-8-9-30(21(12)23-28-18-11-17(26)10-13(2)19(18)29-23)24(31)20-22(32-14(3)27-20)15-4-6-16(25)7-5-15/h4-7,10-12,21H,8-9H2,1-3H3,(H,28,29)/t12-,21-/m0/s1 NZBAPJBYGIRLSE-QKVFXAPYSA-N 334738 US11040966, Example 4.94::US9732075, Example 4.94::[(2S,3S)-2-(6-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(4-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 543 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334738 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334738&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127190 384986898 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657119 C[C@H]1CCN([C@@H]1c1nc2c(C)cc(Cl)cc2[nH]1)C(=O)c1cc(C)ccc1-n1cccn1 InChI=1S/C24H24ClN5O/c1-14-5-6-20(30-9-4-8-26-30)18(11-14)24(31)29-10-7-15(2)22(29)23-27-19-13-17(25)12-16(3)21(19)28-23/h4-6,8-9,11-13,15,22H,7,10H2,1-3H3,(H,27,28)/t15-,22-/m0/s1 HDFPSVAFZJMHRE-NYHFZMIOSA-N 334739 US11040966, Example 4.95::US9732075, Example 4.95::[(2S,3S)-2-(6-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 28.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334739 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334739&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127656 384986899 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657120 C[C@H]1CCN([C@@H]1c1nc2c(C)cc(Cl)cc2[nH]1)C(=O)c1cc(C)ccc1-n1cccn1 InChI=1S/C24H24ClN5O/c1-14-5-6-20(30-9-4-8-26-30)18(11-14)24(31)29-10-7-15(2)22(29)23-27-19-13-17(25)12-16(3)21(19)28-23/h4-6,8-9,11-13,15,22H,7,10H2,1-3H3,(H,27,28)/t15-,22-/m0/s1 HDFPSVAFZJMHRE-NYHFZMIOSA-N 334739 US11040966, Example 4.95::US9732075, Example 4.95::[(2S,3S)-2-(6-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 1170 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334739 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334739&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127656 384986899 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657121 C[C@H]1CCN([C@@H]1c1nc2c(C)cc(Cl)cc2[nH]1)C(=O)c1sc(C)nc1-c1ccc(C)cc1 InChI=1S/C25H25ClN4OS/c1-13-5-7-17(8-6-13)21-23(32-16(4)27-21)25(31)30-10-9-14(2)22(30)24-28-19-12-18(26)11-15(3)20(19)29-24/h5-8,11-12,14,22H,9-10H2,1-4H3,(H,28,29)/t14-,22-/m0/s1 VAWYWUQKZFFETF-FPTDNZKUSA-N 334740 US11040966, Example 4.96::US9732075, Example 4.96::[(2S,3S)-2-(6-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-methyl-4-p-tolyl-thiazol-5-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 31.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334740 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334740&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127103 384986900 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657122 C[C@H]1CCN([C@@H]1c1nc2c(C)cc(Cl)cc2[nH]1)C(=O)c1sc(C)nc1-c1ccc(C)cc1 InChI=1S/C25H25ClN4OS/c1-13-5-7-17(8-6-13)21-23(32-16(4)27-21)25(31)30-10-9-14(2)22(30)24-28-19-12-18(26)11-15(3)20(19)29-24/h5-8,11-12,14,22H,9-10H2,1-4H3,(H,28,29)/t14-,22-/m0/s1 VAWYWUQKZFFETF-FPTDNZKUSA-N 334740 US11040966, Example 4.96::US9732075, Example 4.96::[(2S,3S)-2-(6-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-methyl-4-p-tolyl-thiazol-5-yl)-methanone Orexin receptor type 2 Homo sapiens 996 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334740 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334740&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127103 384986900 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657123 COc1ccc(c(c1)C(=O)N1CC[C@H](C)[C@H]1c1nc2c(C)cc(Cl)cc2[nH]1)-n1nccn1 InChI=1S/C23H23ClN6O2/c1-13-6-9-29(21(13)22-27-18-11-15(24)10-14(2)20(18)28-22)23(31)17-12-16(32-3)4-5-19(17)30-25-7-8-26-30/h4-5,7-8,10-13,21H,6,9H2,1-3H3,(H,27,28)/t13-,21-/m0/s1 PCPHRHBXQANSIF-ZSEKCTLFSA-N 334741 US11040966, Example 4.97::US9732075, Example 4.97::[(2S,3S)-2-(6-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334741 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334741&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127945 384986901 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657124 COc1ccc(c(c1)C(=O)N1CC[C@H](C)[C@H]1c1nc2c(C)cc(Cl)cc2[nH]1)-n1nccn1 InChI=1S/C23H23ClN6O2/c1-13-6-9-29(21(13)22-27-18-11-15(24)10-14(2)20(18)28-22)23(31)17-12-16(32-3)4-5-19(17)30-25-7-8-26-30/h4-5,7-8,10-13,21H,6,9H2,1-3H3,(H,27,28)/t13-,21-/m0/s1 PCPHRHBXQANSIF-ZSEKCTLFSA-N 334741 US11040966, Example 4.97::US9732075, Example 4.97::[(2S,3S)-2-(6-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 129 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334741 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334741&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127945 384986901 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657125 C[C@H]1CCN([C@@H]1c1nc2c(C)cc(Cl)cc2[nH]1)C(=O)c1nc(C)sc1-c1cc(F)cc(F)c1 InChI=1S/C24H21ClF2N4OS/c1-11-4-5-31(21(11)23-29-18-9-15(25)6-12(2)19(18)30-23)24(32)20-22(33-13(3)28-20)14-7-16(26)10-17(27)8-14/h6-11,21H,4-5H2,1-3H3,(H,29,30)/t11-,21-/m0/s1 FQCXYSFMJUWYAN-MQJDWESPSA-N 334742 US11040966, Example 4.98::US9732075, Example 4.98::[(2S,3S)-2-(6-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(3,5-difluoro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334742 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334742&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127341 384986902 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657126 C[C@H]1CCN([C@@H]1c1nc2c(C)cc(Cl)cc2[nH]1)C(=O)c1nc(C)sc1-c1cc(F)cc(F)c1 InChI=1S/C24H21ClF2N4OS/c1-11-4-5-31(21(11)23-29-18-9-15(25)6-12(2)19(18)30-23)24(32)20-22(33-13(3)28-20)14-7-16(26)10-17(27)8-14/h6-11,21H,4-5H2,1-3H3,(H,29,30)/t11-,21-/m0/s1 FQCXYSFMJUWYAN-MQJDWESPSA-N 334742 US11040966, Example 4.98::US9732075, Example 4.98::[(2S,3S)-2-(6-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(3,5-difluoro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 1300 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334742 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334742&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127341 384986902 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657127 C[C@H]1CCN([C@@H]1c1nc2c(C)cc(Cl)cc2[nH]1)C(=O)c1c(F)c(C)ccc1-n1nccn1 InChI=1S/C23H22ClFN6O/c1-12-4-5-17(31-26-7-8-27-31)18(19(12)25)23(32)30-9-6-13(2)21(30)22-28-16-11-15(24)10-14(3)20(16)29-22/h4-5,7-8,10-11,13,21H,6,9H2,1-3H3,(H,28,29)/t13-,21-/m0/s1 PGKHFHUFVHNVEV-ZSEKCTLFSA-N 334743 US11040966, Example 4.99::US9732075, Example 4.99::[(2S,3S)-2-(6-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334743 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334743&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128190 384986903 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657128 C[C@H]1CCN([C@@H]1c1nc2c(C)cc(Cl)cc2[nH]1)C(=O)c1c(F)c(C)ccc1-n1nccn1 InChI=1S/C23H22ClFN6O/c1-12-4-5-17(31-26-7-8-27-31)18(19(12)25)23(32)30-9-6-13(2)21(30)22-28-16-11-15(24)10-14(3)20(16)29-22/h4-5,7-8,10-11,13,21H,6,9H2,1-3H3,(H,28,29)/t13-,21-/m0/s1 PGKHFHUFVHNVEV-ZSEKCTLFSA-N 334743 US11040966, Example 4.99::US9732075, Example 4.99::[(2S,3S)-2-(6-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 981 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334743 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334743&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128190 384986903 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657129 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1cc(C)ccc1-c1ccccn1 InChI=1S/C26H25ClN4O/c1-15-7-8-18(21-6-4-5-10-28-21)19(12-15)26(32)31-11-9-16(2)24(31)25-29-22-13-17(3)20(27)14-23(22)30-25/h4-8,10,12-14,16,24H,9,11H2,1-3H3,(H,29,30)/t16-,24-/m0/s1 HIXZCULZJMIRGR-FYSMJZIKSA-N 334744 US11040966, Example 4.102::US9732075, Example 4.102::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyridin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 10.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334744 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334744&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127961 384986904 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657130 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1cc(C)ccc1-c1ccccn1 InChI=1S/C26H25ClN4O/c1-15-7-8-18(21-6-4-5-10-28-21)19(12-15)26(32)31-11-9-16(2)24(31)25-29-22-13-17(3)20(27)14-23(22)30-25/h4-8,10,12-14,16,24H,9,11H2,1-3H3,(H,29,30)/t16-,24-/m0/s1 HIXZCULZJMIRGR-FYSMJZIKSA-N 334744 US11040966, Example 4.102::US9732075, Example 4.102::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyridin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 103 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334744 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334744&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127961 384986904 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657131 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1cc(Cl)ccc1-c1ccccc1 InChI=1S/C26H23Cl2N3O/c1-15-10-11-31(24(15)25-29-22-12-16(2)21(28)14-23(22)30-25)26(32)20-13-18(27)8-9-19(20)17-6-4-3-5-7-17/h3-9,12-15,24H,10-11H2,1-2H3,(H,29,30)/t15-,24-/m0/s1 MYYWNWGKGXQLPB-OWJWWREXSA-N 334745 (4-Chloro-biphenyl-2-yl)-[(2S,3S)-2-(5-chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone::US11040966, Example 4.103::US9732075, Example 4.103 Orexin/Hypocretin receptor type 1 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334745 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334745&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127775 384986905 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657132 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1cc(Cl)ccc1-c1ccccc1 InChI=1S/C26H23Cl2N3O/c1-15-10-11-31(24(15)25-29-22-12-16(2)21(28)14-23(22)30-25)26(32)20-13-18(27)8-9-19(20)17-6-4-3-5-7-17/h3-9,12-15,24H,10-11H2,1-2H3,(H,29,30)/t15-,24-/m0/s1 MYYWNWGKGXQLPB-OWJWWREXSA-N 334745 (4-Chloro-biphenyl-2-yl)-[(2S,3S)-2-(5-chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone::US11040966, Example 4.103::US9732075, Example 4.103 Orexin receptor type 2 Homo sapiens 178 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334745 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334745&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127775 384986905 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657133 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1cc(C)ccc1-c1cccnc1 InChI=1S/C26H25ClN4O/c1-15-6-7-19(18-5-4-9-28-14-18)20(11-15)26(32)31-10-8-16(2)24(31)25-29-22-12-17(3)21(27)13-23(22)30-25/h4-7,9,11-14,16,24H,8,10H2,1-3H3,(H,29,30)/t16-,24-/m0/s1 ANXLFZIJLMJHRF-FYSMJZIKSA-N 334746 US11040966, Example 4.104::US9732075, Example 4.104::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyridin-3-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 14.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334746 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334746&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127840 384986906 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657134 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1cc(C)ccc1-c1cccnc1 InChI=1S/C26H25ClN4O/c1-15-6-7-19(18-5-4-9-28-14-18)20(11-15)26(32)31-10-8-16(2)24(31)25-29-22-12-17(3)21(27)13-23(22)30-25/h4-7,9,11-14,16,24H,8,10H2,1-3H3,(H,29,30)/t16-,24-/m0/s1 ANXLFZIJLMJHRF-FYSMJZIKSA-N 334746 US11040966, Example 4.104::US9732075, Example 4.104::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyridin-3-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 1660 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334746 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334746&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127840 384986906 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657135 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1cc(F)ccc1-c1ccccc1 InChI=1S/C26H23ClFN3O/c1-15-10-11-31(24(15)25-29-22-12-16(2)21(27)14-23(22)30-25)26(32)20-13-18(28)8-9-19(20)17-6-4-3-5-7-17/h3-9,12-15,24H,10-11H2,1-2H3,(H,29,30)/t15-,24-/m0/s1 UMWXHHFCNWYXQV-OWJWWREXSA-N 334747 US11040966, Example 4.105::US9732075, Example 4.105::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4-fluoro-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334747 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334747&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127602 384986907 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657136 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1cc(F)ccc1-c1ccccc1 InChI=1S/C26H23ClFN3O/c1-15-10-11-31(24(15)25-29-22-12-16(2)21(27)14-23(22)30-25)26(32)20-13-18(28)8-9-19(20)17-6-4-3-5-7-17/h3-9,12-15,24H,10-11H2,1-2H3,(H,29,30)/t15-,24-/m0/s1 UMWXHHFCNWYXQV-OWJWWREXSA-N 334747 US11040966, Example 4.105::US9732075, Example 4.105::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4-fluoro-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 177 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334747 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334747&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127602 384986907 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657137 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1cc(F)ccc1-c1ccccn1 InChI=1S/C25H22ClFN4O/c1-14-8-10-31(23(14)24-29-21-11-15(2)19(26)13-22(21)30-24)25(32)18-12-16(27)6-7-17(18)20-5-3-4-9-28-20/h3-7,9,11-14,23H,8,10H2,1-2H3,(H,29,30)/t14-,23-/m0/s1 OPTMSJDOCVBIAL-PSLXWICFSA-N 334748 US11040966, Example 4.106::US9732075, Example 4.106::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-fluoro-2-pyridin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 23.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334748 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334748&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128096 384986908 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657138 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1cc(F)ccc1-c1ccccn1 InChI=1S/C25H22ClFN4O/c1-14-8-10-31(23(14)24-29-21-11-15(2)19(26)13-22(21)30-24)25(32)18-12-16(27)6-7-17(18)20-5-3-4-9-28-20/h3-7,9,11-14,23H,8,10H2,1-2H3,(H,29,30)/t14-,23-/m0/s1 OPTMSJDOCVBIAL-PSLXWICFSA-N 334748 US11040966, Example 4.106::US9732075, Example 4.106::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-fluoro-2-pyridin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 529 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334748 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334748&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128096 384986908 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657139 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1c(F)cccc1-c1cccnc1 InChI=1S/C25H22ClFN4O/c1-14-8-10-31(23(14)24-29-20-11-15(2)18(26)12-21(20)30-24)25(32)22-17(6-3-7-19(22)27)16-5-4-9-28-13-16/h3-7,9,11-14,23H,8,10H2,1-2H3,(H,29,30)/t14-,23-/m0/s1 SECISWKEZAHASH-PSLXWICFSA-N 334749 US11040966, Example 4.107::US9732075, Example 4.107::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-fluoro-6-pyridin-3-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 47.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334749 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334749&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128189 384986909 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657140 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1c(F)cccc1-c1cccnc1 InChI=1S/C25H22ClFN4O/c1-14-8-10-31(23(14)24-29-20-11-15(2)18(26)12-21(20)30-24)25(32)22-17(6-3-7-19(22)27)16-5-4-9-28-13-16/h3-7,9,11-14,23H,8,10H2,1-2H3,(H,29,30)/t14-,23-/m0/s1 SECISWKEZAHASH-PSLXWICFSA-N 334749 US11040966, Example 4.107::US9732075, Example 4.107::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-fluoro-6-pyridin-3-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 1760 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334749 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334749&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128189 384986909 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657141 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1cc(ccc1-c1ccccc1)C#N InChI=1S/C27H23ClN4O/c1-16-10-11-32(25(16)26-30-23-12-17(2)22(28)14-24(23)31-26)27(33)21-13-18(15-29)8-9-20(21)19-6-4-3-5-7-19/h3-9,12-14,16,25H,10-11H2,1-2H3,(H,30,31)/t16-,25-/m0/s1 JOPRYNNNFTUXRO-LMKMVOKYSA-N 334750 2-[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidine-1-carbonyl]-biphenyl-4-carbonitrile::US11040966, Example 4.108::US9732075, Example 4.108 Orexin/Hypocretin receptor type 1 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334750 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334750&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128298 384986910 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657142 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1cc(ccc1-c1ccccc1)C#N InChI=1S/C27H23ClN4O/c1-16-10-11-32(25(16)26-30-23-12-17(2)22(28)14-24(23)31-26)27(33)21-13-18(15-29)8-9-20(21)19-6-4-3-5-7-19/h3-9,12-14,16,25H,10-11H2,1-2H3,(H,30,31)/t16-,25-/m0/s1 JOPRYNNNFTUXRO-LMKMVOKYSA-N 334750 2-[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidine-1-carbonyl]-biphenyl-4-carbonitrile::US11040966, Example 4.108::US9732075, Example 4.108 Orexin receptor type 2 Homo sapiens 419 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334750 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334750&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128298 384986910 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657143 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1ccc(C)cc1-c1ccccn1 InChI=1S/C26H25ClN4O/c1-15-7-8-18(19(12-15)21-6-4-5-10-28-21)26(32)31-11-9-16(2)24(31)25-29-22-13-17(3)20(27)14-23(22)30-25/h4-8,10,12-14,16,24H,9,11H2,1-3H3,(H,29,30)/t16-,24-/m0/s1 LBFKZBXOXQSKDO-FYSMJZIKSA-N 334751 US11040966, Example 4.109::US9732075, Example 4.109::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4-methyl-2-pyridin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334751 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334751&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128070 384986911 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657144 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1ccc(C)cc1-c1ccccn1 InChI=1S/C26H25ClN4O/c1-15-7-8-18(19(12-15)21-6-4-5-10-28-21)26(32)31-11-9-16(2)24(31)25-29-22-13-17(3)20(27)14-23(22)30-25/h4-8,10,12-14,16,24H,9,11H2,1-3H3,(H,29,30)/t16-,24-/m0/s1 LBFKZBXOXQSKDO-FYSMJZIKSA-N 334751 US11040966, Example 4.109::US9732075, Example 4.109::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4-methyl-2-pyridin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 108 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334751 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334751&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128070 384986911 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657145 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1ccc(C)cc1-c1cccnc1 InChI=1S/C26H25ClN4O/c1-15-6-7-19(20(11-15)18-5-4-9-28-14-18)26(32)31-10-8-16(2)24(31)25-29-22-12-17(3)21(27)13-23(22)30-25/h4-7,9,11-14,16,24H,8,10H2,1-3H3,(H,29,30)/t16-,24-/m0/s1 RGEOGOVZFOFDIK-FYSMJZIKSA-N 334752 US11040966, Example 4.110::US9732075, Example 4.110::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4-methyl-2-pyridin-3-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334752 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334752&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127446 384986912 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657146 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1ccc(C)cc1-c1cccnc1 InChI=1S/C26H25ClN4O/c1-15-6-7-19(20(11-15)18-5-4-9-28-14-18)26(32)31-10-8-16(2)24(31)25-29-22-12-17(3)21(27)13-23(22)30-25/h4-7,9,11-14,16,24H,8,10H2,1-3H3,(H,29,30)/t16-,24-/m0/s1 RGEOGOVZFOFDIK-FYSMJZIKSA-N 334752 US11040966, Example 4.110::US9732075, Example 4.110::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4-methyl-2-pyridin-3-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 1520 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334752 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334752&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127446 384986912 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657147 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1ccc(C)cc1-c1ccccc1 InChI=1S/C27H26ClN3O/c1-16-9-10-20(21(13-16)19-7-5-4-6-8-19)27(32)31-12-11-17(2)25(31)26-29-23-14-18(3)22(28)15-24(23)30-26/h4-10,13-15,17,25H,11-12H2,1-3H3,(H,29,30)/t17-,25-/m0/s1 JMIBZSFVLXVCCF-GKVSMKOHSA-N 334753 US11040966, Example 4.111::US9732075, Example 4.111::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334753 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334753&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127390 384986913 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657148 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1ccc(C)cc1-c1ccccc1 InChI=1S/C27H26ClN3O/c1-16-9-10-20(21(13-16)19-7-5-4-6-8-19)27(32)31-12-11-17(2)25(31)26-29-23-14-18(3)22(28)15-24(23)30-26/h4-10,13-15,17,25H,11-12H2,1-3H3,(H,29,30)/t17-,25-/m0/s1 JMIBZSFVLXVCCF-GKVSMKOHSA-N 334753 US11040966, Example 4.111::US9732075, Example 4.111::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 110 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334753 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334753&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127390 384986913 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657149 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1c(F)cccc1-c1ccccc1 InChI=1S/C26H23ClFN3O/c1-15-11-12-31(24(15)25-29-21-13-16(2)19(27)14-22(21)30-25)26(32)23-18(9-6-10-20(23)28)17-7-4-3-5-8-17/h3-10,13-15,24H,11-12H2,1-2H3,(H,29,30)/t15-,24-/m0/s1 LVPCJLWAICMVGU-OWJWWREXSA-N 334754 US11040966, Example 4.112::US9732075, Example 4.112::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(3-fluoro-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334754 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334754&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128045 384986914 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657150 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1c(F)cccc1-c1ccccc1 InChI=1S/C26H23ClFN3O/c1-15-11-12-31(24(15)25-29-21-13-16(2)19(27)14-22(21)30-25)26(32)23-18(9-6-10-20(23)28)17-7-4-3-5-8-17/h3-10,13-15,24H,11-12H2,1-2H3,(H,29,30)/t15-,24-/m0/s1 LVPCJLWAICMVGU-OWJWWREXSA-N 334754 US11040966, Example 4.112::US9732075, Example 4.112::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(3-fluoro-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 1060 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334754 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334754&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128045 384986914 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657151 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1c(F)c(C)ccc1-c1ccccn1 InChI=1S/C26H24ClFN4O/c1-14-7-8-17(19-6-4-5-10-29-19)22(23(14)28)26(33)32-11-9-15(2)24(32)25-30-20-12-16(3)18(27)13-21(20)31-25/h4-8,10,12-13,15,24H,9,11H2,1-3H3,(H,30,31)/t15-,24-/m0/s1 VINZFNPEULEOQE-OWJWWREXSA-N 334755 US11040966, Example 4.113::US9732075, Example 4.113::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-pyridin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334755 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334755&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127131 384986915 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657152 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1c(F)c(C)ccc1-c1ccccn1 InChI=1S/C26H24ClFN4O/c1-14-7-8-17(19-6-4-5-10-29-19)22(23(14)28)26(33)32-11-9-15(2)24(32)25-30-20-12-16(3)18(27)13-21(20)31-25/h4-8,10,12-13,15,24H,9,11H2,1-3H3,(H,30,31)/t15-,24-/m0/s1 VINZFNPEULEOQE-OWJWWREXSA-N 334755 US11040966, Example 4.113::US9732075, Example 4.113::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-pyridin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 2040 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334755 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334755&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127131 384986915 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657153 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1cc(ccc1-c1ccccc1)C(F)(F)F InChI=1S/C27H23ClF3N3O/c1-15-10-11-34(24(15)25-32-22-12-16(2)21(28)14-23(22)33-25)26(35)20-13-18(27(29,30)31)8-9-19(20)17-6-4-3-5-7-17/h3-9,12-15,24H,10-11H2,1-2H3,(H,32,33)/t15-,24-/m0/s1 LVZMTOJNOKBWLU-OWJWWREXSA-N 334756 US11040966, Example 4.114::US9732075, Example 4.114::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4-trifluoromethyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 33.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334756 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334756&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127865 384986916 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657154 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1cc(ccc1-c1ccccc1)C(F)(F)F InChI=1S/C27H23ClF3N3O/c1-15-10-11-34(24(15)25-32-22-12-16(2)21(28)14-23(22)33-25)26(35)20-13-18(27(29,30)31)8-9-19(20)17-6-4-3-5-7-17/h3-9,12-15,24H,10-11H2,1-2H3,(H,32,33)/t15-,24-/m0/s1 LVZMTOJNOKBWLU-OWJWWREXSA-N 334756 US11040966, Example 4.114::US9732075, Example 4.114::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4-trifluoromethyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 1360 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334756 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334756&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127865 384986916 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657155 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1c(F)c(C)ccc1-c1ccccc1 InChI=1S/C27H25ClFN3O/c1-15-9-10-19(18-7-5-4-6-8-18)23(24(15)29)27(33)32-12-11-16(2)25(32)26-30-21-13-17(3)20(28)14-22(21)31-26/h4-10,13-14,16,25H,11-12H2,1-3H3,(H,30,31)/t16-,25-/m0/s1 VXLNOWNCPKYMAK-LMKMVOKYSA-N 334757 US11040966, Example 4.115::US9732075, Example 4.115::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(3-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334757 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334757&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127764 384986917 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657156 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1c(F)c(C)ccc1-c1ccccc1 InChI=1S/C27H25ClFN3O/c1-15-9-10-19(18-7-5-4-6-8-18)23(24(15)29)27(33)32-12-11-16(2)25(32)26-30-21-13-17(3)20(28)14-22(21)31-26/h4-10,13-14,16,25H,11-12H2,1-3H3,(H,30,31)/t16-,25-/m0/s1 VXLNOWNCPKYMAK-LMKMVOKYSA-N 334757 US11040966, Example 4.115::US9732075, Example 4.115::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(3-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 754 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334757 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334757&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127764 384986917 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657157 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1cc(C)ccc1-c1ccccc1 InChI=1S/C27H26ClN3O/c1-16-9-10-20(19-7-5-4-6-8-19)21(13-16)27(32)31-12-11-17(2)25(31)26-29-23-14-18(3)22(28)15-24(23)30-26/h4-10,13-15,17,25H,11-12H2,1-3H3,(H,29,30)/t17-,25-/m0/s1 FDRYHHDMMKPPLV-GKVSMKOHSA-N 334758 US11040966, Example 4.116::US9732075, Example 4.116::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334758 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334758&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128375 384986918 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657158 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1cc(C)ccc1-c1ccccc1 InChI=1S/C27H26ClN3O/c1-16-9-10-20(19-7-5-4-6-8-19)21(13-16)27(32)31-12-11-17(2)25(31)26-29-23-14-18(3)22(28)15-24(23)30-26/h4-10,13-15,17,25H,11-12H2,1-3H3,(H,29,30)/t17-,25-/m0/s1 FDRYHHDMMKPPLV-GKVSMKOHSA-N 334758 US11040966, Example 4.116::US9732075, Example 4.116::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 198 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334758 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334758&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128375 384986918 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657159 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1c(F)c(C)ccc1-c1cccnc1 InChI=1S/C26H24ClFN4O/c1-14-6-7-18(17-5-4-9-29-13-17)22(23(14)28)26(33)32-10-8-15(2)24(32)25-30-20-11-16(3)19(27)12-21(20)31-25/h4-7,9,11-13,15,24H,8,10H2,1-3H3,(H,30,31)/t15-,24-/m0/s1 QTNOVKFXFOATAH-OWJWWREXSA-N 334759 US11040966, Example 4.117::US9732075, Example 4.117::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-pyridin-3-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 16.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334759 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334759&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127276 384986919 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657160 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1c(F)c(C)ccc1-c1cccnc1 InChI=1S/C26H24ClFN4O/c1-14-6-7-18(17-5-4-9-29-13-17)22(23(14)28)26(33)32-10-8-15(2)24(32)25-30-20-11-16(3)19(27)12-21(20)31-25/h4-7,9,11-13,15,24H,8,10H2,1-3H3,(H,30,31)/t15-,24-/m0/s1 QTNOVKFXFOATAH-OWJWWREXSA-N 334759 US11040966, Example 4.117::US9732075, Example 4.117::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-pyridin-3-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 2570 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334759 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334759&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127276 384986919 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657161 C[C@H]1CCN([C@@H]1c1nc2c(Cl)cccc2[nH]1)C(=O)c1nc(C)sc1-c1ccc(F)cc1 InChI=1S/C23H20ClFN4OS/c1-12-10-11-29(20(12)22-27-17-5-3-4-16(24)18(17)28-22)23(30)19-21(31-13(2)26-19)14-6-8-15(25)9-7-14/h3-9,12,20H,10-11H2,1-2H3,(H,27,28)/t12-,20-/m0/s1 DWFFWKQSEIXJCZ-YUNKPMOVSA-N 334760 US11040966, Example 4.118::US9732075, Example 4.118::[(2S,3S)-2-(4-Chloro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 50.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334760 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334760&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128216 384986920 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657162 C[C@H]1CCN([C@@H]1c1nc2c(Cl)cccc2[nH]1)C(=O)c1nc(C)sc1-c1ccc(F)cc1 InChI=1S/C23H20ClFN4OS/c1-12-10-11-29(20(12)22-27-17-5-3-4-16(24)18(17)28-22)23(30)19-21(31-13(2)26-19)14-6-8-15(25)9-7-14/h3-9,12,20H,10-11H2,1-2H3,(H,27,28)/t12-,20-/m0/s1 DWFFWKQSEIXJCZ-YUNKPMOVSA-N 334760 US11040966, Example 4.118::US9732075, Example 4.118::[(2S,3S)-2-(4-Chloro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 4350 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334760 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334760&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128216 384986920 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657163 C[C@H]1CCN([C@@H]1c1nc2c(Cl)cccc2[nH]1)C(=O)c1nc(C)sc1-c1cc(F)cc(F)c1 InChI=1S/C23H19ClF2N4OS/c1-11-6-7-30(20(11)22-28-17-5-3-4-16(24)18(17)29-22)23(31)19-21(32-12(2)27-19)13-8-14(25)10-15(26)9-13/h3-5,8-11,20H,6-7H2,1-2H3,(H,28,29)/t11-,20-/m0/s1 HRCRABPVGPISFD-YBTHPKLGSA-N 334761 US11040966, Example 4.119::US9732075, Example 4.119::[(2S,3S)-2-(4-Chloro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(3,5-difluoro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 21.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334761 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334761&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127445 384986921 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657164 C[C@H]1CCN([C@@H]1c1nc2c(Cl)cccc2[nH]1)C(=O)c1nc(C)sc1-c1cc(F)cc(F)c1 InChI=1S/C23H19ClF2N4OS/c1-11-6-7-30(20(11)22-28-17-5-3-4-16(24)18(17)29-22)23(31)19-21(32-12(2)27-19)13-8-14(25)10-15(26)9-13/h3-5,8-11,20H,6-7H2,1-2H3,(H,28,29)/t11-,20-/m0/s1 HRCRABPVGPISFD-YBTHPKLGSA-N 334761 US11040966, Example 4.119::US9732075, Example 4.119::[(2S,3S)-2-(4-Chloro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(3,5-difluoro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 2050 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334761 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334761&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127445 384986921 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657165 C[C@H]1CCN([C@@H]1c1nc2c(Cl)cccc2[nH]1)C(=O)c1nc(C)sc1-c1ccc(Cl)cc1 InChI=1S/C23H20Cl2N4OS/c1-12-10-11-29(20(12)22-27-17-5-3-4-16(25)18(17)28-22)23(30)19-21(31-13(2)26-19)14-6-8-15(24)9-7-14/h3-9,12,20H,10-11H2,1-2H3,(H,27,28)/t12-,20-/m0/s1 DWSYAHWATLYWRU-YUNKPMOVSA-N 334762 US11040966, Example 4.120::US9732075, Example 4.120::[(2S,3S)-2-(4-Chloro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(4-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 14.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334762 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334762&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127338 384986922 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657166 C[C@H]1CCN([C@@H]1c1nc2c(Cl)cccc2[nH]1)C(=O)c1nc(C)sc1-c1ccc(Cl)cc1 InChI=1S/C23H20Cl2N4OS/c1-12-10-11-29(20(12)22-27-17-5-3-4-16(25)18(17)28-22)23(30)19-21(31-13(2)26-19)14-6-8-15(24)9-7-14/h3-9,12,20H,10-11H2,1-2H3,(H,27,28)/t12-,20-/m0/s1 DWSYAHWATLYWRU-YUNKPMOVSA-N 334762 US11040966, Example 4.120::US9732075, Example 4.120::[(2S,3S)-2-(4-Chloro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(4-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 725 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334762 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334762&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127338 384986922 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657167 COc1cccc(c1)-c1sc(C)nc1C(=O)N1CC[C@H](C)[C@H]1c1nc2c(Cl)cccc2[nH]1 InChI=1S/C24H23ClN4O2S/c1-13-10-11-29(21(13)23-27-18-9-5-8-17(25)19(18)28-23)24(30)20-22(32-14(2)26-20)15-6-4-7-16(12-15)31-3/h4-9,12-13,21H,10-11H2,1-3H3,(H,27,28)/t13-,21-/m0/s1 QODXQJPUROUTSV-ZSEKCTLFSA-N 334763 US11040966, Example 4.121::US9732075, Example 4.121::[(2S,3S)-2-(4-Chloro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(3-methoxy-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334763 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334763&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128269 384986923 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657168 COc1cccc(c1)-c1sc(C)nc1C(=O)N1CC[C@H](C)[C@H]1c1nc2c(Cl)cccc2[nH]1 InChI=1S/C24H23ClN4O2S/c1-13-10-11-29(21(13)23-27-18-9-5-8-17(25)19(18)28-23)24(30)20-22(32-14(2)26-20)15-6-4-7-16(12-15)31-3/h4-9,12-13,21H,10-11H2,1-3H3,(H,27,28)/t13-,21-/m0/s1 QODXQJPUROUTSV-ZSEKCTLFSA-N 334763 US11040966, Example 4.121::US9732075, Example 4.121::[(2S,3S)-2-(4-Chloro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(3-methoxy-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 475 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334763 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334763&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128269 384986923 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657169 C[C@H]1CCN([C@@H]1c1nc2c(Cl)cccc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(C)c1 InChI=1S/C24H23ClN4OS/c1-13-6-4-7-16(12-13)22-20(26-15(3)31-22)24(30)29-11-10-14(2)21(29)23-27-18-9-5-8-17(25)19(18)28-23/h4-9,12,14,21H,10-11H2,1-3H3,(H,27,28)/t14-,21-/m0/s1 YMXUVOVOEYJPGQ-QKKBWIMNSA-N 334764 US11040966, Example 4.122::US9732075, Example 4.122::[(2S,3S)-2-(4-Chloro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-methyl-5-m-tolyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334764 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334764&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127607 384986924 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657170 C[C@H]1CCN([C@@H]1c1nc2c(Cl)cccc2[nH]1)C(=O)c1nc(C)sc1-c1cccc(C)c1 InChI=1S/C24H23ClN4OS/c1-13-6-4-7-16(12-13)22-20(26-15(3)31-22)24(30)29-11-10-14(2)21(29)23-27-18-9-5-8-17(25)19(18)28-23/h4-9,12,14,21H,10-11H2,1-3H3,(H,27,28)/t14-,21-/m0/s1 YMXUVOVOEYJPGQ-QKKBWIMNSA-N 334764 US11040966, Example 4.122::US9732075, Example 4.122::[(2S,3S)-2-(4-Chloro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-methyl-5-m-tolyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 610 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334764 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334764&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127607 384986924 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657171 C[C@H]1CCN([C@@H]1c1nc2c(Cl)cccc2[nH]1)C(=O)c1nc(C)sc1-c1ccc(Br)cc1 InChI=1S/C23H20BrClN4OS/c1-12-10-11-29(20(12)22-27-17-5-3-4-16(25)18(17)28-22)23(30)19-21(31-13(2)26-19)14-6-8-15(24)9-7-14/h3-9,12,20H,10-11H2,1-2H3,(H,27,28)/t12-,20-/m0/s1 CGPWFVNYILIPJZ-YUNKPMOVSA-N 334765 US11040966, Example 4.123::US9732075, Example 4.123::[5-(4-Bromo-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-2-(4-chloro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 21.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334765 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334765&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127534 384986925 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657172 C[C@H]1CCN([C@@H]1c1nc2c(Cl)cccc2[nH]1)C(=O)c1nc(C)sc1-c1ccc(Br)cc1 InChI=1S/C23H20BrClN4OS/c1-12-10-11-29(20(12)22-27-17-5-3-4-16(25)18(17)28-22)23(30)19-21(31-13(2)26-19)14-6-8-15(24)9-7-14/h3-9,12,20H,10-11H2,1-2H3,(H,27,28)/t12-,20-/m0/s1 CGPWFVNYILIPJZ-YUNKPMOVSA-N 334765 US11040966, Example 4.123::US9732075, Example 4.123::[5-(4-Bromo-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-2-(4-chloro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 871 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334765 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334765&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127534 384986925 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657173 C[C@H]1CCN([C@@H]1c1nc2c(Cl)cccc2[nH]1)C(=O)c1nc(C)sc1-c1ccc(C)cc1 InChI=1S/C24H23ClN4OS/c1-13-7-9-16(10-8-13)22-20(26-15(3)31-22)24(30)29-12-11-14(2)21(29)23-27-18-6-4-5-17(25)19(18)28-23/h4-10,14,21H,11-12H2,1-3H3,(H,27,28)/t14-,21-/m0/s1 AYOFMEJHHMHPGP-QKKBWIMNSA-N 334766 US11040966, Example 4.124::US9732075, Example 4.124::[(2S,3S)-2-(4-Chloro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-methyl-5-p-tolyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334766&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128305 384986926 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657174 C[C@H]1CCN([C@@H]1c1nc2c(Cl)cccc2[nH]1)C(=O)c1nc(C)sc1-c1ccc(C)cc1 InChI=1S/C24H23ClN4OS/c1-13-7-9-16(10-8-13)22-20(26-15(3)31-22)24(30)29-12-11-14(2)21(29)23-27-18-6-4-5-17(25)19(18)28-23/h4-10,14,21H,11-12H2,1-3H3,(H,27,28)/t14-,21-/m0/s1 AYOFMEJHHMHPGP-QKKBWIMNSA-N 334766 US11040966, Example 4.124::US9732075, Example 4.124::[(2S,3S)-2-(4-Chloro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-methyl-5-p-tolyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 591 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334766 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334766&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128305 384986926 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657175 C[C@H]1CCN([C@@H]1c1nc2c(Cl)cccc2[nH]1)C(=O)c1nc(C)sc1-c1ccc(C)c(C)c1 InChI=1S/C25H25ClN4OS/c1-13-8-9-17(12-15(13)3)23-21(27-16(4)32-23)25(31)30-11-10-14(2)22(30)24-28-19-7-5-6-18(26)20(19)29-24/h5-9,12,14,22H,10-11H2,1-4H3,(H,28,29)/t14-,22-/m0/s1 NFAMQGWLSKBGPG-FPTDNZKUSA-N 334767 US11040966, Example 4.125::US9732075, Example 4.125::[(2S,3S)-2-(4-Chloro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(3,4-dimethyl-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334767 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334767&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127065 384986927 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657176 C[C@H]1CCN([C@@H]1c1nc2c(Cl)cccc2[nH]1)C(=O)c1nc(C)sc1-c1ccc(C)c(C)c1 InChI=1S/C25H25ClN4OS/c1-13-8-9-17(12-15(13)3)23-21(27-16(4)32-23)25(31)30-11-10-14(2)22(30)24-28-19-7-5-6-18(26)20(19)29-24/h5-9,12,14,22H,10-11H2,1-4H3,(H,28,29)/t14-,22-/m0/s1 NFAMQGWLSKBGPG-FPTDNZKUSA-N 334767 US11040966, Example 4.125::US9732075, Example 4.125::[(2S,3S)-2-(4-Chloro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(3,4-dimethyl-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 81.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334767 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334767&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127065 384986927 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657177 C[C@H]1CCN([C@@H]1c1nc2c(Cl)cccc2[nH]1)C(=O)c1nc(C)sc1-c1ccc(F)c(F)c1 InChI=1S/C23H19ClF2N4OS/c1-11-8-9-30(20(11)22-28-17-5-3-4-14(24)18(17)29-22)23(31)19-21(32-12(2)27-19)13-6-7-15(25)16(26)10-13/h3-7,10-11,20H,8-9H2,1-2H3,(H,28,29)/t11-,20-/m0/s1 NGMSRQWXQZZCQQ-YBTHPKLGSA-N 334768 US11040966, Example 4.126::US9732075, Example 4.126::[(2S,3S)-2-(4-Chloro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(3,4-difluoro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 43.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334768 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334768&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128184 384986928 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657178 C[C@H]1CCN([C@@H]1c1nc2c(Cl)cccc2[nH]1)C(=O)c1nc(C)sc1-c1ccc(F)c(F)c1 InChI=1S/C23H19ClF2N4OS/c1-11-8-9-30(20(11)22-28-17-5-3-4-14(24)18(17)29-22)23(31)19-21(32-12(2)27-19)13-6-7-15(25)16(26)10-13/h3-7,10-11,20H,8-9H2,1-2H3,(H,28,29)/t11-,20-/m0/s1 NGMSRQWXQZZCQQ-YBTHPKLGSA-N 334768 US11040966, Example 4.126::US9732075, Example 4.126::[(2S,3S)-2-(4-Chloro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(3,4-difluoro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 2380 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334768 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334768&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128184 384986928 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657179 C[C@H]1CCN([C@@H]1c1nc2c(Cl)cccc2[nH]1)C(=O)c1ccsc1-c1ccc(C)c(C)c1 InChI=1S/C25H24ClN3OS/c1-14-7-8-17(13-16(14)3)23-18(10-12-31-23)25(30)29-11-9-15(2)22(29)24-27-20-6-4-5-19(26)21(20)28-24/h4-8,10,12-13,15,22H,9,11H2,1-3H3,(H,27,28)/t15-,22-/m0/s1 PYSPVSXASXGIRN-NYHFZMIOSA-N 334769 US11040966, Example 4.127::US9732075, Example 4.127::[(2S,3S)-2-(4-Chloro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[2-(3,4-dimethyl-phenyl)-thiophen-3-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334769 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334769&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127698 384986929 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657180 C[C@H]1CCN([C@@H]1c1nc2c(Cl)cccc2[nH]1)C(=O)c1ccsc1-c1ccc(C)c(C)c1 InChI=1S/C25H24ClN3OS/c1-14-7-8-17(13-16(14)3)23-18(10-12-31-23)25(30)29-11-9-15(2)22(29)24-27-20-6-4-5-19(26)21(20)28-24/h4-8,10,12-13,15,22H,9,11H2,1-3H3,(H,27,28)/t15-,22-/m0/s1 PYSPVSXASXGIRN-NYHFZMIOSA-N 334769 US11040966, Example 4.127::US9732075, Example 4.127::[(2S,3S)-2-(4-Chloro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[2-(3,4-dimethyl-phenyl)-thiophen-3-yl]-methanone Orexin receptor type 2 Homo sapiens 19.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334769 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334769&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127698 384986929 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657181 C[C@H]1CCN([C@@H]1c1nc2c(Cl)cccc2[nH]1)C(=O)c1nc(sc1-c1ccc(C)c(C)c1)N(C)C InChI=1S/C26H28ClN5OS/c1-14-9-10-17(13-16(14)3)23-21(30-26(34-23)31(4)5)25(33)32-12-11-15(2)22(32)24-28-19-8-6-7-18(27)20(19)29-24/h6-10,13,15,22H,11-12H2,1-5H3,(H,28,29)/t15-,22-/m0/s1 MPGPDRPDYBLHHF-NYHFZMIOSA-N 334770 US11040966, Example 4.128::US9732075, Example 4.128::[(2S,3S)-2-(4-Chloro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[2-dimethylamino-5-(3,4-dimethyl-phenyl)-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334770 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334770&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127719 384986930 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657182 C[C@H]1CCN([C@@H]1c1nc2c(Cl)cccc2[nH]1)C(=O)c1nc(sc1-c1ccc(C)c(C)c1)N(C)C InChI=1S/C26H28ClN5OS/c1-14-9-10-17(13-16(14)3)23-21(30-26(34-23)31(4)5)25(33)32-12-11-15(2)22(32)24-28-19-8-6-7-18(27)20(19)29-24/h6-10,13,15,22H,11-12H2,1-5H3,(H,28,29)/t15-,22-/m0/s1 MPGPDRPDYBLHHF-NYHFZMIOSA-N 334770 US11040966, Example 4.128::US9732075, Example 4.128::[(2S,3S)-2-(4-Chloro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[2-dimethylamino-5-(3,4-dimethyl-phenyl)-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 387 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334770 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334770&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127719 384986930 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657183 COc1ccccc1-c1sc(C)nc1C(=O)N1CC[C@H](C)[C@H]1c1nc2c(Cl)cccc2[nH]1 InChI=1S/C24H23ClN4O2S/c1-13-11-12-29(21(13)23-27-17-9-6-8-16(25)19(17)28-23)24(30)20-22(32-14(2)26-20)15-7-4-5-10-18(15)31-3/h4-10,13,21H,11-12H2,1-3H3,(H,27,28)/t13-,21-/m0/s1 XSNXFFHCKFHWDR-ZSEKCTLFSA-N 334771 US11040966, Example 4.129::US9732075, Example 4.129::[(2S,3S)-2-(4-Chloro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(2-methoxy-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 35.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334771 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334771&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128183 384986931 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657184 COc1ccccc1-c1sc(C)nc1C(=O)N1CC[C@H](C)[C@H]1c1nc2c(Cl)cccc2[nH]1 InChI=1S/C24H23ClN4O2S/c1-13-11-12-29(21(13)23-27-17-9-6-8-16(25)19(17)28-23)24(30)20-22(32-14(2)26-20)15-7-4-5-10-18(15)31-3/h4-10,13,21H,11-12H2,1-3H3,(H,27,28)/t13-,21-/m0/s1 XSNXFFHCKFHWDR-ZSEKCTLFSA-N 334771 US11040966, Example 4.129::US9732075, Example 4.129::[(2S,3S)-2-(4-Chloro-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[5-(2-methoxy-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 2750 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334771 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334771&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128183 384986931 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657185 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1ccc(C)cc1-c1ncccn1 InChI=1S/C25H24ClN5O/c1-14-5-6-17(18(11-14)23-27-8-4-9-28-23)25(32)31-10-7-15(2)22(31)24-29-20-12-16(3)19(26)13-21(20)30-24/h4-6,8-9,11-13,15,22H,7,10H2,1-3H3,(H,29,30)/t15-,22-/m0/s1 BHENNGIUMKGHJN-NYHFZMIOSA-N 334773 US11040966, Example 4.130::US9732075, Example 4.130::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4-methyl-2-pyrimidin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 11.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334773 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334773&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127084 384986933 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657186 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1ccc(C)cc1-c1ncccn1 InChI=1S/C25H24ClN5O/c1-14-5-6-17(18(11-14)23-27-8-4-9-28-23)25(32)31-10-7-15(2)22(31)24-29-20-12-16(3)19(26)13-21(20)30-24/h4-6,8-9,11-13,15,22H,7,10H2,1-3H3,(H,29,30)/t15-,22-/m0/s1 BHENNGIUMKGHJN-NYHFZMIOSA-N 334773 US11040966, Example 4.130::US9732075, Example 4.130::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4-methyl-2-pyrimidin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 128 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334773 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334773&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127084 384986933 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657187 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1cc(F)ccc1-c1ncccn1 InChI=1S/C24H21ClFN5O/c1-13-6-9-31(21(13)23-29-19-10-14(2)18(25)12-20(19)30-23)24(32)17-11-15(26)4-5-16(17)22-27-7-3-8-28-22/h3-5,7-8,10-13,21H,6,9H2,1-2H3,(H,29,30)/t13-,21-/m0/s1 RLIPQQUHTGVFBU-ZSEKCTLFSA-N 334774 US11040966, Example 4.131::US9732075, Example 4.131::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-fluoro-2-pyrimidin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 23.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334774 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334774&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127951 384986934 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657188 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1cc(F)ccc1-c1ncccn1 InChI=1S/C24H21ClFN5O/c1-13-6-9-31(21(13)23-29-19-10-14(2)18(25)12-20(19)30-23)24(32)17-11-15(26)4-5-16(17)22-27-7-3-8-28-22/h3-5,7-8,10-13,21H,6,9H2,1-2H3,(H,29,30)/t13-,21-/m0/s1 RLIPQQUHTGVFBU-ZSEKCTLFSA-N 334774 US11040966, Example 4.131::US9732075, Example 4.131::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-fluoro-2-pyrimidin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 501 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334774 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334774&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127951 384986934 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657189 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1c(F)c(C)ccc1-c1ncccn1 InChI=1S/C25H23ClFN5O/c1-13-5-6-16(23-28-8-4-9-29-23)20(21(13)27)25(33)32-10-7-14(2)22(32)24-30-18-11-15(3)17(26)12-19(18)31-24/h4-6,8-9,11-12,14,22H,7,10H2,1-3H3,(H,30,31)/t14-,22-/m0/s1 MOSMTHOFDFQACM-FPTDNZKUSA-N 334775 US11040966, Example 4.132::US9732075, Example 4.132::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-pyrimidin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 87.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334775 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334775&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127881 384986935 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657190 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1c(F)c(C)ccc1-c1ncccn1 InChI=1S/C25H23ClFN5O/c1-13-5-6-16(23-28-8-4-9-29-23)20(21(13)27)25(33)32-10-7-14(2)22(32)24-30-18-11-15(3)17(26)12-19(18)31-24/h4-6,8-9,11-12,14,22H,7,10H2,1-3H3,(H,30,31)/t14-,22-/m0/s1 MOSMTHOFDFQACM-FPTDNZKUSA-N 334775 US11040966, Example 4.132::US9732075, Example 4.132::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-pyrimidin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 1320 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334775 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334775&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127881 384986935 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657191 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1c(F)cccc1-c1ncccn1 InChI=1S/C24H21ClFN5O/c1-13-7-10-31(21(13)23-29-18-11-14(2)16(25)12-19(18)30-23)24(32)20-15(5-3-6-17(20)26)22-27-8-4-9-28-22/h3-6,8-9,11-13,21H,7,10H2,1-2H3,(H,29,30)/t13-,21-/m0/s1 XNMYLCDDDUGQOL-ZSEKCTLFSA-N 334776 US11040966, Example 4.133::US9732075, Example 4.133::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-fluoro-6-pyrimidin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 25.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334776 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334776&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127567 384986936 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657192 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1c(F)cccc1-c1ncccn1 InChI=1S/C24H21ClFN5O/c1-13-7-10-31(21(13)23-29-18-11-14(2)16(25)12-19(18)30-23)24(32)20-15(5-3-6-17(20)26)22-27-8-4-9-28-22/h3-6,8-9,11-13,21H,7,10H2,1-2H3,(H,29,30)/t13-,21-/m0/s1 XNMYLCDDDUGQOL-ZSEKCTLFSA-N 334776 US11040966, Example 4.133::US9732075, Example 4.133::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-fluoro-6-pyrimidin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 359 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334776 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334776&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127567 384986936 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657193 COc1cccc(c1)C#Cc1ccccc1C(=O)N1CC[C@H](C)[C@H]1c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C29H26ClN3O2/c1-18-15-16-33(27(18)28-31-25-14-13-24(30)19(2)26(25)32-28)29(34)23-10-5-4-8-21(23)12-11-20-7-6-9-22(17-20)35-3/h4-10,13-14,17-18,27H,15-16H2,1-3H3,(H,31,32)/t18-,27-/m0/s1 QFDUIRFVMRTEFQ-MYUZEXMDSA-N 334777 US11040966, Example 4.134::US9732075, Example 4.134::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[2-(3-methoxy-phenylethynyl)-phenyl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334777 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334777&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128202 384986937 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657194 COc1cccc(c1)C#Cc1ccccc1C(=O)N1CC[C@H](C)[C@H]1c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C29H26ClN3O2/c1-18-15-16-33(27(18)28-31-25-14-13-24(30)19(2)26(25)32-28)29(34)23-10-5-4-8-21(23)12-11-20-7-6-9-22(17-20)35-3/h4-10,13-14,17-18,27H,15-16H2,1-3H3,(H,31,32)/t18-,27-/m0/s1 QFDUIRFVMRTEFQ-MYUZEXMDSA-N 334777 US11040966, Example 4.134::US9732075, Example 4.134::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[2-(3-methoxy-phenylethynyl)-phenyl]-methanone Orexin receptor type 2 Homo sapiens 86.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334777 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334777&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128202 384986937 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657195 COc1cccc(c1)C#Cc1ccccc1C(=O)N1CC[C@H](C)[C@H]1c1nc2cc(Cl)c(C)cc2[nH]1 InChI=1S/C29H26ClN3O2/c1-18-13-14-33(27(18)28-31-25-15-19(2)24(30)17-26(25)32-28)29(34)23-10-5-4-8-21(23)12-11-20-7-6-9-22(16-20)35-3/h4-10,15-18,27H,13-14H2,1-3H3,(H,31,32)/t18-,27-/m0/s1 QHOOFEYVMVIMAH-MYUZEXMDSA-N 334778 US11040966, Example 4.135::US9732075, Example 4.135::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[2-(3-methoxy-phenylethynyl)-phenyl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334778 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334778&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128007 384986938 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657196 COc1cccc(c1)C#Cc1ccccc1C(=O)N1CC[C@H](C)[C@H]1c1nc2cc(Cl)c(C)cc2[nH]1 InChI=1S/C29H26ClN3O2/c1-18-13-14-33(27(18)28-31-25-15-19(2)24(30)17-26(25)32-28)29(34)23-10-5-4-8-21(23)12-11-20-7-6-9-22(16-20)35-3/h4-10,15-18,27H,13-14H2,1-3H3,(H,31,32)/t18-,27-/m0/s1 QHOOFEYVMVIMAH-MYUZEXMDSA-N 334778 US11040966, Example 4.135::US9732075, Example 4.135::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-[2-(3-methoxy-phenylethynyl)-phenyl]-methanone Orexin receptor type 2 Homo sapiens 203 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334778 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334778&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128007 384986938 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657197 C[C@H]1CCN([C@@H]1c1nc2cc(ccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1ccc(F)cc1 InChI=1S/C24H20F4N4OS/c1-12-9-10-32(20(12)22-30-17-8-5-15(24(26,27)28)11-18(17)31-22)23(33)19-21(34-13(2)29-19)14-3-6-16(25)7-4-14/h3-8,11-12,20H,9-10H2,1-2H3,(H,30,31)/t12-,20-/m0/s1 OTTDILGYLKXDGN-YUNKPMOVSA-N 334779 US11040966, Example 4.136::US9732075, Example 4.136::[5-(4-Fluoro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 14.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334779 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334779&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127637 384986939 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657198 C[C@H]1CCN([C@@H]1c1nc2cc(ccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1ccc(F)cc1 InChI=1S/C24H20F4N4OS/c1-12-9-10-32(20(12)22-30-17-8-5-15(24(26,27)28)11-18(17)31-22)23(33)19-21(34-13(2)29-19)14-3-6-16(25)7-4-14/h3-8,11-12,20H,9-10H2,1-2H3,(H,30,31)/t12-,20-/m0/s1 OTTDILGYLKXDGN-YUNKPMOVSA-N 334779 US11040966, Example 4.136::US9732075, Example 4.136::[5-(4-Fluoro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 4360 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334779 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334779&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127637 384986939 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657199 COc1cccc(c1)-c1sc(C)nc1C(=O)N1CC[C@H](C)[C@H]1c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C25H23F3N4O2S/c1-13-9-10-32(21(13)23-30-18-8-7-16(25(26,27)28)12-19(18)31-23)24(33)20-22(35-14(2)29-20)15-5-4-6-17(11-15)34-3/h4-8,11-13,21H,9-10H2,1-3H3,(H,30,31)/t13-,21-/m0/s1 DTAANAITYXKMLD-ZSEKCTLFSA-N 334780 US11040966, Example 4.137::US9732075, Example 4.137::[5-(3-Methoxy-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334780 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334780&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127481 384986940 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657200 COc1cccc(c1)-c1sc(C)nc1C(=O)N1CC[C@H](C)[C@H]1c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C25H23F3N4O2S/c1-13-9-10-32(21(13)23-30-18-8-7-16(25(26,27)28)12-19(18)31-23)24(33)20-22(35-14(2)29-20)15-5-4-6-17(11-15)34-3/h4-8,11-13,21H,9-10H2,1-3H3,(H,30,31)/t13-,21-/m0/s1 DTAANAITYXKMLD-ZSEKCTLFSA-N 334780 US11040966, Example 4.137::US9732075, Example 4.137::[5-(3-Methoxy-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 3090 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334780 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334780&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127481 384986940 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657201 C[C@H]1CCN([C@@H]1c1nc2cc(ccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1cccc(C)c1 InChI=1S/C25H23F3N4OS/c1-13-5-4-6-16(11-13)22-20(29-15(3)34-22)24(33)32-10-9-14(2)21(32)23-30-18-8-7-17(25(26,27)28)12-19(18)31-23/h4-8,11-12,14,21H,9-10H2,1-3H3,(H,30,31)/t14-,21-/m0/s1 WGXWESGDVQQWBM-QKKBWIMNSA-N 334781 (2-Methyl-5-m-tolyl-thiazol-4-yl)-[(2S,3S)-3-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 4.138::US9732075, Example 4.138 Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334781 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334781&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127695 384986941 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657202 C[C@H]1CCN([C@@H]1c1nc2cc(ccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1cccc(C)c1 InChI=1S/C25H23F3N4OS/c1-13-5-4-6-16(11-13)22-20(29-15(3)34-22)24(33)32-10-9-14(2)21(32)23-30-18-8-7-17(25(26,27)28)12-19(18)31-23/h4-8,11-12,14,21H,9-10H2,1-3H3,(H,30,31)/t14-,21-/m0/s1 WGXWESGDVQQWBM-QKKBWIMNSA-N 334781 (2-Methyl-5-m-tolyl-thiazol-4-yl)-[(2S,3S)-3-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 4.138::US9732075, Example 4.138 Orexin receptor type 2 Homo sapiens 1340 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334781 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334781&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127695 384986941 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657203 C[C@H]1CCN([C@@H]1c1nc2cc(ccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1ccc(Cl)cc1 InChI=1S/C24H20ClF3N4OS/c1-12-9-10-32(20(12)22-30-17-8-5-15(24(26,27)28)11-18(17)31-22)23(33)19-21(34-13(2)29-19)14-3-6-16(25)7-4-14/h3-8,11-12,20H,9-10H2,1-2H3,(H,30,31)/t12-,20-/m0/s1 YDUCAPHZLRJLGY-YUNKPMOVSA-N 334782 US11040966, Example 4.139::US9732075, Example 4.139::[5-(4-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334782 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334782&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127172 384986942 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657204 C[C@H]1CCN([C@@H]1c1nc2cc(ccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1ccc(Cl)cc1 InChI=1S/C24H20ClF3N4OS/c1-12-9-10-32(20(12)22-30-17-8-5-15(24(26,27)28)11-18(17)31-22)23(33)19-21(34-13(2)29-19)14-3-6-16(25)7-4-14/h3-8,11-12,20H,9-10H2,1-2H3,(H,30,31)/t12-,20-/m0/s1 YDUCAPHZLRJLGY-YUNKPMOVSA-N 334782 US11040966, Example 4.139::US9732075, Example 4.139::[5-(4-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 2260 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334782 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334782&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127172 384986942 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657205 C[C@H]1CCN([C@@H]1c1nc2cc(ccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1ccc(C)cc1 InChI=1S/C25H23F3N4OS/c1-13-4-6-16(7-5-13)22-20(29-15(3)34-22)24(33)32-11-10-14(2)21(32)23-30-18-9-8-17(25(26,27)28)12-19(18)31-23/h4-9,12,14,21H,10-11H2,1-3H3,(H,30,31)/t14-,21-/m0/s1 BFKYTHINBUMHDW-QKKBWIMNSA-N 334783 (2-Methyl-5-p-tolyl-thiazol-4-yl)-[(2S,3S)-3-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 4.140::US9732075, Example 4.140 Orexin/Hypocretin receptor type 1 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334783 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334783&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128181 384986943 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657206 C[C@H]1CCN([C@@H]1c1nc2cc(ccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1ccc(C)cc1 InChI=1S/C25H23F3N4OS/c1-13-4-6-16(7-5-13)22-20(29-15(3)34-22)24(33)32-11-10-14(2)21(32)23-30-18-9-8-17(25(26,27)28)12-19(18)31-23/h4-9,12,14,21H,10-11H2,1-3H3,(H,30,31)/t14-,21-/m0/s1 BFKYTHINBUMHDW-QKKBWIMNSA-N 334783 (2-Methyl-5-p-tolyl-thiazol-4-yl)-[(2S,3S)-3-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 4.140::US9732075, Example 4.140 Orexin receptor type 2 Homo sapiens 2170 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334783 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334783&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128181 384986943 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657207 COc1ccc(cc1)-c1sc(C)nc1C(=O)N1CC[C@H](C)[C@H]1c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C25H23F3N4O2S/c1-13-10-11-32(21(13)23-30-18-9-6-16(25(26,27)28)12-19(18)31-23)24(33)20-22(35-14(2)29-20)15-4-7-17(34-3)8-5-15/h4-9,12-13,21H,10-11H2,1-3H3,(H,30,31)/t13-,21-/m0/s1 KUAHZOFZPKHZLU-ZSEKCTLFSA-N 334784 US11040966, Example 4.141::US9732075, Example 4.141::[5-(4-Methoxy-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334784 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334784&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128024 384986944 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657208 COc1ccc(cc1)-c1sc(C)nc1C(=O)N1CC[C@H](C)[C@H]1c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C25H23F3N4O2S/c1-13-10-11-32(21(13)23-30-18-9-6-16(25(26,27)28)12-19(18)31-23)24(33)20-22(35-14(2)29-20)15-4-7-17(34-3)8-5-15/h4-9,12-13,21H,10-11H2,1-3H3,(H,30,31)/t13-,21-/m0/s1 KUAHZOFZPKHZLU-ZSEKCTLFSA-N 334784 US11040966, Example 4.141::US9732075, Example 4.141::[5-(4-Methoxy-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 2760 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334784 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334784&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128024 384986944 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657209 C[C@H]1CCN([C@@H]1c1nc2cc(ccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1ccc(Br)cc1 InChI=1S/C24H20BrF3N4OS/c1-12-9-10-32(20(12)22-30-17-8-5-15(24(26,27)28)11-18(17)31-22)23(33)19-21(34-13(2)29-19)14-3-6-16(25)7-4-14/h3-8,11-12,20H,9-10H2,1-2H3,(H,30,31)/t12-,20-/m0/s1 JAQGOGOCUAMXQY-YUNKPMOVSA-N 334785 US11040966, Example 4.142::US9732075, Example 4.142::[5-(4-Bromo-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334785 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334785&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127064 384986945 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657210 C[C@H]1CCN([C@@H]1c1nc2cc(ccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1ccc(Br)cc1 InChI=1S/C24H20BrF3N4OS/c1-12-9-10-32(20(12)22-30-17-8-5-15(24(26,27)28)11-18(17)31-22)23(33)19-21(34-13(2)29-19)14-3-6-16(25)7-4-14/h3-8,11-12,20H,9-10H2,1-2H3,(H,30,31)/t12-,20-/m0/s1 JAQGOGOCUAMXQY-YUNKPMOVSA-N 334785 US11040966, Example 4.142::US9732075, Example 4.142::[5-(4-Bromo-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 2160 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334785 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334785&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127064 384986945 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657211 C[C@H]1CCN([C@@H]1c1nc2cc(ccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1ccc(F)c(F)c1 InChI=1S/C24H19F5N4OS/c1-11-7-8-33(20(11)22-31-17-6-4-14(24(27,28)29)10-18(17)32-22)23(34)19-21(35-12(2)30-19)13-3-5-15(25)16(26)9-13/h3-6,9-11,20H,7-8H2,1-2H3,(H,31,32)/t11-,20-/m0/s1 HMBPQFHIKQLMRR-YBTHPKLGSA-N 334786 US11040966, Example 4.143::US9732075, Example 4.143::[5-(3,4-Difluoro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 24.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334786 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334786&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128005 384986946 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657212 C[C@H]1CCN([C@@H]1c1nc2cc(ccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1ccc(F)c(F)c1 InChI=1S/C24H19F5N4OS/c1-11-7-8-33(20(11)22-31-17-6-4-14(24(27,28)29)10-18(17)32-22)23(34)19-21(35-12(2)30-19)13-3-5-15(25)16(26)9-13/h3-6,9-11,20H,7-8H2,1-2H3,(H,31,32)/t11-,20-/m0/s1 HMBPQFHIKQLMRR-YBTHPKLGSA-N 334786 US11040966, Example 4.143::US9732075, Example 4.143::[5-(3,4-Difluoro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 3680 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334786 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334786&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128005 384986946 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657213 C[C@H]1CCN([C@@H]1c1nc2cc(ccc2[nH]1)C(F)(F)F)C(=O)c1ccsc1-c1ccc(C)c(C)c1 InChI=1S/C26H24F3N3OS/c1-14-4-5-17(12-16(14)3)23-19(9-11-34-23)25(33)32-10-8-15(2)22(32)24-30-20-7-6-18(26(27,28)29)13-21(20)31-24/h4-7,9,11-13,15,22H,8,10H2,1-3H3,(H,30,31)/t15-,22-/m0/s1 DOWJNTDCOSRZIF-NYHFZMIOSA-N 334787 US11040966, Example 4.144::US9732075, Example 4.144::[2-(3,4-Dimethyl-phenyl)-thiophen-3-yl]-[(2S,3S)-3-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334787 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334787&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127077 384986947 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657214 C[C@H]1CCN([C@@H]1c1nc2cc(ccc2[nH]1)C(F)(F)F)C(=O)c1ccsc1-c1ccc(C)c(C)c1 InChI=1S/C26H24F3N3OS/c1-14-4-5-17(12-16(14)3)23-19(9-11-34-23)25(33)32-10-8-15(2)22(32)24-30-20-7-6-18(26(27,28)29)13-21(20)31-24/h4-7,9,11-13,15,22H,8,10H2,1-3H3,(H,30,31)/t15-,22-/m0/s1 DOWJNTDCOSRZIF-NYHFZMIOSA-N 334787 US11040966, Example 4.144::US9732075, Example 4.144::[2-(3,4-Dimethyl-phenyl)-thiophen-3-yl]-[(2S,3S)-3-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 463 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334787 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334787&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127077 384986947 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657215 C[C@H]1CCN([C@@H]1c1nc2cc(ccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1ccc(C)c(C)c1 InChI=1S/C26H25F3N4OS/c1-13-5-6-17(11-15(13)3)23-21(30-16(4)35-23)25(34)33-10-9-14(2)22(33)24-31-19-8-7-18(26(27,28)29)12-20(19)32-24/h5-8,11-12,14,22H,9-10H2,1-4H3,(H,31,32)/t14-,22-/m0/s1 HBSKMUVHZAPPQG-FPTDNZKUSA-N 334788 US11040966, Example 4.145::US9732075, Example 4.145::[5-(3,4-Dimethyl-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334788 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334788&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127047 384986948 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657216 C[C@H]1CCN([C@@H]1c1nc2cc(ccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1ccc(C)c(C)c1 InChI=1S/C26H25F3N4OS/c1-13-5-6-17(11-15(13)3)23-21(30-16(4)35-23)25(34)33-10-9-14(2)22(33)24-31-19-8-7-18(26(27,28)29)12-20(19)32-24/h5-8,11-12,14,22H,9-10H2,1-4H3,(H,31,32)/t14-,22-/m0/s1 HBSKMUVHZAPPQG-FPTDNZKUSA-N 334788 US11040966, Example 4.145::US9732075, Example 4.145::[5-(3,4-Dimethyl-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 635 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334788 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334788&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127047 384986948 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657217 C[C@H]1CCN([C@@H]1c1nc2cc(ccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1ccccc1Cl InChI=1S/C24H20ClF3N4OS/c1-12-9-10-32(20(12)22-30-17-8-7-14(24(26,27)28)11-18(17)31-22)23(33)19-21(34-13(2)29-19)15-5-3-4-6-16(15)25/h3-8,11-12,20H,9-10H2,1-2H3,(H,30,31)/t12-,20-/m0/s1 PVNHNYYWPXLFBB-YUNKPMOVSA-N 334789 US11040966, Example 4.146::US9732075, Example 4.146::[5-(2-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334789 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334789&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127623 384986949 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657218 C[C@H]1CCN([C@@H]1c1nc2cc(ccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1ccccc1Cl InChI=1S/C24H20ClF3N4OS/c1-12-9-10-32(20(12)22-30-17-8-7-14(24(26,27)28)11-18(17)31-22)23(33)19-21(34-13(2)29-19)15-5-3-4-6-16(15)25/h3-8,11-12,20H,9-10H2,1-2H3,(H,30,31)/t12-,20-/m0/s1 PVNHNYYWPXLFBB-YUNKPMOVSA-N 334789 US11040966, Example 4.146::US9732075, Example 4.146::[5-(2-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 2110 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334789 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334789&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127623 384986949 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657219 COc1ccccc1-c1sc(C)nc1C(=O)N1CC[C@H](C)[C@H]1c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C25H23F3N4O2S/c1-13-10-11-32(21(13)23-30-17-9-8-15(25(26,27)28)12-18(17)31-23)24(33)20-22(35-14(2)29-20)16-6-4-5-7-19(16)34-3/h4-9,12-13,21H,10-11H2,1-3H3,(H,30,31)/t13-,21-/m0/s1 HSYQQLUUOHCUPB-ZSEKCTLFSA-N 334790 US11040966, Example 4.147::US9732075, Example 4.147::[5-(2-Methoxy-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334790 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334790&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127039 384986950 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657220 COc1ccccc1-c1sc(C)nc1C(=O)N1CC[C@H](C)[C@H]1c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C25H23F3N4O2S/c1-13-10-11-32(21(13)23-30-17-9-8-15(25(26,27)28)12-18(17)31-23)24(33)20-22(35-14(2)29-20)16-6-4-5-7-19(16)34-3/h4-9,12-13,21H,10-11H2,1-3H3,(H,30,31)/t13-,21-/m0/s1 HSYQQLUUOHCUPB-ZSEKCTLFSA-N 334790 US11040966, Example 4.147::US9732075, Example 4.147::[5-(2-Methoxy-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 9650 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334790 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334790&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127039 384986950 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657221 C[C@H]1CCN([C@@H]1c1nc2cc(ccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1cc(F)cc(F)c1 InChI=1S/C24H19F5N4OS/c1-11-5-6-33(20(11)22-31-17-4-3-14(24(27,28)29)9-18(17)32-22)23(34)19-21(35-12(2)30-19)13-7-15(25)10-16(26)8-13/h3-4,7-11,20H,5-6H2,1-2H3,(H,31,32)/t11-,20-/m0/s1 HFYNJWAYQAPCPL-YBTHPKLGSA-N 334791 US11040966, Example 4.148::US9732075, Example 4.148::[5-(3,5-Difluoro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334791 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334791&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127284 384986951 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657222 C[C@H]1CCN([C@@H]1c1nc2cc(ccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1cc(F)cc(F)c1 InChI=1S/C24H19F5N4OS/c1-11-5-6-33(20(11)22-31-17-4-3-14(24(27,28)29)9-18(17)32-22)23(34)19-21(35-12(2)30-19)13-7-15(25)10-16(26)8-13/h3-4,7-11,20H,5-6H2,1-2H3,(H,31,32)/t11-,20-/m0/s1 HFYNJWAYQAPCPL-YBTHPKLGSA-N 334791 US11040966, Example 4.148::US9732075, Example 4.148::[5-(3,5-Difluoro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 3180 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334791 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334791&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127284 384986951 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657223 C[C@H]1CCN([C@@H]1c1nc2c(cccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1ccc(F)cc1 InChI=1S/C24H20F4N4OS/c1-12-10-11-32(20(12)22-30-17-5-3-4-16(18(17)31-22)24(26,27)28)23(33)19-21(34-13(2)29-19)14-6-8-15(25)9-7-14/h3-9,12,20H,10-11H2,1-2H3,(H,30,31)/t12-,20-/m0/s1 FCDLZXAJCXLTRL-YUNKPMOVSA-N 334792 US11040966, Example 4.149::US9732075, Example 4.149::[5-(4-Fluoro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 14.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334792 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334792&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127095 384986952 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657224 C[C@H]1CCN([C@@H]1c1nc2c(cccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1ccc(F)cc1 InChI=1S/C24H20F4N4OS/c1-12-10-11-32(20(12)22-30-17-5-3-4-16(18(17)31-22)24(26,27)28)23(33)19-21(34-13(2)29-19)14-6-8-15(25)9-7-14/h3-9,12,20H,10-11H2,1-2H3,(H,30,31)/t12-,20-/m0/s1 FCDLZXAJCXLTRL-YUNKPMOVSA-N 334792 US11040966, Example 4.149::US9732075, Example 4.149::[5-(4-Fluoro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 752 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334792 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334792&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127095 384986952 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657225 C[C@H]1CCN([C@@H]1c1nc2c(cccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1ccc(Cl)cc1 InChI=1S/C24H20ClF3N4OS/c1-12-10-11-32(20(12)22-30-17-5-3-4-16(18(17)31-22)24(26,27)28)23(33)19-21(34-13(2)29-19)14-6-8-15(25)9-7-14/h3-9,12,20H,10-11H2,1-2H3,(H,30,31)/t12-,20-/m0/s1 MEDCREROABOMSW-YUNKPMOVSA-N 334793 US11040966, Example 4.150::US9732075, Example 4.150::[5-(4-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334793 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334793&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127645 384986953 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657226 C[C@H]1CCN([C@@H]1c1nc2c(cccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1ccc(Cl)cc1 InChI=1S/C24H20ClF3N4OS/c1-12-10-11-32(20(12)22-30-17-5-3-4-16(18(17)31-22)24(26,27)28)23(33)19-21(34-13(2)29-19)14-6-8-15(25)9-7-14/h3-9,12,20H,10-11H2,1-2H3,(H,30,31)/t12-,20-/m0/s1 MEDCREROABOMSW-YUNKPMOVSA-N 334793 US11040966, Example 4.150::US9732075, Example 4.150::[5-(4-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 180 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334793 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334793&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127645 384986953 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657227 C[C@H]1CCN([C@@H]1c1nc2c(cccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1ccc(Br)cc1 InChI=1S/C24H20BrF3N4OS/c1-12-10-11-32(20(12)22-30-17-5-3-4-16(18(17)31-22)24(26,27)28)23(33)19-21(34-13(2)29-19)14-6-8-15(25)9-7-14/h3-9,12,20H,10-11H2,1-2H3,(H,30,31)/t12-,20-/m0/s1 XQPMISWBRYMXLD-YUNKPMOVSA-N 334794 US11040966, Example 4.151::US9732075, Example 4.151::[5-(4-Bromo-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334794 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334794&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127167 384986954 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657228 C[C@H]1CCN([C@@H]1c1nc2c(cccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1ccc(Br)cc1 InChI=1S/C24H20BrF3N4OS/c1-12-10-11-32(20(12)22-30-17-5-3-4-16(18(17)31-22)24(26,27)28)23(33)19-21(34-13(2)29-19)14-6-8-15(25)9-7-14/h3-9,12,20H,10-11H2,1-2H3,(H,30,31)/t12-,20-/m0/s1 XQPMISWBRYMXLD-YUNKPMOVSA-N 334794 US11040966, Example 4.151::US9732075, Example 4.151::[5-(4-Bromo-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 185 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334794 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334794&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127167 384986954 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657229 C[C@H]1CCN([C@@H]1c1nc2c(cccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1ccc(C)c(C)c1 InChI=1S/C26H25F3N4OS/c1-13-8-9-17(12-15(13)3)23-21(30-16(4)35-23)25(34)33-11-10-14(2)22(33)24-31-19-7-5-6-18(20(19)32-24)26(27,28)29/h5-9,12,14,22H,10-11H2,1-4H3,(H,31,32)/t14-,22-/m0/s1 OOZKKUXDWAVKBD-FPTDNZKUSA-N 334795 US11040966, Example 4.152::US9732075, Example 4.152::[5-(3,4-Dimethyl-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334795 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334795&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127355 384986955 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657230 C[C@H]1CCN([C@@H]1c1nc2c(cccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1ccc(C)c(C)c1 InChI=1S/C26H25F3N4OS/c1-13-8-9-17(12-15(13)3)23-21(30-16(4)35-23)25(34)33-11-10-14(2)22(33)24-31-19-7-5-6-18(20(19)32-24)26(27,28)29/h5-9,12,14,22H,10-11H2,1-4H3,(H,31,32)/t14-,22-/m0/s1 OOZKKUXDWAVKBD-FPTDNZKUSA-N 334795 US11040966, Example 4.152::US9732075, Example 4.152::[5-(3,4-Dimethyl-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 40.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334795 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334795&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127355 384986955 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657231 C[C@H]1CCN([C@@H]1c1nc2c(cccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1ccc(C)cc1 InChI=1S/C25H23F3N4OS/c1-13-7-9-16(10-8-13)22-20(29-15(3)34-22)24(33)32-12-11-14(2)21(32)23-30-18-6-4-5-17(19(18)31-23)25(26,27)28/h4-10,14,21H,11-12H2,1-3H3,(H,30,31)/t14-,21-/m0/s1 DEVWYCIKDYFHKV-QKKBWIMNSA-N 334796 (2-Methyl-5-p-tolyl-thiazol-4-yl)-[(2S,3S)-3-methyl-2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 4.153::US9732075, Example 4.153 Orexin/Hypocretin receptor type 1 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334796 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334796&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127006 384986956 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657232 C[C@H]1CCN([C@@H]1c1nc2c(cccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1ccc(C)cc1 InChI=1S/C25H23F3N4OS/c1-13-7-9-16(10-8-13)22-20(29-15(3)34-22)24(33)32-12-11-14(2)21(32)23-30-18-6-4-5-17(19(18)31-23)25(26,27)28/h4-10,14,21H,11-12H2,1-3H3,(H,30,31)/t14-,21-/m0/s1 DEVWYCIKDYFHKV-QKKBWIMNSA-N 334796 (2-Methyl-5-p-tolyl-thiazol-4-yl)-[(2S,3S)-3-methyl-2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 4.153::US9732075, Example 4.153 Orexin receptor type 2 Homo sapiens 80.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334796 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334796&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127006 384986956 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657233 C[C@H]1CCN([C@@H]1c1nc2c(cccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1ccc(F)c(F)c1 InChI=1S/C24H19F5N4OS/c1-11-8-9-33(20(11)22-31-17-5-3-4-14(18(17)32-22)24(27,28)29)23(34)19-21(35-12(2)30-19)13-6-7-15(25)16(26)10-13/h3-7,10-11,20H,8-9H2,1-2H3,(H,31,32)/t11-,20-/m0/s1 OUBIBRIODULKRI-YBTHPKLGSA-N 334797 US11040966, Example 4.154::US9732075, Example 4.154::[5-(3,4-Difluoro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 26.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334797 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334797&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127298 384986957 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657234 C[C@H]1CCN([C@@H]1c1nc2c(cccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1ccc(F)c(F)c1 InChI=1S/C24H19F5N4OS/c1-11-8-9-33(20(11)22-31-17-5-3-4-14(18(17)32-22)24(27,28)29)23(34)19-21(35-12(2)30-19)13-6-7-15(25)16(26)10-13/h3-7,10-11,20H,8-9H2,1-2H3,(H,31,32)/t11-,20-/m0/s1 OUBIBRIODULKRI-YBTHPKLGSA-N 334797 US11040966, Example 4.154::US9732075, Example 4.154::[5-(3,4-Difluoro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 4800 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334797 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334797&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127298 384986957 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657235 C[C@H]1CCN([C@@H]1c1nc2c(cccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1ccccc1Cl InChI=1S/C24H20ClF3N4OS/c1-12-10-11-32(20(12)22-30-17-9-5-7-15(18(17)31-22)24(26,27)28)23(33)19-21(34-13(2)29-19)14-6-3-4-8-16(14)25/h3-9,12,20H,10-11H2,1-2H3,(H,30,31)/t12-,20-/m0/s1 SKBMERBPCTXBHC-YUNKPMOVSA-N 334798 US11040966, Example 4.155::US9732075, Example 4.155::[5-(2-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 42.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334798 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334798&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128228 384986958 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657236 C[C@H]1CCN([C@@H]1c1nc2c(cccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1ccccc1Cl InChI=1S/C24H20ClF3N4OS/c1-12-10-11-32(20(12)22-30-17-9-5-7-15(18(17)31-22)24(26,27)28)23(33)19-21(34-13(2)29-19)14-6-3-4-8-16(14)25/h3-9,12,20H,10-11H2,1-2H3,(H,30,31)/t12-,20-/m0/s1 SKBMERBPCTXBHC-YUNKPMOVSA-N 334798 US11040966, Example 4.155::US9732075, Example 4.155::[5-(2-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 891 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334798 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334798&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128228 384986958 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657237 COc1ccccc1-c1sc(C)nc1C(=O)N1CC[C@H](C)[C@H]1c1nc2c(cccc2[nH]1)C(F)(F)F InChI=1S/C25H23F3N4O2S/c1-13-11-12-32(21(13)23-30-17-9-6-8-16(19(17)31-23)25(26,27)28)24(33)20-22(35-14(2)29-20)15-7-4-5-10-18(15)34-3/h4-10,13,21H,11-12H2,1-3H3,(H,30,31)/t13-,21-/m0/s1 YYQXNSBUFFGYSX-ZSEKCTLFSA-N 334799 US11040966, Example 4.156::US9732075, Example 4.156::[5-(2-Methoxy-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 14.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334799 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334799&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127532 384986959 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657238 COc1ccccc1-c1sc(C)nc1C(=O)N1CC[C@H](C)[C@H]1c1nc2c(cccc2[nH]1)C(F)(F)F InChI=1S/C25H23F3N4O2S/c1-13-11-12-32(21(13)23-30-17-9-6-8-16(19(17)31-23)25(26,27)28)24(33)20-22(35-14(2)29-20)15-7-4-5-10-18(15)34-3/h4-10,13,21H,11-12H2,1-3H3,(H,30,31)/t13-,21-/m0/s1 YYQXNSBUFFGYSX-ZSEKCTLFSA-N 334799 US11040966, Example 4.156::US9732075, Example 4.156::[5-(2-Methoxy-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 489 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334799 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334799&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127532 384986959 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657239 C[C@H]1CCN([C@@H]1c1nc2c(cccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1cc(F)cc(F)c1 InChI=1S/C24H19F5N4OS/c1-11-6-7-33(20(11)22-31-17-5-3-4-16(18(17)32-22)24(27,28)29)23(34)19-21(35-12(2)30-19)13-8-14(25)10-15(26)9-13/h3-5,8-11,20H,6-7H2,1-2H3,(H,31,32)/t11-,20-/m0/s1 YZBWYBNNDWXNHW-YBTHPKLGSA-N 334800 US11040966, Example 4.157::US9732075, Example 4.157::[5-(3,5-Difluoro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334800 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334800&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127677 384986960 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657240 C[C@H]1CCN([C@@H]1c1nc2c(cccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1cc(F)cc(F)c1 InChI=1S/C24H19F5N4OS/c1-11-6-7-33(20(11)22-31-17-5-3-4-16(18(17)32-22)24(27,28)29)23(34)19-21(35-12(2)30-19)13-8-14(25)10-15(26)9-13/h3-5,8-11,20H,6-7H2,1-2H3,(H,31,32)/t11-,20-/m0/s1 YZBWYBNNDWXNHW-YBTHPKLGSA-N 334800 US11040966, Example 4.157::US9732075, Example 4.157::[5-(3,5-Difluoro-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 1710 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334800 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334800&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127677 384986960 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657241 C[C@H]1CCN([C@@H]1c1nc2c(cccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1cccc(C)c1 InChI=1S/C25H23F3N4OS/c1-13-6-4-7-16(12-13)22-20(29-15(3)34-22)24(33)32-11-10-14(2)21(32)23-30-18-9-5-8-17(19(18)31-23)25(26,27)28/h4-9,12,14,21H,10-11H2,1-3H3,(H,30,31)/t14-,21-/m0/s1 MBMGUGOODPDLRY-QKKBWIMNSA-N 334801 (2-Methyl-5-m-tolyl-thiazol-4-yl)-[(2S,3S)-3-methyl-2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 4.158::US9732075, Example 4.158 Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334801 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334801&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127791 384986961 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657242 C[C@H]1CCN([C@@H]1c1nc2c(cccc2[nH]1)C(F)(F)F)C(=O)c1nc(C)sc1-c1cccc(C)c1 InChI=1S/C25H23F3N4OS/c1-13-6-4-7-16(12-13)22-20(29-15(3)34-22)24(33)32-11-10-14(2)21(32)23-30-18-9-5-8-17(19(18)31-23)25(26,27)28/h4-9,12,14,21H,10-11H2,1-3H3,(H,30,31)/t14-,21-/m0/s1 MBMGUGOODPDLRY-QKKBWIMNSA-N 334801 (2-Methyl-5-m-tolyl-thiazol-4-yl)-[(2S,3S)-3-methyl-2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 4.158::US9732075, Example 4.158 Orexin receptor type 2 Homo sapiens 308 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334801 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334801&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127791 384986961 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657243 COc1ccc(cc1)-c1sc(C)nc1C(=O)N1CC[C@H](C)[C@H]1c1nc2c(cccc2[nH]1)C(F)(F)F InChI=1S/C25H23F3N4O2S/c1-13-11-12-32(21(13)23-30-18-6-4-5-17(19(18)31-23)25(26,27)28)24(33)20-22(35-14(2)29-20)15-7-9-16(34-3)10-8-15/h4-10,13,21H,11-12H2,1-3H3,(H,30,31)/t13-,21-/m0/s1 OLGPONWRXCYWQO-ZSEKCTLFSA-N 334802 US11040966, Example 4.159::US9732075, Example 4.159::[5-(4-Methoxy-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334802 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334802&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127541 384986962 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657244 COc1ccc(cc1)-c1sc(C)nc1C(=O)N1CC[C@H](C)[C@H]1c1nc2c(cccc2[nH]1)C(F)(F)F InChI=1S/C25H23F3N4O2S/c1-13-11-12-32(21(13)23-30-18-6-4-5-17(19(18)31-23)25(26,27)28)24(33)20-22(35-14(2)29-20)15-7-9-16(34-3)10-8-15/h4-10,13,21H,11-12H2,1-3H3,(H,30,31)/t13-,21-/m0/s1 OLGPONWRXCYWQO-ZSEKCTLFSA-N 334802 US11040966, Example 4.159::US9732075, Example 4.159::[5-(4-Methoxy-phenyl)-2-methyl-thiazol-4-yl]-[(2S,3S)-3-methyl-2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 215 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334802 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334802&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127541 384986962 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657245 C[C@H]1CCN([C@@H]1c1nc2c(cccc2[nH]1)C(F)(F)F)C(=O)c1ccsc1-c1ccc(C)c(C)c1 InChI=1S/C26H24F3N3OS/c1-14-7-8-17(13-16(14)3)23-18(10-12-34-23)25(33)32-11-9-15(2)22(32)24-30-20-6-4-5-19(21(20)31-24)26(27,28)29/h4-8,10,12-13,15,22H,9,11H2,1-3H3,(H,30,31)/t15-,22-/m0/s1 ZESPBMRBBZNENN-NYHFZMIOSA-N 334803 US11040966, Example 4.160::US9732075, Example 4.160::[2-(3,4-Dimethyl-phenyl)-thiophen-3-yl]-[(2S,3S)-3-methyl-2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334803 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334803&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127536 384986963 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657246 C[C@H]1CCN([C@@H]1c1nc2c(cccc2[nH]1)C(F)(F)F)C(=O)c1ccsc1-c1ccc(C)c(C)c1 InChI=1S/C26H24F3N3OS/c1-14-7-8-17(13-16(14)3)23-18(10-12-34-23)25(33)32-11-9-15(2)22(32)24-30-20-6-4-5-19(21(20)31-24)26(27,28)29/h4-8,10,12-13,15,22H,9,11H2,1-3H3,(H,30,31)/t15-,22-/m0/s1 ZESPBMRBBZNENN-NYHFZMIOSA-N 334803 US11040966, Example 4.160::US9732075, Example 4.160::[2-(3,4-Dimethyl-phenyl)-thiophen-3-yl]-[(2S,3S)-3-methyl-2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 27.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334803 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334803&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127536 384986963 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657247 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1cc(C)ccc1-c1ccccn1 InChI=1S/C26H25ClN4O/c1-15-7-8-18(21-6-4-5-12-28-21)19(14-15)26(32)31-13-11-16(2)24(31)25-29-22-10-9-20(27)17(3)23(22)30-25/h4-10,12,14,16,24H,11,13H2,1-3H3,(H,29,30)/t16-,24-/m0/s1 PKAZGJSTOIIUAN-FYSMJZIKSA-N 334804 US11040966, Example 4.161::US9732075, Example 4.161::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyridin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334804 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334804&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128243 384986964 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657248 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1cc(C)ccc1-c1ccccn1 InChI=1S/C26H25ClN4O/c1-15-7-8-18(21-6-4-5-12-28-21)19(14-15)26(32)31-13-11-16(2)24(31)25-29-22-10-9-20(27)17(3)23(22)30-25/h4-10,12,14,16,24H,11,13H2,1-3H3,(H,29,30)/t16-,24-/m0/s1 PKAZGJSTOIIUAN-FYSMJZIKSA-N 334804 US11040966, Example 4.161::US9732075, Example 4.161::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyridin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 191 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334804 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334804&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128243 384986964 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657249 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1cc(Cl)ccc1-c1ccccc1 InChI=1S/C26H23Cl2N3O/c1-15-12-13-31(24(15)25-29-22-11-10-21(28)16(2)23(22)30-25)26(32)20-14-18(27)8-9-19(20)17-6-4-3-5-7-17/h3-11,14-15,24H,12-13H2,1-2H3,(H,29,30)/t15-,24-/m0/s1 FIGBBBAJTUKBON-OWJWWREXSA-N 334805 (4-Chloro-biphenyl-2-yl)-[(2S,3S)-2-(5-chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone::US11040966, Example 4.162::US9732075, Example 4.162 Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334805 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334805&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127615 384986965 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657250 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1cc(Cl)ccc1-c1ccccc1 InChI=1S/C26H23Cl2N3O/c1-15-12-13-31(24(15)25-29-22-11-10-21(28)16(2)23(22)30-25)26(32)20-14-18(27)8-9-19(20)17-6-4-3-5-7-17/h3-11,14-15,24H,12-13H2,1-2H3,(H,29,30)/t15-,24-/m0/s1 FIGBBBAJTUKBON-OWJWWREXSA-N 334805 (4-Chloro-biphenyl-2-yl)-[(2S,3S)-2-(5-chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-methanone::US11040966, Example 4.162::US9732075, Example 4.162 Orexin receptor type 2 Homo sapiens 299 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334805 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334805&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127615 384986965 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657251 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1cc(C)ccc1-c1cccnc1 InChI=1S/C26H25ClN4O/c1-15-6-7-19(18-5-4-11-28-14-18)20(13-15)26(32)31-12-10-16(2)24(31)25-29-22-9-8-21(27)17(3)23(22)30-25/h4-9,11,13-14,16,24H,10,12H2,1-3H3,(H,29,30)/t16-,24-/m0/s1 WFHRANYURCQTIW-FYSMJZIKSA-N 334806 US11040966, Example 4.163::US9732075, Example 4.163::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyridin-3-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 20.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334806 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334806&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128322 384986966 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657252 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1cc(C)ccc1-c1cccnc1 InChI=1S/C26H25ClN4O/c1-15-6-7-19(18-5-4-11-28-14-18)20(13-15)26(32)31-12-10-16(2)24(31)25-29-22-9-8-21(27)17(3)23(22)30-25/h4-9,11,13-14,16,24H,10,12H2,1-3H3,(H,29,30)/t16-,24-/m0/s1 WFHRANYURCQTIW-FYSMJZIKSA-N 334806 US11040966, Example 4.163::US9732075, Example 4.163::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyridin-3-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 4400 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334806 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334806&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128322 384986966 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657253 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1cc(F)ccc1-c1ccccc1 InChI=1S/C26H23ClFN3O/c1-15-12-13-31(24(15)25-29-22-11-10-21(27)16(2)23(22)30-25)26(32)20-14-18(28)8-9-19(20)17-6-4-3-5-7-17/h3-11,14-15,24H,12-13H2,1-2H3,(H,29,30)/t15-,24-/m0/s1 XABHSXXEMQYSHJ-OWJWWREXSA-N 334807 US11040966, Example 4.164::US9732075, Example 4.164::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4-fluoro-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334807 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334807&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127702 384986967 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657254 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1cc(F)ccc1-c1ccccc1 InChI=1S/C26H23ClFN3O/c1-15-12-13-31(24(15)25-29-22-11-10-21(27)16(2)23(22)30-25)26(32)20-14-18(28)8-9-19(20)17-6-4-3-5-7-17/h3-11,14-15,24H,12-13H2,1-2H3,(H,29,30)/t15-,24-/m0/s1 XABHSXXEMQYSHJ-OWJWWREXSA-N 334807 US11040966, Example 4.164::US9732075, Example 4.164::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4-fluoro-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 725 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334807 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334807&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127702 384986967 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657255 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1cc(F)ccc1-c1ccccn1 InChI=1S/C25H22ClFN4O/c1-14-10-12-31(23(14)24-29-21-9-8-19(26)15(2)22(21)30-24)25(32)18-13-16(27)6-7-17(18)20-5-3-4-11-28-20/h3-9,11,13-14,23H,10,12H2,1-2H3,(H,29,30)/t14-,23-/m0/s1 WOFLTXMTRFTNAK-PSLXWICFSA-N 334808 US11040966, Example 4.165::US9732075, Example 4.165::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-fluoro-2-pyridin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 20.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334808 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334808&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127258 384986968 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657256 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1cc(F)ccc1-c1ccccn1 InChI=1S/C25H22ClFN4O/c1-14-10-12-31(23(14)24-29-21-9-8-19(26)15(2)22(21)30-24)25(32)18-13-16(27)6-7-17(18)20-5-3-4-11-28-20/h3-9,11,13-14,23H,10,12H2,1-2H3,(H,29,30)/t14-,23-/m0/s1 WOFLTXMTRFTNAK-PSLXWICFSA-N 334808 US11040966, Example 4.165::US9732075, Example 4.165::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-fluoro-2-pyridin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 968 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334808 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334808&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127258 384986968 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657257 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1cc(ccc1-c1ccccc1)C#N InChI=1S/C27H23ClN4O/c1-16-12-13-32(25(16)26-30-23-11-10-22(28)17(2)24(23)31-26)27(33)21-14-18(15-29)8-9-20(21)19-6-4-3-5-7-19/h3-11,14,16,25H,12-13H2,1-2H3,(H,30,31)/t16-,25-/m0/s1 DPVNIWJITJOQSD-LMKMVOKYSA-N 334809 2-[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidine-1-carbonyl]-biphenyl-4-carbonitrile::US11040966, Example 4.166::US9732075, Example 4.166 Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334809 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334809&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127085 384986969 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657258 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1cc(ccc1-c1ccccc1)C#N InChI=1S/C27H23ClN4O/c1-16-12-13-32(25(16)26-30-23-11-10-22(28)17(2)24(23)31-26)27(33)21-14-18(15-29)8-9-20(21)19-6-4-3-5-7-19/h3-11,14,16,25H,12-13H2,1-2H3,(H,30,31)/t16-,25-/m0/s1 DPVNIWJITJOQSD-LMKMVOKYSA-N 334809 2-[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidine-1-carbonyl]-biphenyl-4-carbonitrile::US11040966, Example 4.166::US9732075, Example 4.166 Orexin receptor type 2 Homo sapiens 568 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334809 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334809&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127085 384986969 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657259 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1ccc(C)cc1-c1ccccn1 InChI=1S/C26H25ClN4O/c1-15-7-8-18(19(14-15)21-6-4-5-12-28-21)26(32)31-13-11-16(2)24(31)25-29-22-10-9-20(27)17(3)23(22)30-25/h4-10,12,14,16,24H,11,13H2,1-3H3,(H,29,30)/t16-,24-/m0/s1 UWBYFPSFGLWODS-FYSMJZIKSA-N 334810 US11040966, Example 4.167::US9732075, Example 4.167::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4-methyl-2-pyridin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334810 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334810&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127737 384986970 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657260 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1ccc(C)cc1-c1ccccn1 InChI=1S/C26H25ClN4O/c1-15-7-8-18(19(14-15)21-6-4-5-12-28-21)26(32)31-13-11-16(2)24(31)25-29-22-10-9-20(27)17(3)23(22)30-25/h4-10,12,14,16,24H,11,13H2,1-3H3,(H,29,30)/t16-,24-/m0/s1 UWBYFPSFGLWODS-FYSMJZIKSA-N 334810 US11040966, Example 4.167::US9732075, Example 4.167::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4-methyl-2-pyridin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 144 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334810 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334810&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127737 384986970 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657261 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1ccc(C)cc1-c1ccccc1 InChI=1S/C27H26ClN3O/c1-16-9-10-20(21(15-16)19-7-5-4-6-8-19)27(32)31-14-13-17(2)25(31)26-29-23-12-11-22(28)18(3)24(23)30-26/h4-12,15,17,25H,13-14H2,1-3H3,(H,29,30)/t17-,25-/m0/s1 XWFLSBAQIZJNJB-GKVSMKOHSA-N 334811 US11040966, Example 4.168::US9732075, Example 4.168::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 10.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334811 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334811&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127457 384986971 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657262 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1ccc(C)cc1-c1ccccc1 InChI=1S/C27H26ClN3O/c1-16-9-10-20(21(15-16)19-7-5-4-6-8-19)27(32)31-14-13-17(2)25(31)26-29-23-12-11-22(28)18(3)24(23)30-26/h4-12,15,17,25H,13-14H2,1-3H3,(H,29,30)/t17-,25-/m0/s1 XWFLSBAQIZJNJB-GKVSMKOHSA-N 334811 US11040966, Example 4.168::US9732075, Example 4.168::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 486 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334811 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334811&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127457 384986971 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657263 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1c(F)cccc1-c1ccccc1 InChI=1S/C26H23ClFN3O/c1-15-13-14-31(24(15)25-29-21-12-11-19(27)16(2)23(21)30-25)26(32)22-18(9-6-10-20(22)28)17-7-4-3-5-8-17/h3-12,15,24H,13-14H2,1-2H3,(H,29,30)/t15-,24-/m0/s1 CXUTWSQJWLDTGV-OWJWWREXSA-N 334812 US11040966, Example 4.169::US9732075, Example 4.169::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(3-fluoro-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334812 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334812&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127151 384986972 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657264 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1c(F)cccc1-c1ccccc1 InChI=1S/C26H23ClFN3O/c1-15-13-14-31(24(15)25-29-21-12-11-19(27)16(2)23(21)30-25)26(32)22-18(9-6-10-20(22)28)17-7-4-3-5-8-17/h3-12,15,24H,13-14H2,1-2H3,(H,29,30)/t15-,24-/m0/s1 CXUTWSQJWLDTGV-OWJWWREXSA-N 334812 US11040966, Example 4.169::US9732075, Example 4.169::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(3-fluoro-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 892 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334812 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334812&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127151 384986972 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657265 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1cc(ccc1-c1ccccc1)C(F)(F)F InChI=1S/C27H23ClF3N3O/c1-15-12-13-34(24(15)25-32-22-11-10-21(28)16(2)23(22)33-25)26(35)20-14-18(27(29,30)31)8-9-19(20)17-6-4-3-5-7-17/h3-11,14-15,24H,12-13H2,1-2H3,(H,32,33)/t15-,24-/m0/s1 XRVQPAYTTYKUCX-OWJWWREXSA-N 334813 US11040966, Example 4.170::US9732075, Example 4.170::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4-trifluoromethyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 11.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334813 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334813&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127225 384986973 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657266 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1cc(ccc1-c1ccccc1)C(F)(F)F InChI=1S/C27H23ClF3N3O/c1-15-12-13-34(24(15)25-32-22-11-10-21(28)16(2)23(22)33-25)26(35)20-14-18(27(29,30)31)8-9-19(20)17-6-4-3-5-7-17/h3-11,14-15,24H,12-13H2,1-2H3,(H,32,33)/t15-,24-/m0/s1 XRVQPAYTTYKUCX-OWJWWREXSA-N 334813 US11040966, Example 4.170::US9732075, Example 4.170::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4-trifluoromethyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 1430 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334813 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334813&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127225 384986973 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657267 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1c(F)c(C)ccc1-c1ccccc1 InChI=1S/C27H25ClFN3O/c1-15-9-10-19(18-7-5-4-6-8-18)22(23(15)29)27(33)32-14-13-16(2)25(32)26-30-21-12-11-20(28)17(3)24(21)31-26/h4-12,16,25H,13-14H2,1-3H3,(H,30,31)/t16-,25-/m0/s1 IRHPPLSFVLVHBZ-LMKMVOKYSA-N 334814 US11040966, Example 4.171::US9732075, Example 4.171::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(3-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 1.50 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334814 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334814&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128016 384986974 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657268 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1c(F)c(C)ccc1-c1ccccc1 InChI=1S/C27H25ClFN3O/c1-15-9-10-19(18-7-5-4-6-8-18)22(23(15)29)27(33)32-14-13-16(2)25(32)26-30-21-12-11-20(28)17(3)24(21)31-26/h4-12,16,25H,13-14H2,1-3H3,(H,30,31)/t16-,25-/m0/s1 IRHPPLSFVLVHBZ-LMKMVOKYSA-N 334814 US11040966, Example 4.171::US9732075, Example 4.171::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(3-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 571 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334814 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334814&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128016 384986974 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657269 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1cc(C)ccc1-c1ccccc1 InChI=1S/C27H26ClN3O/c1-16-9-10-20(19-7-5-4-6-8-19)21(15-16)27(32)31-14-13-17(2)25(31)26-29-23-12-11-22(28)18(3)24(23)30-26/h4-12,15,17,25H,13-14H2,1-3H3,(H,29,30)/t17-,25-/m0/s1 GSONVRMPHROBLD-GKVSMKOHSA-N 334815 US11040966, Example 4.172::US9732075, Example 4.172::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334815 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334815&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128290 384986975 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657270 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1cc(C)ccc1-c1ccccc1 InChI=1S/C27H26ClN3O/c1-16-9-10-20(19-7-5-4-6-8-19)21(15-16)27(32)31-14-13-17(2)25(31)26-29-23-12-11-22(28)18(3)24(23)30-26/h4-12,15,17,25H,13-14H2,1-3H3,(H,29,30)/t17-,25-/m0/s1 GSONVRMPHROBLD-GKVSMKOHSA-N 334815 US11040966, Example 4.172::US9732075, Example 4.172::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 457 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334815 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334815&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128290 384986975 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657271 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1c(F)c(C)ccc1-c1cccnc1 InChI=1S/C26H24ClFN4O/c1-14-6-7-18(17-5-4-11-29-13-17)21(22(14)28)26(33)32-12-10-15(2)24(32)25-30-20-9-8-19(27)16(3)23(20)31-25/h4-9,11,13,15,24H,10,12H2,1-3H3,(H,30,31)/t15-,24-/m0/s1 QSZJVKQXTFSOHN-OWJWWREXSA-N 334816 US11040966, Example 4.173::US9732075, Example 4.173::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-pyridin-3-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334816 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334816&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127636 384986976 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657272 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1c(F)c(C)ccc1-c1cccnc1 InChI=1S/C26H24ClFN4O/c1-14-6-7-18(17-5-4-11-29-13-17)21(22(14)28)26(33)32-12-10-15(2)24(32)25-30-20-9-8-19(27)16(3)23(20)31-25/h4-9,11,13,15,24H,10,12H2,1-3H3,(H,30,31)/t15-,24-/m0/s1 QSZJVKQXTFSOHN-OWJWWREXSA-N 334816 US11040966, Example 4.173::US9732075, Example 4.173::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-pyridin-3-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 6330 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334816 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334816&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127636 384986976 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657273 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1ccc(C)cc1-c1ncccn1 InChI=1S/C25H24ClN5O/c1-14-5-6-17(18(13-14)23-27-10-4-11-28-23)25(32)31-12-9-15(2)22(31)24-29-20-8-7-19(26)16(3)21(20)30-24/h4-8,10-11,13,15,22H,9,12H2,1-3H3,(H,29,30)/t15-,22-/m0/s1 HFUAAKBNSVZPPB-NYHFZMIOSA-N 334817 US11040966, Example 4.174::US9732075, Example 4.174::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4-methyl-2-pyrimidin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 12.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334817 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334817&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118126991 384986977 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657274 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1ccc(C)cc1-c1ncccn1 InChI=1S/C25H24ClN5O/c1-14-5-6-17(18(13-14)23-27-10-4-11-28-23)25(32)31-12-9-15(2)22(31)24-29-20-8-7-19(26)16(3)21(20)30-24/h4-8,10-11,13,15,22H,9,12H2,1-3H3,(H,29,30)/t15-,22-/m0/s1 HFUAAKBNSVZPPB-NYHFZMIOSA-N 334817 US11040966, Example 4.174::US9732075, Example 4.174::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(4-methyl-2-pyrimidin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 132 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334817 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334817&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118126991 384986977 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657275 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1cc(F)ccc1-c1ncccn1 InChI=1S/C24H21ClFN5O/c1-13-8-11-31(21(13)23-29-19-7-6-18(25)14(2)20(19)30-23)24(32)17-12-15(26)4-5-16(17)22-27-9-3-10-28-22/h3-7,9-10,12-13,21H,8,11H2,1-2H3,(H,29,30)/t13-,21-/m0/s1 MNFARHDBPGVJKH-ZSEKCTLFSA-N 334818 US11040966, Example 4.175::US9732075, Example 4.175::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-fluoro-2-pyrimidin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 14.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334818 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334818&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127466 384986978 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657276 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1cc(F)ccc1-c1ncccn1 InChI=1S/C24H21ClFN5O/c1-13-8-11-31(21(13)23-29-19-7-6-18(25)14(2)20(19)30-23)24(32)17-12-15(26)4-5-16(17)22-27-9-3-10-28-22/h3-7,9-10,12-13,21H,8,11H2,1-2H3,(H,29,30)/t13-,21-/m0/s1 MNFARHDBPGVJKH-ZSEKCTLFSA-N 334818 US11040966, Example 4.175::US9732075, Example 4.175::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-fluoro-2-pyrimidin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 249 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334818 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334818&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127466 384986978 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657277 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1c(F)c(C)ccc1-c1ncccn1 InChI=1S/C25H23ClFN5O/c1-13-5-6-16(23-28-10-4-11-29-23)19(20(13)27)25(33)32-12-9-14(2)22(32)24-30-18-8-7-17(26)15(3)21(18)31-24/h4-8,10-11,14,22H,9,12H2,1-3H3,(H,30,31)/t14-,22-/m0/s1 VURGNBMLEZMRSI-FPTDNZKUSA-N 334819 US11040966, Example 4.176::US9732075, Example 4.176::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-pyrimidin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 15.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334819 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334819&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127309 384986979 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657278 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1c(F)c(C)ccc1-c1ncccn1 InChI=1S/C25H23ClFN5O/c1-13-5-6-16(23-28-10-4-11-29-23)19(20(13)27)25(33)32-12-9-14(2)22(32)24-30-18-8-7-17(26)15(3)21(18)31-24/h4-8,10-11,14,22H,9,12H2,1-3H3,(H,30,31)/t14-,22-/m0/s1 VURGNBMLEZMRSI-FPTDNZKUSA-N 334819 US11040966, Example 4.176::US9732075, Example 4.176::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-pyrimidin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 1067 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334819 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334819&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127309 384986979 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657279 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1c(F)cccc1-c1ncccn1 InChI=1S/C24H21ClFN5O/c1-13-9-12-31(21(13)23-29-18-8-7-16(25)14(2)20(18)30-23)24(32)19-15(5-3-6-17(19)26)22-27-10-4-11-28-22/h3-8,10-11,13,21H,9,12H2,1-2H3,(H,29,30)/t13-,21-/m0/s1 SMZLSIZDWHJTDR-ZSEKCTLFSA-N 334820 US11040966, Example 4.177::US9732075, Example 4.177::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-fluoro-6-pyrimidin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334820 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334820&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127741 384986980 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657280 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1c(F)cccc1-c1ncccn1 InChI=1S/C24H21ClFN5O/c1-13-9-12-31(21(13)23-29-18-8-7-16(25)14(2)20(18)30-23)24(32)19-15(5-3-6-17(19)26)22-27-10-4-11-28-22/h3-8,10-11,13,21H,9,12H2,1-2H3,(H,29,30)/t13-,21-/m0/s1 SMZLSIZDWHJTDR-ZSEKCTLFSA-N 334820 US11040966, Example 4.177::US9732075, Example 4.177::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(2-fluoro-6-pyrimidin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 219 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334820 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334820&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127741 384986980 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657281 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1cc(C)ccc1-c1ncccn1 InChI=1S/C25H24ClN5O/c1-14-5-6-17(23-27-10-4-11-28-23)18(13-14)25(32)31-12-9-15(2)22(31)24-29-20-8-7-19(26)16(3)21(20)30-24/h4-8,10-11,13,15,22H,9,12H2,1-3H3,(H,29,30)/t15-,22-/m0/s1 WSDSQDXCGVOIST-NYHFZMIOSA-N 334821 US11040966, Example 4.178::US9732075, Example 4.178::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334821 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334821&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127104 384986981 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657282 C[C@H]1CCN([C@@H]1c1nc2c(C)c(Cl)ccc2[nH]1)C(=O)c1cc(C)ccc1-c1ncccn1 InChI=1S/C25H24ClN5O/c1-14-5-6-17(23-27-10-4-11-28-23)18(13-14)25(32)31-12-9-15(2)22(31)24-29-20-8-7-19(26)16(3)21(20)30-24/h4-8,10-11,13,15,22H,9,12H2,1-3H3,(H,29,30)/t15-,22-/m0/s1 WSDSQDXCGVOIST-NYHFZMIOSA-N 334821 US11040966, Example 4.178::US9732075, Example 4.178::[(2S,3S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 350 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334821 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334821&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127104 384986981 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657283 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1cc(C)ccc1-c1ncccn1 InChI=1S/C26H27N5O3/c1-15-6-7-17(24-27-9-5-10-28-24)18(12-15)26(32)31-11-8-16(2)23(31)25-29-19-13-21(33-3)22(34-4)14-20(19)30-25/h5-7,9-10,12-14,16,23H,8,11H2,1-4H3,(H,29,30)/t16-,23-/m0/s1 OXMGSGSUHQLEPF-HJPURHCSSA-N 334822 US11040966, Example 4.179::US9732075, Example 4.179::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 27.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334822 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334822&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127395 384986982 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657284 COc1cc2nc([nH]c2cc1OC)[C@@H]1[C@@H](C)CCN1C(=O)c1cc(C)ccc1-c1ncccn1 InChI=1S/C26H27N5O3/c1-15-6-7-17(24-27-9-5-10-28-24)18(12-15)26(32)31-11-8-16(2)23(31)25-29-19-13-21(33-3)22(34-4)14-20(19)30-25/h5-7,9-10,12-14,16,23H,8,11H2,1-4H3,(H,29,30)/t16-,23-/m0/s1 OXMGSGSUHQLEPF-HJPURHCSSA-N 334822 US11040966, Example 4.179::US9732075, Example 4.179::[(2S,3S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 69.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334822 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334822&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127395 384986982 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657285 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1cc(C)ccc1-c1ncccn1 InChI=1S/C25H24ClN5O/c1-14-5-6-17(23-27-8-4-9-28-23)18(11-14)25(32)31-10-7-15(2)22(31)24-29-20-12-16(3)19(26)13-21(20)30-24/h4-6,8-9,11-13,15,22H,7,10H2,1-3H3,(H,29,30)/t15-,22-/m0/s1 SYKZZUXOGPRYNL-NYHFZMIOSA-N 334823 US11040966, Example 4.180::US9732075, Example 4.180::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334823 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334823&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128162 384986983 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657286 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)c(C)cc2[nH]1)C(=O)c1cc(C)ccc1-c1ncccn1 InChI=1S/C25H24ClN5O/c1-14-5-6-17(23-27-8-4-9-28-23)18(11-14)25(32)31-10-7-15(2)22(31)24-29-20-12-16(3)19(26)13-21(20)30-24/h4-6,8-9,11-13,15,22H,7,10H2,1-3H3,(H,29,30)/t15-,22-/m0/s1 SYKZZUXOGPRYNL-NYHFZMIOSA-N 334823 US11040966, Example 4.180::US9732075, Example 4.180::[(2S,3S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 304 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334823 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334823&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128162 384986983 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657287 C[C@H]1CCN([C@@H]1c1nc2ccc(Cl)c(C)c2[nH]1)C(=O)c1cc(C)ccc1-c1ncccn1 InChI=1S/C25H24ClN5O/c1-14-5-6-17(23-27-10-4-11-28-23)18(13-14)25(32)31-12-9-15(2)22(31)24-29-20-8-7-19(26)16(3)21(20)30-24/h4-8,10-11,13,15,22H,9,12H2,1-3H3,(H,29,30)/t15-,22-/m0/s1 WSDSQDXCGVOIST-NYHFZMIOSA-N 334824 US11040966, Example 4.181::US9732075, Example 4.181::[(2S,3S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334824 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334824&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127104 384986984 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657288 C[C@H]1CCN([C@@H]1c1nc2ccc(Cl)c(C)c2[nH]1)C(=O)c1cc(C)ccc1-c1ncccn1 InChI=1S/C25H24ClN5O/c1-14-5-6-17(23-27-10-4-11-28-23)18(13-14)25(32)31-12-9-15(2)22(31)24-29-20-8-7-19(26)16(3)21(20)30-24/h4-8,10-11,13,15,22H,9,12H2,1-3H3,(H,29,30)/t15-,22-/m0/s1 WSDSQDXCGVOIST-NYHFZMIOSA-N 334824 US11040966, Example 4.181::US9732075, Example 4.181::[(2S,3S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 230 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334824 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334824&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127104 384986984 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657289 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)cc(C)c2[nH]1)C(=O)c1cc(C)ccc1-c1ncccn1 InChI=1S/C25H24ClN5O/c1-14-5-6-18(23-27-8-4-9-28-23)19(11-14)25(32)31-10-7-15(2)22(31)24-29-20-13-17(26)12-16(3)21(20)30-24/h4-6,8-9,11-13,15,22H,7,10H2,1-3H3,(H,29,30)/t15-,22-/m0/s1 UFOSJOUWGCIBKV-NYHFZMIOSA-N 334825 US11040966, Example 4.182::US9732075, Example 4.182::[(2S,3S)-2-(5-Chloro-7-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334825 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334825&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127904 384986985 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657290 C[C@H]1CCN([C@@H]1c1nc2cc(Cl)cc(C)c2[nH]1)C(=O)c1cc(C)ccc1-c1ncccn1 InChI=1S/C25H24ClN5O/c1-14-5-6-18(23-27-8-4-9-28-23)19(11-14)25(32)31-10-7-15(2)22(31)24-29-20-13-17(26)12-16(3)21(20)30-24/h4-6,8-9,11-13,15,22H,7,10H2,1-3H3,(H,29,30)/t15-,22-/m0/s1 UFOSJOUWGCIBKV-NYHFZMIOSA-N 334825 US11040966, Example 4.182::US9732075, Example 4.182::[(2S,3S)-2-(5-Chloro-7-methyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 694 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334825 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334825&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127904 384986985 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657291 C[C@H]1CCN([C@@H]1c1nc2cc(C)c(C)cc2[nH]1)C(=O)c1cc(C)ccc1-c1ncccn1 InChI=1S/C26H27N5O/c1-15-6-7-19(24-27-9-5-10-28-24)20(12-15)26(32)31-11-8-16(2)23(31)25-29-21-13-17(3)18(4)14-22(21)30-25/h5-7,9-10,12-14,16,23H,8,11H2,1-4H3,(H,29,30)/t16-,23-/m0/s1 AYMUVQYQCNHTBI-HJPURHCSSA-N 334826 US11040966, Example 4.183::US9732075, Example 4.183::[(2S,3S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 93.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334826 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334826&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128245 384986986 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657292 C[C@H]1CCN([C@@H]1c1nc2cc(C)c(C)cc2[nH]1)C(=O)c1cc(C)ccc1-c1ncccn1 InChI=1S/C26H27N5O/c1-15-6-7-19(24-27-9-5-10-28-24)20(12-15)26(32)31-11-8-16(2)23(31)25-29-21-13-17(3)18(4)14-22(21)30-25/h5-7,9-10,12-14,16,23H,8,11H2,1-4H3,(H,29,30)/t16-,23-/m0/s1 AYMUVQYQCNHTBI-HJPURHCSSA-N 334826 US11040966, Example 4.183::US9732075, Example 4.183::[(2S,3S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-3-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 2256 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334826 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334826&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128245 384986986 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657293 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3cccc(C)c3[nH]2)c(s1)-c1ccccc1 334827 US9732075, Example 5.1::[(S)-2-Methyl-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 26.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334827 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334827&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127672 384986987 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657294 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3cccc(C)c3[nH]2)c(s1)-c1ccccc1 334827 US9732075, Example 5.1::[(S)-2-Methyl-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334827 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334827&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127672 384986987 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657295 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1)-n1nccn1 InChI=1S/C24H26N6O/c1-15-6-7-21(30-25-9-10-26-30)18(12-15)22(31)29-11-5-8-24(29,4)23-27-19-13-16(2)17(3)14-20(19)28-23/h6-7,9-10,12-14H,5,8,11H2,1-4H3,(H,27,28)/t24-/m0/s1 XEPDCTVYWFLFSQ-DEOSSOPVSA-N 334828 US11040966, Example 5.10::US9732075, Example 5.10::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334828 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334828&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127998 384986988 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657296 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1)-n1nccn1 InChI=1S/C24H26N6O/c1-15-6-7-21(30-25-9-10-26-30)18(12-15)22(31)29-11-5-8-24(29,4)23-27-19-13-16(2)17(3)14-20(19)28-23/h6-7,9-10,12-14H,5,8,11H2,1-4H3,(H,27,28)/t24-/m0/s1 XEPDCTVYWFLFSQ-DEOSSOPVSA-N 334828 US11040966, Example 5.10::US9732075, Example 5.10::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 16.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334828 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334828&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127998 384986988 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657297 Cc1ccc(cc1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1 InChI=1S/C29H31N3O/c1-18-7-10-22(11-8-18)23-12-9-19(2)15-24(23)27(33)32-14-6-13-29(32,5)28-30-25-16-20(3)21(4)17-26(25)31-28/h7-12,15-17H,6,13-14H2,1-5H3,(H,30,31)/t29-/m0/s1 GTVJYKUJZOGFAI-LJAQVGFWSA-N 334829 US11040966, Example 5.100::US9732075, Example 5.100::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,4'-dimethyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 17.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334829 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334829&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127760 384986989 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657298 Cc1ccc(cc1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1 InChI=1S/C29H31N3O/c1-18-7-10-22(11-8-18)23-12-9-19(2)15-24(23)27(33)32-14-6-13-29(32,5)28-30-25-16-20(3)21(4)17-26(25)31-28/h7-12,15-17H,6,13-14H2,1-5H3,(H,30,31)/t29-/m0/s1 GTVJYKUJZOGFAI-LJAQVGFWSA-N 334829 US11040966, Example 5.100::US9732075, Example 5.100::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,4'-dimethyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 27.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334829 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334829&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127760 384986989 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657299 COc1cccc(c1)-c1ccccc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1 InChI=1S/C28H29N3O2/c1-18-15-24-25(16-19(18)2)30-27(29-24)28(3)13-8-14-31(28)26(32)23-12-6-5-11-22(23)20-9-7-10-21(17-20)33-4/h5-7,9-12,15-17H,8,13-14H2,1-4H3,(H,29,30)/t28-/m0/s1 VVHOKQDJINEWKI-NDEPHWFRSA-N 334830 US11040966, Example 5.101::US9732075, Example 5.101::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-methoxy-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 59.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334830 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334830&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102266 384986990 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657300 COc1cccc(c1)-c1ccccc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1 InChI=1S/C28H29N3O2/c1-18-15-24-25(16-19(18)2)30-27(29-24)28(3)13-8-14-31(28)26(32)23-12-6-5-11-22(23)20-9-7-10-21(17-20)33-4/h5-7,9-12,15-17H,8,13-14H2,1-4H3,(H,29,30)/t28-/m0/s1 VVHOKQDJINEWKI-NDEPHWFRSA-N 334830 US11040966, Example 5.101::US9732075, Example 5.101::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-methoxy-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 54.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334830 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334830&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102266 384986990 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657301 COc1ccc(cc1)-c1ccccc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1 InChI=1S/C28H29N3O2/c1-18-16-24-25(17-19(18)2)30-27(29-24)28(3)14-7-15-31(28)26(32)23-9-6-5-8-22(23)20-10-12-21(33-4)13-11-20/h5-6,8-13,16-17H,7,14-15H2,1-4H3,(H,29,30)/t28-/m0/s1 XEFXMACVISZBGQ-NDEPHWFRSA-N 334831 US11040966, Example 5.102::US9732075, Example 5.102::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-methoxy-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 34.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334831 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334831&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 130297006 384986991 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657302 COc1ccc(cc1)-c1ccccc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1 InChI=1S/C28H29N3O2/c1-18-16-24-25(17-19(18)2)30-27(29-24)28(3)14-7-15-31(28)26(32)23-9-6-5-8-22(23)20-10-12-21(33-4)13-11-20/h5-6,8-13,16-17H,7,14-15H2,1-4H3,(H,29,30)/t28-/m0/s1 XEFXMACVISZBGQ-NDEPHWFRSA-N 334831 US11040966, Example 5.102::US9732075, Example 5.102::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-methoxy-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 82.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334831 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334831&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 130297006 384986991 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657303 Cc1cc2nc([nH]c2cc1C)[C@]1(C)CCCN1C(=O)c1ccccc1-c1ccccc1F InChI=1S/C27H26FN3O/c1-17-15-23-24(16-18(17)2)30-26(29-23)27(3)13-8-14-31(27)25(32)21-11-5-4-9-19(21)20-10-6-7-12-22(20)28/h4-7,9-12,15-16H,8,13-14H2,1-3H3,(H,29,30)/t27-/m0/s1 WAIRFUYBJHQDIX-MHZLTWQESA-N 334832 US11040966, Example 5.103::US9732075, Example 5.103::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2'-fluoro-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 46.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334832 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334832&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102351 384986992 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657304 Cc1cc2nc([nH]c2cc1C)[C@]1(C)CCCN1C(=O)c1ccccc1-c1ccccc1F InChI=1S/C27H26FN3O/c1-17-15-23-24(16-18(17)2)30-26(29-23)27(3)13-8-14-31(27)25(32)21-11-5-4-9-19(21)20-10-6-7-12-22(20)28/h4-7,9-12,15-16H,8,13-14H2,1-3H3,(H,29,30)/t27-/m0/s1 WAIRFUYBJHQDIX-MHZLTWQESA-N 334832 US11040966, Example 5.103::US9732075, Example 5.103::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2'-fluoro-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 70.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334832 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334832&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102351 384986992 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657305 Cc1cc2nc([nH]c2cc1C)[C@]1(C)CCCN1C(=O)c1ccccc1-c1ccc(F)cc1 InChI=1S/C27H26FN3O/c1-17-15-23-24(16-18(17)2)30-26(29-23)27(3)13-6-14-31(27)25(32)22-8-5-4-7-21(22)19-9-11-20(28)12-10-19/h4-5,7-12,15-16H,6,13-14H2,1-3H3,(H,29,30)/t27-/m0/s1 MQYVGNSLQPAFOQ-MHZLTWQESA-N 334833 US11040966, Example 5.104::US9732075, Example 5.104::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-fluoro-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 92.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334833 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334833&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102408 384986993 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657306 Cc1cc2nc([nH]c2cc1C)[C@]1(C)CCCN1C(=O)c1ccccc1-c1ccc(F)cc1 InChI=1S/C27H26FN3O/c1-17-15-23-24(16-18(17)2)30-26(29-23)27(3)13-6-14-31(27)25(32)22-8-5-4-7-21(22)19-9-11-20(28)12-10-19/h4-5,7-12,15-16H,6,13-14H2,1-3H3,(H,29,30)/t27-/m0/s1 MQYVGNSLQPAFOQ-MHZLTWQESA-N 334833 US11040966, Example 5.104::US9732075, Example 5.104::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-fluoro-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 97.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334833 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334833&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102408 384986993 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657307 Cc1cc2nc([nH]c2cc1C)[C@]1(C)CCCN1C(=O)c1ccccc1-c1cccc(F)c1 InChI=1S/C27H26FN3O/c1-17-14-23-24(15-18(17)2)30-26(29-23)27(3)12-7-13-31(27)25(32)22-11-5-4-10-21(22)19-8-6-9-20(28)16-19/h4-6,8-11,14-16H,7,12-13H2,1-3H3,(H,29,30)/t27-/m0/s1 ISVQHKDAABXWCI-MHZLTWQESA-N 334834 US11040966, Example 5.105::US9732075, Example 5.105::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-fluoro-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 24.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334834 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334834&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127834 384986994 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657308 Cc1cc2nc([nH]c2cc1C)[C@]1(C)CCCN1C(=O)c1ccccc1-c1cccc(F)c1 InChI=1S/C27H26FN3O/c1-17-14-23-24(15-18(17)2)30-26(29-23)27(3)12-7-13-31(27)25(32)22-11-5-4-10-21(22)19-8-6-9-20(28)16-19/h4-6,8-11,14-16H,7,12-13H2,1-3H3,(H,29,30)/t27-/m0/s1 ISVQHKDAABXWCI-MHZLTWQESA-N 334834 US11040966, Example 5.105::US9732075, Example 5.105::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-fluoro-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 28.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334834 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334834&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127834 384986994 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657309 Cc1cccc(c1)-c1ccccc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1 InChI=1S/C28H29N3O/c1-18-9-7-10-21(15-18)22-11-5-6-12-23(22)26(32)31-14-8-13-28(31,4)27-29-24-16-19(2)20(3)17-25(24)30-27/h5-7,9-12,15-17H,8,13-14H2,1-4H3,(H,29,30)/t28-/m0/s1 QEDITNWAIYXSDE-NDEPHWFRSA-N 334835 US11040966, Example 5.106::US9732075, Example 5.106::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 25.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334835 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334835&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128060 384986995 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657310 Cc1cccc(c1)-c1ccccc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1 InChI=1S/C28H29N3O/c1-18-9-7-10-21(15-18)22-11-5-6-12-23(22)26(32)31-14-8-13-28(31,4)27-29-24-16-19(2)20(3)17-25(24)30-27/h5-7,9-12,15-17H,8,13-14H2,1-4H3,(H,29,30)/t28-/m0/s1 QEDITNWAIYXSDE-NDEPHWFRSA-N 334835 US11040966, Example 5.106::US9732075, Example 5.106::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 37.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334835 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334835&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128060 384986995 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657311 Cc1ccc(cc1)-c1ccccc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1 InChI=1S/C28H29N3O/c1-18-10-12-21(13-11-18)22-8-5-6-9-23(22)26(32)31-15-7-14-28(31,4)27-29-24-16-19(2)20(3)17-25(24)30-27/h5-6,8-13,16-17H,7,14-15H2,1-4H3,(H,29,30)/t28-/m0/s1 PAWGTRMUYMKAMJ-NDEPHWFRSA-N 334836 US11040966, Example 5.107::US9732075, Example 5.107::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 58.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334836 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334836&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102504 384986996 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657312 Cc1ccc(cc1)-c1ccccc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1 InChI=1S/C28H29N3O/c1-18-10-12-21(13-11-18)22-8-5-6-9-23(22)26(32)31-15-7-14-28(31,4)27-29-24-16-19(2)20(3)17-25(24)30-27/h5-6,8-13,16-17H,7,14-15H2,1-4H3,(H,29,30)/t28-/m0/s1 PAWGTRMUYMKAMJ-NDEPHWFRSA-N 334836 US11040966, Example 5.107::US9732075, Example 5.107::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 53.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334836 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334836&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102504 384986996 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657313 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(C)ccc2[nH]1)-c1ccc(F)cc1C InChI=1S/C29H30FN3O/c1-17-7-10-23(22-11-9-21(30)16-19(22)3)24(15-17)27(34)33-14-6-13-29(33,5)28-31-25-12-8-18(2)20(4)26(25)32-28/h7-12,15-16H,6,13-14H2,1-5H3,(H,31,32)/t29-/m0/s1 YYBZXUJTIPLWIC-LJAQVGFWSA-N 334837 US11040966, Example 5.108::US9732075, Example 5.108::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-fluoro-4,2'-dimethyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 265 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334837 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334837&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127197 384986997 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657314 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(C)ccc2[nH]1)-c1ccc(F)cc1C InChI=1S/C29H30FN3O/c1-17-7-10-23(22-11-9-21(30)16-19(22)3)24(15-17)27(34)33-14-6-13-29(33,5)28-31-25-12-8-18(2)20(4)26(25)32-28/h7-12,15-16H,6,13-14H2,1-5H3,(H,31,32)/t29-/m0/s1 YYBZXUJTIPLWIC-LJAQVGFWSA-N 334837 US11040966, Example 5.108::US9732075, Example 5.108::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-fluoro-4,2'-dimethyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 161 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334837 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334837&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127197 384986997 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657315 Cc1ccc(-c2cccc(F)c2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(C)ccc2[nH]1 InChI=1S/C28H28FN3O/c1-17-9-11-22(20-7-5-8-21(29)16-20)23(15-17)26(33)32-14-6-13-28(32,4)27-30-24-12-10-18(2)19(3)25(24)31-27/h5,7-12,15-16H,6,13-14H2,1-4H3,(H,30,31)/t28-/m0/s1 VLUXTCAIDBDMPI-NDEPHWFRSA-N 334838 US11040966, Example 5.109::US9732075, Example 5.109::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334838 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334838&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127366 384986998 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657316 Cc1ccc(-c2cccc(F)c2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(C)ccc2[nH]1 InChI=1S/C28H28FN3O/c1-17-9-11-22(20-7-5-8-21(29)16-20)23(15-17)26(33)32-14-6-13-28(32,4)27-30-24-12-10-18(2)19(3)25(24)31-27/h5,7-12,15-16H,6,13-14H2,1-4H3,(H,30,31)/t28-/m0/s1 VLUXTCAIDBDMPI-NDEPHWFRSA-N 334838 US11040966, Example 5.109::US9732075, Example 5.109::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334838 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334838&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127366 384986998 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657317 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(Cl)ccc2[nH]1)-n1nccn1 InChI=1S/C22H21ClN6O/c1-14-4-7-19(29-24-9-10-25-29)16(12-14)20(30)28-11-3-8-22(28,2)21-26-17-6-5-15(23)13-18(17)27-21/h4-7,9-10,12-13H,3,8,11H2,1-2H3,(H,26,27)/t22-/m0/s1 JHGBETRCGZJOBW-QFIPXVFZSA-N 334839 US11040966, Example 5.11::US9732075, Example 5.11::[(S)-2-(5-Chloro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 29.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334839 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334839&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127356 384986999 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657318 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(Cl)ccc2[nH]1)-n1nccn1 InChI=1S/C22H21ClN6O/c1-14-4-7-19(29-24-9-10-25-29)16(12-14)20(30)28-11-3-8-22(28,2)21-26-17-6-5-15(23)13-18(17)27-21/h4-7,9-10,12-13H,3,8,11H2,1-2H3,(H,26,27)/t22-/m0/s1 JHGBETRCGZJOBW-QFIPXVFZSA-N 334839 US11040966, Example 5.11::US9732075, Example 5.11::[(S)-2-(5-Chloro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 413 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334839 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334839&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127356 384986999 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657319 COc1cccc(c1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(C)ccc2[nH]1 InChI=1S/C29H31N3O2/c1-18-10-12-23(21-8-6-9-22(17-21)34-5)24(16-18)27(33)32-15-7-14-29(32,4)28-30-25-13-11-19(2)20(3)26(25)31-28/h6,8-13,16-17H,7,14-15H2,1-5H3,(H,30,31)/t29-/m0/s1 SACAPMKUGKZWCN-LJAQVGFWSA-N 334840 US11040966, Example 5.110::US9732075, Example 5.110::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-methoxy-4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334840 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334840&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127383 384987000 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657320 COc1cccc(c1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(C)ccc2[nH]1 InChI=1S/C29H31N3O2/c1-18-10-12-23(21-8-6-9-22(17-21)34-5)24(16-18)27(33)32-15-7-14-29(32,4)28-30-25-13-11-19(2)20(3)26(25)31-28/h6,8-13,16-17H,7,14-15H2,1-5H3,(H,30,31)/t29-/m0/s1 SACAPMKUGKZWCN-LJAQVGFWSA-N 334840 US11040966, Example 5.110::US9732075, Example 5.110::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-methoxy-4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 14.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334840 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334840&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127383 384987000 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657321 Cc1cccc(c1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(C)ccc2[nH]1 InChI=1S/C29H31N3O/c1-18-8-6-9-22(16-18)23-12-10-19(2)17-24(23)27(33)32-15-7-14-29(32,5)28-30-25-13-11-20(3)21(4)26(25)31-28/h6,8-13,16-17H,7,14-15H2,1-5H3,(H,30,31)/t29-/m0/s1 ONAAJCCLIZLUBD-LJAQVGFWSA-N 334841 US11040966, Example 5.111::US9732075, Example 5.111::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,3'-dimethyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334841 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334841&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127882 384987001 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657322 Cc1cccc(c1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(C)ccc2[nH]1 InChI=1S/C29H31N3O/c1-18-8-6-9-22(16-18)23-12-10-19(2)17-24(23)27(33)32-15-7-14-29(32,5)28-30-25-13-11-20(3)21(4)26(25)31-28/h6,8-13,16-17H,7,14-15H2,1-5H3,(H,30,31)/t29-/m0/s1 ONAAJCCLIZLUBD-LJAQVGFWSA-N 334841 US11040966, Example 5.111::US9732075, Example 5.111::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,3'-dimethyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334841 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334841&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127882 384987001 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657323 COc1ccc(cc1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(C)ccc2[nH]1 InChI=1S/C29H31N3O2/c1-18-7-13-23(21-9-11-22(34-5)12-10-21)24(17-18)27(33)32-16-6-15-29(32,4)28-30-25-14-8-19(2)20(3)26(25)31-28/h7-14,17H,6,15-16H2,1-5H3,(H,30,31)/t29-/m0/s1 LFNXJZHRCAOQKF-LJAQVGFWSA-N 334842 US11040966, Example 5.112::US9732075, Example 5.112::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-methoxy-4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 12.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334842 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334842&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694688 384987002 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657324 COc1ccc(cc1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(C)ccc2[nH]1 InChI=1S/C29H31N3O2/c1-18-7-13-23(21-9-11-22(34-5)12-10-21)24(17-18)27(33)32-16-6-15-29(32,4)28-30-25-14-8-19(2)20(3)26(25)31-28/h7-14,17H,6,15-16H2,1-5H3,(H,30,31)/t29-/m0/s1 LFNXJZHRCAOQKF-LJAQVGFWSA-N 334842 US11040966, Example 5.112::US9732075, Example 5.112::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-methoxy-4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 16.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334842 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334842&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694688 384987002 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657325 Cc1ccc(cc1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(C)ccc2[nH]1 InChI=1S/C29H31N3O/c1-18-7-11-22(12-8-18)23-13-9-19(2)17-24(23)27(33)32-16-6-15-29(32,5)28-30-25-14-10-20(3)21(4)26(25)31-28/h7-14,17H,6,15-16H2,1-5H3,(H,30,31)/t29-/m0/s1 MLEWYAJWEQJCRY-LJAQVGFWSA-N 334843 US11040966, Example 5.113::US9732075, Example 5.113::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,4'-dimethyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 12.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334843 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334843&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694687 384987003 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657326 Cc1ccc(cc1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(C)ccc2[nH]1 InChI=1S/C29H31N3O/c1-18-7-11-22(12-8-18)23-13-9-19(2)17-24(23)27(33)32-16-6-15-29(32,5)28-30-25-14-10-20(3)21(4)26(25)31-28/h7-14,17H,6,15-16H2,1-5H3,(H,30,31)/t29-/m0/s1 MLEWYAJWEQJCRY-LJAQVGFWSA-N 334843 US11040966, Example 5.113::US9732075, Example 5.113::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,4'-dimethyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 15.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334843 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334843&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694687 384987003 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657327 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(C)ccc2[nH]1)-c1ccccc1F InChI=1S/C28H28FN3O/c1-17-10-12-20(21-8-5-6-9-23(21)29)22(16-17)26(33)32-15-7-14-28(32,4)27-30-24-13-11-18(2)19(3)25(24)31-27/h5-6,8-13,16H,7,14-15H2,1-4H3,(H,30,31)/t28-/m0/s1 FVBATYFIMXYBQL-NDEPHWFRSA-N 334844 US11040966, Example 5.114::US9732075, Example 5.114::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2'-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 10.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334844 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334844&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694689 384987004 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657328 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(C)ccc2[nH]1)-c1ccccc1F InChI=1S/C28H28FN3O/c1-17-10-12-20(21-8-5-6-9-23(21)29)22(16-17)26(33)32-15-7-14-28(32,4)27-30-24-13-11-18(2)19(3)25(24)31-27/h5-6,8-13,16H,7,14-15H2,1-4H3,(H,30,31)/t28-/m0/s1 FVBATYFIMXYBQL-NDEPHWFRSA-N 334844 US11040966, Example 5.114::US9732075, Example 5.114::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2'-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 21.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334844 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334844&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694689 384987004 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657329 Cc1ccc(-c2ccc(F)cc2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(C)ccc2[nH]1 InChI=1S/C28H28FN3O/c1-17-6-12-22(20-8-10-21(29)11-9-20)23(16-17)26(33)32-15-5-14-28(32,4)27-30-24-13-7-18(2)19(3)25(24)31-27/h6-13,16H,5,14-15H2,1-4H3,(H,30,31)/t28-/m0/s1 MROXSAYMYARWLC-NDEPHWFRSA-N 334845 US11040966, Example 5.115::US9732075, Example 5.115::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 22.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334845 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334845&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694585 384987005 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657330 Cc1ccc(-c2ccc(F)cc2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(C)ccc2[nH]1 InChI=1S/C28H28FN3O/c1-17-6-12-22(20-8-10-21(29)11-9-20)23(16-17)26(33)32-15-5-14-28(32,4)27-30-24-13-7-18(2)19(3)25(24)31-27/h6-13,16H,5,14-15H2,1-4H3,(H,30,31)/t28-/m0/s1 MROXSAYMYARWLC-NDEPHWFRSA-N 334845 US11040966, Example 5.115::US9732075, Example 5.115::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 18.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334845 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334845&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694585 384987005 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657331 Cc1ccc2[nH]c(nc2c1C)[C@]1(C)CCCN1C(=O)c1ccccc1-c1cccc(F)c1 InChI=1S/C27H26FN3O/c1-17-12-13-23-24(18(17)2)30-26(29-23)27(3)14-7-15-31(27)25(32)22-11-5-4-10-21(22)19-8-6-9-20(28)16-19/h4-6,8-13,16H,7,14-15H2,1-3H3,(H,29,30)/t27-/m0/s1 XZCMURPQAGNXIT-MHZLTWQESA-N 334846 US11040966, Example 5.116::US9732075, Example 5.116::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-fluoro-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 39.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334846 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334846&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128123 384987006 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657332 Cc1ccc2[nH]c(nc2c1C)[C@]1(C)CCCN1C(=O)c1ccccc1-c1cccc(F)c1 InChI=1S/C27H26FN3O/c1-17-12-13-23-24(18(17)2)30-26(29-23)27(3)14-7-15-31(27)25(32)22-11-5-4-10-21(22)19-8-6-9-20(28)16-19/h4-6,8-13,16H,7,14-15H2,1-3H3,(H,29,30)/t27-/m0/s1 XZCMURPQAGNXIT-MHZLTWQESA-N 334846 US11040966, Example 5.116::US9732075, Example 5.116::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-fluoro-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 19.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334846 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334846&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128123 384987006 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657333 COc1cccc(c1)-c1ccccc1C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(C)ccc2[nH]1 InChI=1S/C28H29N3O2/c1-18-13-14-24-25(19(18)2)30-27(29-24)28(3)15-8-16-31(28)26(32)23-12-6-5-11-22(23)20-9-7-10-21(17-20)33-4/h5-7,9-14,17H,8,15-16H2,1-4H3,(H,29,30)/t28-/m0/s1 OEDBNSXSXMLGFD-NDEPHWFRSA-N 334847 US11040966, Example 5.117::US9732075, Example 5.117::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-methoxy-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 57.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334847 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334847&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102380 384987007 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657334 COc1cccc(c1)-c1ccccc1C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(C)ccc2[nH]1 InChI=1S/C28H29N3O2/c1-18-13-14-24-25(19(18)2)30-27(29-24)28(3)15-8-16-31(28)26(32)23-12-6-5-11-22(23)20-9-7-10-21(17-20)33-4/h5-7,9-14,17H,8,15-16H2,1-4H3,(H,29,30)/t28-/m0/s1 OEDBNSXSXMLGFD-NDEPHWFRSA-N 334847 US11040966, Example 5.117::US9732075, Example 5.117::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-methoxy-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 38.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334847 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334847&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102380 384987007 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657335 Cc1cccc(c1)-c1ccccc1C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(C)ccc2[nH]1 InChI=1S/C28H29N3O/c1-18-9-7-10-21(17-18)22-11-5-6-12-23(22)26(32)31-16-8-15-28(31,4)27-29-24-14-13-19(2)20(3)25(24)30-27/h5-7,9-14,17H,8,15-16H2,1-4H3,(H,29,30)/t28-/m0/s1 BQVAWCBKNUTDJG-NDEPHWFRSA-N 334848 US11040966, Example 5.118::US9732075, Example 5.118::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 25.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334848 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334848&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694685 384987008 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657336 Cc1cccc(c1)-c1ccccc1C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(C)ccc2[nH]1 InChI=1S/C28H29N3O/c1-18-9-7-10-21(17-18)22-11-5-6-12-23(22)26(32)31-16-8-15-28(31,4)27-29-24-14-13-19(2)20(3)25(24)30-27/h5-7,9-14,17H,8,15-16H2,1-4H3,(H,29,30)/t28-/m0/s1 BQVAWCBKNUTDJG-NDEPHWFRSA-N 334848 US11040966, Example 5.118::US9732075, Example 5.118::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 35.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334848 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334848&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694685 384987008 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657337 COc1ccc(cc1)-c1ccccc1C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(C)ccc2[nH]1 InChI=1S/C28H29N3O2/c1-18-10-15-24-25(19(18)2)30-27(29-24)28(3)16-7-17-31(28)26(32)23-9-6-5-8-22(23)20-11-13-21(33-4)14-12-20/h5-6,8-15H,7,16-17H2,1-4H3,(H,29,30)/t28-/m0/s1 RZJZCQWBCSXNRD-NDEPHWFRSA-N 334849 US11040966, Example 5.119::US9732075, Example 5.119::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-methoxy-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 30.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334849 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334849&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128091 384987009 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657338 COc1ccc(cc1)-c1ccccc1C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(C)ccc2[nH]1 InChI=1S/C28H29N3O2/c1-18-10-15-24-25(19(18)2)30-27(29-24)28(3)16-7-17-31(28)26(32)23-9-6-5-8-22(23)20-11-13-21(33-4)14-12-20/h5-6,8-15H,7,16-17H2,1-4H3,(H,29,30)/t28-/m0/s1 RZJZCQWBCSXNRD-NDEPHWFRSA-N 334849 US11040966, Example 5.119::US9732075, Example 5.119::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-methoxy-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 29.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334849 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334849&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128091 384987009 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657339 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(F)c(Cl)cc2[nH]1)-n1nccn1 InChI=1S/C22H20ClFN6O/c1-13-4-5-19(30-25-7-8-26-30)14(10-13)20(31)29-9-3-6-22(29,2)21-27-17-11-15(23)16(24)12-18(17)28-21/h4-5,7-8,10-12H,3,6,9H2,1-2H3,(H,27,28)/t22-/m0/s1 RGYVUKDVRWDAJB-QFIPXVFZSA-N 334850 US11040966, Example 5.12::US9732075, Example 5.12::[(S)-2-(6-Chloro-5-fluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 15.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334850 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334850&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127091 384987010 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657340 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(F)c(Cl)cc2[nH]1)-n1nccn1 InChI=1S/C22H20ClFN6O/c1-13-4-5-19(30-25-7-8-26-30)14(10-13)20(31)29-9-3-6-22(29,2)21-27-17-11-15(23)16(24)12-18(17)28-21/h4-5,7-8,10-12H,3,6,9H2,1-2H3,(H,27,28)/t22-/m0/s1 RGYVUKDVRWDAJB-QFIPXVFZSA-N 334850 US11040966, Example 5.12::US9732075, Example 5.12::[(S)-2-(6-Chloro-5-fluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 134 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334850 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334850&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127091 384987010 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657341 Cc1ccc(cc1)-c1ccccc1C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(C)ccc2[nH]1 InChI=1S/C28H29N3O/c1-18-10-13-21(14-11-18)22-8-5-6-9-23(22)26(32)31-17-7-16-28(31,4)27-29-24-15-12-19(2)20(3)25(24)30-27/h5-6,8-15H,7,16-17H2,1-4H3,(H,29,30)/t28-/m0/s1 YQLVZZNCZVPRTP-NDEPHWFRSA-N 334851 US11040966, Example 5.120::US9732075, Example 5.120::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 48.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334851 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334851&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127049 384987011 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657342 Cc1ccc(cc1)-c1ccccc1C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(C)ccc2[nH]1 InChI=1S/C28H29N3O/c1-18-10-13-21(14-11-18)22-8-5-6-9-23(22)26(32)31-17-7-16-28(31,4)27-29-24-15-12-19(2)20(3)25(24)30-27/h5-6,8-15H,7,16-17H2,1-4H3,(H,29,30)/t28-/m0/s1 YQLVZZNCZVPRTP-NDEPHWFRSA-N 334851 US11040966, Example 5.120::US9732075, Example 5.120::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 26.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334851 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334851&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127049 384987011 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657343 Cc1ccc2[nH]c(nc2c1C)[C@]1(C)CCCN1C(=O)c1ccccc1-c1ccccc1F InChI=1S/C27H26FN3O/c1-17-13-14-23-24(18(17)2)30-26(29-23)27(3)15-8-16-31(27)25(32)21-11-5-4-9-19(21)20-10-6-7-12-22(20)28/h4-7,9-14H,8,15-16H2,1-3H3,(H,29,30)/t27-/m0/s1 PPMGNLBWJCRPEK-MHZLTWQESA-N 334852 US11040966, Example 5.121::US9732075, Example 5.121::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2'-fluoro-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 56.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334852 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334852&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102370 384987012 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657344 Cc1ccc2[nH]c(nc2c1C)[C@]1(C)CCCN1C(=O)c1ccccc1-c1ccccc1F InChI=1S/C27H26FN3O/c1-17-13-14-23-24(18(17)2)30-26(29-23)27(3)15-8-16-31(27)25(32)21-11-5-4-9-19(21)20-10-6-7-12-22(20)28/h4-7,9-14H,8,15-16H2,1-3H3,(H,29,30)/t27-/m0/s1 PPMGNLBWJCRPEK-MHZLTWQESA-N 334852 US11040966, Example 5.121::US9732075, Example 5.121::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2'-fluoro-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 43.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334852 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334852&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102370 384987012 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657345 Cc1ccc2[nH]c(nc2c1C)[C@]1(C)CCCN1C(=O)c1ccccc1-c1ccc(F)cc1 InChI=1S/C27H26FN3O/c1-17-9-14-23-24(18(17)2)30-26(29-23)27(3)15-6-16-31(27)25(32)22-8-5-4-7-21(22)19-10-12-20(28)13-11-19/h4-5,7-14H,6,15-16H2,1-3H3,(H,29,30)/t27-/m0/s1 DTNJQXBOAWSSEP-MHZLTWQESA-N 334853 US11040966, Example 5.122::US9732075, Example 5.122::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-fluoro-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 99.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334853 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334853&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102506 384987013 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657346 Cc1ccc2[nH]c(nc2c1C)[C@]1(C)CCCN1C(=O)c1ccccc1-c1ccc(F)cc1 InChI=1S/C27H26FN3O/c1-17-9-14-23-24(18(17)2)30-26(29-23)27(3)15-6-16-31(27)25(32)22-8-5-4-7-21(22)19-10-12-20(28)13-11-19/h4-5,7-14H,6,15-16H2,1-3H3,(H,29,30)/t27-/m0/s1 DTNJQXBOAWSSEP-MHZLTWQESA-N 334853 US11040966, Example 5.122::US9732075, Example 5.122::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-fluoro-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 74.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334853 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334853&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102506 384987013 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657347 C[C@]1(CCCN1C(=O)c1c(F)cccc1-n1nccn1)c1nc2cc(F)c(Br)cc2[nH]1 InChI=1S/C21H17BrF2N6O/c1-21(20-27-15-10-12(22)14(24)11-16(15)28-20)6-3-9-29(21)19(31)18-13(23)4-2-5-17(18)30-25-7-8-26-30/h2,4-5,7-8,10-11H,3,6,9H2,1H3,(H,27,28)/t21-/m0/s1 CIQJYTZEEOXVTI-NRFANRHFSA-N 334854 US11040966, Example 5.123::US9732075, Example 5.123::[(S)-2-(6-Bromo-5-fluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-fluoro-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 146 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334854 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334854&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127517 384987014 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657348 C[C@]1(CCCN1C(=O)c1c(F)cccc1-n1nccn1)c1nc2cc(F)c(Br)cc2[nH]1 InChI=1S/C21H17BrF2N6O/c1-21(20-27-15-10-12(22)14(24)11-16(15)28-20)6-3-9-29(21)19(31)18-13(23)4-2-5-17(18)30-25-7-8-26-30/h2,4-5,7-8,10-11H,3,6,9H2,1H3,(H,27,28)/t21-/m0/s1 CIQJYTZEEOXVTI-NRFANRHFSA-N 334854 US11040966, Example 5.123::US9732075, Example 5.123::[(S)-2-(6-Bromo-5-fluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-fluoro-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 304 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334854 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334854&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127517 384987014 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657349 Cc1ccc(c(C(=O)N2CCC[C@@]2(C)c2nc3cc(F)c(Br)cc3[nH]2)c1F)-n1nccn1 InChI=1S/C22H19BrF2N6O/c1-12-4-5-17(31-26-7-8-27-31)18(19(12)25)20(32)30-9-3-6-22(30,2)21-28-15-10-13(23)14(24)11-16(15)29-21/h4-5,7-8,10-11H,3,6,9H2,1-2H3,(H,28,29)/t22-/m0/s1 CMOWYCBMGGAOQC-QFIPXVFZSA-N 334855 US11040966, Example 5.124::US9732075, Example 5.124::[(S)-2-(6-Bromo-5-fluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 113 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334855 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334855&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127870 384987015 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657350 Cc1ccc(c(C(=O)N2CCC[C@@]2(C)c2nc3cc(F)c(Br)cc3[nH]2)c1F)-n1nccn1 InChI=1S/C22H19BrF2N6O/c1-12-4-5-17(31-26-7-8-27-31)18(19(12)25)20(32)30-9-3-6-22(30,2)21-28-15-10-13(23)14(24)11-16(15)29-21/h4-5,7-8,10-11H,3,6,9H2,1-2H3,(H,28,29)/t22-/m0/s1 CMOWYCBMGGAOQC-QFIPXVFZSA-N 334855 US11040966, Example 5.124::US9732075, Example 5.124::[(S)-2-(6-Bromo-5-fluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 411 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334855 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334855&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127870 384987015 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657351 COc1cc(C(=O)N2CCC[C@@]2(C)c2nc3cc(F)c(Br)cc3[nH]2)c(cc1OC)-n1nccn1 InChI=1S/C23H22BrFN6O3/c1-23(22-28-16-10-14(24)15(25)11-17(16)29-22)5-4-8-30(23)21(32)13-9-19(33-2)20(34-3)12-18(13)31-26-6-7-27-31/h6-7,9-12H,4-5,8H2,1-3H3,(H,28,29)/t23-/m0/s1 DSOCUAIVNOMLTC-QHCPKHFHSA-N 334856 US11040966, Example 5.125::US9732075, Example 5.125::[(S)-2-(6-Bromo-5-fluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,5-dimethoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 84.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334856 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334856&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127792 384987016 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657352 COc1cc(C(=O)N2CCC[C@@]2(C)c2nc3cc(F)c(Br)cc3[nH]2)c(cc1OC)-n1nccn1 InChI=1S/C23H22BrFN6O3/c1-23(22-28-16-10-14(24)15(25)11-17(16)29-22)5-4-8-30(23)21(32)13-9-19(33-2)20(34-3)12-18(13)31-26-6-7-27-31/h6-7,9-12H,4-5,8H2,1-3H3,(H,28,29)/t23-/m0/s1 DSOCUAIVNOMLTC-QHCPKHFHSA-N 334856 US11040966, Example 5.125::US9732075, Example 5.125::[(S)-2-(6-Bromo-5-fluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,5-dimethoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 126 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334856 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334856&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127792 384987016 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657353 C[C@]1(CCCN1C(=O)c1cc(F)ccc1-n1nccn1)c1nc2cc(F)c(Br)cc2[nH]1 InChI=1S/C21H17BrF2N6O/c1-21(20-27-16-10-14(22)15(24)11-17(16)28-20)5-2-8-29(21)19(31)13-9-12(23)3-4-18(13)30-25-6-7-26-30/h3-4,6-7,9-11H,2,5,8H2,1H3,(H,27,28)/t21-/m0/s1 RXWDVNJQNAVRSQ-NRFANRHFSA-N 334857 US11040966, Example 5.126::US9732075, Example 5.126::[(S)-2-(6-Bromo-5-fluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 117 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334857 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334857&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128193 384987017 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657354 C[C@]1(CCCN1C(=O)c1cc(F)ccc1-n1nccn1)c1nc2cc(F)c(Br)cc2[nH]1 InChI=1S/C21H17BrF2N6O/c1-21(20-27-16-10-14(22)15(24)11-17(16)28-20)5-2-8-29(21)19(31)13-9-12(23)3-4-18(13)30-25-6-7-26-30/h3-4,6-7,9-11H,2,5,8H2,1H3,(H,27,28)/t21-/m0/s1 RXWDVNJQNAVRSQ-NRFANRHFSA-N 334857 US11040966, Example 5.126::US9732075, Example 5.126::[(S)-2-(6-Bromo-5-fluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 396 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334857 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334857&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128193 384987017 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657355 Cc1cc(C(=O)N2CCC[C@@]2(C)c2nc3cc(F)c(Br)cc3[nH]2)c(cc1C)-n1nccn1 InChI=1S/C23H22BrFN6O/c1-13-9-15(20(10-14(13)2)31-26-6-7-27-31)21(32)30-8-4-5-23(30,3)22-28-18-11-16(24)17(25)12-19(18)29-22/h6-7,9-12H,4-5,8H2,1-3H3,(H,28,29)/t23-/m0/s1 XVMJBFKNJYLIGG-QHCPKHFHSA-N 334858 US11040966, Example 5.127::US9732075, Example 5.127::[(S)-2-(6-Bromo-5-fluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,5-dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334858 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334858&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127169 384987018 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657356 Cc1cc(C(=O)N2CCC[C@@]2(C)c2nc3cc(F)c(Br)cc3[nH]2)c(cc1C)-n1nccn1 InChI=1S/C23H22BrFN6O/c1-13-9-15(20(10-14(13)2)31-26-6-7-27-31)21(32)30-8-4-5-23(30,3)22-28-18-11-16(24)17(25)12-19(18)29-22/h6-7,9-12H,4-5,8H2,1-3H3,(H,28,29)/t23-/m0/s1 XVMJBFKNJYLIGG-QHCPKHFHSA-N 334858 US11040966, Example 5.127::US9732075, Example 5.127::[(S)-2-(6-Bromo-5-fluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,5-dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334858 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334858&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127169 384987018 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657357 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(F)c(Br)cc2[nH]1)-n1cccn1 InChI=1S/C23H21BrFN5O/c1-14-5-6-20(30-10-4-8-26-30)15(11-14)21(31)29-9-3-7-23(29,2)22-27-18-12-16(24)17(25)13-19(18)28-22/h4-6,8,10-13H,3,7,9H2,1-2H3,(H,27,28)/t23-/m0/s1 OSUXTTPJIXQPOA-QHCPKHFHSA-N 334859 US11040966, Example 5.128::US9732075, Example 5.128::[(S)-2-(6-Bromo-5-fluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 20.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334859 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334859&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128229 384987019 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657358 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(F)c(Br)cc2[nH]1)-n1cccn1 InChI=1S/C23H21BrFN5O/c1-14-5-6-20(30-10-4-8-26-30)15(11-14)21(31)29-9-3-7-23(29,2)22-27-18-12-16(24)17(25)13-19(18)28-22/h4-6,8,10-13H,3,7,9H2,1-2H3,(H,27,28)/t23-/m0/s1 OSUXTTPJIXQPOA-QHCPKHFHSA-N 334859 US11040966, Example 5.128::US9732075, Example 5.128::[(S)-2-(6-Bromo-5-fluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 219 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334859 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334859&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128229 384987019 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657359 C[C@]1(CCCN1C(=O)c1cc(Cl)ccc1-n1nccn1)c1nc2cc(F)c(Br)cc2[nH]1 InChI=1S/C21H17BrClFN6O/c1-21(20-27-16-10-14(22)15(24)11-17(16)28-20)5-2-8-29(21)19(31)13-9-12(23)3-4-18(13)30-25-6-7-26-30/h3-4,6-7,9-11H,2,5,8H2,1H3,(H,27,28)/t21-/m0/s1 GRDDGUBBHILLCH-NRFANRHFSA-N 334860 US11040966, Example 5.129::US9732075, Example 5.129::[(S)-2-(6-Bromo-5-fluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-chloro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 20.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334860 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334860&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127866 384987020 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657360 C[C@]1(CCCN1C(=O)c1cc(Cl)ccc1-n1nccn1)c1nc2cc(F)c(Br)cc2[nH]1 InChI=1S/C21H17BrClFN6O/c1-21(20-27-16-10-14(22)15(24)11-17(16)28-20)5-2-8-29(21)19(31)13-9-12(23)3-4-18(13)30-25-6-7-26-30/h3-4,6-7,9-11H,2,5,8H2,1H3,(H,27,28)/t21-/m0/s1 GRDDGUBBHILLCH-NRFANRHFSA-N 334860 US11040966, Example 5.129::US9732075, Example 5.129::[(S)-2-(6-Bromo-5-fluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-chloro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 62.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334860 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334860&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127866 384987020 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657361 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(C)(C)C)-n1nccn1 InChI=1S/C26H30N6O/c1-17-7-10-22(32-27-12-13-28-32)19(15-17)23(33)31-14-6-11-26(31,5)24-29-20-9-8-18(25(2,3)4)16-21(20)30-24/h7-10,12-13,15-16H,6,11,14H2,1-5H3,(H,29,30)/t26-/m0/s1 UIZYUTFITYIXNJ-SANMLTNESA-N 334861 US11040966, Example 5.13::US9732075, Example 5.13::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334861 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334861&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127396 384987021 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657362 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(C)(C)C)-n1nccn1 InChI=1S/C26H30N6O/c1-17-7-10-22(32-27-12-13-28-32)19(15-17)23(33)31-14-6-11-26(31,5)24-29-20-9-8-18(25(2,3)4)16-21(20)30-24/h7-10,12-13,15-16H,6,11,14H2,1-5H3,(H,29,30)/t26-/m0/s1 UIZYUTFITYIXNJ-SANMLTNESA-N 334861 US11040966, Example 5.13::US9732075, Example 5.13::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 31.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334861 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334861&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127396 384987021 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657363 Cc1ccc(C(=O)N2CCC[C@@]2(C)c2nc3cc(F)c(Br)cc3[nH]2)c(c1)-n1nccn1 InChI=1S/C22H20BrFN6O/c1-13-4-5-14(19(10-13)30-25-7-8-26-30)20(31)29-9-3-6-22(29,2)21-27-17-11-15(23)16(24)12-18(17)28-21/h4-5,7-8,10-12H,3,6,9H2,1-2H3,(H,27,28)/t22-/m0/s1 ITOBHWBVSLHWKH-QFIPXVFZSA-N 334862 US11040966, Example 5.130::US9732075, Example 5.130::[(S)-2-(6-Bromo-5-fluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 24.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334862 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334862&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128302 384987022 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657364 Cc1ccc(C(=O)N2CCC[C@@]2(C)c2nc3cc(F)c(Br)cc3[nH]2)c(c1)-n1nccn1 InChI=1S/C22H20BrFN6O/c1-13-4-5-14(19(10-13)30-25-7-8-26-30)20(31)29-9-3-6-22(29,2)21-27-17-11-15(23)16(24)12-18(17)28-21/h4-5,7-8,10-12H,3,6,9H2,1-2H3,(H,27,28)/t22-/m0/s1 ITOBHWBVSLHWKH-QFIPXVFZSA-N 334862 US11040966, Example 5.130::US9732075, Example 5.130::[(S)-2-(6-Bromo-5-fluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 58.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334862 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334862&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128302 384987022 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657365 Cc1ccc(c(n1)C(=O)N1CCC[C@@]1(C)c1nc2cc(F)c(Br)cc2[nH]1)-n1nccn1 InChI=1S/C21H19BrFN7O/c1-12-4-5-17(30-24-7-8-25-30)18(26-12)19(31)29-9-3-6-21(29,2)20-27-15-10-13(22)14(23)11-16(15)28-20/h4-5,7-8,10-11H,3,6,9H2,1-2H3,(H,27,28)/t21-/m0/s1 GBHBXSJWPYVORA-NRFANRHFSA-N 334863 US11040966, Example 5.131::US9732075, Example 5.131::[(S)-2-(6-Bromo-5-fluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 15.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334863 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334863&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127137 384987023 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657366 Cc1ccc(c(n1)C(=O)N1CCC[C@@]1(C)c1nc2cc(F)c(Br)cc2[nH]1)-n1nccn1 InChI=1S/C21H19BrFN7O/c1-12-4-5-17(30-24-7-8-25-30)18(26-12)19(31)29-9-3-6-21(29,2)20-27-15-10-13(22)14(23)11-16(15)28-20/h4-5,7-8,10-11H,3,6,9H2,1-2H3,(H,27,28)/t21-/m0/s1 GBHBXSJWPYVORA-NRFANRHFSA-N 334863 US11040966, Example 5.131::US9732075, Example 5.131::[(S)-2-(6-Bromo-5-fluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone Orexin receptor type 2 Homo sapiens 178 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334863 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334863&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127137 384987023 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657367 COc1ccc(c(C(=O)N2CCC[C@@]2(C)c2nc3cc(F)c(Br)cc3[nH]2)c1F)-n1nccn1 InChI=1S/C22H19BrF2N6O2/c1-22(21-28-14-10-12(23)13(24)11-15(14)29-21)6-3-9-30(22)20(32)18-16(31-26-7-8-27-31)4-5-17(33-2)19(18)25/h4-5,7-8,10-11H,3,6,9H2,1-2H3,(H,28,29)/t22-/m0/s1 VYSNGMLKCGSKNF-QFIPXVFZSA-N 334864 US11040966, Example 5.132::US9732075, Example 5.132::[(S)-2-(6-Bromo-5-fluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methoxy-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 54.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334864 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334864&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127738 384987024 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657368 COc1ccc(c(C(=O)N2CCC[C@@]2(C)c2nc3cc(F)c(Br)cc3[nH]2)c1F)-n1nccn1 InChI=1S/C22H19BrF2N6O2/c1-22(21-28-14-10-12(23)13(24)11-15(14)29-21)6-3-9-30(22)20(32)18-16(31-26-7-8-27-31)4-5-17(33-2)19(18)25/h4-5,7-8,10-11H,3,6,9H2,1-2H3,(H,28,29)/t22-/m0/s1 VYSNGMLKCGSKNF-QFIPXVFZSA-N 334864 US11040966, Example 5.132::US9732075, Example 5.132::[(S)-2-(6-Bromo-5-fluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methoxy-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 615 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334864 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334864&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127738 384987024 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657369 C[C@]1(CCCN1C(=O)c1c(F)cccc1-n1nccn1)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C22H17ClF4N6O/c1-21(20-30-15-10-12(22(25,26)27)13(23)11-16(15)31-20)6-3-9-32(21)19(34)18-14(24)4-2-5-17(18)33-28-7-8-29-33/h2,4-5,7-8,10-11H,3,6,9H2,1H3,(H,30,31)/t21-/m0/s1 LYWZLIQLNTXTCV-NRFANRHFSA-N 334865 US11040966, Example 5.133::US9732075, Example 5.133::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-fluoro-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 11.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334865 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334865&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127774 384987025 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657370 C[C@]1(CCCN1C(=O)c1c(F)cccc1-n1nccn1)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C22H17ClF4N6O/c1-21(20-30-15-10-12(22(25,26)27)13(23)11-16(15)31-20)6-3-9-32(21)19(34)18-14(24)4-2-5-17(18)33-28-7-8-29-33/h2,4-5,7-8,10-11H,3,6,9H2,1H3,(H,30,31)/t21-/m0/s1 LYWZLIQLNTXTCV-NRFANRHFSA-N 334865 US11040966, Example 5.133::US9732075, Example 5.133::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-fluoro-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 45.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334865 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334865&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127774 384987025 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657371 Cc1ccc(c(C(=O)N2CCC[C@@]2(C)c2nc3cc(c(Cl)cc3[nH]2)C(F)(F)F)c1F)-n1nccn1 InChI=1S/C23H19ClF4N6O/c1-12-4-5-17(34-29-7-8-30-34)18(19(12)25)20(35)33-9-3-6-22(33,2)21-31-15-10-13(23(26,27)28)14(24)11-16(15)32-21/h4-5,7-8,10-11H,3,6,9H2,1-2H3,(H,31,32)/t22-/m0/s1 PFZCJMHTXHMVCO-QFIPXVFZSA-N 334866 US11040966, Example 5.134::US9732075, Example 5.134::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334866 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334866&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127240 384987026 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657372 Cc1ccc(c(C(=O)N2CCC[C@@]2(C)c2nc3cc(c(Cl)cc3[nH]2)C(F)(F)F)c1F)-n1nccn1 InChI=1S/C23H19ClF4N6O/c1-12-4-5-17(34-29-7-8-30-34)18(19(12)25)20(35)33-9-3-6-22(33,2)21-31-15-10-13(23(26,27)28)14(24)11-16(15)32-21/h4-5,7-8,10-11H,3,6,9H2,1-2H3,(H,31,32)/t22-/m0/s1 PFZCJMHTXHMVCO-QFIPXVFZSA-N 334866 US11040966, Example 5.134::US9732075, Example 5.134::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 20.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334866 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334866&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127240 384987026 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657373 COc1cc(C(=O)N2CCC[C@@]2(C)c2nc3cc(c(Cl)cc3[nH]2)C(F)(F)F)c(cc1OC)-n1nccn1 InChI=1S/C24H22ClF3N6O3/c1-23(22-31-16-10-14(24(26,27)28)15(25)11-17(16)32-22)5-4-8-33(23)21(35)13-9-19(36-2)20(37-3)12-18(13)34-29-6-7-30-34/h6-7,9-12H,4-5,8H2,1-3H3,(H,31,32)/t23-/m0/s1 XIMPJUJVVCBPDX-QHCPKHFHSA-N 334867 US11040966, Example 5.135::US9732075, Example 5.135::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,5-dimethoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 10.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334867 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334867&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127978 384987027 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657374 COc1cc(C(=O)N2CCC[C@@]2(C)c2nc3cc(c(Cl)cc3[nH]2)C(F)(F)F)c(cc1OC)-n1nccn1 InChI=1S/C24H22ClF3N6O3/c1-23(22-31-16-10-14(24(26,27)28)15(25)11-17(16)32-22)5-4-8-33(23)21(35)13-9-19(36-2)20(37-3)12-18(13)34-29-6-7-30-34/h6-7,9-12H,4-5,8H2,1-3H3,(H,31,32)/t23-/m0/s1 XIMPJUJVVCBPDX-QHCPKHFHSA-N 334867 US11040966, Example 5.135::US9732075, Example 5.135::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,5-dimethoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 49.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334867 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334867&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127978 384987027 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657375 C[C@]1(CCCN1C(=O)c1cc(F)ccc1-n1nccn1)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C22H17ClF4N6O/c1-21(20-30-16-10-14(22(25,26)27)15(23)11-17(16)31-20)5-2-8-32(21)19(34)13-9-12(24)3-4-18(13)33-28-6-7-29-33/h3-4,6-7,9-11H,2,5,8H2,1H3,(H,30,31)/t21-/m0/s1 JELJIYGZOWMDMG-NRFANRHFSA-N 334868 US11040966, Example 5.136::US9732075, Example 5.136::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334868 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334868&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127388 384987028 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657376 C[C@]1(CCCN1C(=O)c1cc(F)ccc1-n1nccn1)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C22H17ClF4N6O/c1-21(20-30-16-10-14(22(25,26)27)15(23)11-17(16)31-20)5-2-8-32(21)19(34)13-9-12(24)3-4-18(13)33-28-6-7-29-33/h3-4,6-7,9-11H,2,5,8H2,1H3,(H,30,31)/t21-/m0/s1 JELJIYGZOWMDMG-NRFANRHFSA-N 334868 US11040966, Example 5.136::US9732075, Example 5.136::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 35.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334868 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334868&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127388 384987028 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657377 Cc1cc(C(=O)N2CCC[C@@]2(C)c2nc3cc(c(Cl)cc3[nH]2)C(F)(F)F)c(cc1C)-n1nccn1 InChI=1S/C24H22ClF3N6O/c1-13-9-15(20(10-14(13)2)34-29-6-7-30-34)21(35)33-8-4-5-23(33,3)22-31-18-11-16(24(26,27)28)17(25)12-19(18)32-22/h6-7,9-12H,4-5,8H2,1-3H3,(H,31,32)/t23-/m0/s1 AXADJOXVBYMSJX-QHCPKHFHSA-N 334869 US11040966, Example 5.137::US9732075, Example 5.137::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,5-dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334869 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334869&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127482 384987029 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657378 Cc1cc(C(=O)N2CCC[C@@]2(C)c2nc3cc(c(Cl)cc3[nH]2)C(F)(F)F)c(cc1C)-n1nccn1 InChI=1S/C24H22ClF3N6O/c1-13-9-15(20(10-14(13)2)34-29-6-7-30-34)21(35)33-8-4-5-23(33,3)22-31-18-11-16(24(26,27)28)17(25)12-19(18)32-22/h6-7,9-12H,4-5,8H2,1-3H3,(H,31,32)/t23-/m0/s1 AXADJOXVBYMSJX-QHCPKHFHSA-N 334869 US11040966, Example 5.137::US9732075, Example 5.137::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,5-dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334869 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334869&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127482 384987029 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657379 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F)-n1cccn1 InChI=1S/C24H21ClF3N5O/c1-14-5-6-20(33-10-4-8-29-33)15(11-14)21(34)32-9-3-7-23(32,2)22-30-18-12-16(24(26,27)28)17(25)13-19(18)31-22/h4-6,8,10-13H,3,7,9H2,1-2H3,(H,30,31)/t23-/m0/s1 NUZVJZMCEKEJIS-QHCPKHFHSA-N 334870 US11040966, Example 5.138::US9732075, Example 5.138::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334870 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334870&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127452 384987030 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657380 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F)-n1cccn1 InChI=1S/C24H21ClF3N5O/c1-14-5-6-20(33-10-4-8-29-33)15(11-14)21(34)32-9-3-7-23(32,2)22-30-18-12-16(24(26,27)28)17(25)13-19(18)31-22/h4-6,8,10-13H,3,7,9H2,1-2H3,(H,30,31)/t23-/m0/s1 NUZVJZMCEKEJIS-QHCPKHFHSA-N 334870 US11040966, Example 5.138::US9732075, Example 5.138::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 10.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334870 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334870&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127452 384987030 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657381 C[C@]1(CCCN1C(=O)c1cc(Cl)ccc1-n1nccn1)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C22H17Cl2F3N6O/c1-21(20-30-16-10-14(22(25,26)27)15(24)11-17(16)31-20)5-2-8-32(21)19(34)13-9-12(23)3-4-18(13)33-28-6-7-29-33/h3-4,6-7,9-11H,2,5,8H2,1H3,(H,30,31)/t21-/m0/s1 RVCFNBOYKMTUDC-NRFANRHFSA-N 334871 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(6-chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone::US11040966, Example 5.139::US9732075, Example 5.139 Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334871 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334871&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127612 384987031 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657382 C[C@]1(CCCN1C(=O)c1cc(Cl)ccc1-n1nccn1)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C22H17Cl2F3N6O/c1-21(20-30-16-10-14(22(25,26)27)15(24)11-17(16)31-20)5-2-8-32(21)19(34)13-9-12(23)3-4-18(13)33-28-6-7-29-33/h3-4,6-7,9-11H,2,5,8H2,1H3,(H,30,31)/t21-/m0/s1 RVCFNBOYKMTUDC-NRFANRHFSA-N 334871 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(6-chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone::US11040966, Example 5.139::US9732075, Example 5.139 Orexin receptor type 2 Homo sapiens 21.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334871 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334871&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127612 384987031 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657383 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(Cl)cc(cc2[nH]1)C(F)(F)F)-n1nccn1 InChI=1S/C23H20ClF3N6O/c1-13-4-5-18(33-28-7-8-29-33)15(10-13)20(34)32-9-3-6-22(32,2)21-30-17-12-14(23(25,26)27)11-16(24)19(17)31-21/h4-5,7-8,10-12H,3,6,9H2,1-2H3,(H,30,31)/t22-/m0/s1 HMZIXNYLVIPJPT-QFIPXVFZSA-N 334872 US11040966, Example 5.14::US9732075, Example 5.14::[(S)-2-(4-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334872 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334872&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127450 384987032 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657384 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(Cl)cc(cc2[nH]1)C(F)(F)F)-n1nccn1 InChI=1S/C23H20ClF3N6O/c1-13-4-5-18(33-28-7-8-29-33)15(10-13)20(34)32-9-3-6-22(32,2)21-30-17-12-14(23(25,26)27)11-16(24)19(17)31-21/h4-5,7-8,10-12H,3,6,9H2,1-2H3,(H,30,31)/t22-/m0/s1 HMZIXNYLVIPJPT-QFIPXVFZSA-N 334872 US11040966, Example 5.14::US9732075, Example 5.14::[(S)-2-(4-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 31.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334872 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334872&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127450 384987032 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657385 Cc1ccc(C(=O)N2CCC[C@@]2(C)c2nc3cc(c(Cl)cc3[nH]2)C(F)(F)F)c(c1)-n1nccn1 InChI=1S/C23H20ClF3N6O/c1-13-4-5-14(19(10-13)33-28-7-8-29-33)20(34)32-9-3-6-22(32,2)21-30-17-11-15(23(25,26)27)16(24)12-18(17)31-21/h4-5,7-8,10-12H,3,6,9H2,1-2H3,(H,30,31)/t22-/m0/s1 UFYOBMRLIYNTDM-QFIPXVFZSA-N 334873 US11040966, Example 5.140::US9732075, Example 5.140::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334873 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334873&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695100 384987033 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657386 Cc1ccc(C(=O)N2CCC[C@@]2(C)c2nc3cc(c(Cl)cc3[nH]2)C(F)(F)F)c(c1)-n1nccn1 InChI=1S/C23H20ClF3N6O/c1-13-4-5-14(19(10-13)33-28-7-8-29-33)20(34)32-9-3-6-22(32,2)21-30-17-11-15(23(25,26)27)16(24)12-18(17)31-21/h4-5,7-8,10-12H,3,6,9H2,1-2H3,(H,30,31)/t22-/m0/s1 UFYOBMRLIYNTDM-QFIPXVFZSA-N 334873 US11040966, Example 5.140::US9732075, Example 5.140::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 28.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334873 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334873&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695100 384987033 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657387 C[C@]1(CCCN1C(=O)c1ccccc1-n1cccn1)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C23H19ClF3N5O/c1-22(21-29-17-12-15(23(25,26)27)16(24)13-18(17)30-21)8-4-10-31(22)20(33)14-6-2-3-7-19(14)32-11-5-9-28-32/h2-3,5-7,9,11-13H,4,8,10H2,1H3,(H,29,30)/t22-/m0/s1 ABECTXIJNHIGAY-QFIPXVFZSA-N 334874 US11040966, Example 5.141::US9732075, Example 5.141::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-pyrazol-1-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 27.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334874 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334874&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127424 384987034 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657388 C[C@]1(CCCN1C(=O)c1ccccc1-n1cccn1)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C23H19ClF3N5O/c1-22(21-29-17-12-15(23(25,26)27)16(24)13-18(17)30-21)8-4-10-31(22)20(33)14-6-2-3-7-19(14)32-11-5-9-28-32/h2-3,5-7,9,11-13H,4,8,10H2,1H3,(H,29,30)/t22-/m0/s1 ABECTXIJNHIGAY-QFIPXVFZSA-N 334874 US11040966, Example 5.141::US9732075, Example 5.141::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-pyrazol-1-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 244 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334874 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334874&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127424 384987034 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657389 C[C@]1(CCCN1C(=O)c1ccccc1-n1nccn1)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C22H18ClF3N6O/c1-21(20-29-16-11-14(22(24,25)26)15(23)12-17(16)30-20)7-4-10-31(21)19(33)13-5-2-3-6-18(13)32-27-8-9-28-32/h2-3,5-6,8-9,11-12H,4,7,10H2,1H3,(H,29,30)/t21-/m0/s1 KVMPYKVPMCJIBK-NRFANRHFSA-N 334875 US11040966, Example 5.142::US9732075, Example 5.142::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334875 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334875&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694994 384987035 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657390 C[C@]1(CCCN1C(=O)c1ccccc1-n1nccn1)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C22H18ClF3N6O/c1-21(20-29-16-11-14(22(24,25)26)15(23)12-17(16)30-20)7-4-10-31(21)19(33)13-5-2-3-6-18(13)32-27-8-9-28-32/h2-3,5-6,8-9,11-12H,4,7,10H2,1H3,(H,29,30)/t21-/m0/s1 KVMPYKVPMCJIBK-NRFANRHFSA-N 334875 US11040966, Example 5.142::US9732075, Example 5.142::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 24.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334875 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334875&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694994 384987035 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657391 Cc1ccc(c(n1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F)-n1cccn1 InChI=1S/C23H20ClF3N6O/c1-13-5-6-18(33-10-4-8-28-33)19(29-13)20(34)32-9-3-7-22(32,2)21-30-16-11-14(23(25,26)27)15(24)12-17(16)31-21/h4-6,8,10-12H,3,7,9H2,1-2H3,(H,30,31)/t22-/m0/s1 CBLYKKFVYZQXBE-QFIPXVFZSA-N 334876 US11040966, Example 5.143::US9732075, Example 5.143::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(6-methyl-3-pyrazol-1-yl-pyridin-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334876 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334876&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127386 384987036 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657392 Cc1ccc(c(n1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F)-n1cccn1 InChI=1S/C23H20ClF3N6O/c1-13-5-6-18(33-10-4-8-28-33)19(29-13)20(34)32-9-3-7-22(32,2)21-30-16-11-14(23(25,26)27)15(24)12-17(16)31-21/h4-6,8,10-12H,3,7,9H2,1-2H3,(H,30,31)/t22-/m0/s1 CBLYKKFVYZQXBE-QFIPXVFZSA-N 334876 US11040966, Example 5.143::US9732075, Example 5.143::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(6-methyl-3-pyrazol-1-yl-pyridin-2-yl)-methanone Orexin receptor type 2 Homo sapiens 82.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334876 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334876&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127386 384987036 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657393 C[C@]1(CCCN1C(=O)c1cc(ccc1-n1nccn1)C(F)(F)F)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C23H17ClF6N6O/c1-21(20-33-16-10-14(23(28,29)30)15(24)11-17(16)34-20)5-2-8-35(21)19(37)13-9-12(22(25,26)27)3-4-18(13)36-31-6-7-32-36/h3-4,6-7,9-11H,2,5,8H2,1H3,(H,33,34)/t21-/m0/s1 RDRKTXBESXXNKN-NRFANRHFSA-N 334877 US11040966, Example 5.144::US9732075, Example 5.144::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoromethyl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 20.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334877 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334877&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127121 384987037 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657394 C[C@]1(CCCN1C(=O)c1cc(ccc1-n1nccn1)C(F)(F)F)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C23H17ClF6N6O/c1-21(20-33-16-10-14(23(28,29)30)15(24)11-17(16)34-20)5-2-8-35(21)19(37)13-9-12(22(25,26)27)3-4-18(13)36-31-6-7-32-36/h3-4,6-7,9-11H,2,5,8H2,1H3,(H,33,34)/t21-/m0/s1 RDRKTXBESXXNKN-NRFANRHFSA-N 334877 US11040966, Example 5.144::US9732075, Example 5.144::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoromethyl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 210 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334877 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334877&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127121 384987037 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657395 Cc1ccc(c(n1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F)-n1nccn1 InChI=1S/C22H19ClF3N7O/c1-12-4-5-17(33-27-7-8-28-33)18(29-12)19(34)32-9-3-6-21(32,2)20-30-15-10-13(22(24,25)26)14(23)11-16(15)31-20/h4-5,7-8,10-11H,3,6,9H2,1-2H3,(H,30,31)/t21-/m0/s1 OCZZWUHZTQKADF-NRFANRHFSA-N 334878 US11040966, Example 5.145::US9732075, Example 5.145::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334878 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334878&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695102 384987038 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657396 Cc1ccc(c(n1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F)-n1nccn1 InChI=1S/C22H19ClF3N7O/c1-12-4-5-17(33-27-7-8-28-33)18(29-12)19(34)32-9-3-6-21(32,2)20-30-15-10-13(22(24,25)26)14(23)11-16(15)31-20/h4-5,7-8,10-11H,3,6,9H2,1-2H3,(H,30,31)/t21-/m0/s1 OCZZWUHZTQKADF-NRFANRHFSA-N 334878 US11040966, Example 5.145::US9732075, Example 5.145::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone Orexin receptor type 2 Homo sapiens 30.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334878 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334878&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695102 384987038 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657397 COc1ccc(c(C(=O)N2CCC[C@@]2(C)c2nc3cc(c(Cl)cc3[nH]2)C(F)(F)F)c1F)-n1nccn1 InChI=1S/C23H19ClF4N6O2/c1-22(21-31-14-10-12(23(26,27)28)13(24)11-15(14)32-21)6-3-9-33(22)20(35)18-16(34-29-7-8-30-34)4-5-17(36-2)19(18)25/h4-5,7-8,10-11H,3,6,9H2,1-2H3,(H,31,32)/t22-/m0/s1 OWARWAJXMCLOJC-QFIPXVFZSA-N 334879 US11040966, Example 5.146::US9732075, Example 5.146::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methoxy-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 15.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334879 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334879&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694992 384987039 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657398 COc1ccc(c(C(=O)N2CCC[C@@]2(C)c2nc3cc(c(Cl)cc3[nH]2)C(F)(F)F)c1F)-n1nccn1 InChI=1S/C23H19ClF4N6O2/c1-22(21-31-14-10-12(23(26,27)28)13(24)11-15(14)32-21)6-3-9-33(22)20(35)18-16(34-29-7-8-30-34)4-5-17(36-2)19(18)25/h4-5,7-8,10-11H,3,6,9H2,1-2H3,(H,31,32)/t22-/m0/s1 OWARWAJXMCLOJC-QFIPXVFZSA-N 334879 US11040966, Example 5.146::US9732075, Example 5.146::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methoxy-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 43.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334879 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334879&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694992 384987039 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657399 C[C@]1(CCCN1C(=O)c1cc(OC(F)(F)F)ccc1-n1nccn1)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C23H17ClF6N6O2/c1-21(20-33-16-10-14(22(25,26)27)15(24)11-17(16)34-20)5-2-8-35(21)19(37)13-9-12(38-23(28,29)30)3-4-18(13)36-31-6-7-32-36/h3-4,6-7,9-11H,2,5,8H2,1H3,(H,33,34)/t21-/m0/s1 SAHMGWAHRTUSEG-NRFANRHFSA-N 334880 US11040966, Example 5.147::US9732075, Example 5.147::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluorometh-oxy-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 27.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334880 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334880&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128014 384987040 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657400 C[C@]1(CCCN1C(=O)c1cc(OC(F)(F)F)ccc1-n1nccn1)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C23H17ClF6N6O2/c1-21(20-33-16-10-14(22(25,26)27)15(24)11-17(16)34-20)5-2-8-35(21)19(37)13-9-12(38-23(28,29)30)3-4-18(13)36-31-6-7-32-36/h3-4,6-7,9-11H,2,5,8H2,1H3,(H,33,34)/t21-/m0/s1 SAHMGWAHRTUSEG-NRFANRHFSA-N 334880 US11040966, Example 5.147::US9732075, Example 5.147::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluorometh-oxy-phenyl)-methanone Orexin receptor type 2 Homo sapiens 112 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334880 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334880&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128014 384987040 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657401 COc1ccccc1-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C28H25ClF3N3O2/c1-16-9-10-17(18-7-4-5-8-24(18)37-3)19(13-16)25(36)35-12-6-11-27(35,2)26-33-22-14-20(28(30,31)32)21(29)15-23(22)34-26/h4-5,7-10,13-15H,6,11-12H2,1-3H3,(H,33,34)/t27-/m0/s1 ARCORKOUFDLLJJ-MHZLTWQESA-N 334881 US11040966, Example 5.148::US9732075, Example 5.148::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2'-methoxy-4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 35.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334881 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334881&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127412 384987041 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657402 COc1ccccc1-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C28H25ClF3N3O2/c1-16-9-10-17(18-7-4-5-8-24(18)37-3)19(13-16)25(36)35-12-6-11-27(35,2)26-33-22-14-20(28(30,31)32)21(29)15-23(22)34-26/h4-5,7-10,13-15H,6,11-12H2,1-3H3,(H,33,34)/t27-/m0/s1 ARCORKOUFDLLJJ-MHZLTWQESA-N 334881 US11040966, Example 5.148::US9732075, Example 5.148::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2'-methoxy-4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 159 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334881 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334881&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127412 384987041 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657403 COc1cccc(c1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C28H25ClF3N3O2/c1-16-8-9-19(17-6-4-7-18(13-17)37-3)20(12-16)25(36)35-11-5-10-27(35,2)26-33-23-14-21(28(30,31)32)22(29)15-24(23)34-26/h4,6-9,12-15H,5,10-11H2,1-3H3,(H,33,34)/t27-/m0/s1 SPNKHSFFGNCOPO-MHZLTWQESA-N 334882 US11040966, Example 5.149::US9732075, Example 5.149::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-methoxy-4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 21.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334882 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334882&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694995 384987042 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657404 COc1cccc(c1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C28H25ClF3N3O2/c1-16-8-9-19(17-6-4-7-18(13-17)37-3)20(12-16)25(36)35-11-5-10-27(35,2)26-33-23-14-21(28(30,31)32)22(29)15-24(23)34-26/h4,6-9,12-15H,5,10-11H2,1-3H3,(H,33,34)/t27-/m0/s1 SPNKHSFFGNCOPO-MHZLTWQESA-N 334882 US11040966, Example 5.149::US9732075, Example 5.149::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-methoxy-4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 26.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334882 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334882&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694995 384987042 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657405 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(Cl)c(C)cc2[nH]1)-n1nccn1 InChI=1S/C23H23ClN6O/c1-14-5-6-20(30-25-8-9-26-30)16(11-14)21(31)29-10-4-7-23(29,3)22-27-18-12-15(2)17(24)13-19(18)28-22/h5-6,8-9,11-13H,4,7,10H2,1-3H3,(H,27,28)/t23-/m0/s1 LWXMERDCRWOCQF-QHCPKHFHSA-N 334883 US11040966, Example 5.15::US9732075, Example 5.15::[(S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334883 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334883&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694993 384987043 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657406 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(Cl)c(C)cc2[nH]1)-n1nccn1 InChI=1S/C23H23ClN6O/c1-14-5-6-20(30-25-8-9-26-30)16(11-14)21(31)29-10-4-7-23(29,3)22-27-18-12-15(2)17(24)13-19(18)28-22/h5-6,8-9,11-13H,4,7,10H2,1-3H3,(H,27,28)/t23-/m0/s1 LWXMERDCRWOCQF-QHCPKHFHSA-N 334883 US11040966, Example 5.15::US9732075, Example 5.15::[(S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 22.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334883 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334883&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694993 384987043 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657407 COc1ccc(cc1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C28H25ClF3N3O2/c1-16-5-10-19(17-6-8-18(37-3)9-7-17)20(13-16)25(36)35-12-4-11-27(35,2)26-33-23-14-21(28(30,31)32)22(29)15-24(23)34-26/h5-10,13-15H,4,11-12H2,1-3H3,(H,33,34)/t27-/m0/s1 CCZFQNOIIRTIBE-MHZLTWQESA-N 334884 US11040966, Example 5.150::US9732075, Example 5.150::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-methoxy-4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 37.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334884 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334884&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128037 384987044 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657408 COc1ccc(cc1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C28H25ClF3N3O2/c1-16-5-10-19(17-6-8-18(37-3)9-7-17)20(13-16)25(36)35-12-4-11-27(35,2)26-33-23-14-21(28(30,31)32)22(29)15-24(23)34-26/h5-10,13-15H,4,11-12H2,1-3H3,(H,33,34)/t27-/m0/s1 CCZFQNOIIRTIBE-MHZLTWQESA-N 334884 US11040966, Example 5.150::US9732075, Example 5.150::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-methoxy-4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 49.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334884 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334884&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128037 384987044 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657409 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F)-c1ccccc1F InChI=1S/C27H22ClF4N3O/c1-15-8-9-16(17-6-3-4-7-21(17)29)18(12-15)24(36)35-11-5-10-26(35,2)25-33-22-13-19(27(30,31)32)20(28)14-23(22)34-25/h3-4,6-9,12-14H,5,10-11H2,1-2H3,(H,33,34)/t26-/m0/s1 XYCKHVGUGDRECK-SANMLTNESA-N 334885 US11040966, Example 5.151::US9732075, Example 5.151::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2'-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 20.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334885 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334885&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695098 384987045 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657410 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F)-c1ccccc1F InChI=1S/C27H22ClF4N3O/c1-15-8-9-16(17-6-3-4-7-21(17)29)18(12-15)24(36)35-11-5-10-26(35,2)25-33-22-13-19(27(30,31)32)20(28)14-23(22)34-25/h3-4,6-9,12-14H,5,10-11H2,1-2H3,(H,33,34)/t26-/m0/s1 XYCKHVGUGDRECK-SANMLTNESA-N 334885 US11040966, Example 5.151::US9732075, Example 5.151::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2'-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 40.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334885 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334885&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695098 384987045 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657411 Cc1ccc(-c2ccc(F)cc2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C27H22ClF4N3O/c1-15-4-9-18(16-5-7-17(29)8-6-16)19(12-15)24(36)35-11-3-10-26(35,2)25-33-22-13-20(27(30,31)32)21(28)14-23(22)34-25/h4-9,12-14H,3,10-11H2,1-2H3,(H,33,34)/t26-/m0/s1 MXSMDHDHIZEBJS-SANMLTNESA-N 334886 US11040966, Example 5.152::US9732075, Example 5.152::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 24.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334886 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334886&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127648 384987046 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657412 Cc1ccc(-c2ccc(F)cc2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C27H22ClF4N3O/c1-15-4-9-18(16-5-7-17(29)8-6-16)19(12-15)24(36)35-11-3-10-26(35,2)25-33-22-13-20(27(30,31)32)21(28)14-23(22)34-25/h4-9,12-14H,3,10-11H2,1-2H3,(H,33,34)/t26-/m0/s1 MXSMDHDHIZEBJS-SANMLTNESA-N 334886 US11040966, Example 5.152::US9732075, Example 5.152::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 51.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334886 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334886&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127648 384987046 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657413 Cc1ccc(-c2cccc(F)c2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C27H22ClF4N3O/c1-15-7-8-18(16-5-3-6-17(29)12-16)19(11-15)24(36)35-10-4-9-26(35,2)25-33-22-13-20(27(30,31)32)21(28)14-23(22)34-25/h3,5-8,11-14H,4,9-10H2,1-2H3,(H,33,34)/t26-/m0/s1 ZCMHEZQPLZZTAZ-SANMLTNESA-N 334887 US11040966, Example 5.153::US9732075, Example 5.153::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 22.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334887 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334887&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694996 384987047 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657414 Cc1ccc(-c2cccc(F)c2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C27H22ClF4N3O/c1-15-7-8-18(16-5-3-6-17(29)12-16)19(11-15)24(36)35-10-4-9-26(35,2)25-33-22-13-20(27(30,31)32)21(28)14-23(22)34-25/h3,5-8,11-14H,4,9-10H2,1-2H3,(H,33,34)/t26-/m0/s1 ZCMHEZQPLZZTAZ-SANMLTNESA-N 334887 US11040966, Example 5.153::US9732075, Example 5.153::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 35.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334887 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334887&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694996 384987047 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657415 Cc1ccc(cc1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C28H25ClF3N3O/c1-16-5-8-18(9-6-16)19-10-7-17(2)13-20(19)25(36)35-12-4-11-27(35,3)26-33-23-14-21(28(30,31)32)22(29)15-24(23)34-26/h5-10,13-15H,4,11-12H2,1-3H3,(H,33,34)/t27-/m0/s1 FXKDZHDPJITFLP-MHZLTWQESA-N 334888 US11040966, Example 5.154::US9732075, Example 5.154::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,4'-dimethyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 59.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334888 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334888&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127687 384987048 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657416 Cc1ccc(cc1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C28H25ClF3N3O/c1-16-5-8-18(9-6-16)19-10-7-17(2)13-20(19)25(36)35-12-4-11-27(35,3)26-33-23-14-21(28(30,31)32)22(29)15-24(23)34-26/h5-10,13-15H,4,11-12H2,1-3H3,(H,33,34)/t27-/m0/s1 FXKDZHDPJITFLP-MHZLTWQESA-N 334888 US11040966, Example 5.154::US9732075, Example 5.154::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,4'-dimethyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 61.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334888 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334888&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127687 384987048 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657417 Cc1ccc(-c2cccc(c2)C(F)(F)F)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C28H22ClF6N3O/c1-15-7-8-18(16-5-3-6-17(12-16)27(30,31)32)19(11-15)24(39)38-10-4-9-26(38,2)25-36-22-13-20(28(33,34)35)21(29)14-23(22)37-25/h3,5-8,11-14H,4,9-10H2,1-2H3,(H,36,37)/t26-/m0/s1 CCDLLBNMKKXVND-SANMLTNESA-N 334889 US11040966, Example 5.155::US9732075, Example 5.155::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4-methyl-3'-trifluoromethyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 134 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334889 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334889&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127992 384987049 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657418 Cc1ccc(-c2cccc(c2)C(F)(F)F)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C28H22ClF6N3O/c1-15-7-8-18(16-5-3-6-17(12-16)27(30,31)32)19(11-15)24(39)38-10-4-9-26(38,2)25-36-22-13-20(28(33,34)35)21(29)14-23(22)37-25/h3,5-8,11-14H,4,9-10H2,1-2H3,(H,36,37)/t26-/m0/s1 CCDLLBNMKKXVND-SANMLTNESA-N 334889 US11040966, Example 5.155::US9732075, Example 5.155::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4-methyl-3'-trifluoromethyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 249 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334889 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334889&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127992 384987049 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657419 Cc1ccc(-c2ccc3OCOc3c2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C28H23ClF3N3O3/c1-15-4-6-17(16-5-7-23-24(11-16)38-14-37-23)18(10-15)25(36)35-9-3-8-27(35,2)26-33-21-12-19(28(30,31)32)20(29)13-22(21)34-26/h4-7,10-13H,3,8-9,14H2,1-2H3,(H,33,34)/t27-/m0/s1 FTGJOLOBFYSUKB-MHZLTWQESA-N 334890 (2-Benzo[1,3]dioxol-5-yl-5-methyl-phenyl)-[(S)-2-(6-chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone::US11040966, Example 5.156::US9732075, Example 5.156 Orexin/Hypocretin receptor type 1 Homo sapiens 38.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334890 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334890&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127788 384987050 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657420 Cc1ccc(-c2ccc3OCOc3c2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C28H23ClF3N3O3/c1-15-4-6-17(16-5-7-23-24(11-16)38-14-37-23)18(10-15)25(36)35-9-3-8-27(35,2)26-33-21-12-19(28(30,31)32)20(29)13-22(21)34-26/h4-7,10-13H,3,8-9,14H2,1-2H3,(H,33,34)/t27-/m0/s1 FTGJOLOBFYSUKB-MHZLTWQESA-N 334890 (2-Benzo[1,3]dioxol-5-yl-5-methyl-phenyl)-[(S)-2-(6-chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone::US11040966, Example 5.156::US9732075, Example 5.156 Orexin receptor type 2 Homo sapiens 54.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334890 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334890&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127788 384987050 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657421 Cc1ccc(-c2ccc(cc2)C(F)(F)F)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C28H22ClF6N3O/c1-15-4-9-18(16-5-7-17(8-6-16)27(30,31)32)19(12-15)24(39)38-11-3-10-26(38,2)25-36-22-13-20(28(33,34)35)21(29)14-23(22)37-25/h4-9,12-14H,3,10-11H2,1-2H3,(H,36,37)/t26-/m0/s1 NONHWPDPZWTBNG-SANMLTNESA-N 334891 US11040966, Example 5.157::US9732075, Example 5.157::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4-methyl-4'-trifluoromethyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 367 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334891 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334891&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127576 384987051 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657422 Cc1ccc(-c2ccc(cc2)C(F)(F)F)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C28H22ClF6N3O/c1-15-4-9-18(16-5-7-17(8-6-16)27(30,31)32)19(12-15)24(39)38-11-3-10-26(38,2)25-36-22-13-20(28(33,34)35)21(29)14-23(22)37-25/h4-9,12-14H,3,10-11H2,1-2H3,(H,36,37)/t26-/m0/s1 NONHWPDPZWTBNG-SANMLTNESA-N 334891 US11040966, Example 5.157::US9732075, Example 5.157::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4-methyl-4'-trifluoromethyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 538 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334891 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334891&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127576 384987051 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657423 Cc1ccc(-c2ccc(OC(F)(F)F)cc2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C28H22ClF6N3O2/c1-15-4-9-18(16-5-7-17(8-6-16)40-28(33,34)35)19(12-15)24(39)38-11-3-10-26(38,2)25-36-22-13-20(27(30,31)32)21(29)14-23(22)37-25/h4-9,12-14H,3,10-11H2,1-2H3,(H,36,37)/t26-/m0/s1 YLWSVPOEELDXDC-SANMLTNESA-N 334892 US11040966, Example 5.158::US9732075, Example 5.158::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4-methyl-4'-trifluoromethoxy-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 525 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334892 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334892&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127934 384987052 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657424 Cc1ccc(-c2ccc(OC(F)(F)F)cc2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C28H22ClF6N3O2/c1-15-4-9-18(16-5-7-17(8-6-16)40-28(33,34)35)19(12-15)24(39)38-11-3-10-26(38,2)25-36-22-13-20(27(30,31)32)21(29)14-23(22)37-25/h4-9,12-14H,3,10-11H2,1-2H3,(H,36,37)/t26-/m0/s1 YLWSVPOEELDXDC-SANMLTNESA-N 334892 US11040966, Example 5.158::US9732075, Example 5.158::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4-methyl-4'-trifluoromethoxy-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 879 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334892 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334892&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127934 384987052 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657425 Cc1ccc(-c2cccc(c2)C#N)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C28H22ClF3N4O/c1-16-7-8-19(18-6-3-5-17(12-18)15-33)20(11-16)25(37)36-10-4-9-27(36,2)26-34-23-13-21(28(30,31)32)22(29)14-24(23)35-26/h3,5-8,11-14H,4,9-10H2,1-2H3,(H,34,35)/t27-/m0/s1 WPJXIHBNBGDCEC-MHZLTWQESA-N 334893 2'-[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidine-1-carbonyl]-4'-methyl-biphenyl-3-carbonitrile::US11040966, Example 5.159::US9732075, Example 5.159 Orexin/Hypocretin receptor type 1 Homo sapiens 23.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334893 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334893&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127183 384987053 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657426 Cc1ccc(-c2cccc(c2)C#N)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C28H22ClF3N4O/c1-16-7-8-19(18-6-3-5-17(12-18)15-33)20(11-16)25(37)36-10-4-9-27(36,2)26-34-23-13-21(28(30,31)32)22(29)14-24(23)35-26/h3,5-8,11-14H,4,9-10H2,1-2H3,(H,34,35)/t27-/m0/s1 WPJXIHBNBGDCEC-MHZLTWQESA-N 334893 2'-[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidine-1-carbonyl]-4'-methyl-biphenyl-3-carbonitrile::US11040966, Example 5.159::US9732075, Example 5.159 Orexin receptor type 2 Homo sapiens 37.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334893 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334893&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127183 384987053 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657427 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)cc(C)cc2[nH]1)-n1nccn1 InChI=1S/C24H26N6O/c1-15-6-7-20(30-25-9-10-26-30)18(13-15)22(31)29-11-5-8-24(29,4)23-27-19-14-16(2)12-17(3)21(19)28-23/h6-7,9-10,12-14H,5,8,11H2,1-4H3,(H,27,28)/t24-/m0/s1 RFNUEZIKHIFYIQ-DEOSSOPVSA-N 334894 US11040966, Example 5.16::US9732075, Example 5.16::[(S)-2-(4,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 16.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334894 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334894&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694893 384987054 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657428 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)cc(C)cc2[nH]1)-n1nccn1 InChI=1S/C24H26N6O/c1-15-6-7-20(30-25-9-10-26-30)18(13-15)22(31)29-11-5-8-24(29,4)23-27-19-14-16(2)12-17(3)21(19)28-23/h6-7,9-10,12-14H,5,8,11H2,1-4H3,(H,27,28)/t24-/m0/s1 RFNUEZIKHIFYIQ-DEOSSOPVSA-N 334894 US11040966, Example 5.16::US9732075, Example 5.16::[(S)-2-(4,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 18.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334894 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334894&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694893 384987054 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657429 Cc1ccc(-c2ccc(cc2)C#N)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C28H22ClF3N4O/c1-16-4-9-19(18-7-5-17(15-33)6-8-18)20(12-16)25(37)36-11-3-10-27(36,2)26-34-23-13-21(28(30,31)32)22(29)14-24(23)35-26/h4-9,12-14H,3,10-11H2,1-2H3,(H,34,35)/t27-/m0/s1 GVVKKHVXHRGSGC-MHZLTWQESA-N 334895 2'-[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidine-1-carbonyl]-4'-methyl-biphenyl-4-carbonitrile::US11040966, Example 5.160::US9732075, Example 5.160 Orexin/Hypocretin receptor type 1 Homo sapiens 38.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334895 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334895&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127734 384987055 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657430 Cc1ccc(-c2ccc(cc2)C#N)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C28H22ClF3N4O/c1-16-4-9-19(18-7-5-17(15-33)6-8-18)20(12-16)25(37)36-11-3-10-27(36,2)26-34-23-13-21(28(30,31)32)22(29)14-24(23)35-26/h4-9,12-14H,3,10-11H2,1-2H3,(H,34,35)/t27-/m0/s1 GVVKKHVXHRGSGC-MHZLTWQESA-N 334895 2'-[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidine-1-carbonyl]-4'-methyl-biphenyl-4-carbonitrile::US11040966, Example 5.160::US9732075, Example 5.160 Orexin receptor type 2 Homo sapiens 113 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334895 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334895&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127734 384987055 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657431 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F)-c1cccc(C)c1C InChI=1S/C29H27ClF3N3O/c1-16-9-10-20(19-8-5-7-17(2)18(19)3)21(13-16)26(37)36-12-6-11-28(36,4)27-34-24-14-22(29(31,32)33)23(30)15-25(24)35-27/h5,7-10,13-15H,6,11-12H2,1-4H3,(H,34,35)/t28-/m0/s1 IMXLNKLDXANFCS-NDEPHWFRSA-N 334896 US11040966, Example 5.161::US9732075, Example 5.161::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,2',3'-trimethyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 405 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334896 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334896&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127988 384987056 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657432 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F)-c1cccc(C)c1C InChI=1S/C29H27ClF3N3O/c1-16-9-10-20(19-8-5-7-17(2)18(19)3)21(13-16)26(37)36-12-6-11-28(36,4)27-34-24-14-22(29(31,32)33)23(30)15-25(24)35-27/h5,7-10,13-15H,6,11-12H2,1-4H3,(H,34,35)/t28-/m0/s1 IMXLNKLDXANFCS-NDEPHWFRSA-N 334896 US11040966, Example 5.161::US9732075, Example 5.161::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,2',3'-trimethyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 388 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334896 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334896&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127988 384987056 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657433 CCOc1ccc(cc1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C29H27ClF3N3O2/c1-4-38-19-9-7-18(8-10-19)20-11-6-17(2)14-21(20)26(37)36-13-5-12-28(36,3)27-34-24-15-22(29(31,32)33)23(30)16-25(24)35-27/h6-11,14-16H,4-5,12-13H2,1-3H3,(H,34,35)/t28-/m0/s1 RTWKENFMDMAEQA-NDEPHWFRSA-N 334897 US11040966, Example 5.162::US9732075, Example 5.162::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-ethoxy-4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 252 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334897 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334897&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127384 384987057 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657434 CCOc1ccc(cc1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C29H27ClF3N3O2/c1-4-38-19-9-7-18(8-10-19)20-11-6-17(2)14-21(20)26(37)36-13-5-12-28(36,3)27-34-24-15-22(29(31,32)33)23(30)16-25(24)35-27/h6-11,14-16H,4-5,12-13H2,1-3H3,(H,34,35)/t28-/m0/s1 RTWKENFMDMAEQA-NDEPHWFRSA-N 334897 US11040966, Example 5.162::US9732075, Example 5.162::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-ethoxy-4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 250 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334897 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334897&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127384 384987057 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657435 Cc1ccc(-c2cccc(OC(F)(F)F)c2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C28H22ClF6N3O2/c1-15-7-8-18(16-5-3-6-17(12-16)40-28(33,34)35)19(11-15)24(39)38-10-4-9-26(38,2)25-36-22-13-20(27(30,31)32)21(29)14-23(22)37-25/h3,5-8,11-14H,4,9-10H2,1-2H3,(H,36,37)/t26-/m0/s1 RIYMBXBCSJMBHS-SANMLTNESA-N 334898 US11040966, Example 5.163::US9732075, Example 5.163::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4-methyl-3'-trifluoromethoxy-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 142 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334898 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334898&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128200 384987058 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657436 Cc1ccc(-c2cccc(OC(F)(F)F)c2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C28H22ClF6N3O2/c1-15-7-8-18(16-5-3-6-17(12-16)40-28(33,34)35)19(11-15)24(39)38-10-4-9-26(38,2)25-36-22-13-20(27(30,31)32)21(29)14-23(22)37-25/h3,5-8,11-14H,4,9-10H2,1-2H3,(H,36,37)/t26-/m0/s1 RIYMBXBCSJMBHS-SANMLTNESA-N 334898 US11040966, Example 5.163::US9732075, Example 5.163::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4-methyl-3'-trifluoromethoxy-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 401 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334898 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334898&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128200 384987058 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657437 C[C@]1(CCCN1C(=O)c1c(F)cccc1-n1nccn1)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C22H18F4N6O/c1-21(20-29-15-7-6-13(22(24,25)26)12-16(15)30-20)8-3-11-31(21)19(33)18-14(23)4-2-5-17(18)32-27-9-10-28-32/h2,4-7,9-10,12H,3,8,11H2,1H3,(H,29,30)/t21-/m0/s1 JRFQVTHALCZPHC-NRFANRHFSA-N 334899 (2-Fluoro-6-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.164::US9732075, Example 5.164 Orexin/Hypocretin receptor type 1 Homo sapiens 104 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334899 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334899&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128023 384987059 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657438 C[C@]1(CCCN1C(=O)c1c(F)cccc1-n1nccn1)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C22H18F4N6O/c1-21(20-29-15-7-6-13(22(24,25)26)12-16(15)30-20)8-3-11-31(21)19(33)18-14(23)4-2-5-17(18)32-27-9-10-28-32/h2,4-7,9-10,12H,3,8,11H2,1H3,(H,29,30)/t21-/m0/s1 JRFQVTHALCZPHC-NRFANRHFSA-N 334899 (2-Fluoro-6-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.164::US9732075, Example 5.164 Orexin receptor type 2 Homo sapiens 419 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334899 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334899&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128023 384987059 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657439 C[C@]1(CCCN1C(=O)c1cc(F)ccc1-n1nccn1)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C22H18F4N6O/c1-21(20-29-16-5-3-13(22(24,25)26)11-17(16)30-20)7-2-10-31(21)19(33)15-12-14(23)4-6-18(15)32-27-8-9-28-32/h3-6,8-9,11-12H,2,7,10H2,1H3,(H,29,30)/t21-/m0/s1 MIOXUQJEONXBGM-NRFANRHFSA-N 334900 (5-Fluoro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.165::US9732075, Example 5.165 Orexin/Hypocretin receptor type 1 Homo sapiens 65.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334900 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334900&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128175 384987060 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657440 C[C@]1(CCCN1C(=O)c1cc(F)ccc1-n1nccn1)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C22H18F4N6O/c1-21(20-29-16-5-3-13(22(24,25)26)11-17(16)30-20)7-2-10-31(21)19(33)15-12-14(23)4-6-18(15)32-27-8-9-28-32/h3-6,8-9,11-12H,2,7,10H2,1H3,(H,29,30)/t21-/m0/s1 MIOXUQJEONXBGM-NRFANRHFSA-N 334900 (5-Fluoro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.165::US9732075, Example 5.165 Orexin receptor type 2 Homo sapiens 355 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334900 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334900&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128175 384987060 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657441 C[C@]1(CCCN1C(=O)c1cc(Cl)ccc1-n1nccn1)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C22H18ClF3N6O/c1-21(20-29-16-5-3-13(22(24,25)26)11-17(16)30-20)7-2-10-31(21)19(33)15-12-14(23)4-6-18(15)32-27-8-9-28-32/h3-6,8-9,11-12H,2,7,10H2,1H3,(H,29,30)/t21-/m0/s1 UNMLRSSPKDXIGH-NRFANRHFSA-N 334901 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.166::US9732075, Example 5.166 Orexin/Hypocretin receptor type 1 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334901 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334901&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694892 384987061 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657442 C[C@]1(CCCN1C(=O)c1cc(Cl)ccc1-n1nccn1)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C22H18ClF3N6O/c1-21(20-29-16-5-3-13(22(24,25)26)11-17(16)30-20)7-2-10-31(21)19(33)15-12-14(23)4-6-18(15)32-27-8-9-28-32/h3-6,8-9,11-12H,2,7,10H2,1H3,(H,29,30)/t21-/m0/s1 UNMLRSSPKDXIGH-NRFANRHFSA-N 334901 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.166::US9732075, Example 5.166 Orexin receptor type 2 Homo sapiens 59.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334901 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334901&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694892 384987061 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657443 C[C@]1(CCCN1C(=O)c1ccccc1-n1nccn1)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C22H19F3N6O/c1-21(20-28-16-8-7-14(22(23,24)25)13-17(16)29-20)9-4-12-30(21)19(32)15-5-2-3-6-18(15)31-26-10-11-27-31/h2-3,5-8,10-11,13H,4,9,12H2,1H3,(H,28,29)/t21-/m0/s1 GIHOVVXWCXWDOL-NRFANRHFSA-N 334902 US11040966, Example 5.167::US9732075, Example 5.167::[(S)-2-Methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 91.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334902 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334902&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102377 384987062 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657444 C[C@]1(CCCN1C(=O)c1ccccc1-n1nccn1)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C22H19F3N6O/c1-21(20-28-16-8-7-14(22(23,24)25)13-17(16)29-20)9-4-12-30(21)19(32)15-5-2-3-6-18(15)31-26-10-11-27-31/h2-3,5-8,10-11,13H,4,9,12H2,1H3,(H,28,29)/t21-/m0/s1 GIHOVVXWCXWDOL-NRFANRHFSA-N 334902 US11040966, Example 5.167::US9732075, Example 5.167::[(S)-2-Methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 351 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334902 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334902&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102377 384987062 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657445 COc1ccc(c(C(=O)N2CCC[C@@]2(C)c2nc3cc(ccc3[nH]2)C(F)(F)F)c1F)-n1nccn1 InChI=1S/C23H20F4N6O2/c1-22(21-30-14-5-4-13(23(25,26)27)12-15(14)31-21)8-3-11-32(22)20(34)18-16(33-28-9-10-29-33)6-7-17(35-2)19(18)24/h4-7,9-10,12H,3,8,11H2,1-2H3,(H,30,31)/t22-/m0/s1 LPIQKQFKMBNGRD-QFIPXVFZSA-N 334903 (2-Fluoro-3-methoxy-6-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.168::US9732075, Example 5.168 Orexin/Hypocretin receptor type 1 Homo sapiens 64.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334903 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334903&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128036 384987063 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657446 COc1ccc(c(C(=O)N2CCC[C@@]2(C)c2nc3cc(ccc3[nH]2)C(F)(F)F)c1F)-n1nccn1 InChI=1S/C23H20F4N6O2/c1-22(21-30-14-5-4-13(23(25,26)27)12-15(14)31-21)8-3-11-32(22)20(34)18-16(33-28-9-10-29-33)6-7-17(35-2)19(18)24/h4-7,9-10,12H,3,8,11H2,1-2H3,(H,30,31)/t22-/m0/s1 LPIQKQFKMBNGRD-QFIPXVFZSA-N 334903 (2-Fluoro-3-methoxy-6-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.168::US9732075, Example 5.168 Orexin receptor type 2 Homo sapiens 570 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334903 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334903&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128036 384987063 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657447 Cc1ccc(c(C(=O)N2CCC[C@@]2(C)c2nc3cc(ccc3[nH]2)C(F)(F)F)c1F)-n1nccn1 InChI=1S/C23H20F4N6O/c1-13-4-7-17(33-28-9-10-29-33)18(19(13)24)20(34)32-11-3-8-22(32,2)21-30-15-6-5-14(23(25,26)27)12-16(15)31-21/h4-7,9-10,12H,3,8,11H2,1-2H3,(H,30,31)/t22-/m0/s1 CLFMEHJJIKJZME-QFIPXVFZSA-N 334904 (2-Fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.169::US9732075, Example 5.169 Orexin/Hypocretin receptor type 1 Homo sapiens 63.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334904 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334904&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127243 384987064 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657448 Cc1ccc(c(C(=O)N2CCC[C@@]2(C)c2nc3cc(ccc3[nH]2)C(F)(F)F)c1F)-n1nccn1 InChI=1S/C23H20F4N6O/c1-13-4-7-17(33-28-9-10-29-33)18(19(13)24)20(34)32-11-3-8-22(32,2)21-30-15-6-5-14(23(25,26)27)12-16(15)31-21/h4-7,9-10,12H,3,8,11H2,1-2H3,(H,30,31)/t22-/m0/s1 CLFMEHJJIKJZME-QFIPXVFZSA-N 334904 (2-Fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.169::US9732075, Example 5.169 Orexin receptor type 2 Homo sapiens 197 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334904 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334904&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127243 384987064 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657449 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(cccc2[nH]1)C(F)(F)F)-n1nccn1 InChI=1S/C23H21F3N6O/c1-14-7-8-18(32-27-10-11-28-32)15(13-14)20(33)31-12-4-9-22(31,2)21-29-17-6-3-5-16(19(17)30-21)23(24,25)26/h3,5-8,10-11,13H,4,9,12H2,1-2H3,(H,29,30)/t22-/m0/s1 QVINISRBQKHIBL-QFIPXVFZSA-N 334905 (5-Methyl-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.17::US9732075, Example 5.17 Orexin/Hypocretin receptor type 1 Homo sapiens 11.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334905 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334905&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127057 384987065 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657450 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(cccc2[nH]1)C(F)(F)F)-n1nccn1 InChI=1S/C23H21F3N6O/c1-14-7-8-18(32-27-10-11-28-32)15(13-14)20(33)31-12-4-9-22(31,2)21-29-17-6-3-5-16(19(17)30-21)23(24,25)26/h3,5-8,10-11,13H,4,9,12H2,1-2H3,(H,29,30)/t22-/m0/s1 QVINISRBQKHIBL-QFIPXVFZSA-N 334905 (5-Methyl-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(4-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.17::US9732075, Example 5.17 Orexin receptor type 2 Homo sapiens 76.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334905 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334905&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127057 384987065 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657451 Cc1cc(C(=O)N2CCC[C@@]2(C)c2nc3cc(ccc3[nH]2)C(F)(F)F)c(cc1C)-n1nccn1 InChI=1S/C24H23F3N6O/c1-14-11-17(20(12-15(14)2)33-28-8-9-29-33)21(34)32-10-4-7-23(32,3)22-30-18-6-5-16(24(25,26)27)13-19(18)31-22/h5-6,8-9,11-13H,4,7,10H2,1-3H3,(H,30,31)/t23-/m0/s1 YRVNCTCKYNIFSU-QHCPKHFHSA-N 334906 (4,5-Dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.170::US9732075, Example 5.170 Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334906 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334906&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695200 384987066 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657452 Cc1cc(C(=O)N2CCC[C@@]2(C)c2nc3cc(ccc3[nH]2)C(F)(F)F)c(cc1C)-n1nccn1 InChI=1S/C24H23F3N6O/c1-14-11-17(20(12-15(14)2)33-28-8-9-29-33)21(34)32-10-4-7-23(32,3)22-30-18-6-5-16(24(25,26)27)13-19(18)31-22/h5-6,8-9,11-13H,4,7,10H2,1-3H3,(H,30,31)/t23-/m0/s1 YRVNCTCKYNIFSU-QHCPKHFHSA-N 334906 (4,5-Dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.170::US9732075, Example 5.170 Orexin receptor type 2 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334906 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334906&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695200 384987066 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657453 Cc1ccc(C(=O)N2CCC[C@@]2(C)c2nc3cc(ccc3[nH]2)C(F)(F)F)c(c1)-n1nccn1 InChI=1S/C23H21F3N6O/c1-14-4-6-16(19(12-14)32-27-9-10-28-32)20(33)31-11-3-8-22(31,2)21-29-17-7-5-15(23(24,25)26)13-18(17)30-21/h4-7,9-10,12-13H,3,8,11H2,1-2H3,(H,29,30)/t22-/m0/s1 JSMYHRNRXDFXQW-QFIPXVFZSA-N 334907 (4-Methyl-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.171::US9732075, Example 5.171 Orexin/Hypocretin receptor type 1 Homo sapiens 12.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334907 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334907&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695201 384987067 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657454 Cc1ccc(C(=O)N2CCC[C@@]2(C)c2nc3cc(ccc3[nH]2)C(F)(F)F)c(c1)-n1nccn1 InChI=1S/C23H21F3N6O/c1-14-4-6-16(19(12-14)32-27-9-10-28-32)20(33)31-11-3-8-22(31,2)21-29-17-7-5-15(23(24,25)26)13-18(17)30-21/h4-7,9-10,12-13H,3,8,11H2,1-2H3,(H,29,30)/t22-/m0/s1 JSMYHRNRXDFXQW-QFIPXVFZSA-N 334907 (4-Methyl-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.171::US9732075, Example 5.171 Orexin receptor type 2 Homo sapiens 58.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334907 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334907&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695201 384987067 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657455 C[C@]1(CCCN1C(=O)c1cc(ccc1-n1nccn1)C(F)(F)F)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C23H18F6N6O/c1-21(20-32-16-5-3-14(23(27,28)29)12-17(16)33-20)7-2-10-34(21)19(36)15-11-13(22(24,25)26)4-6-18(15)35-30-8-9-31-35/h3-6,8-9,11-12H,2,7,10H2,1H3,(H,32,33)/t21-/m0/s1 CUFFIAKNDMLTRT-NRFANRHFSA-N 334908 US11040966, Example 5.172::US9732075, Example 5.172::[(S)-2-Methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoromethyl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 92.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334908 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334908&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127495 384987068 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657456 C[C@]1(CCCN1C(=O)c1cc(ccc1-n1nccn1)C(F)(F)F)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C23H18F6N6O/c1-21(20-32-16-5-3-14(23(27,28)29)12-17(16)33-20)7-2-10-34(21)19(36)15-11-13(22(24,25)26)4-6-18(15)35-30-8-9-31-35/h3-6,8-9,11-12H,2,7,10H2,1H3,(H,32,33)/t21-/m0/s1 CUFFIAKNDMLTRT-NRFANRHFSA-N 334908 US11040966, Example 5.172::US9732075, Example 5.172::[(S)-2-Methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoromethyl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 704 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334908 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334908&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127495 384987068 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657457 C[C@]1(CCCN1C(=O)c1cc(OC(F)(F)F)ccc1-n1nccn1)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C23H18F6N6O2/c1-21(20-32-16-5-3-13(22(24,25)26)11-17(16)33-20)7-2-10-34(21)19(36)15-12-14(37-23(27,28)29)4-6-18(15)35-30-8-9-31-35/h3-6,8-9,11-12H,2,7,10H2,1H3,(H,32,33)/t21-/m0/s1 JZQUDIXJXFYXAJ-NRFANRHFSA-N 334909 US11040966, Example 5.173::US9732075, Example 5.173::[(S)-2-Methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoromethoxy-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 290 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334909 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334909&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128032 384987069 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657458 C[C@]1(CCCN1C(=O)c1cc(OC(F)(F)F)ccc1-n1nccn1)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C23H18F6N6O2/c1-21(20-32-16-5-3-13(22(24,25)26)11-17(16)33-20)7-2-10-34(21)19(36)15-12-14(37-23(27,28)29)4-6-18(15)35-30-8-9-31-35/h3-6,8-9,11-12H,2,7,10H2,1H3,(H,32,33)/t21-/m0/s1 JZQUDIXJXFYXAJ-NRFANRHFSA-N 334909 US11040966, Example 5.173::US9732075, Example 5.173::[(S)-2-Methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoromethoxy-phenyl)-methanone Orexin receptor type 2 Homo sapiens 1138 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334909 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334909&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128032 384987069 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657459 COc1cc(C(=O)N2CCC[C@@]2(C)c2nc3cc(ccc3[nH]2)C(F)(F)F)c(cc1OC)-n1nccn1 InChI=1S/C24H23F3N6O3/c1-23(22-30-16-6-5-14(24(25,26)27)11-17(16)31-22)7-4-10-32(23)21(34)15-12-19(35-2)20(36-3)13-18(15)33-28-8-9-29-33/h5-6,8-9,11-13H,4,7,10H2,1-3H3,(H,30,31)/t23-/m0/s1 DXCCIHIVOCDNCI-QHCPKHFHSA-N 334910 (4,5-Dimethoxy-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.174::US9732075, Example 5.174 Orexin/Hypocretin receptor type 1 Homo sapiens 59.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334910 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334910&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127960 384987070 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657460 COc1cc(C(=O)N2CCC[C@@]2(C)c2nc3cc(ccc3[nH]2)C(F)(F)F)c(cc1OC)-n1nccn1 InChI=1S/C24H23F3N6O3/c1-23(22-30-16-6-5-14(24(25,26)27)11-17(16)31-22)7-4-10-32(23)21(34)15-12-19(35-2)20(36-3)13-18(15)33-28-8-9-29-33/h5-6,8-9,11-13H,4,7,10H2,1-3H3,(H,30,31)/t23-/m0/s1 DXCCIHIVOCDNCI-QHCPKHFHSA-N 334910 (4,5-Dimethoxy-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.174::US9732075, Example 5.174 Orexin receptor type 2 Homo sapiens 133 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334910 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334910&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127960 384987070 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657461 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F)-n1cccn1 InChI=1S/C24H22F3N5O/c1-15-5-8-20(32-12-4-10-28-32)17(13-15)21(33)31-11-3-9-23(31,2)22-29-18-7-6-16(24(25,26)27)14-19(18)30-22/h4-8,10,12-14H,3,9,11H2,1-2H3,(H,29,30)/t23-/m0/s1 OCDYQLGNKPKROM-QHCPKHFHSA-N 334911 (5-Methyl-2-pyrazol-1-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.175::US9732075, Example 5.175 Orexin/Hypocretin receptor type 1 Homo sapiens 24.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334911 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334911&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127544 384987071 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657462 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F)-n1cccn1 InChI=1S/C24H22F3N5O/c1-15-5-8-20(32-12-4-10-28-32)17(13-15)21(33)31-11-3-9-23(31,2)22-29-18-7-6-16(24(25,26)27)14-19(18)30-22/h4-8,10,12-14H,3,9,11H2,1-2H3,(H,29,30)/t23-/m0/s1 OCDYQLGNKPKROM-QHCPKHFHSA-N 334911 (5-Methyl-2-pyrazol-1-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.175::US9732075, Example 5.175 Orexin receptor type 2 Homo sapiens 355 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334911 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334911&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127544 384987071 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657463 C[C@]1(CCCN1C(=O)c1ccccc1-n1cccn1)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C23H20F3N5O/c1-22(21-28-17-9-8-15(23(24,25)26)14-18(17)29-21)10-4-12-30(22)20(32)16-6-2-3-7-19(16)31-13-5-11-27-31/h2-3,5-9,11,13-14H,4,10,12H2,1H3,(H,28,29)/t22-/m0/s1 GDYCGICJXRQFAZ-QFIPXVFZSA-N 334912 US11040966, Example 5.176::US9732075, Example 5.176::[(S)-2-Methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-pyrazol-1-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 389 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334912 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334912&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102498 384987072 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657464 C[C@]1(CCCN1C(=O)c1ccccc1-n1cccn1)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C23H20F3N5O/c1-22(21-28-17-9-8-15(23(24,25)26)14-18(17)29-21)10-4-12-30(22)20(32)16-6-2-3-7-19(16)31-13-5-11-27-31/h2-3,5-9,11,13-14H,4,10,12H2,1H3,(H,28,29)/t22-/m0/s1 GDYCGICJXRQFAZ-QFIPXVFZSA-N 334912 US11040966, Example 5.176::US9732075, Example 5.176::[(S)-2-Methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-pyrazol-1-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 1067 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334912 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334912&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102498 384987072 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657465 Cc1ccc(c(n1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F)-n1cccn1 InChI=1S/C23H21F3N6O/c1-14-5-8-18(32-12-4-10-27-32)19(28-14)20(33)31-11-3-9-22(31,2)21-29-16-7-6-15(23(24,25)26)13-17(16)30-21/h4-8,10,12-13H,3,9,11H2,1-2H3,(H,29,30)/t22-/m0/s1 JMWMNHFOAOWAHL-QFIPXVFZSA-N 334913 (6-Methyl-3-pyrazol-1-yl-pyridin-2-yl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.177::US9732075, Example 5.177 Orexin/Hypocretin receptor type 1 Homo sapiens 76.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334913 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334913&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128015 384987073 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657466 Cc1ccc(c(n1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F)-n1cccn1 InChI=1S/C23H21F3N6O/c1-14-5-8-18(32-12-4-10-27-32)19(28-14)20(33)31-11-3-9-22(31,2)21-29-16-7-6-15(23(24,25)26)13-17(16)30-21/h4-8,10,12-13H,3,9,11H2,1-2H3,(H,29,30)/t22-/m0/s1 JMWMNHFOAOWAHL-QFIPXVFZSA-N 334913 (6-Methyl-3-pyrazol-1-yl-pyridin-2-yl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.177::US9732075, Example 5.177 Orexin receptor type 2 Homo sapiens 860 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334913 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334913&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128015 384987073 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657467 Cc1ccc(c(n1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F)-n1nccn1 InChI=1S/C22H20F3N7O/c1-13-4-7-17(32-26-9-10-27-32)18(28-13)19(33)31-11-3-8-21(31,2)20-29-15-6-5-14(22(23,24)25)12-16(15)30-20/h4-7,9-10,12H,3,8,11H2,1-2H3,(H,29,30)/t21-/m0/s1 RMYMZTBMWFNHTE-NRFANRHFSA-N 334914 (6-Methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.178::US9732075, Example 5.178 Orexin/Hypocretin receptor type 1 Homo sapiens 20.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334914 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334914&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127217 384987074 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657468 Cc1ccc(c(n1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F)-n1nccn1 InChI=1S/C22H20F3N7O/c1-13-4-7-17(32-26-9-10-27-32)18(28-13)19(33)31-11-3-8-21(31,2)20-29-15-6-5-14(22(23,24)25)12-16(15)30-20/h4-7,9-10,12H,3,8,11H2,1-2H3,(H,29,30)/t21-/m0/s1 RMYMZTBMWFNHTE-NRFANRHFSA-N 334914 (6-Methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.178::US9732075, Example 5.178 Orexin receptor type 2 Homo sapiens 280 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334914 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334914&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127217 384987074 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657469 Cc1cccc(C(=O)N2CCC[C@@]2(C)c2nc3cc(ccc3[nH]2)C(F)(F)F)c1-n1nccn1 InChI=1S/C23H21F3N6O/c1-14-5-3-6-16(19(14)32-27-10-11-28-32)20(33)31-12-4-9-22(31,2)21-29-17-8-7-15(23(24,25)26)13-18(17)30-21/h3,5-8,10-11,13H,4,9,12H2,1-2H3,(H,29,30)/t22-/m0/s1 UHURFRFGTPGBBQ-QFIPXVFZSA-N 334915 (3-Methyl-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.179::US9732075, Example 5.179 Orexin/Hypocretin receptor type 1 Homo sapiens 368 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334915 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334915&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127573 384987075 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657470 Cc1cccc(C(=O)N2CCC[C@@]2(C)c2nc3cc(ccc3[nH]2)C(F)(F)F)c1-n1nccn1 InChI=1S/C23H21F3N6O/c1-14-5-3-6-16(19(14)32-27-10-11-28-32)20(33)31-12-4-9-22(31,2)21-29-17-8-7-15(23(24,25)26)13-18(17)30-21/h3,5-8,10-11,13H,4,9,12H2,1-2H3,(H,29,30)/t22-/m0/s1 UHURFRFGTPGBBQ-QFIPXVFZSA-N 334915 (3-Methyl-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.179::US9732075, Example 5.179 Orexin receptor type 2 Homo sapiens 1125 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334915 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334915&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127573 384987075 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657471 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(Br)cccc2[nH]1)-n1nccn1 InChI=1S/C22H21BrN6O/c1-14-7-8-18(29-24-10-11-25-29)15(13-14)20(30)28-12-4-9-22(28,2)21-26-17-6-3-5-16(23)19(17)27-21/h3,5-8,10-11,13H,4,9,12H2,1-2H3,(H,26,27)/t22-/m0/s1 CDIDBCUHDFTYTC-QFIPXVFZSA-N 334916 US11040966, Example 5.18::US9732075, Example 5.18::[(S)-2-(4-Bromo-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 23.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334916 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334916&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694891 384987076 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657472 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(Br)cccc2[nH]1)-n1nccn1 InChI=1S/C22H21BrN6O/c1-14-7-8-18(29-24-10-11-25-29)15(13-14)20(30)28-12-4-9-22(28,2)21-26-17-6-3-5-16(23)19(17)27-21/h3,5-8,10-11,13H,4,9,12H2,1-2H3,(H,26,27)/t22-/m0/s1 CDIDBCUHDFTYTC-QFIPXVFZSA-N 334916 US11040966, Example 5.18::US9732075, Example 5.18::[(S)-2-(4-Bromo-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 84.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334916 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334916&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694891 384987076 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657473 C[C@]1(CCCN1C(=O)c1cc(ccc1-n1nccn1)C#N)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C23H18F3N7O/c1-22(21-30-17-5-4-15(23(24,25)26)12-18(17)31-21)7-2-10-32(22)20(34)16-11-14(13-27)3-6-19(16)33-28-8-9-29-33/h3-6,8-9,11-12H,2,7,10H2,1H3,(H,30,31)/t22-/m0/s1 IQJRTUZGWDZKEF-QFIPXVFZSA-N 334917 3-[(S)-2-Methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidine-1-carbonyl]4-[1,2,3]triazol-2-yl-benzonitrile::US11040966, Example 5.180::US9732075, Example 5.180 Orexin/Hypocretin receptor type 1 Homo sapiens 42.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334917 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334917&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102290 384987077 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657474 C[C@]1(CCCN1C(=O)c1cc(ccc1-n1nccn1)C#N)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C23H18F3N7O/c1-22(21-30-17-5-4-15(23(24,25)26)12-18(17)31-21)7-2-10-32(22)20(34)16-11-14(13-27)3-6-19(16)33-28-8-9-29-33/h3-6,8-9,11-12H,2,7,10H2,1H3,(H,30,31)/t22-/m0/s1 IQJRTUZGWDZKEF-QFIPXVFZSA-N 334917 3-[(S)-2-Methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidine-1-carbonyl]4-[1,2,3]triazol-2-yl-benzonitrile::US11040966, Example 5.180::US9732075, Example 5.180 Orexin receptor type 2 Homo sapiens 261 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334917 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334917&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102290 384987077 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657475 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F)-c1ccc(F)cc1C InChI=1S/C28H25F4N3O/c1-16-5-8-21(20-9-7-19(29)14-17(20)2)22(13-16)25(36)35-12-4-11-27(35,3)26-33-23-10-6-18(28(30,31)32)15-24(23)34-26/h5-10,13-15H,4,11-12H2,1-3H3,(H,33,34)/t27-/m0/s1 XLJCABDZEPUHLU-MHZLTWQESA-N 334918 (4'-Fluoro-4,2'-dimethyl-biphenyl-2-yl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.181::US9732075, Example 5.181 Orexin/Hypocretin receptor type 1 Homo sapiens 385 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334918 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334918&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128246 384987078 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657476 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F)-c1ccc(F)cc1C InChI=1S/C28H25F4N3O/c1-16-5-8-21(20-9-7-19(29)14-17(20)2)22(13-16)25(36)35-12-4-11-27(35,3)26-33-23-10-6-18(28(30,31)32)15-24(23)34-26/h5-10,13-15H,4,11-12H2,1-3H3,(H,33,34)/t27-/m0/s1 XLJCABDZEPUHLU-MHZLTWQESA-N 334918 (4'-Fluoro-4,2'-dimethyl-biphenyl-2-yl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.181::US9732075, Example 5.181 Orexin receptor type 2 Homo sapiens 556 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334918 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334918&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128246 384987078 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657477 Cc1ccc(-c2cccc(F)c2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C27H23F4N3O/c1-16-7-9-20(17-5-3-6-19(28)14-17)21(13-16)24(35)34-12-4-11-26(34,2)25-32-22-10-8-18(27(29,30)31)15-23(22)33-25/h3,5-10,13-15H,4,11-12H2,1-2H3,(H,32,33)/t26-/m0/s1 LUPMEOABJQBYGG-SANMLTNESA-N 334919 (3'-Fluoro-4-methyl-biphenyl-2-yl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.182::US9732075, Example 5.182 Orexin/Hypocretin receptor type 1 Homo sapiens 10.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334919 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334919&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695202 384987079 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657478 Cc1ccc(-c2cccc(F)c2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C27H23F4N3O/c1-16-7-9-20(17-5-3-6-19(28)14-17)21(13-16)24(35)34-12-4-11-26(34,2)25-32-22-10-8-18(27(29,30)31)15-23(22)33-25/h3,5-10,13-15H,4,11-12H2,1-2H3,(H,32,33)/t26-/m0/s1 LUPMEOABJQBYGG-SANMLTNESA-N 334919 (3'-Fluoro-4-methyl-biphenyl-2-yl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.182::US9732075, Example 5.182 Orexin receptor type 2 Homo sapiens 55.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334919 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334919&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695202 384987079 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657479 Cc1ccc(-c2ccc(cc2)C(F)(F)F)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C28H23F6N3O/c1-16-4-10-20(17-5-7-18(8-6-17)27(29,30)31)21(14-16)24(38)37-13-3-12-26(37,2)25-35-22-11-9-19(28(32,33)34)15-23(22)36-25/h4-11,14-15H,3,12-13H2,1-2H3,(H,35,36)/t26-/m0/s1 RYKFXCOVJLRVRX-SANMLTNESA-N 334920 US11040966, Example 5.183::US9732075, Example 5.183::[(S)-2-Methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(4-methyl-4'-trifluoromethyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 339 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334920 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334920&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128074 384987080 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657480 Cc1ccc(-c2ccc(cc2)C(F)(F)F)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C28H23F6N3O/c1-16-4-10-20(17-5-7-18(8-6-17)27(29,30)31)21(14-16)24(38)37-13-3-12-26(37,2)25-35-22-11-9-19(28(32,33)34)15-23(22)36-25/h4-11,14-15H,3,12-13H2,1-2H3,(H,35,36)/t26-/m0/s1 RYKFXCOVJLRVRX-SANMLTNESA-N 334920 US11040966, Example 5.183::US9732075, Example 5.183::[(S)-2-Methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(4-methyl-4'-trifluoromethyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 1165 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334920 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334920&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128074 384987080 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657481 Cc1ccc(-c2cccc(OC(F)(F)F)c2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C28H23F6N3O2/c1-16-7-9-20(17-5-3-6-19(14-17)39-28(32,33)34)21(13-16)24(38)37-12-4-11-26(37,2)25-35-22-10-8-18(27(29,30)31)15-23(22)36-25/h3,5-10,13-15H,4,11-12H2,1-2H3,(H,35,36)/t26-/m0/s1 RHGSGGRXDIIROG-SANMLTNESA-N 334921 (4-Methyl-3'-trifluoromethoxy-biphenyl-2-yl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.184::US9732075, Example 5.184 Orexin/Hypocretin receptor type 1 Homo sapiens 300 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334921 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334921&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127269 384987081 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657482 Cc1ccc(-c2cccc(OC(F)(F)F)c2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C28H23F6N3O2/c1-16-7-9-20(17-5-3-6-19(14-17)39-28(32,33)34)21(13-16)24(38)37-12-4-11-26(37,2)25-35-22-10-8-18(27(29,30)31)15-23(22)36-25/h3,5-10,13-15H,4,11-12H2,1-2H3,(H,35,36)/t26-/m0/s1 RHGSGGRXDIIROG-SANMLTNESA-N 334921 (4-Methyl-3'-trifluoromethoxy-biphenyl-2-yl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.184::US9732075, Example 5.184 Orexin receptor type 2 Homo sapiens 413 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334921 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334921&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127269 384987081 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657483 COc1ccccc1-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C28H26F3N3O2/c1-17-9-11-19(20-7-4-5-8-24(20)36-3)21(15-17)25(35)34-14-6-13-27(34,2)26-32-22-12-10-18(28(29,30)31)16-23(22)33-26/h4-5,7-12,15-16H,6,13-14H2,1-3H3,(H,32,33)/t27-/m0/s1 ZUNVALJWNMAFLH-MHZLTWQESA-N 334922 (2'-Methoxy-4-methyl-biphenyl-2-yl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.185::US9732075, Example 5.185 Orexin/Hypocretin receptor type 1 Homo sapiens 91.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334922 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334922&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127819 384987082 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657484 COc1ccccc1-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C28H26F3N3O2/c1-17-9-11-19(20-7-4-5-8-24(20)36-3)21(15-17)25(35)34-14-6-13-27(34,2)26-32-22-12-10-18(28(29,30)31)16-23(22)33-26/h4-5,7-12,15-16H,6,13-14H2,1-3H3,(H,32,33)/t27-/m0/s1 ZUNVALJWNMAFLH-MHZLTWQESA-N 334922 (2'-Methoxy-4-methyl-biphenyl-2-yl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.185::US9732075, Example 5.185 Orexin receptor type 2 Homo sapiens 283 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334922 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334922&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127819 384987082 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657485 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F)-c1ccccc1C InChI=1S/C28H26F3N3O/c1-17-9-11-21(20-8-5-4-7-18(20)2)22(15-17)25(35)34-14-6-13-27(34,3)26-32-23-12-10-19(28(29,30)31)16-24(23)33-26/h4-5,7-12,15-16H,6,13-14H2,1-3H3,(H,32,33)/t27-/m0/s1 LSKVOSQWMGPJCS-MHZLTWQESA-N 334923 (4,2'-Dimethyl-biphenyl-2-yl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.186::US9732075, Example 5.186 Orexin/Hypocretin receptor type 1 Homo sapiens 120 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334923 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334923&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102368 384987083 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657486 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F)-c1ccccc1C InChI=1S/C28H26F3N3O/c1-17-9-11-21(20-8-5-4-7-18(20)2)22(15-17)25(35)34-14-6-13-27(34,3)26-32-23-12-10-19(28(29,30)31)16-24(23)33-26/h4-5,7-12,15-16H,6,13-14H2,1-3H3,(H,32,33)/t27-/m0/s1 LSKVOSQWMGPJCS-MHZLTWQESA-N 334923 (4,2'-Dimethyl-biphenyl-2-yl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.186::US9732075, Example 5.186 Orexin receptor type 2 Homo sapiens 294 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334923 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334923&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102368 384987083 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657487 Cc1ccc(-c2ccc(OC(F)(F)F)cc2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C28H23F6N3O2/c1-16-4-10-20(17-5-8-19(9-6-17)39-28(32,33)34)21(14-16)24(38)37-13-3-12-26(37,2)25-35-22-11-7-18(27(29,30)31)15-23(22)36-25/h4-11,14-15H,3,12-13H2,1-2H3,(H,35,36)/t26-/m0/s1 CEJMLLAXAQFXTF-SANMLTNESA-N 334924 (4-Methyl-4'-trifluoromethoxy-biphenyl-2-yl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.187::US9732075, Example 5.187 Orexin/Hypocretin receptor type 1 Homo sapiens 310 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334924 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334924&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127274 384987084 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657488 Cc1ccc(-c2ccc(OC(F)(F)F)cc2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C28H23F6N3O2/c1-16-4-10-20(17-5-8-19(9-6-17)39-28(32,33)34)21(14-16)24(38)37-13-3-12-26(37,2)25-35-22-11-7-18(27(29,30)31)15-23(22)36-25/h4-11,14-15H,3,12-13H2,1-2H3,(H,35,36)/t26-/m0/s1 CEJMLLAXAQFXTF-SANMLTNESA-N 334924 (4-Methyl-4'-trifluoromethoxy-biphenyl-2-yl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.187::US9732075, Example 5.187 Orexin receptor type 2 Homo sapiens >2589 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334924 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334924&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127274 384987084 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657489 COc1cccc(c1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C28H26F3N3O2/c1-17-8-10-21(18-6-4-7-20(15-18)36-3)22(14-17)25(35)34-13-5-12-27(34,2)26-32-23-11-9-19(28(29,30)31)16-24(23)33-26/h4,6-11,14-16H,5,12-13H2,1-3H3,(H,32,33)/t27-/m0/s1 XVXMMOHUGOMVSX-MHZLTWQESA-N 334925 (3'-Methoxy-4-methyl-biphenyl-2-yl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.188::US9732075, Example 5.188 Orexin/Hypocretin receptor type 1 Homo sapiens 23.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334925 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334925&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127339 384987085 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657490 COc1cccc(c1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C28H26F3N3O2/c1-17-8-10-21(18-6-4-7-20(15-18)36-3)22(14-17)25(35)34-13-5-12-27(34,2)26-32-23-11-9-19(28(29,30)31)16-24(23)33-26/h4,6-11,14-16H,5,12-13H2,1-3H3,(H,32,33)/t27-/m0/s1 XVXMMOHUGOMVSX-MHZLTWQESA-N 334925 (3'-Methoxy-4-methyl-biphenyl-2-yl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.188::US9732075, Example 5.188 Orexin receptor type 2 Homo sapiens 119 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334925 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334925&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127339 384987085 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657491 Cc1cccc(c1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C28H26F3N3O/c1-17-6-4-7-19(14-17)21-10-8-18(2)15-22(21)25(35)34-13-5-12-27(34,3)26-32-23-11-9-20(28(29,30)31)16-24(23)33-26/h4,6-11,14-16H,5,12-13H2,1-3H3,(H,32,33)/t27-/m0/s1 ZPWJGTZDVXXUBW-MHZLTWQESA-N 334926 (4,3'-Dimethyl-biphenyl-2-yl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.189::US9732075, Example 5.189 Orexin/Hypocretin receptor type 1 Homo sapiens 16.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334926 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334926&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695296 384987086 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657492 Cc1cccc(c1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C28H26F3N3O/c1-17-6-4-7-19(14-17)21-10-8-18(2)15-22(21)25(35)34-13-5-12-27(34,3)26-32-23-11-9-20(28(29,30)31)16-24(23)33-26/h4,6-11,14-16H,5,12-13H2,1-3H3,(H,32,33)/t27-/m0/s1 ZPWJGTZDVXXUBW-MHZLTWQESA-N 334926 (4,3'-Dimethyl-biphenyl-2-yl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.189::US9732075, Example 5.189 Orexin receptor type 2 Homo sapiens 62.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334926 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334926&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695296 384987086 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657493 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(Br)cc(C)c2[nH]1)-n1nccn1 InChI=1S/C23H23BrN6O/c1-14-5-6-19(30-25-8-9-26-30)17(11-14)21(31)29-10-4-7-23(29,3)22-27-18-13-16(24)12-15(2)20(18)28-22/h5-6,8-9,11-13H,4,7,10H2,1-3H3,(H,27,28)/t23-/m0/s1 XSONELHLKWDPKV-QHCPKHFHSA-N 334927 US11040966, Example 5.19::US9732075, Example 5.19::US9914721, Ex. 2::[(S)-2-(5-Bromo-7-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334927 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334927&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127782 384987087 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657494 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(Br)cc(C)c2[nH]1)-n1nccn1 InChI=1S/C23H23BrN6O/c1-14-5-6-19(30-25-8-9-26-30)17(11-14)21(31)29-10-4-7-23(29,3)22-27-18-13-16(24)12-15(2)20(18)28-22/h5-6,8-9,11-13H,4,7,10H2,1-3H3,(H,27,28)/t23-/m0/s1 XSONELHLKWDPKV-QHCPKHFHSA-N 334927 US11040966, Example 5.19::US9732075, Example 5.19::US9914721, Ex. 2::[(S)-2-(5-Bromo-7-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 20.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334927 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334927&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127782 384987087 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657495 Cc1ccc(-c2cccc(c2)C#N)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C28H23F3N4O/c1-17-7-9-21(19-6-3-5-18(14-19)16-32)22(13-17)25(36)35-12-4-11-27(35,2)26-33-23-10-8-20(28(29,30)31)15-24(23)34-26/h3,5-10,13-15H,4,11-12H2,1-2H3,(H,33,34)/t27-/m0/s1 DHCCDMRRLMRBGA-MHZLTWQESA-N 334928 4'-Methyl-2'-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidine-1-carbonyl]-biphenyl-3-carbonitrile::US11040966, Example 5.190::US9732075, Example 5.190 Orexin/Hypocretin receptor type 1 Homo sapiens 58.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334928 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334928&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127577 384987088 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657496 Cc1ccc(-c2cccc(c2)C#N)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C28H23F3N4O/c1-17-7-9-21(19-6-3-5-18(14-19)16-32)22(13-17)25(36)35-12-4-11-27(35,2)26-33-23-10-8-20(28(29,30)31)15-24(23)34-26/h3,5-10,13-15H,4,11-12H2,1-2H3,(H,33,34)/t27-/m0/s1 DHCCDMRRLMRBGA-MHZLTWQESA-N 334928 4'-Methyl-2'-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidine-1-carbonyl]-biphenyl-3-carbonitrile::US11040966, Example 5.190::US9732075, Example 5.190 Orexin receptor type 2 Homo sapiens 119 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334928 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334928&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127577 384987088 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657497 COc1ccc(cc1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C28H26F3N3O2/c1-17-5-11-21(18-6-9-20(36-3)10-7-18)22(15-17)25(35)34-14-4-13-27(34,2)26-32-23-12-8-19(28(29,30)31)16-24(23)33-26/h5-12,15-16H,4,13-14H2,1-3H3,(H,32,33)/t27-/m0/s1 BHKMJDJGCMWMET-MHZLTWQESA-N 334929 (4'-Methoxy-4-methyl-biphenyl-2-yl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.191::US9732075, Example 5.191 Orexin/Hypocretin receptor type 1 Homo sapiens 18.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334929 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334929&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127031 384987089 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657498 COc1ccc(cc1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C28H26F3N3O2/c1-17-5-11-21(18-6-9-20(36-3)10-7-18)22(15-17)25(35)34-14-4-13-27(34,2)26-32-23-12-8-19(28(29,30)31)16-24(23)33-26/h5-12,15-16H,4,13-14H2,1-3H3,(H,32,33)/t27-/m0/s1 BHKMJDJGCMWMET-MHZLTWQESA-N 334929 (4'-Methoxy-4-methyl-biphenyl-2-yl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.191::US9732075, Example 5.191 Orexin receptor type 2 Homo sapiens 69.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334929 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334929&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127031 384987089 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657499 Cc1ccc(cc1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C28H26F3N3O/c1-17-5-8-19(9-6-17)21-11-7-18(2)15-22(21)25(35)34-14-4-13-27(34,3)26-32-23-12-10-20(28(29,30)31)16-24(23)33-26/h5-12,15-16H,4,13-14H2,1-3H3,(H,32,33)/t27-/m0/s1 CIANNZBNOKOVOX-MHZLTWQESA-N 334930 (4,4'-Dimethyl-biphenyl-2-yl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.192::US9732075, Example 5.192 Orexin/Hypocretin receptor type 1 Homo sapiens 23.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334930 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334930&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127829 384987090 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657500 Cc1ccc(cc1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C28H26F3N3O/c1-17-5-8-19(9-6-17)21-11-7-18(2)15-22(21)25(35)34-14-4-13-27(34,3)26-32-23-12-10-20(28(29,30)31)16-24(23)33-26/h5-12,15-16H,4,13-14H2,1-3H3,(H,32,33)/t27-/m0/s1 CIANNZBNOKOVOX-MHZLTWQESA-N 334930 (4,4'-Dimethyl-biphenyl-2-yl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.192::US9732075, Example 5.192 Orexin receptor type 2 Homo sapiens 88.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334930 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334930&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127829 384987090 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657501 Cc1ccc(-c2ccc(cc2)C#N)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C28H23F3N4O/c1-17-4-10-21(19-7-5-18(16-32)6-8-19)22(14-17)25(36)35-13-3-12-27(35,2)26-33-23-11-9-20(28(29,30)31)15-24(23)34-26/h4-11,14-15H,3,12-13H2,1-2H3,(H,33,34)/t27-/m0/s1 ZXGFVCLHJLSSNQ-MHZLTWQESA-N 334931 4'-Methyl-2'-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidine-1-carbonyl]-biphenyl-4-carbonitrile::US11040966, Example 5.193::US9732075, Example 5.193 Orexin/Hypocretin receptor type 1 Homo sapiens 24.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334931 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334931&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127769 384987091 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657502 Cc1ccc(-c2ccc(cc2)C#N)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C28H23F3N4O/c1-17-4-10-21(19-7-5-18(16-32)6-8-19)22(14-17)25(36)35-13-3-12-27(35,2)26-33-23-11-9-20(28(29,30)31)15-24(23)34-26/h4-11,14-15H,3,12-13H2,1-2H3,(H,33,34)/t27-/m0/s1 ZXGFVCLHJLSSNQ-MHZLTWQESA-N 334931 4'-Methyl-2'-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidine-1-carbonyl]-biphenyl-4-carbonitrile::US11040966, Example 5.193::US9732075, Example 5.193 Orexin receptor type 2 Homo sapiens 203 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334931 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334931&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127769 384987091 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657503 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F)-c1ccccc1F InChI=1S/C27H23F4N3O/c1-16-8-10-18(19-6-3-4-7-21(19)28)20(14-16)24(35)34-13-5-12-26(34,2)25-32-22-11-9-17(27(29,30)31)15-23(22)33-25/h3-4,6-11,14-15H,5,12-13H2,1-2H3,(H,32,33)/t26-/m0/s1 XWCWVDDJUNCXDW-SANMLTNESA-N 334932 (2'-Fluoro-4-methyl-biphenyl-2-yl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.194::US9732075, Example 5.194 Orexin/Hypocretin receptor type 1 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334932 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334932&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127408 384987092 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657504 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F)-c1ccccc1F InChI=1S/C27H23F4N3O/c1-16-8-10-18(19-6-3-4-7-21(19)28)20(14-16)24(35)34-13-5-12-26(34,2)25-32-22-11-9-17(27(29,30)31)15-23(22)33-25/h3-4,6-11,14-15H,5,12-13H2,1-2H3,(H,32,33)/t26-/m0/s1 XWCWVDDJUNCXDW-SANMLTNESA-N 334932 (2'-Fluoro-4-methyl-biphenyl-2-yl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.194::US9732075, Example 5.194 Orexin receptor type 2 Homo sapiens 98.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334932 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334932&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127408 384987092 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657505 Cc1ccc(-c2cccc(c2)C(F)(F)F)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C28H23F6N3O/c1-16-7-9-20(17-5-3-6-18(14-17)27(29,30)31)21(13-16)24(38)37-12-4-11-26(37,2)25-35-22-10-8-19(28(32,33)34)15-23(22)36-25/h3,5-10,13-15H,4,11-12H2,1-2H3,(H,35,36)/t26-/m0/s1 GBNNDEXNKIXAKY-SANMLTNESA-N 334933 US11040966, Example 5.195::US9732075, Example 5.195::[(S)-2-Methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(4-methyl-3'-trifluoromethyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 73.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334933 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334933&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128048 384987093 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657506 Cc1ccc(-c2cccc(c2)C(F)(F)F)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C28H23F6N3O/c1-16-7-9-20(17-5-3-6-18(14-17)27(29,30)31)21(13-16)24(38)37-12-4-11-26(37,2)25-35-22-10-8-19(28(32,33)34)15-23(22)36-25/h3,5-10,13-15H,4,11-12H2,1-2H3,(H,35,36)/t26-/m0/s1 GBNNDEXNKIXAKY-SANMLTNESA-N 334933 US11040966, Example 5.195::US9732075, Example 5.195::[(S)-2-Methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(4-methyl-3'-trifluoromethyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 102 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334933 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334933&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128048 384987093 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657507 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F)-c1cccc(C)c1C InChI=1S/C29H28F3N3O/c1-17-9-11-22(21-8-5-7-18(2)19(21)3)23(15-17)26(36)35-14-6-13-28(35,4)27-33-24-12-10-20(29(30,31)32)16-25(24)34-27/h5,7-12,15-16H,6,13-14H2,1-4H3,(H,33,34)/t28-/m0/s1 GEXXUNUUVMICCM-NDEPHWFRSA-N 334934 US11040966, Example 5.196::US9732075, Example 5.196::[(S)-2-Methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(4,2',3'-trimethyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 91.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334934 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334934&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127977 384987094 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657508 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F)-c1cccc(C)c1C InChI=1S/C29H28F3N3O/c1-17-9-11-22(21-8-5-7-18(2)19(21)3)23(15-17)26(36)35-14-6-13-28(35,4)27-33-24-12-10-20(29(30,31)32)16-25(24)34-27/h5,7-12,15-16H,6,13-14H2,1-4H3,(H,33,34)/t28-/m0/s1 GEXXUNUUVMICCM-NDEPHWFRSA-N 334934 US11040966, Example 5.196::US9732075, Example 5.196::[(S)-2-Methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(4,2',3'-trimethyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 199 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334934 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334934&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127977 384987094 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657509 Cc1ccc(-c2ccc(F)cc2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C27H23F4N3O/c1-16-4-10-20(17-5-8-19(28)9-6-17)21(14-16)24(35)34-13-3-12-26(34,2)25-32-22-11-7-18(27(29,30)31)15-23(22)33-25/h4-11,14-15H,3,12-13H2,1-2H3,(H,32,33)/t26-/m0/s1 BVAUVZJCJFEFMF-SANMLTNESA-N 334935 (4'-Fluoro-4-methyl-biphenyl-2-yl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.197::US9732075, Example 5.197 Orexin/Hypocretin receptor type 1 Homo sapiens 18.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334935 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334935&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128022 384987095 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657510 Cc1ccc(-c2ccc(F)cc2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C27H23F4N3O/c1-16-4-10-20(17-5-8-19(28)9-6-17)21(14-16)24(35)34-13-3-12-26(34,2)25-32-22-11-7-18(27(29,30)31)15-23(22)33-25/h4-11,14-15H,3,12-13H2,1-2H3,(H,32,33)/t26-/m0/s1 BVAUVZJCJFEFMF-SANMLTNESA-N 334935 (4'-Fluoro-4-methyl-biphenyl-2-yl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.197::US9732075, Example 5.197 Orexin receptor type 2 Homo sapiens 166 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334935 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334935&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128022 384987095 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657511 Cc1ccc(-c2ccc3OCOc3c2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C28H24F3N3O3/c1-16-4-7-19(17-5-9-23-24(13-17)37-15-36-23)20(12-16)25(35)34-11-3-10-27(34,2)26-32-21-8-6-18(28(29,30)31)14-22(21)33-26/h4-9,12-14H,3,10-11,15H2,1-2H3,(H,32,33)/t27-/m0/s1 ZZBYFZSASXCIMG-MHZLTWQESA-N 334936 (2-Benzo[1,3]dioxol-5-yl-5-methyl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.198::US9732075, Example 5.198 Orexin/Hypocretin receptor type 1 Homo sapiens 18.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334936 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334936&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127594 384987096 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657512 Cc1ccc(-c2ccc3OCOc3c2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C28H24F3N3O3/c1-16-4-7-19(17-5-9-23-24(13-17)37-15-36-23)20(12-16)25(35)34-11-3-10-27(34,2)26-32-21-8-6-18(28(29,30)31)14-22(21)33-26/h4-9,12-14H,3,10-11,15H2,1-2H3,(H,32,33)/t27-/m0/s1 ZZBYFZSASXCIMG-MHZLTWQESA-N 334936 (2-Benzo[1,3]dioxol-5-yl-5-methyl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.198::US9732075, Example 5.198 Orexin receptor type 2 Homo sapiens 34.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334936 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334936&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127594 384987096 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657513 Cc1cc(C(=O)N2CCC[C@@]2(C)c2nc3c(F)c(F)ccc3[nH]2)c(cc1C)-n1nccn1 InChI=1S/C23H22F2N6O/c1-13-11-15(18(12-14(13)2)31-26-8-9-27-31)21(32)30-10-4-7-23(30,3)22-28-17-6-5-16(24)19(25)20(17)29-22/h5-6,8-9,11-12H,4,7,10H2,1-3H3,(H,28,29)/t23-/m0/s1 KBTKPZZZMUFLKJ-QHCPKHFHSA-N 334937 US11040966, Example 5.199::US9732075, Example 5.199::[(S)-2-(4,5-Difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,5-dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 12.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334937 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334937&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127941 384987097 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657514 Cc1cc(C(=O)N2CCC[C@@]2(C)c2nc3c(F)c(F)ccc3[nH]2)c(cc1C)-n1nccn1 InChI=1S/C23H22F2N6O/c1-13-11-15(18(12-14(13)2)31-26-8-9-27-31)21(32)30-10-4-7-23(30,3)22-28-17-6-5-16(24)19(25)20(17)29-22/h5-6,8-9,11-12H,4,7,10H2,1-3H3,(H,28,29)/t23-/m0/s1 KBTKPZZZMUFLKJ-QHCPKHFHSA-N 334937 US11040966, Example 5.199::US9732075, Example 5.199::[(S)-2-(4,5-Difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,5-dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 83.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334937 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334937&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127941 384987097 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657515 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(Cl)ccc2[nH]1)-n1nccn1 InChI=1S/C23H23ClN6O/c1-14-5-8-19(30-25-10-11-26-30)16(13-14)21(31)29-12-4-9-23(29,3)22-27-18-7-6-17(24)15(2)20(18)28-22/h5-8,10-11,13H,4,9,12H2,1-3H3,(H,27,28)/t23-/m0/s1 QBUUWXRHTRREJU-QHCPKHFHSA-N 334938 US11040966, Example 5.2::US9732075, Example 5.2::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334938 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334938&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127624 384987098 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657516 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(Cl)ccc2[nH]1)-n1nccn1 InChI=1S/C23H23ClN6O/c1-14-5-8-19(30-25-10-11-26-30)16(13-14)21(31)29-12-4-9-23(29,3)22-27-18-7-6-17(24)15(2)20(18)28-22/h5-8,10-11,13H,4,9,12H2,1-3H3,(H,27,28)/t23-/m0/s1 QBUUWXRHTRREJU-QHCPKHFHSA-N 334938 US11040966, Example 5.2::US9732075, Example 5.2::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334938 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334938&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127624 384987098 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657517 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(OC(F)(F)F)ccc2[nH]1)-n1nccn1 InChI=1S/C23H21F3N6O2/c1-14-4-7-19(32-27-9-10-28-32)16(12-14)20(33)31-11-3-8-22(31,2)21-29-17-6-5-15(13-18(17)30-21)34-23(24,25)26/h4-7,9-10,12-13H,3,8,11H2,1-2H3,(H,29,30)/t22-/m0/s1 DOWZCWSQZJMWOI-QFIPXVFZSA-N 334939 (5-Methyl-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.20::US9732075, Example 5.20::US9914721, Ex. 3 Orexin/Hypocretin receptor type 1 Homo sapiens 19.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334939 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334939&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127458 384987099 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657518 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(OC(F)(F)F)ccc2[nH]1)-n1nccn1 InChI=1S/C23H21F3N6O2/c1-14-4-7-19(32-27-9-10-28-32)16(12-14)20(33)31-11-3-8-22(31,2)21-29-17-6-5-15(13-18(17)30-21)34-23(24,25)26/h4-7,9-10,12-13H,3,8,11H2,1-2H3,(H,29,30)/t22-/m0/s1 DOWZCWSQZJMWOI-QFIPXVFZSA-N 334939 (5-Methyl-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.20::US9732075, Example 5.20::US9914721, Ex. 3 Orexin receptor type 2 Homo sapiens 161 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334939 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334939&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127458 384987099 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657519 C[C@]1(CCCN1C(=O)c1cc(Cl)ccc1-n1nccn1)c1nc2c(F)c(F)ccc2[nH]1 InChI=1S/C21H17ClF2N6O/c1-21(20-27-15-5-4-14(23)17(24)18(15)28-20)7-2-10-29(21)19(31)13-11-12(22)3-6-16(13)30-25-8-9-26-30/h3-6,8-9,11H,2,7,10H2,1H3,(H,27,28)/t21-/m0/s1 JDRMJPKMJKTUHN-NRFANRHFSA-N 334940 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(4,5-difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone::US11040966, Example 5.200::US9732075, Example 5.200 Orexin/Hypocretin receptor type 1 Homo sapiens 115 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334940 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334940&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127066 384987100 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657520 C[C@]1(CCCN1C(=O)c1cc(Cl)ccc1-n1nccn1)c1nc2c(F)c(F)ccc2[nH]1 InChI=1S/C21H17ClF2N6O/c1-21(20-27-15-5-4-14(23)17(24)18(15)28-20)7-2-10-29(21)19(31)13-11-12(22)3-6-16(13)30-25-8-9-26-30/h3-6,8-9,11H,2,7,10H2,1H3,(H,27,28)/t21-/m0/s1 JDRMJPKMJKTUHN-NRFANRHFSA-N 334940 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(4,5-difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone::US11040966, Example 5.200::US9732075, Example 5.200 Orexin receptor type 2 Homo sapiens 517 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334940 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334940&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127066 384987100 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657521 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(F)c(F)ccc2[nH]1)-n1cccn1 InChI=1S/C23H21F2N5O/c1-14-5-8-18(30-12-4-10-26-30)15(13-14)21(31)29-11-3-9-23(29,2)22-27-17-7-6-16(24)19(25)20(17)28-22/h4-8,10,12-13H,3,9,11H2,1-2H3,(H,27,28)/t23-/m0/s1 ZODDQINEDFOVTK-QHCPKHFHSA-N 334941 US11040966, Example 5.201::US9732075, Example 5.201::[(S)-2-(4,5-Difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 265 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334941 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334941&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102385 384987101 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657522 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(F)c(F)ccc2[nH]1)-n1cccn1 InChI=1S/C23H21F2N5O/c1-14-5-8-18(30-12-4-10-26-30)15(13-14)21(31)29-11-3-9-23(29,2)22-27-17-7-6-16(24)19(25)20(17)28-22/h4-8,10,12-13H,3,9,11H2,1-2H3,(H,27,28)/t23-/m0/s1 ZODDQINEDFOVTK-QHCPKHFHSA-N 334941 US11040966, Example 5.201::US9732075, Example 5.201::[(S)-2-(4,5-Difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 861 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334941 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334941&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102385 384987101 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657523 Cc1ccc(C(=O)N2CCC[C@@]2(C)c2nc3c(F)c(F)ccc3[nH]2)c(c1)-n1nccn1 InChI=1S/C22H20F2N6O/c1-13-4-5-14(17(12-13)30-25-9-10-26-30)20(31)29-11-3-8-22(29,2)21-27-16-7-6-15(23)18(24)19(16)28-21/h4-7,9-10,12H,3,8,11H2,1-2H3,(H,27,28)/t22-/m0/s1 YJIJGNIVTXUULB-QFIPXVFZSA-N 334942 US11040966, Example 5.202::US9732075, Example 5.202::[(S)-2-(4,5-Difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 227 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334942 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334942&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128059 384987102 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657524 Cc1ccc(C(=O)N2CCC[C@@]2(C)c2nc3c(F)c(F)ccc3[nH]2)c(c1)-n1nccn1 InChI=1S/C22H20F2N6O/c1-13-4-5-14(17(12-13)30-25-9-10-26-30)20(31)29-11-3-8-22(29,2)21-27-16-7-6-15(23)18(24)19(16)28-21/h4-7,9-10,12H,3,8,11H2,1-2H3,(H,27,28)/t22-/m0/s1 YJIJGNIVTXUULB-QFIPXVFZSA-N 334942 US11040966, Example 5.202::US9732075, Example 5.202::[(S)-2-(4,5-Difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 924 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334942 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334942&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128059 384987102 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657525 COc1ccc(c(C(=O)N2CCC[C@@]2(C)c2nc3c(F)c(F)ccc3[nH]2)c1F)-n1nccn1 InChI=1S/C22H19F3N6O2/c1-22(21-28-13-5-4-12(23)17(24)19(13)29-21)8-3-11-30(22)20(32)16-14(31-26-9-10-27-31)6-7-15(33-2)18(16)25/h4-7,9-10H,3,8,11H2,1-2H3,(H,28,29)/t22-/m0/s1 GSFHRSQVJWRTMZ-QFIPXVFZSA-N 334943 US11040966, Example 5.203::US9732075, Example 5.203::[(S)-2-(4,5-Difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methoxy-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 195 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334943 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334943&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128099 384987103 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657526 COc1ccc(c(C(=O)N2CCC[C@@]2(C)c2nc3c(F)c(F)ccc3[nH]2)c1F)-n1nccn1 InChI=1S/C22H19F3N6O2/c1-22(21-28-13-5-4-12(23)17(24)19(13)29-21)8-3-11-30(22)20(32)16-14(31-26-9-10-27-31)6-7-15(33-2)18(16)25/h4-7,9-10H,3,8,11H2,1-2H3,(H,28,29)/t22-/m0/s1 GSFHRSQVJWRTMZ-QFIPXVFZSA-N 334943 US11040966, Example 5.203::US9732075, Example 5.203::[(S)-2-(4,5-Difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methoxy-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 1380 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334943 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334943&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128099 384987103 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657527 C[C@]1(CCCN1C(=O)c1cc(F)ccc1-n1nccn1)c1nc2c(F)c(F)ccc2[nH]1 InChI=1S/C21H17F3N6O/c1-21(20-27-15-5-4-14(23)17(24)18(15)28-20)7-2-10-29(21)19(31)13-11-12(22)3-6-16(13)30-25-8-9-26-30/h3-6,8-9,11H,2,7,10H2,1H3,(H,27,28)/t21-/m0/s1 FAGFQFCRLWOYOW-NRFANRHFSA-N 334944 US11040966, Example 5.204::US9732075, Example 5.204::[(S)-2-(4,5-Difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 360 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334944 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334944&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127786 384987104 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657528 C[C@]1(CCCN1C(=O)c1cc(F)ccc1-n1nccn1)c1nc2c(F)c(F)ccc2[nH]1 InChI=1S/C21H17F3N6O/c1-21(20-27-15-5-4-14(23)17(24)18(15)28-20)7-2-10-29(21)19(31)13-11-12(22)3-6-16(13)30-25-8-9-26-30/h3-6,8-9,11H,2,7,10H2,1H3,(H,27,28)/t21-/m0/s1 FAGFQFCRLWOYOW-NRFANRHFSA-N 334944 US11040966, Example 5.204::US9732075, Example 5.204::[(S)-2-(4,5-Difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 900 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334944 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334944&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127786 384987104 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657529 Cc1ccc(c(n1)C(=O)N1CCC[C@@]1(C)c1nc2c(F)c(F)ccc2[nH]1)-n1nccn1 InChI=1S/C21H19F2N7O/c1-12-4-7-15(30-24-9-10-25-30)18(26-12)19(31)29-11-3-8-21(29,2)20-27-14-6-5-13(22)16(23)17(14)28-20/h4-7,9-10H,3,8,11H2,1-2H3,(H,27,28)/t21-/m0/s1 GKCWRTQGIQLARU-NRFANRHFSA-N 334945 US11040966, Example 5.205::US9732075, Example 5.205::[(S)-2-(4,5-Difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 149 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334945 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334945&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127839 384987105 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657530 Cc1ccc(c(n1)C(=O)N1CCC[C@@]1(C)c1nc2c(F)c(F)ccc2[nH]1)-n1nccn1 InChI=1S/C21H19F2N7O/c1-12-4-7-15(30-24-9-10-25-30)18(26-12)19(31)29-11-3-8-21(29,2)20-27-14-6-5-13(22)16(23)17(14)28-20/h4-7,9-10H,3,8,11H2,1-2H3,(H,27,28)/t21-/m0/s1 GKCWRTQGIQLARU-NRFANRHFSA-N 334945 US11040966, Example 5.205::US9732075, Example 5.205::[(S)-2-(4,5-Difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone Orexin receptor type 2 Homo sapiens 852 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334945 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334945&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127839 384987105 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657531 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(F)c(F)ccc3[nH]2)c(s1)-c1ccccc1 InChI=1S/C23H20F2N4OS/c1-13-26-19(20(31-13)14-7-4-3-5-8-14)21(30)29-12-6-11-23(29,2)22-27-16-10-9-15(24)17(25)18(16)28-22/h3-5,7-10H,6,11-12H2,1-2H3,(H,27,28)/t23-/m0/s1 SRIQMAPLMIOZHF-QHCPKHFHSA-N 334946 US11040966, Example 5.206::US9732075, Example 5.206::[(S)-2-(4,5-Difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 19.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334946 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334946&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128026 384987106 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657532 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(F)c(F)ccc3[nH]2)c(s1)-c1ccccc1 InChI=1S/C23H20F2N4OS/c1-13-26-19(20(31-13)14-7-4-3-5-8-14)21(30)29-12-6-11-23(29,2)22-27-16-10-9-15(24)17(25)18(16)28-22/h3-5,7-10H,6,11-12H2,1-2H3,(H,27,28)/t23-/m0/s1 SRIQMAPLMIOZHF-QHCPKHFHSA-N 334946 US11040966, Example 5.206::US9732075, Example 5.206::[(S)-2-(4,5-Difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 117 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334946 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334946&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128026 384987106 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657533 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(F)c(F)ccc3[nH]2)c(s1)-c1cccc(Cl)c1 InChI=1S/C23H19ClF2N4OS/c1-12-27-19(20(32-12)13-5-3-6-14(24)11-13)21(31)30-10-4-9-23(30,2)22-28-16-8-7-15(25)17(26)18(16)29-22/h3,5-8,11H,4,9-10H2,1-2H3,(H,28,29)/t23-/m0/s1 OHRMJKSLTJECNY-QHCPKHFHSA-N 334947 US11040966, Example 5.207::US9732075, Example 5.207::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(4,5-difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 15.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334947 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334947&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127198 384987107 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657534 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(F)c(F)ccc3[nH]2)c(s1)-c1cccc(Cl)c1 InChI=1S/C23H19ClF2N4OS/c1-12-27-19(20(32-12)13-5-3-6-14(24)11-13)21(31)30-10-4-9-23(30,2)22-28-16-8-7-15(25)17(26)18(16)29-22/h3,5-8,11H,4,9-10H2,1-2H3,(H,28,29)/t23-/m0/s1 OHRMJKSLTJECNY-QHCPKHFHSA-N 334947 US11040966, Example 5.207::US9732075, Example 5.207::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(4,5-difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 78.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334947 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334947&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127198 384987107 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657535 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(F)c(F)ccc3[nH]2)c(s1)-c1ccc(F)cc1 InChI=1S/C23H19F3N4OS/c1-12-27-19(20(32-12)13-4-6-14(24)7-5-13)21(31)30-11-3-10-23(30,2)22-28-16-9-8-15(25)17(26)18(16)29-22/h4-9H,3,10-11H2,1-2H3,(H,28,29)/t23-/m0/s1 RKJIPYSFMMLREC-QHCPKHFHSA-N 334948 US11040966, Example 5.208::US9732075, Example 5.208::[(S)-2-(4,5-Difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 53.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334948 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334948&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127170 384987108 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657536 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(F)c(F)ccc3[nH]2)c(s1)-c1ccc(F)cc1 InChI=1S/C23H19F3N4OS/c1-12-27-19(20(32-12)13-4-6-14(24)7-5-13)21(31)30-11-3-10-23(30,2)22-28-16-9-8-15(25)17(26)18(16)29-22/h4-9H,3,10-11H2,1-2H3,(H,28,29)/t23-/m0/s1 RKJIPYSFMMLREC-QHCPKHFHSA-N 334948 US11040966, Example 5.208::US9732075, Example 5.208::[(S)-2-(4,5-Difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 284 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334948 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334948&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127170 384987108 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657537 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(F)c(F)ccc3[nH]2)c(s1)-c1ccc(C)cc1 InChI=1S/C24H22F2N4OS/c1-13-5-7-15(8-6-13)21-20(27-14(2)32-21)22(31)30-12-4-11-24(30,3)23-28-17-10-9-16(25)18(26)19(17)29-23/h5-10H,4,11-12H2,1-3H3,(H,28,29)/t24-/m0/s1 OCNSXCZEMWBQOA-DEOSSOPVSA-N 334949 US11040966, Example 5.209::US9732075, Example 5.209::[(S)-2-(4,5-Difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-methyl-5-p-tolyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 17.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334949 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334949&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127713 384987109 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657538 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(F)c(F)ccc3[nH]2)c(s1)-c1ccc(C)cc1 InChI=1S/C24H22F2N4OS/c1-13-5-7-15(8-6-13)21-20(27-14(2)32-21)22(31)30-12-4-11-24(30,3)23-28-17-10-9-16(25)18(26)19(17)29-23/h5-10H,4,11-12H2,1-3H3,(H,28,29)/t24-/m0/s1 OCNSXCZEMWBQOA-DEOSSOPVSA-N 334949 US11040966, Example 5.209::US9732075, Example 5.209::[(S)-2-(4,5-Difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-methyl-5-p-tolyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 101 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334949 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334949&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127713 384987109 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657539 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C24H26N6O3/c1-15-6-7-19(30-25-9-10-26-30)16(12-15)22(31)29-11-5-8-24(29,2)23-27-17-13-20(32-3)21(33-4)14-18(17)28-23/h6-7,9-10,12-14H,5,8,11H2,1-4H3,(H,27,28)/t24-/m0/s1 XSNFSFXKMQPCNT-DEOSSOPVSA-N 334950 US11040966, Example 5.21::US9732075, Example 5.21::US9914721, Ex. 4::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 22.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334950 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334950&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695203 384987110 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657540 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C24H26N6O3/c1-15-6-7-19(30-25-9-10-26-30)16(12-15)22(31)29-11-5-8-24(29,2)23-27-17-13-20(32-3)21(33-4)14-18(17)28-23/h6-7,9-10,12-14H,5,8,11H2,1-4H3,(H,27,28)/t24-/m0/s1 XSNFSFXKMQPCNT-DEOSSOPVSA-N 334950 US11040966, Example 5.21::US9732075, Example 5.21::US9914721, Ex. 4::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 18.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334950 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334950&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695203 384987110 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657541 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(F)c(F)ccc3[nH]2)c(s1)-c1cccc(C)c1 InChI=1S/C24H22F2N4OS/c1-13-6-4-7-15(12-13)21-20(27-14(2)32-21)22(31)30-11-5-10-24(30,3)23-28-17-9-8-16(25)18(26)19(17)29-23/h4,6-9,12H,5,10-11H2,1-3H3,(H,28,29)/t24-/m0/s1 QNFGBHOABLCVGZ-DEOSSOPVSA-N 334951 US11040966, Example 5.210::US9732075, Example 5.210::[(S)-2-(4,5-Difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-methyl-5-m-tolyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334951 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334951&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695204 384987111 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657542 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(F)c(F)ccc3[nH]2)c(s1)-c1cccc(C)c1 InChI=1S/C24H22F2N4OS/c1-13-6-4-7-15(12-13)21-20(27-14(2)32-21)22(31)30-11-5-10-24(30,3)23-28-17-9-8-16(25)18(26)19(17)29-23/h4,6-9,12H,5,10-11H2,1-3H3,(H,28,29)/t24-/m0/s1 QNFGBHOABLCVGZ-DEOSSOPVSA-N 334951 US11040966, Example 5.210::US9732075, Example 5.210::[(S)-2-(4,5-Difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-methyl-5-m-tolyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 27.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334951 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334951&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695204 384987111 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657543 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(F)c(F)ccc3[nH]2)c(s1)-c1ccc(Cl)cc1 InChI=1S/C23H19ClF2N4OS/c1-12-27-19(20(32-12)13-4-6-14(24)7-5-13)21(31)30-11-3-10-23(30,2)22-28-16-9-8-15(25)17(26)18(16)29-22/h4-9H,3,10-11H2,1-2H3,(H,28,29)/t23-/m0/s1 NMPZITPNATUWFC-QHCPKHFHSA-N 334952 US11040966, Example 5.211::US9732075, Example 5.211::[5-(4-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(4,5-difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 27.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334952 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334952&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127026 384987112 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657544 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(F)c(F)ccc3[nH]2)c(s1)-c1ccc(Cl)cc1 InChI=1S/C23H19ClF2N4OS/c1-12-27-19(20(32-12)13-4-6-14(24)7-5-13)21(31)30-11-3-10-23(30,2)22-28-16-9-8-15(25)17(26)18(16)29-22/h4-9H,3,10-11H2,1-2H3,(H,28,29)/t23-/m0/s1 NMPZITPNATUWFC-QHCPKHFHSA-N 334952 US11040966, Example 5.211::US9732075, Example 5.211::[5-(4-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(4,5-difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 159 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334952 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334952&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127026 384987112 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657545 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(F)c(F)ccc3[nH]2)c(s1)-c1cccc(F)c1 InChI=1S/C23H19F3N4OS/c1-12-27-19(20(32-12)13-5-3-6-14(24)11-13)21(31)30-10-4-9-23(30,2)22-28-16-8-7-15(25)17(26)18(16)29-22/h3,5-8,11H,4,9-10H2,1-2H3,(H,28,29)/t23-/m0/s1 SNKGEZBFYZEDDZ-QHCPKHFHSA-N 334953 US11040966, Example 5.212::US9732075, Example 5.212::[(S)-2-(4,5-Difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(3-fluoro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 26.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334953 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334953&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127078 384987113 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657546 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(F)c(F)ccc3[nH]2)c(s1)-c1cccc(F)c1 InChI=1S/C23H19F3N4OS/c1-12-27-19(20(32-12)13-5-3-6-14(24)11-13)21(31)30-10-4-9-23(30,2)22-28-16-8-7-15(25)17(26)18(16)29-22/h3,5-8,11H,4,9-10H2,1-2H3,(H,28,29)/t23-/m0/s1 SNKGEZBFYZEDDZ-QHCPKHFHSA-N 334953 US11040966, Example 5.212::US9732075, Example 5.212::[(S)-2-(4,5-Difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(3-fluoro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 239 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334953 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334953&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127078 384987113 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657547 COc1cccc(c1)-c1sc(C)nc1C(=O)N1CCC[C@@]1(C)c1nc2c(F)c(F)ccc2[nH]1 InChI=1S/C24H22F2N4O2S/c1-13-27-20(21(33-13)14-6-4-7-15(12-14)32-3)22(31)30-11-5-10-24(30,2)23-28-17-9-8-16(25)18(26)19(17)29-23/h4,6-9,12H,5,10-11H2,1-3H3,(H,28,29)/t24-/m0/s1 MPUAMASGRCRYBN-DEOSSOPVSA-N 334954 US11040966, Example 5.213::US9732075, Example 5.213::[(S)-2-(4,5-Difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(3-methoxy-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 16.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334954 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334954&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127558 384987114 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657548 COc1cccc(c1)-c1sc(C)nc1C(=O)N1CCC[C@@]1(C)c1nc2c(F)c(F)ccc2[nH]1 InChI=1S/C24H22F2N4O2S/c1-13-27-20(21(33-13)14-6-4-7-15(12-14)32-3)22(31)30-11-5-10-24(30,2)23-28-17-9-8-16(25)18(26)19(17)29-23/h4,6-9,12H,5,10-11H2,1-3H3,(H,28,29)/t24-/m0/s1 MPUAMASGRCRYBN-DEOSSOPVSA-N 334954 US11040966, Example 5.213::US9732075, Example 5.213::[(S)-2-(4,5-Difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(3-methoxy-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 51.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334954 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334954&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127558 384987114 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657549 Cc1ccc(-c2ncccn2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C25H24ClN5O/c1-15-6-7-17(22-27-11-5-12-28-22)18(14-15)23(32)31-13-4-10-25(31,3)24-29-20-9-8-19(26)16(2)21(20)30-24/h5-9,11-12,14H,4,10,13H2,1-3H3,(H,29,30)/t25-/m0/s1 ZXEWKIMFKPFZMU-VWLOTQADSA-N 334955 US11040966, Example 5.214::US9732075, Example 5.214::US9914721, Ex. 10::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334955 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334955&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128176 384987115 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657550 Cc1ccc(-c2ncccn2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C25H24ClN5O/c1-15-6-7-17(22-27-11-5-12-28-22)18(14-15)23(32)31-13-4-10-25(31,3)24-29-20-9-8-19(26)16(2)21(20)30-24/h5-9,11-12,14H,4,10,13H2,1-3H3,(H,29,30)/t25-/m0/s1 ZXEWKIMFKPFZMU-VWLOTQADSA-N 334955 US11040966, Example 5.214::US9732075, Example 5.214::US9914721, Ex. 10::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334955 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334955&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128176 384987115 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657551 Cc1ccc(-c2ccccn2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C26H25ClN4O/c1-16-8-9-18(21-7-4-5-13-28-21)19(15-16)24(32)31-14-6-12-26(31,3)25-29-22-11-10-20(27)17(2)23(22)30-25/h4-5,7-11,13,15H,6,12,14H2,1-3H3,(H,29,30)/t26-/m0/s1 APOGCVQZYGMWMJ-SANMLTNESA-N 334956 US11040966, Example 5.215::US9732075, Example 5.215::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyridin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334956 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334956&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695101 384987116 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657552 Cc1ccc(-c2ccccn2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C26H25ClN4O/c1-16-8-9-18(21-7-4-5-13-28-21)19(15-16)24(32)31-14-6-12-26(31,3)25-29-22-11-10-20(27)17(2)23(22)30-25/h4-5,7-11,13,15H,6,12,14H2,1-3H3,(H,29,30)/t26-/m0/s1 APOGCVQZYGMWMJ-SANMLTNESA-N 334956 US11040966, Example 5.215::US9732075, Example 5.215::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyridin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 11.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334956 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334956&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695101 384987116 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657553 Cc1ccc(-c2cccnc2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C26H25ClN4O/c1-16-7-8-19(18-6-4-12-28-15-18)20(14-16)24(32)31-13-5-11-26(31,3)25-29-22-10-9-21(27)17(2)23(22)30-25/h4,6-10,12,14-15H,5,11,13H2,1-3H3,(H,29,30)/t26-/m0/s1 AGAQFIOCCWWMOS-SANMLTNESA-N 334957 US11040966, Example 5.217::US9732075, Example 5.216::US9732075, Example 5.217::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyridin-3-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 15.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334957 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334957&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695099 384987117 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657554 Cc1ccc(-c2cccnc2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C26H25ClN4O/c1-16-7-8-19(18-6-4-12-28-15-18)20(14-16)24(32)31-13-5-11-26(31,3)25-29-22-10-9-21(27)17(2)23(22)30-25/h4,6-10,12,14-15H,5,11,13H2,1-3H3,(H,29,30)/t26-/m0/s1 AGAQFIOCCWWMOS-SANMLTNESA-N 334957 US11040966, Example 5.217::US9732075, Example 5.216::US9732075, Example 5.217::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyridin-3-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 45.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334957 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334957&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695099 384987117 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657555 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(F)cc2[nH]1)C(F)(F)F)-n1nccn1 InChI=1S/C23H20F4N6O/c1-13-4-5-19(33-28-7-8-29-33)14(10-13)20(34)32-9-3-6-22(32,2)21-30-17-11-15(23(25,26)27)16(24)12-18(17)31-21/h4-5,7-8,10-12H,3,6,9H2,1-2H3,(H,30,31)/t22-/m0/s1 QTQNLAZEPPCMLN-QFIPXVFZSA-N 334958 US11040966, Example 5.22::US9732075, Example 5.22::[(S)-2-(6-Fluoro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334958 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334958&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127889 384987118 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657556 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(F)cc2[nH]1)C(F)(F)F)-n1nccn1 InChI=1S/C23H20F4N6O/c1-13-4-5-19(33-28-7-8-29-33)14(10-13)20(34)32-9-3-6-22(32,2)21-30-17-11-15(23(25,26)27)16(24)12-18(17)31-21/h4-5,7-8,10-12H,3,6,9H2,1-2H3,(H,30,31)/t22-/m0/s1 QTQNLAZEPPCMLN-QFIPXVFZSA-N 334958 US11040966, Example 5.22::US9732075, Example 5.22::[(S)-2-(6-Fluoro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 86.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334958 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334958&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127889 384987118 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657557 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(F)c(Br)cc2[nH]1)-n1nccn1 InChI=1S/C22H20BrFN6O/c1-13-4-5-19(30-25-7-8-26-30)14(10-13)20(31)29-9-3-6-22(29,2)21-27-17-11-15(23)16(24)12-18(17)28-21/h4-5,7-8,10-12H,3,6,9H2,1-2H3,(H,27,28)/t22-/m0/s1 VCQFUAGWDVFPQB-QFIPXVFZSA-N 334959 US11040966, Example 5.23::US9732075, Example 5.23::US9914721, Ex. 5::[(S)-2-(6-Bromo-5-fluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 15.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334959 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334959&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127682 384987119 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657558 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(F)c(Br)cc2[nH]1)-n1nccn1 InChI=1S/C22H20BrFN6O/c1-13-4-5-19(30-25-7-8-26-30)14(10-13)20(31)29-9-3-6-22(29,2)21-27-17-11-15(23)16(24)12-18(17)28-21/h4-5,7-8,10-12H,3,6,9H2,1-2H3,(H,27,28)/t22-/m0/s1 VCQFUAGWDVFPQB-QFIPXVFZSA-N 334959 US11040966, Example 5.23::US9732075, Example 5.23::US9914721, Ex. 5::[(S)-2-(6-Bromo-5-fluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 80.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334959 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334959&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127682 384987119 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657559 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F)-n1nccn1 InChI=1S/C23H20ClF3N6O/c1-13-4-5-19(33-28-7-8-29-33)14(10-13)20(34)32-9-3-6-22(32,2)21-30-17-11-15(23(25,26)27)16(24)12-18(17)31-21/h4-5,7-8,10-12H,3,6,9H2,1-2H3,(H,30,31)/t22-/m0/s1 JVWVAASSQXQBNF-QFIPXVFZSA-N 334960 US11040966, Example 5.24::US9732075, Example 5.24::US9914721, Ex. 6::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334960 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334960&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127931 384987120 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657560 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F)-n1nccn1 InChI=1S/C23H20ClF3N6O/c1-13-4-5-19(33-28-7-8-29-33)14(10-13)20(34)32-9-3-6-22(32,2)21-30-17-11-15(23(25,26)27)16(24)12-18(17)31-21/h4-5,7-8,10-12H,3,6,9H2,1-2H3,(H,30,31)/t22-/m0/s1 JVWVAASSQXQBNF-QFIPXVFZSA-N 334960 US11040966, Example 5.24::US9732075, Example 5.24::US9914721, Ex. 6::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334960 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334960&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127931 384987120 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657561 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(Br)cc(F)cc2[nH]1)-n1nccn1 InChI=1S/C22H20BrFN6O/c1-13-4-5-18(30-25-7-8-26-30)15(10-13)20(31)29-9-3-6-22(29,2)21-27-17-12-14(24)11-16(23)19(17)28-21/h4-5,7-8,10-12H,3,6,9H2,1-2H3,(H,27,28)/t22-/m0/s1 NBHIWTNDQZKTIO-QFIPXVFZSA-N 334961 US11040966, Example 5.25::US9732075, Example 5.25::[(S)-2-(4-Bromo-6-fluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 27.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334961 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334961&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128277 384987121 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657562 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(Br)cc(F)cc2[nH]1)-n1nccn1 InChI=1S/C22H20BrFN6O/c1-13-4-5-18(30-25-7-8-26-30)15(10-13)20(31)29-9-3-6-22(29,2)21-27-17-12-14(24)11-16(23)19(17)28-21/h4-5,7-8,10-12H,3,6,9H2,1-2H3,(H,27,28)/t22-/m0/s1 NBHIWTNDQZKTIO-QFIPXVFZSA-N 334961 US11040966, Example 5.25::US9732075, Example 5.25::[(S)-2-(4-Bromo-6-fluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 81.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334961 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334961&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128277 384987121 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657563 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(Cl)cccc2[nH]1)-n1nccn1 InChI=1S/C22H21ClN6O/c1-14-7-8-18(29-24-10-11-25-29)15(13-14)20(30)28-12-4-9-22(28,2)21-26-17-6-3-5-16(23)19(17)27-21/h3,5-8,10-11,13H,4,9,12H2,1-2H3,(H,26,27)/t22-/m0/s1 ILYPGEWTTWFVFH-QFIPXVFZSA-N 334962 US11040966, Example 5.26::US9732075, Example 5.26::[(S)-2-(4-Chloro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 39.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334962 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334962&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128222 384987122 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657564 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(Cl)cccc2[nH]1)-n1nccn1 InChI=1S/C22H21ClN6O/c1-14-7-8-18(29-24-10-11-25-29)15(13-14)20(30)28-12-4-9-22(28,2)21-26-17-6-3-5-16(23)19(17)27-21/h3,5-8,10-11,13H,4,9,12H2,1-2H3,(H,26,27)/t22-/m0/s1 ILYPGEWTTWFVFH-QFIPXVFZSA-N 334962 US11040966, Example 5.26::US9732075, Example 5.26::[(S)-2-(4-Chloro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 197 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334962 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334962&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128222 384987122 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657565 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(F)c(F)ccc2[nH]1)-n1nccn1 InChI=1S/C22H20F2N6O/c1-13-4-7-17(30-25-9-10-26-30)14(12-13)20(31)29-11-3-8-22(29,2)21-27-16-6-5-15(23)18(24)19(16)28-21/h4-7,9-10,12H,3,8,11H2,1-2H3,(H,27,28)/t22-/m0/s1 ULGNTJYGFUBGPP-QFIPXVFZSA-N 334963 US11040966, Example 5.27::US9732075, Example 5.27::[(S)-2-(4,5-Difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 46.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334963 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334963&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127178 384987123 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657566 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(F)c(F)ccc2[nH]1)-n1nccn1 InChI=1S/C22H20F2N6O/c1-13-4-7-17(30-25-9-10-26-30)14(12-13)20(31)29-11-3-8-22(29,2)21-27-16-6-5-15(23)18(24)19(16)28-21/h4-7,9-10,12H,3,8,11H2,1-2H3,(H,27,28)/t22-/m0/s1 ULGNTJYGFUBGPP-QFIPXVFZSA-N 334963 US11040966, Example 5.27::US9732075, Example 5.27::[(S)-2-(4,5-Difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 507 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334963 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334963&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127178 384987123 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657567 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(C)ccc2[nH]1)-n1nccn1 InChI=1S/C24H26N6O/c1-15-6-9-20(30-25-11-12-26-30)18(14-15)22(31)29-13-5-10-24(29,4)23-27-19-8-7-16(2)17(3)21(19)28-23/h6-9,11-12,14H,5,10,13H2,1-4H3,(H,27,28)/t24-/m0/s1 LEGFFCFGSFQDHY-DEOSSOPVSA-N 334964 US11040966, Example 5.28::US9732075, Example 5.28::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334964 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334964&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127289 384987124 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657568 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(C)ccc2[nH]1)-n1nccn1 InChI=1S/C24H26N6O/c1-15-6-9-20(30-25-11-12-26-30)18(14-15)22(31)29-13-5-10-24(29,4)23-27-19-8-7-16(2)17(3)21(19)28-23/h6-9,11-12,14H,5,10,13H2,1-4H3,(H,27,28)/t24-/m0/s1 LEGFFCFGSFQDHY-DEOSSOPVSA-N 334964 US11040966, Example 5.28::US9732075, Example 5.28::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 19.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334964 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334964&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127289 384987124 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657569 CC(C)c1cccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C25H28N6O/c1-16(2)18-7-5-8-20-22(18)29-24(28-20)25(4)11-6-14-30(25)23(32)19-15-17(3)9-10-21(19)31-26-12-13-27-31/h5,7-10,12-13,15-16H,6,11,14H2,1-4H3,(H,28,29)/t25-/m0/s1 YYHQHVXIDJNXRG-VWLOTQADSA-N 334965 US11040966, Example 5.29::US9732075, Example 5.29::[(S)-2-(4-Isopropyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334965 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334965&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127529 384987125 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657570 CC(C)c1cccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C25H28N6O/c1-16(2)18-7-5-8-20-22(18)29-24(28-20)25(4)11-6-14-30(25)23(32)19-15-17(3)9-10-21(19)31-26-12-13-27-31/h5,7-10,12-13,15-16H,6,11,14H2,1-4H3,(H,28,29)/t25-/m0/s1 YYHQHVXIDJNXRG-VWLOTQADSA-N 334965 US11040966, Example 5.29::US9732075, Example 5.29::[(S)-2-(4-Isopropyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 59.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334965 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334965&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127529 384987125 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657571 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccccc1 InChI=1S/C24H23ClN4OS/c1-14-17(25)10-11-18-19(14)28-23(27-18)24(3)12-7-13-29(24)22(30)20-21(31-15(2)26-20)16-8-5-4-6-9-16/h4-6,8-11H,7,12-13H2,1-3H3,(H,27,28)/t24-/m0/s1 LLZRXSUDUAIYKG-DEOSSOPVSA-N 334966 US11040966, Example 5.3::US9732075, Example 5.3::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334966 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334966&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127550 384987126 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657572 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccccc1 InChI=1S/C24H23ClN4OS/c1-14-17(25)10-11-18-19(14)28-23(27-18)24(3)12-7-13-29(24)22(30)20-21(31-15(2)26-20)16-8-5-4-6-9-16/h4-6,8-11H,7,12-13H2,1-3H3,(H,27,28)/t24-/m0/s1 LLZRXSUDUAIYKG-DEOSSOPVSA-N 334966 US11040966, Example 5.3::US9732075, Example 5.3::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334966 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334966&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127550 384987126 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657573 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(SC(F)(F)F)ccc2[nH]1)-n1nccn1 InChI=1S/C23H21F3N6OS/c1-14-4-7-19(32-27-9-10-28-32)16(12-14)20(33)31-11-3-8-22(31,2)21-29-17-6-5-15(13-18(17)30-21)34-23(24,25)26/h4-7,9-10,12-13H,3,8,11H2,1-2H3,(H,29,30)/t22-/m0/s1 YYRSESSZIFNYPG-QFIPXVFZSA-N 334967 (5-Methyl-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.30::US9732075, Example 5.30 Orexin/Hypocretin receptor type 1 Homo sapiens 57.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334967 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334967&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128081 384987127 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657574 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(SC(F)(F)F)ccc2[nH]1)-n1nccn1 InChI=1S/C23H21F3N6OS/c1-14-4-7-19(32-27-9-10-28-32)16(12-14)20(33)31-11-3-8-22(31,2)21-29-17-6-5-15(13-18(17)30-21)34-23(24,25)26/h4-7,9-10,12-13H,3,8,11H2,1-2H3,(H,29,30)/t22-/m0/s1 YYRSESSZIFNYPG-QFIPXVFZSA-N 334967 (5-Methyl-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.30::US9732075, Example 5.30 Orexin receptor type 2 Homo sapiens 164 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334967 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334967&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128081 384987127 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657575 COc1ccc(OC)c2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C24H26N6O3/c1-15-6-7-17(30-25-11-12-26-30)16(14-15)22(31)29-13-5-10-24(29,2)23-27-20-18(32-3)8-9-19(33-4)21(20)28-23/h6-9,11-12,14H,5,10,13H2,1-4H3,(H,27,28)/t24-/m0/s1 JLBGNWDBUKQIFM-DEOSSOPVSA-N 334968 US11040966, Example 5.31::US9732075, Example 5.31::[(S)-2-(4,7-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 44.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334968 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334968&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127215 384987128 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657576 COc1ccc(OC)c2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C24H26N6O3/c1-15-6-7-17(30-25-11-12-26-30)16(14-15)22(31)29-13-5-10-24(29,2)23-27-20-18(32-3)8-9-19(33-4)21(20)28-23/h6-9,11-12,14H,5,10,13H2,1-4H3,(H,27,28)/t24-/m0/s1 JLBGNWDBUKQIFM-DEOSSOPVSA-N 334968 US11040966, Example 5.31::US9732075, Example 5.31::[(S)-2-(4,7-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 740 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334968 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334968&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127215 384987128 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657577 COc1ccc2[nH]c(nc2c1)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C23H24N6O2/c1-15-5-8-20(29-24-10-11-25-29)17(13-15)21(30)28-12-4-9-23(28,2)22-26-18-7-6-16(31-3)14-19(18)27-22/h5-8,10-11,13-14H,4,9,12H2,1-3H3,(H,26,27)/t23-/m0/s1 WOCNVKFXRLZKCA-QHCPKHFHSA-N 334969 US11040966, Example 5.32::US9732075, Example 5.32::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 90.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334969 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334969&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127663 384987129 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657578 COc1ccc2[nH]c(nc2c1)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C23H24N6O2/c1-15-5-8-20(29-24-10-11-25-29)17(13-15)21(30)28-12-4-9-23(28,2)22-26-18-7-6-16(31-3)14-19(18)27-22/h5-8,10-11,13-14H,4,9,12H2,1-3H3,(H,26,27)/t23-/m0/s1 WOCNVKFXRLZKCA-QHCPKHFHSA-N 334969 US11040966, Example 5.32::US9732075, Example 5.32::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 46.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334969 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334969&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127663 384987129 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657579 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c3OCCOc3ccc2[nH]1)-n1nccn1 InChI=1S/C24H24N6O3/c1-15-4-6-18(30-25-9-10-26-30)16(14-15)22(31)29-11-3-8-24(29,2)23-27-17-5-7-19-21(20(17)28-23)33-13-12-32-19/h4-7,9-10,14H,3,8,11-13H2,1-2H3,(H,27,28)/t24-/m0/s1 QXPNKSQHKNGBBW-DEOSSOPVSA-N 334970 US11040966, Example 5.33::US9732075, Example 5.33::[(S)-2-(7,8-Dihydro-3H-6,9-dioxa-1,3-diaza-cyclopenta[a]naph-thalen-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 25.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334970 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334970&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127630 384987130 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657580 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c3OCCOc3ccc2[nH]1)-n1nccn1 InChI=1S/C24H24N6O3/c1-15-4-6-18(30-25-9-10-26-30)16(14-15)22(31)29-11-3-8-24(29,2)23-27-17-5-7-19-21(20(17)28-23)33-13-12-32-19/h4-7,9-10,14H,3,8,11-13H2,1-2H3,(H,27,28)/t24-/m0/s1 QXPNKSQHKNGBBW-DEOSSOPVSA-N 334970 US11040966, Example 5.33::US9732075, Example 5.33::[(S)-2-(7,8-Dihydro-3H-6,9-dioxa-1,3-diaza-cyclopenta[a]naph-thalen-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 29.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334970 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334970&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127630 384987130 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657581 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C22H20Cl2N6O/c1-13-16(24)5-6-17-19(13)28-21(27-17)22(2)8-3-11-29(22)20(31)15-12-14(23)4-7-18(15)30-25-9-10-26-30/h4-7,9-10,12H,3,8,11H2,1-2H3,(H,27,28)/t22-/m0/s1 ZDGPOSKGUZNOIJ-QFIPXVFZSA-N 334971 US11040966, Example 5.34::US9732075, Example 5.34::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-chloro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334971 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334971&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127871 384987131 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657582 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C22H20Cl2N6O/c1-13-16(24)5-6-17-19(13)28-21(27-17)22(2)8-3-11-29(22)20(31)15-12-14(23)4-7-18(15)30-25-9-10-26-30/h4-7,9-10,12H,3,8,11H2,1-2H3,(H,27,28)/t22-/m0/s1 ZDGPOSKGUZNOIJ-QFIPXVFZSA-N 334971 US11040966, Example 5.34::US9732075, Example 5.34::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-chloro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334971 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334971&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127871 384987131 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657583 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1cc(OC(F)(F)F)ccc1-n1nccn1 InChI=1S/C23H20ClF3N6O2/c1-13-16(24)5-6-17-19(13)31-21(30-17)22(2)8-3-11-32(22)20(34)15-12-14(35-23(25,26)27)4-7-18(15)33-28-9-10-29-33/h4-7,9-10,12H,3,8,11H2,1-2H3,(H,30,31)/t22-/m0/s1 MSJAIHLNFKEDGJ-QFIPXVFZSA-N 334972 US11040966, Example 5.35::US9732075, Example 5.35::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoromethoxy-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 102 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334972 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334972&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127417 384987132 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657584 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1cc(OC(F)(F)F)ccc1-n1nccn1 InChI=1S/C23H20ClF3N6O2/c1-13-16(24)5-6-17-19(13)31-21(30-17)22(2)8-3-11-32(22)20(34)15-12-14(35-23(25,26)27)4-7-18(15)33-28-9-10-29-33/h4-7,9-10,12H,3,8,11H2,1-2H3,(H,30,31)/t22-/m0/s1 MSJAIHLNFKEDGJ-QFIPXVFZSA-N 334972 US11040966, Example 5.35::US9732075, Example 5.35::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoromethoxy-phenyl)-methanone Orexin receptor type 2 Homo sapiens 99.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334972 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334972&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127417 384987132 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657585 COc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(Cl)ccc2[nH]1)-n1nccn1 InChI=1S/C23H23ClN6O2/c1-14-17(24)6-7-18-20(14)28-22(27-18)23(2)9-4-12-29(23)21(31)16-13-15(32-3)5-8-19(16)30-25-10-11-26-30/h5-8,10-11,13H,4,9,12H2,1-3H3,(H,27,28)/t23-/m0/s1 NBGABHGMJVIVBW-QHCPKHFHSA-N 334973 US11040966, Example 5.36::US9732075, Example 5.36::US9914721, Ex. 7::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334973 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334973&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 91801202 384987133 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657586 COc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(Cl)ccc2[nH]1)-n1nccn1 InChI=1S/C23H23ClN6O2/c1-14-17(24)6-7-18-20(14)28-22(27-18)23(2)9-4-12-29(23)21(31)16-13-15(32-3)5-8-19(16)30-25-10-11-26-30/h5-8,10-11,13H,4,9,12H2,1-3H3,(H,27,28)/t23-/m0/s1 NBGABHGMJVIVBW-QHCPKHFHSA-N 334973 US11040966, Example 5.36::US9732075, Example 5.36::US9914721, Ex. 7::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334973 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334973&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 91801202 384987133 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657587 COc1ccc(c(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c1F)-n1nccn1 InChI=1S/C23H22ClFN6O2/c1-13-14(24)5-6-15-20(13)29-22(28-15)23(2)9-4-12-30(23)21(32)18-16(31-26-10-11-27-31)7-8-17(33-3)19(18)25/h5-8,10-11H,4,9,12H2,1-3H3,(H,28,29)/t23-/m0/s1 ZIOLGWZUALIXFS-QHCPKHFHSA-N 334974 US11040966, Example 5.37::US9732075, Example 5.37::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methoxy-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 10.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334974 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334974&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128220 384987134 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657588 COc1ccc(c(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c1F)-n1nccn1 InChI=1S/C23H22ClFN6O2/c1-13-14(24)5-6-15-20(13)29-22(28-15)23(2)9-4-12-30(23)21(32)18-16(31-26-10-11-27-31)7-8-17(33-3)19(18)25/h5-8,10-11H,4,9,12H2,1-3H3,(H,28,29)/t23-/m0/s1 ZIOLGWZUALIXFS-QHCPKHFHSA-N 334974 US11040966, Example 5.37::US9732075, Example 5.37::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methoxy-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 16.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334974 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334974&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128220 384987134 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657589 Cc1ccc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(c1)-n1nccn1 InChI=1S/C23H23ClN6O/c1-14-5-6-16(19(13-14)30-25-10-11-26-30)21(31)29-12-4-9-23(29,3)22-27-18-8-7-17(24)15(2)20(18)28-22/h5-8,10-11,13H,4,9,12H2,1-3H3,(H,27,28)/t23-/m0/s1 LZIZZUSWJHWVCS-QHCPKHFHSA-N 334975 US11040966, Example 5.38::US9732075, Example 5.38::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334975 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334975&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127621 384987135 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657590 Cc1ccc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(c1)-n1nccn1 InChI=1S/C23H23ClN6O/c1-14-5-6-16(19(13-14)30-25-10-11-26-30)21(31)29-12-4-9-23(29,3)22-27-18-8-7-17(24)15(2)20(18)28-22/h5-8,10-11,13H,4,9,12H2,1-3H3,(H,27,28)/t23-/m0/s1 LZIZZUSWJHWVCS-QHCPKHFHSA-N 334975 US11040966, Example 5.38::US9732075, Example 5.38::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 12.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334975 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334975&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127621 384987135 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657591 COc1cc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(cc1OC)-n1nccn1 InChI=1S/C24H25ClN6O3/c1-14-16(25)6-7-17-21(14)29-23(28-17)24(2)8-5-11-30(24)22(32)15-12-19(33-3)20(34-4)13-18(15)31-26-9-10-27-31/h6-7,9-10,12-13H,5,8,11H2,1-4H3,(H,28,29)/t24-/m0/s1 PKKBSOLNDPYHKH-DEOSSOPVSA-N 334976 US11040966, Example 5.39::US9732075, Example 5.39::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,5-dimethoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 36.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334976 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334976&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127041 384987136 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657592 COc1cc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(cc1OC)-n1nccn1 InChI=1S/C24H25ClN6O3/c1-14-16(25)6-7-17-21(14)29-23(28-17)24(2)8-5-11-30(24)22(32)15-12-19(33-3)20(34-4)13-18(15)31-26-9-10-27-31/h6-7,9-10,12-13H,5,8,11H2,1-4H3,(H,28,29)/t24-/m0/s1 PKKBSOLNDPYHKH-DEOSSOPVSA-N 334976 US11040966, Example 5.39::US9732075, Example 5.39::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,5-dimethoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 20.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334976 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334976&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127041 384987136 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657593 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)cccc3[nH]2)c(s1)-c1cccc(Cl)c1 InChI=1S/C24H23ClN4OS/c1-14-7-4-10-18-19(14)28-23(27-18)24(3)11-6-12-29(24)22(30)20-21(31-15(2)26-20)16-8-5-9-17(25)13-16/h4-5,7-10,13H,6,11-12H2,1-3H3,(H,27,28)/t24-/m0/s1 RQFWKADMJMBRDJ-DEOSSOPVSA-N 334977 US11040966, Example 5.4::US9732075, Example 5.4::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-methyl-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 10.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334977 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334977&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127513 384987137 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657594 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)cccc3[nH]2)c(s1)-c1cccc(Cl)c1 InChI=1S/C24H23ClN4OS/c1-14-7-4-10-18-19(14)28-23(27-18)24(3)11-6-12-29(24)22(30)20-21(31-15(2)26-20)16-8-5-9-17(25)13-16/h4-5,7-10,13H,6,11-12H2,1-3H3,(H,27,28)/t24-/m0/s1 RQFWKADMJMBRDJ-DEOSSOPVSA-N 334977 US11040966, Example 5.4::US9732075, Example 5.4::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-methyl-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334977 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334977&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127513 384987137 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657595 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1cc(ccc1-n1nccn1)C(F)(F)F InChI=1S/C23H20ClF3N6O/c1-13-16(24)5-6-17-19(13)31-21(30-17)22(2)8-3-11-32(22)20(34)15-12-14(23(25,26)27)4-7-18(15)33-28-9-10-29-33/h4-7,9-10,12H,3,8,11H2,1-2H3,(H,30,31)/t22-/m0/s1 DJANONISNRIVCE-QFIPXVFZSA-N 334978 US11040966, Example 5.40::US9732075, Example 5.40::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoromethyl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 44.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334978 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334978&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127234 384987138 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657596 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1cc(ccc1-n1nccn1)C(F)(F)F InChI=1S/C23H20ClF3N6O/c1-13-16(24)5-6-17-19(13)31-21(30-17)22(2)8-3-11-32(22)20(34)15-12-14(23(25,26)27)4-7-18(15)33-28-9-10-29-33/h4-7,9-10,12H,3,8,11H2,1-2H3,(H,30,31)/t22-/m0/s1 DJANONISNRIVCE-QFIPXVFZSA-N 334978 US11040966, Example 5.40::US9732075, Example 5.40::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoromethyl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 91.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334978 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334978&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127234 384987138 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657597 Cc1cc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(cc1C)-n1nccn1 InChI=1S/C24H25ClN6O/c1-14-12-17(20(13-15(14)2)31-26-9-10-27-31)22(32)30-11-5-8-24(30,4)23-28-19-7-6-18(25)16(3)21(19)29-23/h6-7,9-10,12-13H,5,8,11H2,1-4H3,(H,28,29)/t24-/m0/s1 OTINXPNLFIWYGI-DEOSSOPVSA-N 334979 US11040966, Example 5.41::US9732075, Example 5.41::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,5-dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334979 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334979&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127747 384987139 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657598 Cc1cc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(cc1C)-n1nccn1 InChI=1S/C24H25ClN6O/c1-14-12-17(20(13-15(14)2)31-26-9-10-27-31)22(32)30-11-5-8-24(30,4)23-28-19-7-6-18(25)16(3)21(19)29-23/h6-7,9-10,12-13H,5,8,11H2,1-4H3,(H,28,29)/t24-/m0/s1 OTINXPNLFIWYGI-DEOSSOPVSA-N 334979 US11040966, Example 5.41::US9732075, Example 5.41::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,5-dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334979 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334979&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127747 384987139 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657599 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1ccccc1-n1cccn1 InChI=1S/C23H22ClN5O/c1-15-17(24)9-10-18-20(15)27-22(26-18)23(2)11-5-13-28(23)21(30)16-7-3-4-8-19(16)29-14-6-12-25-29/h3-4,6-10,12,14H,5,11,13H2,1-2H3,(H,26,27)/t23-/m0/s1 IGUAJOQMZQNGFY-QHCPKHFHSA-N 334980 US11040966, Example 5.42::US9732075, Example 5.42::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-pyrazol-1-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 49.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334980 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334980&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102394 384987140 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657600 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1ccccc1-n1cccn1 InChI=1S/C23H22ClN5O/c1-15-17(24)9-10-18-20(15)27-22(26-18)23(2)11-5-13-28(23)21(30)16-7-3-4-8-19(16)29-14-6-12-25-29/h3-4,6-10,12,14H,5,11,13H2,1-2H3,(H,26,27)/t23-/m0/s1 IGUAJOQMZQNGFY-QHCPKHFHSA-N 334980 US11040966, Example 5.42::US9732075, Example 5.42::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-pyrazol-1-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 75.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334980 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334980&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102394 384987140 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657601 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(Cl)ccc2[nH]1)-n1cccn1 InChI=1S/C24H24ClN5O/c1-15-6-9-20(30-13-5-11-26-30)17(14-15)22(31)29-12-4-10-24(29,3)23-27-19-8-7-18(25)16(2)21(19)28-23/h5-9,11,13-14H,4,10,12H2,1-3H3,(H,27,28)/t24-/m0/s1 AWYCCGHIHBHRDF-DEOSSOPVSA-N 334981 US11040966, Example 5.43::US9732075, Example 5.43::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334981 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334981&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127174 384987141 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657602 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(Cl)ccc2[nH]1)-n1cccn1 InChI=1S/C24H24ClN5O/c1-15-6-9-20(30-13-5-11-26-30)17(14-15)22(31)29-12-4-10-24(29,3)23-27-19-8-7-18(25)16(2)21(19)28-23/h5-9,11,13-14H,4,10,12H2,1-3H3,(H,27,28)/t24-/m0/s1 AWYCCGHIHBHRDF-DEOSSOPVSA-N 334981 US11040966, Example 5.43::US9732075, Example 5.43::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 14.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334981 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334981&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127174 384987141 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657603 Cc1ccc(c(n1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(Cl)ccc2[nH]1)-n1cccn1 InChI=1S/C23H23ClN6O/c1-14-6-9-18(30-13-5-11-25-30)20(26-14)21(31)29-12-4-10-23(29,3)22-27-17-8-7-16(24)15(2)19(17)28-22/h5-9,11,13H,4,10,12H2,1-3H3,(H,27,28)/t23-/m0/s1 ZKTDYXONFXIQFE-QHCPKHFHSA-N 334982 US11040966, Example 5.44::US9732075, Example 5.44::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(6-methyl-3-pyrazol-1-yl-pyridin-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334982 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334982&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127562 384987142 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657604 Cc1ccc(c(n1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(Cl)ccc2[nH]1)-n1cccn1 InChI=1S/C23H23ClN6O/c1-14-6-9-18(30-13-5-11-25-30)20(26-14)21(31)29-12-4-10-23(29,3)22-27-17-8-7-16(24)15(2)19(17)28-22/h5-9,11,13H,4,10,12H2,1-3H3,(H,27,28)/t23-/m0/s1 ZKTDYXONFXIQFE-QHCPKHFHSA-N 334982 US11040966, Example 5.44::US9732075, Example 5.44::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(6-methyl-3-pyrazol-1-yl-pyridin-2-yl)-methanone Orexin receptor type 2 Homo sapiens 29.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334982 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334982&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127562 384987142 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657605 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1cc(F)ccc1-n1nccn1 InChI=1S/C22H20ClFN6O/c1-13-16(23)5-6-17-19(13)28-21(27-17)22(2)8-3-11-29(22)20(31)15-12-14(24)4-7-18(15)30-25-9-10-26-30/h4-7,9-10,12H,3,8,11H2,1-2H3,(H,27,28)/t22-/m0/s1 FXUGMHFFZBBRQC-QFIPXVFZSA-N 334983 US11040966, Example 5.45::US9732075, Example 5.45::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334983 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334983&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127252 384987143 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657606 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1cc(F)ccc1-n1nccn1 InChI=1S/C22H20ClFN6O/c1-13-16(23)5-6-17-19(13)28-21(27-17)22(2)8-3-11-29(22)20(31)15-12-14(24)4-7-18(15)30-25-9-10-26-30/h4-7,9-10,12H,3,8,11H2,1-2H3,(H,27,28)/t22-/m0/s1 FXUGMHFFZBBRQC-QFIPXVFZSA-N 334983 US11040966, Example 5.45::US9732075, Example 5.45::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 12.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334983 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334983&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127252 384987143 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657607 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H21ClN6O/c1-14-16(23)8-9-17-19(14)27-21(26-17)22(2)10-5-13-28(22)20(30)15-6-3-4-7-18(15)29-24-11-12-25-29/h3-4,6-9,11-12H,5,10,13H2,1-2H3,(H,26,27)/t22-/m0/s1 HZZFIYQZIORVRU-QFIPXVFZSA-N 334984 US11040966, Example 5.46::US9732075, Example 5.46::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334984 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334984&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127114 384987144 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657608 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H21ClN6O/c1-14-16(23)8-9-17-19(14)27-21(26-17)22(2)10-5-13-28(22)20(30)15-6-3-4-7-18(15)29-24-11-12-25-29/h3-4,6-9,11-12H,5,10,13H2,1-2H3,(H,26,27)/t22-/m0/s1 HZZFIYQZIORVRU-QFIPXVFZSA-N 334984 US11040966, Example 5.46::US9732075, Example 5.46::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 14.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334984 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334984&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127114 384987144 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657609 Cc1ccc(c(n1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(Cl)ccc2[nH]1)-n1nccn1 InChI=1S/C22H22ClN7O/c1-13-5-8-17(30-24-10-11-25-30)19(26-13)20(31)29-12-4-9-22(29,3)21-27-16-7-6-15(23)14(2)18(16)28-21/h5-8,10-11H,4,9,12H2,1-3H3,(H,27,28)/t22-/m0/s1 SBLKQHKKTLFVDU-QFIPXVFZSA-N 334985 US11040966, Example 5.47::US9732075, Example 5.47::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334985 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334985&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127867 384987145 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657610 Cc1ccc(c(n1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(Cl)ccc2[nH]1)-n1nccn1 InChI=1S/C22H22ClN7O/c1-13-5-8-17(30-24-10-11-25-30)19(26-13)20(31)29-12-4-9-22(29,3)21-27-16-7-6-15(23)14(2)18(16)28-21/h5-8,10-11H,4,9,12H2,1-3H3,(H,27,28)/t22-/m0/s1 SBLKQHKKTLFVDU-QFIPXVFZSA-N 334985 US11040966, Example 5.47::US9732075, Example 5.47::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone Orexin receptor type 2 Homo sapiens 15.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334985 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334985&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127867 384987145 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657611 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1c(F)cccc1-n1nccn1 InChI=1S/C22H20ClFN6O/c1-13-14(23)7-8-16-19(13)28-21(27-16)22(2)9-4-12-29(22)20(31)18-15(24)5-3-6-17(18)30-25-10-11-26-30/h3,5-8,10-11H,4,9,12H2,1-2H3,(H,27,28)/t22-/m0/s1 JEPFQBXIDQOYSW-QFIPXVFZSA-N 334986 US11040966, Example 5.48::US9732075, Example 5.48::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-fluoro-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 12.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334986 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334986&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128279 384987146 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657612 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1c(F)cccc1-n1nccn1 InChI=1S/C22H20ClFN6O/c1-13-14(23)7-8-16-19(13)28-21(27-16)22(2)9-4-12-29(22)20(31)18-15(24)5-3-6-17(18)30-25-10-11-26-30/h3,5-8,10-11H,4,9,12H2,1-2H3,(H,27,28)/t22-/m0/s1 JEPFQBXIDQOYSW-QFIPXVFZSA-N 334986 US11040966, Example 5.48::US9732075, Example 5.48::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-fluoro-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 25.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334986 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334986&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128279 384987146 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657613 Cc1cccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C22H21ClN6O/c1-14-5-3-6-17-19(14)27-21(26-17)22(2)9-4-12-28(22)20(30)16-13-15(23)7-8-18(16)29-24-10-11-25-29/h3,5-8,10-11,13H,4,9,12H2,1-2H3,(H,26,27)/t22-/m0/s1 QWPMZCFRGUXICY-QFIPXVFZSA-N 334987 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.49::US9732075, Example 5.49 Orexin/Hypocretin receptor type 1 Homo sapiens 85.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334987 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334987&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102242 384987147 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657614 Cc1cccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C22H21ClN6O/c1-14-5-3-6-17-19(14)27-21(26-17)22(2)9-4-12-28(22)20(30)16-13-15(23)7-8-18(16)29-24-10-11-25-29/h3,5-8,10-11,13H,4,9,12H2,1-2H3,(H,26,27)/t22-/m0/s1 QWPMZCFRGUXICY-QFIPXVFZSA-N 334987 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.49::US9732075, Example 5.49 Orexin receptor type 2 Homo sapiens 114 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334987 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334987&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102242 384987147 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657615 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1cccc(Cl)c1 InChI=1S/C24H22Cl2N4OS/c1-13-17(26)8-9-18-19(13)29-23(28-18)24(3)10-5-11-30(24)22(31)20-21(32-14(2)27-20)15-6-4-7-16(25)12-15/h4,6-9,12H,5,10-11H2,1-3H3,(H,28,29)/t24-/m0/s1 BHVUTIRHZGGMHB-DEOSSOPVSA-N 334988 US11040966, Example 5.5::US9732075, Example 5.5::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334988 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334988&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127464 384987148 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657616 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1cccc(Cl)c1 InChI=1S/C24H22Cl2N4OS/c1-13-17(26)8-9-18-19(13)29-23(28-18)24(3)10-5-11-30(24)22(31)20-21(32-14(2)27-20)15-6-4-7-16(25)12-15/h4,6-9,12H,5,10-11H2,1-3H3,(H,28,29)/t24-/m0/s1 BHVUTIRHZGGMHB-DEOSSOPVSA-N 334988 US11040966, Example 5.5::US9732075, Example 5.5::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334988 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334988&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127464 384987148 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657617 COc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)cccc2[nH]1)-n1nccn1 InChI=1S/C23H24N6O2/c1-15-6-4-7-18-20(15)27-22(26-18)23(2)10-5-13-28(23)21(30)17-14-16(31-3)8-9-19(17)29-24-11-12-25-29/h4,6-9,11-12,14H,5,10,13H2,1-3H3,(H,26,27)/t23-/m0/s1 RKLZNOXRSXQGAQ-QHCPKHFHSA-N 334989 (5-Methoxy-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.50::US9732075, Example 5.50 Orexin/Hypocretin receptor type 1 Homo sapiens 49.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334989 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334989&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128035 384987149 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657618 COc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)cccc2[nH]1)-n1nccn1 InChI=1S/C23H24N6O2/c1-15-6-4-7-18-20(15)27-22(26-18)23(2)10-5-13-28(23)21(30)17-14-16(31-3)8-9-19(17)29-24-11-12-25-29/h4,6-9,11-12,14H,5,10,13H2,1-3H3,(H,26,27)/t23-/m0/s1 RKLZNOXRSXQGAQ-QHCPKHFHSA-N 334989 (5-Methoxy-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.50::US9732075, Example 5.50 Orexin receptor type 2 Homo sapiens 33.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334989 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334989&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128035 384987149 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657619 Cc1cc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)cccc3[nH]2)c(cc1C)-n1nccn1 InChI=1S/C24H26N6O/c1-15-7-5-8-19-21(15)28-23(27-19)24(4)9-6-12-29(24)22(31)18-13-16(2)17(3)14-20(18)30-25-10-11-26-30/h5,7-8,10-11,13-14H,6,9,12H2,1-4H3,(H,27,28)/t24-/m0/s1 QIHOXAKNGBYYPI-DEOSSOPVSA-N 334990 (4,5-Dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.51::US9732075, Example 5.51 Orexin/Hypocretin receptor type 1 Homo sapiens 10.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334990 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334990&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128194 384987150 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657620 Cc1cc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)cccc3[nH]2)c(cc1C)-n1nccn1 InChI=1S/C24H26N6O/c1-15-7-5-8-19-21(15)28-23(27-19)24(4)9-6-12-29(24)22(31)18-13-16(2)17(3)14-20(18)30-25-10-11-26-30/h5,7-8,10-11,13-14H,6,9,12H2,1-4H3,(H,27,28)/t24-/m0/s1 QIHOXAKNGBYYPI-DEOSSOPVSA-N 334990 (4,5-Dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.51::US9732075, Example 5.51 Orexin receptor type 2 Homo sapiens 18.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334990 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334990&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128194 384987150 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657621 Cc1cccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H22N6O/c1-15-7-5-9-17-19(15)26-21(25-17)22(2)11-6-14-27(22)20(29)16-8-3-4-10-18(16)28-23-12-13-24-28/h3-5,7-10,12-13H,6,11,14H2,1-2H3,(H,25,26)/t22-/m0/s1 OOZAMDZTWMIVJW-QFIPXVFZSA-N 334991 US11040966, Example 5.52::US9732075, Example 5.52::[(S)-2-Methyl-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 107 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334991 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334991&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102359 384987151 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657622 Cc1cccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H22N6O/c1-15-7-5-9-17-19(15)26-21(25-17)22(2)11-6-14-27(22)20(29)16-8-3-4-10-18(16)28-23-12-13-24-28/h3-5,7-10,12-13H,6,11,14H2,1-2H3,(H,25,26)/t22-/m0/s1 OOZAMDZTWMIVJW-QFIPXVFZSA-N 334991 US11040966, Example 5.52::US9732075, Example 5.52::[(S)-2-Methyl-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 43.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334991 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334991&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102359 384987151 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657623 Cc1cc2nc([nH]c2cc1C)[C@]1(C)CCCN1C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C23H23ClN6O/c1-14-11-18-19(12-15(14)2)28-22(27-18)23(3)7-4-10-29(23)21(31)17-13-16(24)5-6-20(17)30-25-8-9-26-30/h5-6,8-9,11-13H,4,7,10H2,1-3H3,(H,27,28)/t23-/m0/s1 GWQRTNQWCSOTSN-QHCPKHFHSA-N 334992 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(5,6-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone::US11040966, Example 5.53::US9732075, Example 5.53 Orexin/Hypocretin receptor type 1 Homo sapiens 24.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334992 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334992&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127347 384987152 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657624 Cc1cc2nc([nH]c2cc1C)[C@]1(C)CCCN1C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C23H23ClN6O/c1-14-11-18-19(12-15(14)2)28-22(27-18)23(3)7-4-10-29(23)21(31)17-13-16(24)5-6-20(17)30-25-8-9-26-30/h5-6,8-9,11-13H,4,7,10H2,1-3H3,(H,27,28)/t23-/m0/s1 GWQRTNQWCSOTSN-QHCPKHFHSA-N 334992 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(5,6-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone::US11040966, Example 5.53::US9732075, Example 5.53 Orexin receptor type 2 Homo sapiens 23.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334992 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334992&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127347 384987152 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657625 COc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1)-n1nccn1 InChI=1S/C24H26N6O2/c1-15-12-19-20(13-16(15)2)28-23(27-19)24(3)8-5-11-29(24)22(31)18-14-17(32-4)6-7-21(18)30-25-9-10-26-30/h6-7,9-10,12-14H,5,8,11H2,1-4H3,(H,27,28)/t24-/m0/s1 KEUMWEXJBAZPAZ-DEOSSOPVSA-N 334993 US11040966, Example 5.54::US9732075, Example 5.54::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 33.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334993 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334993&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128240 384987153 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657626 COc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1)-n1nccn1 InChI=1S/C24H26N6O2/c1-15-12-19-20(13-16(15)2)28-23(27-19)24(3)8-5-11-29(24)22(31)18-14-17(32-4)6-7-21(18)30-25-9-10-26-30/h6-7,9-10,12-14H,5,8,11H2,1-4H3,(H,27,28)/t24-/m0/s1 KEUMWEXJBAZPAZ-DEOSSOPVSA-N 334993 US11040966, Example 5.54::US9732075, Example 5.54::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 20.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334993 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334993&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128240 384987153 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657627 COc1ccc(c(C(=O)N2CCC[C@@]2(C)c2nc3cc(C)c(C)cc3[nH]2)c1F)-n1nccn1 InChI=1S/C24H25FN6O2/c1-14-12-16-17(13-15(14)2)29-23(28-16)24(3)8-5-11-30(24)22(32)20-18(31-26-9-10-27-31)6-7-19(33-4)21(20)25/h6-7,9-10,12-13H,5,8,11H2,1-4H3,(H,28,29)/t24-/m0/s1 IFRYNUFYRDDSNR-DEOSSOPVSA-N 334994 US11040966, Example 5.55::US9732075, Example 5.55::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methoxy-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 113 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334994 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334994&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128287 384987154 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657628 COc1ccc(c(C(=O)N2CCC[C@@]2(C)c2nc3cc(C)c(C)cc3[nH]2)c1F)-n1nccn1 InChI=1S/C24H25FN6O2/c1-14-12-16-17(13-15(14)2)29-23(28-16)24(3)8-5-11-30(24)22(32)20-18(31-26-9-10-27-31)6-7-19(33-4)21(20)25/h6-7,9-10,12-13H,5,8,11H2,1-4H3,(H,28,29)/t24-/m0/s1 IFRYNUFYRDDSNR-DEOSSOPVSA-N 334994 US11040966, Example 5.55::US9732075, Example 5.55::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methoxy-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 202 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334994 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334994&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128287 384987154 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657629 Cc1ccc(C(=O)N2CCC[C@@]2(C)c2nc3cc(C)c(C)cc3[nH]2)c(c1)-n1nccn1 InChI=1S/C24H26N6O/c1-15-6-7-18(21(12-15)30-25-9-10-26-30)22(31)29-11-5-8-24(29,4)23-27-19-13-16(2)17(3)14-20(19)28-23/h6-7,9-10,12-14H,5,8,11H2,1-4H3,(H,27,28)/t24-/m0/s1 GTRYXLFCAWCOJP-DEOSSOPVSA-N 334995 US11040966, Example 5.56::US9732075, Example 5.56::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 12.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334995 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334995&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127781 384987155 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657630 Cc1ccc(C(=O)N2CCC[C@@]2(C)c2nc3cc(C)c(C)cc3[nH]2)c(c1)-n1nccn1 InChI=1S/C24H26N6O/c1-15-6-7-18(21(12-15)30-25-9-10-26-30)22(31)29-11-5-8-24(29,4)23-27-19-13-16(2)17(3)14-20(19)28-23/h6-7,9-10,12-14H,5,8,11H2,1-4H3,(H,27,28)/t24-/m0/s1 GTRYXLFCAWCOJP-DEOSSOPVSA-N 334995 US11040966, Example 5.56::US9732075, Example 5.56::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 15.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334995 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334995&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127781 384987155 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657631 COc1cc(C(=O)N2CCC[C@@]2(C)c2nc3cc(C)c(C)cc3[nH]2)c(cc1OC)-n1nccn1 InChI=1S/C25H28N6O3/c1-15-11-18-19(12-16(15)2)29-24(28-18)25(3)7-6-10-30(25)23(32)17-13-21(33-4)22(34-5)14-20(17)31-26-8-9-27-31/h8-9,11-14H,6-7,10H2,1-5H3,(H,28,29)/t25-/m0/s1 WUOMKQDVSLFVIB-VWLOTQADSA-N 334996 (4,5-Dimethoxy-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(5,6-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone::US11040966, Example 5.57::US9732075, Example 5.57 Orexin/Hypocretin receptor type 1 Homo sapiens 57.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334996 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334996&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127478 384987156 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657632 COc1cc(C(=O)N2CCC[C@@]2(C)c2nc3cc(C)c(C)cc3[nH]2)c(cc1OC)-n1nccn1 InChI=1S/C25H28N6O3/c1-15-11-18-19(12-16(15)2)29-24(28-18)25(3)7-6-10-30(25)23(32)17-13-21(33-4)22(34-5)14-20(17)31-26-8-9-27-31/h8-9,11-14H,6-7,10H2,1-5H3,(H,28,29)/t25-/m0/s1 WUOMKQDVSLFVIB-VWLOTQADSA-N 334996 (4,5-Dimethoxy-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(5,6-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone::US11040966, Example 5.57::US9732075, Example 5.57 Orexin receptor type 2 Homo sapiens 55.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334996 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334996&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127478 384987156 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657633 Cc1cc(C(=O)N2CCC[C@@]2(C)c2nc3cc(C)c(C)cc3[nH]2)c(cc1C)-n1nccn1 InChI=1S/C25H28N6O/c1-15-11-19(22(14-18(15)4)31-26-8-9-27-31)23(32)30-10-6-7-25(30,5)24-28-20-12-16(2)17(3)13-21(20)29-24/h8-9,11-14H,6-7,10H2,1-5H3,(H,28,29)/t25-/m0/s1 UXINVWZBFDJHKA-VWLOTQADSA-N 334997 US11040966, Example 5.58::US9732075, Example 5.58::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,5-dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334997 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334997&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128265 384987157 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657634 Cc1cc(C(=O)N2CCC[C@@]2(C)c2nc3cc(C)c(C)cc3[nH]2)c(cc1C)-n1nccn1 InChI=1S/C25H28N6O/c1-15-11-19(22(14-18(15)4)31-26-8-9-27-31)23(32)30-10-6-7-25(30,5)24-28-20-12-16(2)17(3)13-21(20)29-24/h8-9,11-14H,6-7,10H2,1-5H3,(H,28,29)/t25-/m0/s1 UXINVWZBFDJHKA-VWLOTQADSA-N 334997 US11040966, Example 5.58::US9732075, Example 5.58::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,5-dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334997 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334997&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128265 384987157 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657635 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1)-n1cccn1 InChI=1S/C25H27N5O/c1-16-7-8-22(30-12-6-10-26-30)19(13-16)23(31)29-11-5-9-25(29,4)24-27-20-14-17(2)18(3)15-21(20)28-24/h6-8,10,12-15H,5,9,11H2,1-4H3,(H,27,28)/t25-/m0/s1 GBCOTPFASSOFOZ-VWLOTQADSA-N 334998 US11040966, Example 5.59::US9732075, Example 5.59::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 42.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334998 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334998&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128264 384987158 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657636 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1)-n1cccn1 InChI=1S/C25H27N5O/c1-16-7-8-22(30-12-6-10-26-30)19(13-16)23(31)29-11-5-9-25(29,4)24-27-20-14-17(2)18(3)15-21(20)28-24/h6-8,10,12-15H,5,9,11H2,1-4H3,(H,27,28)/t25-/m0/s1 GBCOTPFASSOFOZ-VWLOTQADSA-N 334998 US11040966, Example 5.59::US9732075, Example 5.59::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 84.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334998 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334998&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128264 384987158 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657637 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)cccc2[nH]1)-n1nccn1 InChI=1S/C23H24N6O/c1-15-8-9-19(29-24-11-12-25-29)17(14-15)21(30)28-13-5-10-23(28,3)22-26-18-7-4-6-16(2)20(18)27-22/h4,6-9,11-12,14H,5,10,13H2,1-3H3,(H,26,27)/t23-/m0/s1 MPJLVWFWAOFGIH-QHCPKHFHSA-N 334999 US11040966, Example 5.6::US9732075, Example 5.6::[(S)-2-Methyl-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 32.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334999 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334999&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127233 384987159 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657638 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)cccc2[nH]1)-n1nccn1 InChI=1S/C23H24N6O/c1-15-8-9-19(29-24-11-12-25-29)17(14-15)21(30)28-13-5-10-23(28,3)22-26-18-7-4-6-16(2)20(18)27-22/h4,6-9,11-12,14H,5,10,13H2,1-3H3,(H,26,27)/t23-/m0/s1 MPJLVWFWAOFGIH-QHCPKHFHSA-N 334999 US11040966, Example 5.6::US9732075, Example 5.6::[(S)-2-Methyl-2-(4-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 59.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334999 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334999&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127233 384987159 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657639 Cc1cc2nc([nH]c2cc1C)[C@]1(C)CCCN1C(=O)c1cc(F)ccc1-n1nccn1 InChI=1S/C23H23FN6O/c1-14-11-18-19(12-15(14)2)28-22(27-18)23(3)7-4-10-29(23)21(31)17-13-16(24)5-6-20(17)30-25-8-9-26-30/h5-6,8-9,11-13H,4,7,10H2,1-3H3,(H,27,28)/t23-/m0/s1 HJTFCRBGAWTZHF-QHCPKHFHSA-N 335000 US11040966, Example 5.60::US9732075, Example 5.60::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 156 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335000 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335000&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127372 384987160 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657640 Cc1cc2nc([nH]c2cc1C)[C@]1(C)CCCN1C(=O)c1cc(F)ccc1-n1nccn1 InChI=1S/C23H23FN6O/c1-14-11-18-19(12-15(14)2)28-22(27-18)23(3)7-4-10-29(23)21(31)17-13-16(24)5-6-20(17)30-25-8-9-26-30/h5-6,8-9,11-13H,4,7,10H2,1-3H3,(H,27,28)/t23-/m0/s1 HJTFCRBGAWTZHF-QHCPKHFHSA-N 335000 US11040966, Example 5.60::US9732075, Example 5.60::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 54.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335000 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335000&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127372 384987160 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657641 Cc1cc2nc([nH]c2cc1C)[C@]1(C)CCCN1C(=O)c1ccccc1-n1nccn1 InChI=1S/C23H24N6O/c1-15-13-18-19(14-16(15)2)27-22(26-18)23(3)9-6-12-28(23)21(30)17-7-4-5-8-20(17)29-24-10-11-25-29/h4-5,7-8,10-11,13-14H,6,9,12H2,1-3H3,(H,26,27)/t23-/m0/s1 JCRAAEQVUKXNRE-QHCPKHFHSA-N 335001 US11040966, Example 5.61::US9732075, Example 5.61::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 112 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335001 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335001&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127664 384987161 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657642 Cc1cc2nc([nH]c2cc1C)[C@]1(C)CCCN1C(=O)c1ccccc1-n1nccn1 InChI=1S/C23H24N6O/c1-15-13-18-19(14-16(15)2)27-22(26-18)23(3)9-6-12-28(23)21(30)17-7-4-5-8-20(17)29-24-10-11-25-29/h4-5,7-8,10-11,13-14H,6,9,12H2,1-3H3,(H,26,27)/t23-/m0/s1 JCRAAEQVUKXNRE-QHCPKHFHSA-N 335001 US11040966, Example 5.61::US9732075, Example 5.61::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 26.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335001 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335001&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127664 384987161 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657643 Cc1ccc(c(n1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1)-n1nccn1 InChI=1S/C23H25N7O/c1-14-12-17-18(13-15(14)2)28-22(27-17)23(4)8-5-11-29(23)21(31)20-19(7-6-16(3)26-20)30-24-9-10-25-30/h6-7,9-10,12-13H,5,8,11H2,1-4H3,(H,27,28)/t23-/m0/s1 OVZVXTRBJGBXLZ-QHCPKHFHSA-N 335002 US11040966, Example 5.62::US9732075, Example 5.62::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 35.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335002 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335002&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127926 384987162 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657644 Cc1ccc(c(n1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1)-n1nccn1 InChI=1S/C23H25N7O/c1-14-12-17-18(13-15(14)2)28-22(27-17)23(4)8-5-11-29(23)21(31)20-19(7-6-16(3)26-20)30-24-9-10-25-30/h6-7,9-10,12-13H,5,8,11H2,1-4H3,(H,27,28)/t23-/m0/s1 OVZVXTRBJGBXLZ-QHCPKHFHSA-N 335002 US11040966, Example 5.62::US9732075, Example 5.62::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone Orexin receptor type 2 Homo sapiens 130 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335002 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335002&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127926 384987162 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657645 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C23H23ClN6O3/c1-23(22-27-16-12-19(32-2)20(33-3)13-17(16)28-22)7-4-10-29(23)21(31)15-11-14(24)5-6-18(15)30-25-8-9-26-30/h5-6,8-9,11-13H,4,7,10H2,1-3H3,(H,27,28)/t23-/m0/s1 WRTMDRWKXMIWFX-QHCPKHFHSA-N 335003 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(5,6-dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone::US11040966, Example 5.64::US9732075, Example 5.64 Orexin/Hypocretin receptor type 1 Homo sapiens 17.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335003 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335003&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127062 384987163 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657646 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C23H23ClN6O3/c1-23(22-27-16-12-19(32-2)20(33-3)13-17(16)28-22)7-4-10-29(23)21(31)15-11-14(24)5-6-18(15)30-25-8-9-26-30/h5-6,8-9,11-13H,4,7,10H2,1-3H3,(H,27,28)/t23-/m0/s1 WRTMDRWKXMIWFX-QHCPKHFHSA-N 335003 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(5,6-dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone::US11040966, Example 5.64::US9732075, Example 5.64 Orexin receptor type 2 Homo sapiens 19.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335003 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335003&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127062 384987163 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657647 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1cc(F)ccc1-n1nccn1 InChI=1S/C23H23FN6O3/c1-23(22-27-16-12-19(32-2)20(33-3)13-17(16)28-22)7-4-10-29(23)21(31)15-11-14(24)5-6-18(15)30-25-8-9-26-30/h5-6,8-9,11-13H,4,7,10H2,1-3H3,(H,27,28)/t23-/m0/s1 QAYKWVOFVKTOMS-QHCPKHFHSA-N 335004 US11040966, Example 5.65::US9732075, Example 5.65::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 200 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335004 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335004&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128077 384987164 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657648 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1cc(F)ccc1-n1nccn1 InChI=1S/C23H23FN6O3/c1-23(22-27-16-12-19(32-2)20(33-3)13-17(16)28-22)7-4-10-29(23)21(31)15-11-14(24)5-6-18(15)30-25-8-9-26-30/h5-6,8-9,11-13H,4,7,10H2,1-3H3,(H,27,28)/t23-/m0/s1 QAYKWVOFVKTOMS-QHCPKHFHSA-N 335004 US11040966, Example 5.65::US9732075, Example 5.65::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 154 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335004 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335004&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128077 384987164 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657649 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1c(F)cccc1-n1nccn1 InChI=1S/C23H23FN6O3/c1-23(22-27-15-12-18(32-2)19(33-3)13-16(15)28-22)8-5-11-29(23)21(31)20-14(24)6-4-7-17(20)30-25-9-10-26-30/h4,6-7,9-10,12-13H,5,8,11H2,1-3H3,(H,27,28)/t23-/m0/s1 XQMMQDLTPAYETF-QHCPKHFHSA-N 335005 US11040966, Example 5.66::US9732075, Example 5.66::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-fluoro-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 872 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335005 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335005&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127316 384987165 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657650 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1c(F)cccc1-n1nccn1 InChI=1S/C23H23FN6O3/c1-23(22-27-15-12-18(32-2)19(33-3)13-16(15)28-22)8-5-11-29(23)21(31)20-14(24)6-4-7-17(20)30-25-9-10-26-30/h4,6-7,9-10,12-13H,5,8,11H2,1-3H3,(H,27,28)/t23-/m0/s1 XQMMQDLTPAYETF-QHCPKHFHSA-N 335005 US11040966, Example 5.66::US9732075, Example 5.66::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-fluoro-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 458 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335005 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335005&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127316 384987165 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657651 COc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(OC)c(OC)cc2[nH]1)-n1nccn1 InChI=1S/C24H26N6O4/c1-24(23-27-17-13-20(33-3)21(34-4)14-18(17)28-23)8-5-11-29(24)22(31)16-12-15(32-2)6-7-19(16)30-25-9-10-26-30/h6-7,9-10,12-14H,5,8,11H2,1-4H3,(H,27,28)/t24-/m0/s1 JAOXZMJRODOOQL-DEOSSOPVSA-N 335006 US11040966, Example 5.67::US9732075, Example 5.67::US9914721, Ex. 8::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 27.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335006 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335006&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128072 384987166 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657652 COc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(OC)c(OC)cc2[nH]1)-n1nccn1 InChI=1S/C24H26N6O4/c1-24(23-27-17-13-20(33-3)21(34-4)14-18(17)28-23)8-5-11-29(24)22(31)16-12-15(32-2)6-7-19(16)30-25-9-10-26-30/h6-7,9-10,12-14H,5,8,11H2,1-4H3,(H,27,28)/t24-/m0/s1 JAOXZMJRODOOQL-DEOSSOPVSA-N 335006 US11040966, Example 5.67::US9732075, Example 5.67::US9914721, Ex. 8::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 23.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335006 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335006&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128072 384987166 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657653 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1c(F)c(C)ccc1-n1nccn1 InChI=1S/C24H25FN6O3/c1-14-6-7-17(31-26-9-10-27-31)20(21(14)25)22(32)30-11-5-8-24(30,2)23-28-15-12-18(33-3)19(34-4)13-16(15)29-23/h6-7,9-10,12-13H,5,8,11H2,1-4H3,(H,28,29)/t24-/m0/s1 CJJHWTUSQLZKKE-DEOSSOPVSA-N 335007 US11040966, Example 5.68::US9732075, Example 5.68::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 141 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335007 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335007&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128154 384987167 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657654 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1c(F)c(C)ccc1-n1nccn1 InChI=1S/C24H25FN6O3/c1-14-6-7-17(31-26-9-10-27-31)20(21(14)25)22(32)30-11-5-8-24(30,2)23-28-15-12-18(33-3)19(34-4)13-16(15)29-23/h6-7,9-10,12-13H,5,8,11H2,1-4H3,(H,28,29)/t24-/m0/s1 CJJHWTUSQLZKKE-DEOSSOPVSA-N 335007 US11040966, Example 5.68::US9732075, Example 5.68::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 150 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335007 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335007&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128154 384987167 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657655 COc1ccc(c(C(=O)N2CCC[C@@]2(C)c2nc3cc(OC)c(OC)cc3[nH]2)c1F)-n1nccn1 InChI=1S/C24H25FN6O4/c1-24(23-28-14-12-18(34-3)19(35-4)13-15(14)29-23)8-5-11-30(24)22(32)20-16(31-26-9-10-27-31)6-7-17(33-2)21(20)25/h6-7,9-10,12-13H,5,8,11H2,1-4H3,(H,28,29)/t24-/m0/s1 VCGDWTXNEHVLAT-DEOSSOPVSA-N 335008 US11040966, Example 5.69::US9732075, Example 5.69::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methoxy-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 414 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335008 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335008&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127060 384987168 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657656 COc1ccc(c(C(=O)N2CCC[C@@]2(C)c2nc3cc(OC)c(OC)cc3[nH]2)c1F)-n1nccn1 InChI=1S/C24H25FN6O4/c1-24(23-28-14-12-18(34-3)19(35-4)13-15(14)29-23)8-5-11-30(24)22(32)20-16(31-26-9-10-27-31)6-7-17(33-2)21(20)25/h6-7,9-10,12-13H,5,8,11H2,1-4H3,(H,28,29)/t24-/m0/s1 VCGDWTXNEHVLAT-DEOSSOPVSA-N 335008 US11040966, Example 5.69::US9732075, Example 5.69::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-fluoro-3-methoxy-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 1200 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335008 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335008&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127060 384987168 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657657 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(Cl)c(Cl)cc2[nH]1)-n1nccn1 InChI=1S/C22H20Cl2N6O/c1-13-4-5-19(30-25-7-8-26-30)14(10-13)20(31)29-9-3-6-22(29,2)21-27-17-11-15(23)16(24)12-18(17)28-21/h4-5,7-8,10-12H,3,6,9H2,1-2H3,(H,27,28)/t22-/m0/s1 CJQXFBHBGVQHCH-QFIPXVFZSA-N 335009 US11040966, Example 5.7::US9732075, Example 5.7::[(S)-2-(5,6-Dichloro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335009 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335009&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127768 384987169 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657658 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(Cl)c(Cl)cc2[nH]1)-n1nccn1 InChI=1S/C22H20Cl2N6O/c1-13-4-5-19(30-25-7-8-26-30)14(10-13)20(31)29-9-3-6-22(29,2)21-27-17-11-15(23)16(24)12-18(17)28-21/h4-5,7-8,10-12H,3,6,9H2,1-2H3,(H,27,28)/t22-/m0/s1 CJQXFBHBGVQHCH-QFIPXVFZSA-N 335009 US11040966, Example 5.7::US9732075, Example 5.7::[(S)-2-(5,6-Dichloro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 29.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335009 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335009&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127768 384987169 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657659 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1ccc(C)cc1-n1nccn1 InChI=1S/C24H26N6O3/c1-15-6-7-16(19(12-15)30-25-9-10-26-30)22(31)29-11-5-8-24(29,2)23-27-17-13-20(32-3)21(33-4)14-18(17)28-23/h6-7,9-10,12-14H,5,8,11H2,1-4H3,(H,27,28)/t24-/m0/s1 GPQNYCMXDKOBMB-DEOSSOPVSA-N 335010 US11040966, Example 5.70::US9732075, Example 5.70::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 31.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335010 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335010&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128863 384987170 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657660 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1ccc(C)cc1-n1nccn1 InChI=1S/C24H26N6O3/c1-15-6-7-16(19(12-15)30-25-9-10-26-30)22(31)29-11-5-8-24(29,2)23-27-17-13-20(32-3)21(33-4)14-18(17)28-23/h6-7,9-10,12-14H,5,8,11H2,1-4H3,(H,27,28)/t24-/m0/s1 GPQNYCMXDKOBMB-DEOSSOPVSA-N 335010 US11040966, Example 5.70::US9732075, Example 5.70::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 83.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335010 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335010&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128863 384987170 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657661 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1cc(ccc1-n1nccn1)C(F)(F)F InChI=1S/C24H23F3N6O3/c1-23(22-30-16-12-19(35-2)20(36-3)13-17(16)31-22)7-4-10-32(23)21(34)15-11-14(24(25,26)27)5-6-18(15)33-28-8-9-29-33/h5-6,8-9,11-13H,4,7,10H2,1-3H3,(H,30,31)/t23-/m0/s1 ALUNFUOPUIMWJW-QHCPKHFHSA-N 335011 US11040966, Example 5.71::US9732075, Example 5.71::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoromethyl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 56.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335011 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335011&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127302 384987171 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657662 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1cc(ccc1-n1nccn1)C(F)(F)F InChI=1S/C24H23F3N6O3/c1-23(22-30-16-12-19(35-2)20(36-3)13-17(16)31-22)7-4-10-32(23)21(34)15-11-14(24(25,26)27)5-6-18(15)33-28-8-9-29-33/h5-6,8-9,11-13H,4,7,10H2,1-3H3,(H,30,31)/t23-/m0/s1 ALUNFUOPUIMWJW-QHCPKHFHSA-N 335011 US11040966, Example 5.71::US9732075, Example 5.71::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoromethyl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 22.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335011 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335011&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127302 384987171 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657663 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1cc(C)c(C)cc1-n1nccn1 InChI=1S/C25H28N6O3/c1-15-11-17(20(12-16(15)2)31-26-8-9-27-31)23(32)30-10-6-7-25(30,3)24-28-18-13-21(33-4)22(34-5)14-19(18)29-24/h8-9,11-14H,6-7,10H2,1-5H3,(H,28,29)/t25-/m0/s1 IWAIPAUQLIXWMD-VWLOTQADSA-N 335012 US11040966, Example 5.72::US9732075, Example 5.72::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,5-dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 19.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335012 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335012&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127303 384987172 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657664 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1cc(C)c(C)cc1-n1nccn1 InChI=1S/C25H28N6O3/c1-15-11-17(20(12-16(15)2)31-26-8-9-27-31)23(32)30-10-6-7-25(30,3)24-28-18-13-21(33-4)22(34-5)14-19(18)29-24/h8-9,11-14H,6-7,10H2,1-5H3,(H,28,29)/t25-/m0/s1 IWAIPAUQLIXWMD-VWLOTQADSA-N 335012 US11040966, Example 5.72::US9732075, Example 5.72::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,5-dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 16.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335012 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335012&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127303 384987172 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657665 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1ccccc1-n1nccn1 InChI=1S/C23H24N6O3/c1-23(22-26-16-13-19(31-2)20(32-3)14-17(16)27-22)9-6-12-28(23)21(30)15-7-4-5-8-18(15)29-24-10-11-25-29/h4-5,7-8,10-11,13-14H,6,9,12H2,1-3H3,(H,26,27)/t23-/m0/s1 VJUSURXZPHYJMH-QHCPKHFHSA-N 335013 US11040966, Example 5.73::US9732075, Example 5.73::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 98.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335013 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335013&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102347 384987173 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657666 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1ccccc1-n1nccn1 InChI=1S/C23H24N6O3/c1-23(22-26-16-13-19(31-2)20(32-3)14-17(16)27-22)9-6-12-28(23)21(30)15-7-4-5-8-18(15)29-24-10-11-25-29/h4-5,7-8,10-11,13-14H,6,9,12H2,1-3H3,(H,26,27)/t23-/m0/s1 VJUSURXZPHYJMH-QHCPKHFHSA-N 335013 US11040966, Example 5.73::US9732075, Example 5.73::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 57.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335013 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335013&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102347 384987173 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657667 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1nc(C)sc1-c1ccc(cc1)C(F)(F)F InChI=1S/C26H25F3N4O3S/c1-14-30-21(22(37-14)15-6-8-16(9-7-15)26(27,28)29)23(34)33-11-5-10-25(33,2)24-31-17-12-19(35-3)20(36-4)13-18(17)32-24/h6-9,12-13H,5,10-11H2,1-4H3,(H,31,32)/t25-/m0/s1 IFEBHXKVKDHYNG-VWLOTQADSA-N 335014 US11040966, Example 5.74::US9732075, Example 5.74::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[2-methyl-5-(4-trifluoromethyl-phenyl)-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 592 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335014 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335014&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127701 384987174 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657668 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1nc(C)sc1-c1ccc(cc1)C(F)(F)F InChI=1S/C26H25F3N4O3S/c1-14-30-21(22(37-14)15-6-8-16(9-7-15)26(27,28)29)23(34)33-11-5-10-25(33,2)24-31-17-12-19(35-3)20(36-4)13-18(17)32-24/h6-9,12-13H,5,10-11H2,1-4H3,(H,31,32)/t25-/m0/s1 IFEBHXKVKDHYNG-VWLOTQADSA-N 335014 US11040966, Example 5.74::US9732075, Example 5.74::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[2-methyl-5-(4-trifluoromethyl-phenyl)-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 414 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335014 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335014&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127701 384987174 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657669 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1sc(C)nc1-c1ccc(C)cc1 InChI=1S/C26H28N4O3S/c1-15-7-9-17(10-8-15)22-23(34-16(2)27-22)24(31)30-12-6-11-26(30,3)25-28-18-13-20(32-4)21(33-5)14-19(18)29-25/h7-10,13-14H,6,11-12H2,1-5H3,(H,28,29)/t26-/m0/s1 RGJAHOZUYWRNSL-SANMLTNESA-N 335015 US11040966, Example 5.75::US9732075, Example 5.75::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-methyl-4-p-tolyl-thiazol-5-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 300 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335015 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335015&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127342 384987175 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657670 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1sc(C)nc1-c1ccc(C)cc1 InChI=1S/C26H28N4O3S/c1-15-7-9-17(10-8-15)22-23(34-16(2)27-22)24(31)30-12-6-11-26(30,3)25-28-18-13-20(32-4)21(33-5)14-19(18)29-25/h7-10,13-14H,6,11-12H2,1-5H3,(H,28,29)/t26-/m0/s1 RGJAHOZUYWRNSL-SANMLTNESA-N 335015 US11040966, Example 5.75::US9732075, Example 5.75::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-methyl-4-p-tolyl-thiazol-5-yl)-methanone Orexin receptor type 2 Homo sapiens 126 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335015 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335015&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127342 384987175 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657671 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1nc(C)sc1-c1cc(F)cc(F)c1 InChI=1S/C25H24F2N4O3S/c1-13-28-21(22(35-13)14-8-15(26)10-16(27)9-14)23(32)31-7-5-6-25(31,2)24-29-17-11-19(33-3)20(34-4)12-18(17)30-24/h8-12H,5-7H2,1-4H3,(H,29,30)/t25-/m0/s1 PPRDGSMIGCVYHT-VWLOTQADSA-N 335016 US11040966, Example 5.76::US9732075, Example 5.76::[5-(3,5-Difluoro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(5,6-dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 33.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335016 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335016&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127753 384987176 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657672 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1nc(C)sc1-c1cc(F)cc(F)c1 InChI=1S/C25H24F2N4O3S/c1-13-28-21(22(35-13)14-8-15(26)10-16(27)9-14)23(32)31-7-5-6-25(31,2)24-29-17-11-19(33-3)20(34-4)12-18(17)30-24/h8-12H,5-7H2,1-4H3,(H,29,30)/t25-/m0/s1 PPRDGSMIGCVYHT-VWLOTQADSA-N 335016 US11040966, Example 5.76::US9732075, Example 5.76::[5-(3,5-Difluoro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(5,6-dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 47.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335016 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335016&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127753 384987176 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657673 COc1ccc(cn1)-c1sc(C)nc1C(=O)N1CCC[C@@]1(C)c1nc2cc(OC)c(OC)cc2[nH]1 InChI=1S/C25H27N5O4S/c1-14-27-21(22(35-14)15-7-8-20(34-5)26-13-15)23(31)30-10-6-9-25(30,2)24-28-16-11-18(32-3)19(33-4)12-17(16)29-24/h7-8,11-13H,6,9-10H2,1-5H3,(H,28,29)/t25-/m0/s1 RRGDMYQGFYSBMA-VWLOTQADSA-N 335017 US11040966, Example 5.77::US9732075, Example 5.77::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(6-methoxy-pyridin-3-yl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 64.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335017 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335017&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128231 384987177 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657674 COc1ccc(cn1)-c1sc(C)nc1C(=O)N1CCC[C@@]1(C)c1nc2cc(OC)c(OC)cc2[nH]1 InChI=1S/C25H27N5O4S/c1-14-27-21(22(35-14)15-7-8-20(34-5)26-13-15)23(31)30-10-6-9-25(30,2)24-28-16-11-18(32-3)19(33-4)12-17(16)29-24/h7-8,11-13H,6,9-10H2,1-5H3,(H,28,29)/t25-/m0/s1 RRGDMYQGFYSBMA-VWLOTQADSA-N 335017 US11040966, Example 5.77::US9732075, Example 5.77::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(6-methoxy-pyridin-3-yl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 153 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335017 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335017&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128231 384987177 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657675 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1nc(C)sc1-c1ccc(F)cc1 InChI=1S/C25H25FN4O3S/c1-14-27-21(22(34-14)15-6-8-16(26)9-7-15)23(31)30-11-5-10-25(30,2)24-28-17-12-19(32-3)20(33-4)13-18(17)29-24/h6-9,12-13H,5,10-11H2,1-4H3,(H,28,29)/t25-/m0/s1 NEYXTEBKQYEGMH-VWLOTQADSA-N 335018 US11040966, Example 5.78::US9732075, Example 5.78::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 31.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335018 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335018&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127075 384987178 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657676 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1nc(C)sc1-c1ccc(F)cc1 InChI=1S/C25H25FN4O3S/c1-14-27-21(22(34-14)15-6-8-16(26)9-7-15)23(31)30-11-5-10-25(30,2)24-28-17-12-19(32-3)20(33-4)13-18(17)29-24/h6-9,12-13H,5,10-11H2,1-4H3,(H,28,29)/t25-/m0/s1 NEYXTEBKQYEGMH-VWLOTQADSA-N 335018 US11040966, Example 5.78::US9732075, Example 5.78::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 72.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335018 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335018&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127075 384987178 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657677 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1nc(C)sc1-c1ccc(Cl)cc1 InChI=1S/C25H25ClN4O3S/c1-14-27-21(22(34-14)15-6-8-16(26)9-7-15)23(31)30-11-5-10-25(30,2)24-28-17-12-19(32-3)20(33-4)13-18(17)29-24/h6-9,12-13H,5,10-11H2,1-4H3,(H,28,29)/t25-/m0/s1 RRUWLBHGELLTTJ-VWLOTQADSA-N 335019 US11040966, Example 5.79::US9732075, Example 5.79::[5-(4-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(5,6-dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 43.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335019 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335019&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128075 384987179 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657678 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1nc(C)sc1-c1ccc(Cl)cc1 InChI=1S/C25H25ClN4O3S/c1-14-27-21(22(34-14)15-6-8-16(26)9-7-15)23(31)30-11-5-10-25(30,2)24-28-17-12-19(32-3)20(33-4)13-18(17)29-24/h6-9,12-13H,5,10-11H2,1-4H3,(H,28,29)/t25-/m0/s1 RRUWLBHGELLTTJ-VWLOTQADSA-N 335019 US11040966, Example 5.79::US9732075, Example 5.79::[5-(4-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(5,6-dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 97.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335019 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335019&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128075 384987179 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657679 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(Br)ccc2[nH]1)-n1nccn1 InChI=1S/C22H21BrN6O/c1-14-4-7-19(29-24-9-10-25-29)16(12-14)20(30)28-11-3-8-22(28,2)21-26-17-6-5-15(23)13-18(17)27-21/h4-7,9-10,12-13H,3,8,11H2,1-2H3,(H,26,27)/t22-/m0/s1 STSFXZAEYFJTLA-QFIPXVFZSA-N 335020 US11040966, Example 5.8::US9732075, Example 5.8::[(S)-2-(5-Bromo-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335020 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335020&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127722 384987180 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657680 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(Br)ccc2[nH]1)-n1nccn1 InChI=1S/C22H21BrN6O/c1-14-4-7-19(29-24-9-10-25-29)16(12-14)20(30)28-11-3-8-22(28,2)21-26-17-6-5-15(23)13-18(17)27-21/h4-7,9-10,12-13H,3,8,11H2,1-2H3,(H,26,27)/t22-/m0/s1 STSFXZAEYFJTLA-QFIPXVFZSA-N 335020 US11040966, Example 5.8::US9732075, Example 5.8::[(S)-2-(5-Bromo-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 129 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335020 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335020&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127722 384987180 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657681 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1ncsc1-c1cccc(Cl)c1 InChI=1S/C24H23ClN4O3S/c1-24(23-27-16-11-18(31-2)19(32-3)12-17(16)28-23)8-5-9-29(24)22(30)20-21(33-13-26-20)14-6-4-7-15(25)10-14/h4,6-7,10-13H,5,8-9H2,1-3H3,(H,27,28)/t24-/m0/s1 BUYYHMHJMIDCOI-DEOSSOPVSA-N 335021 US11040966, Example 5.80::US9732075, Example 5.80::[5-(3-Chloro-phenyl)-thiazol-4-yl]-[(S)-2-(5,6-dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 548 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335021 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335021&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102257 384987181 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657682 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1ncsc1-c1cccc(Cl)c1 InChI=1S/C24H23ClN4O3S/c1-24(23-27-16-11-18(31-2)19(32-3)12-17(16)28-23)8-5-9-29(24)22(30)20-21(33-13-26-20)14-6-4-7-15(25)10-14/h4,6-7,10-13H,5,8-9H2,1-3H3,(H,27,28)/t24-/m0/s1 BUYYHMHJMIDCOI-DEOSSOPVSA-N 335021 US11040966, Example 5.80::US9732075, Example 5.80::[5-(3-Chloro-phenyl)-thiazol-4-yl]-[(S)-2-(5,6-dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 360 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335021 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335021&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102257 384987181 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657683 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1ccccc1-n1cccn1 InChI=1S/C24H25N5O3/c1-24(23-26-17-14-20(31-2)21(32-3)15-18(17)27-23)10-6-12-28(24)22(30)16-8-4-5-9-19(16)29-13-7-11-25-29/h4-5,7-9,11,13-15H,6,10,12H2,1-3H3,(H,26,27)/t24-/m0/s1 HZILEIZTXNUFKQ-DEOSSOPVSA-N 335022 US11040966, Example 5.81::US9732075, Example 5.81::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-pyrazol-1-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 258 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335022 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335022&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102478 384987182 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657684 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1ccccc1-n1cccn1 InChI=1S/C24H25N5O3/c1-24(23-26-17-14-20(31-2)21(32-3)15-18(17)27-23)10-6-12-28(24)22(30)16-8-4-5-9-19(16)29-13-7-11-25-29/h4-5,7-9,11,13-15H,6,10,12H2,1-3H3,(H,26,27)/t24-/m0/s1 HZILEIZTXNUFKQ-DEOSSOPVSA-N 335022 US11040966, Example 5.81::US9732075, Example 5.81::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-pyrazol-1-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 130 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335022 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335022&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102478 384987182 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657685 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-n1cccn1 InChI=1S/C25H27N5O3/c1-16-7-8-20(30-12-6-10-26-30)17(13-16)23(31)29-11-5-9-25(29,2)24-27-18-14-21(32-3)22(33-4)15-19(18)28-24/h6-8,10,12-15H,5,9,11H2,1-4H3,(H,27,28)/t25-/m0/s1 XWYOWTGUVQJLBN-VWLOTQADSA-N 335023 US11040966, Example 5.82::US9732075, Example 5.82::US9914721, Ex. 9::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 27.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335023 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335023&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127293 384987183 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657686 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-n1cccn1 InChI=1S/C25H27N5O3/c1-16-7-8-20(30-12-6-10-26-30)17(13-16)23(31)29-11-5-9-25(29,2)24-27-18-14-21(32-3)22(33-4)15-19(18)28-24/h6-8,10,12-15H,5,9,11H2,1-4H3,(H,27,28)/t25-/m0/s1 XWYOWTGUVQJLBN-VWLOTQADSA-N 335023 US11040966, Example 5.82::US9732075, Example 5.82::US9914721, Ex. 9::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 15.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335023 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335023&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127293 384987183 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657687 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1nc(C)ccc1-n1cccn1 InChI=1S/C24H26N6O3/c1-15-7-8-18(30-12-6-10-25-30)21(26-15)22(31)29-11-5-9-24(29,2)23-27-16-13-19(32-3)20(33-4)14-17(16)28-23/h6-8,10,12-14H,5,9,11H2,1-4H3,(H,27,28)/t24-/m0/s1 SLHLUKGBOXVPPE-DEOSSOPVSA-N 335024 US11040966, Example 5.83::US9732075, Example 5.83::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(6-methyl-3-pyrazol-1-yl-pyridin-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 426 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335024 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335024&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127694 384987184 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657688 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1nc(C)ccc1-n1cccn1 InChI=1S/C24H26N6O3/c1-15-7-8-18(30-12-6-10-25-30)21(26-15)22(31)29-11-5-9-24(29,2)23-27-16-13-19(32-3)20(33-4)14-17(16)28-23/h6-8,10,12-14H,5,9,11H2,1-4H3,(H,27,28)/t24-/m0/s1 SLHLUKGBOXVPPE-DEOSSOPVSA-N 335024 US11040966, Example 5.83::US9732075, Example 5.83::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(6-methyl-3-pyrazol-1-yl-pyridin-2-yl)-methanone Orexin receptor type 2 Homo sapiens 104 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335024 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335024&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127694 384987184 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657689 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1cc(OC(F)(F)F)ccc1-n1nccn1 InChI=1S/C24H23F3N6O4/c1-23(22-30-16-12-19(35-2)20(36-3)13-17(16)31-22)7-4-10-32(23)21(34)15-11-14(37-24(25,26)27)5-6-18(15)33-28-8-9-29-33/h5-6,8-9,11-13H,4,7,10H2,1-3H3,(H,30,31)/t23-/m0/s1 CLDLFXTZTBSGMD-QHCPKHFHSA-N 335025 US11040966, Example 5.84::US9732075, Example 5.84::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoromethoxy-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 138 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335025 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335025&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127228 384987185 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657690 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1cc(OC(F)(F)F)ccc1-n1nccn1 InChI=1S/C24H23F3N6O4/c1-23(22-30-16-12-19(35-2)20(36-3)13-17(16)31-22)7-4-10-32(23)21(34)15-11-14(37-24(25,26)27)5-6-18(15)33-28-8-9-29-33/h5-6,8-9,11-13H,4,7,10H2,1-3H3,(H,30,31)/t23-/m0/s1 CLDLFXTZTBSGMD-QHCPKHFHSA-N 335025 US11040966, Example 5.84::US9732075, Example 5.84::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoromethoxy-phenyl)-methanone Orexin receptor type 2 Homo sapiens 76.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335025 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335025&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127228 384987185 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657691 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1nc(C)ccc1-n1nccn1 InChI=1S/C23H25N7O3/c1-14-6-7-17(30-24-9-10-25-30)20(26-14)21(31)29-11-5-8-23(29,2)22-27-15-12-18(32-3)19(33-4)13-16(15)28-22/h6-7,9-10,12-13H,5,8,11H2,1-4H3,(H,27,28)/t23-/m0/s1 ATCWRQXGKOKPRP-QHCPKHFHSA-N 335026 US11040966, Example 5.85::US9732075, Example 5.85::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 316 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335026 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335026&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128101 384987186 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657692 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1nc(C)ccc1-n1nccn1 InChI=1S/C23H25N7O3/c1-14-6-7-17(30-24-9-10-25-30)20(26-14)21(31)29-11-5-8-23(29,2)22-27-15-12-18(32-3)19(33-4)13-16(15)28-22/h6-7,9-10,12-13H,5,8,11H2,1-4H3,(H,27,28)/t23-/m0/s1 ATCWRQXGKOKPRP-QHCPKHFHSA-N 335026 US11040966, Example 5.85::US9732075, Example 5.85::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone Orexin receptor type 2 Homo sapiens 114 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335026 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335026&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128101 384987186 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657693 COc1cc(C(=O)N2CCC[C@@]2(C)c2nc3cc(OC)c(OC)cc3[nH]2)c(cc1OC)-n1nccn1 InChI=1S/C25H28N6O5/c1-25(24-28-16-12-20(34-3)21(35-4)13-17(16)29-24)7-6-10-30(25)23(32)15-11-19(33-2)22(36-5)14-18(15)31-26-8-9-27-31/h8-9,11-14H,6-7,10H2,1-5H3,(H,28,29)/t25-/m0/s1 OPHGAJCCBUGMNX-VWLOTQADSA-N 335027 US11040966, Example 5.86::US9732075, Example 5.86::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,5-dimethoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 94.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335027 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335027&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128315 384987187 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657694 COc1cc(C(=O)N2CCC[C@@]2(C)c2nc3cc(OC)c(OC)cc3[nH]2)c(cc1OC)-n1nccn1 InChI=1S/C25H28N6O5/c1-25(24-28-16-12-20(34-3)21(35-4)13-17(16)29-24)7-6-10-30(25)23(32)15-11-19(33-2)22(36-5)14-18(15)31-26-8-9-27-31/h8-9,11-14H,6-7,10H2,1-5H3,(H,28,29)/t25-/m0/s1 OPHGAJCCBUGMNX-VWLOTQADSA-N 335027 US11040966, Example 5.86::US9732075, Example 5.86::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,5-dimethoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 85.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335027 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335027&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128315 384987187 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657695 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1ccccc1-c1cccc(C)c1 InChI=1S/C28H29N3O3/c1-18-9-7-10-19(15-18)20-11-5-6-12-21(20)26(32)31-14-8-13-28(31,2)27-29-22-16-24(33-3)25(34-4)17-23(22)30-27/h5-7,9-12,15-17H,8,13-14H2,1-4H3,(H,29,30)/t28-/m0/s1 HEUXKEORDYQXIM-NDEPHWFRSA-N 335028 US11040966, Example 5.87::US9732075, Example 5.87::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 203 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335028 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335028&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102407 384987188 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657696 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1ccccc1-c1cccc(C)c1 InChI=1S/C28H29N3O3/c1-18-9-7-10-19(15-18)20-11-5-6-12-21(20)26(32)31-14-8-13-28(31,2)27-29-22-16-24(33-3)25(34-4)17-23(22)30-27/h5-7,9-12,15-17H,8,13-14H2,1-4H3,(H,29,30)/t28-/m0/s1 HEUXKEORDYQXIM-NDEPHWFRSA-N 335028 US11040966, Example 5.87::US9732075, Example 5.87::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 157 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335028 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335028&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102407 384987188 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657697 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1ccccc1-c1ccc(C)cc1 InChI=1S/C28H29N3O3/c1-18-10-12-19(13-11-18)20-8-5-6-9-21(20)26(32)31-15-7-14-28(31,2)27-29-22-16-24(33-3)25(34-4)17-23(22)30-27/h5-6,8-13,16-17H,7,14-15H2,1-4H3,(H,29,30)/t28-/m0/s1 TUYUAKMDZIGCET-NDEPHWFRSA-N 335029 US11040966, Example 5.88::US9732075, Example 5.88::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 192 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335029 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335029&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102341 384987189 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657698 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1ccccc1-c1ccc(C)cc1 InChI=1S/C28H29N3O3/c1-18-10-12-19(13-11-18)20-8-5-6-9-21(20)26(32)31-15-7-14-28(31,2)27-29-22-16-24(33-3)25(34-4)17-23(22)30-27/h5-6,8-13,16-17H,7,14-15H2,1-4H3,(H,29,30)/t28-/m0/s1 TUYUAKMDZIGCET-NDEPHWFRSA-N 335029 US11040966, Example 5.88::US9732075, Example 5.88::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 166 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335029 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335029&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102341 384987189 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657699 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1cnc(C)nc1-c1cccc(C)c1 InChI=1S/C27H29N5O3/c1-16-8-6-9-18(12-16)24-19(15-28-17(2)29-24)25(33)32-11-7-10-27(32,3)26-30-20-13-22(34-4)23(35-5)14-21(20)31-26/h6,8-9,12-15H,7,10-11H2,1-5H3,(H,30,31)/t27-/m0/s1 BESGUDGRVCITQP-MHZLTWQESA-N 335030 US11040966, Example 5.89::US9732075, Example 5.89::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-methyl-4-m-tolyl-pyrimidin-5-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 148 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335030 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335030&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127942 384987190 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657700 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1cnc(C)nc1-c1cccc(C)c1 InChI=1S/C27H29N5O3/c1-16-8-6-9-18(12-16)24-19(15-28-17(2)29-24)25(33)32-11-7-10-27(32,3)26-30-20-13-22(34-4)23(35-5)14-21(20)31-26/h6,8-9,12-15H,7,10-11H2,1-5H3,(H,30,31)/t27-/m0/s1 BESGUDGRVCITQP-MHZLTWQESA-N 335030 US11040966, Example 5.89::US9732075, Example 5.89::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-methyl-4-m-tolyl-pyrimidin-5-yl)-methanone Orexin receptor type 2 Homo sapiens 119 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335030 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335030&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127942 384987190 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657701 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F)-n1nccn1 InChI=1S/C23H21F3N6O/c1-14-4-7-19(32-27-9-10-28-32)16(12-14)20(33)31-11-3-8-22(31,2)21-29-17-6-5-15(23(24,25)26)13-18(17)30-21/h4-7,9-10,12-13H,3,8,11H2,1-2H3,(H,29,30)/t22-/m0/s1 VGDLIWVHXXDXQV-QFIPXVFZSA-N 335031 (5-Methyl-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.9::US9732075, Example 5.9::US9914721, Ex. 1 Orexin/Hypocretin receptor type 1 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335031 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335031&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127872 384987191 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657702 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F)-n1nccn1 InChI=1S/C23H21F3N6O/c1-14-4-7-19(32-27-9-10-28-32)16(12-14)20(33)31-11-3-8-22(31,2)21-29-17-6-5-15(23(24,25)26)13-18(17)30-21/h4-7,9-10,12-13H,3,8,11H2,1-2H3,(H,29,30)/t22-/m0/s1 VGDLIWVHXXDXQV-QFIPXVFZSA-N 335031 (5-Methyl-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.9::US9732075, Example 5.9::US9914721, Ex. 1 Orexin receptor type 2 Homo sapiens 81.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335031 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335031&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127872 384987191 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657703 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1cncnc1-c1ccccc1 InChI=1S/C25H25N5O3/c1-25(24-28-18-12-20(32-2)21(33-3)13-19(18)29-24)10-7-11-30(25)23(31)17-14-26-15-27-22(17)16-8-5-4-6-9-16/h4-6,8-9,12-15H,7,10-11H2,1-3H3,(H,28,29)/t25-/m0/s1 RRGIIUBEDKAPRF-VWLOTQADSA-N 335032 US11040966, Example 5.90::US9732075, Example 5.90::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4-phenyl-pyrimidin-5-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 232 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335032 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335032&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102283 384987192 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657704 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1cncnc1-c1ccccc1 InChI=1S/C25H25N5O3/c1-25(24-28-18-12-20(32-2)21(33-3)13-19(18)29-24)10-7-11-30(25)23(31)17-14-26-15-27-22(17)16-8-5-4-6-9-16/h4-6,8-9,12-15H,7,10-11H2,1-3H3,(H,28,29)/t25-/m0/s1 RRGIIUBEDKAPRF-VWLOTQADSA-N 335032 US11040966, Example 5.90::US9732075, Example 5.90::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4-phenyl-pyrimidin-5-yl)-methanone Orexin receptor type 2 Homo sapiens 473 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335032 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335032&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102283 384987192 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657705 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1)-c1ccc(F)cc1C InChI=1S/C29H30FN3O/c1-17-7-9-23(22-10-8-21(30)14-20(22)4)24(13-17)27(34)33-12-6-11-29(33,5)28-31-25-15-18(2)19(3)16-26(25)32-28/h7-10,13-16H,6,11-12H2,1-5H3,(H,31,32)/t29-/m0/s1 XYRIMVVEGQLBNO-LJAQVGFWSA-N 335033 US11040966, Example 5.91::US9732075, Example 5.91::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-fluoro-4,2'-dimethyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 217 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335033 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335033&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128271 384987193 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657706 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1)-c1ccc(F)cc1C InChI=1S/C29H30FN3O/c1-17-7-9-23(22-10-8-21(30)14-20(22)4)24(13-17)27(34)33-12-6-11-29(33,5)28-31-25-15-18(2)19(3)16-26(25)32-28/h7-10,13-16H,6,11-12H2,1-5H3,(H,31,32)/t29-/m0/s1 XYRIMVVEGQLBNO-LJAQVGFWSA-N 335033 US11040966, Example 5.91::US9732075, Example 5.91::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-fluoro-4,2'-dimethyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 1290 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335033 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335033&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128271 384987193 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657707 COc1ccccc1-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1 InChI=1S/C29H31N3O2/c1-18-11-12-21(22-9-6-7-10-26(22)34-5)23(15-18)27(33)32-14-8-13-29(32,4)28-30-24-16-19(2)20(3)17-25(24)31-28/h6-7,9-12,15-17H,8,13-14H2,1-5H3,(H,30,31)/t29-/m0/s1 TVAWIZQHHZDXHY-LJAQVGFWSA-N 335034 US11040966, Example 5.92::US9732075, Example 5.92::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2'-methoxy-4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 62.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335034 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335034&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127676 384987194 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657708 COc1ccccc1-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1 InChI=1S/C29H31N3O2/c1-18-11-12-21(22-9-6-7-10-26(22)34-5)23(15-18)27(33)32-14-8-13-29(32,4)28-30-24-16-19(2)20(3)17-25(24)31-28/h6-7,9-12,15-17H,8,13-14H2,1-5H3,(H,30,31)/t29-/m0/s1 TVAWIZQHHZDXHY-LJAQVGFWSA-N 335034 US11040966, Example 5.92::US9732075, Example 5.92::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2'-methoxy-4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 177 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335034 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335034&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127676 384987194 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657709 COc1cccc(c1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1 InChI=1S/C29H31N3O2/c1-18-10-11-23(21-8-6-9-22(17-21)34-5)24(14-18)27(33)32-13-7-12-29(32,4)28-30-25-15-19(2)20(3)16-26(25)31-28/h6,8-11,14-17H,7,12-13H2,1-5H3,(H,30,31)/t29-/m0/s1 XYMRNJDGUHFXIT-LJAQVGFWSA-N 335035 US11040966, Example 5.93::US9732075, Example 5.93::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-methoxy-4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 15.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335035 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335035&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695496 384987195 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657710 COc1cccc(c1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1 InChI=1S/C29H31N3O2/c1-18-10-11-23(21-8-6-9-22(17-21)34-5)24(14-18)27(33)32-13-7-12-29(32,4)28-30-25-15-19(2)20(3)16-26(25)31-28/h6,8-11,14-17H,7,12-13H2,1-5H3,(H,30,31)/t29-/m0/s1 XYMRNJDGUHFXIT-LJAQVGFWSA-N 335035 US11040966, Example 5.93::US9732075, Example 5.93::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-methoxy-4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 19.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335035 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335035&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695496 384987195 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657711 COc1ccc(cc1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1 InChI=1S/C29H31N3O2/c1-18-7-12-23(21-8-10-22(34-5)11-9-21)24(15-18)27(33)32-14-6-13-29(32,4)28-30-25-16-19(2)20(3)17-26(25)31-28/h7-12,15-17H,6,13-14H2,1-5H3,(H,30,31)/t29-/m0/s1 RYXBVHKKGAZTJT-LJAQVGFWSA-N 335036 US11040966, Example 5.94::US9732075, Example 5.94::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-methoxy-4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 14.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335036 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335036&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695397 384987196 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657712 COc1ccc(cc1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1 InChI=1S/C29H31N3O2/c1-18-7-12-23(21-8-10-22(34-5)11-9-21)24(15-18)27(33)32-14-6-13-29(32,4)28-30-25-16-19(2)20(3)17-26(25)31-28/h7-12,15-17H,6,13-14H2,1-5H3,(H,30,31)/t29-/m0/s1 RYXBVHKKGAZTJT-LJAQVGFWSA-N 335036 US11040966, Example 5.94::US9732075, Example 5.94::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-methoxy-4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 37.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335036 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335036&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695397 384987196 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657713 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1)-c1ccccc1F InChI=1S/C28H28FN3O/c1-17-10-11-20(21-8-5-6-9-23(21)29)22(14-17)26(33)32-13-7-12-28(32,4)27-30-24-15-18(2)19(3)16-25(24)31-27/h5-6,8-11,14-16H,7,12-13H2,1-4H3,(H,30,31)/t28-/m0/s1 YCMLLXSTKGODLC-NDEPHWFRSA-N 335037 US11040966, Example 5.95::US9732075, Example 5.95::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2'-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 11.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335037 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335037&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695398 384987197 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657714 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1)-c1ccccc1F InChI=1S/C28H28FN3O/c1-17-10-11-20(21-8-5-6-9-23(21)29)22(14-17)26(33)32-13-7-12-28(32,4)27-30-24-15-18(2)19(3)16-25(24)31-27/h5-6,8-11,14-16H,7,12-13H2,1-4H3,(H,30,31)/t28-/m0/s1 YCMLLXSTKGODLC-NDEPHWFRSA-N 335037 US11040966, Example 5.95::US9732075, Example 5.95::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2'-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 29.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335037 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335037&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695398 384987197 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657715 Cc1ccc(-c2ccc(F)cc2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1 InChI=1S/C28H28FN3O/c1-17-6-11-22(20-7-9-21(29)10-8-20)23(14-17)26(33)32-13-5-12-28(32,4)27-30-24-15-18(2)19(3)16-25(24)31-27/h6-11,14-16H,5,12-13H2,1-4H3,(H,30,31)/t28-/m0/s1 GNXDHAJSVSYHOQ-NDEPHWFRSA-N 335038 US11040966, Example 5.96::US9732075, Example 5.96::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335038 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335038&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695395 384987198 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657716 Cc1ccc(-c2ccc(F)cc2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1 InChI=1S/C28H28FN3O/c1-17-6-11-22(20-7-9-21(29)10-8-20)23(14-17)26(33)32-13-5-12-28(32,4)27-30-24-15-18(2)19(3)16-25(24)31-27/h6-11,14-16H,5,12-13H2,1-4H3,(H,30,31)/t28-/m0/s1 GNXDHAJSVSYHOQ-NDEPHWFRSA-N 335038 US11040966, Example 5.96::US9732075, Example 5.96::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 32.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335038 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335038&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695395 384987198 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657717 Cc1ccc(-c2cccc(F)c2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1 InChI=1S/C28H28FN3O/c1-17-9-10-22(20-7-5-8-21(29)16-20)23(13-17)26(33)32-12-6-11-28(32,4)27-30-24-14-18(2)19(3)15-25(24)31-27/h5,7-10,13-16H,6,11-12H2,1-4H3,(H,30,31)/t28-/m0/s1 UEFZDHYPRDHDRC-NDEPHWFRSA-N 335039 US11040966, Example 5.97::US9732075, Example 5.97::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335039 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335039&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695394 384987199 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657718 Cc1ccc(-c2cccc(F)c2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1 InChI=1S/C28H28FN3O/c1-17-9-10-22(20-7-5-8-21(29)16-20)23(13-17)26(33)32-12-6-11-28(32,4)27-30-24-14-18(2)19(3)15-25(24)31-27/h5,7-10,13-16H,6,11-12H2,1-4H3,(H,30,31)/t28-/m0/s1 UEFZDHYPRDHDRC-NDEPHWFRSA-N 335039 US11040966, Example 5.97::US9732075, Example 5.97::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 11.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335039 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335039&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695394 384987199 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657719 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1)-c1ccccc1C InChI=1S/C29H31N3O/c1-18-11-12-23(22-10-7-6-9-19(22)2)24(15-18)27(33)32-14-8-13-29(32,5)28-30-25-16-20(3)21(4)17-26(25)31-28/h6-7,9-12,15-17H,8,13-14H2,1-5H3,(H,30,31)/t29-/m0/s1 VGEBXJHKLFJCHN-LJAQVGFWSA-N 335040 US11040966, Example 5.98::US9732075, Example 5.98::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,2'-dimethyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 120 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335040 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335040&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102446 384987200 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657720 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1)-c1ccccc1C InChI=1S/C29H31N3O/c1-18-11-12-23(22-10-7-6-9-19(22)2)24(15-18)27(33)32-14-8-13-29(32,5)28-30-25-16-20(3)21(4)17-26(25)31-28/h6-7,9-12,15-17H,8,13-14H2,1-5H3,(H,30,31)/t29-/m0/s1 VGEBXJHKLFJCHN-LJAQVGFWSA-N 335040 US11040966, Example 5.98::US9732075, Example 5.98::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,2'-dimethyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 264 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335040 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335040&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102446 384987200 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657721 Cc1cccc(c1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1 InChI=1S/C29H31N3O/c1-18-8-6-9-22(14-18)23-11-10-19(2)15-24(23)27(33)32-13-7-12-29(32,5)28-30-25-16-20(3)21(4)17-26(25)31-28/h6,8-11,14-17H,7,12-13H2,1-5H3,(H,30,31)/t29-/m0/s1 GGTXICXOTGNXER-LJAQVGFWSA-N 335041 US11040966, Example 5.99::US9732075, Example 5.99::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,3'-dimethyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335041 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335041&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695396 384987201 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657722 Cc1cccc(c1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1 InChI=1S/C29H31N3O/c1-18-8-6-9-22(14-18)23-11-10-19(2)15-24(23)27(33)32-13-7-12-29(32,5)28-30-25-16-20(3)21(4)17-26(25)31-28/h6,8-11,14-17H,7,12-13H2,1-5H3,(H,30,31)/t29-/m0/s1 GGTXICXOTGNXER-LJAQVGFWSA-N 335041 US11040966, Example 5.99::US9732075, Example 5.99::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,3'-dimethyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 11.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335041 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335041&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695396 384987201 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657723 Cc1ccc(-c2cccnc2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C26H25ClN4O/c1-16-7-8-19(18-6-4-12-28-15-18)20(14-16)24(32)31-13-5-11-26(31,3)25-29-22-10-9-21(27)17(2)23(22)30-25/h4,6-10,12,14-15H,5,11,13H2,1-3H3,(H,29,30)/t26-/m0/s1 AGAQFIOCCWWMOS-SANMLTNESA-N 334957 US11040966, Example 5.217::US9732075, Example 5.216::US9732075, Example 5.217::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyridin-3-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 98.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334957 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334957&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695099 384987117 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657724 Cc1ccc(-c2cccnc2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C26H25ClN4O/c1-16-7-8-19(18-6-4-12-28-15-18)20(14-16)24(32)31-13-5-11-26(31,3)25-29-22-10-9-21(27)17(2)23(22)30-25/h4,6-10,12,14-15H,5,11,13H2,1-3H3,(H,29,30)/t26-/m0/s1 AGAQFIOCCWWMOS-SANMLTNESA-N 334957 US11040966, Example 5.217::US9732075, Example 5.216::US9732075, Example 5.217::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyridin-3-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 274 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=334957 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=334957&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695099 384987117 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657725 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1cc(F)ccc1-c1ccccc1 InChI=1S/C26H23ClFN3O/c1-16-21(27)11-12-22-23(16)30-25(29-22)26(2)13-6-14-31(26)24(32)20-15-18(28)9-10-19(20)17-7-4-3-5-8-17/h3-5,7-12,15H,6,13-14H2,1-2H3,(H,29,30)/t26-/m0/s1 VRVGBSOOJBRLAI-SANMLTNESA-N 335043 US11040966, Example 5.218::US9732075, Example 5.218::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4-fluoro-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335043 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335043&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127590 384987202 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657726 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1cc(F)ccc1-c1ccccc1 InChI=1S/C26H23ClFN3O/c1-16-21(27)11-12-22-23(16)30-25(29-22)26(2)13-6-14-31(26)24(32)20-15-18(28)9-10-19(20)17-7-4-3-5-8-17/h3-5,7-12,15H,6,13-14H2,1-2H3,(H,29,30)/t26-/m0/s1 VRVGBSOOJBRLAI-SANMLTNESA-N 335043 US11040966, Example 5.218::US9732075, Example 5.218::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4-fluoro-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 36.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335043 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335043&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127590 384987202 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657727 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1cc(F)ccc1-c1ccccn1 InChI=1S/C25H22ClFN4O/c1-15-19(26)9-10-21-22(15)30-24(29-21)25(2)11-5-13-31(25)23(32)18-14-16(27)7-8-17(18)20-6-3-4-12-28-20/h3-4,6-10,12,14H,5,11,13H2,1-2H3,(H,29,30)/t25-/m0/s1 NKWDQTGWZUKIGN-VWLOTQADSA-N 335044 US11040966, Example 5.219::US9732075, Example 5.219::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-fluoro-2-pyridin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 19.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335044 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335044&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128097 384987203 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657728 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1cc(F)ccc1-c1ccccn1 InChI=1S/C25H22ClFN4O/c1-15-19(26)9-10-21-22(15)30-24(29-21)25(2)11-5-13-31(25)23(32)18-14-16(27)7-8-17(18)20-6-3-4-12-28-20/h3-4,6-10,12,14H,5,11,13H2,1-2H3,(H,29,30)/t25-/m0/s1 NKWDQTGWZUKIGN-VWLOTQADSA-N 335044 US11040966, Example 5.219::US9732075, Example 5.219::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-fluoro-2-pyridin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 72.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335044 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335044&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128097 384987203 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657729 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1cc(F)ccc1-c1cccnc1 InChI=1S/C25H22ClFN4O/c1-15-20(26)8-9-21-22(15)30-24(29-21)25(2)10-4-12-31(25)23(32)19-13-17(27)6-7-18(19)16-5-3-11-28-14-16/h3,5-9,11,13-14H,4,10,12H2,1-2H3,(H,29,30)/t25-/m0/s1 MHWVPSMWBIWREJ-VWLOTQADSA-N 335045 US11040966, Example 5.220::US9732075, Example 5.220::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-fluoro-2-pyridin-3-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 98.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335045 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335045&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128292 384987204 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657730 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1cc(F)ccc1-c1cccnc1 InChI=1S/C25H22ClFN4O/c1-15-20(26)8-9-21-22(15)30-24(29-21)25(2)10-4-12-31(25)23(32)19-13-17(27)6-7-18(19)16-5-3-11-28-14-16/h3,5-9,11,13-14H,4,10,12H2,1-2H3,(H,29,30)/t25-/m0/s1 MHWVPSMWBIWREJ-VWLOTQADSA-N 335045 US11040966, Example 5.220::US9732075, Example 5.220::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-fluoro-2-pyridin-3-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 249 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335045 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335045&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128292 384987204 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657731 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1c(F)cccc1-c1ccccn1 InChI=1S/C25H22ClFN4O/c1-15-17(26)10-11-20-22(15)30-24(29-20)25(2)12-6-14-31(25)23(32)21-16(7-5-8-18(21)27)19-9-3-4-13-28-19/h3-5,7-11,13H,6,12,14H2,1-2H3,(H,29,30)/t25-/m0/s1 JGPPTWMAUDXPKB-VWLOTQADSA-N 335046 US11040966, Example 5.221::US9732075, Example 5.221::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-fluoro-6-pyridin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 19.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335046 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335046&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128208 384987205 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657732 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1c(F)cccc1-c1ccccn1 InChI=1S/C25H22ClFN4O/c1-15-17(26)10-11-20-22(15)30-24(29-20)25(2)12-6-14-31(25)23(32)21-16(7-5-8-18(21)27)19-9-3-4-13-28-19/h3-5,7-11,13H,6,12,14H2,1-2H3,(H,29,30)/t25-/m0/s1 JGPPTWMAUDXPKB-VWLOTQADSA-N 335046 US11040966, Example 5.221::US9732075, Example 5.221::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-fluoro-6-pyridin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 83.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335046 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335046&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128208 384987205 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657733 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1c(F)cccc1-c1ncccn1 InChI=1S/C24H21ClFN5O/c1-14-16(25)8-9-18-20(14)30-23(29-18)24(2)10-4-13-31(24)22(32)19-15(6-3-7-17(19)26)21-27-11-5-12-28-21/h3,5-9,11-12H,4,10,13H2,1-2H3,(H,29,30)/t24-/m0/s1 IBTFIUNIXOVRNS-DEOSSOPVSA-N 335047 US11040966, Example 5.222::US9732075, Example 5.222::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-fluoro-6-pyrimidin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 26.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335047 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335047&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127182 384987206 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657734 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1c(F)cccc1-c1ncccn1 InChI=1S/C24H21ClFN5O/c1-14-16(25)8-9-18-20(14)30-23(29-18)24(2)10-4-13-31(24)22(32)19-15(6-3-7-17(19)26)21-27-11-5-12-28-21/h3,5-9,11-12H,4,10,13H2,1-2H3,(H,29,30)/t24-/m0/s1 IBTFIUNIXOVRNS-DEOSSOPVSA-N 335047 US11040966, Example 5.222::US9732075, Example 5.222::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-fluoro-6-pyrimidin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 68.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335047 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335047&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127182 384987206 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657735 Cc1ccc(-c2ccccc2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C27H26ClN3O/c1-17-10-11-20(19-8-5-4-6-9-19)21(16-17)25(32)31-15-7-14-27(31,3)26-29-23-13-12-22(28)18(2)24(23)30-26/h4-6,8-13,16H,7,14-15H2,1-3H3,(H,29,30)/t27-/m0/s1 VNEMVCXDERLURH-MHZLTWQESA-N 335048 US11040966, Example 5.223::US9732075, Example 5.223::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335048 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335048&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127629 384987207 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657736 Cc1ccc(-c2ccccc2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C27H26ClN3O/c1-17-10-11-20(19-8-5-4-6-9-19)21(16-17)25(32)31-15-7-14-27(31,3)26-29-23-13-12-22(28)18(2)24(23)30-26/h4-6,8-13,16H,7,14-15H2,1-3H3,(H,29,30)/t27-/m0/s1 VNEMVCXDERLURH-MHZLTWQESA-N 335048 US11040966, Example 5.223::US9732075, Example 5.223::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 12.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335048 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335048&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127629 384987207 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657737 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1cc(F)ccc1-c1ncccn1 InChI=1S/C24H21ClFN5O/c1-14-18(25)7-8-19-20(14)30-23(29-19)24(2)9-3-12-31(24)22(32)17-13-15(26)5-6-16(17)21-27-10-4-11-28-21/h4-8,10-11,13H,3,9,12H2,1-2H3,(H,29,30)/t24-/m0/s1 LLDKGDWBNRWLNX-DEOSSOPVSA-N 335049 US11040966, Example 5.224::US9732075, Example 5.224::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-fluoro-2-pyrimidin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335049 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335049&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128185 384987208 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657738 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1cc(F)ccc1-c1ncccn1 InChI=1S/C24H21ClFN5O/c1-14-18(25)7-8-19-20(14)30-23(29-19)24(2)9-3-12-31(24)22(32)17-13-15(26)5-6-16(17)21-27-10-4-11-28-21/h4-8,10-11,13H,3,9,12H2,1-2H3,(H,29,30)/t24-/m0/s1 LLDKGDWBNRWLNX-DEOSSOPVSA-N 335049 US11040966, Example 5.224::US9732075, Example 5.224::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-fluoro-2-pyrimidin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 21.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335049 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335049&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128185 384987208 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657739 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1c(F)cccc1-c1ccccc1 InChI=1S/C26H23ClFN3O/c1-16-19(27)12-13-21-23(16)30-25(29-21)26(2)14-7-15-31(26)24(32)22-18(10-6-11-20(22)28)17-8-4-3-5-9-17/h3-6,8-13H,7,14-15H2,1-2H3,(H,29,30)/t26-/m0/s1 WXGMYXDRWXHPPZ-SANMLTNESA-N 335050 US11040966, Example 5.225::US9732075, Example 5.225::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3-fluoro-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 16.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335050 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335050&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127732 384987209 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657740 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1c(F)cccc1-c1ccccc1 InChI=1S/C26H23ClFN3O/c1-16-19(27)12-13-21-23(16)30-25(29-21)26(2)14-7-15-31(26)24(32)22-18(10-6-11-20(22)28)17-8-4-3-5-9-17/h3-6,8-13H,7,14-15H2,1-2H3,(H,29,30)/t26-/m0/s1 WXGMYXDRWXHPPZ-SANMLTNESA-N 335050 US11040966, Example 5.225::US9732075, Example 5.225::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3-fluoro-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 44.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335050 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335050&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127732 384987209 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657741 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1nc(sc1-c1ccc(F)cc1)-c1ccccc1 InChI=1S/C29H24ClFN4OS/c1-17-21(30)13-14-22-23(17)34-28(32-22)29(2)15-6-16-35(29)27(36)24-25(18-9-11-20(31)12-10-18)37-26(33-24)19-7-4-3-5-8-19/h3-5,7-14H,6,15-16H2,1-2H3,(H,32,34)/t29-/m0/s1 WCWAERCDCJXAOR-LJAQVGFWSA-N 335051 US11040966, Example 5.226::US9732075, Example 5.226::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-phenyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335051 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335051&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127073 384987210 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657742 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1nc(sc1-c1ccc(F)cc1)-c1ccccc1 InChI=1S/C29H24ClFN4OS/c1-17-21(30)13-14-22-23(17)34-28(32-22)29(2)15-6-16-35(29)27(36)24-25(18-9-11-20(31)12-10-18)37-26(33-24)19-7-4-3-5-8-19/h3-5,7-14H,6,15-16H2,1-2H3,(H,32,34)/t29-/m0/s1 WCWAERCDCJXAOR-LJAQVGFWSA-N 335051 US11040966, Example 5.226::US9732075, Example 5.226::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-phenyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 155 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335051 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335051&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127073 384987210 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657743 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1nc(sc1-c1ccc(F)cc1)-c1ccc(F)cc1 InChI=1S/C29H23ClF2N4OS/c1-16-21(30)12-13-22-23(16)35-28(33-22)29(2)14-3-15-36(29)27(37)24-25(17-4-8-19(31)9-5-17)38-26(34-24)18-6-10-20(32)11-7-18/h4-13H,3,14-15H2,1-2H3,(H,33,35)/t29-/m0/s1 GZUFHYMFQWALCS-LJAQVGFWSA-N 335052 US11040966, Example 5.227::US9732075, Example 5.227::[2,5-Bis-(4-fluoro-phenyl)-thiazol-4-yl]-[(S)-2-(5-chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 20.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335052 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335052&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127523 384987211 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657744 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1nc(sc1-c1ccc(F)cc1)-c1ccc(F)cc1 InChI=1S/C29H23ClF2N4OS/c1-16-21(30)12-13-22-23(16)35-28(33-22)29(2)14-3-15-36(29)27(37)24-25(17-4-8-19(31)9-5-17)38-26(34-24)18-6-10-20(32)11-7-18/h4-13H,3,14-15H2,1-2H3,(H,33,35)/t29-/m0/s1 GZUFHYMFQWALCS-LJAQVGFWSA-N 335052 US11040966, Example 5.227::US9732075, Example 5.227::[2,5-Bis-(4-fluoro-phenyl)-thiazol-4-yl]-[(S)-2-(5-chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 521 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335052 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335052&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127523 384987211 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657745 Cc1ccccc1-c1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccc(F)cc1 InChI=1S/C30H26ClFN4OS/c1-17-7-4-5-8-21(17)27-34-25(26(38-27)19-9-11-20(32)12-10-19)28(37)36-16-6-15-30(36,3)29-33-23-14-13-22(31)18(2)24(23)35-29/h4-5,7-14H,6,15-16H2,1-3H3,(H,33,35)/t30-/m0/s1 VIIJYMITGPYSRV-PMERELPUSA-N 335053 US9732075, Example 5.228::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-o-tolyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 56.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335053 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335053&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 138752657 384987212 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657746 Cc1ccccc1-c1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccc(F)cc1 InChI=1S/C30H26ClFN4OS/c1-17-7-4-5-8-21(17)27-34-25(26(38-27)19-9-11-20(32)12-10-19)28(37)36-16-6-15-30(36,3)29-33-23-14-13-22(31)18(2)24(23)35-29/h4-5,7-14H,6,15-16H2,1-3H3,(H,33,35)/t30-/m0/s1 VIIJYMITGPYSRV-PMERELPUSA-N 335053 US9732075, Example 5.228::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-o-tolyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 2030 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335053 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335053&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 138752657 384987212 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657747 COc1ccccc1-c1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccc(F)cc1 InChI=1S/C30H26ClFN4O2S/c1-17-21(31)13-14-22-24(17)35-29(33-22)30(2)15-6-16-36(30)28(37)25-26(18-9-11-19(32)12-10-18)39-27(34-25)20-7-4-5-8-23(20)38-3/h4-5,7-14H,6,15-16H2,1-3H3,(H,33,35)/t30-/m0/s1 FWYDZNZVUPJEMI-PMERELPUSA-N 335054 US11040966, Example 5.229::US9732075, Example 5.229::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-(2-methoxy-phenyl)-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 54.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335054 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335054&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128128 384987213 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657748 COc1ccccc1-c1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccc(F)cc1 InChI=1S/C30H26ClFN4O2S/c1-17-21(31)13-14-22-24(17)35-29(33-22)30(2)15-6-16-36(30)28(37)25-26(18-9-11-19(32)12-10-18)39-27(34-25)20-7-4-5-8-23(20)38-3/h4-5,7-14H,6,15-16H2,1-3H3,(H,33,35)/t30-/m0/s1 FWYDZNZVUPJEMI-PMERELPUSA-N 335054 US11040966, Example 5.229::US9732075, Example 5.229::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-(2-methoxy-phenyl)-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 858 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335054 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335054&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128128 384987213 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657749 Cc1cccc(c1)-c1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccc(F)cc1 InChI=1S/C30H26ClFN4OS/c1-17-6-4-7-20(16-17)27-34-25(26(38-27)19-8-10-21(32)11-9-19)28(37)36-15-5-14-30(36,3)29-33-23-13-12-22(31)18(2)24(23)35-29/h4,6-13,16H,5,14-15H2,1-3H3,(H,33,35)/t30-/m0/s1 OJTYBORBGLUMDO-PMERELPUSA-N 335055 US11040966, Example 5.230::US9732075, Example 5.230::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-m-tolyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 21.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335055 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335055&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118126990 384987214 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657750 Cc1cccc(c1)-c1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccc(F)cc1 InChI=1S/C30H26ClFN4OS/c1-17-6-4-7-20(16-17)27-34-25(26(38-27)19-8-10-21(32)11-9-19)28(37)36-15-5-14-30(36,3)29-33-23-13-12-22(31)18(2)24(23)35-29/h4,6-13,16H,5,14-15H2,1-3H3,(H,33,35)/t30-/m0/s1 OJTYBORBGLUMDO-PMERELPUSA-N 335055 US11040966, Example 5.230::US9732075, Example 5.230::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-m-tolyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 530 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335055 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335055&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118126990 384987214 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657751 COc1cccc(c1)-c1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccc(F)cc1 InChI=1S/C30H26ClFN4O2S/c1-17-22(31)12-13-23-24(17)35-29(33-23)30(2)14-5-15-36(30)28(37)25-26(18-8-10-20(32)11-9-18)39-27(34-25)19-6-4-7-21(16-19)38-3/h4,6-13,16H,5,14-15H2,1-3H3,(H,33,35)/t30-/m0/s1 GSEUADRLDQYGNY-PMERELPUSA-N 335056 US11040966, Example 5.231::US9732075, Example 5.231::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-(3-methoxy-phenyl)-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 15.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335056 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335056&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127956 384987215 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657752 COc1cccc(c1)-c1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccc(F)cc1 InChI=1S/C30H26ClFN4O2S/c1-17-22(31)12-13-23-24(17)35-29(33-23)30(2)14-5-15-36(30)28(37)25-26(18-8-10-20(32)11-9-18)39-27(34-25)19-6-4-7-21(16-19)38-3/h4,6-13,16H,5,14-15H2,1-3H3,(H,33,35)/t30-/m0/s1 GSEUADRLDQYGNY-PMERELPUSA-N 335056 US11040966, Example 5.231::US9732075, Example 5.231::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-(3-methoxy-phenyl)-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 135 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335056 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335056&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127956 384987215 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657753 Cc1ccc(cc1)-c1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccc(F)cc1 InChI=1S/C30H26ClFN4OS/c1-17-5-7-20(8-6-17)27-34-25(26(38-27)19-9-11-21(32)12-10-19)28(37)36-16-4-15-30(36,3)29-33-23-14-13-22(31)18(2)24(23)35-29/h5-14H,4,15-16H2,1-3H3,(H,33,35)/t30-/m0/s1 BPRZIUSVKPCMJS-PMERELPUSA-N 335057 US11040966, Example 5.232::US9732075, Example 5.232::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-p-tolyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 20.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335057 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335057&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128156 384987216 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657754 Cc1ccc(cc1)-c1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccc(F)cc1 InChI=1S/C30H26ClFN4OS/c1-17-5-7-20(8-6-17)27-34-25(26(38-27)19-9-11-21(32)12-10-19)28(37)36-16-4-15-30(36,3)29-33-23-14-13-22(31)18(2)24(23)35-29/h5-14H,4,15-16H2,1-3H3,(H,33,35)/t30-/m0/s1 BPRZIUSVKPCMJS-PMERELPUSA-N 335057 US11040966, Example 5.232::US9732075, Example 5.232::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-p-tolyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 2055 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335057 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335057&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128156 384987216 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657755 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1nc(sc1-c1ccc(F)cc1)-c1ccccc1F InChI=1S/C29H23ClF2N4OS/c1-16-20(30)12-13-22-23(16)35-28(33-22)29(2)14-5-15-36(29)27(37)24-25(17-8-10-18(31)11-9-17)38-26(34-24)19-6-3-4-7-21(19)32/h3-4,6-13H,5,14-15H2,1-2H3,(H,33,35)/t29-/m0/s1 UZOPRRHLLVNIAE-LJAQVGFWSA-N 335058 US11040966, Example 5.233::US9732075, Example 5.233::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-(2-fluoro-phenyl)-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335058 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335058&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127265 384987217 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657756 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1nc(sc1-c1ccc(F)cc1)-c1ccccc1F InChI=1S/C29H23ClF2N4OS/c1-16-20(30)12-13-22-23(16)35-28(33-22)29(2)14-5-15-36(29)27(37)24-25(17-8-10-18(31)11-9-17)38-26(34-24)19-6-3-4-7-21(19)32/h3-4,6-13H,5,14-15H2,1-2H3,(H,33,35)/t29-/m0/s1 UZOPRRHLLVNIAE-LJAQVGFWSA-N 335058 US11040966, Example 5.233::US9732075, Example 5.233::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-(2-fluoro-phenyl)-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 263 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335058 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335058&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127265 384987217 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657757 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1nc(sc1-c1ccc(F)cc1)-c1cccc(F)c1 InChI=1S/C29H23ClF2N4OS/c1-16-21(30)11-12-22-23(16)35-28(33-22)29(2)13-4-14-36(29)27(37)24-25(17-7-9-19(31)10-8-17)38-26(34-24)18-5-3-6-20(32)15-18/h3,5-12,15H,4,13-14H2,1-2H3,(H,33,35)/t29-/m0/s1 MSQILLMLGVAZKC-LJAQVGFWSA-N 335059 US11040966, Example 5.234::US9732075, Example 5.234::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-(3-fluoro-phenyl)-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335059 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335059&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127591 384987218 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657758 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1nc(sc1-c1ccc(F)cc1)-c1cccc(F)c1 InChI=1S/C29H23ClF2N4OS/c1-16-21(30)11-12-22-23(16)35-28(33-22)29(2)13-4-14-36(29)27(37)24-25(17-7-9-19(31)10-8-17)38-26(34-24)18-5-3-6-20(32)15-18/h3,5-12,15H,4,13-14H2,1-2H3,(H,33,35)/t29-/m0/s1 MSQILLMLGVAZKC-LJAQVGFWSA-N 335059 US11040966, Example 5.234::US9732075, Example 5.234::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-(3-fluoro-phenyl)-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 131 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335059 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335059&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127591 384987218 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657759 Cc1cc(C(=O)N2CCC[C@@]2(C)c2nc3cc(OC(F)(F)F)ccc3[nH]2)c(cc1C)-n1nccn1 InChI=1S/C24H23F3N6O2/c1-14-11-17(20(12-15(14)2)33-28-8-9-29-33)21(34)32-10-4-7-23(32,3)22-30-18-6-5-16(13-19(18)31-22)35-24(25,26)27/h5-6,8-9,11-13H,4,7,10H2,1-3H3,(H,30,31)/t23-/m0/s1 LBJZNSFFKPMUSD-QHCPKHFHSA-N 335060 (4,5-Dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.235::US9732075, Example 5.235 Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335060 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335060&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127051 384987219 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657760 Cc1cc(C(=O)N2CCC[C@@]2(C)c2nc3cc(OC(F)(F)F)ccc3[nH]2)c(cc1C)-n1nccn1 InChI=1S/C24H23F3N6O2/c1-14-11-17(20(12-15(14)2)33-28-8-9-29-33)21(34)32-10-4-7-23(32,3)22-30-18-6-5-16(13-19(18)31-22)35-24(25,26)27/h5-6,8-9,11-13H,4,7,10H2,1-3H3,(H,30,31)/t23-/m0/s1 LBJZNSFFKPMUSD-QHCPKHFHSA-N 335060 (4,5-Dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.235::US9732075, Example 5.235 Orexin receptor type 2 Homo sapiens 16.5 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335060 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335060&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127051 384987219 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657761 Cc1ccc(-c2ccccc2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(OC(F)(F)F)ccc2[nH]1 InChI=1S/C27H24F3N3O2/c1-17-9-11-20(18-7-4-3-5-8-18)21(15-17)24(34)33-14-6-13-26(33,2)25-31-22-12-10-19(16-23(22)32-25)35-27(28,29)30/h3-5,7-12,15-16H,6,13-14H2,1-2H3,(H,31,32)/t26-/m0/s1 ZYTJMFQVNVHMRD-SANMLTNESA-N 335061 (4-Methyl-biphenyl-2-yl)-[(S)-2-methyl-2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.236::US9732075, Example 5.236 Orexin/Hypocretin receptor type 1 Homo sapiens 26.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335061 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335061&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128230 384987220 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657762 Cc1ccc(-c2ccccc2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(OC(F)(F)F)ccc2[nH]1 InChI=1S/C27H24F3N3O2/c1-17-9-11-20(18-7-4-3-5-8-18)21(15-17)24(34)33-14-6-13-26(33,2)25-31-22-12-10-19(16-23(22)32-25)35-27(28,29)30/h3-5,7-12,15-16H,6,13-14H2,1-2H3,(H,31,32)/t26-/m0/s1 ZYTJMFQVNVHMRD-SANMLTNESA-N 335061 (4-Methyl-biphenyl-2-yl)-[(S)-2-methyl-2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.236::US9732075, Example 5.236 Orexin receptor type 2 Homo sapiens 173 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335061 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335061&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128230 384987220 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657763 COc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(OC(F)(F)F)ccc2[nH]1)-n1nccn1 InChI=1S/C23H21F3N6O3/c1-22(21-29-17-6-4-15(13-18(17)30-21)35-23(24,25)26)8-3-11-31(22)20(33)16-12-14(34-2)5-7-19(16)32-27-9-10-28-32/h4-7,9-10,12-13H,3,8,11H2,1-2H3,(H,29,30)/t22-/m0/s1 YQEAISIONMPFFG-QFIPXVFZSA-N 335062 (5-Methoxy-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.237::US9732075, Example 5.237 Orexin/Hypocretin receptor type 1 Homo sapiens 58.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335062 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335062&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127854 384987221 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657764 COc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(OC(F)(F)F)ccc2[nH]1)-n1nccn1 InChI=1S/C23H21F3N6O3/c1-22(21-29-17-6-4-15(13-18(17)30-21)35-23(24,25)26)8-3-11-31(22)20(33)16-12-14(34-2)5-7-19(16)32-27-9-10-28-32/h4-7,9-10,12-13H,3,8,11H2,1-2H3,(H,29,30)/t22-/m0/s1 YQEAISIONMPFFG-QFIPXVFZSA-N 335062 (5-Methoxy-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.237::US9732075, Example 5.237 Orexin receptor type 2 Homo sapiens 223 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335062 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335062&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127854 384987221 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657765 Cc1ccc(C(=O)N2CCC[C@@]2(C)c2nc3cc(OC(F)(F)F)ccc3[nH]2)c(c1)-n1nccn1 InChI=1S/C23H21F3N6O2/c1-14-4-6-16(19(12-14)32-27-9-10-28-32)20(33)31-11-3-8-22(31,2)21-29-17-7-5-15(13-18(17)30-21)34-23(24,25)26/h4-7,9-10,12-13H,3,8,11H2,1-2H3,(H,29,30)/t22-/m0/s1 KTYWFAVNRDNONI-QFIPXVFZSA-N 335063 (4-Methyl-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.238::US9732075, Example 5.238 Orexin/Hypocretin receptor type 1 Homo sapiens 23.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335063 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335063&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127456 384987222 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657766 Cc1ccc(C(=O)N2CCC[C@@]2(C)c2nc3cc(OC(F)(F)F)ccc3[nH]2)c(c1)-n1nccn1 InChI=1S/C23H21F3N6O2/c1-14-4-6-16(19(12-14)32-27-9-10-28-32)20(33)31-11-3-8-22(31,2)21-29-17-7-5-15(13-18(17)30-21)34-23(24,25)26/h4-7,9-10,12-13H,3,8,11H2,1-2H3,(H,29,30)/t22-/m0/s1 KTYWFAVNRDNONI-QFIPXVFZSA-N 335063 (4-Methyl-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.238::US9732075, Example 5.238 Orexin receptor type 2 Homo sapiens 91.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335063 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335063&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127456 384987222 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657767 Cc1ccc(-c2ccccn2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(OC(F)(F)F)ccc2[nH]1 InChI=1S/C26H23F3N4O2/c1-16-7-9-18(20-6-3-4-12-30-20)19(14-16)23(34)33-13-5-11-25(33,2)24-31-21-10-8-17(15-22(21)32-24)35-26(27,28)29/h3-4,6-10,12,14-15H,5,11,13H2,1-2H3,(H,31,32)/t25-/m0/s1 CNIVXMKUFJVRMO-VWLOTQADSA-N 335064 (5-Methyl-2-pyridin-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.239::US9732075, Example 5.239 Orexin/Hypocretin receptor type 1 Homo sapiens 35.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335064 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335064&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128165 384987223 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657768 Cc1ccc(-c2ccccn2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(OC(F)(F)F)ccc2[nH]1 InChI=1S/C26H23F3N4O2/c1-16-7-9-18(20-6-3-4-12-30-20)19(14-16)23(34)33-13-5-11-25(33,2)24-31-21-10-8-17(15-22(21)32-24)35-26(27,28)29/h3-4,6-10,12,14-15H,5,11,13H2,1-2H3,(H,31,32)/t25-/m0/s1 CNIVXMKUFJVRMO-VWLOTQADSA-N 335064 (5-Methyl-2-pyridin-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.239::US9732075, Example 5.239 Orexin receptor type 2 Homo sapiens 594 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335064 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335064&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128165 384987223 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657769 Cc1ccc(C(=O)N2CCC[C@@]2(C)c2nc3cc(OC(F)(F)F)ccc3[nH]2)c(c1)-c1ccccn1 InChI=1S/C26H23F3N4O2/c1-16-7-9-18(19(14-16)20-6-3-4-12-30-20)23(34)33-13-5-11-25(33,2)24-31-21-10-8-17(15-22(21)32-24)35-26(27,28)29/h3-4,6-10,12,14-15H,5,11,13H2,1-2H3,(H,31,32)/t25-/m0/s1 BGCVCDXDLBAJDW-VWLOTQADSA-N 335065 (4-Methyl-2-pyridin-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.240::US9732075, Example 5.240 Orexin/Hypocretin receptor type 1 Homo sapiens 38.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335065 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335065&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127721 384987224 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657770 Cc1ccc(C(=O)N2CCC[C@@]2(C)c2nc3cc(OC(F)(F)F)ccc3[nH]2)c(c1)-c1ccccn1 InChI=1S/C26H23F3N4O2/c1-16-7-9-18(19(14-16)20-6-3-4-12-30-20)23(34)33-13-5-11-25(33,2)24-31-21-10-8-17(15-22(21)32-24)35-26(27,28)29/h3-4,6-10,12,14-15H,5,11,13H2,1-2H3,(H,31,32)/t25-/m0/s1 BGCVCDXDLBAJDW-VWLOTQADSA-N 335065 (4-Methyl-2-pyridin-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.240::US9732075, Example 5.240 Orexin receptor type 2 Homo sapiens 232 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335065 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335065&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127721 384987224 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657771 Cc1ccc(C(=O)N2CCC[C@@]2(C)c2nc3cc(OC(F)(F)F)ccc3[nH]2)c(c1)-c1cccnc1 InChI=1S/C26H23F3N4O2/c1-16-6-8-19(20(13-16)17-5-3-11-30-15-17)23(34)33-12-4-10-25(33,2)24-31-21-9-7-18(14-22(21)32-24)35-26(27,28)29/h3,5-9,11,13-15H,4,10,12H2,1-2H3,(H,31,32)/t25-/m0/s1 IATWIZWLWPXEJY-VWLOTQADSA-N 335066 (4-Methyl-2-pyridin-3-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.241::US9732075, Example 5.241 Orexin/Hypocretin receptor type 1 Homo sapiens 54.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335066 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335066&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127337 384987225 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657772 Cc1ccc(C(=O)N2CCC[C@@]2(C)c2nc3cc(OC(F)(F)F)ccc3[nH]2)c(c1)-c1cccnc1 InChI=1S/C26H23F3N4O2/c1-16-6-8-19(20(13-16)17-5-3-11-30-15-17)23(34)33-12-4-10-25(33,2)24-31-21-9-7-18(14-22(21)32-24)35-26(27,28)29/h3,5-9,11,13-15H,4,10,12H2,1-2H3,(H,31,32)/t25-/m0/s1 IATWIZWLWPXEJY-VWLOTQADSA-N 335066 (4-Methyl-2-pyridin-3-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.241::US9732075, Example 5.241 Orexin receptor type 2 Homo sapiens 1000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335066 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335066&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127337 384987225 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657773 Cc1ccc(C(=O)N2CCC[C@@]2(C)c2nc3cc(OC(F)(F)F)ccc3[nH]2)c(c1)-c1ccccc1 InChI=1S/C27H24F3N3O2/c1-17-9-11-20(21(15-17)18-7-4-3-5-8-18)24(34)33-14-6-13-26(33,2)25-31-22-12-10-19(16-23(22)32-25)35-27(28,29)30/h3-5,7-12,15-16H,6,13-14H2,1-2H3,(H,31,32)/t26-/m0/s1 XDMMDSGPFNNXIO-SANMLTNESA-N 335067 (5-Methyl-biphenyl-2-yl)-[(S)-2-methyl-2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.242::US9732075, Example 5.242 Orexin/Hypocretin receptor type 1 Homo sapiens 56.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335067 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335067&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102513 384987226 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657774 Cc1ccc(C(=O)N2CCC[C@@]2(C)c2nc3cc(OC(F)(F)F)ccc3[nH]2)c(c1)-c1ccccc1 InChI=1S/C27H24F3N3O2/c1-17-9-11-20(21(15-17)18-7-4-3-5-8-18)24(34)33-14-6-13-26(33,2)25-31-22-12-10-19(16-23(22)32-25)35-27(28,29)30/h3-5,7-12,15-16H,6,13-14H2,1-2H3,(H,31,32)/t26-/m0/s1 XDMMDSGPFNNXIO-SANMLTNESA-N 335067 (5-Methyl-biphenyl-2-yl)-[(S)-2-methyl-2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.242::US9732075, Example 5.242 Orexin receptor type 2 Homo sapiens 401 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335067 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335067&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102513 384987226 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657775 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3cc(OC(F)(F)F)ccc3[nH]2)c(s1)-c1ccccc1C InChI=1S/C25H23F3N4O2S/c1-14-7-4-5-8-17(14)21-20(29-15(2)35-21)22(33)32-12-6-11-24(32,3)23-30-18-10-9-16(13-19(18)31-23)34-25(26,27)28/h4-5,7-10,13H,6,11-12H2,1-3H3,(H,30,31)/t24-/m0/s1 SXFORXFRTWPISY-DEOSSOPVSA-N 335068 (2-Methyl-5-o-tolyl-thiazol-4-yl)-[(S)-2-methyl-2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.243::US9732075, Example 5.243 Orexin/Hypocretin receptor type 1 Homo sapiens 88.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335068 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335068&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127377 384987227 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657776 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3cc(OC(F)(F)F)ccc3[nH]2)c(s1)-c1ccccc1C InChI=1S/C25H23F3N4O2S/c1-14-7-4-5-8-17(14)21-20(29-15(2)35-21)22(33)32-12-6-11-24(32,3)23-30-18-10-9-16(13-19(18)31-23)34-25(26,27)28/h4-5,7-10,13H,6,11-12H2,1-3H3,(H,30,31)/t24-/m0/s1 SXFORXFRTWPISY-DEOSSOPVSA-N 335068 (2-Methyl-5-o-tolyl-thiazol-4-yl)-[(S)-2-methyl-2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.243::US9732075, Example 5.243 Orexin receptor type 2 Homo sapiens 1120 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335068 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335068&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127377 384987227 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657777 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3cc(OC(F)(F)F)ccc3[nH]2)c(s1)-c1cccc(Cl)c1Cl InChI=1S/C24H19Cl2F3N4O2S/c1-12-30-19(20(36-12)14-5-3-6-15(25)18(14)26)21(34)33-10-4-9-23(33,2)22-31-16-8-7-13(11-17(16)32-22)35-24(27,28)29/h3,5-8,11H,4,9-10H2,1-2H3,(H,31,32)/t23-/m0/s1 NCJMWLCMOHFZCN-QHCPKHFHSA-N 335069 US11040966, Example 5.244::US9732075, Example 5.244::[5-(2,3-Dichloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-methyl-2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 62.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335069 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335069&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127795 384987228 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657778 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3cc(OC(F)(F)F)ccc3[nH]2)c(s1)-c1cccc(Cl)c1Cl InChI=1S/C24H19Cl2F3N4O2S/c1-12-30-19(20(36-12)14-5-3-6-15(25)18(14)26)21(34)33-10-4-9-23(33,2)22-31-16-8-7-13(11-17(16)32-22)35-24(27,28)29/h3,5-8,11H,4,9-10H2,1-2H3,(H,31,32)/t23-/m0/s1 NCJMWLCMOHFZCN-QHCPKHFHSA-N 335069 US11040966, Example 5.244::US9732075, Example 5.244::[5-(2,3-Dichloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-methyl-2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 641 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335069 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335069&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127795 384987228 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657779 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3cc(OC(F)(F)F)ccc3[nH]2)c(s1)-c1ccc(C)c(C)c1 InChI=1S/C26H25F3N4O2S/c1-14-6-7-17(12-15(14)2)22-21(30-16(3)36-22)23(34)33-11-5-10-25(33,4)24-31-19-9-8-18(13-20(19)32-24)35-26(27,28)29/h6-9,12-13H,5,10-11H2,1-4H3,(H,31,32)/t25-/m0/s1 HQVATFSVRAOBKU-VWLOTQADSA-N 335070 US11040966, Example 5.245::US9732075, Example 5.245::[5-(3,4-Dimethyl-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-methyl-2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 14.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335070 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335070&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127111 384987229 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657780 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3cc(OC(F)(F)F)ccc3[nH]2)c(s1)-c1ccc(C)c(C)c1 InChI=1S/C26H25F3N4O2S/c1-14-6-7-17(12-15(14)2)22-21(30-16(3)36-22)23(34)33-11-5-10-25(33,4)24-31-19-9-8-18(13-20(19)32-24)35-26(27,28)29/h6-9,12-13H,5,10-11H2,1-4H3,(H,31,32)/t25-/m0/s1 HQVATFSVRAOBKU-VWLOTQADSA-N 335070 US11040966, Example 5.245::US9732075, Example 5.245::[5-(3,4-Dimethyl-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-methyl-2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 80.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335070 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335070&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127111 384987229 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657781 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3cc(OC(F)(F)F)ccc3[nH]2)c(s1)-c1cc(F)cc(F)c1 InChI=1S/C24H19F5N4O2S/c1-12-30-19(20(36-12)13-8-14(25)10-15(26)9-13)21(34)33-7-3-6-23(33,2)22-31-17-5-4-16(11-18(17)32-22)35-24(27,28)29/h4-5,8-11H,3,6-7H2,1-2H3,(H,31,32)/t23-/m0/s1 MTLKVJGRTAQPSQ-QHCPKHFHSA-N 335071 US11040966, Example 5.246::US9732075, Example 5.246::[5-(3,5-Difluoro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-methyl-2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 28.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335071 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335071&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127140 384987230 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657782 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3cc(OC(F)(F)F)ccc3[nH]2)c(s1)-c1cc(F)cc(F)c1 InChI=1S/C24H19F5N4O2S/c1-12-30-19(20(36-12)13-8-14(25)10-15(26)9-13)21(34)33-7-3-6-23(33,2)22-31-17-5-4-16(11-18(17)32-22)35-24(27,28)29/h4-5,8-11H,3,6-7H2,1-2H3,(H,31,32)/t23-/m0/s1 MTLKVJGRTAQPSQ-QHCPKHFHSA-N 335071 US11040966, Example 5.246::US9732075, Example 5.246::[5-(3,5-Difluoro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-methyl-2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 533 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335071 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335071&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127140 384987230 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657783 COc1cccc(c1)-c1sc(C)nc1C(=O)N1CCC[C@@]1(C)c1nc2cc(OC(F)(F)F)ccc2[nH]1 InChI=1S/C25H23F3N4O3S/c1-14-29-20(21(36-14)15-6-4-7-16(12-15)34-3)22(33)32-11-5-10-24(32,2)23-30-18-9-8-17(13-19(18)31-23)35-25(26,27)28/h4,6-9,12-13H,5,10-11H2,1-3H3,(H,30,31)/t24-/m0/s1 DNKHPDSXRMDYOJ-DEOSSOPVSA-N 335072 US11040966, Example 5.247::US9732075, Example 5.247::[5-(3-Methoxy-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-methyl-2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 10.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335072 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335072&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127348 384987231 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657784 COc1cccc(c1)-c1sc(C)nc1C(=O)N1CCC[C@@]1(C)c1nc2cc(OC(F)(F)F)ccc2[nH]1 InChI=1S/C25H23F3N4O3S/c1-14-29-20(21(36-14)15-6-4-7-16(12-15)34-3)22(33)32-11-5-10-24(32,2)23-30-18-9-8-17(13-19(18)31-23)35-25(26,27)28/h4,6-9,12-13H,5,10-11H2,1-3H3,(H,30,31)/t24-/m0/s1 DNKHPDSXRMDYOJ-DEOSSOPVSA-N 335072 US11040966, Example 5.247::US9732075, Example 5.247::[5-(3-Methoxy-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-methyl-2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 136 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335072 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335072&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127348 384987231 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657785 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3cc(OC(F)(F)F)ccc3[nH]2)c(s1)-c1ccc(F)cc1 InChI=1S/C24H20F4N4O2S/c1-13-29-19(20(35-13)14-4-6-15(25)7-5-14)21(33)32-11-3-10-23(32,2)22-30-17-9-8-16(12-18(17)31-22)34-24(26,27)28/h4-9,12H,3,10-11H2,1-2H3,(H,30,31)/t23-/m0/s1 MQNKLBDKKXJIME-QHCPKHFHSA-N 335073 US11040966, Example 5.248::US9732075, Example 5.248::[5-(4-Fluoro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-methyl-2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 22.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335073 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335073&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127850 384987232 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657786 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3cc(OC(F)(F)F)ccc3[nH]2)c(s1)-c1ccc(F)cc1 InChI=1S/C24H20F4N4O2S/c1-13-29-19(20(35-13)14-4-6-15(25)7-5-14)21(33)32-11-3-10-23(32,2)22-30-17-9-8-16(12-18(17)31-22)34-24(26,27)28/h4-9,12H,3,10-11H2,1-2H3,(H,30,31)/t23-/m0/s1 MQNKLBDKKXJIME-QHCPKHFHSA-N 335073 US11040966, Example 5.248::US9732075, Example 5.248::[5-(4-Fluoro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-methyl-2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 494 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335073 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335073&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127850 384987232 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657787 COc1cccc(c1)C#Cc1ccccc1C(=O)N1CCC[C@@]1(C)c1nc2c(C)cc(Br)cc2[nH]1 InChI=1S/C29H26BrN3O2/c1-19-16-22(30)18-25-26(19)32-28(31-25)29(2)14-7-15-33(29)27(34)24-11-5-4-9-21(24)13-12-20-8-6-10-23(17-20)35-3/h4-6,8-11,16-18H,7,14-15H2,1-3H3,(H,31,32)/t29-/m0/s1 IJEFRNJFBSZHIP-LJAQVGFWSA-N 335074 US11040966, Example 5.249::US9732075, Example 5.249::[(S)-2-(6-Bromo-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[2-(3-methoxy-phenylethynyl)-phenyl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 38.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335074 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335074&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127720 384987233 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657788 COc1cccc(c1)C#Cc1ccccc1C(=O)N1CCC[C@@]1(C)c1nc2c(C)cc(Br)cc2[nH]1 InChI=1S/C29H26BrN3O2/c1-19-16-22(30)18-25-26(19)32-28(31-25)29(2)14-7-15-33(29)27(34)24-11-5-4-9-21(24)13-12-20-8-6-10-23(17-20)35-3/h4-6,8-11,16-18H,7,14-15H2,1-3H3,(H,31,32)/t29-/m0/s1 IJEFRNJFBSZHIP-LJAQVGFWSA-N 335074 US11040966, Example 5.249::US9732075, Example 5.249::[(S)-2-(6-Bromo-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[2-(3-methoxy-phenylethynyl)-phenyl]-methanone Orexin receptor type 2 Homo sapiens 53.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335074 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335074&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127720 384987233 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657789 COc1cccc(c1)C#Cc1ccccc1C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C29H24F3N3O2/c1-28(27-33-24-14-13-21(29(30,31)32)18-25(24)34-27)15-6-16-35(28)26(36)23-10-4-3-8-20(23)12-11-19-7-5-9-22(17-19)37-2/h3-5,7-10,13-14,17-18H,6,15-16H2,1-2H3,(H,33,34)/t28-/m0/s1 BZAJWRAPCSZYGU-NDEPHWFRSA-N 335075 US11040966, Example 5.250::US9732075, Example 5.250::[2-(3-Methoxy-phenylethynyl)-phenyl]-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 184 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335075 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335075&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128105 384987234 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657790 COc1cccc(c1)C#Cc1ccccc1C(=O)N1CCC[C@@]1(C)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C29H24F3N3O2/c1-28(27-33-24-14-13-21(29(30,31)32)18-25(24)34-27)15-6-16-35(28)26(36)23-10-4-3-8-20(23)12-11-19-7-5-9-22(17-19)37-2/h3-5,7-10,13-14,17-18H,6,15-16H2,1-2H3,(H,33,34)/t28-/m0/s1 BZAJWRAPCSZYGU-NDEPHWFRSA-N 335075 US11040966, Example 5.250::US9732075, Example 5.250::[2-(3-Methoxy-phenylethynyl)-phenyl]-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 992 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335075 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335075&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128105 384987234 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657791 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1nc(sc1-c1ccc(F)cc1)-c1cccc(F)c1F InChI=1S/C29H22ClF3N4OS/c1-15-19(30)11-12-21-23(15)36-28(34-21)29(2)13-4-14-37(29)27(38)24-25(16-7-9-17(31)10-8-16)39-26(35-24)18-5-3-6-20(32)22(18)33/h3,5-12H,4,13-14H2,1-2H3,(H,34,36)/t29-/m0/s1 NSJMDFAFVJMALS-LJAQVGFWSA-N 335076 US11040966, Example 5.251::US9732075, Example 5.251::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[2-(2,3-difluoro-phenyl)-5-(4-fluoro-phenyl)-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335076 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335076&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127449 384987235 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657792 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1nc(sc1-c1ccc(F)cc1)-c1cccc(F)c1F InChI=1S/C29H22ClF3N4OS/c1-15-19(30)11-12-21-23(15)36-28(34-21)29(2)13-4-14-37(29)27(38)24-25(16-7-9-17(31)10-8-16)39-26(35-24)18-5-3-6-20(32)22(18)33/h3,5-12H,4,13-14H2,1-2H3,(H,34,36)/t29-/m0/s1 NSJMDFAFVJMALS-LJAQVGFWSA-N 335076 US11040966, Example 5.251::US9732075, Example 5.251::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[2-(2,3-difluoro-phenyl)-5-(4-fluoro-phenyl)-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 774 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335076 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335076&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127449 384987235 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657793 Cc1cc(ccc1F)-c1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccc(F)cc1 InChI=1S/C30H25ClF2N4OS/c1-16-15-19(7-11-22(16)33)27-35-25(26(39-27)18-5-8-20(32)9-6-18)28(38)37-14-4-13-30(37,3)29-34-23-12-10-21(31)17(2)24(23)36-29/h5-12,15H,4,13-14H2,1-3H3,(H,34,36)/t30-/m0/s1 KAKBYZRNFMPQHH-PMERELPUSA-N 335077 US11040966, Example 5.252::US9732075, Example 5.252::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[2-(4-fluoro-3-methyl-phenyl)-5-(4-fluoro-phenyl)-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 20.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335077 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335077&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127096 384987236 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657794 Cc1cc(ccc1F)-c1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccc(F)cc1 InChI=1S/C30H25ClF2N4OS/c1-16-15-19(7-11-22(16)33)27-35-25(26(39-27)18-5-8-20(32)9-6-18)28(38)37-14-4-13-30(37,3)29-34-23-12-10-21(31)17(2)24(23)36-29/h5-12,15H,4,13-14H2,1-3H3,(H,34,36)/t30-/m0/s1 KAKBYZRNFMPQHH-PMERELPUSA-N 335077 US11040966, Example 5.252::US9732075, Example 5.252::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[2-(4-fluoro-3-methyl-phenyl)-5-(4-fluoro-phenyl)-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 1640 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335077 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335077&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127096 384987236 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657795 Cc1ccc(-c2nc(C(=O)N3CCC[C@@]3(C)c3nc4c(C)c(Cl)ccc4[nH]3)c(s2)-c2ccc(F)cc2)c(F)c1 InChI=1S/C30H25ClF2N4OS/c1-16-5-10-20(22(33)15-16)27-35-25(26(39-27)18-6-8-19(32)9-7-18)28(38)37-14-4-13-30(37,3)29-34-23-12-11-21(31)17(2)24(23)36-29/h5-12,15H,4,13-14H2,1-3H3,(H,34,36)/t30-/m0/s1 VIZGOVGQIZGMLC-PMERELPUSA-N 335078 US11040966, Example 5.253::US9732075, Example 5.253::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[2-(2-fluoro-4-methyl-phenyl)-5-(4-fluoro-phenyl)-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 12.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335078 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335078&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127434 384987237 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657796 Cc1ccc(-c2nc(C(=O)N3CCC[C@@]3(C)c3nc4c(C)c(Cl)ccc4[nH]3)c(s2)-c2ccc(F)cc2)c(F)c1 InChI=1S/C30H25ClF2N4OS/c1-16-5-10-20(22(33)15-16)27-35-25(26(39-27)18-6-8-19(32)9-7-18)28(38)37-14-4-13-30(37,3)29-34-23-12-11-21(31)17(2)24(23)36-29/h5-12,15H,4,13-14H2,1-3H3,(H,34,36)/t30-/m0/s1 VIZGOVGQIZGMLC-PMERELPUSA-N 335078 US11040966, Example 5.253::US9732075, Example 5.253::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[2-(2-fluoro-4-methyl-phenyl)-5-(4-fluoro-phenyl)-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 1187 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335078 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335078&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127434 384987237 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657797 Cc1ccc(cc1C)-c1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccc(F)cc1 InChI=1S/C31H28ClFN4OS/c1-17-6-7-21(16-18(17)2)28-35-26(27(39-28)20-8-10-22(33)11-9-20)29(38)37-15-5-14-31(37,4)30-34-24-13-12-23(32)19(3)25(24)36-30/h6-13,16H,5,14-15H2,1-4H3,(H,34,36)/t31-/m0/s1 WMMMRFRCCNPINT-HKBQPEDESA-N 335079 US11040966, Example 5.254::US9732075, Example 5.254::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[2-(3,4-dimethyl-phenyl)-5-(4-fluoro-phenyl)-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 39.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335079 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335079&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127158 384987238 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657798 Cc1ccc(cc1C)-c1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccc(F)cc1 InChI=1S/C31H28ClFN4OS/c1-17-6-7-21(16-18(17)2)28-35-26(27(39-28)20-8-10-22(33)11-9-20)29(38)37-15-5-14-31(37,4)30-34-24-13-12-23(32)19(3)25(24)36-30/h6-13,16H,5,14-15H2,1-4H3,(H,34,36)/t31-/m0/s1 WMMMRFRCCNPINT-HKBQPEDESA-N 335079 US11040966, Example 5.254::US9732075, Example 5.254::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[2-(3,4-dimethyl-phenyl)-5-(4-fluoro-phenyl)-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 9270 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335079 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335079&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127158 384987238 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657799 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1nc(sc1-c1ccc(F)cc1)-c1cccc(c1)C#N InChI=1S/C30H23ClFN5OS/c1-17-22(31)11-12-23-24(17)36-29(34-23)30(2)13-4-14-37(30)28(38)25-26(19-7-9-21(32)10-8-19)39-27(35-25)20-6-3-5-18(15-20)16-33/h3,5-12,15H,4,13-14H2,1-2H3,(H,34,36)/t30-/m0/s1 RGQDQGMCUZKIIP-PMERELPUSA-N 335080 3-[4-[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidine-1-carbonyl]-5-(4-fluoro-phenyl)-thiazol-2-yl]-benzonitrile::US11040966, Example 5.255::US9732075, Example 5.255 Orexin/Hypocretin receptor type 1 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335080 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335080&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127856 384987239 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657800 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1nc(sc1-c1ccc(F)cc1)-c1cccc(c1)C#N InChI=1S/C30H23ClFN5OS/c1-17-22(31)11-12-23-24(17)36-29(34-23)30(2)13-4-14-37(30)28(38)25-26(19-7-9-21(32)10-8-19)39-27(35-25)20-6-3-5-18(15-20)16-33/h3,5-12,15H,4,13-14H2,1-2H3,(H,34,36)/t30-/m0/s1 RGQDQGMCUZKIIP-PMERELPUSA-N 335080 3-[4-[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidine-1-carbonyl]-5-(4-fluoro-phenyl)-thiazol-2-yl]-benzonitrile::US11040966, Example 5.255::US9732075, Example 5.255 Orexin receptor type 2 Homo sapiens 145 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335080 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335080&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127856 384987239 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657801 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1nc(sc1-c1ccc(F)cc1)-c1ccccc1Cl InChI=1S/C29H23Cl2FN4OS/c1-16-20(30)12-13-22-23(16)35-28(33-22)29(2)14-5-15-36(29)27(37)24-25(17-8-10-18(32)11-9-17)38-26(34-24)19-6-3-4-7-21(19)31/h3-4,6-13H,5,14-15H2,1-2H3,(H,33,35)/t29-/m0/s1 YGPJRSITDYKFHH-LJAQVGFWSA-N 335081 US11040966, Example 5.256::US9732075, Example 5.256::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[2-(2-chloro-phenyl)-5-(4-fluoro-phenyl)-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335081 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335081&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127706 384987240 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657802 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1nc(sc1-c1ccc(F)cc1)-c1ccccc1Cl InChI=1S/C29H23Cl2FN4OS/c1-16-20(30)12-13-22-23(16)35-28(33-22)29(2)14-5-15-36(29)27(37)24-25(17-8-10-18(32)11-9-17)38-26(34-24)19-6-3-4-7-21(19)31/h3-4,6-13H,5,14-15H2,1-2H3,(H,33,35)/t29-/m0/s1 YGPJRSITDYKFHH-LJAQVGFWSA-N 335081 US11040966, Example 5.256::US9732075, Example 5.256::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[2-(2-chloro-phenyl)-5-(4-fluoro-phenyl)-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 402 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335081 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335081&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127706 384987240 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657803 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1nc(sc1-c1ccc(F)cc1)-c1cccc(Cl)c1 InChI=1S/C29H23Cl2FN4OS/c1-16-21(31)11-12-22-23(16)35-28(33-22)29(2)13-4-14-36(29)27(37)24-25(17-7-9-20(32)10-8-17)38-26(34-24)18-5-3-6-19(30)15-18/h3,5-12,15H,4,13-14H2,1-2H3,(H,33,35)/t29-/m0/s1 GJMLLBLYTBBGSM-LJAQVGFWSA-N 335082 US11040966, Example 5.257::US9732075, Example 5.257::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[2-(3-chloro-phenyl)-5-(4-fluoro-phenyl)-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335082 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335082&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128110 384987241 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657804 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1nc(sc1-c1ccc(F)cc1)-c1cccc(Cl)c1 InChI=1S/C29H23Cl2FN4OS/c1-16-21(31)11-12-22-23(16)35-28(33-22)29(2)13-4-14-36(29)27(37)24-25(17-7-9-20(32)10-8-17)38-26(34-24)18-5-3-6-19(30)15-18/h3,5-12,15H,4,13-14H2,1-2H3,(H,33,35)/t29-/m0/s1 GJMLLBLYTBBGSM-LJAQVGFWSA-N 335082 US11040966, Example 5.257::US9732075, Example 5.257::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[2-(3-chloro-phenyl)-5-(4-fluoro-phenyl)-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 329 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335082 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335082&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128110 384987241 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657805 Cc1ccc(cc1Cl)-c1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccc(F)cc1 InChI=1S/C30H25Cl2FN4OS/c1-16-5-6-19(15-22(16)32)27-35-25(26(39-27)18-7-9-20(33)10-8-18)28(38)37-14-4-13-30(37,3)29-34-23-12-11-21(31)17(2)24(23)36-29/h5-12,15H,4,13-14H2,1-3H3,(H,34,36)/t30-/m0/s1 BYYUDYOLLPJRFJ-PMERELPUSA-N 335083 US11040966, Example 5.258::US9732075, Example 5.258::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[2-(3-chloro-4-methyl-phenyl)-5-(4-fluoro-phenyl)-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 36.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335083 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335083&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128374 384987242 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657806 Cc1ccc(cc1Cl)-c1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccc(F)cc1 InChI=1S/C30H25Cl2FN4OS/c1-16-5-6-19(15-22(16)32)27-35-25(26(39-27)18-7-9-20(33)10-8-18)28(38)37-14-4-13-30(37,3)29-34-23-12-11-21(31)17(2)24(23)36-29/h5-12,15H,4,13-14H2,1-3H3,(H,34,36)/t30-/m0/s1 BYYUDYOLLPJRFJ-PMERELPUSA-N 335083 US11040966, Example 5.258::US9732075, Example 5.258::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[2-(3-chloro-4-methyl-phenyl)-5-(4-fluoro-phenyl)-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 6520 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335083 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335083&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128374 384987242 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657807 Cc1cc(F)ccc1-c1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccc(F)cc1 InChI=1S/C30H25ClF2N4OS/c1-16-15-20(33)9-10-21(16)27-35-25(26(39-27)18-5-7-19(32)8-6-18)28(38)37-14-4-13-30(37,3)29-34-23-12-11-22(31)17(2)24(23)36-29/h5-12,15H,4,13-14H2,1-3H3,(H,34,36)/t30-/m0/s1 FOUTVJNYMONXMR-PMERELPUSA-N 335084 US11040966, Example 5.259::US9732075, Example 5.259::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[2-(4-fluoro-2-methyl-phenyl)-5-(4-fluoro-phenyl)-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 29.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335084 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335084&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127763 384987243 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657808 Cc1cc(F)ccc1-c1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccc(F)cc1 InChI=1S/C30H25ClF2N4OS/c1-16-15-20(33)9-10-21(16)27-35-25(26(39-27)18-5-7-19(32)8-6-18)28(38)37-14-4-13-30(37,3)29-34-23-12-11-22(31)17(2)24(23)36-29/h5-12,15H,4,13-14H2,1-3H3,(H,34,36)/t30-/m0/s1 FOUTVJNYMONXMR-PMERELPUSA-N 335084 US11040966, Example 5.259::US9732075, Example 5.259::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[2-(4-fluoro-2-methyl-phenyl)-5-(4-fluoro-phenyl)-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 4660 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335084 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335084&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127763 384987243 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657809 COc1cc(F)ccc1-c1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccc(F)cc1 InChI=1S/C30H25ClF2N4O2S/c1-16-21(31)11-12-22-24(16)36-29(34-22)30(2)13-4-14-37(30)28(38)25-26(17-5-7-18(32)8-6-17)40-27(35-25)20-10-9-19(33)15-23(20)39-3/h5-12,15H,4,13-14H2,1-3H3,(H,34,36)/t30-/m0/s1 OPVUQHWBLFWOOZ-PMERELPUSA-N 335085 US11040966, Example 5.260::US9732075, Example 5.260::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[2-(4-fluoro-2-methoxy-phenyl)-5-(4-fluoro-phenyl)-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 20.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335085 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335085&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127053 384987244 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657810 COc1cc(F)ccc1-c1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccc(F)cc1 InChI=1S/C30H25ClF2N4O2S/c1-16-21(31)11-12-22-24(16)36-29(34-22)30(2)13-4-14-37(30)28(38)25-26(17-5-7-18(32)8-6-17)40-27(35-25)20-10-9-19(33)15-23(20)39-3/h5-12,15H,4,13-14H2,1-3H3,(H,34,36)/t30-/m0/s1 OPVUQHWBLFWOOZ-PMERELPUSA-N 335085 US11040966, Example 5.260::US9732075, Example 5.260::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[2-(4-fluoro-2-methoxy-phenyl)-5-(4-fluoro-phenyl)-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 2870 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335085 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335085&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127053 384987244 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657811 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1nc(sc1-c1ccc(F)cc1)-c1cc(F)ccc1F InChI=1S/C29H22ClF3N4OS/c1-15-20(30)9-11-22-23(15)36-28(34-22)29(2)12-3-13-37(29)27(38)24-25(16-4-6-17(31)7-5-16)39-26(35-24)19-14-18(32)8-10-21(19)33/h4-11,14H,3,12-13H2,1-2H3,(H,34,36)/t29-/m0/s1 QQRIUHPUFYGSTQ-LJAQVGFWSA-N 335086 US11040966, Example 5.261::US9732075, Example 5.261::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[2-(2,5-difluoro-phenyl)-5-(4-fluoro-phenyl)-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335086 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335086&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127325 384987245 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657812 Cc1c(Cl)ccc2[nH]c(nc12)[C@]1(C)CCCN1C(=O)c1nc(sc1-c1ccc(F)cc1)-c1cc(F)ccc1F InChI=1S/C29H22ClF3N4OS/c1-15-20(30)9-11-22-23(15)36-28(34-22)29(2)12-3-13-37(29)27(38)24-25(16-4-6-17(31)7-5-16)39-26(35-24)19-14-18(32)8-10-21(19)33/h4-11,14H,3,12-13H2,1-2H3,(H,34,36)/t29-/m0/s1 QQRIUHPUFYGSTQ-LJAQVGFWSA-N 335086 US11040966, Example 5.261::US9732075, Example 5.261::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[2-(2,5-difluoro-phenyl)-5-(4-fluoro-phenyl)-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 466 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335086 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335086&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127325 384987245 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657813 C[C@]1(CCCN1C(=O)c1cc(Br)ccc1-c1ccccc1)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C26H21BrF3N3O/c1-25(24-31-21-11-8-17(26(28,29)30)14-22(21)32-24)12-5-13-33(25)23(34)20-15-18(27)9-10-19(20)16-6-3-2-4-7-16/h2-4,6-11,14-15H,5,12-13H2,1H3,(H,31,32)/t25-/m0/s1 URIHGJROOMIUNL-VWLOTQADSA-N 335087 (4-Bromo-biphenyl-2-yl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.262::US9732075, Example 5.262 Orexin/Hypocretin receptor type 1 Homo sapiens 113 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335087 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335087&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127439 384987246 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657814 C[C@]1(CCCN1C(=O)c1cc(Br)ccc1-c1ccccc1)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C26H21BrF3N3O/c1-25(24-31-21-11-8-17(26(28,29)30)14-22(21)32-24)12-5-13-33(25)23(34)20-15-18(27)9-10-19(20)16-6-3-2-4-7-16/h2-4,6-11,14-15H,5,12-13H2,1H3,(H,31,32)/t25-/m0/s1 URIHGJROOMIUNL-VWLOTQADSA-N 335087 (4-Bromo-biphenyl-2-yl)-[(S)-2-methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.262::US9732075, Example 5.262 Orexin receptor type 2 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335087 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335087&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127439 384987246 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657815 Cc1cc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(cn1)-n1nccn1 InChI=1S/C22H22ClN7O/c1-13-11-15(18(12-24-13)30-25-8-9-26-30)20(31)29-10-4-7-22(29,3)21-27-17-6-5-16(23)14(2)19(17)28-21/h5-6,8-9,11-12H,4,7,10H2,1-3H3,(H,27,28)/t22-/m0/s1 LCCNOSUOLSDBSU-QFIPXVFZSA-N 335088 US11040966, Example 5.263::US9732075, Example 5.263::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-methyl-5-[1,2,3]triazol-2-yl-pyridin-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 56.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335088 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335088&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127894 384987247 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657816 Cc1cc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(cn1)-n1nccn1 InChI=1S/C22H22ClN7O/c1-13-11-15(18(12-24-13)30-25-8-9-26-30)20(31)29-10-4-7-22(29,3)21-27-17-6-5-16(23)14(2)19(17)28-21/h5-6,8-9,11-12H,4,7,10H2,1-3H3,(H,27,28)/t22-/m0/s1 LCCNOSUOLSDBSU-QFIPXVFZSA-N 335088 US11040966, Example 5.263::US9732075, Example 5.263::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-methyl-5-[1,2,3]triazol-2-yl-pyridin-4-yl)-methanone Orexin receptor type 2 Homo sapiens 304 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335088 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335088&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127894 384987247 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657817 Cc1cc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(cn1)-c1ccccc1 InChI=1S/C26H25ClN4O/c1-16-14-19(20(15-28-16)18-8-5-4-6-9-18)24(32)31-13-7-12-26(31,3)25-29-22-11-10-21(27)17(2)23(22)30-25/h4-6,8-11,14-15H,7,12-13H2,1-3H3,(H,29,30)/t26-/m0/s1 NKZMXRDIESRCEW-SANMLTNESA-N 335089 US11040966, Example 5.264::US9732075, Example 5.264::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-methyl-5-phenyl-pyridin-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 25.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335089 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335089&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127543 384987248 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657818 Cc1cc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c(cn1)-c1ccccc1 InChI=1S/C26H25ClN4O/c1-16-14-19(20(15-28-16)18-8-5-4-6-9-18)24(32)31-13-7-12-26(31,3)25-29-22-11-10-21(27)17(2)23(22)30-25/h4-6,8-11,14-15H,7,12-13H2,1-3H3,(H,29,30)/t26-/m0/s1 NKZMXRDIESRCEW-SANMLTNESA-N 335089 US11040966, Example 5.264::US9732075, Example 5.264::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-methyl-5-phenyl-pyridin-4-yl)-methanone Orexin receptor type 2 Homo sapiens 65.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335089 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335089&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127543 384987248 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657819 C[C@]1(CCCN1C(=O)c1cc(ccc1-c1ccccc1)-c1cccnc1)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C31H25F3N4O/c1-30(29-36-26-13-11-23(31(32,33)34)18-27(26)37-29)14-6-16-38(30)28(39)25-17-21(22-9-5-15-35-19-22)10-12-24(25)20-7-3-2-4-8-20/h2-5,7-13,15,17-19H,6,14,16H2,1H3,(H,36,37)/t30-/m0/s1 MNFSRFCQJOCZES-PMERELPUSA-N 335090 US11040966, Example 5.265::US9732075, Example 5.265::[(S)-2-Methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(4-pyridin-3-yl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335090 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335090&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127411 384987249 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657820 C[C@]1(CCCN1C(=O)c1cc(ccc1-c1ccccc1)-c1cccnc1)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C31H25F3N4O/c1-30(29-36-26-13-11-23(31(32,33)34)18-27(26)37-29)14-6-16-38(30)28(39)25-17-21(22-9-5-15-35-19-22)10-12-24(25)20-7-3-2-4-8-20/h2-5,7-13,15,17-19H,6,14,16H2,1H3,(H,36,37)/t30-/m0/s1 MNFSRFCQJOCZES-PMERELPUSA-N 335090 US11040966, Example 5.265::US9732075, Example 5.265::[(S)-2-Methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(4-pyridin-3-yl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 32.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335090 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335090&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127411 384987249 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657821 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(C)c(Br)cc2[nH]1)-n1nccn1 InChI=1S/C24H25BrN6O/c1-14-6-7-20(31-26-9-10-27-31)17(12-14)22(32)30-11-5-8-24(30,4)23-28-19-13-18(25)15(2)16(3)21(19)29-23/h6-7,9-10,12-13H,5,8,11H2,1-4H3,(H,28,29)/t24-/m0/s1 MCOBUUIPLMSSOE-DEOSSOPVSA-N 335091 US11040966, Example 5.266::US9732075, Example 5.266::[(S)-2-(6-Bromo-4,5-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335091 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335091&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127899 384987250 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657822 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(C)c(Br)cc2[nH]1)-n1nccn1 InChI=1S/C24H25BrN6O/c1-14-6-7-20(31-26-9-10-27-31)17(12-14)22(32)30-11-5-8-24(30,4)23-28-19-13-18(25)15(2)16(3)21(19)29-23/h6-7,9-10,12-13H,5,8,11H2,1-4H3,(H,28,29)/t24-/m0/s1 MCOBUUIPLMSSOE-DEOSSOPVSA-N 335091 US11040966, Example 5.266::US9732075, Example 5.266::[(S)-2-(6-Bromo-4,5-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335091 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335091&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127899 384987250 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657823 Cc1ccc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(C)c(Br)cc3[nH]2)c(c1C)-n1nccn1 InChI=1S/C25H27BrN6O/c1-14-7-8-18(22(15(14)2)32-27-10-11-28-32)23(33)31-12-6-9-25(31,5)24-29-20-13-19(26)16(3)17(4)21(20)30-24/h7-8,10-11,13H,6,9,12H2,1-5H3,(H,29,30)/t25-/m0/s1 RNZYUSAAEUHHQI-VWLOTQADSA-N 335092 US11040966, Example 5.267::US9732075, Example 5.267::[(S)-2-(6-Bromo-4,5-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3,4-dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 12.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335092 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335092&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127487 384987251 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657824 Cc1ccc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(C)c(Br)cc3[nH]2)c(c1C)-n1nccn1 InChI=1S/C25H27BrN6O/c1-14-7-8-18(22(15(14)2)32-27-10-11-28-32)23(33)31-12-6-9-25(31,5)24-29-20-13-19(26)16(3)17(4)21(20)30-24/h7-8,10-11,13H,6,9,12H2,1-5H3,(H,29,30)/t25-/m0/s1 RNZYUSAAEUHHQI-VWLOTQADSA-N 335092 US11040966, Example 5.267::US9732075, Example 5.267::[(S)-2-(6-Bromo-4,5-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3,4-dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 105 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335092 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335092&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127487 384987251 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657825 Cc1c(Br)cc2[nH]c(nc2c1C)[C@]1(C)CCCN1C(=O)c1c(F)cccc1-n1nccn1 InChI=1S/C23H22BrFN6O/c1-13-14(2)20-17(12-15(13)24)28-22(29-20)23(3)8-5-11-30(23)21(32)19-16(25)6-4-7-18(19)31-26-9-10-27-31/h4,6-7,9-10,12H,5,8,11H2,1-3H3,(H,28,29)/t23-/m0/s1 CUSXCIDGKYZTEG-QHCPKHFHSA-N 335093 US11040966, Example 5.268::US9732075, Example 5.268::[(S)-2-(6-Bromo-4,5-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-fluoro-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335093 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335093&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127470 384987252 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657826 Cc1c(Br)cc2[nH]c(nc2c1C)[C@]1(C)CCCN1C(=O)c1c(F)cccc1-n1nccn1 InChI=1S/C23H22BrFN6O/c1-13-14(2)20-17(12-15(13)24)28-22(29-20)23(3)8-5-11-30(23)21(32)19-16(25)6-4-7-18(19)31-26-9-10-27-31/h4,6-7,9-10,12H,5,8,11H2,1-3H3,(H,28,29)/t23-/m0/s1 CUSXCIDGKYZTEG-QHCPKHFHSA-N 335093 US11040966, Example 5.268::US9732075, Example 5.268::[(S)-2-(6-Bromo-4,5-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-fluoro-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335093 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335093&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127470 384987252 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657827 Cc1c(Br)cc2[nH]c(nc2c1C)[C@]1(C)CCCN1C(=O)c1ccccc1-c1ccccc1 InChI=1S/C27H26BrN3O/c1-17-18(2)24-23(16-22(17)28)29-26(30-24)27(3)14-9-15-31(27)25(32)21-13-8-7-12-20(21)19-10-5-4-6-11-19/h4-8,10-13,16H,9,14-15H2,1-3H3,(H,29,30)/t27-/m0/s1 GCEGPCZEVRQING-MHZLTWQESA-N 335094 Biphenyl-2-yl-[(S)-2-(6-bromo-4,5-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone::US11040966, Example 5.269::US9732075, Example 5.269 Orexin/Hypocretin receptor type 1 Homo sapiens 15.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335094 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335094&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127691 384987253 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657828 Cc1c(Br)cc2[nH]c(nc2c1C)[C@]1(C)CCCN1C(=O)c1ccccc1-c1ccccc1 InChI=1S/C27H26BrN3O/c1-17-18(2)24-23(16-22(17)28)29-26(30-24)27(3)14-9-15-31(27)25(32)21-13-8-7-12-20(21)19-10-5-4-6-11-19/h4-8,10-13,16H,9,14-15H2,1-3H3,(H,29,30)/t27-/m0/s1 GCEGPCZEVRQING-MHZLTWQESA-N 335094 Biphenyl-2-yl-[(S)-2-(6-bromo-4,5-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone::US11040966, Example 5.269::US9732075, Example 5.269 Orexin receptor type 2 Homo sapiens 22.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335094 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335094&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127691 384987253 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657829 Cc1ccc(-c2ccccc2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(C)c(Br)cc2[nH]1 InChI=1S/C28H28BrN3O/c1-17-11-12-21(20-9-6-5-7-10-20)22(15-17)26(33)32-14-8-13-28(32,4)27-30-24-16-23(29)18(2)19(3)25(24)31-27/h5-7,9-12,15-16H,8,13-14H2,1-4H3,(H,30,31)/t28-/m0/s1 ZMKWWPVVAQCJOU-NDEPHWFRSA-N 335095 US11040966, Example 5.270::US9732075, Example 5.270::[(S)-2-(6-Bromo-4,5-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335095 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335095&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127742 384987254 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657830 Cc1ccc(-c2ccccc2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(C)c(Br)cc2[nH]1 InChI=1S/C28H28BrN3O/c1-17-11-12-21(20-9-6-5-7-10-20)22(15-17)26(33)32-14-8-13-28(32,4)27-30-24-16-23(29)18(2)19(3)25(24)31-27/h5-7,9-12,15-16H,8,13-14H2,1-4H3,(H,30,31)/t28-/m0/s1 ZMKWWPVVAQCJOU-NDEPHWFRSA-N 335095 US11040966, Example 5.270::US9732075, Example 5.270::[(S)-2-(6-Bromo-4,5-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335095 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335095&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127742 384987254 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657831 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(C)c(Br)cc3[nH]2)c(s1)-c1ccccc1C InChI=1S/C26H27BrN4OS/c1-14-9-6-7-10-18(14)23-22(28-17(4)33-23)24(32)31-12-8-11-26(31,5)25-29-20-13-19(27)15(2)16(3)21(20)30-25/h6-7,9-10,13H,8,11-12H2,1-5H3,(H,29,30)/t26-/m0/s1 LBTMSWKGHBWYAU-SANMLTNESA-N 335096 US11040966, Example 5.271::US9732075, Example 5.271::[(S)-2-(6-Bromo-4,5-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-methyl-5-o-tolyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335096 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335096&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127244 384987255 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657832 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(C)c(Br)cc3[nH]2)c(s1)-c1ccccc1C InChI=1S/C26H27BrN4OS/c1-14-9-6-7-10-18(14)23-22(28-17(4)33-23)24(32)31-12-8-11-26(31,5)25-29-20-13-19(27)15(2)16(3)21(20)30-25/h6-7,9-10,13H,8,11-12H2,1-5H3,(H,29,30)/t26-/m0/s1 LBTMSWKGHBWYAU-SANMLTNESA-N 335096 US11040966, Example 5.271::US9732075, Example 5.271::[(S)-2-(6-Bromo-4,5-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-methyl-5-o-tolyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335096 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335096&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127244 384987255 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657833 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(C)c(Br)cc3[nH]2)c(s1)-c1cccc(Cl)c1Cl InChI=1S/C25H23BrCl2N4OS/c1-12-13(2)20-18(11-16(12)26)30-24(31-20)25(4)9-6-10-32(25)23(33)21-22(34-14(3)29-21)15-7-5-8-17(27)19(15)28/h5,7-8,11H,6,9-10H2,1-4H3,(H,30,31)/t25-/m0/s1 LPQIEPKNGXGMFS-VWLOTQADSA-N 335097 US11040966, Example 5.272::US9732075, Example 5.272::[(S)-2-(6-Bromo-4,5-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(2,3-dichloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335097 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335097&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127115 384987256 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657834 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(C)c(Br)cc3[nH]2)c(s1)-c1cccc(Cl)c1Cl InChI=1S/C25H23BrCl2N4OS/c1-12-13(2)20-18(11-16(12)26)30-24(31-20)25(4)9-6-10-32(25)23(33)21-22(34-14(3)29-21)15-7-5-8-17(27)19(15)28/h5,7-8,11H,6,9-10H2,1-4H3,(H,30,31)/t25-/m0/s1 LPQIEPKNGXGMFS-VWLOTQADSA-N 335097 US11040966, Example 5.272::US9732075, Example 5.272::[(S)-2-(6-Bromo-4,5-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(2,3-dichloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 12.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335097 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335097&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127115 384987256 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657835 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(C)c(Br)cc3[nH]2)c(s1)-c1ccc(C)c(C)c1 InChI=1S/C27H29BrN4OS/c1-14-8-9-19(12-15(14)2)24-23(29-18(5)34-24)25(33)32-11-7-10-27(32,6)26-30-21-13-20(28)16(3)17(4)22(21)31-26/h8-9,12-13H,7,10-11H2,1-6H3,(H,30,31)/t27-/m0/s1 MEEJUXPSVMACDZ-MHZLTWQESA-N 335098 US11040966, Example 5.273::US9732075, Example 5.273::[(S)-2-(6-Bromo-4,5-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(3,4-dimethyl-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335098 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335098&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127130 384987257 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657836 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(C)c(Br)cc3[nH]2)c(s1)-c1ccc(C)c(C)c1 InChI=1S/C27H29BrN4OS/c1-14-8-9-19(12-15(14)2)24-23(29-18(5)34-24)25(33)32-11-7-10-27(32,6)26-30-21-13-20(28)16(3)17(4)22(21)31-26/h8-9,12-13H,7,10-11H2,1-6H3,(H,30,31)/t27-/m0/s1 MEEJUXPSVMACDZ-MHZLTWQESA-N 335098 US11040966, Example 5.273::US9732075, Example 5.273::[(S)-2-(6-Bromo-4,5-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(3,4-dimethyl-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 12.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335098 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335098&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127130 384987257 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657837 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(C)c(Br)cc3[nH]2)c(s1)-c1cc(F)cc(F)c1 InChI=1S/C25H23BrF2N4OS/c1-12-13(2)20-19(11-18(12)26)30-24(31-20)25(4)6-5-7-32(25)23(33)21-22(34-14(3)29-21)15-8-16(27)10-17(28)9-15/h8-11H,5-7H2,1-4H3,(H,30,31)/t25-/m0/s1 LOYYUSOWAAROMT-VWLOTQADSA-N 335099 US11040966, Example 5.274::US9732075, Example 5.274::[(S)-2-(6-Bromo-4,5-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(3,5-difluoro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335099 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335099&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127399 384987258 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657838 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(C)c(Br)cc3[nH]2)c(s1)-c1cc(F)cc(F)c1 InChI=1S/C25H23BrF2N4OS/c1-12-13(2)20-19(11-18(12)26)30-24(31-20)25(4)6-5-7-32(25)23(33)21-22(34-14(3)29-21)15-8-16(27)10-17(28)9-15/h8-11H,5-7H2,1-4H3,(H,30,31)/t25-/m0/s1 LOYYUSOWAAROMT-VWLOTQADSA-N 335099 US11040966, Example 5.274::US9732075, Example 5.274::[(S)-2-(6-Bromo-4,5-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(3,5-difluoro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335099 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335099&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127399 384987258 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657839 COc1cccc(c1)-c1sc(C)nc1C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(C)c(Br)cc2[nH]1 InChI=1S/C26H27BrN4O2S/c1-14-15(2)21-20(13-19(14)27)29-25(30-21)26(4)10-7-11-31(26)24(32)22-23(34-16(3)28-22)17-8-6-9-18(12-17)33-5/h6,8-9,12-13H,7,10-11H2,1-5H3,(H,29,30)/t26-/m0/s1 IFJJSOARPDDDJB-SANMLTNESA-N 335100 US11040966, Example 5.275::US9732075, Example 5.275::[(S)-2-(6-Bromo-4,5-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(3-methoxy-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335100 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335100&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127021 384987259 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657840 COc1cccc(c1)-c1sc(C)nc1C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(C)c(Br)cc2[nH]1 InChI=1S/C26H27BrN4O2S/c1-14-15(2)21-20(13-19(14)27)29-25(30-21)26(4)10-7-11-31(26)24(32)22-23(34-16(3)28-22)17-8-6-9-18(12-17)33-5/h6,8-9,12-13H,7,10-11H2,1-5H3,(H,29,30)/t26-/m0/s1 IFJJSOARPDDDJB-SANMLTNESA-N 335100 US11040966, Example 5.275::US9732075, Example 5.275::[(S)-2-(6-Bromo-4,5-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(3-methoxy-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335100 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335100&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127021 384987259 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657841 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(C)c(Br)cc3[nH]2)c(s1)-c1ccc(F)cc1 InChI=1S/C25H24BrFN4OS/c1-13-14(2)20-19(12-18(13)26)29-24(30-20)25(4)10-5-11-31(25)23(32)21-22(33-15(3)28-21)16-6-8-17(27)9-7-16/h6-9,12H,5,10-11H2,1-4H3,(H,29,30)/t25-/m0/s1 WOMLJIMOFFDWMO-VWLOTQADSA-N 335101 US11040966, Example 5.276::US9732075, Example 5.276::[(S)-2-(6-Bromo-4,5-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335101 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335101&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127362 384987260 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657842 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(C)c(Br)cc3[nH]2)c(s1)-c1ccc(F)cc1 InChI=1S/C25H24BrFN4OS/c1-13-14(2)20-19(12-18(13)26)29-24(30-20)25(4)10-5-11-31(25)23(32)21-22(33-15(3)28-21)16-6-8-17(27)9-7-16/h6-9,12H,5,10-11H2,1-4H3,(H,29,30)/t25-/m0/s1 WOMLJIMOFFDWMO-VWLOTQADSA-N 335101 US11040966, Example 5.276::US9732075, Example 5.276::[(S)-2-(6-Bromo-4,5-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335101 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335101&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127362 384987260 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657843 Cc1ccc(-c2ncccn2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(Br)cc(C)c2[nH]1 InChI=1S/C25H24BrN5O/c1-15-6-7-18(22-27-9-5-10-28-22)19(12-15)23(32)31-11-4-8-25(31,3)24-29-20-14-17(26)13-16(2)21(20)30-24/h5-7,9-10,12-14H,4,8,11H2,1-3H3,(H,29,30)/t25-/m0/s1 CXFXCNXDHHKIKS-VWLOTQADSA-N 335102 US11040966, Example 5.277::US9732075, Example 5.277::US9914721, Ex. 11::[(S)-2-(5-Bromo-7-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335102 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335102&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127525 384987261 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657844 Cc1ccc(-c2ncccn2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(Br)cc(C)c2[nH]1 InChI=1S/C25H24BrN5O/c1-15-6-7-18(22-27-9-5-10-28-22)19(12-15)23(32)31-11-4-8-25(31,3)24-29-20-14-17(26)13-16(2)21(20)30-24/h5-7,9-10,12-14H,4,8,11H2,1-3H3,(H,29,30)/t25-/m0/s1 CXFXCNXDHHKIKS-VWLOTQADSA-N 335102 US11040966, Example 5.277::US9732075, Example 5.277::US9914721, Ex. 11::[(S)-2-(5-Bromo-7-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 21.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335102 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335102&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127525 384987261 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657845 Cc1ccc(-c2ncccn2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cccc(C)c2[nH]1 InChI=1S/C25H25N5O/c1-16-9-10-18(22-26-12-6-13-27-22)19(15-16)23(31)30-14-5-11-25(30,3)24-28-20-8-4-7-17(2)21(20)29-24/h4,6-10,12-13,15H,5,11,14H2,1-3H3,(H,28,29)/t25-/m0/s1 JVXZGXZUTRSGGA-VWLOTQADSA-N 335103 US11040966, Example 5.278::US9732075, Example 5.278::[(S)-2-Methyl-2-(7-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 22.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335103 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335103&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127134 384987262 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657846 Cc1ccc(-c2ncccn2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cccc(C)c2[nH]1 InChI=1S/C25H25N5O/c1-16-9-10-18(22-26-12-6-13-27-22)19(15-16)23(31)30-14-5-11-25(30,3)24-28-20-8-4-7-17(2)21(20)29-24/h4,6-10,12-13,15H,5,11,14H2,1-3H3,(H,28,29)/t25-/m0/s1 JVXZGXZUTRSGGA-VWLOTQADSA-N 335103 US11040966, Example 5.278::US9732075, Example 5.278::[(S)-2-Methyl-2-(7-methyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 31.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335103 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335103&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127134 384987262 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657847 Cc1ccc(-c2ncccn2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C25H21ClF3N5O/c1-14-5-6-15(21-30-8-4-9-31-21)16(11-14)22(35)34-10-3-7-24(34,2)23-32-19-12-17(25(27,28)29)18(26)13-20(19)33-23/h4-6,8-9,11-13H,3,7,10H2,1-2H3,(H,32,33)/t24-/m0/s1 WVPBMKQMORLKAZ-DEOSSOPVSA-N 335104 US11040966, Example 5.279::US9732075, Example 5.279::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335104 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335104&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127582 384987263 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657848 Cc1ccc(-c2ncccn2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2[nH]1)C(F)(F)F InChI=1S/C25H21ClF3N5O/c1-14-5-6-15(21-30-8-4-9-31-21)16(11-14)22(35)34-10-3-7-24(34,2)23-32-19-12-17(25(27,28)29)18(26)13-20(19)33-23/h4-6,8-9,11-13H,3,7,10H2,1-2H3,(H,32,33)/t24-/m0/s1 WVPBMKQMORLKAZ-DEOSSOPVSA-N 335104 US11040966, Example 5.279::US9732075, Example 5.279::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335104 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335104&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127582 384987263 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657849 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-c1ncccn1 InChI=1S/C26H27N5O3/c1-16-7-8-17(23-27-10-6-11-28-23)18(13-16)24(32)31-12-5-9-26(31,2)25-29-19-14-21(33-3)22(34-4)15-20(19)30-25/h6-8,10-11,13-15H,5,9,12H2,1-4H3,(H,29,30)/t26-/m0/s1 DEHDONPZVLMUGY-SANMLTNESA-N 335105 US11040966, Example 5.280::US9732075, Example 5.280::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 36.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335105 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335105&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127052 384987264 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657850 COc1cc2nc([nH]c2cc1OC)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-c1ncccn1 InChI=1S/C26H27N5O3/c1-16-7-8-17(23-27-10-6-11-28-23)18(13-16)24(32)31-12-5-9-26(31,2)25-29-19-14-21(33-3)22(34-4)15-20(19)30-25/h6-8,10-11,13-15H,5,9,12H2,1-4H3,(H,29,30)/t26-/m0/s1 DEHDONPZVLMUGY-SANMLTNESA-N 335105 US11040966, Example 5.280::US9732075, Example 5.280::[(S)-2-(5,6-Dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 16.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335105 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335105&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127052 384987264 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657851 Cc1ccc(-c2ncccn2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(OC(F)(F)F)ccc2[nH]1 InChI=1S/C25H22F3N5O2/c1-15-5-7-17(21-29-10-4-11-30-21)18(13-15)22(34)33-12-3-9-24(33,2)23-31-19-8-6-16(14-20(19)32-23)35-25(26,27)28/h4-8,10-11,13-14H,3,9,12H2,1-2H3,(H,31,32)/t24-/m0/s1 OISXHCHFJPIZQE-DEOSSOPVSA-N 335106 (5-Methyl-2-pyrimidin-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.281::US9732075, Example 5.281 Orexin/Hypocretin receptor type 1 Homo sapiens 34.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335106 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335106&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127987 384987265 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657852 Cc1ccc(-c2ncccn2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(OC(F)(F)F)ccc2[nH]1 InChI=1S/C25H22F3N5O2/c1-15-5-7-17(21-29-10-4-11-30-21)18(13-15)22(34)33-12-3-9-24(33,2)23-31-19-8-6-16(14-20(19)32-23)35-25(26,27)28/h4-8,10-11,13-14H,3,9,12H2,1-2H3,(H,31,32)/t24-/m0/s1 OISXHCHFJPIZQE-DEOSSOPVSA-N 335106 (5-Methyl-2-pyrimidin-2-yl-phenyl)-[(S)-2-methyl-2-(5-trifluoromethoxy-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 5.281::US9732075, Example 5.281 Orexin receptor type 2 Homo sapiens 380 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335106 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335106&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127987 384987265 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657853 Cc1ccc(-c2ncccn2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(F)c(Br)cc2[nH]1 InChI=1S/C24H21BrFN5O/c1-14-5-6-15(21-27-8-4-9-28-21)16(11-14)22(32)31-10-3-7-24(31,2)23-29-19-12-17(25)18(26)13-20(19)30-23/h4-6,8-9,11-13H,3,7,10H2,1-2H3,(H,29,30)/t24-/m0/s1 GAKMDUDMVGELOF-DEOSSOPVSA-N 335107 US11040966, Example 5.282::US9732075, Example 5.282::[(S)-2-(6-Bromo-5-fluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 47.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335107 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335107&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127974 384987266 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657854 Cc1ccc(-c2ncccn2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(F)c(Br)cc2[nH]1 InChI=1S/C24H21BrFN5O/c1-14-5-6-15(21-27-8-4-9-28-21)16(11-14)22(32)31-10-3-7-24(31,2)23-29-19-12-17(25)18(26)13-20(19)30-23/h4-6,8-9,11-13H,3,7,10H2,1-2H3,(H,29,30)/t24-/m0/s1 GAKMDUDMVGELOF-DEOSSOPVSA-N 335107 US11040966, Example 5.282::US9732075, Example 5.282::[(S)-2-(6-Bromo-5-fluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 97.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335107 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335107&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127974 384987266 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657855 Cc1ccc(-c2ncccn2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2ccc(F)c(F)c2[nH]1 InChI=1S/C24H21F2N5O/c1-14-5-6-15(21-27-10-4-11-28-21)16(13-14)22(32)31-12-3-9-24(31,2)23-29-18-8-7-17(25)19(26)20(18)30-23/h4-8,10-11,13H,3,9,12H2,1-2H3,(H,29,30)/t24-/m0/s1 PBUNGIHOGWABQE-DEOSSOPVSA-N 335108 US11040966, Example 5.283::US9732075, Example 5.283::[(S)-2-(6,7-Difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 87.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335108 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335108&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128146 384987267 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657856 Cc1ccc(-c2ncccn2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2ccc(F)c(F)c2[nH]1 InChI=1S/C24H21F2N5O/c1-14-5-6-15(21-27-10-4-11-28-21)16(13-14)22(32)31-12-3-9-24(31,2)23-29-18-8-7-17(25)19(26)20(18)30-23/h4-8,10-11,13H,3,9,12H2,1-2H3,(H,29,30)/t24-/m0/s1 PBUNGIHOGWABQE-DEOSSOPVSA-N 335108 US11040966, Example 5.283::US9732075, Example 5.283::[(S)-2-(6,7-Difluoro-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 397 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335108 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335108&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128146 384987267 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657857 Cc1ccc(-c2ncccn2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1 InChI=1S/C26H27N5O/c1-16-7-8-19(23-27-10-6-11-28-23)20(13-16)24(32)31-12-5-9-26(31,4)25-29-21-14-17(2)18(3)15-22(21)30-25/h6-8,10-11,13-15H,5,9,12H2,1-4H3,(H,29,30)/t26-/m0/s1 IVUUKPPBLBVNSQ-SANMLTNESA-N 335109 US11040966, Example 5.284::US9732075, Example 5.284::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 10.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335109 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335109&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127752 384987268 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657858 Cc1ccc(-c2ncccn2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2[nH]1 InChI=1S/C26H27N5O/c1-16-7-8-19(23-27-10-6-11-28-23)20(13-16)24(32)31-12-5-9-26(31,4)25-29-21-14-17(2)18(3)15-22(21)30-25/h6-8,10-11,13-15H,5,9,12H2,1-4H3,(H,29,30)/t26-/m0/s1 IVUUKPPBLBVNSQ-SANMLTNESA-N 335109 US11040966, Example 5.284::US9732075, Example 5.284::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 18.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335109 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335109&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127752 384987268 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657859 C[C@]1(CCCN1C(=O)c1nc(sc1-c1ccc(F)cc1)-c1ccccc1)c1nc2cc(Cl)c(cc2[nH]1)C(F)(F)F InChI=1S/C29H21ClF4N4OS/c1-28(27-35-21-14-19(29(32,33)34)20(30)15-22(21)36-27)12-5-13-38(28)26(39)23-24(16-8-10-18(31)11-9-16)40-25(37-23)17-6-3-2-4-7-17/h2-4,6-11,14-15H,5,12-13H2,1H3,(H,35,36)/t28-/m0/s1 JRWAMDQNFJNXKK-NDEPHWFRSA-N 335110 US11040966, Example 5.285::US9732075, Example 5.285::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-phenyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 32.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335110 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335110&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127981 384987269 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657860 C[C@]1(CCCN1C(=O)c1nc(sc1-c1ccc(F)cc1)-c1ccccc1)c1nc2cc(Cl)c(cc2[nH]1)C(F)(F)F InChI=1S/C29H21ClF4N4OS/c1-28(27-35-21-14-19(29(32,33)34)20(30)15-22(21)36-27)12-5-13-38(28)26(39)23-24(16-8-10-18(31)11-9-16)40-25(37-23)17-6-3-2-4-7-17/h2-4,6-11,14-15H,5,12-13H2,1H3,(H,35,36)/t28-/m0/s1 JRWAMDQNFJNXKK-NDEPHWFRSA-N 335110 US11040966, Example 5.285::US9732075, Example 5.285::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-phenyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 452 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335110 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335110&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127981 384987269 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657861 Cc1ccccc1-c1nc(C(=O)N2CCC[C@@]2(C)c2nc3cc(Cl)c(cc3[nH]2)C(F)(F)F)c(s1)-c1ccc(F)cc1 InChI=1S/C30H23ClF4N4OS/c1-16-6-3-4-7-19(16)26-38-24(25(41-26)17-8-10-18(32)11-9-17)27(40)39-13-5-12-29(39,2)28-36-22-14-20(30(33,34)35)21(31)15-23(22)37-28/h3-4,6-11,14-15H,5,12-13H2,1-2H3,(H,36,37)/t29-/m0/s1 BJJGSYQHHKESLX-LJAQVGFWSA-N 335111 US11040966, Example 5.286::US9732075, Example 5.286::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-o-tolyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 40.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335111 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335111&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128113 384987270 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657862 Cc1ccccc1-c1nc(C(=O)N2CCC[C@@]2(C)c2nc3cc(Cl)c(cc3[nH]2)C(F)(F)F)c(s1)-c1ccc(F)cc1 InChI=1S/C30H23ClF4N4OS/c1-16-6-3-4-7-19(16)26-38-24(25(41-26)17-8-10-18(32)11-9-17)27(40)39-13-5-12-29(39,2)28-36-22-14-20(30(33,34)35)21(31)15-23(22)37-28/h3-4,6-11,14-15H,5,12-13H2,1-2H3,(H,36,37)/t29-/m0/s1 BJJGSYQHHKESLX-LJAQVGFWSA-N 335111 US11040966, Example 5.286::US9732075, Example 5.286::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-o-tolyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 4592 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335111 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335111&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128113 384987270 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657863 Cc1cccc(c1)-c1nc(C(=O)N2CCC[C@@]2(C)c2nc3cc(Cl)c(cc3[nH]2)C(F)(F)F)c(s1)-c1ccc(F)cc1 InChI=1S/C30H23ClF4N4OS/c1-16-5-3-6-18(13-16)26-38-24(25(41-26)17-7-9-19(32)10-8-17)27(40)39-12-4-11-29(39,2)28-36-22-14-20(30(33,34)35)21(31)15-23(22)37-28/h3,5-10,13-15H,4,11-12H2,1-2H3,(H,36,37)/t29-/m0/s1 ZSCJAMPVEPJYCO-LJAQVGFWSA-N 335112 US11040966, Example 5.287::US9732075, Example 5.287::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-m-tolyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 53.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335112 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335112&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128114 384987271 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657864 Cc1cccc(c1)-c1nc(C(=O)N2CCC[C@@]2(C)c2nc3cc(Cl)c(cc3[nH]2)C(F)(F)F)c(s1)-c1ccc(F)cc1 InChI=1S/C30H23ClF4N4OS/c1-16-5-3-6-18(13-16)26-38-24(25(41-26)17-7-9-19(32)10-8-17)27(40)39-12-4-11-29(39,2)28-36-22-14-20(30(33,34)35)21(31)15-23(22)37-28/h3,5-10,13-15H,4,11-12H2,1-2H3,(H,36,37)/t29-/m0/s1 ZSCJAMPVEPJYCO-LJAQVGFWSA-N 335112 US11040966, Example 5.287::US9732075, Example 5.287::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-m-tolyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 1165 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335112 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335112&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128114 384987271 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657865 Cc1ccc(cc1)-c1nc(C(=O)N2CCC[C@@]2(C)c2nc3cc(Cl)c(cc3[nH]2)C(F)(F)F)c(s1)-c1ccc(F)cc1 InChI=1S/C30H23ClF4N4OS/c1-16-4-6-18(7-5-16)26-38-24(25(41-26)17-8-10-19(32)11-9-17)27(40)39-13-3-12-29(39,2)28-36-22-14-20(30(33,34)35)21(31)15-23(22)37-28/h4-11,14-15H,3,12-13H2,1-2H3,(H,36,37)/t29-/m0/s1 NDZZQHWDAOMKTE-LJAQVGFWSA-N 335113 US11040966, Example 5.288::US9732075, Example 5.288::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-p-tolyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 38.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335113 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335113&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127375 384987272 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657866 Cc1ccc(cc1)-c1nc(C(=O)N2CCC[C@@]2(C)c2nc3cc(Cl)c(cc3[nH]2)C(F)(F)F)c(s1)-c1ccc(F)cc1 InChI=1S/C30H23ClF4N4OS/c1-16-4-6-18(7-5-16)26-38-24(25(41-26)17-8-10-19(32)11-9-17)27(40)39-13-3-12-29(39,2)28-36-22-14-20(30(33,34)35)21(31)15-23(22)37-28/h4-11,14-15H,3,12-13H2,1-2H3,(H,36,37)/t29-/m0/s1 NDZZQHWDAOMKTE-LJAQVGFWSA-N 335113 US11040966, Example 5.288::US9732075, Example 5.288::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-p-tolyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 1340 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335113 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335113&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127375 384987272 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657867 C[C@]1(CCCN1C(=O)c1nc(sc1-c1ccc(F)cc1)-c1ccccc1F)c1nc2cc(Cl)c(cc2[nH]1)C(F)(F)F InChI=1S/C29H20ClF5N4OS/c1-28(27-36-21-13-18(29(33,34)35)19(30)14-22(21)37-27)11-4-12-39(28)26(40)23-24(15-7-9-16(31)10-8-15)41-25(38-23)17-5-2-3-6-20(17)32/h2-3,5-10,13-14H,4,11-12H2,1H3,(H,36,37)/t28-/m0/s1 PIWZVORIQCRZPS-NDEPHWFRSA-N 335114 US11040966, Example 5.289::US9732075, Example 5.289::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-(2-fluoro-phenyl)-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 38.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335114 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335114&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127625 384987273 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657868 C[C@]1(CCCN1C(=O)c1nc(sc1-c1ccc(F)cc1)-c1ccccc1F)c1nc2cc(Cl)c(cc2[nH]1)C(F)(F)F InChI=1S/C29H20ClF5N4OS/c1-28(27-36-21-13-18(29(33,34)35)19(30)14-22(21)37-27)11-4-12-39(28)26(40)23-24(15-7-9-16(31)10-8-15)41-25(38-23)17-5-2-3-6-20(17)32/h2-3,5-10,13-14H,4,11-12H2,1H3,(H,36,37)/t28-/m0/s1 PIWZVORIQCRZPS-NDEPHWFRSA-N 335114 US11040966, Example 5.289::US9732075, Example 5.289::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-(2-fluoro-phenyl)-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 532 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335114 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335114&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127625 384987273 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657869 C[C@]1(CCCN1C(=O)c1nc(sc1-c1ccc(F)cc1)-c1cccc(F)c1)c1nc2cc(Cl)c(cc2[nH]1)C(F)(F)F InChI=1S/C29H20ClF5N4OS/c1-28(27-36-21-13-19(29(33,34)35)20(30)14-22(21)37-27)10-3-11-39(28)26(40)23-24(15-6-8-17(31)9-7-15)41-25(38-23)16-4-2-5-18(32)12-16/h2,4-9,12-14H,3,10-11H2,1H3,(H,36,37)/t28-/m0/s1 TWFIAPLBNCNWBR-NDEPHWFRSA-N 335115 US11040966, Example 5.290::US9732075, Example 5.290::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-(3-fluoro-phenyl)-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 33.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335115 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335115&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128000 384987274 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657870 C[C@]1(CCCN1C(=O)c1nc(sc1-c1ccc(F)cc1)-c1cccc(F)c1)c1nc2cc(Cl)c(cc2[nH]1)C(F)(F)F InChI=1S/C29H20ClF5N4OS/c1-28(27-36-21-13-19(29(33,34)35)20(30)14-22(21)37-27)10-3-11-39(28)26(40)23-24(15-6-8-17(31)9-7-15)41-25(38-23)16-4-2-5-18(32)12-16/h2,4-9,12-14H,3,10-11H2,1H3,(H,36,37)/t28-/m0/s1 TWFIAPLBNCNWBR-NDEPHWFRSA-N 335115 US11040966, Example 5.290::US9732075, Example 5.290::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-(3-fluoro-phenyl)-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 2140 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335115 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335115&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128000 384987274 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657871 C[C@]1(CCCN1C(=O)c1nc(sc1-c1ccc(F)cc1)-c1ccc(F)cc1)c1nc2cc(Cl)c(cc2[nH]1)C(F)(F)F InChI=1S/C29H20ClF5N4OS/c1-28(27-36-21-13-19(29(33,34)35)20(30)14-22(21)37-27)11-2-12-39(28)26(40)23-24(15-3-7-17(31)8-4-15)41-25(38-23)16-5-9-18(32)10-6-16/h3-10,13-14H,2,11-12H2,1H3,(H,36,37)/t28-/m0/s1 BEBSJFMBUMEWMA-NDEPHWFRSA-N 335116 US11040966, Example 5.291::US9732075, Example 5.291::[2,5-Bis-(4-fluoro-phenyl)-thiazol-4-yl]-[(S)-2-(5-chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 48.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335116 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335116&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127354 384987275 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657872 C[C@]1(CCCN1C(=O)c1nc(sc1-c1ccc(F)cc1)-c1ccc(F)cc1)c1nc2cc(Cl)c(cc2[nH]1)C(F)(F)F InChI=1S/C29H20ClF5N4OS/c1-28(27-36-21-13-19(29(33,34)35)20(30)14-22(21)37-27)11-2-12-39(28)26(40)23-24(15-3-7-17(31)8-4-15)41-25(38-23)16-5-9-18(32)10-6-16/h3-10,13-14H,2,11-12H2,1H3,(H,36,37)/t28-/m0/s1 BEBSJFMBUMEWMA-NDEPHWFRSA-N 335116 US11040966, Example 5.291::US9732075, Example 5.291::[2,5-Bis-(4-fluoro-phenyl)-thiazol-4-yl]-[(S)-2-(5-chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 347 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335116 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335116&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127354 384987275 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657873 COc1cccc(c1)-c1nc(C(=O)N2CCC[C@@]2(C)c2nc3cc(Cl)c(cc3[nH]2)C(F)(F)F)c(s1)-c1ccc(F)cc1 InChI=1S/C30H23ClF4N4O2S/c1-29(28-36-22-14-20(30(33,34)35)21(31)15-23(22)37-28)11-4-12-39(29)27(40)24-25(16-7-9-18(32)10-8-16)42-26(38-24)17-5-3-6-19(13-17)41-2/h3,5-10,13-15H,4,11-12H2,1-2H3,(H,36,37)/t29-/m0/s1 KXZFGVLRGRWKAF-LJAQVGFWSA-N 335117 US11040966, Example 5.292::US9732075, Example 5.292::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-(3-methoxy-phenyl)-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 34.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335117 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335117&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127716 384987276 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657874 COc1cccc(c1)-c1nc(C(=O)N2CCC[C@@]2(C)c2nc3cc(Cl)c(cc3[nH]2)C(F)(F)F)c(s1)-c1ccc(F)cc1 InChI=1S/C30H23ClF4N4O2S/c1-29(28-36-22-14-20(30(33,34)35)21(31)15-23(22)37-28)11-4-12-39(29)27(40)24-25(16-7-9-18(32)10-8-16)42-26(38-24)17-5-3-6-19(13-17)41-2/h3,5-10,13-15H,4,11-12H2,1-2H3,(H,36,37)/t29-/m0/s1 KXZFGVLRGRWKAF-LJAQVGFWSA-N 335117 US11040966, Example 5.292::US9732075, Example 5.292::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-(3-methoxy-phenyl)-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 671 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335117 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335117&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127716 384987276 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657875 COc1ccc(cc1)-c1nc(C(=O)N2CCC[C@@]2(C)c2nc3cc(Cl)c(cc3[nH]2)C(F)(F)F)c(s1)-c1ccc(F)cc1 InChI=1S/C30H23ClF4N4O2S/c1-29(28-36-22-14-20(30(33,34)35)21(31)15-23(22)37-28)12-3-13-39(29)27(40)24-25(16-4-8-18(32)9-5-16)42-26(38-24)17-6-10-19(41-2)11-7-17/h4-11,14-15H,3,12-13H2,1-2H3,(H,36,37)/t29-/m0/s1 FHEQBGJHVHCPBT-LJAQVGFWSA-N 335118 US11040966, Example 5.293::US9732075, Example 5.293::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-(4-methoxy-phenyl)-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 77.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335118 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335118&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127858 384987277 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657876 COc1ccc(cc1)-c1nc(C(=O)N2CCC[C@@]2(C)c2nc3cc(Cl)c(cc3[nH]2)C(F)(F)F)c(s1)-c1ccc(F)cc1 InChI=1S/C30H23ClF4N4O2S/c1-29(28-36-22-14-20(30(33,34)35)21(31)15-23(22)37-28)12-3-13-39(29)27(40)24-25(16-4-8-18(32)9-5-16)42-26(38-24)17-6-10-19(41-2)11-7-17/h4-11,14-15H,3,12-13H2,1-2H3,(H,36,37)/t29-/m0/s1 FHEQBGJHVHCPBT-LJAQVGFWSA-N 335118 US11040966, Example 5.293::US9732075, Example 5.293::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-(4-methoxy-phenyl)-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 4040 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335118 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335118&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127858 384987277 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657877 C[C@]1(CCCN1C(=O)c1nc(sc1-c1ccc(F)cc1)-c1ccccc1F)c1nc2ccc(cc2[nH]1)C(F)(F)F InChI=1S/C29H21F5N4OS/c1-28(27-35-21-12-9-17(29(32,33)34)15-22(21)36-27)13-4-14-38(28)26(39)23-24(16-7-10-18(30)11-8-16)40-25(37-23)19-5-2-3-6-20(19)31/h2-3,5-12,15H,4,13-14H2,1H3,(H,35,36)/t28-/m0/s1 COACNYGCJPSHOE-NDEPHWFRSA-N 335119 US11040966, Example 5.294::US9732075, Example 5.294::[5-(4-Fluoro-phenyl)-2-(2-fluoro-phenyl)-thiazol-4-yl]-[(S)-2-methyl-2-(6-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 39.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335119 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335119&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128157 384987278 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657878 C[C@]1(CCCN1C(=O)c1nc(sc1-c1ccc(F)cc1)-c1ccccc1F)c1nc2ccc(cc2[nH]1)C(F)(F)F InChI=1S/C29H21F5N4OS/c1-28(27-35-21-12-9-17(29(32,33)34)15-22(21)36-27)13-4-14-38(28)26(39)23-24(16-7-10-18(30)11-8-16)40-25(37-23)19-5-2-3-6-20(19)31/h2-3,5-12,15H,4,13-14H2,1H3,(H,35,36)/t28-/m0/s1 COACNYGCJPSHOE-NDEPHWFRSA-N 335119 US11040966, Example 5.294::US9732075, Example 5.294::[5-(4-Fluoro-phenyl)-2-(2-fluoro-phenyl)-thiazol-4-yl]-[(S)-2-methyl-2-(6-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 714 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335119 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335119&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128157 384987278 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657879 C[C@]1(CCCN1C(=O)c1cc(ccc1-n1nccn1)-c1cccc(c1)C#N)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C29H22F3N7O/c1-28(27-36-23-8-7-21(29(30,31)32)16-24(23)37-27)10-3-13-38(28)26(40)22-15-20(19-5-2-4-18(14-19)17-33)6-9-25(22)39-34-11-12-35-39/h2,4-9,11-12,14-16H,3,10,13H2,1H3,(H,36,37)/t28-/m0/s1 NIPSJYKLXTWOPT-NDEPHWFRSA-N 335120 3'-[(S)-2-Methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidine-1-carbonyl]-4'-[1,2,3]triazol-2-yl-biphenyl-3-carbonitrile::US11040966, Example 5.295::US9732075, Example 5.295 Orexin/Hypocretin receptor type 1 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335120 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335120&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127708 384987279 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657880 C[C@]1(CCCN1C(=O)c1cc(ccc1-n1nccn1)-c1cccc(c1)C#N)c1nc2cc(ccc2[nH]1)C(F)(F)F InChI=1S/C29H22F3N7O/c1-28(27-36-23-8-7-21(29(30,31)32)16-24(23)37-27)10-3-13-38(28)26(40)22-15-20(19-5-2-4-18(14-19)17-33)6-9-25(22)39-34-11-12-35-39/h2,4-9,11-12,14-16H,3,10,13H2,1H3,(H,36,37)/t28-/m0/s1 NIPSJYKLXTWOPT-NDEPHWFRSA-N 335120 3'-[(S)-2-Methyl-2-(5-trifluoromethyl-1H-benzoimidazol-2-yl)-pyrrolidine-1-carbonyl]-4'-[1,2,3]triazol-2-yl-biphenyl-3-carbonitrile::US11040966, Example 5.295::US9732075, Example 5.295 Orexin receptor type 2 Homo sapiens 254 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335120 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335120&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127708 384987279 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657881 COc1cccc(c1)-c1ccc(OC)c(F)c1C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C28H27ClFN3O3/c1-16-20(29)10-11-21-25(16)32-27(31-21)28(2)13-6-14-33(28)26(34)23-19(9-12-22(36-4)24(23)30)17-7-5-8-18(15-17)35-3/h5,7-12,15H,6,13-14H2,1-4H3,(H,31,32)/t28-/m0/s1 WVEINRJKPLRHFY-NDEPHWFRSA-N 335121 US11040966, Example 5.296::US9732075, Example 5.296::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3-fluoro-4,3'-dimethoxy-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 25.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335121 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335121&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127015 384987280 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657882 COc1cccc(c1)-c1ccc(OC)c(F)c1C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C28H27ClFN3O3/c1-16-20(29)10-11-21-25(16)32-27(31-21)28(2)13-6-14-33(28)26(34)23-19(9-12-22(36-4)24(23)30)17-7-5-8-18(15-17)35-3/h5,7-12,15H,6,13-14H2,1-4H3,(H,31,32)/t28-/m0/s1 WVEINRJKPLRHFY-NDEPHWFRSA-N 335121 US11040966, Example 5.296::US9732075, Example 5.296::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3-fluoro-4,3'-dimethoxy-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 31.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335121 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335121&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127015 384987280 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657883 COc1ccc(cc1)-c1ccc(OC)c(F)c1C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C28H27ClFN3O3/c1-16-20(29)11-12-21-25(16)32-27(31-21)28(2)14-5-15-33(28)26(34)23-19(10-13-22(36-4)24(23)30)17-6-8-18(35-3)9-7-17/h6-13H,5,14-15H2,1-4H3,(H,31,32)/t28-/m0/s1 LDASZAPWQDPTSQ-NDEPHWFRSA-N 335122 US11040966, Example 5.297::US9732075, Example 5.297::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3-fluoro-4,4'-dimethoxy-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 41.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335122 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335122&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128179 384987281 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657884 COc1ccc(cc1)-c1ccc(OC)c(F)c1C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C28H27ClFN3O3/c1-16-20(29)11-12-21-25(16)32-27(31-21)28(2)14-5-15-33(28)26(34)23-19(10-13-22(36-4)24(23)30)17-6-8-18(35-3)9-7-17/h6-13H,5,14-15H2,1-4H3,(H,31,32)/t28-/m0/s1 LDASZAPWQDPTSQ-NDEPHWFRSA-N 335122 US11040966, Example 5.297::US9732075, Example 5.297::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3-fluoro-4,4'-dimethoxy-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 57.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335122 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335122&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128179 384987281 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657885 COc1ccc(-c2ccccc2F)c(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c1F InChI=1S/C27H24ClF2N3O2/c1-15-18(28)10-11-20-24(15)32-26(31-20)27(2)13-6-14-33(27)25(34)22-17(9-12-21(35-3)23(22)30)16-7-4-5-8-19(16)29/h4-5,7-12H,6,13-14H2,1-3H3,(H,31,32)/t27-/m0/s1 RMFYNBCLUKCAII-MHZLTWQESA-N 335123 US11040966, Example 5.298::US9732075, Example 5.298::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3,2'-difluoro-4-methoxy-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 15.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335123 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335123&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127619 384987282 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657886 COc1ccc(-c2ccccc2F)c(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c1F InChI=1S/C27H24ClF2N3O2/c1-15-18(28)10-11-20-24(15)32-26(31-20)27(2)13-6-14-33(27)25(34)22-17(9-12-21(35-3)23(22)30)16-7-4-5-8-19(16)29/h4-5,7-12H,6,13-14H2,1-3H3,(H,31,32)/t27-/m0/s1 RMFYNBCLUKCAII-MHZLTWQESA-N 335123 US11040966, Example 5.298::US9732075, Example 5.298::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3,2'-difluoro-4-methoxy-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 21.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335123 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335123&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127619 384987282 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657887 COc1ccc(-c2ccc(F)cc2)c(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c1F InChI=1S/C27H24ClF2N3O2/c1-15-19(28)10-11-20-24(15)32-26(31-20)27(2)13-4-14-33(27)25(34)22-18(9-12-21(35-3)23(22)30)16-5-7-17(29)8-6-16/h5-12H,4,13-14H2,1-3H3,(H,31,32)/t27-/m0/s1 AWCXCBDFXCQJOP-MHZLTWQESA-N 335124 US11040966, Example 5.299::US9732075, Example 5.299::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3,4'-difluoro-4-methoxy-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 17.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335124 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335124&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127739 384987283 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657888 COc1ccc(-c2ccc(F)cc2)c(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c1F InChI=1S/C27H24ClF2N3O2/c1-15-19(28)10-11-20-24(15)32-26(31-20)27(2)13-4-14-33(27)25(34)22-18(9-12-21(35-3)23(22)30)16-5-7-17(29)8-6-16/h5-12H,4,13-14H2,1-3H3,(H,31,32)/t27-/m0/s1 AWCXCBDFXCQJOP-MHZLTWQESA-N 335124 US11040966, Example 5.299::US9732075, Example 5.299::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3,4'-difluoro-4-methoxy-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 21.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335124 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335124&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127739 384987283 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657889 COc1ccc(-c2cccc(F)c2)c(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c1F InChI=1S/C27H24ClF2N3O2/c1-15-19(28)9-10-20-24(15)32-26(31-20)27(2)12-5-13-33(27)25(34)22-18(8-11-21(35-3)23(22)30)16-6-4-7-17(29)14-16/h4,6-11,14H,5,12-13H2,1-3H3,(H,31,32)/t27-/m0/s1 WDPBINQVAFUHBW-MHZLTWQESA-N 335125 US11040966, Example 5.300::US9732075, Example 5.300::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3,3'-difluoro-4-methoxy-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 10.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335125 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335125&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127888 384987284 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657890 COc1ccc(-c2cccc(F)c2)c(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c1F InChI=1S/C27H24ClF2N3O2/c1-15-19(28)9-10-20-24(15)32-26(31-20)27(2)12-5-13-33(27)25(34)22-18(8-11-21(35-3)23(22)30)16-6-4-7-17(29)14-16/h4,6-11,14H,5,12-13H2,1-3H3,(H,31,32)/t27-/m0/s1 WDPBINQVAFUHBW-MHZLTWQESA-N 335125 US11040966, Example 5.300::US9732075, Example 5.300::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3,3'-difluoro-4-methoxy-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 18.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335125 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335125&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127888 384987284 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657891 COc1ccc(-c2cccc(C)c2)c(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c1F InChI=1S/C28H27ClFN3O2/c1-16-7-5-8-18(15-16)19-9-12-22(35-4)24(30)23(19)26(34)33-14-6-13-28(33,3)27-31-21-11-10-20(29)17(2)25(21)32-27/h5,7-12,15H,6,13-14H2,1-4H3,(H,31,32)/t28-/m0/s1 LGLCYSWMISWOJF-NDEPHWFRSA-N 335126 US11040966, Example 5.301::US9732075, Example 5.301::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3-fluoro-4-methoxy-3'-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 24.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335126 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335126&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127634 384987285 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657892 COc1ccc(-c2cccc(C)c2)c(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c1F InChI=1S/C28H27ClFN3O2/c1-16-7-5-8-18(15-16)19-9-12-22(35-4)24(30)23(19)26(34)33-14-6-13-28(33,3)27-31-21-11-10-20(29)17(2)25(21)32-27/h5,7-12,15H,6,13-14H2,1-4H3,(H,31,32)/t28-/m0/s1 LGLCYSWMISWOJF-NDEPHWFRSA-N 335126 US11040966, Example 5.301::US9732075, Example 5.301::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3-fluoro-4-methoxy-3'-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 16.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335126 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335126&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127634 384987285 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657893 COc1ccc(-c2ccc(C)cc2)c(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c1F InChI=1S/C28H27ClFN3O2/c1-16-6-8-18(9-7-16)19-10-13-22(35-4)24(30)23(19)26(34)33-15-5-14-28(33,3)27-31-21-12-11-20(29)17(2)25(21)32-27/h6-13H,5,14-15H2,1-4H3,(H,31,32)/t28-/m0/s1 NHJTWAHPRAVJIY-NDEPHWFRSA-N 335127 US11040966, Example 5.302::US9732075, Example 5.302::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3-fluoro-4-methoxy-4'-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 28.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335127 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335127&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127557 384987286 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657894 COc1ccc(-c2ccc(C)cc2)c(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c1F InChI=1S/C28H27ClFN3O2/c1-16-6-8-18(9-7-16)19-10-13-22(35-4)24(30)23(19)26(34)33-15-5-14-28(33,3)27-31-21-12-11-20(29)17(2)25(21)32-27/h6-13H,5,14-15H2,1-4H3,(H,31,32)/t28-/m0/s1 NHJTWAHPRAVJIY-NDEPHWFRSA-N 335127 US11040966, Example 5.302::US9732075, Example 5.302::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3-fluoro-4-methoxy-4'-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 42.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335127 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335127&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127557 384987286 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657895 COc1ccc(-c2cccc(c2)C(F)(F)F)c(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c1F InChI=1S/C28H24ClF4N3O2/c1-15-19(29)9-10-20-24(15)35-26(34-20)27(2)12-5-13-36(27)25(37)22-18(8-11-21(38-3)23(22)30)16-6-4-7-17(14-16)28(31,32)33/h4,6-11,14H,5,12-13H2,1-3H3,(H,34,35)/t27-/m0/s1 FXRZHZWBUBRWGW-MHZLTWQESA-N 335128 US11040966, Example 5.303::US9732075, Example 5.303::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3-fluoro-4-methoxy-3'-trifluoromethyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 29.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335128 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335128&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127129 384987287 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657896 COc1ccc(-c2cccc(c2)C(F)(F)F)c(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c1F InChI=1S/C28H24ClF4N3O2/c1-15-19(29)9-10-20-24(15)35-26(34-20)27(2)12-5-13-36(27)25(37)22-18(8-11-21(38-3)23(22)30)16-6-4-7-17(14-16)28(31,32)33/h4,6-11,14H,5,12-13H2,1-3H3,(H,34,35)/t27-/m0/s1 FXRZHZWBUBRWGW-MHZLTWQESA-N 335128 US11040966, Example 5.303::US9732075, Example 5.303::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3-fluoro-4-methoxy-3'-trifluoromethyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 21.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335128 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335128&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127129 384987287 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657897 COc1c(F)c(ccc1-c1ccc2OCOc2c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C28H25ClFN3O4/c1-15-19(29)8-9-20-24(15)32-27(31-20)28(2)11-4-12-33(28)26(34)18-7-6-17(25(35-3)23(18)30)16-5-10-21-22(13-16)37-14-36-21/h5-10,13H,4,11-12,14H2,1-3H3,(H,31,32)/t28-/m0/s1 YEQKRXHOOOMDGX-NDEPHWFRSA-N 335129 (6-Benzo[1,3]dioxol-5-yl-2-fluoro-3-methoxy-phenyl)-[(S)-2-(5-chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone::US9732075, Example 5.304 Orexin/Hypocretin receptor type 1 Homo sapiens 19.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335129 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335129&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127369 384987288 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657898 COc1c(F)c(ccc1-c1ccc2OCOc2c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(Cl)ccc2[nH]1 InChI=1S/C28H25ClFN3O4/c1-15-19(29)8-9-20-24(15)32-27(31-20)28(2)11-4-12-33(28)26(34)18-7-6-17(25(35-3)23(18)30)16-5-10-21-22(13-16)37-14-36-21/h5-10,13H,4,11-12,14H2,1-3H3,(H,31,32)/t28-/m0/s1 YEQKRXHOOOMDGX-NDEPHWFRSA-N 335129 (6-Benzo[1,3]dioxol-5-yl-2-fluoro-3-methoxy-phenyl)-[(S)-2-(5-chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone::US9732075, Example 5.304 Orexin receptor type 2 Homo sapiens 86.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335129 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335129&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127369 384987288 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657899 COc1ccc(-c2ccc(cc2)C(F)(F)F)c(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c1F InChI=1S/C28H24ClF4N3O2/c1-15-19(29)10-11-20-24(15)35-26(34-20)27(2)13-4-14-36(27)25(37)22-18(9-12-21(38-3)23(22)30)16-5-7-17(8-6-16)28(31,32)33/h5-12H,4,13-14H2,1-3H3,(H,34,35)/t27-/m0/s1 QWJBHVJNOHYWKF-MHZLTWQESA-N 335130 US11040966, Example 5.305::US9732075, Example 5.305::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3-fluoro-4-methoxy-4'-trifluoromethyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 35.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335130 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335130&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128177 384987289 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657900 COc1ccc(-c2ccc(cc2)C(F)(F)F)c(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c1F InChI=1S/C28H24ClF4N3O2/c1-15-19(29)10-11-20-24(15)35-26(34-20)27(2)13-4-14-36(27)25(37)22-18(9-12-21(38-3)23(22)30)16-5-7-17(8-6-16)28(31,32)33/h5-12H,4,13-14H2,1-3H3,(H,34,35)/t27-/m0/s1 QWJBHVJNOHYWKF-MHZLTWQESA-N 335130 US11040966, Example 5.305::US9732075, Example 5.305::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3-fluoro-4-methoxy-4'-trifluoromethyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 41.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335130 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335130&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128177 384987289 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657901 COc1ccc(-c2ccc(OC(F)(F)F)cc2)c(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c1F InChI=1S/C28H24ClF4N3O3/c1-15-19(29)10-11-20-24(15)35-26(34-20)27(2)13-4-14-36(27)25(37)22-18(9-12-21(38-3)23(22)30)16-5-7-17(8-6-16)39-28(31,32)33/h5-12H,4,13-14H2,1-3H3,(H,34,35)/t27-/m0/s1 OLJHRKSGFAJEAN-MHZLTWQESA-N 335131 US11040966, Example 5.306::US9732075, Example 5.306::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3-fluoro-4-methoxy-4'-trifluoromethoxy-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 33.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335131 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335131&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127940 384987290 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657902 COc1ccc(-c2ccc(OC(F)(F)F)cc2)c(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c1F InChI=1S/C28H24ClF4N3O3/c1-15-19(29)10-11-20-24(15)35-26(34-20)27(2)13-4-14-36(27)25(37)22-18(9-12-21(38-3)23(22)30)16-5-7-17(8-6-16)39-28(31,32)33/h5-12H,4,13-14H2,1-3H3,(H,34,35)/t27-/m0/s1 OLJHRKSGFAJEAN-MHZLTWQESA-N 335131 US11040966, Example 5.306::US9732075, Example 5.306::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3-fluoro-4-methoxy-4'-trifluoromethoxy-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 69.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335131 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335131&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127940 384987290 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657903 COc1ccc(-c2cccc(c2)C#N)c(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c1F InChI=1S/C28H24ClFN4O2/c1-16-20(29)9-10-21-25(16)33-27(32-21)28(2)12-5-13-34(28)26(35)23-19(8-11-22(36-3)24(23)30)18-7-4-6-17(14-18)15-31/h4,6-11,14H,5,12-13H2,1-3H3,(H,32,33)/t28-/m0/s1 UQWDQPWJPMOPBV-NDEPHWFRSA-N 335132 2'-[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidine-1-carbonyl]-3'-fluoro-4'-methoxy-biphenyl-3-carbonitrile::US11040966, Example 5.307::US9732075, Example 5.307 Orexin/Hypocretin receptor type 1 Homo sapiens 20.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335132 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335132&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127230 384987291 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657904 COc1ccc(-c2cccc(c2)C#N)c(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c1F InChI=1S/C28H24ClFN4O2/c1-16-20(29)9-10-21-25(16)33-27(32-21)28(2)12-5-13-34(28)26(35)23-19(8-11-22(36-3)24(23)30)18-7-4-6-17(14-18)15-31/h4,6-11,14H,5,12-13H2,1-3H3,(H,32,33)/t28-/m0/s1 UQWDQPWJPMOPBV-NDEPHWFRSA-N 335132 2'-[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidine-1-carbonyl]-3'-fluoro-4'-methoxy-biphenyl-3-carbonitrile::US11040966, Example 5.307::US9732075, Example 5.307 Orexin receptor type 2 Homo sapiens 49.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335132 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335132&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127230 384987291 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657905 COc1ccc(-c2ccc(cc2)C#N)c(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c1F InChI=1S/C28H24ClFN4O2/c1-16-20(29)10-11-21-25(16)33-27(32-21)28(2)13-4-14-34(28)26(35)23-19(9-12-22(36-3)24(23)30)18-7-5-17(15-31)6-8-18/h5-12H,4,13-14H2,1-3H3,(H,32,33)/t28-/m0/s1 ZOVIJJVOZDPONS-NDEPHWFRSA-N 335133 2'-[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidine-1-carbonyl]-3'-fluoro-4'-methoxy-biphenyl-4-carbonitrile::US11040966, Example 5.308::US9732075, Example 5.308 Orexin/Hypocretin receptor type 1 Homo sapiens 21.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335133 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335133&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127465 384987292 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657906 COc1ccc(-c2ccc(cc2)C#N)c(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c1F InChI=1S/C28H24ClFN4O2/c1-16-20(29)10-11-21-25(16)33-27(32-21)28(2)13-4-14-34(28)26(35)23-19(9-12-22(36-3)24(23)30)18-7-5-17(15-31)6-8-18/h5-12H,4,13-14H2,1-3H3,(H,32,33)/t28-/m0/s1 ZOVIJJVOZDPONS-NDEPHWFRSA-N 335133 2'-[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidine-1-carbonyl]-3'-fluoro-4'-methoxy-biphenyl-4-carbonitrile::US11040966, Example 5.308::US9732075, Example 5.308 Orexin receptor type 2 Homo sapiens 122 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335133 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335133&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127465 384987292 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657907 COc1ccc(-c2cccc(OC(F)(F)F)c2)c(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c1F InChI=1S/C28H24ClF4N3O3/c1-15-19(29)9-10-20-24(15)35-26(34-20)27(2)12-5-13-36(27)25(37)22-18(8-11-21(38-3)23(22)30)16-6-4-7-17(14-16)39-28(31,32)33/h4,6-11,14H,5,12-13H2,1-3H3,(H,34,35)/t27-/m0/s1 KVQMPNGBXHCERI-MHZLTWQESA-N 335134 US11040966, Example 5.309::US9732075, Example 5.309::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3-fluoro-4-methoxy-3'-trifluoromethoxy-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 23.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335134 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335134&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127922 384987293 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657908 COc1ccc(-c2cccc(OC(F)(F)F)c2)c(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3[nH]2)c1F InChI=1S/C28H24ClF4N3O3/c1-15-19(29)9-10-20-24(15)35-26(34-20)27(2)12-5-13-36(27)25(37)22-18(8-11-21(38-3)23(22)30)16-6-4-7-17(14-16)39-28(31,32)33/h4,6-11,14H,5,12-13H2,1-3H3,(H,34,35)/t27-/m0/s1 KVQMPNGBXHCERI-MHZLTWQESA-N 335134 US11040966, Example 5.309::US9732075, Example 5.309::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3-fluoro-4-methoxy-3'-trifluoromethoxy-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 21.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335134 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335134&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127922 384987293 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657909 Cc1cc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)cc(Br)cc3[nH]2)c(cn1)-c1ccccc1 InChI=1S/C26H25BrN4O/c1-16-12-19(27)14-22-23(16)30-25(29-22)26(3)10-7-11-31(26)24(32)20-13-17(2)28-15-21(20)18-8-5-4-6-9-18/h4-6,8-9,12-15H,7,10-11H2,1-3H3,(H,29,30)/t26-/m0/s1 XJFSMLBDVGOZEL-SANMLTNESA-N 335135 US11040966, Example 5.310::US9732075, Example 5.310::[(S)-2-(6-Bromo-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-methyl-5-phenyl-pyridin-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 32.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335135 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335135&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127291 384987294 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657910 Cc1cc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)cc(Br)cc3[nH]2)c(cn1)-c1ccccc1 InChI=1S/C26H25BrN4O/c1-16-12-19(27)14-22-23(16)30-25(29-22)26(3)10-7-11-31(26)24(32)20-13-17(2)28-15-21(20)18-8-5-4-6-9-18/h4-6,8-9,12-15H,7,10-11H2,1-3H3,(H,29,30)/t26-/m0/s1 XJFSMLBDVGOZEL-SANMLTNESA-N 335135 US11040966, Example 5.310::US9732075, Example 5.310::[(S)-2-(6-Bromo-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-methyl-5-phenyl-pyridin-4-yl)-methanone Orexin receptor type 2 Homo sapiens 70.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335135 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335135&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127291 384987294 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657911 COc1ccc2nc([nH]c2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1ccc(F)cc1 335136 US9732075, Example 6.1::[5-(4-Fluoro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 367 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335136 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335136&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127504 384987295 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657912 COc1ccc2nc([nH]c2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1ccc(F)cc1 335136 US9732075, Example 6.1::[5-(4-Fluoro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 33.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335136 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335136&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127504 384987295 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657913 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(sc1-c1ccccc1)C1CC1 InChI=1S/C26H24N4O2S/c1-15-12-21(24-27-19-11-10-18(32-2)13-20(19)28-24)30(14-15)26(31)22-23(16-6-4-3-5-7-16)33-25(29-22)17-8-9-17/h3-7,10-11,13,17,21H,1,8-9,12,14H2,2H3,(H,27,28)/t21-/m0/s1 XVEAOCPGIRMOIJ-NRFANRHFSA-N 335137 (2-Cyclopropyl-5-phenyl-thiazol-4-yl)-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone::US11040966, Example 6.10::US9732075, Example 6.10 Orexin/Hypocretin receptor type 1 Homo sapiens 206 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335137 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335137&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128069 384987296 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657914 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(sc1-c1ccccc1)C1CC1 InChI=1S/C26H24N4O2S/c1-15-12-21(24-27-19-11-10-18(32-2)13-20(19)28-24)30(14-15)26(31)22-23(16-6-4-3-5-7-16)33-25(29-22)17-8-9-17/h3-7,10-11,13,17,21H,1,8-9,12,14H2,2H3,(H,27,28)/t21-/m0/s1 XVEAOCPGIRMOIJ-NRFANRHFSA-N 335137 (2-Cyclopropyl-5-phenyl-thiazol-4-yl)-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone::US11040966, Example 6.10::US9732075, Example 6.10 Orexin receptor type 2 Homo sapiens 81.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335137 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335137&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128069 384987296 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657915 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3cccc(C)c3[nH]2)c(s1)-c1ccc(Br)cc1 InChI=1S/C24H21BrN4OS/c1-13-11-19(23-27-18-6-4-5-14(2)20(18)28-23)29(12-13)24(30)21-22(31-15(3)26-21)16-7-9-17(25)10-8-16/h4-10,19H,1,11-12H2,2-3H3,(H,27,28)/t19-/m0/s1 LFKISXXTSDLWIK-IBGZPJMESA-N 335138 US11040966, Example 6.100::US9732075, Example 6.100::[5-(4-Bromo-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 55.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335138 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335138&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695498 384987297 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657916 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3cccc(C)c3[nH]2)c(s1)-c1ccc(Br)cc1 InChI=1S/C24H21BrN4OS/c1-13-11-19(23-27-18-6-4-5-14(2)20(18)28-23)29(12-13)24(30)21-22(31-15(3)26-21)16-7-9-17(25)10-8-16/h4-10,19H,1,11-12H2,2-3H3,(H,27,28)/t19-/m0/s1 LFKISXXTSDLWIK-IBGZPJMESA-N 335138 US11040966, Example 6.100::US9732075, Example 6.100::[5-(4-Bromo-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335138 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335138&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695498 384987297 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657917 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3cccc(C)c3[nH]2)c(s1)-c1cccc(C)c1 InChI=1S/C25H24N4OS/c1-14-7-5-9-18(11-14)23-22(26-17(4)31-23)25(30)29-13-15(2)12-20(29)24-27-19-10-6-8-16(3)21(19)28-24/h5-11,20H,2,12-13H2,1,3-4H3,(H,27,28)/t20-/m0/s1 GZRZSBRCCDOXHS-FQEVSTJZSA-N 335139 US11040966, Example 6.101::US9732075, Example 6.101::[(S)-2-(7-Methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-methyl-5-m-tolyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 10.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335139 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335139&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695300 384987298 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657918 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3cccc(C)c3[nH]2)c(s1)-c1cccc(C)c1 InChI=1S/C25H24N4OS/c1-14-7-5-9-18(11-14)23-22(26-17(4)31-23)25(30)29-13-15(2)12-20(29)24-27-19-10-6-8-16(3)21(19)28-24/h5-11,20H,2,12-13H2,1,3-4H3,(H,27,28)/t20-/m0/s1 GZRZSBRCCDOXHS-FQEVSTJZSA-N 335139 US11040966, Example 6.101::US9732075, Example 6.101::[(S)-2-(7-Methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-methyl-5-m-tolyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 0.900 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335139 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335139&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695300 384987298 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657919 Cc1cccc2nc([nH]c12)[C@@H]1CC(=C)CN1C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C22H19ClN6O/c1-13-10-19(21-26-17-5-3-4-14(2)20(17)27-21)28(12-13)22(30)16-11-15(23)6-7-18(16)29-24-8-9-25-29/h3-9,11,19H,1,10,12H2,2H3,(H,26,27)/t19-/m0/s1 RHKAPTDLQJUNIQ-IBGZPJMESA-N 335140 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone::US11040966, Example 6.102::US9732075, Example 6.102 Orexin/Hypocretin receptor type 1 Homo sapiens 364 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335140 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335140&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127973 384987299 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657920 Cc1cccc2nc([nH]c12)[C@@H]1CC(=C)CN1C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C22H19ClN6O/c1-13-10-19(21-26-17-5-3-4-14(2)20(17)27-21)28(12-13)22(30)16-11-15(23)6-7-18(16)29-24-8-9-25-29/h3-9,11,19H,1,10,12H2,2H3,(H,26,27)/t19-/m0/s1 RHKAPTDLQJUNIQ-IBGZPJMESA-N 335140 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone::US11040966, Example 6.102::US9732075, Example 6.102 Orexin receptor type 2 Homo sapiens 32.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335140 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335140&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127973 384987299 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657921 COc1ccc(cn1)-c1sc(C)nc1C(=O)N1CC(=C)C[C@H]1c1nc2cccc(C)c2[nH]1 InChI=1S/C24H23N5O2S/c1-13-10-18(23-27-17-7-5-6-14(2)20(17)28-23)29(12-13)24(30)21-22(32-15(3)26-21)16-8-9-19(31-4)25-11-16/h5-9,11,18H,1,10,12H2,2-4H3,(H,27,28)/t18-/m0/s1 DEHXQHXUFIVLJT-SFHVURJKSA-N 335141 US11040966, Example 6.103::US9732075, Example 6.103::[5-(6-Methoxy-pyridin-3-yl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methyl-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 184 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335141 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335141&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127175 384987300 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657922 COc1ccc(cn1)-c1sc(C)nc1C(=O)N1CC(=C)C[C@H]1c1nc2cccc(C)c2[nH]1 InChI=1S/C24H23N5O2S/c1-13-10-18(23-27-17-7-5-6-14(2)20(17)28-23)29(12-13)24(30)21-22(32-15(3)26-21)16-8-9-19(31-4)25-11-16/h5-9,11,18H,1,10,12H2,2-4H3,(H,27,28)/t18-/m0/s1 DEHXQHXUFIVLJT-SFHVURJKSA-N 335141 US11040966, Example 6.103::US9732075, Example 6.103::[5-(6-Methoxy-pyridin-3-yl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methyl-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335141 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335141&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127175 384987300 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657923 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3cccc(C)c3[nH]2)c(s1)-c1cccc(Br)c1 InChI=1S/C24H21BrN4OS/c1-13-10-19(23-27-18-9-4-6-14(2)20(18)28-23)29(12-13)24(30)21-22(31-15(3)26-21)16-7-5-8-17(25)11-16/h4-9,11,19H,1,10,12H2,2-3H3,(H,27,28)/t19-/m0/s1 CEFUBZHXLUSJPE-IBGZPJMESA-N 335142 US11040966, Example 6.104::US9732075, Example 6.104::[5-(3-Bromo-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335142 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335142&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695399 384987301 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657924 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3cccc(C)c3[nH]2)c(s1)-c1cccc(Br)c1 InChI=1S/C24H21BrN4OS/c1-13-10-19(23-27-18-9-4-6-14(2)20(18)28-23)29(12-13)24(30)21-22(31-15(3)26-21)16-7-5-8-17(25)11-16/h4-9,11,19H,1,10,12H2,2-3H3,(H,27,28)/t19-/m0/s1 CEFUBZHXLUSJPE-IBGZPJMESA-N 335142 US11040966, Example 6.104::US9732075, Example 6.104::[5-(3-Bromo-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 0.800 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335142 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335142&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695399 384987301 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657925 Cc1ccc(c(n1)C(=O)N1CC(=C)C[C@H]1c1nc2cccc(C)c2[nH]1)-n1cccn1 InChI=1S/C23H22N6O/c1-14-12-19(22-26-17-7-4-6-15(2)20(17)27-22)28(13-14)23(30)21-18(9-8-16(3)25-21)29-11-5-10-24-29/h4-11,19H,1,12-13H2,2-3H3,(H,26,27)/t19-/m0/s1 CTUIYHOUERTMHH-IBGZPJMESA-N 335143 US11040966, Example 6.105::US9732075, Example 6.105::[(S)-2-(7-Methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(6-methyl-3-pyrazol-1-yl-pyridin-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 1060 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335143 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335143&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127123 384987302 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657926 Cc1ccc(c(n1)C(=O)N1CC(=C)C[C@H]1c1nc2cccc(C)c2[nH]1)-n1cccn1 InChI=1S/C23H22N6O/c1-14-12-19(22-26-17-7-4-6-15(2)20(17)27-22)28(13-14)23(30)21-18(9-8-16(3)25-21)29-11-5-10-24-29/h4-11,19H,1,12-13H2,2-3H3,(H,26,27)/t19-/m0/s1 CTUIYHOUERTMHH-IBGZPJMESA-N 335143 US11040966, Example 6.105::US9732075, Example 6.105::[(S)-2-(7-Methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(6-methyl-3-pyrazol-1-yl-pyridin-2-yl)-methanone Orexin receptor type 2 Homo sapiens 77.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335143 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335143&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127123 384987302 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657927 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3cccc(C)c3[nH]2)c(s1)-c1ccc(F)cc1 InChI=1S/C24H21FN4OS/c1-13-11-19(23-27-18-6-4-5-14(2)20(18)28-23)29(12-13)24(30)21-22(31-15(3)26-21)16-7-9-17(25)10-8-16/h4-10,19H,1,11-12H2,2-3H3,(H,27,28)/t19-/m0/s1 LKJVMTZGYDHCII-IBGZPJMESA-N 335144 US11040966, Example 6.106::US9732075, Example 6.106::[5-(4-Fluoro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 99.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335144 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335144&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127168 384987303 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657928 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3cccc(C)c3[nH]2)c(s1)-c1ccc(F)cc1 InChI=1S/C24H21FN4OS/c1-13-11-19(23-27-18-6-4-5-14(2)20(18)28-23)29(12-13)24(30)21-22(31-15(3)26-21)16-7-9-17(25)10-8-16/h4-10,19H,1,11-12H2,2-3H3,(H,27,28)/t19-/m0/s1 LKJVMTZGYDHCII-IBGZPJMESA-N 335144 US11040966, Example 6.106::US9732075, Example 6.106::[5-(4-Fluoro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335144 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335144&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127168 384987303 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657929 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3cccc(C)c3[nH]2)c(s1)-c1cc(C)cc(C)c1 InChI=1S/C26H26N4OS/c1-14-9-15(2)11-19(10-14)24-23(27-18(5)32-24)26(31)30-13-16(3)12-21(30)25-28-20-8-6-7-17(4)22(20)29-25/h6-11,21H,3,12-13H2,1-2,4-5H3,(H,28,29)/t21-/m0/s1 KQQRIMHEEAJWNE-NRFANRHFSA-N 335145 US11040966, Example 6.107::US9732075, Example 6.107::[5-(3,5-Dimethyl-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 74.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335145 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335145&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695497 384987304 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657930 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3cccc(C)c3[nH]2)c(s1)-c1cc(C)cc(C)c1 InChI=1S/C26H26N4OS/c1-14-9-15(2)11-19(10-14)24-23(27-18(5)32-24)26(31)30-13-16(3)12-21(30)25-28-20-8-6-7-17(4)22(20)29-25/h6-11,21H,3,12-13H2,1-2,4-5H3,(H,28,29)/t21-/m0/s1 KQQRIMHEEAJWNE-NRFANRHFSA-N 335145 US11040966, Example 6.107::US9732075, Example 6.107::[5-(3,5-Dimethyl-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 16.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335145 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335145&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695497 384987304 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657931 Cc1cc(C(=O)N2CC(=C)C[C@H]2c2nc3cccc(C)c3[nH]2)c(cc1C)-n1nccn1 InChI=1S/C24H24N6O/c1-14-10-21(23-27-19-7-5-6-15(2)22(19)28-23)29(13-14)24(31)18-11-16(3)17(4)12-20(18)30-25-8-9-26-30/h5-9,11-12,21H,1,10,13H2,2-4H3,(H,27,28)/t21-/m0/s1 NLCCTTKFIBSEHA-NRFANRHFSA-N 335146 (4,5-Dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone::US11040966, Example 6.108::US9732075, Example 6.108 Orexin/Hypocretin receptor type 1 Homo sapiens 414 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335146 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335146&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127207 384987305 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657932 Cc1cc(C(=O)N2CC(=C)C[C@H]2c2nc3cccc(C)c3[nH]2)c(cc1C)-n1nccn1 InChI=1S/C24H24N6O/c1-14-10-21(23-27-19-7-5-6-15(2)22(19)28-23)29(13-14)24(31)18-11-16(3)17(4)12-20(18)30-25-8-9-26-30/h5-9,11-12,21H,1,10,13H2,2-4H3,(H,27,28)/t21-/m0/s1 NLCCTTKFIBSEHA-NRFANRHFSA-N 335146 (4,5-Dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone::US11040966, Example 6.108::US9732075, Example 6.108 Orexin receptor type 2 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335146 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335146&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127207 384987305 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657933 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3cccc(C)c3[nH]2)c(s1)-c1ccc(Cl)cc1 InChI=1S/C24H21ClN4OS/c1-13-11-19(23-27-18-6-4-5-14(2)20(18)28-23)29(12-13)24(30)21-22(31-15(3)26-21)16-7-9-17(25)10-8-16/h4-10,19H,1,11-12H2,2-3H3,(H,27,28)/t19-/m0/s1 PCVVFZUFWINAQQ-IBGZPJMESA-N 335147 US11040966, Example 6.109::US9732075, Example 6.109::[5-(4-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 112 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335147 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335147&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127599 384987306 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657934 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3cccc(C)c3[nH]2)c(s1)-c1ccc(Cl)cc1 InChI=1S/C24H21ClN4OS/c1-13-11-19(23-27-18-6-4-5-14(2)20(18)28-23)29(12-13)24(30)21-22(31-15(3)26-21)16-7-9-17(25)10-8-16/h4-10,19H,1,11-12H2,2-3H3,(H,27,28)/t19-/m0/s1 PCVVFZUFWINAQQ-IBGZPJMESA-N 335147 US11040966, Example 6.109::US9732075, Example 6.109::[5-(4-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335147 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335147&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127599 384987306 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657935 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1cnc(C)nc1-c1cccc(C)c1 InChI=1S/C26H25N5O2/c1-15-6-5-7-18(10-15)24-20(13-27-17(3)28-24)26(32)31-14-16(2)11-23(31)25-29-21-9-8-19(33-4)12-22(21)30-25/h5-10,12-13,23H,2,11,14H2,1,3-4H3,(H,29,30)/t23-/m0/s1 UINDGRKAEKTELE-QHCPKHFHSA-N 335148 US11040966, Example 6.11::US9732075, Example 6.11::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-(2-methyl-4-m-tolyl-pyrimidin-5-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 135 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335148 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335148&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127154 384987307 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657936 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1cnc(C)nc1-c1cccc(C)c1 InChI=1S/C26H25N5O2/c1-15-6-5-7-18(10-15)24-20(13-27-17(3)28-24)26(32)31-14-16(2)11-23(31)25-29-21-9-8-19(33-4)12-22(21)30-25/h5-10,12-13,23H,2,11,14H2,1,3-4H3,(H,29,30)/t23-/m0/s1 UINDGRKAEKTELE-QHCPKHFHSA-N 335148 US11040966, Example 6.11::US9732075, Example 6.11::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-(2-methyl-4-m-tolyl-pyrimidin-5-yl)-methanone Orexin receptor type 2 Homo sapiens 56.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335148 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335148&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127154 384987307 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657937 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3cccc(C)c3[nH]2)c(s1)-c1ccc(F)c(Br)c1 InChI=1S/C24H20BrFN4OS/c1-12-9-19(23-28-18-6-4-5-13(2)20(18)29-23)30(11-12)24(31)21-22(32-14(3)27-21)15-7-8-17(26)16(25)10-15/h4-8,10,19H,1,9,11H2,2-3H3,(H,28,29)/t19-/m0/s1 CFSZFZQNXIYCLF-IBGZPJMESA-N 335149 US11040966, Example 6.110::US9732075, Example 6.110::[5-(3-Bromo-4-fluoro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 15.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335149&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127846 384987308 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657938 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3cccc(C)c3[nH]2)c(s1)-c1ccc(F)c(Br)c1 InChI=1S/C24H20BrFN4OS/c1-12-9-19(23-28-18-6-4-5-13(2)20(18)29-23)30(11-12)24(31)21-22(32-14(3)27-21)15-7-8-17(26)16(25)10-15/h4-8,10,19H,1,9,11H2,2-3H3,(H,28,29)/t19-/m0/s1 CFSZFZQNXIYCLF-IBGZPJMESA-N 335149 US11040966, Example 6.110::US9732075, Example 6.110::[5-(3-Bromo-4-fluoro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335149 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335149&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127846 384987308 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657939 COc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2cccc(C)c2[nH]1)-n1nccn1 InChI=1S/C23H22N6O2/c1-14-11-20(22-26-18-6-4-5-15(2)21(18)27-22)28(13-14)23(30)17-12-16(31-3)7-8-19(17)29-24-9-10-25-29/h4-10,12,20H,1,11,13H2,2-3H3,(H,26,27)/t20-/m0/s1 VIGULHTZAIBLNK-FQEVSTJZSA-N 335150 (5-Methoxy-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone::US11040966, Example 6.111::US9732075, Example 6.111 Orexin/Hypocretin receptor type 1 Homo sapiens 272 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335150 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335150&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127159 384987309 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657940 COc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2cccc(C)c2[nH]1)-n1nccn1 InChI=1S/C23H22N6O2/c1-14-11-20(22-26-18-6-4-5-15(2)21(18)27-22)28(13-14)23(30)17-12-16(31-3)7-8-19(17)29-24-9-10-25-29/h4-10,12,20H,1,11,13H2,2-3H3,(H,26,27)/t20-/m0/s1 VIGULHTZAIBLNK-FQEVSTJZSA-N 335150 (5-Methoxy-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone::US11040966, Example 6.111::US9732075, Example 6.111 Orexin receptor type 2 Homo sapiens 14.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335150 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335150&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127159 384987309 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657941 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3cccc(C)c3[nH]2)c(s1)-c1cccc(c1)C(F)(F)F InChI=1S/C25H21F3N4OS/c1-13-10-19(23-30-18-9-4-6-14(2)20(18)31-23)32(12-13)24(33)21-22(34-15(3)29-21)16-7-5-8-17(11-16)25(26,27)28/h4-9,11,19H,1,10,12H2,2-3H3,(H,30,31)/t19-/m0/s1 RFGPAFUPYJFKHK-IBGZPJMESA-N 335151 US11040966, Example 6.112::US9732075, Example 6.112::[(S)-2-(7-Methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[2-methyl-5-(3-trifluoromethyl-phenyl)-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 15.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335151 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335151&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127042 384987310 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657942 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3cccc(C)c3[nH]2)c(s1)-c1cccc(c1)C(F)(F)F InChI=1S/C25H21F3N4OS/c1-13-10-19(23-30-18-9-4-6-14(2)20(18)31-23)32(12-13)24(33)21-22(34-15(3)29-21)16-7-5-8-17(11-16)25(26,27)28/h4-9,11,19H,1,10,12H2,2-3H3,(H,30,31)/t19-/m0/s1 RFGPAFUPYJFKHK-IBGZPJMESA-N 335151 US11040966, Example 6.112::US9732075, Example 6.112::[(S)-2-(7-Methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[2-methyl-5-(3-trifluoromethyl-phenyl)-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 0.700 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335151 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335151&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127042 384987310 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657943 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3cccc(C)c3[nH]2)c(s1)-c1ccc(Cl)c(Cl)c1 InChI=1S/C24H20Cl2N4OS/c1-12-9-19(23-28-18-6-4-5-13(2)20(18)29-23)30(11-12)24(31)21-22(32-14(3)27-21)15-7-8-16(25)17(26)10-15/h4-8,10,19H,1,9,11H2,2-3H3,(H,28,29)/t19-/m0/s1 XBKLSMQHNWPYAS-IBGZPJMESA-N 335152 US11040966, Example 6.113::US9732075, Example 6.113::[5-(3,4-Dichloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335152 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335152&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127028 384987311 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657944 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3cccc(C)c3[nH]2)c(s1)-c1ccc(Cl)c(Cl)c1 InChI=1S/C24H20Cl2N4OS/c1-12-9-19(23-28-18-6-4-5-13(2)20(18)29-23)30(11-12)24(31)21-22(32-14(3)27-21)15-7-8-16(25)17(26)10-15/h4-8,10,19H,1,9,11H2,2-3H3,(H,28,29)/t19-/m0/s1 XBKLSMQHNWPYAS-IBGZPJMESA-N 335152 US11040966, Example 6.113::US9732075, Example 6.113::[5-(3,4-Dichloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335152 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335152&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127028 384987311 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657945 COc1cccc(c1)-c1sc(C)nc1C(=O)N1CC(=C)C[C@H]1c1nc2cccc(C)c2[nH]1 InChI=1S/C25H24N4O2S/c1-14-11-20(24-27-19-10-5-7-15(2)21(19)28-24)29(13-14)25(30)22-23(32-16(3)26-22)17-8-6-9-18(12-17)31-4/h5-10,12,20H,1,11,13H2,2-4H3,(H,27,28)/t20-/m0/s1 JRMALTNQDGGHAS-FQEVSTJZSA-N 335153 US11040966, Example 6.114::US9732075, Example 6.114::[5-(3-Methoxy-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 16.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335153 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335153&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127286 384987312 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657946 COc1cccc(c1)-c1sc(C)nc1C(=O)N1CC(=C)C[C@H]1c1nc2cccc(C)c2[nH]1 InChI=1S/C25H24N4O2S/c1-14-11-20(24-27-19-10-5-7-15(2)21(19)28-24)29(13-14)25(30)22-23(32-16(3)26-22)17-8-6-9-18(12-17)31-4/h5-10,12,20H,1,11,13H2,2-4H3,(H,27,28)/t20-/m0/s1 JRMALTNQDGGHAS-FQEVSTJZSA-N 335153 US11040966, Example 6.114::US9732075, Example 6.114::[5-(3-Methoxy-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 0.700 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335153 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335153&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127286 384987312 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657947 Cc1ccc(c(n1)C(=O)N1CC(=C)C[C@H]1c1nc2cccc(C)c2[nH]1)-n1nccn1 InChI=1S/C22H21N7O/c1-13-11-18(21-26-16-6-4-5-14(2)19(16)27-21)28(12-13)22(30)20-17(8-7-15(3)25-20)29-23-9-10-24-29/h4-10,18H,1,11-12H2,2-3H3,(H,26,27)/t18-/m0/s1 SXIJDVGGCLAGHN-SFHVURJKSA-N 335154 US11040966, Example 6.115::US9732075, Example 6.115::[(S)-2-(7-Methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 333 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335154 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335154&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127471 384987313 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657948 Cc1ccc(c(n1)C(=O)N1CC(=C)C[C@H]1c1nc2cccc(C)c2[nH]1)-n1nccn1 InChI=1S/C22H21N7O/c1-13-11-18(21-26-16-6-4-5-14(2)19(16)27-21)28(12-13)22(30)20-17(8-7-15(3)25-20)29-23-9-10-24-29/h4-10,18H,1,11-12H2,2-3H3,(H,26,27)/t18-/m0/s1 SXIJDVGGCLAGHN-SFHVURJKSA-N 335154 US11040966, Example 6.115::US9732075, Example 6.115::[(S)-2-(7-Methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone Orexin receptor type 2 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335154 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335154&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127471 384987313 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657949 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3ccc(Cl)c(C)c3[nH]2)c(s1)-c1ccc(Br)cc1 InChI=1S/C24H20BrClN4OS/c1-12-10-19(23-28-18-9-8-17(26)13(2)20(18)29-23)30(11-12)24(31)21-22(32-14(3)27-21)15-4-6-16(25)7-5-15/h4-9,19H,1,10-11H2,2-3H3,(H,28,29)/t19-/m0/s1 GPDVOLXLGIEJML-IBGZPJMESA-N 335155 US11040966, Example 6.116::US9732075, Example 6.116::[5-(4-Bromo-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(6-chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 14.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335155 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335155&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127878 384987314 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657950 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3ccc(Cl)c(C)c3[nH]2)c(s1)-c1ccc(Br)cc1 InChI=1S/C24H20BrClN4OS/c1-12-10-19(23-28-18-9-8-17(26)13(2)20(18)29-23)30(11-12)24(31)21-22(32-14(3)27-21)15-4-6-16(25)7-5-15/h4-9,19H,1,10-11H2,2-3H3,(H,28,29)/t19-/m0/s1 GPDVOLXLGIEJML-IBGZPJMESA-N 335155 US11040966, Example 6.116::US9732075, Example 6.116::[5-(4-Bromo-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(6-chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335155 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335155&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127878 384987314 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657951 COc1ccc(cn1)-c1sc(C)nc1C(=O)N1CC(=C)C[C@H]1c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C24H22ClN5O2S/c1-12-9-18(23-28-17-7-6-16(25)13(2)20(17)29-23)30(11-12)24(31)21-22(33-14(3)27-21)15-5-8-19(32-4)26-10-15/h5-8,10,18H,1,9,11H2,2-4H3,(H,28,29)/t18-/m0/s1 XYLRNNCVRQSSFY-SFHVURJKSA-N 335156 US11040966, Example 6.117::US9732075, Example 6.117::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(6-methoxy-pyridin-3-yl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 19.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335156 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335156&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127502 384987315 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657952 COc1ccc(cn1)-c1sc(C)nc1C(=O)N1CC(=C)C[C@H]1c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C24H22ClN5O2S/c1-12-9-18(23-28-17-7-6-16(25)13(2)20(17)29-23)30(11-12)24(31)21-22(33-14(3)27-21)15-5-8-19(32-4)26-10-15/h5-8,10,18H,1,9,11H2,2-4H3,(H,28,29)/t18-/m0/s1 XYLRNNCVRQSSFY-SFHVURJKSA-N 335156 US11040966, Example 6.117::US9732075, Example 6.117::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(6-methoxy-pyridin-3-yl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335156 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335156&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127502 384987315 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657953 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3ccc(Cl)c(C)c3[nH]2)c(s1)-c1ccc(F)cc1 InChI=1S/C24H20ClFN4OS/c1-12-10-19(23-28-18-9-8-17(25)13(2)20(18)29-23)30(11-12)24(31)21-22(32-14(3)27-21)15-4-6-16(26)7-5-15/h4-9,19H,1,10-11H2,2-3H3,(H,28,29)/t19-/m0/s1 OIJKAYYFBFCTLI-IBGZPJMESA-N 335157 US11040966, Example 6.118::US9732075, Example 6.118::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 21.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335157 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335157&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127475 384987316 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657954 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3ccc(Cl)c(C)c3[nH]2)c(s1)-c1ccc(F)cc1 InChI=1S/C24H20ClFN4OS/c1-12-10-19(23-28-18-9-8-17(25)13(2)20(18)29-23)30(11-12)24(31)21-22(32-14(3)27-21)15-4-6-16(26)7-5-15/h4-9,19H,1,10-11H2,2-3H3,(H,28,29)/t19-/m0/s1 OIJKAYYFBFCTLI-IBGZPJMESA-N 335157 US11040966, Example 6.118::US9732075, Example 6.118::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(4-fluoro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335157 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335157&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127475 384987316 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657955 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3ccc(Cl)c(C)c3[nH]2)c(s1)-c1ccc(Cl)cc1 InChI=1S/C24H20Cl2N4OS/c1-12-10-19(23-28-18-9-8-17(26)13(2)20(18)29-23)30(11-12)24(31)21-22(32-14(3)27-21)15-4-6-16(25)7-5-15/h4-9,19H,1,10-11H2,2-3H3,(H,28,29)/t19-/m0/s1 AYIGFRHNJKQGKY-IBGZPJMESA-N 335158 US11040966, Example 6.119::US9732075, Example 6.119::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(4-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 14.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335158 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335158&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127780 384987317 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657956 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3ccc(Cl)c(C)c3[nH]2)c(s1)-c1ccc(Cl)cc1 InChI=1S/C24H20Cl2N4OS/c1-12-10-19(23-28-18-9-8-17(26)13(2)20(18)29-23)30(11-12)24(31)21-22(32-14(3)27-21)15-4-6-16(25)7-5-15/h4-9,19H,1,10-11H2,2-3H3,(H,28,29)/t19-/m0/s1 AYIGFRHNJKQGKY-IBGZPJMESA-N 335158 US11040966, Example 6.119::US9732075, Example 6.119::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(4-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335158 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335158&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127780 384987317 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657957 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C23H22N6O2/c1-14-4-7-20(29-24-8-9-25-29)17(10-14)23(30)28-13-15(2)11-21(28)22-26-18-6-5-16(31-3)12-19(18)27-22/h4-10,12,21H,2,11,13H2,1,3H3,(H,26,27)/t21-/m0/s1 OOZUCTFBTSAPOX-NRFANRHFSA-N 335159 US11040966, Example 6.12::US9732075, Example 6.12::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 317 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335159 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335159&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127469 384987318 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657958 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C23H22N6O2/c1-14-4-7-20(29-24-8-9-25-29)17(10-14)23(30)28-13-15(2)11-21(28)22-26-18-6-5-16(31-3)12-19(18)27-22/h4-10,12,21H,2,11,13H2,1,3H3,(H,26,27)/t21-/m0/s1 OOZUCTFBTSAPOX-NRFANRHFSA-N 335159 US11040966, Example 6.12::US9732075, Example 6.12::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335159 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335159&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127469 384987318 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657959 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3ccc(Cl)c(C)c3[nH]2)c(s1)-c1cccc(c1)C(F)(F)F InChI=1S/C25H20ClF3N4OS/c1-12-9-19(23-31-18-8-7-17(26)13(2)20(18)32-23)33(11-12)24(34)21-22(35-14(3)30-21)15-5-4-6-16(10-15)25(27,28)29/h4-8,10,19H,1,9,11H2,2-3H3,(H,31,32)/t19-/m0/s1 PTZUKCQLHNBFEQ-IBGZPJMESA-N 335160 US11040966, Example 6.120::US9732075, Example 6.120::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[2-methyl-5-(3-trifluoromethyl-phenyl)-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335160 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335160&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118126998 384987319 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657960 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3ccc(Cl)c(C)c3[nH]2)c(s1)-c1cccc(c1)C(F)(F)F InChI=1S/C25H20ClF3N4OS/c1-12-9-19(23-31-18-8-7-17(26)13(2)20(18)32-23)33(11-12)24(34)21-22(35-14(3)30-21)15-5-4-6-16(10-15)25(27,28)29/h4-8,10,19H,1,9,11H2,2-3H3,(H,31,32)/t19-/m0/s1 PTZUKCQLHNBFEQ-IBGZPJMESA-N 335160 US11040966, Example 6.120::US9732075, Example 6.120::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[2-methyl-5-(3-trifluoromethyl-phenyl)-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 0.600 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335160 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335160&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118126998 384987319 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657961 COc1cccc(c1)-c1sc(C)nc1C(=O)N1CC(=C)C[C@H]1c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C25H23ClN4O2S/c1-13-10-20(24-28-19-9-8-18(26)14(2)21(19)29-24)30(12-13)25(31)22-23(33-15(3)27-22)16-6-5-7-17(11-16)32-4/h5-9,11,20H,1,10,12H2,2-4H3,(H,28,29)/t20-/m0/s1 TZAQHYIVSIBZMW-FQEVSTJZSA-N 335161 US11040966, Example 6.121::US9732075, Example 6.121::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(3-methoxy-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335161&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695490 384987320 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657962 COc1cccc(c1)-c1sc(C)nc1C(=O)N1CC(=C)C[C@H]1c1nc2ccc(Cl)c(C)c2[nH]1 InChI=1S/C25H23ClN4O2S/c1-13-10-20(24-28-19-9-8-18(26)14(2)21(19)29-24)30(12-13)25(31)22-23(33-15(3)27-22)16-6-5-7-17(11-16)32-4/h5-9,11,20H,1,10,12H2,2-4H3,(H,28,29)/t20-/m0/s1 TZAQHYIVSIBZMW-FQEVSTJZSA-N 335161 US11040966, Example 6.121::US9732075, Example 6.121::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(3-methoxy-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 0.500 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335161 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335161&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695490 384987320 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657963 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3ccc(Cl)c(C)c3[nH]2)c(s1)-c1cccc(C)c1 InChI=1S/C25H23ClN4OS/c1-13-6-5-7-17(10-13)23-22(27-16(4)32-23)25(31)30-12-14(2)11-20(30)24-28-19-9-8-18(26)15(3)21(19)29-24/h5-10,20H,2,11-12H2,1,3-4H3,(H,28,29)/t20-/m0/s1 DJPWHBDTSPGVAZ-FQEVSTJZSA-N 335162 US11040966, Example 6.122::US9732075, Example 6.122::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-methyl-5-m-tolyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 0.900 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335162&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127398 384987321 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657964 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3ccc(Cl)c(C)c3[nH]2)c(s1)-c1cccc(C)c1 InChI=1S/C25H23ClN4OS/c1-13-6-5-7-17(10-13)23-22(27-16(4)32-23)25(31)30-12-14(2)11-20(30)24-28-19-9-8-18(26)15(3)21(19)29-24/h5-10,20H,2,11-12H2,1,3-4H3,(H,28,29)/t20-/m0/s1 DJPWHBDTSPGVAZ-FQEVSTJZSA-N 335162 US11040966, Example 6.122::US9732075, Example 6.122::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-methyl-5-m-tolyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 0.600 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335162 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335162&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127398 384987321 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657965 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3ccc(Cl)c(C)c3[nH]2)c(s1)-c1cccc(Br)c1 InChI=1S/C24H20BrClN4OS/c1-12-9-19(23-28-18-8-7-17(26)13(2)20(18)29-23)30(11-12)24(31)21-22(32-14(3)27-21)15-5-4-6-16(25)10-15/h4-8,10,19H,1,9,11H2,2-3H3,(H,28,29)/t19-/m0/s1 JMGVQWNUFFUFRB-IBGZPJMESA-N 335163 US11040966, Example 6.123::US9732075, Example 6.123::[5-(3-Bromo-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(6-chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335163 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335163&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127873 384987322 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657966 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3ccc(Cl)c(C)c3[nH]2)c(s1)-c1cccc(Br)c1 InChI=1S/C24H20BrClN4OS/c1-12-9-19(23-28-18-8-7-17(26)13(2)20(18)29-23)30(11-12)24(31)21-22(32-14(3)27-21)15-5-4-6-16(25)10-15/h4-8,10,19H,1,9,11H2,2-3H3,(H,28,29)/t19-/m0/s1 JMGVQWNUFFUFRB-IBGZPJMESA-N 335163 US11040966, Example 6.123::US9732075, Example 6.123::[5-(3-Bromo-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(6-chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 0.700 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335163 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335163&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127873 384987322 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657967 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3ccc(Cl)c(C)c3[nH]2)c(s1)-c1cc(C)cc(C)c1 InChI=1S/C26H25ClN4OS/c1-13-8-14(2)10-18(9-13)24-23(28-17(5)33-24)26(32)31-12-15(3)11-21(31)25-29-20-7-6-19(27)16(4)22(20)30-25/h6-10,21H,3,11-12H2,1-2,4-5H3,(H,29,30)/t21-/m0/s1 RSOSHFPRIPHDQX-NRFANRHFSA-N 335164 US11040966, Example 6.124::US9732075, Example 6.124::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(3,5-dimethyl-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 15.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335164 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335164&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127426 384987323 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657968 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3ccc(Cl)c(C)c3[nH]2)c(s1)-c1cc(C)cc(C)c1 InChI=1S/C26H25ClN4OS/c1-13-8-14(2)10-18(9-13)24-23(28-17(5)33-24)26(32)31-12-15(3)11-21(31)25-29-20-7-6-19(27)16(4)22(20)30-25/h6-10,21H,3,11-12H2,1-2,4-5H3,(H,29,30)/t21-/m0/s1 RSOSHFPRIPHDQX-NRFANRHFSA-N 335164 US11040966, Example 6.124::US9732075, Example 6.124::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(3,5-dimethyl-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335164 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335164&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127426 384987323 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657969 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3ccc(Cl)c(C)c3[nH]2)c(s1)-c1ccc(F)c(Br)c1 InChI=1S/C24H19BrClFN4OS/c1-11-8-19(23-29-18-7-5-16(26)12(2)20(18)30-23)31(10-11)24(32)21-22(33-13(3)28-21)14-4-6-17(27)15(25)9-14/h4-7,9,19H,1,8,10H2,2-3H3,(H,29,30)/t19-/m0/s1 DIKCPRSWFGQRLD-IBGZPJMESA-N 335165 US11040966, Example 6.125::US9732075, Example 6.125::[5-(3-Bromo-4-fluoro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(6-chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335165 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335165&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127660 384987324 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657970 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3ccc(Cl)c(C)c3[nH]2)c(s1)-c1ccc(F)c(Br)c1 InChI=1S/C24H19BrClFN4OS/c1-11-8-19(23-29-18-7-5-16(26)12(2)20(18)30-23)31(10-11)24(32)21-22(33-13(3)28-21)14-4-6-17(27)15(25)9-14/h4-7,9,19H,1,8,10H2,2-3H3,(H,29,30)/t19-/m0/s1 DIKCPRSWFGQRLD-IBGZPJMESA-N 335165 US11040966, Example 6.125::US9732075, Example 6.125::[5-(3-Bromo-4-fluoro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(6-chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 0.800 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335165 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335165&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127660 384987324 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657971 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3ccc(Cl)c(C)c3[nH]2)c(s1)-c1ccc(Cl)c(Cl)c1 InChI=1S/C24H19Cl3N4OS/c1-11-8-19(23-29-18-7-6-15(25)12(2)20(18)30-23)31(10-11)24(32)21-22(33-13(3)28-21)14-4-5-16(26)17(27)9-14/h4-7,9,19H,1,8,10H2,2-3H3,(H,29,30)/t19-/m0/s1 SKRGGMWIJIAQDK-IBGZPJMESA-N 335166 US11040966, Example 6.126::US9732075, Example 6.126::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(3,4-dichloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335166&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128104 384987325 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657972 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3ccc(Cl)c(C)c3[nH]2)c(s1)-c1ccc(Cl)c(Cl)c1 InChI=1S/C24H19Cl3N4OS/c1-11-8-19(23-29-18-7-6-15(25)12(2)20(18)30-23)31(10-11)24(32)21-22(33-13(3)28-21)14-4-5-16(26)17(27)9-14/h4-7,9,19H,1,8,10H2,2-3H3,(H,29,30)/t19-/m0/s1 SKRGGMWIJIAQDK-IBGZPJMESA-N 335166 US11040966, Example 6.126::US9732075, Example 6.126::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(3,4-dichloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 0.800 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335166 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335166&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128104 384987325 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657973 Cc1ccc(c(n1)C(=O)N1CC(=C)C[C@H]1c1nc2ccc(Cl)c(C)c2[nH]1)-n1nccn1 InChI=1S/C22H20ClN7O/c1-12-10-18(21-27-16-6-5-15(23)14(3)19(16)28-21)29(11-12)22(31)20-17(7-4-13(2)26-20)30-24-8-9-25-30/h4-9,18H,1,10-11H2,2-3H3,(H,27,28)/t18-/m0/s1 NFLWNYJGNBARES-SFHVURJKSA-N 335167 US11040966, Example 6.127::US9732075, Example 6.127::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 17.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335167 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335167&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127023 384987326 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657974 Cc1ccc(c(n1)C(=O)N1CC(=C)C[C@H]1c1nc2ccc(Cl)c(C)c2[nH]1)-n1nccn1 InChI=1S/C22H20ClN7O/c1-12-10-18(21-27-16-6-5-15(23)14(3)19(16)28-21)29(11-12)22(31)20-17(7-4-13(2)26-20)30-24-8-9-25-30/h4-9,18H,1,10-11H2,2-3H3,(H,27,28)/t18-/m0/s1 NFLWNYJGNBARES-SFHVURJKSA-N 335167 US11040966, Example 6.127::US9732075, Example 6.127::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone Orexin receptor type 2 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335167 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335167&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127023 384987326 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657975 Cc1c(Cl)ccc2nc([nH]c12)[C@@H]1CC(=C)CN1C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C22H18Cl2N6O/c1-12-9-19(21-27-17-5-4-16(24)13(2)20(17)28-21)29(11-12)22(31)15-10-14(23)3-6-18(15)30-25-7-8-26-30/h3-8,10,19H,1,9,11H2,2H3,(H,27,28)/t19-/m0/s1 WMSOKWMKDYBMFL-IBGZPJMESA-N 335168 US11040966, Example 6.128::US9732075, Example 6.128::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-chloro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 20.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335168 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335168&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127297 384987327 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657976 Cc1c(Cl)ccc2nc([nH]c12)[C@@H]1CC(=C)CN1C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C22H18Cl2N6O/c1-12-9-19(21-27-17-5-4-16(24)13(2)20(17)28-21)29(11-12)22(31)15-10-14(23)3-6-18(15)30-25-7-8-26-30/h3-8,10,19H,1,9,11H2,2H3,(H,27,28)/t19-/m0/s1 WMSOKWMKDYBMFL-IBGZPJMESA-N 335168 US11040966, Example 6.128::US9732075, Example 6.128::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-chloro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335168 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335168&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127297 384987327 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657977 Cc1c(Cl)ccc2nc([nH]c12)[C@@H]1CC(=C)CN1C(=O)c1cc(ccc1-n1nccn1)C(F)(F)F InChI=1S/C23H18ClF3N6O/c1-12-9-19(21-30-17-5-4-16(24)13(2)20(17)31-21)32(11-12)22(34)15-10-14(23(25,26)27)3-6-18(15)33-28-7-8-29-33/h3-8,10,19H,1,9,11H2,2H3,(H,30,31)/t19-/m0/s1 XEIFHAXDRZKPFR-IBGZPJMESA-N 335169 US11040966, Example 6.129::US9732075, Example 6.129::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methyl-ene-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoromethyl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 215 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335169&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127947 384987328 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657978 Cc1c(Cl)ccc2nc([nH]c12)[C@@H]1CC(=C)CN1C(=O)c1cc(ccc1-n1nccn1)C(F)(F)F InChI=1S/C23H18ClF3N6O/c1-12-9-19(21-30-17-5-4-16(24)13(2)20(17)31-21)32(11-12)22(34)15-10-14(23(25,26)27)3-6-18(15)33-28-7-8-29-33/h3-8,10,19H,1,9,11H2,2H3,(H,30,31)/t19-/m0/s1 XEIFHAXDRZKPFR-IBGZPJMESA-N 335169 US11040966, Example 6.129::US9732075, Example 6.129::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methyl-ene-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoromethyl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 39.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335169 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335169&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127947 384987328 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657979 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H20N6O2/c1-14-11-20(21-25-17-8-7-15(30-2)12-18(17)26-21)27(13-14)22(29)16-5-3-4-6-19(16)28-23-9-10-24-28/h3-10,12,20H,1,11,13H2,2H3,(H,25,26)/t20-/m0/s1 SLKDBHCQGPYVFB-FQEVSTJZSA-N 335170 US11040966, Example 6.13::US9732075, Example 6.13::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 155 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335170 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335170&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128274 384987329 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657980 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H20N6O2/c1-14-11-20(21-25-17-8-7-15(30-2)12-18(17)26-21)27(13-14)22(29)16-5-3-4-6-19(16)28-23-9-10-24-28/h3-10,12,20H,1,11,13H2,2H3,(H,25,26)/t20-/m0/s1 SLKDBHCQGPYVFB-FQEVSTJZSA-N 335170 US11040966, Example 6.13::US9732075, Example 6.13::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 17.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335170 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335170&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128274 384987329 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657981 Cc1cc(C(=O)N2CC(=C)C[C@H]2c2nc3ccc(Cl)c(C)c3[nH]2)c(cc1C)-n1nccn1 InChI=1S/C24H23ClN6O/c1-13-9-21(23-28-19-6-5-18(25)16(4)22(19)29-23)30(12-13)24(32)17-10-14(2)15(3)11-20(17)31-26-7-8-27-31/h5-8,10-11,21H,1,9,12H2,2-4H3,(H,28,29)/t21-/m0/s1 ZZUZMFIWZAUINT-NRFANRHFSA-N 335171 US11040966, Example 6.130::US9732075, Example 6.130::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methyl-ene-pyrrolidin-1-yl]-(4,5-dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 11.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335171 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335171&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694584 384987330 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657982 Cc1cc(C(=O)N2CC(=C)C[C@H]2c2nc3ccc(Cl)c(C)c3[nH]2)c(cc1C)-n1nccn1 InChI=1S/C24H23ClN6O/c1-13-9-21(23-28-19-6-5-18(25)16(4)22(19)29-23)30(12-13)24(32)17-10-14(2)15(3)11-20(17)31-26-7-8-27-31/h5-8,10-11,21H,1,9,12H2,2-4H3,(H,28,29)/t21-/m0/s1 ZZUZMFIWZAUINT-NRFANRHFSA-N 335171 US11040966, Example 6.130::US9732075, Example 6.130::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methyl-ene-pyrrolidin-1-yl]-(4,5-dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 0.600 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335171 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335171&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694584 384987330 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657983 COc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2ccc(Cl)c(C)c2[nH]1)-n1nccn1 InChI=1S/C23H21ClN6O2/c1-13-10-20(22-27-18-6-5-17(24)14(2)21(18)28-22)29(12-13)23(31)16-11-15(32-3)4-7-19(16)30-25-8-9-26-30/h4-9,11,20H,1,10,12H2,2-3H3,(H,27,28)/t20-/m0/s1 IYMUFCLJMFWSHR-FQEVSTJZSA-N 335172 US11040966, Example 6.131::US9732075, Example 6.131::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methyl-ene-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335172 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335172&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694686 384987331 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657984 COc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2ccc(Cl)c(C)c2[nH]1)-n1nccn1 InChI=1S/C23H21ClN6O2/c1-13-10-20(22-27-18-6-5-17(24)14(2)21(18)28-22)29(12-13)23(31)16-11-15(32-3)4-7-19(16)30-25-8-9-26-30/h4-9,11,20H,1,10,12H2,2-3H3,(H,27,28)/t20-/m0/s1 IYMUFCLJMFWSHR-FQEVSTJZSA-N 335172 US11040966, Example 6.131::US9732075, Example 6.131::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methyl-ene-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 0.500 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335172 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335172&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694686 384987331 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657985 Cc1ccc(c(C(=O)N2CC(=C)C[C@H]2c2nc3ccc(Cl)c(C)c3[nH]2)c1F)-n1nccn1 InChI=1S/C23H20ClFN6O/c1-12-10-18(22-28-16-6-5-15(24)14(3)21(16)29-22)30(11-12)23(32)19-17(31-26-8-9-27-31)7-4-13(2)20(19)25/h4-9,18H,1,10-11H2,2-3H3,(H,28,29)/t18-/m0/s1 MDMUZMNPDNQTMF-SFHVURJKSA-N 335173 US11040966, Example 6.132::US9732075, Example 6.132::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methyl-ene-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335173 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335173&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694583 384987332 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657986 Cc1ccc(c(C(=O)N2CC(=C)C[C@H]2c2nc3ccc(Cl)c(C)c3[nH]2)c1F)-n1nccn1 InChI=1S/C23H20ClFN6O/c1-12-10-18(22-28-16-6-5-15(24)14(3)21(16)29-22)30(11-12)23(32)19-17(31-26-8-9-27-31)7-4-13(2)20(19)25/h4-9,18H,1,10-11H2,2-3H3,(H,28,29)/t18-/m0/s1 MDMUZMNPDNQTMF-SFHVURJKSA-N 335173 US11040966, Example 6.132::US9732075, Example 6.132::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methyl-ene-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335173 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335173&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694583 384987332 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657987 COc1ccc(c(C(=O)N2CC(=C)C[C@H]2c2nc3ccc(Cl)c(C)c3[nH]2)c1F)-n1nccn1 InChI=1S/C23H20ClFN6O2/c1-12-10-17(22-28-15-5-4-14(24)13(2)21(15)29-22)30(11-12)23(32)19-16(31-26-8-9-27-31)6-7-18(33-3)20(19)25/h4-9,17H,1,10-11H2,2-3H3,(H,28,29)/t17-/m0/s1 FZZMSUDTQOQSBH-KRWDZBQOSA-N 335174 US11040966, Example 6.133::US9732075, Example 6.133::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methyl-ene-pyrrolidin-1-yl]-(2-fluoro-3-methoxy-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335174 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335174&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694582 384987333 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657988 COc1ccc(c(C(=O)N2CC(=C)C[C@H]2c2nc3ccc(Cl)c(C)c3[nH]2)c1F)-n1nccn1 InChI=1S/C23H20ClFN6O2/c1-12-10-17(22-28-15-5-4-14(24)13(2)21(15)29-22)30(11-12)23(32)19-16(31-26-8-9-27-31)6-7-18(33-3)20(19)25/h4-9,17H,1,10-11H2,2-3H3,(H,28,29)/t17-/m0/s1 FZZMSUDTQOQSBH-KRWDZBQOSA-N 335174 US11040966, Example 6.133::US9732075, Example 6.133::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methyl-ene-pyrrolidin-1-yl]-(2-fluoro-3-methoxy-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335174 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335174&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694582 384987333 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657989 Cc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2ccc(Cl)c(C)c2[nH]1)-n1cccn1 InChI=1S/C24H22ClN5O/c1-14-5-8-20(30-10-4-9-26-30)17(11-14)24(31)29-13-15(2)12-21(29)23-27-19-7-6-18(25)16(3)22(19)28-23/h4-11,21H,2,12-13H2,1,3H3,(H,27,28)/t21-/m0/s1 AFHHDFJTQNISNL-NRFANRHFSA-N 335175 US11040966, Example 6.134::US9732075, Example 6.134::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methyl-ene-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 75.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335175 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335175&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127611 384987334 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657990 Cc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2ccc(Cl)c(C)c2[nH]1)-n1cccn1 InChI=1S/C24H22ClN5O/c1-14-5-8-20(30-10-4-9-26-30)17(11-14)24(31)29-13-15(2)12-21(29)23-27-19-7-6-18(25)16(3)22(19)28-23/h4-11,21H,2,12-13H2,1,3H3,(H,27,28)/t21-/m0/s1 AFHHDFJTQNISNL-NRFANRHFSA-N 335175 US11040966, Example 6.134::US9732075, Example 6.134::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methyl-ene-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 10.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335175 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335175&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127611 384987334 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657991 Cc1ccc(c(n1)C(=O)N1CC(=C)C[C@H]1c1nc2ccc(Cl)c(C)c2[nH]1)-n1cccn1 InChI=1S/C23H21ClN6O/c1-13-11-19(22-27-17-7-6-16(24)15(3)20(17)28-22)29(12-13)23(31)21-18(8-5-14(2)26-21)30-10-4-9-25-30/h4-10,19H,1,11-12H2,2-3H3,(H,27,28)/t19-/m0/s1 HLGWLGMOMLHIKH-IBGZPJMESA-N 335176 US11040966, Example 6.135::US9732075, Example 6.135::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methyl-ene-pyrrolidin-1-yl]-(6-methyl-3-pyrazol-1-yl-pyridin-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 83.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335176 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335176&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127080 384987335 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657992 Cc1ccc(c(n1)C(=O)N1CC(=C)C[C@H]1c1nc2ccc(Cl)c(C)c2[nH]1)-n1cccn1 InChI=1S/C23H21ClN6O/c1-13-11-19(22-27-17-7-6-16(24)15(3)20(17)28-22)29(12-13)23(31)21-18(8-5-14(2)26-21)30-10-4-9-25-30/h4-10,19H,1,11-12H2,2-3H3,(H,27,28)/t19-/m0/s1 HLGWLGMOMLHIKH-IBGZPJMESA-N 335176 US11040966, Example 6.135::US9732075, Example 6.135::[(S)-2-(6-Chloro-7-methyl-1H-benzoimidazol-2-yl)-4-methyl-ene-pyrrolidin-1-yl]-(6-methyl-3-pyrazol-1-yl-pyridin-2-yl)-methanone Orexin receptor type 2 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335176 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335176&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127080 384987335 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657993 COc1ccc2nc([nH]c2c1)[C@@H]1CC(=C)CN1C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C22H19ClN6O2/c1-13-9-20(21-26-17-5-4-15(31-2)11-18(17)27-21)28(12-13)22(30)16-10-14(23)3-6-19(16)29-24-7-8-25-29/h3-8,10-11,20H,1,9,12H2,2H3,(H,26,27)/t20-/m0/s1 QELOKFYTJKRCOA-FQEVSTJZSA-N 335177 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone::US11040966, Example 6.136::US9732075, Example 6.136 Orexin/Hypocretin receptor type 1 Homo sapiens 765 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335177 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335177&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127352 384987336 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657994 COc1ccc2nc([nH]c2c1)[C@@H]1CC(=C)CN1C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C22H19ClN6O2/c1-13-9-20(21-26-17-5-4-15(31-2)11-18(17)27-21)28(12-13)22(30)16-10-14(23)3-6-19(16)29-24-7-8-25-29/h3-8,10-11,20H,1,9,12H2,2H3,(H,26,27)/t20-/m0/s1 QELOKFYTJKRCOA-FQEVSTJZSA-N 335177 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone::US11040966, Example 6.136::US9732075, Example 6.136 Orexin receptor type 2 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335177 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335177&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127352 384987336 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657995 COc1ccc2nc([nH]c2c1)[C@@H]1CC(=C)CN1C(=O)c1cc(C)ccc1-n1cccn1 InChI=1S/C24H23N5O2/c1-15-5-8-21(29-10-4-9-25-29)18(11-15)24(30)28-14-16(2)12-22(28)23-26-19-7-6-17(31-3)13-20(19)27-23/h4-11,13,22H,2,12,14H2,1,3H3,(H,26,27)/t22-/m0/s1 ORPFJJWFLSSMQY-QFIPXVFZSA-N 335178 US11040966, Example 6.137::US9732075, Example 6.137::[(S)-2-(6-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 4950 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335178 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335178&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127249 384987337 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657996 COc1ccc2nc([nH]c2c1)[C@@H]1CC(=C)CN1C(=O)c1cc(C)ccc1-n1cccn1 InChI=1S/C24H23N5O2/c1-15-5-8-21(29-10-4-9-25-29)18(11-15)24(30)28-14-16(2)12-22(28)23-26-19-7-6-17(31-3)13-20(19)27-23/h4-11,13,22H,2,12,14H2,1,3H3,(H,26,27)/t22-/m0/s1 ORPFJJWFLSSMQY-QFIPXVFZSA-N 335178 US11040966, Example 6.137::US9732075, Example 6.137::[(S)-2-(6-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 23.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335178 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335178&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127249 384987337 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657997 COc1ccc2nc([nH]c2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(C)ccc1-n1cccn1 InChI=1S/C23H22N6O2/c1-14-11-20(22-26-17-7-6-16(31-3)12-18(17)27-22)28(13-14)23(30)21-19(8-5-15(2)25-21)29-10-4-9-24-29/h4-10,12,20H,1,11,13H2,2-3H3,(H,26,27)/t20-/m0/s1 MRPHUDJMPZTNKP-FQEVSTJZSA-N 335179 US11040966, Example 6.138::US9732075, Example 6.138::[(S)-2-(6-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-(6-methyl-3-pyrazol-1-yl-pyridin-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens >6970 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335179&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127860 384987338 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 657998 COc1ccc2nc([nH]c2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(C)ccc1-n1cccn1 InChI=1S/C23H22N6O2/c1-14-11-20(22-26-17-7-6-16(31-3)12-18(17)27-22)28(13-14)23(30)21-19(8-5-15(2)25-21)29-10-4-9-24-29/h4-10,12,20H,1,11,13H2,2-3H3,(H,26,27)/t20-/m0/s1 MRPHUDJMPZTNKP-FQEVSTJZSA-N 335179 US11040966, Example 6.138::US9732075, Example 6.138::[(S)-2-(6-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-(6-methyl-3-pyrazol-1-yl-pyridin-2-yl)-methanone Orexin receptor type 2 Homo sapiens 34.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335179 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335179&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127860 384987338 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 657999 COc1ccc2nc([nH]c2c1)[C@@H]1CC(=C)CN1C(=O)c1cc(C)c(C)cc1-n1nccn1 InChI=1S/C24H24N6O2/c1-14-9-22(23-27-19-6-5-17(32-4)12-20(19)28-23)29(13-14)24(31)18-10-15(2)16(3)11-21(18)30-25-7-8-26-30/h5-8,10-12,22H,1,9,13H2,2-4H3,(H,27,28)/t22-/m0/s1 XSKYYULXLGRXSP-QFIPXVFZSA-N 335180 (4,5-Dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone::US11040966, Example 6.139::US9732075, Example 6.139 Orexin/Hypocretin receptor type 1 Homo sapiens 137 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335180 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335180&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127191 384987339 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658000 COc1ccc2nc([nH]c2c1)[C@@H]1CC(=C)CN1C(=O)c1cc(C)c(C)cc1-n1nccn1 InChI=1S/C24H24N6O2/c1-14-9-22(23-27-19-6-5-17(32-4)12-20(19)28-23)29(13-14)24(31)18-10-15(2)16(3)11-21(18)30-25-7-8-26-30/h5-8,10-12,22H,1,9,13H2,2-4H3,(H,27,28)/t22-/m0/s1 XSKYYULXLGRXSP-QFIPXVFZSA-N 335180 (4,5-Dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone::US11040966, Example 6.139::US9732075, Example 6.139 Orexin receptor type 2 Homo sapiens 0.600 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335180 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335180&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127191 384987339 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658001 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1ccccc1-c1cccc(C)c1 InChI=1S/C27H25N3O2/c1-17-7-6-8-19(13-17)21-9-4-5-10-22(21)27(31)30-16-18(2)14-25(30)26-28-23-12-11-20(32-3)15-24(23)29-26/h4-13,15,25H,2,14,16H2,1,3H3,(H,28,29)/t25-/m0/s1 MKXDKLLXGGSEJC-VWLOTQADSA-N 335181 US11040966, Example 6.14::US9732075, Example 6.14::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-(3'-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 87.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335181 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335181&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127477 384987340 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658002 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1ccccc1-c1cccc(C)c1 InChI=1S/C27H25N3O2/c1-17-7-6-8-19(13-17)21-9-4-5-10-22(21)27(31)30-16-18(2)14-25(30)26-28-23-12-11-20(32-3)15-24(23)29-26/h4-13,15,25H,2,14,16H2,1,3H3,(H,28,29)/t25-/m0/s1 MKXDKLLXGGSEJC-VWLOTQADSA-N 335181 US11040966, Example 6.14::US9732075, Example 6.14::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-(3'-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 12.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335181 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335181&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127477 384987340 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658003 COc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2ccc(OC)cc2[nH]1)-n1nccn1 InChI=1S/C23H22N6O3/c1-14-10-21(22-26-18-6-4-16(32-3)12-19(18)27-22)28(13-14)23(30)17-11-15(31-2)5-7-20(17)29-24-8-9-25-29/h4-9,11-12,21H,1,10,13H2,2-3H3,(H,26,27)/t21-/m0/s1 WCCQLIPHSHVDLI-NRFANRHFSA-N 335182 US11040966, Example 6.140::US9732075, Example 6.140::[(S)-2-(6-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 667 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335182 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335182&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127838 384987341 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658004 COc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2ccc(OC)cc2[nH]1)-n1nccn1 InChI=1S/C23H22N6O3/c1-14-10-21(22-26-18-6-4-16(32-3)12-19(18)27-22)28(13-14)23(30)17-11-15(31-2)5-7-20(17)29-24-8-9-25-29/h4-9,11-12,21H,1,10,13H2,2-3H3,(H,26,27)/t21-/m0/s1 WCCQLIPHSHVDLI-NRFANRHFSA-N 335182 US11040966, Example 6.140::US9732075, Example 6.140::[(S)-2-(6-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 10.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335182 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335182&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127838 384987341 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658005 COc1ccc2nc([nH]c2c1)[C@@H]1CC(=C)CN1C(=O)c1c(F)c(C)ccc1-n1nccn1 InChI=1S/C23H21FN6O2/c1-13-10-19(22-27-16-6-5-15(32-3)11-17(16)28-22)29(12-13)23(31)20-18(30-25-8-9-26-30)7-4-14(2)21(20)24/h4-9,11,19H,1,10,12H2,2-3H3,(H,27,28)/t19-/m0/s1 SPYDYJFNWACDJI-IBGZPJMESA-N 335183 (2-Fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone::US11040966, Example 6.141::US9732075, Example 6.141 Orexin/Hypocretin receptor type 1 Homo sapiens 883 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335183&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118126995 384987342 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658006 COc1ccc2nc([nH]c2c1)[C@@H]1CC(=C)CN1C(=O)c1c(F)c(C)ccc1-n1nccn1 InChI=1S/C23H21FN6O2/c1-13-10-19(22-27-16-6-5-15(32-3)11-17(16)28-22)29(12-13)23(31)20-18(30-25-8-9-26-30)7-4-14(2)21(20)24/h4-9,11,19H,1,10,12H2,2-3H3,(H,27,28)/t19-/m0/s1 SPYDYJFNWACDJI-IBGZPJMESA-N 335183 (2-Fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone::US11040966, Example 6.141::US9732075, Example 6.141 Orexin receptor type 2 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335183 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335183&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118126995 384987342 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658007 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3cc(c(Cl)cc3[nH]2)C(F)(F)F)c(s1)-c1ccc(C)c(C)c1 InChI=1S/C26H22ClF3N4OS/c1-12-7-21(24-32-19-9-17(26(28,29)30)18(27)10-20(19)33-24)34(11-12)25(35)22-23(36-15(4)31-22)16-6-5-13(2)14(3)8-16/h5-6,8-10,21H,1,7,11H2,2-4H3,(H,32,33)/t21-/m0/s1 AERRSEVAWWKADY-NRFANRHFSA-N 335184 US11040966, Example 6.142::US9732075, Example 6.142::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(3,4-dimethyl-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 17.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335184 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335184&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128031 384987343 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658008 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3cc(c(Cl)cc3[nH]2)C(F)(F)F)c(s1)-c1ccc(C)c(C)c1 InChI=1S/C26H22ClF3N4OS/c1-12-7-21(24-32-19-9-17(26(28,29)30)18(27)10-20(19)33-24)34(11-12)25(35)22-23(36-15(4)31-22)16-6-5-13(2)14(3)8-16/h5-6,8-10,21H,1,7,11H2,2-4H3,(H,32,33)/t21-/m0/s1 AERRSEVAWWKADY-NRFANRHFSA-N 335184 US11040966, Example 6.142::US9732075, Example 6.142::[(S)-2-(6-Chloro-5-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(3,4-dimethyl-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 22.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335184 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335184&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128031 384987343 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658009 COc1ccc2[nH]c(nc2c1)C1(C)CC(=C)CN1C(=O)c1nc(C)sc1-c1cccc(C)c1 335185 US11040966, Example 6.143::US9732075, Example 6.143::rac-[2-(5-Methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-(2-methyl-5-m-tolyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335185 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335185&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694484 384987344 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658010 COc1ccc2[nH]c(nc2c1)C1(C)CC(=C)CN1C(=O)c1nc(C)sc1-c1cccc(C)c1 335185 US11040966, Example 6.143::US9732075, Example 6.143::rac-[2-(5-Methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-(2-methyl-5-m-tolyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 32.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335185 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335185&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694484 384987344 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658011 COc1ccc2[nH]c(nc2c1)C1(C)CC(=C)CN1C(=O)c1nc(sc1-c1ccc(C)c(C)c1)N(C)C 335186 US11040966, Example 6.144::US9732075, Example 6.144::rac-[2-Dimethylamino-5-(3,4-dimethyl-phenyl)-thiazol-4-yl]-[2-(5-methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 15.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335186 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335186&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72694581 384987345 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658012 COc1ccc2[nH]c(nc2c1)C1(C)CC(=C)CN1C(=O)c1nc(sc1-c1ccc(C)c(C)c1)N(C)C 335186 US11040966, Example 6.144::US9732075, Example 6.144::rac-[2-Dimethylamino-5-(3,4-dimethyl-phenyl)-thiazol-4-yl]-[2-(5-methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 56.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335186 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335186&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72694581 384987345 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658013 COc1ccc2[nH]c(nc2c1)C1(C)CC(=C)CN1C(=O)c1nc(C)sc1-c1ccc(C)c(C)c1 335187 US11040966, Example 6.145::US9732075, Example 6.145::rac-[5-(3,4-Dimethyl-phenyl)-2-methyl-thiazol-4-yl]-[2-(5-methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 21.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335187 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335187&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127238 384987346 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658014 COc1ccc2[nH]c(nc2c1)C1(C)CC(=C)CN1C(=O)c1nc(C)sc1-c1ccc(C)c(C)c1 335187 US11040966, Example 6.145::US9732075, Example 6.145::rac-[5-(3,4-Dimethyl-phenyl)-2-methyl-thiazol-4-yl]-[2-(5-methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 75.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335187 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335187&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127238 384987346 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658015 COc1ccc2[nH]c(nc2c1)C1(C)CC(=C)CN1C(=O)c1nc(C)sc1-c1ccc(Cl)cc1 335188 US11040966, Example 6.146::US9732075, Example 6.146::rac-[5-(4-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(5-methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 16.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335188 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335188&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695597 384987347 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658016 COc1ccc2[nH]c(nc2c1)C1(C)CC(=C)CN1C(=O)c1nc(C)sc1-c1ccc(Cl)cc1 335188 US11040966, Example 6.146::US9732075, Example 6.146::rac-[5-(4-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(5-methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 33.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335188 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335188&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695597 384987347 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658017 COc1ccc(cc1)-c1sc(C)nc1C(=O)N1CC(=C)CC1(C)c1nc2cc(OC)ccc2[nH]1 335189 US11040966, Example 6.147::US9732075, Example 6.147::rac-[2-(5-Methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-[5-(4-methoxy-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335189&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695696 384987348 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658018 COc1ccc(cc1)-c1sc(C)nc1C(=O)N1CC(=C)CC1(C)c1nc2cc(OC)ccc2[nH]1 335189 US11040966, Example 6.147::US9732075, Example 6.147::rac-[2-(5-Methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-[5-(4-methoxy-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 34.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335189 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335189&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695696 384987348 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658019 COc1ccc2[nH]c(nc2c1)C1(C)CC(=C)CN1C(=O)c1nc(C)sc1-c1ccc(C)cc1 335190 US11040966, Example 6.148::US9732075, Example 6.148::rac-[2-(5-Methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-(2-methyl-5-p-tolyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 19.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335190 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335190&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695599 384987349 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658020 COc1ccc2[nH]c(nc2c1)C1(C)CC(=C)CN1C(=O)c1nc(C)sc1-c1ccc(C)cc1 335190 US11040966, Example 6.148::US9732075, Example 6.148::rac-[2-(5-Methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-(2-methyl-5-p-tolyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 40.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335190 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335190&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695599 384987349 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658021 COc1ccc2[nH]c(nc2c1)C1(C)CC(=C)CN1C(=O)c1ccccc1-c1ccc(C)c(C)c1 335191 US11040966, Example 6.149::US9732075, Example 6.149::rac-(3',4'-Dimethyl-biphenyl-2-yl)-[2-(5-methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 59.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335191 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335191&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127218 384987350 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658022 COc1ccc2[nH]c(nc2c1)C1(C)CC(=C)CN1C(=O)c1ccccc1-c1ccc(C)c(C)c1 335191 US11040966, Example 6.149::US9732075, Example 6.149::rac-(3',4'-Dimethyl-biphenyl-2-yl)-[2-(5-methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 90.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335191 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335191&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127218 384987350 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658023 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1ccccc1-c1ccc(C)cc1 InChI=1S/C27H25N3O2/c1-17-8-10-19(11-9-17)21-6-4-5-7-22(21)27(31)30-16-18(2)14-25(30)26-28-23-13-12-20(32-3)15-24(23)29-26/h4-13,15,25H,2,14,16H2,1,3H3,(H,28,29)/t25-/m0/s1 KAXREJIDRGZNPT-VWLOTQADSA-N 335192 US11040966, Example 6.15::US9732075, Example 6.15::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-(4'-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 298 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335192&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102337 384987351 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658024 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1ccccc1-c1ccc(C)cc1 InChI=1S/C27H25N3O2/c1-17-8-10-19(11-9-17)21-6-4-5-7-22(21)27(31)30-16-18(2)14-25(30)26-28-23-13-12-20(32-3)15-24(23)29-26/h4-13,15,25H,2,14,16H2,1,3H3,(H,28,29)/t25-/m0/s1 KAXREJIDRGZNPT-VWLOTQADSA-N 335192 US11040966, Example 6.15::US9732075, Example 6.15::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-(4'-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 37.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335192 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335192&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102337 384987351 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658025 COc1ccc2[nH]c(nc2c1)C1(C)CC(=C)CN1C(=O)c1ccccc1-c1ccccc1 335193 US11040966, Example 6.150::US9732075, Example 6.150::rac-Biphenyl-2-yl-[2-(5-methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 218 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335193 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335193&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102345 384987352 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658026 COc1ccc2[nH]c(nc2c1)C1(C)CC(=C)CN1C(=O)c1ccccc1-c1ccccc1 335193 US11040966, Example 6.150::US9732075, Example 6.150::rac-Biphenyl-2-yl-[2-(5-methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 91.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335193 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335193&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102345 384987352 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658027 COc1ccc2[nH]c(nc2c1)C1(C)CC(=C)CN1C(=O)c1ccccc1-c1ccc(F)c(C)c1 335194 US11040966, Example 6.151::US9732075, Example 6.151::rac-(4'-Fluoro-3'-methyl-biphenyl-2-yl)-[2-(5-methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 46.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335194 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335194&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128076 384987353 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658028 COc1ccc2[nH]c(nc2c1)C1(C)CC(=C)CN1C(=O)c1ccccc1-c1ccc(F)c(C)c1 335194 US11040966, Example 6.151::US9732075, Example 6.151::rac-(4'-Fluoro-3'-methyl-biphenyl-2-yl)-[2-(5-methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 44.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335194 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335194&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128076 384987353 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658029 COc1ccc2[nH]c(nc2c1)C1(C)CC(=C)CN1C(=O)c1nc(sc1-c1cccc(Cl)c1)N(C)C 335195 US11040966, Example 6.152::US9732075, Example 6.152::rac-[5-(3-Chloro-phenyl)-2-dimethylamino-thiazol-4-yl]-[2-(5-methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335195&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695598 384987354 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658030 COc1ccc2[nH]c(nc2c1)C1(C)CC(=C)CN1C(=O)c1nc(sc1-c1cccc(Cl)c1)N(C)C 335195 US11040966, Example 6.152::US9732075, Example 6.152::rac-[5-(3-Chloro-phenyl)-2-dimethylamino-thiazol-4-yl]-[2-(5-methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 20.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335195 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335195&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695598 384987354 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658031 COc1ccc2[nH]c(nc2c1)C1(C)CC(=C)CN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1 335196 US11040966, Example 6.153::US9732075, Example 6.153::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(5-methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335196 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335196&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127346 384987355 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658032 COc1ccc2[nH]c(nc2c1)C1(C)CC(=C)CN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1 335196 US11040966, Example 6.153::US9732075, Example 6.153::rac-[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[2-(5-methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 16.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335196 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335196&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127346 384987355 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658033 COc1ccc2[nH]c(nc2c1)C1(C)CC(=C)CN1C(=O)c1nc(C)sc1-c1ccccc1 335197 US11040966, Example 6.154::US9732075, Example 6.154::rac-[2-(5-Methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 32.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335197 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335197&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127393 384987356 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658034 COc1ccc2[nH]c(nc2c1)C1(C)CC(=C)CN1C(=O)c1nc(C)sc1-c1ccccc1 335197 US11040966, Example 6.154::US9732075, Example 6.154::rac-[2-(5-Methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 38.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335197 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335197&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127393 384987356 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658035 COc1ccc2[nH]c(nc2c1)C1(C)CC(=C)CN1C(=O)c1ccccc1-n1nccn1 335198 US11040966, Example 6.155::US9732075, Example 6.155::rac-[2-(5-Methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 649 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335198 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335198&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128143 384987357 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658036 COc1ccc2[nH]c(nc2c1)C1(C)CC(=C)CN1C(=O)c1ccccc1-n1nccn1 335198 US11040966, Example 6.155::US9732075, Example 6.155::rac-[2-(5-Methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 105 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335198 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335198&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128143 384987357 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658037 COc1ccc2[nH]c(nc2c1)C1(C)CC(=C)CN1C(=O)c1cc(C)ccc1-n1nccn1 335199 US11040966, Example 6.156::US9732075, Example 6.156::rac-[2-(5-Methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 34.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335199 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335199&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128153 384987358 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658038 COc1ccc2[nH]c(nc2c1)C1(C)CC(=C)CN1C(=O)c1cc(C)ccc1-n1nccn1 335199 US11040966, Example 6.156::US9732075, Example 6.156::rac-[2-(5-Methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 12.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335199 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335199&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128153 384987358 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658039 COc1ccc2[nH]c(nc2c1)C1(C)CC(=C)CN1C(=O)c1cc(Cl)ccc1-n1nccn1 335200 US11040966, Example 6.157::US9732075, Example 6.157::rac-(5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[2-(5-methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 70.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335200 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335200&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695596 384987359 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658040 COc1ccc2[nH]c(nc2c1)C1(C)CC(=C)CN1C(=O)c1cc(Cl)ccc1-n1nccn1 335200 US11040966, Example 6.157::US9732075, Example 6.157::rac-(5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[2-(5-methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 21.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335200 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335200&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695596 384987359 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658041 COc1ccc(c(c1)C(=O)N1CC(=C)CC1(C)c1nc2cc(OC)ccc2[nH]1)-n1nccn1 335201 US11040966, Example 6.158::US9732075, Example 6.158::rac-[2-(5-Methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 57.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335201&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128214 384987360 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658042 COc1ccc(c(c1)C(=O)N1CC(=C)CC1(C)c1nc2cc(OC)ccc2[nH]1)-n1nccn1 335201 US11040966, Example 6.158::US9732075, Example 6.158::rac-[2-(5-Methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 35.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335201 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335201&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128214 384987360 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658043 COc1ccc2[nH]c(nc2c1)C1(C)CC(=C)CN1C(=O)c1cc(C)c(C)cc1-n1nccn1 335202 US11040966, Example 6.159::US9732075, Example 6.159::rac-(4,5-Dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-[2-(5-methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 11.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335202&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695595 384987361 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658044 COc1ccc2[nH]c(nc2c1)C1(C)CC(=C)CN1C(=O)c1cc(C)c(C)cc1-n1nccn1 335202 US11040966, Example 6.159::US9732075, Example 6.159::rac-(4,5-Dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-[2-(5-methoxy-1H-benzoimidazol-2-yl)-2-methyl-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 10.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335202 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335202&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695595 384987361 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658045 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1cnc(C)nc1-c1ccccc1 InChI=1S/C25H23N5O2/c1-15-11-22(24-28-20-10-9-18(32-3)12-21(20)29-24)30(14-15)25(31)19-13-26-16(2)27-23(19)17-7-5-4-6-8-17/h4-10,12-13,22H,1,11,14H2,2-3H3,(H,28,29)/t22-/m0/s1 CQNVMAHMRXSYNY-QFIPXVFZSA-N 335203 US11040966, Example 6.16::US9732075, Example 6.16::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-(2-methyl-4-phenyl-pyrimidin-5-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 307 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335203 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335203&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127314 384987362 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658046 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1cnc(C)nc1-c1ccccc1 InChI=1S/C25H23N5O2/c1-15-11-22(24-28-20-10-9-18(32-3)12-21(20)29-24)30(14-15)25(31)19-13-26-16(2)27-23(19)17-7-5-4-6-8-17/h4-10,12-13,22H,1,11,14H2,2-3H3,(H,28,29)/t22-/m0/s1 CQNVMAHMRXSYNY-QFIPXVFZSA-N 335203 US11040966, Example 6.16::US9732075, Example 6.16::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-(2-methyl-4-phenyl-pyrimidin-5-yl)-methanone Orexin receptor type 2 Homo sapiens 151 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335203 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335203&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127314 384987362 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658047 CC(C)(C)c1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1cc(F)ccc1-n1nccn1 InChI=1S/C25H25FN6O/c1-15-11-22(23-29-19-7-5-16(25(2,3)4)12-20(19)30-23)31(14-15)24(33)18-13-17(26)6-8-21(18)32-27-9-10-28-32/h5-10,12-13,22H,1,11,14H2,2-4H3,(H,29,30)/t22-/m0/s1 PYJNVMZDALNWIQ-QFIPXVFZSA-N 335204 US11040966, Example 6.160::US9732075, Example 6.160::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 326 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335204 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335204&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128235 384987363 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658048 CC(C)(C)c1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1cc(F)ccc1-n1nccn1 InChI=1S/C25H25FN6O/c1-15-11-22(23-29-19-7-5-16(25(2,3)4)12-20(19)30-23)31(14-15)24(33)18-13-17(26)6-8-21(18)32-27-9-10-28-32/h5-10,12-13,22H,1,11,14H2,2-4H3,(H,29,30)/t22-/m0/s1 PYJNVMZDALNWIQ-QFIPXVFZSA-N 335204 US11040966, Example 6.160::US9732075, Example 6.160::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335204 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335204&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128235 384987363 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658049 CC(C)(C)c1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C25H25ClN6O/c1-15-11-22(23-29-19-7-5-16(25(2,3)4)12-20(19)30-23)31(14-15)24(33)18-13-17(26)6-8-21(18)32-27-9-10-28-32/h5-10,12-13,22H,1,11,14H2,2-4H3,(H,29,30)/t22-/m0/s1 SRLJJYWAUOSWIO-QFIPXVFZSA-N 335205 US11040966, Example 6.161::US9732075, Example 6.161::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-chloro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 51.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335205&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127740 384987364 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658050 CC(C)(C)c1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C25H25ClN6O/c1-15-11-22(23-29-19-7-5-16(25(2,3)4)12-20(19)30-23)31(14-15)24(33)18-13-17(26)6-8-21(18)32-27-9-10-28-32/h5-10,12-13,22H,1,11,14H2,2-4H3,(H,29,30)/t22-/m0/s1 SRLJJYWAUOSWIO-QFIPXVFZSA-N 335205 US11040966, Example 6.161::US9732075, Example 6.161::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-chloro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335205 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335205&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127740 384987364 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658051 CC(C)(C)c1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1ccccc1-n1nccn1 InChI=1S/C25H26N6O/c1-16-13-22(23-28-19-10-9-17(25(2,3)4)14-20(19)29-23)30(15-16)24(32)18-7-5-6-8-21(18)31-26-11-12-27-31/h5-12,14,22H,1,13,15H2,2-4H3,(H,28,29)/t22-/m0/s1 IXUDMSDRTJNPJS-QFIPXVFZSA-N 335206 US11040966, Example 6.162::US9732075, Example 6.162::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 330 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335206 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335206&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128130 384987365 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658052 CC(C)(C)c1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1ccccc1-n1nccn1 InChI=1S/C25H26N6O/c1-16-13-22(23-28-19-10-9-17(25(2,3)4)14-20(19)29-23)30(15-16)24(32)18-7-5-6-8-21(18)31-26-11-12-27-31/h5-12,14,22H,1,13,15H2,2-4H3,(H,28,29)/t22-/m0/s1 IXUDMSDRTJNPJS-QFIPXVFZSA-N 335206 US11040966, Example 6.162::US9732075, Example 6.162::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335206 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335206&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128130 384987365 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658053 COc1ccc(c(C(=O)N2CC(=C)C[C@H]2c2nc3cc(ccc3[nH]2)C(C)(C)C)c1F)-n1nccn1 InChI=1S/C26H27FN6O2/c1-15-12-20(24-30-17-7-6-16(26(2,3)4)13-18(17)31-24)32(14-15)25(34)22-19(33-28-10-11-29-33)8-9-21(35-5)23(22)27/h6-11,13,20H,1,12,14H2,2-5H3,(H,30,31)/t20-/m0/s1 HLQDQGXSQBXUBX-FQEVSTJZSA-N 335207 US11040966, Example 6.163::US9732075, Example 6.163::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-fluoro-3-methoxy-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 259 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335207 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335207&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127626 384987366 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658054 COc1ccc(c(C(=O)N2CC(=C)C[C@H]2c2nc3cc(ccc3[nH]2)C(C)(C)C)c1F)-n1nccn1 InChI=1S/C26H27FN6O2/c1-15-12-20(24-30-17-7-6-16(26(2,3)4)13-18(17)31-24)32(14-15)25(34)22-19(33-28-10-11-29-33)8-9-21(35-5)23(22)27/h6-11,13,20H,1,12,14H2,2-5H3,(H,30,31)/t20-/m0/s1 HLQDQGXSQBXUBX-FQEVSTJZSA-N 335207 US11040966, Example 6.163::US9732075, Example 6.163::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-fluoro-3-methoxy-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 72.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335207 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335207&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127626 384987366 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658055 Cc1ccc(c(C(=O)N2CC(=C)C[C@H]2c2nc3cc(ccc3[nH]2)C(C)(C)C)c1F)-n1nccn1 InChI=1S/C26H27FN6O/c1-15-12-21(24-30-18-8-7-17(26(3,4)5)13-19(18)31-24)32(14-15)25(34)22-20(33-28-10-11-29-33)9-6-16(2)23(22)27/h6-11,13,21H,1,12,14H2,2-5H3,(H,30,31)/t21-/m0/s1 SNFKNHLGASJYGA-NRFANRHFSA-N 335208 US11040966, Example 6.164::US9732075, Example 6.164::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 100.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335208 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335208&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127628 384987367 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658056 Cc1ccc(c(C(=O)N2CC(=C)C[C@H]2c2nc3cc(ccc3[nH]2)C(C)(C)C)c1F)-n1nccn1 InChI=1S/C26H27FN6O/c1-15-12-21(24-30-18-8-7-17(26(3,4)5)13-19(18)31-24)32(14-15)25(34)22-20(33-28-10-11-29-33)9-6-16(2)23(22)27/h6-11,13,21H,1,12,14H2,2-5H3,(H,30,31)/t21-/m0/s1 SNFKNHLGASJYGA-NRFANRHFSA-N 335208 US11040966, Example 6.164::US9732075, Example 6.164::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335208 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335208&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127628 384987367 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658057 Cc1cc(C(=O)N2CC(=C)C[C@H]2c2nc3cc(ccc3[nH]2)C(C)(C)C)c(cc1C)-n1nccn1 InChI=1S/C27H30N6O/c1-16-11-24(25-30-21-8-7-19(27(4,5)6)14-22(21)31-25)32(15-16)26(34)20-12-17(2)18(3)13-23(20)33-28-9-10-29-33/h7-10,12-14,24H,1,11,15H2,2-6H3,(H,30,31)/t24-/m0/s1 FLQJJNFFBYVWBI-DEOSSOPVSA-N 335209 US11040966, Example 6.165::US9732075, Example 6.165::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(4,5-dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335209 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335209&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695793 384987368 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658058 Cc1cc(C(=O)N2CC(=C)C[C@H]2c2nc3cc(ccc3[nH]2)C(C)(C)C)c(cc1C)-n1nccn1 InChI=1S/C27H30N6O/c1-16-11-24(25-30-21-8-7-19(27(4,5)6)14-22(21)31-25)32(15-16)26(34)20-12-17(2)18(3)13-23(20)33-28-9-10-29-33/h7-10,12-14,24H,1,11,15H2,2-6H3,(H,30,31)/t24-/m0/s1 FLQJJNFFBYVWBI-DEOSSOPVSA-N 335209 US11040966, Example 6.165::US9732075, Example 6.165::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(4,5-dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335209 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335209&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695793 384987368 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658059 Cc1ccc(C(=O)N2CC(=C)C[C@H]2c2nc3cc(ccc3[nH]2)C(C)(C)C)c(c1)-n1nccn1 InChI=1S/C26H28N6O/c1-16-6-8-19(22(12-16)32-27-10-11-28-32)25(33)31-15-17(2)13-23(31)24-29-20-9-7-18(26(3,4)5)14-21(20)30-24/h6-12,14,23H,2,13,15H2,1,3-5H3,(H,29,30)/t23-/m0/s1 HXNPXGFIGJDACM-QHCPKHFHSA-N 335210 US11040966, Example 6.166::US9732075, Example 6.166::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 33.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335210&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127416 384987369 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658060 Cc1ccc(C(=O)N2CC(=C)C[C@H]2c2nc3cc(ccc3[nH]2)C(C)(C)C)c(c1)-n1nccn1 InChI=1S/C26H28N6O/c1-16-6-8-19(22(12-16)32-27-10-11-28-32)25(33)31-15-17(2)13-23(31)24-29-20-9-7-18(26(3,4)5)14-21(20)30-24/h6-12,14,23H,2,13,15H2,1,3-5H3,(H,29,30)/t23-/m0/s1 HXNPXGFIGJDACM-QHCPKHFHSA-N 335210 US11040966, Example 6.166::US9732075, Example 6.166::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335210 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335210&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127416 384987369 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658061 Cc1cccc(c1C(=O)N1CC(=C)C[C@H]1c1nc2cc(ccc2[nH]1)C(C)(C)C)-n1nccn1 InChI=1S/C26H28N6O/c1-16-13-22(24-29-19-10-9-18(26(3,4)5)14-20(19)30-24)31(15-16)25(33)23-17(2)7-6-8-21(23)32-27-11-12-28-32/h6-12,14,22H,1,13,15H2,2-5H3,(H,29,30)/t22-/m0/s1 QOSZGDXMIZHECH-QFIPXVFZSA-N 335211 US11040966, Example 6.167::US9732075, Example 6.167::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 573 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335211 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335211&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127206 384987370 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658062 Cc1cccc(c1C(=O)N1CC(=C)C[C@H]1c1nc2cc(ccc2[nH]1)C(C)(C)C)-n1nccn1 InChI=1S/C26H28N6O/c1-16-13-22(24-29-19-10-9-18(26(3,4)5)14-20(19)30-24)31(15-16)25(33)23-17(2)7-6-8-21(23)32-27-11-12-28-32/h6-12,14,22H,1,13,15H2,2-5H3,(H,29,30)/t22-/m0/s1 QOSZGDXMIZHECH-QFIPXVFZSA-N 335211 US11040966, Example 6.167::US9732075, Example 6.167::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 25.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335211 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335211&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127206 384987370 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658063 CC(C)(C)c1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1cc(ccc1-n1nccn1)C(F)(F)F InChI=1S/C26H25F3N6O/c1-15-11-22(23-32-19-7-5-16(25(2,3)4)13-20(19)33-23)34(14-15)24(36)18-12-17(26(27,28)29)6-8-21(18)35-30-9-10-31-35/h5-10,12-13,22H,1,11,14H2,2-4H3,(H,32,33)/t22-/m0/s1 BEVXRAMIPHZSQN-QFIPXVFZSA-N 335212 US11040966, Example 6.168::US9732075, Example 6.168::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoromethyl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 261 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335212 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335212&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127248 384987371 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658064 CC(C)(C)c1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1cc(ccc1-n1nccn1)C(F)(F)F InChI=1S/C26H25F3N6O/c1-15-11-22(23-32-19-7-5-16(25(2,3)4)13-20(19)33-23)34(14-15)24(36)18-12-17(26(27,28)29)6-8-21(18)35-30-9-10-31-35/h5-10,12-13,22H,1,11,14H2,2-4H3,(H,32,33)/t22-/m0/s1 BEVXRAMIPHZSQN-QFIPXVFZSA-N 335212 US11040966, Example 6.168::US9732075, Example 6.168::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoromethyl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 54.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335212 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335212&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127248 384987371 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658065 CC(C)(C)c1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1cc(OC(F)(F)F)ccc1-n1nccn1 InChI=1S/C26H25F3N6O2/c1-15-11-22(23-32-19-7-5-16(25(2,3)4)12-20(19)33-23)34(14-15)24(36)18-13-17(37-26(27,28)29)6-8-21(18)35-30-9-10-31-35/h5-10,12-13,22H,1,11,14H2,2-4H3,(H,32,33)/t22-/m0/s1 OOZUWXJMUQHOCO-QFIPXVFZSA-N 335213 US11040966, Example 6.169::US9732075, Example 6.169::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoromethoxy-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 344 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335213 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335213&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127815 384987372 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658066 CC(C)(C)c1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1cc(OC(F)(F)F)ccc1-n1nccn1 InChI=1S/C26H25F3N6O2/c1-15-11-22(23-32-19-7-5-16(25(2,3)4)12-20(19)33-23)34(14-15)24(36)18-13-17(37-26(27,28)29)6-8-21(18)35-30-9-10-31-35/h5-10,12-13,22H,1,11,14H2,2-4H3,(H,32,33)/t22-/m0/s1 OOZUWXJMUQHOCO-QFIPXVFZSA-N 335213 US11040966, Example 6.169::US9732075, Example 6.169::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoromethoxy-phenyl)-methanone Orexin receptor type 2 Homo sapiens 479 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335213 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335213&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127815 384987372 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658067 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1cncnc1-c1cccc(C)c1 InChI=1S/C25H23N5O2/c1-15-5-4-6-17(9-15)23-19(12-26-14-27-23)25(31)30-13-16(2)10-22(30)24-28-20-8-7-18(32-3)11-21(20)29-24/h4-9,11-12,14,22H,2,10,13H2,1,3H3,(H,28,29)/t22-/m0/s1 BWAWBGVVGVJCLS-QFIPXVFZSA-N 335214 US11040966, Example 6.17::US9732075, Example 6.17::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-(4-m-tolyl-pyrimidin-5-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 308 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335214 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335214&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102286 384987373 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658068 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1cncnc1-c1cccc(C)c1 InChI=1S/C25H23N5O2/c1-15-5-4-6-17(9-15)23-19(12-26-14-27-23)25(31)30-13-16(2)10-22(30)24-28-20-8-7-18(32-3)11-21(20)29-24/h4-9,11-12,14,22H,2,10,13H2,1,3H3,(H,28,29)/t22-/m0/s1 BWAWBGVVGVJCLS-QFIPXVFZSA-N 335214 US11040966, Example 6.17::US9732075, Example 6.17::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-(4-m-tolyl-pyrimidin-5-yl)-methanone Orexin receptor type 2 Homo sapiens 47.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335214 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335214&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102286 384987373 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658069 COc1cc(C(=O)N2CC(=C)C[C@H]2c2nc3cc(ccc3[nH]2)C(C)(C)C)c(cc1OC)-n1nccn1 InChI=1S/C27H30N6O3/c1-16-11-22(25-30-19-8-7-17(27(2,3)4)12-20(19)31-25)32(15-16)26(34)18-13-23(35-5)24(36-6)14-21(18)33-28-9-10-29-33/h7-10,12-14,22H,1,11,15H2,2-6H3,(H,30,31)/t22-/m0/s1 KDPQZFNDNILOTA-QFIPXVFZSA-N 335215 US11040966, Example 6.170::US9732075, Example 6.170::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(4,5-dimethoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 18.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335215 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335215&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127036 384987374 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658070 COc1cc(C(=O)N2CC(=C)C[C@H]2c2nc3cc(ccc3[nH]2)C(C)(C)C)c(cc1OC)-n1nccn1 InChI=1S/C27H30N6O3/c1-16-11-22(25-30-19-8-7-17(27(2,3)4)12-20(19)31-25)32(15-16)26(34)18-13-23(35-5)24(36-6)14-21(18)33-28-9-10-29-33/h7-10,12-14,22H,1,11,15H2,2-6H3,(H,30,31)/t22-/m0/s1 KDPQZFNDNILOTA-QFIPXVFZSA-N 335215 US11040966, Example 6.170::US9732075, Example 6.170::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(4,5-dimethoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 15.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335215 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335215&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127036 384987374 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658071 Cc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2cc(ccc2[nH]1)C(C)(C)C)-n1cccn1 InChI=1S/C27H29N5O/c1-17-7-10-23(32-12-6-11-28-32)20(13-17)26(33)31-16-18(2)14-24(31)25-29-21-9-8-19(27(3,4)5)15-22(21)30-25/h6-13,15,24H,2,14,16H2,1,3-5H3,(H,29,30)/t24-/m0/s1 YPUWMBWLERDLEG-DEOSSOPVSA-N 335216 US11040966, Example 6.171::US9732075, Example 6.171::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 162 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335216 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335216&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127963 384987375 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658072 Cc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2cc(ccc2[nH]1)C(C)(C)C)-n1cccn1 InChI=1S/C27H29N5O/c1-17-7-10-23(32-12-6-11-28-32)20(13-17)26(33)31-16-18(2)14-24(31)25-29-21-9-8-19(27(3,4)5)15-22(21)30-25/h6-13,15,24H,2,14,16H2,1,3-5H3,(H,29,30)/t24-/m0/s1 YPUWMBWLERDLEG-DEOSSOPVSA-N 335216 US11040966, Example 6.171::US9732075, Example 6.171::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 19.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335216 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335216&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127963 384987375 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658073 CC(C)(C)c1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1ccccc1-n1cccn1 InChI=1S/C26H27N5O/c1-17-14-23(24-28-20-11-10-18(26(2,3)4)15-21(20)29-24)30(16-17)25(32)19-8-5-6-9-22(19)31-13-7-12-27-31/h5-13,15,23H,1,14,16H2,2-4H3,(H,28,29)/t23-/m0/s1 PQPHXSLJUIKWAJ-QHCPKHFHSA-N 335217 US11040966, Example 6.172::US9732075, Example 6.172::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-pyrazol-1-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 1260 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335217 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335217&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102302 384987376 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658074 CC(C)(C)c1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1ccccc1-n1cccn1 InChI=1S/C26H27N5O/c1-17-14-23(24-28-20-11-10-18(26(2,3)4)15-21(20)29-24)30(16-17)25(32)19-8-5-6-9-22(19)31-13-7-12-27-31/h5-13,15,23H,1,14,16H2,2-4H3,(H,28,29)/t23-/m0/s1 PQPHXSLJUIKWAJ-QHCPKHFHSA-N 335217 US11040966, Example 6.172::US9732075, Example 6.172::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-pyrazol-1-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 67.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335217 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335217&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102302 384987376 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658075 Cc1ccc(c(n1)C(=O)N1CC(=C)C[C@H]1c1nc2cc(ccc2[nH]1)C(C)(C)C)-n1cccn1 InChI=1S/C26H28N6O/c1-16-13-22(24-29-19-9-8-18(26(3,4)5)14-20(19)30-24)31(15-16)25(33)23-21(10-7-17(2)28-23)32-12-6-11-27-32/h6-12,14,22H,1,13,15H2,2-5H3,(H,29,30)/t22-/m0/s1 KSFOLIGTKWKSFK-QFIPXVFZSA-N 335218 US11040966, Example 6.173::US9732075, Example 6.173::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(6-methyl-3-pyrazol-1-yl-pyridin-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 842 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335218 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335218&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128252 384987377 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658076 Cc1ccc(c(n1)C(=O)N1CC(=C)C[C@H]1c1nc2cc(ccc2[nH]1)C(C)(C)C)-n1cccn1 InChI=1S/C26H28N6O/c1-16-13-22(24-29-19-9-8-18(26(3,4)5)14-20(19)30-24)31(15-16)25(33)23-21(10-7-17(2)28-23)32-12-6-11-27-32/h6-12,14,22H,1,13,15H2,2-5H3,(H,29,30)/t22-/m0/s1 KSFOLIGTKWKSFK-QFIPXVFZSA-N 335218 US11040966, Example 6.173::US9732075, Example 6.173::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(6-methyl-3-pyrazol-1-yl-pyridin-2-yl)-methanone Orexin receptor type 2 Homo sapiens 64.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335218 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335218&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128252 384987377 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658077 Cc1ccc(c(n1)C(=O)N1CC(=C)C[C@H]1c1nc2cc(ccc2[nH]1)C(C)(C)C)-n1nccn1 InChI=1S/C25H27N7O/c1-15-12-21(23-29-18-8-7-17(25(3,4)5)13-19(18)30-23)31(14-15)24(33)22-20(9-6-16(2)28-22)32-26-10-11-27-32/h6-11,13,21H,1,12,14H2,2-5H3,(H,29,30)/t21-/m0/s1 WZWQZVPBFWNPJY-NRFANRHFSA-N 335219 US11040966, Example 6.174::US9732075, Example 6.174::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 233 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335219 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335219&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127409 384987378 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658078 Cc1ccc(c(n1)C(=O)N1CC(=C)C[C@H]1c1nc2cc(ccc2[nH]1)C(C)(C)C)-n1nccn1 InChI=1S/C25H27N7O/c1-15-12-21(23-29-18-8-7-17(25(3,4)5)13-19(18)30-23)31(14-15)24(33)22-20(9-6-16(2)28-22)32-26-10-11-27-32/h6-11,13,21H,1,12,14H2,2-5H3,(H,29,30)/t21-/m0/s1 WZWQZVPBFWNPJY-NRFANRHFSA-N 335219 US11040966, Example 6.174::US9732075, Example 6.174::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone Orexin receptor type 2 Homo sapiens 15.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335219 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335219&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127409 384987378 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658079 Fc1cccc(c1C(=O)N1CC(=C)C[C@H]1c1nc2cc(Cl)c(cc2[nH]1)C(F)(F)F)-n1nccn1 InChI=1S/C22H15ClF4N6O/c1-11-7-18(20-30-15-8-12(22(25,26)27)13(23)9-16(15)31-20)32(10-11)21(34)19-14(24)3-2-4-17(19)33-28-5-6-29-33/h2-6,8-9,18H,1,7,10H2,(H,30,31)/t18-/m0/s1 DUPMRLZYWKVRTO-SFHVURJKSA-N 335220 US11040966, Example 6.175::US9732075, Example 6.175::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-fluoro-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 77.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335220 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335220&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127068 384987379 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658080 Fc1cccc(c1C(=O)N1CC(=C)C[C@H]1c1nc2cc(Cl)c(cc2[nH]1)C(F)(F)F)-n1nccn1 InChI=1S/C22H15ClF4N6O/c1-11-7-18(20-30-15-8-12(22(25,26)27)13(23)9-16(15)31-20)32(10-11)21(34)19-14(24)3-2-4-17(19)33-28-5-6-29-33/h2-6,8-9,18H,1,7,10H2,(H,30,31)/t18-/m0/s1 DUPMRLZYWKVRTO-SFHVURJKSA-N 335220 US11040966, Example 6.175::US9732075, Example 6.175::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-fluoro-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 19.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335220 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335220&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127068 384987379 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658081 Fc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2cc(Cl)c(cc2[nH]1)C(F)(F)F)-n1nccn1 InChI=1S/C22H15ClF4N6O/c1-11-6-19(20-30-16-8-14(22(25,26)27)15(23)9-17(16)31-20)32(10-11)21(34)13-7-12(24)2-3-18(13)33-28-4-5-29-33/h2-5,7-9,19H,1,6,10H2,(H,30,31)/t19-/m0/s1 ATCLXDDIAJSTQC-IBGZPJMESA-N 335221 US11040966, Example 6.176::US9732075, Example 6.176::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 58.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335221 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335221&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127440 384987380 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658082 Fc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2cc(Cl)c(cc2[nH]1)C(F)(F)F)-n1nccn1 InChI=1S/C22H15ClF4N6O/c1-11-6-19(20-30-16-8-14(22(25,26)27)15(23)9-17(16)31-20)32(10-11)21(34)13-7-12(24)2-3-18(13)33-28-4-5-29-33/h2-5,7-9,19H,1,6,10H2,(H,30,31)/t19-/m0/s1 ATCLXDDIAJSTQC-IBGZPJMESA-N 335221 US11040966, Example 6.176::US9732075, Example 6.176::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 18.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335221 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335221&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127440 384987380 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658083 FC(F)(F)c1cc2[nH]c(nc2cc1Cl)[C@@H]1CC(=C)CN1C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C22H15Cl2F3N6O/c1-11-6-19(20-30-16-8-14(22(25,26)27)15(24)9-17(16)31-20)32(10-11)21(34)13-7-12(23)2-3-18(13)33-28-4-5-29-33/h2-5,7-9,19H,1,6,10H2,(H,30,31)/t19-/m0/s1 PCZCMYYGMSKDSS-IBGZPJMESA-N 335222 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(5-chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone::US11040966, Example 6.177::US9732075, Example 6.177 Orexin/Hypocretin receptor type 1 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335222 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335222&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127824 384987381 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658084 FC(F)(F)c1cc2[nH]c(nc2cc1Cl)[C@@H]1CC(=C)CN1C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C22H15Cl2F3N6O/c1-11-6-19(20-30-16-8-14(22(25,26)27)15(24)9-17(16)31-20)32(10-11)21(34)13-7-12(23)2-3-18(13)33-28-4-5-29-33/h2-5,7-9,19H,1,6,10H2,(H,30,31)/t19-/m0/s1 PCZCMYYGMSKDSS-IBGZPJMESA-N 335222 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(5-chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone::US11040966, Example 6.177::US9732075, Example 6.177 Orexin receptor type 2 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335222 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335222&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127824 384987381 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658085 FC(F)(F)c1cc2[nH]c(nc2cc1Cl)[C@@H]1CC(=C)CN1C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H16ClF3N6O/c1-12-8-19(20-29-16-9-14(22(24,25)26)15(23)10-17(16)30-20)31(11-12)21(33)13-4-2-3-5-18(13)32-27-6-7-28-32/h2-7,9-10,19H,1,8,11H2,(H,29,30)/t19-/m0/s1 JWEDXYQRVXFQOM-IBGZPJMESA-N 335223 US11040966, Example 6.178::US9732075, Example 6.178::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 44.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335223 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335223&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127496 384987382 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658086 FC(F)(F)c1cc2[nH]c(nc2cc1Cl)[C@@H]1CC(=C)CN1C(=O)c1ccccc1-n1nccn1 InChI=1S/C22H16ClF3N6O/c1-12-8-19(20-29-16-9-14(22(24,25)26)15(23)10-17(16)30-20)31(11-12)21(33)13-4-2-3-5-18(13)32-27-6-7-28-32/h2-7,9-10,19H,1,8,11H2,(H,29,30)/t19-/m0/s1 JWEDXYQRVXFQOM-IBGZPJMESA-N 335223 US11040966, Example 6.178::US9732075, Example 6.178::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 10.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335223 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335223&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127496 384987382 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658087 COc1ccc(c(C(=O)N2CC(=C)C[C@H]2c2nc3cc(Cl)c(cc3[nH]2)C(F)(F)F)c1F)-n1nccn1 InChI=1S/C23H17ClF4N6O2/c1-11-7-17(21-31-14-8-12(23(26,27)28)13(24)9-15(14)32-21)33(10-11)22(35)19-16(34-29-5-6-30-34)3-4-18(36-2)20(19)25/h3-6,8-9,17H,1,7,10H2,2H3,(H,31,32)/t17-/m0/s1 VKEMFJQLLXIQRP-KRWDZBQOSA-N 335224 US11040966, Example 6.179::US9732075, Example 6.179::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-fluoro-3-methoxy-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335224 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335224&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128028 384987383 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658088 COc1ccc(c(C(=O)N2CC(=C)C[C@H]2c2nc3cc(Cl)c(cc3[nH]2)C(F)(F)F)c1F)-n1nccn1 InChI=1S/C23H17ClF4N6O2/c1-11-7-17(21-31-14-8-12(23(26,27)28)13(24)9-15(14)32-21)33(10-11)22(35)19-16(34-29-5-6-30-34)3-4-18(36-2)20(19)25/h3-6,8-9,17H,1,7,10H2,2H3,(H,31,32)/t17-/m0/s1 VKEMFJQLLXIQRP-KRWDZBQOSA-N 335224 US11040966, Example 6.179::US9732075, Example 6.179::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-fluoro-3-methoxy-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335224 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335224&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128028 384987383 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658089 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1cc(F)ccc1-n1nccn1 InChI=1S/C22H19FN6O2/c1-13-9-20(21-26-17-5-4-15(31-2)11-18(17)27-21)28(12-13)22(30)16-10-14(23)3-6-19(16)29-24-7-8-25-29/h3-8,10-11,20H,1,9,12H2,2H3,(H,26,27)/t20-/m0/s1 VQMDDYLZVYKHML-FQEVSTJZSA-N 335225 (5-Fluoro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone::US11040966, Example 6.18::US9732075, Example 6.18 Orexin/Hypocretin receptor type 1 Homo sapiens 1530 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335225 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335225&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127665 384987384 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658090 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1cc(F)ccc1-n1nccn1 InChI=1S/C22H19FN6O2/c1-13-9-20(21-26-17-5-4-15(31-2)11-18(17)27-21)28(12-13)22(30)16-10-14(23)3-6-19(16)29-24-7-8-25-29/h3-8,10-11,20H,1,9,12H2,2H3,(H,26,27)/t20-/m0/s1 VQMDDYLZVYKHML-FQEVSTJZSA-N 335225 (5-Fluoro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone::US11040966, Example 6.18::US9732075, Example 6.18 Orexin receptor type 2 Homo sapiens 29.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335225 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335225&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127665 384987384 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658091 Cc1ccc(c(C(=O)N2CC(=C)C[C@H]2c2nc3cc(Cl)c(cc3[nH]2)C(F)(F)F)c1F)-n1nccn1 InChI=1S/C23H17ClF4N6O/c1-11-7-18(21-31-15-8-13(23(26,27)28)14(24)9-16(15)32-21)33(10-11)22(35)19-17(34-29-5-6-30-34)4-3-12(2)20(19)25/h3-6,8-9,18H,1,7,10H2,2H3,(H,31,32)/t18-/m0/s1 NHPWYNHLVFIBNO-SFHVURJKSA-N 335226 US11040966, Example 6.180::US9732075, Example 6.180::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335226 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335226&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127421 384987385 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658092 Cc1ccc(c(C(=O)N2CC(=C)C[C@H]2c2nc3cc(Cl)c(cc3[nH]2)C(F)(F)F)c1F)-n1nccn1 InChI=1S/C23H17ClF4N6O/c1-11-7-18(21-31-15-8-13(23(26,27)28)14(24)9-16(15)32-21)33(10-11)22(35)19-17(34-29-5-6-30-34)4-3-12(2)20(19)25/h3-6,8-9,18H,1,7,10H2,2H3,(H,31,32)/t18-/m0/s1 NHPWYNHLVFIBNO-SFHVURJKSA-N 335226 US11040966, Example 6.180::US9732075, Example 6.180::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335226 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335226&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127421 384987385 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658093 Cc1cc(C(=O)N2CC(=C)C[C@H]2c2nc3cc(Cl)c(cc3[nH]2)C(F)(F)F)c(cc1C)-n1nccn1 InChI=1S/C24H20ClF3N6O/c1-12-6-21(22-31-18-9-16(24(26,27)28)17(25)10-19(18)32-22)33(11-12)23(35)15-7-13(2)14(3)8-20(15)34-29-4-5-30-34/h4-5,7-10,21H,1,6,11H2,2-3H3,(H,31,32)/t21-/m0/s1 JATRWMMRGOEDHU-NRFANRHFSA-N 335227 US11040966, Example 6.181::US9732075, Example 6.181::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(4,5-dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335227 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335227&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127711 384987386 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658094 Cc1cc(C(=O)N2CC(=C)C[C@H]2c2nc3cc(Cl)c(cc3[nH]2)C(F)(F)F)c(cc1C)-n1nccn1 InChI=1S/C24H20ClF3N6O/c1-12-6-21(22-31-18-9-16(24(26,27)28)17(25)10-19(18)32-22)33(11-12)23(35)15-7-13(2)14(3)8-20(15)34-29-4-5-30-34/h4-5,7-10,21H,1,6,11H2,2-3H3,(H,31,32)/t21-/m0/s1 JATRWMMRGOEDHU-NRFANRHFSA-N 335227 US11040966, Example 6.181::US9732075, Example 6.181::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(4,5-dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335227 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335227&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127711 384987386 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658095 Cc1ccc(C(=O)N2CC(=C)C[C@H]2c2nc3cc(Cl)c(cc3[nH]2)C(F)(F)F)c(c1)-n1nccn1 InChI=1S/C23H18ClF3N6O/c1-12-3-4-14(19(7-12)33-28-5-6-29-33)22(34)32-11-13(2)8-20(32)21-30-17-9-15(23(25,26)27)16(24)10-18(17)31-21/h3-7,9-10,20H,2,8,11H2,1H3,(H,30,31)/t20-/m0/s1 MNUNSKOSZLHUMO-FQEVSTJZSA-N 335228 US11040966, Example 6.182::US9732075, Example 6.182::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 12.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335228 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335228&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127933 384987387 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658096 Cc1ccc(C(=O)N2CC(=C)C[C@H]2c2nc3cc(Cl)c(cc3[nH]2)C(F)(F)F)c(c1)-n1nccn1 InChI=1S/C23H18ClF3N6O/c1-12-3-4-14(19(7-12)33-28-5-6-29-33)22(34)32-11-13(2)8-20(32)21-30-17-9-15(23(25,26)27)16(24)10-18(17)31-21/h3-7,9-10,20H,2,8,11H2,1H3,(H,30,31)/t20-/m0/s1 MNUNSKOSZLHUMO-FQEVSTJZSA-N 335228 US11040966, Example 6.182::US9732075, Example 6.182::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335228 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335228&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127933 384987387 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658097 Cc1cccc(c1C(=O)N1CC(=C)C[C@H]1c1nc2cc(Cl)c(cc2[nH]1)C(F)(F)F)-n1nccn1 InChI=1S/C23H18ClF3N6O/c1-12-8-19(21-30-16-9-14(23(25,26)27)15(24)10-17(16)31-21)32(11-12)22(34)20-13(2)4-3-5-18(20)33-28-6-7-29-33/h3-7,9-10,19H,1,8,11H2,2H3,(H,30,31)/t19-/m0/s1 KFTLZSWJWWPZTE-IBGZPJMESA-N 335229 US11040966, Example 6.183::US9732075, Example 6.183::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 127 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335229 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335229&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128043 384987388 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658098 Cc1cccc(c1C(=O)N1CC(=C)C[C@H]1c1nc2cc(Cl)c(cc2[nH]1)C(F)(F)F)-n1nccn1 InChI=1S/C23H18ClF3N6O/c1-12-8-19(21-30-16-9-14(23(25,26)27)15(24)10-17(16)31-21)32(11-12)22(34)20-13(2)4-3-5-18(20)33-28-6-7-29-33/h3-7,9-10,19H,1,8,11H2,2H3,(H,30,31)/t19-/m0/s1 KFTLZSWJWWPZTE-IBGZPJMESA-N 335229 US11040966, Example 6.183::US9732075, Example 6.183::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 21.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335229 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335229&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128043 384987388 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658099 FC(F)(F)c1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2cc(Cl)c(cc2[nH]1)C(F)(F)F)-n1nccn1 InChI=1S/C23H15ClF6N6O/c1-11-6-19(20-33-16-8-14(23(28,29)30)15(24)9-17(16)34-20)35(10-11)21(37)13-7-12(22(25,26)27)2-3-18(13)36-31-4-5-32-36/h2-5,7-9,19H,1,6,10H2,(H,33,34)/t19-/m0/s1 ADFCMFAOLVPSJZ-IBGZPJMESA-N 335230 US11040966, Example 6.184::US9732075, Example 6.184::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoro-methyl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 67.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335230 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335230&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127124 384987389 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658100 FC(F)(F)c1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2cc(Cl)c(cc2[nH]1)C(F)(F)F)-n1nccn1 InChI=1S/C23H15ClF6N6O/c1-11-6-19(20-33-16-8-14(23(28,29)30)15(24)9-17(16)34-20)35(10-11)21(37)13-7-12(22(25,26)27)2-3-18(13)36-31-4-5-32-36/h2-5,7-9,19H,1,6,10H2,(H,33,34)/t19-/m0/s1 ADFCMFAOLVPSJZ-IBGZPJMESA-N 335230 US11040966, Example 6.184::US9732075, Example 6.184::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoro-methyl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 73.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335230 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335230&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127124 384987389 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658101 FC(F)(F)Oc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2cc(Cl)c(cc2[nH]1)C(F)(F)F)-n1nccn1 InChI=1S/C23H15ClF6N6O2/c1-11-6-19(20-33-16-8-14(22(25,26)27)15(24)9-17(16)34-20)35(10-11)21(37)13-7-12(38-23(28,29)30)2-3-18(13)36-31-4-5-32-36/h2-5,7-9,19H,1,6,10H2,(H,33,34)/t19-/m0/s1 OWPFXVUUAZEFTR-IBGZPJMESA-N 335231 US11040966, Example 6.185::US9732075, Example 6.185::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoromethoxy-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 239 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335231 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335231&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128180 384987390 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658102 FC(F)(F)Oc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2cc(Cl)c(cc2[nH]1)C(F)(F)F)-n1nccn1 InChI=1S/C23H15ClF6N6O2/c1-11-6-19(20-33-16-8-14(22(25,26)27)15(24)9-17(16)34-20)35(10-11)21(37)13-7-12(38-23(28,29)30)2-3-18(13)36-31-4-5-32-36/h2-5,7-9,19H,1,6,10H2,(H,33,34)/t19-/m0/s1 OWPFXVUUAZEFTR-IBGZPJMESA-N 335231 US11040966, Example 6.185::US9732075, Example 6.185::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-5-trifluoromethoxy-phenyl)-methanone Orexin receptor type 2 Homo sapiens 103 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335231 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335231&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128180 384987390 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658103 COc1cc(C(=O)N2CC(=C)C[C@H]2c2nc3cc(Cl)c(cc3[nH]2)C(F)(F)F)c(cc1OC)-n1nccn1 InChI=1S/C24H20ClF3N6O3/c1-12-6-19(22-31-16-8-14(24(26,27)28)15(25)9-17(16)32-22)33(11-12)23(35)13-7-20(36-2)21(37-3)10-18(13)34-29-4-5-30-34/h4-5,7-10,19H,1,6,11H2,2-3H3,(H,31,32)/t19-/m0/s1 BCVPTQVZVGOGIH-IBGZPJMESA-N 335232 US11040966, Example 6.186::US9732075, Example 6.186::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(4,5-dimethoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 27.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335232 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335232&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127072 384987391 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658104 COc1cc(C(=O)N2CC(=C)C[C@H]2c2nc3cc(Cl)c(cc3[nH]2)C(F)(F)F)c(cc1OC)-n1nccn1 InChI=1S/C24H20ClF3N6O3/c1-12-6-19(22-31-16-8-14(24(26,27)28)15(25)9-17(16)32-22)33(11-12)23(35)13-7-20(36-2)21(37-3)10-18(13)34-29-4-5-30-34/h4-5,7-10,19H,1,6,11H2,2-3H3,(H,31,32)/t19-/m0/s1 BCVPTQVZVGOGIH-IBGZPJMESA-N 335232 US11040966, Example 6.186::US9732075, Example 6.186::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(4,5-dimethoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335232 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335232&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127072 384987391 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658105 Cc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2cc(Cl)c(cc2[nH]1)C(F)(F)F)-n1cccn1 InChI=1S/C24H19ClF3N5O/c1-13-4-5-20(33-7-3-6-29-33)15(8-13)23(34)32-12-14(2)9-21(32)22-30-18-10-16(24(26,27)28)17(25)11-19(18)31-22/h3-8,10-11,21H,2,9,12H2,1H3,(H,30,31)/t21-/m0/s1 FVVWFCZTMFWMEU-NRFANRHFSA-N 335233 US11040966, Example 6.187::US9732075, Example 6.187::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 24.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335233 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335233&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127833 384987392 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658106 Cc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2cc(Cl)c(cc2[nH]1)C(F)(F)F)-n1cccn1 InChI=1S/C24H19ClF3N5O/c1-13-4-5-20(33-7-3-6-29-33)15(8-13)23(34)32-12-14(2)9-21(32)22-30-18-10-16(24(26,27)28)17(25)11-19(18)31-22/h3-8,10-11,21H,2,9,12H2,1H3,(H,30,31)/t21-/m0/s1 FVVWFCZTMFWMEU-NRFANRHFSA-N 335233 US11040966, Example 6.187::US9732075, Example 6.187::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 15.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335233 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335233&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127833 384987392 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658107 FC(F)(F)c1cc2[nH]c(nc2cc1Cl)[C@@H]1CC(=C)CN1C(=O)c1ccccc1-n1cccn1 InChI=1S/C23H17ClF3N5O/c1-13-9-20(21-29-17-10-15(23(25,26)27)16(24)11-18(17)30-21)31(12-13)22(33)14-5-2-3-6-19(14)32-8-4-7-28-32/h2-8,10-11,20H,1,9,12H2,(H,29,30)/t20-/m0/s1 DCGHDLKMOANZKQ-FQEVSTJZSA-N 335234 US11040966, Example 6.188::US9732075, Example 6.188::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-pyrazol-1-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 115 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335234 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335234&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127150 384987393 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658108 FC(F)(F)c1cc2[nH]c(nc2cc1Cl)[C@@H]1CC(=C)CN1C(=O)c1ccccc1-n1cccn1 InChI=1S/C23H17ClF3N5O/c1-13-9-20(21-29-17-10-15(23(25,26)27)16(24)11-18(17)30-21)31(12-13)22(33)14-5-2-3-6-19(14)32-8-4-7-28-32/h2-8,10-11,20H,1,9,12H2,(H,29,30)/t20-/m0/s1 DCGHDLKMOANZKQ-FQEVSTJZSA-N 335234 US11040966, Example 6.188::US9732075, Example 6.188::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-pyrazol-1-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 66.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335234 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335234&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127150 384987393 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658109 Cc1ccc(c(n1)C(=O)N1CC(=C)C[C@H]1c1nc2cc(Cl)c(cc2[nH]1)C(F)(F)F)-n1cccn1 InChI=1S/C23H18ClF3N6O/c1-12-8-19(21-30-16-9-14(23(25,26)27)15(24)10-17(16)31-21)32(11-12)22(34)20-18(5-4-13(2)29-20)33-7-3-6-28-33/h3-7,9-10,19H,1,8,11H2,2H3,(H,30,31)/t19-/m0/s1 LTBSVTPWDNTTDZ-IBGZPJMESA-N 335235 US11040966, Example 6.189::US9732075, Example 6.189::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(6-methyl-3-pyrazol-1-yl-pyridin-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 47.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335235 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335235&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127843 384987394 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658110 Cc1ccc(c(n1)C(=O)N1CC(=C)C[C@H]1c1nc2cc(Cl)c(cc2[nH]1)C(F)(F)F)-n1cccn1 InChI=1S/C23H18ClF3N6O/c1-12-8-19(21-30-16-9-14(23(25,26)27)15(24)10-17(16)31-21)32(11-12)22(34)20-18(5-4-13(2)29-20)33-7-3-6-28-33/h3-7,9-10,19H,1,8,11H2,2H3,(H,30,31)/t19-/m0/s1 LTBSVTPWDNTTDZ-IBGZPJMESA-N 335235 US11040966, Example 6.189::US9732075, Example 6.189::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(6-methyl-3-pyrazol-1-yl-pyridin-2-yl)-methanone Orexin receptor type 2 Homo sapiens 25.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335235 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335235&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127843 384987394 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658111 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1c(F)cccc1-n1nccn1 InChI=1S/C22H19FN6O2/c1-13-10-19(21-26-16-7-6-14(31-2)11-17(16)27-21)28(12-13)22(30)20-15(23)4-3-5-18(20)29-24-8-9-25-29/h3-9,11,19H,1,10,12H2,2H3,(H,26,27)/t19-/m0/s1 DEIRGISQSYVPIK-IBGZPJMESA-N 335236 (2-Fluoro-6-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone::US11040966, Example 6.19::US9732075, Example 6.19 Orexin/Hypocretin receptor type 1 Homo sapiens 1530 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335236 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335236&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127222 384987395 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658112 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1c(F)cccc1-n1nccn1 InChI=1S/C22H19FN6O2/c1-13-10-19(21-26-16-7-6-14(31-2)11-17(16)27-21)28(12-13)22(30)20-15(23)4-3-5-18(20)29-24-8-9-25-29/h3-9,11,19H,1,10,12H2,2H3,(H,26,27)/t19-/m0/s1 DEIRGISQSYVPIK-IBGZPJMESA-N 335236 (2-Fluoro-6-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone::US11040966, Example 6.19::US9732075, Example 6.19 Orexin receptor type 2 Homo sapiens 61.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335236 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335236&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127222 384987395 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658113 Cc1ccc(c(n1)C(=O)N1CC(=C)C[C@H]1c1nc2cc(Cl)c(cc2[nH]1)C(F)(F)F)-n1nccn1 InChI=1S/C22H17ClF3N7O/c1-11-7-18(20-30-15-8-13(22(24,25)26)14(23)9-16(15)31-20)32(10-11)21(34)19-17(4-3-12(2)29-19)33-27-5-6-28-33/h3-6,8-9,18H,1,7,10H2,2H3,(H,30,31)/t18-/m0/s1 QGDVINLHLFFGCH-SFHVURJKSA-N 335237 US11040966, Example 6.190::US9732075, Example 6.190::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 10.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335237 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335237&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127669 384987396 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658114 Cc1ccc(c(n1)C(=O)N1CC(=C)C[C@H]1c1nc2cc(Cl)c(cc2[nH]1)C(F)(F)F)-n1nccn1 InChI=1S/C22H17ClF3N7O/c1-11-7-18(20-30-15-8-13(22(24,25)26)14(23)9-16(15)31-20)32(10-11)21(34)19-17(4-3-12(2)29-19)33-27-5-6-28-33/h3-6,8-9,18H,1,7,10H2,2H3,(H,30,31)/t18-/m0/s1 QGDVINLHLFFGCH-SFHVURJKSA-N 335237 US11040966, Example 6.190::US9732075, Example 6.190::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone Orexin receptor type 2 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335237 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335237&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127669 384987396 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658115 Cc1cc2nc([nH]c2cc1C)[C@@H]1CC(=C)CN1C(=O)c1c(F)cccc1-n1nccn1 InChI=1S/C23H21FN6O/c1-13-9-20(22-27-17-10-14(2)15(3)11-18(17)28-22)29(12-13)23(31)21-16(24)5-4-6-19(21)30-25-7-8-26-30/h4-8,10-11,20H,1,9,12H2,2-3H3,(H,27,28)/t20-/m0/s1 ZYFAPCPVLVCAGT-FQEVSTJZSA-N 335238 US11040966, Example 6.192::US9732075, Example 6.191::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-fluoro-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 134 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335238 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335238&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128056 384987397 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658116 Cc1cc2nc([nH]c2cc1C)[C@@H]1CC(=C)CN1C(=O)c1c(F)cccc1-n1nccn1 InChI=1S/C23H21FN6O/c1-13-9-20(22-27-17-10-14(2)15(3)11-18(17)28-22)29(12-13)23(31)21-16(24)5-4-6-19(21)30-25-7-8-26-30/h4-8,10-11,20H,1,9,12H2,2-3H3,(H,27,28)/t20-/m0/s1 ZYFAPCPVLVCAGT-FQEVSTJZSA-N 335238 US11040966, Example 6.192::US9732075, Example 6.191::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-fluoro-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335238 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335238&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128056 384987397 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658117 Cc1cc2nc([nH]c2cc1C)[C@@H]1CC(=C)CN1C(=O)c1cc(F)ccc1-n1nccn1 InChI=1S/C23H21FN6O/c1-13-8-21(22-27-18-9-14(2)15(3)10-19(18)28-22)29(12-13)23(31)17-11-16(24)4-5-20(17)30-25-6-7-26-30/h4-7,9-11,21H,1,8,12H2,2-3H3,(H,27,28)/t21-/m0/s1 IQGAYGNHCFWEPJ-NRFANRHFSA-N 335239 US9732075, Example 6.192::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 48.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335239 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335239&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127595 384987398 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658118 Cc1cc2nc([nH]c2cc1C)[C@@H]1CC(=C)CN1C(=O)c1cc(F)ccc1-n1nccn1 InChI=1S/C23H21FN6O/c1-13-8-21(22-27-18-9-14(2)15(3)10-19(18)28-22)29(12-13)23(31)17-11-16(24)4-5-20(17)30-25-6-7-26-30/h4-7,9-11,21H,1,8,12H2,2-3H3,(H,27,28)/t21-/m0/s1 IQGAYGNHCFWEPJ-NRFANRHFSA-N 335239 US9732075, Example 6.192::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-fluoro-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335239 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335239&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127595 384987398 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658119 Cc1cc2nc([nH]c2cc1C)[C@@H]1CC(=C)CN1C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C23H21ClN6O/c1-13-8-21(22-27-18-9-14(2)15(3)10-19(18)28-22)29(12-13)23(31)17-11-16(24)4-5-20(17)30-25-6-7-26-30/h4-7,9-11,21H,1,8,12H2,2-3H3,(H,27,28)/t21-/m0/s1 NHEHKIBDSZAWQD-NRFANRHFSA-N 335240 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(5,6-dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone::US11040966, Example 6.193::US9732075, Example 6.193 Orexin/Hypocretin receptor type 1 Homo sapiens 41.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335240 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335240&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127317 384987399 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658120 Cc1cc2nc([nH]c2cc1C)[C@@H]1CC(=C)CN1C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C23H21ClN6O/c1-13-8-21(22-27-18-9-14(2)15(3)10-19(18)28-22)29(12-13)23(31)17-11-16(24)4-5-20(17)30-25-6-7-26-30/h4-7,9-11,21H,1,8,12H2,2-3H3,(H,27,28)/t21-/m0/s1 NHEHKIBDSZAWQD-NRFANRHFSA-N 335240 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(5,6-dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone::US11040966, Example 6.193::US9732075, Example 6.193 Orexin receptor type 2 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335240 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335240&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127317 384987399 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658121 Cc1cc2nc([nH]c2cc1C)[C@@H]1CC(=C)CN1C(=O)c1ccccc1-n1nccn1 InChI=1S/C23H22N6O/c1-14-10-21(22-26-18-11-15(2)16(3)12-19(18)27-22)28(13-14)23(30)17-6-4-5-7-20(17)29-24-8-9-25-29/h4-9,11-12,21H,1,10,13H2,2-3H3,(H,26,27)/t21-/m0/s1 DLVLLKYWAYBERE-NRFANRHFSA-N 335241 US11040966, Example 6.194::US9732075, Example 6.194::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 51.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335241 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335241&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127425 384987400 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658122 Cc1cc2nc([nH]c2cc1C)[C@@H]1CC(=C)CN1C(=O)c1ccccc1-n1nccn1 InChI=1S/C23H22N6O/c1-14-10-21(22-26-18-11-15(2)16(3)12-19(18)27-22)28(13-14)23(30)17-6-4-5-7-20(17)29-24-8-9-25-29/h4-9,11-12,21H,1,10,13H2,2-3H3,(H,26,27)/t21-/m0/s1 DLVLLKYWAYBERE-NRFANRHFSA-N 335241 US11040966, Example 6.194::US9732075, Example 6.194::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335241 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335241&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127425 384987400 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658123 COc1ccc(c(C(=O)N2CC(=C)C[C@H]2c2nc3cc(C)c(C)cc3[nH]2)c1F)-n1nccn1 InChI=1S/C24H23FN6O2/c1-13-9-19(23-28-16-10-14(2)15(3)11-17(16)29-23)30(12-13)24(32)21-18(31-26-7-8-27-31)5-6-20(33-4)22(21)25/h5-8,10-11,19H,1,9,12H2,2-4H3,(H,28,29)/t19-/m0/s1 DPYRDMRHPOOKEG-IBGZPJMESA-N 335242 US11040966, Example 6.195::US9732075, Example 6.195::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-fluoro-3-methoxy-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 43.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335242 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335242&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127278 384987401 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658124 COc1ccc(c(C(=O)N2CC(=C)C[C@H]2c2nc3cc(C)c(C)cc3[nH]2)c1F)-n1nccn1 InChI=1S/C24H23FN6O2/c1-13-9-19(23-28-16-10-14(2)15(3)11-17(16)29-23)30(12-13)24(32)21-18(31-26-7-8-27-31)5-6-20(33-4)22(21)25/h5-8,10-11,19H,1,9,12H2,2-4H3,(H,28,29)/t19-/m0/s1 DPYRDMRHPOOKEG-IBGZPJMESA-N 335242 US11040966, Example 6.195::US9732075, Example 6.195::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-fluoro-3-methoxy-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 11.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335242 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335242&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127278 384987401 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658125 Cc1ccc(c(C(=O)N2CC(=C)C[C@H]2c2nc3cc(C)c(C)cc3[nH]2)c1F)-n1nccn1 InChI=1S/C24H23FN6O/c1-13-9-20(23-28-17-10-15(3)16(4)11-18(17)29-23)30(12-13)24(32)21-19(31-26-7-8-27-31)6-5-14(2)22(21)25/h5-8,10-11,20H,1,9,12H2,2-4H3,(H,28,29)/t20-/m0/s1 ULCIKPSKEABELY-FQEVSTJZSA-N 335243 US11040966, Example 6.196::US9732075, Example 6.196::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 59.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335243 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335243&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127750 384987402 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658126 Cc1ccc(c(C(=O)N2CC(=C)C[C@H]2c2nc3cc(C)c(C)cc3[nH]2)c1F)-n1nccn1 InChI=1S/C24H23FN6O/c1-13-9-20(23-28-17-10-15(3)16(4)11-18(17)29-23)30(12-13)24(32)21-19(31-26-7-8-27-31)6-5-14(2)22(21)25/h5-8,10-11,20H,1,9,12H2,2-4H3,(H,28,29)/t20-/m0/s1 ULCIKPSKEABELY-FQEVSTJZSA-N 335243 US11040966, Example 6.196::US9732075, Example 6.196::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-fluoro-3-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 12.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335243 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335243&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127750 384987402 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658127 Cc1cc(C(=O)N2CC(=C)C[C@H]2c2nc3cc(C)c(C)cc3[nH]2)c(cc1C)-n1nccn1 InChI=1S/C25H26N6O/c1-14-8-23(24-28-20-10-16(3)17(4)11-21(20)29-24)30(13-14)25(32)19-9-15(2)18(5)12-22(19)31-26-6-7-27-31/h6-7,9-12,23H,1,8,13H2,2-5H3,(H,28,29)/t23-/m0/s1 DAOILFTWRKNBCA-QHCPKHFHSA-N 335244 US11040966, Example 6.197::US9732075, Example 6.197::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(4,5-dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335244 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335244&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127037 384987403 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658128 Cc1cc(C(=O)N2CC(=C)C[C@H]2c2nc3cc(C)c(C)cc3[nH]2)c(cc1C)-n1nccn1 InChI=1S/C25H26N6O/c1-14-8-23(24-28-20-10-16(3)17(4)11-21(20)29-24)30(13-14)25(32)19-9-15(2)18(5)12-22(19)31-26-6-7-27-31/h6-7,9-12,23H,1,8,13H2,2-5H3,(H,28,29)/t23-/m0/s1 DAOILFTWRKNBCA-QHCPKHFHSA-N 335244 US11040966, Example 6.197::US9732075, Example 6.197::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(4,5-dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335244 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335244&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127037 384987403 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658129 COc1ccc(cc1)-c1sc(C)nc1C(=O)N1CC(=C)C[C@H]1c1nc2cc(OC)ccc2[nH]1 InChI=1S/C25H24N4O3S/c1-14-11-21(24-27-19-10-9-18(32-4)12-20(19)28-24)29(13-14)25(30)22-23(33-15(2)26-22)16-5-7-17(31-3)8-6-16/h5-10,12,21H,1,11,13H2,2-4H3,(H,27,28)/t21-/m0/s1 UYJACMRWYZAAEV-NRFANRHFSA-N 335245 US11040966, Example 6.2::US9732075, Example 6.2::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-[5-(4-methoxy-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 223 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335245 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335245&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127913 384987404 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658130 COc1ccc(cc1)-c1sc(C)nc1C(=O)N1CC(=C)C[C@H]1c1nc2cc(OC)ccc2[nH]1 InChI=1S/C25H24N4O3S/c1-14-11-21(24-27-19-10-9-18(32-4)12-20(19)28-24)29(13-14)25(30)22-23(33-15(2)26-22)16-5-7-17(31-3)8-6-16/h5-10,12,21H,1,11,13H2,2-4H3,(H,27,28)/t21-/m0/s1 UYJACMRWYZAAEV-NRFANRHFSA-N 335245 US11040966, Example 6.2::US9732075, Example 6.2::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-[5-(4-methoxy-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 17.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335245 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335245&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127913 384987404 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658131 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1ccccc1-c1nc(C)no1 InChI=1S/C23H21N5O3/c1-13-10-20(21-25-18-9-8-15(30-3)11-19(18)26-21)28(12-13)23(29)17-7-5-4-6-16(17)22-24-14(2)27-31-22/h4-9,11,20H,1,10,12H2,2-3H3,(H,25,26)/t20-/m0/s1 CEOIZTKCASJAEM-FQEVSTJZSA-N 335246 US11040966, Example 6.20::US9732075, Example 6.20::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-[2-(3-methyl-[1,2,4]oxadiazol-5-yl)-phenyl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 1750 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335246 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335246&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127143 384987405 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658132 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1ccccc1-c1nc(C)no1 InChI=1S/C23H21N5O3/c1-13-10-20(21-25-18-9-8-15(30-3)11-19(18)26-21)28(12-13)23(29)17-7-5-4-6-16(17)22-24-14(2)27-31-22/h4-9,11,20H,1,10,12H2,2-3H3,(H,25,26)/t20-/m0/s1 CEOIZTKCASJAEM-FQEVSTJZSA-N 335246 US11040966, Example 6.20::US9732075, Example 6.20::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-[2-(3-methyl-[1,2,4]oxadiazol-5-yl)-phenyl]-methanone Orexin receptor type 2 Homo sapiens 49.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335246 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335246&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127143 384987405 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658133 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1ccccc1-c1csc(C)n1 InChI=1S/C24H22N4O2S/c1-14-10-22(23-26-19-9-8-16(30-3)11-20(19)27-23)28(12-14)24(29)18-7-5-4-6-17(18)21-13-31-15(2)25-21/h4-9,11,13,22H,1,10,12H2,2-3H3,(H,26,27)/t22-/m0/s1 JUOOETQIQXNRCN-QFIPXVFZSA-N 335247 US11040966, Example 6.21::US9732075, Example 6.21::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-[2-(2-methyl-thiazol-4-yl)-phenyl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 1970 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335247 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335247&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127184 384987406 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658134 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1ccccc1-c1csc(C)n1 InChI=1S/C24H22N4O2S/c1-14-10-22(23-26-19-9-8-16(30-3)11-20(19)27-23)28(12-14)24(29)18-7-5-4-6-17(18)21-13-31-15(2)25-21/h4-9,11,13,22H,1,10,12H2,2-3H3,(H,26,27)/t22-/m0/s1 JUOOETQIQXNRCN-QFIPXVFZSA-N 335247 US11040966, Example 6.21::US9732075, Example 6.21::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-[2-(2-methyl-thiazol-4-yl)-phenyl]-methanone Orexin receptor type 2 Homo sapiens 76.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335247 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335247&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127184 384987406 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658135 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1ccc(Br)cc1 InChI=1S/C24H21BrN4O2S/c1-13-10-20(23-27-18-9-8-17(31-3)11-19(18)28-23)29(12-13)24(30)21-22(32-14(2)26-21)15-4-6-16(25)7-5-15/h4-9,11,20H,1,10,12H2,2-3H3,(H,27,28)/t20-/m0/s1 DOUWQPXXCMNFIL-FQEVSTJZSA-N 335248 US11040966, Example 6.22::US9732075, Example 6.22::[5-(4-Bromo-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 410 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335248 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335248&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127468 384987407 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658136 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1ccc(Br)cc1 InChI=1S/C24H21BrN4O2S/c1-13-10-20(23-27-18-9-8-17(31-3)11-19(18)28-23)29(12-13)24(30)21-22(32-14(2)26-21)15-4-6-16(25)7-5-15/h4-9,11,20H,1,10,12H2,2-3H3,(H,27,28)/t20-/m0/s1 DOUWQPXXCMNFIL-FQEVSTJZSA-N 335248 US11040966, Example 6.22::US9732075, Example 6.22::[5-(4-Bromo-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 19.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335248 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335248&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127468 384987407 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658137 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1Cl InChI=1S/C24H20Cl2N4O2S/c1-12-9-19(23-28-17-8-7-14(32-3)10-18(17)29-23)30(11-12)24(31)21-22(33-13(2)27-21)15-5-4-6-16(25)20(15)26/h4-8,10,19H,1,9,11H2,2-3H3,(H,28,29)/t19-/m0/s1 PUSOBOFWGMFVMJ-IBGZPJMESA-N 335249 US11040966, Example 6.23::US9732075, Example 6.23::[5-(2,3-Dichloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 452 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335249 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335249&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127916 384987408 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658138 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1Cl InChI=1S/C24H20Cl2N4O2S/c1-12-9-19(23-28-17-8-7-14(32-3)10-18(17)29-23)30(11-12)24(31)21-22(33-13(2)27-21)15-5-4-6-16(25)20(15)26/h4-8,10,19H,1,9,11H2,2-3H3,(H,28,29)/t19-/m0/s1 PUSOBOFWGMFVMJ-IBGZPJMESA-N 335249 US11040966, Example 6.23::US9732075, Example 6.23::[5-(2,3-Dichloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 67.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335249 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335249&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127916 384987408 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658139 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1ccc(F)c(Br)c1 InChI=1S/C24H20BrFN4O2S/c1-12-8-20(23-28-18-7-5-15(32-3)10-19(18)29-23)30(11-12)24(31)21-22(33-13(2)27-21)14-4-6-17(26)16(25)9-14/h4-7,9-10,20H,1,8,11H2,2-3H3,(H,28,29)/t20-/m0/s1 MPMCSCIPKSBAPT-FQEVSTJZSA-N 335250 US11040966, Example 6.24::US9732075, Example 6.24::[5-(3-Bromo-4-fluoro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 53.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335250 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335250&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127312 384987409 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658140 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1ccc(F)c(Br)c1 InChI=1S/C24H20BrFN4O2S/c1-12-8-20(23-28-18-7-5-15(32-3)10-19(18)29-23)30(11-12)24(31)21-22(33-13(2)27-21)14-4-6-17(26)16(25)9-14/h4-7,9-10,20H,1,8,11H2,2-3H3,(H,28,29)/t20-/m0/s1 MPMCSCIPKSBAPT-FQEVSTJZSA-N 335250 US11040966, Example 6.24::US9732075, Example 6.24::[5-(3-Bromo-4-fluoro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 17.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335250 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335250&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127312 384987409 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658141 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(sc1-c1ccc(C)c(F)c1)C1CC1 InChI=1S/C27H25FN4O2S/c1-14-10-22(25-29-20-9-8-18(34-3)12-21(20)30-25)32(13-14)27(33)23-24(35-26(31-23)16-6-7-16)17-5-4-15(2)19(28)11-17/h4-5,8-9,11-12,16,22H,1,6-7,10,13H2,2-3H3,(H,29,30)/t22-/m0/s1 KRXUCZAVOQKMPR-QFIPXVFZSA-N 335251 US11040966, Example 6.25::US9732075, Example 6.25::[2-Cyclopropyl-5-(3-fluoro-4-methyl-phenyl)-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 154 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335251 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335251&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128285 384987410 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658142 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(sc1-c1ccc(C)c(F)c1)C1CC1 InChI=1S/C27H25FN4O2S/c1-14-10-22(25-29-20-9-8-18(34-3)12-21(20)30-25)32(13-14)27(33)23-24(35-26(31-23)16-6-7-16)17-5-4-15(2)19(28)11-17/h4-5,8-9,11-12,16,22H,1,6-7,10,13H2,2-3H3,(H,29,30)/t22-/m0/s1 KRXUCZAVOQKMPR-QFIPXVFZSA-N 335251 US11040966, Example 6.25::US9732075, Example 6.25::[2-Cyclopropyl-5-(3-fluoro-4-methyl-phenyl)-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 52.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335251 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335251&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128285 384987410 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658143 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(sc1-c1cccc(C)c1)C1CC1 InChI=1S/C27H26N4O2S/c1-15-5-4-6-18(11-15)24-23(30-26(34-24)17-7-8-17)27(32)31-14-16(2)12-22(31)25-28-20-10-9-19(33-3)13-21(20)29-25/h4-6,9-11,13,17,22H,2,7-8,12,14H2,1,3H3,(H,28,29)/t22-/m0/s1 ZKWUTQXFTBKBJC-QFIPXVFZSA-N 335252 (2-Cyclopropyl-5-m-tolyl-thiazol-4-yl)-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone::US11040966, Example 6.26::US9732075, Example 6.26 Orexin/Hypocretin receptor type 1 Homo sapiens 26.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335252 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335252&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127098 384987411 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658144 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(sc1-c1cccc(C)c1)C1CC1 InChI=1S/C27H26N4O2S/c1-15-5-4-6-18(11-15)24-23(30-26(34-24)17-7-8-17)27(32)31-14-16(2)12-22(31)25-28-20-10-9-19(33-3)13-21(20)29-25/h4-6,9-11,13,17,22H,2,7-8,12,14H2,1,3H3,(H,28,29)/t22-/m0/s1 ZKWUTQXFTBKBJC-QFIPXVFZSA-N 335252 (2-Cyclopropyl-5-m-tolyl-thiazol-4-yl)-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone::US11040966, Example 6.26::US9732075, Example 6.26 Orexin receptor type 2 Homo sapiens 24.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335252 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335252&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127098 384987411 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658145 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(sc1-c1ccc(C)c(C)c1)N(C)C InChI=1S/C27H29N5O2S/c1-15-11-22(25-28-20-10-9-19(34-6)13-21(20)29-25)32(14-15)26(33)23-24(35-27(30-23)31(4)5)18-8-7-16(2)17(3)12-18/h7-10,12-13,22H,1,11,14H2,2-6H3,(H,28,29)/t22-/m0/s1 BOSWEVDHBVSIFV-QFIPXVFZSA-N 335253 US11040966, Example 6.27::US9732075, Example 6.27::[2-Dimethylamino-5-(3,4-dimethyl-phenyl)-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335253 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335253&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127459 384987412 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658146 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(sc1-c1ccc(C)c(C)c1)N(C)C InChI=1S/C27H29N5O2S/c1-15-11-22(25-28-20-10-9-19(34-6)13-21(20)29-25)32(14-15)26(33)23-24(35-27(30-23)31(4)5)18-8-7-16(2)17(3)12-18/h7-10,12-13,22H,1,11,14H2,2-6H3,(H,28,29)/t22-/m0/s1 BOSWEVDHBVSIFV-QFIPXVFZSA-N 335253 US11040966, Example 6.27::US9732075, Example 6.27::[2-Dimethylamino-5-(3,4-dimethyl-phenyl)-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335253 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335253&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127459 384987412 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658147 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(sc1-c1cccc(Br)c1)C1CC1 InChI=1S/C26H23BrN4O2S/c1-14-10-21(24-28-19-9-8-18(33-2)12-20(19)29-24)31(13-14)26(32)22-23(16-4-3-5-17(27)11-16)34-25(30-22)15-6-7-15/h3-5,8-9,11-12,15,21H,1,6-7,10,13H2,2H3,(H,28,29)/t21-/m0/s1 OHQCGZCOYDETDA-NRFANRHFSA-N 335254 US11040966, Example 6.28::US9732075, Example 6.28::[5-(3-Bromo-phenyl)-2-cyclopropyl-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 20.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335254 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335254&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695297 384987413 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658148 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(sc1-c1cccc(Br)c1)C1CC1 InChI=1S/C26H23BrN4O2S/c1-14-10-21(24-28-19-9-8-18(33-2)12-20(19)29-24)31(13-14)26(32)22-23(16-4-3-5-17(27)11-16)34-25(30-22)15-6-7-15/h3-5,8-9,11-12,15,21H,1,6-7,10,13H2,2H3,(H,28,29)/t21-/m0/s1 OHQCGZCOYDETDA-NRFANRHFSA-N 335254 US11040966, Example 6.28::US9732075, Example 6.28::[5-(3-Bromo-phenyl)-2-cyclopropyl-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 15.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335254 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335254&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695297 384987413 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658149 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(sc1-c1cccc(F)c1)N1CCCC1 InChI=1S/C27H26FN5O2S/c1-16-12-22(25-29-20-9-8-19(35-2)14-21(20)30-25)33(15-16)26(34)23-24(17-6-5-7-18(28)13-17)36-27(31-23)32-10-3-4-11-32/h5-9,13-14,22H,1,3-4,10-12,15H2,2H3,(H,29,30)/t22-/m0/s1 KMCWPNVVCHNJGY-QFIPXVFZSA-N 335255 US11040966, Example 6.29::US9732075, Example 6.29::[5-(3-Fluoro-phenyl)-2-pyrrolidin-1-yl-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 69.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335255 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335255&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127301 384987414 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658150 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(sc1-c1cccc(F)c1)N1CCCC1 InChI=1S/C27H26FN5O2S/c1-16-12-22(25-29-20-9-8-19(35-2)14-21(20)30-25)33(15-16)26(34)23-24(17-6-5-7-18(28)13-17)36-27(31-23)32-10-3-4-11-32/h5-9,13-14,22H,1,3-4,10-12,15H2,2H3,(H,29,30)/t22-/m0/s1 KMCWPNVVCHNJGY-QFIPXVFZSA-N 335255 US11040966, Example 6.29::US9732075, Example 6.29::[5-(3-Fluoro-phenyl)-2-pyrrolidin-1-yl-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 92.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335255 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335255&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127301 384987414 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658151 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1ccccc1 InChI=1S/C24H22N4O2S/c1-14-11-20(23-26-18-10-9-17(30-3)12-19(18)27-23)28(13-14)24(29)21-22(31-15(2)25-21)16-7-5-4-6-8-16/h4-10,12,20H,1,11,13H2,2-3H3,(H,26,27)/t20-/m0/s1 BZKCZPCCMKHXDT-FQEVSTJZSA-N 335256 US11040966, Example 6.3::US9732075, Example 6.3::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 243 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335256&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127827 384987415 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658152 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1ccccc1 InChI=1S/C24H22N4O2S/c1-14-11-20(23-26-18-10-9-17(30-3)12-19(18)27-23)28(13-14)24(29)21-22(31-15(2)25-21)16-7-5-4-6-8-16/h4-10,12,20H,1,11,13H2,2-3H3,(H,26,27)/t20-/m0/s1 BZKCZPCCMKHXDT-FQEVSTJZSA-N 335256 US11040966, Example 6.3::US9732075, Example 6.3::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 18.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335256 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335256&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127827 384987415 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658153 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1cccc(c1)C(F)(F)F InChI=1S/C25H21F3N4O2S/c1-13-9-20(23-30-18-8-7-17(34-3)11-19(18)31-23)32(12-13)24(33)21-22(35-14(2)29-21)15-5-4-6-16(10-15)25(26,27)28/h4-8,10-11,20H,1,9,12H2,2-3H3,(H,30,31)/t20-/m0/s1 QCRDPLYRZJGEIH-FQEVSTJZSA-N 335257 US11040966, Example 6.30::US9732075, Example 6.30::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-[2-methyl-5-(3-trifluoromethyl-phenyl)-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 203 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335257 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335257&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127394 384987416 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658154 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1cccc(c1)C(F)(F)F InChI=1S/C25H21F3N4O2S/c1-13-9-20(23-30-18-8-7-17(34-3)11-19(18)31-23)32(12-13)24(33)21-22(35-14(2)29-21)15-5-4-6-16(10-15)25(26,27)28/h4-8,10-11,20H,1,9,12H2,2-3H3,(H,30,31)/t20-/m0/s1 QCRDPLYRZJGEIH-FQEVSTJZSA-N 335257 US11040966, Example 6.30::US9732075, Example 6.30::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-[2-methyl-5-(3-trifluoromethyl-phenyl)-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 31.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335257 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335257&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127394 384987416 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658155 COc1cccc(c1)-c1sc(nc1C(=O)N1CC(=C)C[C@H]1c1nc2cc(OC)ccc2[nH]1)C1CC1 InChI=1S/C27H26N4O3S/c1-15-11-22(25-28-20-10-9-19(34-3)13-21(20)29-25)31(14-15)27(32)23-24(35-26(30-23)16-7-8-16)17-5-4-6-18(12-17)33-2/h4-6,9-10,12-13,16,22H,1,7-8,11,14H2,2-3H3,(H,28,29)/t22-/m0/s1 GHDFUOBPQQVKTL-QFIPXVFZSA-N 335258 US11040966, Example 6.31::US9732075, Example 6.31::[2-Cyclopropyl-5-(3-methoxy-phenyl)-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 41.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335258 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335258&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695298 384987417 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658156 COc1cccc(c1)-c1sc(nc1C(=O)N1CC(=C)C[C@H]1c1nc2cc(OC)ccc2[nH]1)C1CC1 InChI=1S/C27H26N4O3S/c1-15-11-22(25-28-20-10-9-19(34-3)13-21(20)29-25)31(14-15)27(32)23-24(35-26(30-23)16-7-8-16)17-5-4-6-18(12-17)33-2/h4-6,9-10,12-13,16,22H,1,7-8,11,14H2,2-3H3,(H,28,29)/t22-/m0/s1 GHDFUOBPQQVKTL-QFIPXVFZSA-N 335258 US11040966, Example 6.31::US9732075, Example 6.31::[2-Cyclopropyl-5-(3-methoxy-phenyl)-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 22.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335258 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335258&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695298 384987417 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658157 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1ncsc1-c1cccc(Cl)c1 InChI=1S/C23H19ClN4O2S/c1-13-8-19(22-26-17-7-6-16(30-2)10-18(17)27-22)28(11-13)23(29)20-21(31-12-25-20)14-4-3-5-15(24)9-14/h3-7,9-10,12,19H,1,8,11H2,2H3,(H,26,27)/t19-/m0/s1 JUCQHIDXGKSMCB-IBGZPJMESA-N 335259 US11040966, Example 6.32::US9732075, Example 6.32::[5-(3-Chloro-phenyl)-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 814 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335259 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335259&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102296 384987418 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658158 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1ncsc1-c1cccc(Cl)c1 InChI=1S/C23H19ClN4O2S/c1-13-8-19(22-26-17-7-6-16(30-2)10-18(17)27-22)28(11-13)23(29)20-21(31-12-25-20)14-4-3-5-15(24)9-14/h3-7,9-10,12,19H,1,8,11H2,2H3,(H,26,27)/t19-/m0/s1 JUCQHIDXGKSMCB-IBGZPJMESA-N 335259 US11040966, Example 6.32::US9732075, Example 6.32::[5-(3-Chloro-phenyl)-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 103 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335259 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335259&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102296 384987418 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658159 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1cccc(F)c1 InChI=1S/C24H21FN4O2S/c1-13-9-20(23-27-18-8-7-17(31-3)11-19(18)28-23)29(12-13)24(30)21-22(32-14(2)26-21)15-5-4-6-16(25)10-15/h4-8,10-11,20H,1,9,12H2,2-3H3,(H,27,28)/t20-/m0/s1 KNGFPSUTROHZQU-FQEVSTJZSA-N 335260 US11040966, Example 6.33::US9732075, Example 6.33::[5-(3-Fluoro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 213 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335260 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335260&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127079 384987419 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658160 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1cccc(F)c1 InChI=1S/C24H21FN4O2S/c1-13-9-20(23-27-18-8-7-17(31-3)11-19(18)28-23)29(12-13)24(30)21-22(32-14(2)26-21)15-5-4-6-16(25)10-15/h4-8,10-11,20H,1,9,12H2,2-3H3,(H,27,28)/t20-/m0/s1 KNGFPSUTROHZQU-FQEVSTJZSA-N 335260 US11040966, Example 6.33::US9732075, Example 6.33::[5-(3-Fluoro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 23.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335260 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335260&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127079 384987419 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658161 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1ccccc1Cl InChI=1S/C24H21ClN4O2S/c1-13-10-20(23-27-18-9-8-15(31-3)11-19(18)28-23)29(12-13)24(30)21-22(32-14(2)26-21)16-6-4-5-7-17(16)25/h4-9,11,20H,1,10,12H2,2-3H3,(H,27,28)/t20-/m0/s1 VPCDCFYLBPXNFH-FQEVSTJZSA-N 335261 US11040966, Example 6.34::US9732075, Example 6.34::[5-(2-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 398 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335261 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335261&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127539 384987420 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658162 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1ccccc1Cl InChI=1S/C24H21ClN4O2S/c1-13-10-20(23-27-18-9-8-15(31-3)11-19(18)28-23)29(12-13)24(30)21-22(32-14(2)26-21)16-6-4-5-7-17(16)25/h4-9,11,20H,1,10,12H2,2-3H3,(H,27,28)/t20-/m0/s1 VPCDCFYLBPXNFH-FQEVSTJZSA-N 335261 US11040966, Example 6.34::US9732075, Example 6.34::[5-(2-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 66.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335261 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335261&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127539 384987420 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658163 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(sc1-c1ccc(C)cc1)C1CC1 InChI=1S/C27H26N4O2S/c1-15-4-6-17(7-5-15)24-23(30-26(34-24)18-8-9-18)27(32)31-14-16(2)12-22(31)25-28-20-11-10-19(33-3)13-21(20)29-25/h4-7,10-11,13,18,22H,2,8-9,12,14H2,1,3H3,(H,28,29)/t22-/m0/s1 CJLNNJFBHCONPQ-QFIPXVFZSA-N 335262 (2-Cyclopropyl-5-p-tolyl-thiazol-4-yl)-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone::US11040966, Example 6.35::US9732075, Example 6.35 Orexin/Hypocretin receptor type 1 Homo sapiens 146 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335262 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335262&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127756 384987421 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658164 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(sc1-c1ccc(C)cc1)C1CC1 InChI=1S/C27H26N4O2S/c1-15-4-6-17(7-5-15)24-23(30-26(34-24)18-8-9-18)27(32)31-14-16(2)12-22(31)25-28-20-11-10-19(33-3)13-21(20)29-25/h4-7,10-11,13,18,22H,2,8-9,12,14H2,1,3H3,(H,28,29)/t22-/m0/s1 CJLNNJFBHCONPQ-QFIPXVFZSA-N 335262 (2-Cyclopropyl-5-p-tolyl-thiazol-4-yl)-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone::US11040966, Example 6.35::US9732075, Example 6.35 Orexin receptor type 2 Homo sapiens 80.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335262 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335262&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127756 384987421 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658165 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1cc(C)sc1-c1ccc(C)c(C)c1 InChI=1S/C27H27N3O2S/c1-15-10-24(26-28-22-9-8-20(32-5)13-23(22)29-26)30(14-15)27(31)21-12-18(4)33-25(21)19-7-6-16(2)17(3)11-19/h6-9,11-13,24H,1,10,14H2,2-5H3,(H,28,29)/t24-/m0/s1 VLOHAXSJLPIXTQ-DEOSSOPVSA-N 335263 US11040966, Example 6.36::US9732075, Example 6.36::[2-(3,4-Dimethyl-phenyl)-5-methyl-thiophen-3-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 15.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335263 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335263&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118126992 384987422 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658166 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1cc(C)sc1-c1ccc(C)c(C)c1 InChI=1S/C27H27N3O2S/c1-15-10-24(26-28-22-9-8-20(32-5)13-23(22)29-26)30(14-15)27(31)21-12-18(4)33-25(21)19-7-6-16(2)17(3)11-19/h6-9,11-13,24H,1,10,14H2,2-5H3,(H,28,29)/t24-/m0/s1 VLOHAXSJLPIXTQ-DEOSSOPVSA-N 335263 US11040966, Example 6.36::US9732075, Example 6.36::[2-(3,4-Dimethyl-phenyl)-5-methyl-thiophen-3-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335263 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335263&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118126992 384987422 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658167 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1cc(F)cc(F)c1 InChI=1S/C24H20F2N4O2S/c1-12-6-20(23-28-18-5-4-17(32-3)10-19(18)29-23)30(11-12)24(31)21-22(33-13(2)27-21)14-7-15(25)9-16(26)8-14/h4-5,7-10,20H,1,6,11H2,2-3H3,(H,28,29)/t20-/m0/s1 BPXGDAOTPWVQQR-FQEVSTJZSA-N 335264 US11040966, Example 6.37::US9732075, Example 6.37::[5-(3,5-Difluoro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 422 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335264 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335264&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127729 384987423 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658168 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1cc(F)cc(F)c1 InChI=1S/C24H20F2N4O2S/c1-12-6-20(23-28-18-5-4-17(32-3)10-19(18)29-23)30(11-12)24(31)21-22(33-13(2)27-21)14-7-15(25)9-16(26)8-14/h4-5,7-10,20H,1,6,11H2,2-3H3,(H,28,29)/t20-/m0/s1 BPXGDAOTPWVQQR-FQEVSTJZSA-N 335264 US11040966, Example 6.37::US9732075, Example 6.37::[5-(3,5-Difluoro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 45.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335264 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335264&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127729 384987423 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658169 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1ccsc1-c1cccc(C)c1 InChI=1S/C25H23N3O2S/c1-15-5-4-6-17(11-15)23-19(9-10-31-23)25(29)28-14-16(2)12-22(28)24-26-20-8-7-18(30-3)13-21(20)27-24/h4-11,13,22H,2,12,14H2,1,3H3,(H,26,27)/t22-/m0/s1 AWRGSLINNFJNAZ-QFIPXVFZSA-N 335265 US11040966, Example 6.38::US9732075, Example 6.38::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-(2-m-tolyl-thiophen-3-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 269 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335265 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335265&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127538 384987424 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658170 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1ccsc1-c1cccc(C)c1 InChI=1S/C25H23N3O2S/c1-15-5-4-6-17(11-15)23-19(9-10-31-23)25(29)28-14-16(2)12-22(28)24-26-20-8-7-18(30-3)13-21(20)27-24/h4-11,13,22H,2,12,14H2,1,3H3,(H,26,27)/t22-/m0/s1 AWRGSLINNFJNAZ-QFIPXVFZSA-N 335265 US11040966, Example 6.38::US9732075, Example 6.38::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-(2-m-tolyl-thiophen-3-yl)-methanone Orexin receptor type 2 Homo sapiens 19.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335265 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335265&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127538 384987424 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658171 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1ccsc1-c1ccc(C)c(C)c1 InChI=1S/C26H25N3O2S/c1-15-11-23(25-27-21-8-7-19(31-4)13-22(21)28-25)29(14-15)26(30)20-9-10-32-24(20)18-6-5-16(2)17(3)12-18/h5-10,12-13,23H,1,11,14H2,2-4H3,(H,27,28)/t23-/m0/s1 LGXVRWFSKQATCI-QHCPKHFHSA-N 335266 US11040966, Example 6.39::US9732075, Example 6.39::[2-(3,4-Dimethyl-phenyl)-thiophen-3-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 106 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335266 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335266&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127125 384987425 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658172 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1ccsc1-c1ccc(C)c(C)c1 InChI=1S/C26H25N3O2S/c1-15-11-23(25-27-21-8-7-19(31-4)13-22(21)28-25)29(14-15)26(30)20-9-10-32-24(20)18-6-5-16(2)17(3)12-18/h5-10,12-13,23H,1,11,14H2,2-4H3,(H,27,28)/t23-/m0/s1 LGXVRWFSKQATCI-QHCPKHFHSA-N 335266 US11040966, Example 6.39::US9732075, Example 6.39::[2-(3,4-Dimethyl-phenyl)-thiophen-3-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335266 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335266&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127125 384987425 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658173 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nccnc1-c1ccc(C)cc1 InChI=1S/C25H23N5O2/c1-15-4-6-17(7-5-15)22-23(27-11-10-26-22)25(31)30-14-16(2)12-21(30)24-28-19-9-8-18(32-3)13-20(19)29-24/h4-11,13,21H,2,12,14H2,1,3H3,(H,28,29)/t21-/m0/s1 CWSJYLNNFBKRAO-NRFANRHFSA-N 335267 US11040966, Example 6.4::US9732075, Example 6.4::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-(3-p-tolyl-pyrazin-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2510 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335267 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335267&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102320 384987426 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658174 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nccnc1-c1ccc(C)cc1 InChI=1S/C25H23N5O2/c1-15-4-6-17(7-5-15)22-23(27-11-10-26-22)25(31)30-14-16(2)12-21(30)24-28-19-9-8-18(32-3)13-20(19)29-24/h4-11,13,21H,2,12,14H2,1,3H3,(H,28,29)/t21-/m0/s1 CWSJYLNNFBKRAO-NRFANRHFSA-N 335267 US11040966, Example 6.4::US9732075, Example 6.4::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-(3-p-tolyl-pyrazin-2-yl)-methanone Orexin receptor type 2 Homo sapiens 118 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335267 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335267&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102320 384987426 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658175 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3c(C)cccc3[nH]2)c(s1)-c1ccccc1 InChI=1S/C24H22N4OS/c1-14-12-19(23-26-18-11-7-8-15(2)20(18)27-23)28(13-14)24(29)21-22(30-16(3)25-21)17-9-5-4-6-10-17/h4-11,19H,1,12-13H2,2-3H3,(H,26,27)/t19-/m0/s1 CQHIJNMEVUISIX-IBGZPJMESA-N 335268 US11040966, Example 6.40::US9732075, Example 6.40::[(S)-2-(4-Methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 70.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335268 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335268&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127918 384987427 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658176 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3c(C)cccc3[nH]2)c(s1)-c1ccccc1 InChI=1S/C24H22N4OS/c1-14-12-19(23-26-18-11-7-8-15(2)20(18)27-23)28(13-14)24(29)21-22(30-16(3)25-21)17-9-5-4-6-10-17/h4-11,19H,1,12-13H2,2-3H3,(H,26,27)/t19-/m0/s1 CQHIJNMEVUISIX-IBGZPJMESA-N 335268 US11040966, Example 6.40::US9732075, Example 6.40::[(S)-2-(4-Methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335268 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335268&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127918 384987427 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658177 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccccc1 InChI=1S/C24H21ClN4OS/c1-13-11-19(23-27-18-10-9-17(25)14(2)20(18)28-23)29(12-13)24(30)21-22(31-15(3)26-21)16-7-5-4-6-8-16/h4-10,19H,1,11-12H2,2-3H3,(H,27,28)/t19-/m0/s1 STCNMOVPLMYXAN-IBGZPJMESA-N 335269 US11040966, Example 6.41::US9732075, Example 6.41::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335269 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335269&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695698 384987428 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658178 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccccc1 InChI=1S/C24H21ClN4OS/c1-13-11-19(23-27-18-10-9-17(25)14(2)20(18)28-23)29(12-13)24(30)21-22(31-15(3)26-21)16-7-5-4-6-8-16/h4-10,19H,1,11-12H2,2-3H3,(H,27,28)/t19-/m0/s1 STCNMOVPLMYXAN-IBGZPJMESA-N 335269 US11040966, Example 6.41::US9732075, Example 6.41::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-methyl-5-phenyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335269 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335269&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695698 384987428 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658179 Cc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2c(C)c(Cl)ccc2[nH]1)-n1nccn1 InChI=1S/C23H21ClN6O/c1-13-4-7-19(30-25-8-9-26-30)16(10-13)23(31)29-12-14(2)11-20(29)22-27-18-6-5-17(24)15(3)21(18)28-22/h4-10,20H,2,11-12H2,1,3H3,(H,27,28)/t20-/m0/s1 XWMUMMVILIGXDD-FQEVSTJZSA-N 335270 US11040966, Example 6.42::US9732075, Example 6.42::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 12.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335270 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335270&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695794 384987429 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658180 Cc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2c(C)c(Cl)ccc2[nH]1)-n1nccn1 InChI=1S/C23H21ClN6O/c1-13-4-7-19(30-25-8-9-26-30)16(10-13)23(31)29-12-14(2)11-20(29)22-27-18-6-5-17(24)15(3)21(18)28-22/h4-10,20H,2,11-12H2,1,3H3,(H,27,28)/t20-/m0/s1 XWMUMMVILIGXDD-FQEVSTJZSA-N 335270 US11040966, Example 6.42::US9732075, Example 6.42::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335270 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335270&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695794 384987429 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658181 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3ccccc3[nH]2)c(s1)-c1cccc(Cl)c1 InChI=1S/C23H19ClN4OS/c1-13-10-19(22-26-17-8-3-4-9-18(17)27-22)28(12-13)23(29)20-21(30-14(2)25-20)15-6-5-7-16(24)11-15/h3-9,11,19H,1,10,12H2,2H3,(H,26,27)/t19-/m0/s1 IKXKSHOLRREPSM-IBGZPJMESA-N 335271 US11040966, Example 6.43::US9732075, Example 6.43::[(S)-2-(1H-Benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 368 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335271 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335271&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102399 384987430 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658182 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3ccccc3[nH]2)c(s1)-c1cccc(Cl)c1 InChI=1S/C23H19ClN4OS/c1-13-10-19(22-26-17-8-3-4-9-18(17)27-22)28(12-13)23(29)20-21(30-14(2)25-20)15-6-5-7-16(24)11-15/h3-9,11,19H,1,10,12H2,2H3,(H,26,27)/t19-/m0/s1 IKXKSHOLRREPSM-IBGZPJMESA-N 335271 US11040966, Example 6.43::US9732075, Example 6.43::[(S)-2-(1H-Benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 62.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335271 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335271&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102399 384987430 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658183 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3c(C)cccc3[nH]2)c(s1)-c1cccc(Cl)c1 InChI=1S/C24H21ClN4OS/c1-13-10-19(23-27-18-9-4-6-14(2)20(18)28-23)29(12-13)24(30)21-22(31-15(3)26-21)16-7-5-8-17(25)11-16/h4-9,11,19H,1,10,12H2,2-3H3,(H,27,28)/t19-/m0/s1 UURXFYJBJKQNHB-IBGZPJMESA-N 335272 US11040966, Example 6.44::US9732075, Example 6.44::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(4-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 10.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335272 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335272&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695500 384987431 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658184 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3c(C)cccc3[nH]2)c(s1)-c1cccc(Cl)c1 InChI=1S/C24H21ClN4OS/c1-13-10-19(23-27-18-9-4-6-14(2)20(18)28-23)29(12-13)24(30)21-22(31-15(3)26-21)16-7-5-8-17(25)11-16/h4-9,11,19H,1,10,12H2,2-3H3,(H,27,28)/t19-/m0/s1 UURXFYJBJKQNHB-IBGZPJMESA-N 335272 US11040966, Example 6.44::US9732075, Example 6.44::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(4-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335272 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335272&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695500 384987431 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658185 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1cccc(Cl)c1 InChI=1S/C24H20Cl2N4OS/c1-12-9-19(23-28-18-8-7-17(26)13(2)20(18)29-23)30(11-12)24(31)21-22(32-14(3)27-21)15-5-4-6-16(25)10-15/h4-8,10,19H,1,9,11H2,2-3H3,(H,28,29)/t19-/m0/s1 NNEYHDHJHDRFBV-IBGZPJMESA-N 335273 US11040966, Example 6.45::US9732075, Example 6.45::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335273 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335273&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127565 384987432 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658186 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1cccc(Cl)c1 InChI=1S/C24H20Cl2N4OS/c1-12-9-19(23-28-18-8-7-17(26)13(2)20(18)29-23)30(11-12)24(31)21-22(32-14(3)27-21)15-5-4-6-16(25)10-15/h4-8,10,19H,1,9,11H2,2-3H3,(H,28,29)/t19-/m0/s1 NNEYHDHJHDRFBV-IBGZPJMESA-N 335273 US11040966, Example 6.45::US9732075, Example 6.45::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335273 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335273&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127565 384987432 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658187 COc1ccc2nc([nH]c2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1ccc(C)c(C)c1 InChI=1S/C26H26N4O2S/c1-14-10-22(25-28-20-9-8-19(32-5)12-21(20)29-25)30(13-14)26(31)23-24(33-17(4)27-23)18-7-6-15(2)16(3)11-18/h6-9,11-12,22H,1,10,13H2,2-5H3,(H,28,29)/t22-/m0/s1 UYNPCVHRRZNCOG-QFIPXVFZSA-N 335274 US11040966, Example 6.46::US9732075, Example 6.46::[5-(3,4-Dimethyl-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 30.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335274 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335274&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695499 384987433 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658188 COc1ccc2nc([nH]c2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1ccc(C)c(C)c1 InChI=1S/C26H26N4O2S/c1-14-10-22(25-28-20-9-8-19(32-5)12-21(20)29-25)30(13-14)26(31)23-24(33-17(4)27-23)18-7-6-15(2)16(3)11-18/h6-9,11-12,22H,1,10,13H2,2-5H3,(H,28,29)/t22-/m0/s1 UYNPCVHRRZNCOG-QFIPXVFZSA-N 335274 US11040966, Example 6.46::US9732075, Example 6.46::[5-(3,4-Dimethyl-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(6-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335274 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335274&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695499 384987433 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658189 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3c(C)c(C)ccc3[nH]2)c(s1)-c1ccc(C)c(C)c1 InChI=1S/C27H28N4OS/c1-14-11-22(26-29-21-10-8-16(3)18(5)23(21)30-26)31(13-14)27(32)24-25(33-19(6)28-24)20-9-7-15(2)17(4)12-20/h7-10,12,22H,1,11,13H2,2-6H3,(H,29,30)/t22-/m0/s1 ZGXURSBUSGZSFT-QFIPXVFZSA-N 335275 US11040966, Example 6.47::US9732075, Example 6.47::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(3,4-dimethyl-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335275 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335275&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127126 384987434 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658190 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3c(C)c(C)ccc3[nH]2)c(s1)-c1ccc(C)c(C)c1 InChI=1S/C27H28N4OS/c1-14-11-22(26-29-21-10-8-16(3)18(5)23(21)30-26)31(13-14)27(32)24-25(33-19(6)28-24)20-9-7-15(2)17(4)12-20/h7-10,12,22H,1,11,13H2,2-6H3,(H,29,30)/t22-/m0/s1 ZGXURSBUSGZSFT-QFIPXVFZSA-N 335275 US11040966, Example 6.47::US9732075, Example 6.47::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(3,4-dimethyl-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335275 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335275&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127126 384987434 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658191 COc1ccc(OC)c2[nH]c(nc12)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1ccc(C)c(C)c1 InChI=1S/C27H28N4O3S/c1-14-11-19(26-29-22-20(33-5)9-10-21(34-6)23(22)30-26)31(13-14)27(32)24-25(35-17(4)28-24)18-8-7-15(2)16(3)12-18/h7-10,12,19H,1,11,13H2,2-6H3,(H,29,30)/t19-/m0/s1 MIEIWPANAMLZKV-IBGZPJMESA-N 335276 US11040966, Example 6.48::US9732075, Example 6.48::[(S)-2-(4,7-Dimethoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(3,4-dimethyl-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 14.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335276&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127657 384987435 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658192 COc1ccc(OC)c2[nH]c(nc12)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1ccc(C)c(C)c1 InChI=1S/C27H28N4O3S/c1-14-11-19(26-29-22-20(33-5)9-10-21(34-6)23(22)30-26)31(13-14)27(32)24-25(35-17(4)28-24)18-8-7-15(2)16(3)12-18/h7-10,12,19H,1,11,13H2,2-6H3,(H,29,30)/t19-/m0/s1 MIEIWPANAMLZKV-IBGZPJMESA-N 335276 US11040966, Example 6.48::US9732075, Example 6.48::[(S)-2-(4,7-Dimethoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(3,4-dimethyl-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335276 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335276&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127657 384987435 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658193 CSc1cccc2[nH]c(nc12)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1ccc(C)c(C)c1 InChI=1S/C26H26N4OS2/c1-14-11-20(25-28-19-7-6-8-21(32-5)22(19)29-25)30(13-14)26(31)23-24(33-17(4)27-23)18-10-9-15(2)16(3)12-18/h6-10,12,20H,1,11,13H2,2-5H3,(H,28,29)/t20-/m0/s1 LNVMEGYQWMZUBX-FQEVSTJZSA-N 335277 US11040966, Example 6.49::US9732075, Example 6.49::[5-(3,4-Dimethyl-phenyl)-2-methyl-thiazol-4-yl]-[(S)-4-methylene-2-(4-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335277 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335277&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695299 384987436 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658194 CSc1cccc2[nH]c(nc12)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1ccc(C)c(C)c1 InChI=1S/C26H26N4OS2/c1-14-11-20(25-28-19-7-6-8-21(32-5)22(19)29-25)30(13-14)26(31)23-24(33-17(4)27-23)18-10-9-15(2)16(3)12-18/h6-10,12,20H,1,11,13H2,2-5H3,(H,28,29)/t20-/m0/s1 LNVMEGYQWMZUBX-FQEVSTJZSA-N 335277 US11040966, Example 6.49::US9732075, Example 6.49::[5-(3,4-Dimethyl-phenyl)-2-methyl-thiazol-4-yl]-[(S)-4-methylene-2-(4-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335277 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335277&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695299 384987436 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658195 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1ccc(Cl)cc1 InChI=1S/C24H21ClN4O2S/c1-13-10-20(23-27-18-9-8-17(31-3)11-19(18)28-23)29(12-13)24(30)21-22(32-14(2)26-21)15-4-6-16(25)7-5-15/h4-9,11,20H,1,10,12H2,2-3H3,(H,27,28)/t20-/m0/s1 YEIBMVQZGZOUHI-FQEVSTJZSA-N 335278 US11040966, Example 6.5::US9732075, Example 6.5::[5-(4-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 216 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335278 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335278&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127153 384987437 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658196 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1ccc(Cl)cc1 InChI=1S/C24H21ClN4O2S/c1-13-10-20(23-27-18-9-8-17(31-3)11-19(18)28-23)29(12-13)24(30)21-22(32-14(2)26-21)15-4-6-16(25)7-5-15/h4-9,11,20H,1,10,12H2,2-3H3,(H,27,28)/t20-/m0/s1 YEIBMVQZGZOUHI-FQEVSTJZSA-N 335278 US11040966, Example 6.5::US9732075, Example 6.5::[5-(4-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 19.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335278 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335278&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127153 384987437 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658197 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3c(Br)cccc3[nH]2)c(s1)-c1ccc(C)c(C)c1 InChI=1S/C25H23BrN4OS/c1-13-10-20(24-28-19-7-5-6-18(26)21(19)29-24)30(12-13)25(31)22-23(32-16(4)27-22)17-9-8-14(2)15(3)11-17/h5-9,11,20H,1,10,12H2,2-4H3,(H,28,29)/t20-/m0/s1 BXUWYSLYFZPFOP-FQEVSTJZSA-N 335279 US11040966, Example 6.50::US9732075, Example 6.50::[(S)-2-(4-Bromo-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(3,4-dimethyl-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335279 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335279&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127447 384987438 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658198 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3c(Br)cccc3[nH]2)c(s1)-c1ccc(C)c(C)c1 InChI=1S/C25H23BrN4OS/c1-13-10-20(24-28-19-7-5-6-18(26)21(19)29-24)30(12-13)25(31)22-23(32-16(4)27-22)17-9-8-14(2)15(3)11-17/h5-9,11,20H,1,10,12H2,2-4H3,(H,28,29)/t20-/m0/s1 BXUWYSLYFZPFOP-FQEVSTJZSA-N 335279 US11040966, Example 6.50::US9732075, Example 6.50::[(S)-2-(4-Bromo-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(3,4-dimethyl-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335279 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335279&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127447 384987438 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658199 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3c(Cl)cccc3[nH]2)c(s1)-c1ccc(C)c(C)c1 InChI=1S/C25H23ClN4OS/c1-13-10-20(24-28-19-7-5-6-18(26)21(19)29-24)30(12-13)25(31)22-23(32-16(4)27-22)17-9-8-14(2)15(3)11-17/h5-9,11,20H,1,10,12H2,2-4H3,(H,28,29)/t20-/m0/s1 FAUMLKIFIPFSRN-FQEVSTJZSA-N 335280 US11040966, Example 6.51::US9732075, Example 6.51::[(S)-2-(4-Chloro-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(3,4-dimethyl-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335280 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335280&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127214 384987439 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658200 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3c(Cl)cccc3[nH]2)c(s1)-c1ccc(C)c(C)c1 InChI=1S/C25H23ClN4OS/c1-13-10-20(24-28-19-7-5-6-18(26)21(19)29-24)30(12-13)25(31)22-23(32-16(4)27-22)17-9-8-14(2)15(3)11-17/h5-9,11,20H,1,10,12H2,2-4H3,(H,28,29)/t20-/m0/s1 FAUMLKIFIPFSRN-FQEVSTJZSA-N 335280 US11040966, Example 6.51::US9732075, Example 6.51::[(S)-2-(4-Chloro-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(3,4-dimethyl-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335280 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335280&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127214 384987439 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658201 CSc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1ccc(C)c(C)c1 InChI=1S/C26H26N4OS2/c1-14-10-22(25-28-20-9-8-19(32-5)12-21(20)29-25)30(13-14)26(31)23-24(33-17(4)27-23)18-7-6-15(2)16(3)11-18/h6-9,11-12,22H,1,10,13H2,2-5H3,(H,28,29)/t22-/m0/s1 XJHUXYZRPRBTGY-QFIPXVFZSA-N 335281 US11040966, Example 6.52::US9732075, Example 6.52::[5-(3,4-Dimethyl-phenyl)-2-methyl-thiazol-4-yl]-[(S)-4-methylene-2-(5-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335281 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335281&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695701 384987440 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658202 CSc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1ccc(C)c(C)c1 InChI=1S/C26H26N4OS2/c1-14-10-22(25-28-20-9-8-19(32-5)12-21(20)29-25)30(13-14)26(31)23-24(33-17(4)27-23)18-7-6-15(2)16(3)11-18/h6-9,11-12,22H,1,10,13H2,2-5H3,(H,28,29)/t22-/m0/s1 XJHUXYZRPRBTGY-QFIPXVFZSA-N 335281 US11040966, Example 6.52::US9732075, Example 6.52::[5-(3,4-Dimethyl-phenyl)-2-methyl-thiazol-4-yl]-[(S)-4-methylene-2-(5-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335281 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335281&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695701 384987440 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658203 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3c(C)cccc3[nH]2)c(s1)-c1ccc(C)c(C)c1 InChI=1S/C26H26N4OS/c1-14-11-21(25-28-20-8-6-7-16(3)22(20)29-25)30(13-14)26(31)23-24(32-18(5)27-23)19-10-9-15(2)17(4)12-19/h6-10,12,21H,1,11,13H2,2-5H3,(H,28,29)/t21-/m0/s1 FCYJFENZGHEDRB-NRFANRHFSA-N 335282 US11040966, Example 6.53::US9732075, Example 6.53::[5-(3,4-Dimethyl-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(4-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335282 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335282&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695791 384987441 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658204 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3c(C)cccc3[nH]2)c(s1)-c1ccc(C)c(C)c1 InChI=1S/C26H26N4OS/c1-14-11-21(25-28-20-8-6-7-16(3)22(20)29-25)30(13-14)26(31)23-24(32-18(5)27-23)19-10-9-15(2)17(4)12-19/h6-10,12,21H,1,11,13H2,2-5H3,(H,28,29)/t21-/m0/s1 FCYJFENZGHEDRB-NRFANRHFSA-N 335282 US11040966, Example 6.53::US9732075, Example 6.53::[5-(3,4-Dimethyl-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(4-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335282 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335282&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695791 384987441 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658205 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccc(C)c(C)c1 InChI=1S/C26H25ClN4OS/c1-13-10-21(25-29-20-9-8-19(27)16(4)22(20)30-25)31(12-13)26(32)23-24(33-17(5)28-23)18-7-6-14(2)15(3)11-18/h6-9,11,21H,1,10,12H2,2-5H3,(H,29,30)/t21-/m0/s1 PYDZIRFKTNHXGE-NRFANRHFSA-N 335283 US11040966, Example 6.54::US9732075, Example 6.54::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(3,4-dimethyl-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335283 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335283&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127212 384987442 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658206 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccc(C)c(C)c1 InChI=1S/C26H25ClN4OS/c1-13-10-21(25-29-20-9-8-19(27)16(4)22(20)30-25)31(12-13)26(32)23-24(33-17(5)28-23)18-7-6-14(2)15(3)11-18/h6-9,11,21H,1,10,12H2,2-5H3,(H,29,30)/t21-/m0/s1 PYDZIRFKTNHXGE-NRFANRHFSA-N 335283 US11040966, Example 6.54::US9732075, Example 6.54::[(S)-2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(3,4-dimethyl-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335283 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335283&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127212 384987442 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658207 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3cc(Cl)c(C)cc3[nH]2)c(s1)-c1ccc(C)c(C)c1 InChI=1S/C26H25ClN4OS/c1-13-8-22(25-29-20-10-16(4)19(27)11-21(20)30-25)31(12-13)26(32)23-24(33-17(5)28-23)18-7-6-14(2)15(3)9-18/h6-7,9-11,22H,1,8,12H2,2-5H3,(H,29,30)/t22-/m0/s1 VPGMOJNQLSGSJB-QFIPXVFZSA-N 335284 US11040966, Example 6.55::US9732075, Example 6.55::[(S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(3,4-dimethyl-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335284&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128319 384987443 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658208 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3cc(Cl)c(C)cc3[nH]2)c(s1)-c1ccc(C)c(C)c1 InChI=1S/C26H25ClN4OS/c1-13-8-22(25-29-20-10-16(4)19(27)11-21(20)30-25)31(12-13)26(32)23-24(33-17(5)28-23)18-7-6-14(2)15(3)9-18/h6-7,9-11,22H,1,8,12H2,2-5H3,(H,29,30)/t22-/m0/s1 VPGMOJNQLSGSJB-QFIPXVFZSA-N 335284 US11040966, Example 6.55::US9732075, Example 6.55::[(S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(3,4-dimethyl-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335284 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335284&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128319 384987443 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658209 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3cc(C)c(C)cc3[nH]2)c(s1)-c1ccc(C)c(C)c1 InChI=1S/C27H28N4OS/c1-14-9-23(26-29-21-11-17(4)18(5)12-22(21)30-26)31(13-14)27(32)24-25(33-19(6)28-24)20-8-7-15(2)16(3)10-20/h7-8,10-12,23H,1,9,13H2,2-6H3,(H,29,30)/t23-/m0/s1 JHHAXFCLUCKEST-QHCPKHFHSA-N 335285 US11040966, Example 6.56::US9732075, Example 6.56::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(3,4-dimethyl-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335285 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335285&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127365 384987444 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658210 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3cc(C)c(C)cc3[nH]2)c(s1)-c1ccc(C)c(C)c1 InChI=1S/C27H28N4OS/c1-14-9-23(26-29-21-11-17(4)18(5)12-22(21)30-26)31(13-14)27(32)24-25(33-19(6)28-24)20-8-7-15(2)16(3)10-20/h7-8,10-12,23H,1,9,13H2,2-6H3,(H,29,30)/t23-/m0/s1 JHHAXFCLUCKEST-QHCPKHFHSA-N 335285 US11040966, Example 6.56::US9732075, Example 6.56::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(3,4-dimethyl-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335285 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335285&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127365 384987444 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658211 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3cc(ccc3[nH]2)C(C)(C)C)c(s1)-c1ccc(C)c(C)c1 InChI=1S/C29H32N4OS/c1-16-12-24(27-31-22-11-10-21(29(5,6)7)14-23(22)32-27)33(15-16)28(34)25-26(35-19(4)30-25)20-9-8-17(2)18(3)13-20/h8-11,13-14,24H,1,12,15H2,2-7H3,(H,31,32)/t24-/m0/s1 YGXJEUOLAHXSGH-DEOSSOPVSA-N 335286 US11040966, Example 6.57::US9732075, Example 6.57::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(3,4-dimethyl-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 11.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335286 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335286&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127444 384987445 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658212 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3cc(ccc3[nH]2)C(C)(C)C)c(s1)-c1ccc(C)c(C)c1 InChI=1S/C29H32N4OS/c1-16-12-24(27-31-22-11-10-21(29(5,6)7)14-23(22)32-27)33(15-16)28(34)25-26(35-19(4)30-25)20-9-8-17(2)18(3)13-20/h8-11,13-14,24H,1,12,15H2,2-7H3,(H,31,32)/t24-/m0/s1 YGXJEUOLAHXSGH-DEOSSOPVSA-N 335286 US11040966, Example 6.57::US9732075, Example 6.57::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(3,4-dimethyl-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 11.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335286 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335286&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127444 384987445 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658213 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3c(C)cc(C)cc3[nH]2)c(s1)-c1ccc(C)c(C)c1 InChI=1S/C27H28N4OS/c1-14-9-18(5)23-21(10-14)29-26(30-23)22-11-15(2)13-31(22)27(32)24-25(33-19(6)28-24)20-8-7-16(3)17(4)12-20/h7-10,12,22H,2,11,13H2,1,3-6H3,(H,29,30)/t22-/m0/s1 UCGAGGJWCWXTIP-QFIPXVFZSA-N 335287 US11040966, Example 6.58::US9732075, Example 6.58::[(S)-2-(4,6-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(3,4-dimethyl-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335287 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335287&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127681 384987446 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658214 Cc1nc(C(=O)N2CC(=C)C[C@H]2c2nc3c(C)cc(C)cc3[nH]2)c(s1)-c1ccc(C)c(C)c1 InChI=1S/C27H28N4OS/c1-14-9-18(5)23-21(10-14)29-26(30-23)22-11-15(2)13-31(22)27(32)24-25(33-19(6)28-24)20-8-7-16(3)17(4)12-20/h7-10,12,22H,2,11,13H2,1,3-6H3,(H,29,30)/t22-/m0/s1 UCGAGGJWCWXTIP-QFIPXVFZSA-N 335287 US11040966, Example 6.58::US9732075, Example 6.58::[(S)-2-(4,6-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[5-(3,4-dimethyl-phenyl)-2-methyl-thiazol-4-yl]-methanone Orexin receptor type 2 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335287 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335287&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127681 384987446 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658215 CSc1cccc2nc([nH]c12)[C@@H]1CC(=C)CN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C23H22N6OS/c1-14-7-8-18(29-24-9-10-25-29)16(11-14)23(30)28-13-15(2)12-19(28)22-26-17-5-4-6-20(31-3)21(17)27-22/h4-11,19H,2,12-13H2,1,3H3,(H,26,27)/t19-/m0/s1 GUWPZXCYVNNNKJ-IBGZPJMESA-N 335288 US11040966, Example 6.59::US9732075, Example 6.59::[(S)-4-Methylene-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 76.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335288 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335288&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127451 384987447 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658216 CSc1cccc2nc([nH]c12)[C@@H]1CC(=C)CN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C23H22N6OS/c1-14-7-8-18(29-24-9-10-25-29)16(11-14)23(30)28-13-15(2)12-19(28)22-26-17-5-4-6-20(31-3)21(17)27-22/h4-11,19H,2,12-13H2,1,3H3,(H,26,27)/t19-/m0/s1 GUWPZXCYVNNNKJ-IBGZPJMESA-N 335288 US11040966, Example 6.59::US9732075, Example 6.59::[(S)-4-Methylene-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 10.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335288 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335288&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127451 384987447 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658217 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nccnc1-c1cccc(C)c1 InChI=1S/C25H23N5O2/c1-15-5-4-6-17(11-15)22-23(27-10-9-26-22)25(31)30-14-16(2)12-21(30)24-28-19-8-7-18(32-3)13-20(19)29-24/h4-11,13,21H,2,12,14H2,1,3H3,(H,28,29)/t21-/m0/s1 HEVIGAIHOBMTTM-NRFANRHFSA-N 335289 US11040966, Example 6.6::US9732075, Example 6.6::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-(3-m-tolyl-pyrazin-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 477 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335289 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335289&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 124102483 384987448 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658218 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nccnc1-c1cccc(C)c1 InChI=1S/C25H23N5O2/c1-15-5-4-6-17(11-15)22-23(27-10-9-26-22)25(31)30-14-16(2)12-21(30)24-28-19-8-7-18(32-3)13-20(19)29-24/h4-11,13,21H,2,12,14H2,1,3H3,(H,28,29)/t21-/m0/s1 HEVIGAIHOBMTTM-NRFANRHFSA-N 335289 US11040966, Example 6.6::US9732075, Example 6.6::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-(3-m-tolyl-pyrazin-2-yl)-methanone Orexin receptor type 2 Homo sapiens 52.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335289 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335289&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 124102483 384987448 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658219 CSc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C23H22N6OS/c1-14-4-7-20(29-24-8-9-25-29)17(10-14)23(30)28-13-15(2)11-21(28)22-26-18-6-5-16(31-3)12-19(18)27-22/h4-10,12,21H,2,11,13H2,1,3H3,(H,26,27)/t21-/m0/s1 ZKMISGCKDFKKEO-NRFANRHFSA-N 335290 US11040966, Example 6.60::US9732075, Example 6.60::[(S)-4-Methylene-2-(5-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 83.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335290 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335290&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127285 384987449 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658220 CSc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C23H22N6OS/c1-14-4-7-20(29-24-8-9-25-29)17(10-14)23(30)28-13-15(2)11-21(28)22-26-18-6-5-16(31-3)12-19(18)27-22/h4-10,12,21H,2,11,13H2,1,3H3,(H,26,27)/t21-/m0/s1 ZKMISGCKDFKKEO-NRFANRHFSA-N 335290 US11040966, Example 6.60::US9732075, Example 6.60::[(S)-4-Methylene-2-(5-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335290 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335290&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127285 384987449 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658221 Cc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2cc(C)c(C)cc2[nH]1)-n1nccn1 InChI=1S/C24H24N6O/c1-14-5-6-21(30-25-7-8-26-30)18(9-14)24(31)29-13-15(2)10-22(29)23-27-19-11-16(3)17(4)12-20(19)28-23/h5-9,11-12,22H,2,10,13H2,1,3-4H3,(H,27,28)/t22-/m0/s1 ARBCVUWIJBHLRE-QFIPXVFZSA-N 335291 US11040966, Example 6.61::US9732075, Example 6.61::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 41.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335291 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335291&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695792 384987450 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658222 Cc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2cc(C)c(C)cc2[nH]1)-n1nccn1 InChI=1S/C24H24N6O/c1-14-5-6-21(30-25-7-8-26-30)18(9-14)24(31)29-13-15(2)10-22(29)23-27-19-11-16(3)17(4)12-20(19)28-23/h5-9,11-12,22H,2,10,13H2,1,3-4H3,(H,27,28)/t22-/m0/s1 ARBCVUWIJBHLRE-QFIPXVFZSA-N 335291 US11040966, Example 6.61::US9732075, Example 6.61::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335291 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335291&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695792 384987450 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658223 Cc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2c(C)cc(C)cc2[nH]1)-n1nccn1 InChI=1S/C24H24N6O/c1-14-5-6-20(30-25-7-8-26-30)18(10-14)24(31)29-13-16(3)12-21(29)23-27-19-11-15(2)9-17(4)22(19)28-23/h5-11,21H,3,12-13H2,1-2,4H3,(H,27,28)/t21-/m0/s1 OTGTVXFMBPITGZ-NRFANRHFSA-N 335292 US11040966, Example 6.62::US9732075, Example 6.62::[(S)-2-(4,6-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 44.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335292 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335292&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695796 384987451 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658224 Cc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2c(C)cc(C)cc2[nH]1)-n1nccn1 InChI=1S/C24H24N6O/c1-14-5-6-20(30-25-7-8-26-30)18(10-14)24(31)29-13-16(3)12-21(29)23-27-19-11-15(2)9-17(4)22(19)28-23/h5-11,21H,3,12-13H2,1-2,4H3,(H,27,28)/t21-/m0/s1 OTGTVXFMBPITGZ-NRFANRHFSA-N 335292 US11040966, Example 6.62::US9732075, Example 6.62::[(S)-2-(4,6-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335292 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335292&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695796 384987451 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658225 Cc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2c(C)c(C)ccc2[nH]1)-n1nccn1 InChI=1S/C24H24N6O/c1-14-5-8-20(30-25-9-10-26-30)18(11-14)24(31)29-13-15(2)12-21(29)23-27-19-7-6-16(3)17(4)22(19)28-23/h5-11,21H,2,12-13H2,1,3-4H3,(H,27,28)/t21-/m0/s1 SNBCFSAYNNCLDS-NRFANRHFSA-N 335293 US11040966, Example 6.63::US9732075, Example 6.63::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 88.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335293 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335293&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128259 384987452 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658226 Cc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2c(C)c(C)ccc2[nH]1)-n1nccn1 InChI=1S/C24H24N6O/c1-14-5-8-20(30-25-9-10-26-30)18(11-14)24(31)29-13-15(2)12-21(29)23-27-19-7-6-16(3)17(4)22(19)28-23/h5-11,21H,2,12-13H2,1,3-4H3,(H,27,28)/t21-/m0/s1 SNBCFSAYNNCLDS-NRFANRHFSA-N 335293 US11040966, Example 6.63::US9732075, Example 6.63::[(S)-2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335293 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335293&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128259 384987452 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658227 Cc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2c(Br)cccc2[nH]1)-n1nccn1 InChI=1S/C22H19BrN6O/c1-13-6-7-18(29-24-8-9-25-29)15(10-13)22(30)28-12-14(2)11-19(28)21-26-17-5-3-4-16(23)20(17)27-21/h3-10,19H,2,11-12H2,1H3,(H,26,27)/t19-/m0/s1 DKRIPYRJKGNUCR-IBGZPJMESA-N 335294 US11040966, Example 6.64::US9732075, Example 6.64::[(S)-2-(4-Bromo-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 142 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335294 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335294&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128372 384987453 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658228 Cc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2c(Br)cccc2[nH]1)-n1nccn1 InChI=1S/C22H19BrN6O/c1-13-6-7-18(29-24-8-9-25-29)15(10-13)22(30)28-12-14(2)11-19(28)21-26-17-5-3-4-16(23)20(17)27-21/h3-10,19H,2,11-12H2,1H3,(H,26,27)/t19-/m0/s1 DKRIPYRJKGNUCR-IBGZPJMESA-N 335294 US11040966, Example 6.64::US9732075, Example 6.64::[(S)-2-(4-Bromo-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 33.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335294 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335294&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128372 384987453 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658229 Cc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2cc(Cl)c(C)cc2[nH]1)-n1nccn1 InChI=1S/C23H21ClN6O/c1-13-4-5-20(30-25-6-7-26-30)16(8-13)23(31)29-12-14(2)9-21(29)22-27-18-10-15(3)17(24)11-19(18)28-22/h4-8,10-11,21H,2,9,12H2,1,3H3,(H,27,28)/t21-/m0/s1 VUGJMWYSWHTWFF-NRFANRHFSA-N 335295 US11040966, Example 6.65::US9732075, Example 6.65::[(S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 34.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335295 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335295&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695699 384987454 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658230 Cc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2cc(Cl)c(C)cc2[nH]1)-n1nccn1 InChI=1S/C23H21ClN6O/c1-13-4-5-20(30-25-6-7-26-30)16(8-13)23(31)29-12-14(2)9-21(29)22-27-18-10-15(3)17(24)11-19(18)28-22/h4-8,10-11,21H,2,9,12H2,1,3H3,(H,27,28)/t21-/m0/s1 VUGJMWYSWHTWFF-NRFANRHFSA-N 335295 US11040966, Example 6.65::US9732075, Example 6.65::[(S)-2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335295 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335295&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695699 384987454 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658231 Cc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2cc(ccc2[nH]1)C(C)(C)C)-n1nccn1 InChI=1S/C26H28N6O/c1-16-6-9-22(32-27-10-11-28-32)19(12-16)25(33)31-15-17(2)13-23(31)24-29-20-8-7-18(26(3,4)5)14-21(20)30-24/h6-12,14,23H,2,13,15H2,1,3-5H3,(H,29,30)/t23-/m0/s1 PKXRGEAMPIYIFY-QHCPKHFHSA-N 335296 US11040966, Example 6.66::US9732075, Example 6.66::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 57.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335296 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335296&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127255 384987455 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658232 Cc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2cc(ccc2[nH]1)C(C)(C)C)-n1nccn1 InChI=1S/C26H28N6O/c1-16-6-9-22(32-27-10-11-28-32)19(12-16)25(33)31-15-17(2)13-23(31)24-29-20-8-7-18(26(3,4)5)14-21(20)30-24/h6-12,14,23H,2,13,15H2,1,3-5H3,(H,29,30)/t23-/m0/s1 PKXRGEAMPIYIFY-QHCPKHFHSA-N 335296 US11040966, Example 6.66::US9732075, Example 6.66::[(S)-2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335296 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335296&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127255 384987455 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658233 Cc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2cc(Cl)c(cc2[nH]1)C(F)(F)F)-n1nccn1 InChI=1S/C23H18ClF3N6O/c1-12-3-4-19(33-28-5-6-29-33)14(7-12)22(34)32-11-13(2)8-20(32)21-30-17-9-15(23(25,26)27)16(24)10-18(17)31-21/h3-7,9-10,20H,2,8,11H2,1H3,(H,30,31)/t20-/m0/s1 UXAKNZMSCWINPA-FQEVSTJZSA-N 335297 US11040966, Example 6.67::US9732075, Example 6.67::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335297 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335297&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695700 384987456 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658234 Cc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2cc(Cl)c(cc2[nH]1)C(F)(F)F)-n1nccn1 InChI=1S/C23H18ClF3N6O/c1-12-3-4-19(33-28-5-6-29-33)14(7-12)22(34)32-11-13(2)8-20(32)21-30-17-9-15(23(25,26)27)16(24)10-18(17)31-21/h3-7,9-10,20H,2,8,11H2,1H3,(H,30,31)/t20-/m0/s1 UXAKNZMSCWINPA-FQEVSTJZSA-N 335297 US11040966, Example 6.67::US9732075, Example 6.67::[(S)-2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335297 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335297&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695700 384987456 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658235 COc1ccc(OC)c2[nH]c(nc12)[C@@H]1CC(=C)CN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C24H24N6O3/c1-14-5-6-17(30-25-9-10-26-30)16(11-14)24(31)29-13-15(2)12-18(29)23-27-21-19(32-3)7-8-20(33-4)22(21)28-23/h5-11,18H,2,12-13H2,1,3-4H3,(H,27,28)/t18-/m0/s1 ZPMYPIMEGJXJAF-SFHVURJKSA-N 335298 US11040966, Example 6.68::US9732075, Example 6.68::[(S)-2-(4,7-Dimethoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 767 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335298 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335298&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127930 384987457 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658236 COc1ccc(OC)c2[nH]c(nc12)[C@@H]1CC(=C)CN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C24H24N6O3/c1-14-5-6-17(30-25-9-10-26-30)16(11-14)24(31)29-13-15(2)12-18(29)23-27-21-19(32-3)7-8-20(33-4)22(21)28-23/h5-11,18H,2,12-13H2,1,3-4H3,(H,27,28)/t18-/m0/s1 ZPMYPIMEGJXJAF-SFHVURJKSA-N 335298 US11040966, Example 6.68::US9732075, Example 6.68::[(S)-2-(4,7-Dimethoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 62.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335298 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335298&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127930 384987457 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658237 Cc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2cccc(Cl)c2[nH]1)-n1nccn1 InChI=1S/C22H19ClN6O/c1-13-6-7-18(29-24-8-9-25-29)15(10-13)22(30)28-12-14(2)11-19(28)21-26-17-5-3-4-16(23)20(17)27-21/h3-10,19H,2,11-12H2,1H3,(H,26,27)/t19-/m0/s1 HTJVTFAVAXQARY-IBGZPJMESA-N 335299 US11040966, Example 6.69::US9732075, Example 6.69::[(S)-2-(7-Chloro-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 389 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335299 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335299&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127173 384987458 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658238 Cc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2cccc(Cl)c2[nH]1)-n1nccn1 InChI=1S/C22H19ClN6O/c1-13-6-7-18(29-24-8-9-25-29)15(10-13)22(30)28-12-14(2)11-19(28)21-26-17-5-3-4-16(23)20(17)27-21/h3-10,19H,2,11-12H2,1H3,(H,26,27)/t19-/m0/s1 HTJVTFAVAXQARY-IBGZPJMESA-N 335299 US11040966, Example 6.69::US9732075, Example 6.69::[(S)-2-(7-Chloro-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 51.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335299 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335299&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127173 384987458 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658239 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1cccc(C)c1 InChI=1S/C25H24N4O2S/c1-14-6-5-7-17(10-14)23-22(26-16(3)32-23)25(30)29-13-15(2)11-21(29)24-27-19-9-8-18(31-4)12-20(19)28-24/h5-10,12,21H,2,11,13H2,1,3-4H3,(H,27,28)/t21-/m0/s1 JGSAZINDEZSQOU-NRFANRHFSA-N 335300 US11040966, Example 6.7::US9732075, Example 6.7::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-(2-methyl-5-m-tolyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 15.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335300 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335300&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695795 384987459 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658240 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1cccc(C)c1 InChI=1S/C25H24N4O2S/c1-14-6-5-7-17(10-14)23-22(26-16(3)32-23)25(30)29-13-15(2)11-21(29)24-27-19-9-8-18(31-4)12-20(19)28-24/h5-10,12,21H,2,11,13H2,1,3-4H3,(H,27,28)/t21-/m0/s1 JGSAZINDEZSQOU-NRFANRHFSA-N 335300 US11040966, Example 6.7::US9732075, Example 6.7::[(S)-2-(5-Methoxy-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-(2-methyl-5-m-tolyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335300 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335300&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695795 384987459 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658241 COc1ccc2[nH]c(nc2c1)C1CC(=C)CN1C(=O)c1cc(C)sc1-c1ccc(C)c(C)c1 335301 US11040966, Example 6.71::US9732075, Example 6.71::rac-[2-(3,4-Dimethyl-phenyl)-5-methyl-thiophen-3-yl]-[2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 24.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335301 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335301&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695594 384987460 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658242 COc1ccc2[nH]c(nc2c1)C1CC(=C)CN1C(=O)c1cc(C)sc1-c1ccc(C)c(C)c1 335301 US11040966, Example 6.71::US9732075, Example 6.71::rac-[2-(3,4-Dimethyl-phenyl)-5-methyl-thiophen-3-yl]-[2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335301 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335301&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695594 384987460 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658243 CSc1cccc2nc([nH]c12)C1CC(=C)CN1C(=O)c1cc(C)sc1-c1ccc(C)c(C)c1 335302 US11040966, Example 6.72::US9732075, Example 6.72::rac-[2-(3,4-Dimethyl-phenyl)-5-methyl-thiophen-3-yl]-[4-methylene-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335302 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335302&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127239 384987461 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658244 CSc1cccc2nc([nH]c12)C1CC(=C)CN1C(=O)c1cc(C)sc1-c1ccc(C)c(C)c1 335302 US11040966, Example 6.72::US9732075, Example 6.72::rac-[2-(3,4-Dimethyl-phenyl)-5-methyl-thiophen-3-yl]-[4-methylene-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335302 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335302&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127239 384987461 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658245 CSc1ccc2[nH]c(nc2c1)C1CC(=C)CN1C(=O)c1cc(C)sc1-c1ccc(C)c(C)c1 335303 US11040966, Example 6.73::US9732075, Example 6.73::rac-[2-(3,4-Dimethyl-phenyl)-5-methyl-thiophen-3-yl]-[4-methylene-2-(5-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 10.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335303 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335303&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695495 384987462 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658246 CSc1ccc2[nH]c(nc2c1)C1CC(=C)CN1C(=O)c1cc(C)sc1-c1ccc(C)c(C)c1 335303 US11040966, Example 6.73::US9732075, Example 6.73::rac-[2-(3,4-Dimethyl-phenyl)-5-methyl-thiophen-3-yl]-[4-methylene-2-(5-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335303 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335303&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695495 384987462 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658247 Cc1cc(C(=O)N2CC(=C)CC2c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccc(C)c(C)c1 335304 US11040966, Example 6.74::US9732075, Example 6.74::rac-[2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[2-(3,4-dimethyl-phenyl)-5-methyl-thiophen-3-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335304 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335304&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695697 384987463 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658248 Cc1cc(C(=O)N2CC(=C)CC2c2nc3c(C)c(Cl)ccc3[nH]2)c(s1)-c1ccc(C)c(C)c1 335304 US11040966, Example 6.74::US9732075, Example 6.74::rac-[2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[2-(3,4-dimethyl-phenyl)-5-methyl-thiophen-3-yl]-methanone Orexin receptor type 2 Homo sapiens 11.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335304 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335304&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695697 384987463 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658249 Cc1cc(C(=O)N2CC(=C)CC2c2nc3cc(C)c(C)cc3[nH]2)c(s1)-c1ccc(C)c(C)c1 335305 US11040966, Example 6.75::US9732075, Example 6.75::rac-[2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[2-(3,4-dimethyl-phenyl)-5-methyl-thiophen-3-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335305 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335305&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128226 384987464 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658250 Cc1cc(C(=O)N2CC(=C)CC2c2nc3cc(C)c(C)cc3[nH]2)c(s1)-c1ccc(C)c(C)c1 335305 US11040966, Example 6.75::US9732075, Example 6.75::rac-[2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[2-(3,4-dimethyl-phenyl)-5-methyl-thiophen-3-yl]-methanone Orexin receptor type 2 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335305 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335305&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128226 384987464 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658251 Cc1cc(C(=O)N2CC(=C)CC2c2nc3c(C)cc(C)cc3[nH]2)c(s1)-c1ccc(C)c(C)c1 335306 US11040966, Example 6.76::US9732075, Example 6.76::rac-[2-(4,6-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[2-(3,4-dimethyl-phenyl)-5-methyl-thiophen-3-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335306 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335306&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127201 384987465 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658252 Cc1cc(C(=O)N2CC(=C)CC2c2nc3c(C)cc(C)cc3[nH]2)c(s1)-c1ccc(C)c(C)c1 335306 US11040966, Example 6.76::US9732075, Example 6.76::rac-[2-(4,6-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[2-(3,4-dimethyl-phenyl)-5-methyl-thiophen-3-yl]-methanone Orexin receptor type 2 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335306 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335306&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127201 384987465 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658253 Cc1cc(C(=O)N2CC(=C)CC2c2nc3c(C)c(C)ccc3[nH]2)c(s1)-c1ccc(C)c(C)c1 335307 US11040966, Example 6.77::US9732075, Example 6.77::rac-[2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[2-(3,4-dimethyl-phenyl)-5-methyl-thiophen-3-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335307 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335307&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127510 384987466 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658254 Cc1cc(C(=O)N2CC(=C)CC2c2nc3c(C)c(C)ccc3[nH]2)c(s1)-c1ccc(C)c(C)c1 335307 US11040966, Example 6.77::US9732075, Example 6.77::rac-[2-(4,5-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[2-(3,4-dimethyl-phenyl)-5-methyl-thiophen-3-yl]-methanone Orexin receptor type 2 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335307 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335307&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127510 384987466 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658255 Cc1cc(C(=O)N2CC(=C)CC2c2nc3c(Br)cccc3[nH]2)c(s1)-c1ccc(C)c(C)c1 335308 US11040966, Example 6.78::US9732075, Example 6.78::rac-[2-(4-Bromo-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[2-(3,4-dimethyl-phenyl)-5-methyl-thiophen-3-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335308 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335308&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127537 384987467 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658256 Cc1cc(C(=O)N2CC(=C)CC2c2nc3c(Br)cccc3[nH]2)c(s1)-c1ccc(C)c(C)c1 335308 US11040966, Example 6.78::US9732075, Example 6.78::rac-[2-(4-Bromo-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[2-(3,4-dimethyl-phenyl)-5-methyl-thiophen-3-yl]-methanone Orexin receptor type 2 Homo sapiens 12.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335308 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335308&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127537 384987467 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658257 Cc1cc(C(=O)N2CC(=C)CC2c2nc3c(C)cccc3[nH]2)c(s1)-c1ccc(C)c(C)c1 335309 US11040966, Example 6.79::US9732075, Example 6.79::rac-[2-(3,4-Dimethyl-phenyl)-5-methyl-thiophen-3-yl]-[2-(4-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335309 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335309&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127032 384987468 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658258 Cc1cc(C(=O)N2CC(=C)CC2c2nc3c(C)cccc3[nH]2)c(s1)-c1ccc(C)c(C)c1 335309 US11040966, Example 6.79::US9732075, Example 6.79::rac-[2-(3,4-Dimethyl-phenyl)-5-methyl-thiophen-3-yl]-[2-(4-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335309 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335309&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127032 384987468 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658259 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C24H21ClN4O2S/c1-13-9-20(23-27-18-8-7-17(31-3)11-19(18)28-23)29(12-13)24(30)21-22(32-14(2)26-21)15-5-4-6-16(25)10-15/h4-8,10-11,20H,1,9,12H2,2-3H3,(H,27,28)/t20-/m0/s1 GHPUAFZXBOSWMH-FQEVSTJZSA-N 335310 US11040966, Example 6.8::US9732075, Example 6.8::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 21.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335310 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335310&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127012 384987469 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658260 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C24H21ClN4O2S/c1-13-9-20(23-27-18-8-7-17(31-3)11-19(18)28-23)29(12-13)24(30)21-22(32-14(2)26-21)15-5-4-6-16(25)10-15/h4-8,10-11,20H,1,9,12H2,2-3H3,(H,27,28)/t20-/m0/s1 GHPUAFZXBOSWMH-FQEVSTJZSA-N 335310 US11040966, Example 6.8::US9732075, Example 6.8::[5-(3-Chloro-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335310 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335310&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127012 384987469 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658261 Cc1cc(C(=O)N2CC(=C)CC2c2nc3cc(Cl)c(C)cc3[nH]2)c(s1)-c1ccc(C)c(C)c1 335311 US11040966, Example 6.80::US9732075, Example 6.80::rac-[2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[2-(3,4-dimethyl-phenyl)-5-methyl-thiophen-3-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335311 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335311&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127855 384987470 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658262 Cc1cc(C(=O)N2CC(=C)CC2c2nc3cc(Cl)c(C)cc3[nH]2)c(s1)-c1ccc(C)c(C)c1 335311 US11040966, Example 6.80::US9732075, Example 6.80::rac-[2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[2-(3,4-dimethyl-phenyl)-5-methyl-thiophen-3-yl]-methanone Orexin receptor type 2 Homo sapiens 19.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335311 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335311&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127855 384987470 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658263 Cc1cc(C(=O)N2CC(=C)CC2c2nc3cc(ccc3[nH]2)C(C)(C)C)c(s1)-c1ccc(C)c(C)c1 335312 US11040966, Example 6.81::US9732075, Example 6.81::rac-[2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[2-(3,4-dimethyl-phenyl)-5-methyl-thiophen-3-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 19.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335312 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335312&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127533 384987471 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658264 Cc1cc(C(=O)N2CC(=C)CC2c2nc3cc(ccc3[nH]2)C(C)(C)C)c(s1)-c1ccc(C)c(C)c1 335312 US11040966, Example 6.81::US9732075, Example 6.81::rac-[2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[2-(3,4-dimethyl-phenyl)-5-methyl-thiophen-3-yl]-methanone Orexin receptor type 2 Homo sapiens 23.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335312 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335312&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127533 384987471 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658265 Cc1cc(C(=O)N2CC(=C)CC2c2nc3cc(Cl)c(cc3[nH]2)C(F)(F)F)c(s1)-c1ccc(C)c(C)c1 335313 US11040966, Example 6.82::US9732075, Example 6.82::rac-[2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-[2-(3,4-dimethyl-phenyl)-5-methyl-thiophen-3-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 36.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335313 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335313&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127374 384987472 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658266 Cc1cc(C(=O)N2CC(=C)CC2c2nc3cc(Cl)c(cc3[nH]2)C(F)(F)F)c(s1)-c1ccc(C)c(C)c1 335313 US11040966, Example 6.82::US9732075, Example 6.82::rac-[2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-[2-(3,4-dimethyl-phenyl)-5-methyl-thiophen-3-yl]-methanone Orexin receptor type 2 Homo sapiens 208 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335313 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335313&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127374 384987472 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658267 COc1ccc(OC)c2[nH]c(nc12)C1CC(=C)CN1C(=O)c1cc(C)sc1-c1ccc(C)c(C)c1 335314 US11040966, Example 6.83::US9732075, Example 6.83::rac-[2-(4,7-Dimethoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[2-(3,4-dimethyl-phenyl)-5-methyl-thiophen-3-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335314 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335314&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127013 384987473 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658268 COc1ccc(OC)c2[nH]c(nc12)C1CC(=C)CN1C(=O)c1cc(C)sc1-c1ccc(C)c(C)c1 335314 US11040966, Example 6.83::US9732075, Example 6.83::rac-[2-(4,7-Dimethoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[2-(3,4-dimethyl-phenyl)-5-methyl-thiophen-3-yl]-methanone Orexin receptor type 2 Homo sapiens 23.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335314 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335314&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127013 384987473 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658269 Cc1cc(C(=O)N2CC(=C)CC2c2nc3cccc(Cl)c3[nH]2)c(s1)-c1ccc(C)c(C)c1 335315 US11040966, Example 6.84::US9732075, Example 6.84::rac-[2-(7-Chloro-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[2-(3,4-dimethyl-phenyl)-5-methyl-thiophen-3-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335315 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335315&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127321 384987474 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658270 Cc1cc(C(=O)N2CC(=C)CC2c2nc3cccc(Cl)c3[nH]2)c(s1)-c1ccc(C)c(C)c1 335315 US11040966, Example 6.84::US9732075, Example 6.84::rac-[2-(7-Chloro-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-[2-(3,4-dimethyl-phenyl)-5-methyl-thiophen-3-yl]-methanone Orexin receptor type 2 Homo sapiens 14.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335315 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335315&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127321 384987474 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658271 Cc1cc(C(=O)N2CC(=C)CC2c2nc3cc4ccccc4cc3[nH]2)c(s1)-c1ccc(C)c(C)c1 335316 US11040966, Example 6.85::US9732075, Example 6.85::rac-[2-(3,4-Dimethyl-phenyl)-5-methyl-thiophen-3-yl]-[4-methylene-2-(1H-naphtho[2,3-d]imidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 108 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335316 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335316&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127649 384987475 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658272 Cc1cc(C(=O)N2CC(=C)CC2c2nc3cc4ccccc4cc3[nH]2)c(s1)-c1ccc(C)c(C)c1 335316 US11040966, Example 6.85::US9732075, Example 6.85::rac-[2-(3,4-Dimethyl-phenyl)-5-methyl-thiophen-3-yl]-[4-methylene-2-(1H-naphtho[2,3-d]imidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 42.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335316 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335316&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127649 384987475 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658273 COc1ccc2[nH]c(nc2c1)C1CC(=C)CN1C(=O)c1nc(sc1-c1cccc(C)c1)C1CC1 335317 US11040966, Example 6.86::US9732075, Example 6.86::rac-(2-Cyclopropyl-5-m-tolyl-thiazol-4-yl)-[2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 22.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335317 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335317&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127148 384987476 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658274 COc1ccc2[nH]c(nc2c1)C1CC(=C)CN1C(=O)c1nc(sc1-c1cccc(C)c1)C1CC1 335317 US11040966, Example 6.86::US9732075, Example 6.86::rac-(2-Cyclopropyl-5-m-tolyl-thiazol-4-yl)-[2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 20.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335317 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335317&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127148 384987476 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658275 CSc1cccc2nc([nH]c12)C1CC(=C)CN1C(=O)c1nc(sc1-c1cccc(C)c1)C1CC1 335318 US11040966, Example 6.87::US9732075, Example 6.87::rac-(2-Cyclopropyl-5-m-tolyl-thiazol-4-yl)-[4-methylene-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335318 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335318&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127644 384987477 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658276 CSc1cccc2nc([nH]c12)C1CC(=C)CN1C(=O)c1nc(sc1-c1cccc(C)c1)C1CC1 335318 US11040966, Example 6.87::US9732075, Example 6.87::rac-(2-Cyclopropyl-5-m-tolyl-thiazol-4-yl)-[4-methylene-2-(7-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335318 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335318&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127644 384987477 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658277 CSc1ccc2[nH]c(nc2c1)C1CC(=C)CN1C(=O)c1nc(sc1-c1cccc(C)c1)C1CC1 335319 US11040966, Example 6.88::US9732075, Example 6.88::rac-(2-Cyclopropyl-5-m-tolyl-thiazol-4-yl)-[4-methylene-2-(5-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 20.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335319 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335319&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127887 384987478 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658278 CSc1ccc2[nH]c(nc2c1)C1CC(=C)CN1C(=O)c1nc(sc1-c1cccc(C)c1)C1CC1 335319 US11040966, Example 6.88::US9732075, Example 6.88::rac-(2-Cyclopropyl-5-m-tolyl-thiazol-4-yl)-[4-methylene-2-(5-methylsulfanyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 15.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335319 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335319&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127887 384987478 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658279 Cc1cccc(c1)-c1sc(nc1C(=O)N1CC(=C)CC1c1nc2c(C)c(Cl)ccc2[nH]1)C1CC1 335320 US11040966, Example 6.89::US9732075, Example 6.89::rac-[2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-cyclopropyl-5-m-tolyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335320 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335320&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127216 384987479 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658280 Cc1cccc(c1)-c1sc(nc1C(=O)N1CC(=C)CC1c1nc2c(C)c(Cl)ccc2[nH]1)C1CC1 335320 US11040966, Example 6.89::US9732075, Example 6.89::rac-[2-(5-Chloro-4-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-cyclopropyl-5-m-tolyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335320 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335320&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127216 384987479 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658281 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1ccc(C)c(C)c1 InChI=1S/C26H26N4O2S/c1-14-10-22(25-28-20-9-8-19(32-5)12-21(20)29-25)30(13-14)26(31)23-24(33-17(4)27-23)18-7-6-15(2)16(3)11-18/h6-9,11-12,22H,1,10,13H2,2-5H3,(H,28,29)/t22-/m0/s1 UYNPCVHRRZNCOG-QFIPXVFZSA-N 335321 US11040966, Example 6.9::US9732075, Example 6.9::[5-(3,4-Dimethyl-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335321 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335321&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 72695499 384987480 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658282 COc1ccc2[nH]c(nc2c1)[C@@H]1CC(=C)CN1C(=O)c1nc(C)sc1-c1ccc(C)c(C)c1 InChI=1S/C26H26N4O2S/c1-14-10-22(25-28-20-9-8-19(32-5)12-21(20)29-25)30(13-14)26(31)23-24(33-17(4)27-23)18-7-6-15(2)16(3)11-18/h6-9,11-12,22H,1,10,13H2,2-5H3,(H,28,29)/t22-/m0/s1 UYNPCVHRRZNCOG-QFIPXVFZSA-N 335321 US11040966, Example 6.9::US9732075, Example 6.9::[5-(3,4-Dimethyl-phenyl)-2-methyl-thiazol-4-yl]-[(S)-2-(5-methoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335321 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335321&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 72695499 384987480 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658283 Cc1cccc(c1)-c1sc(nc1C(=O)N1CC(=C)CC1c1nc2cc(C)c(C)cc2[nH]1)C1CC1 335322 US11040966, Example 6.90::US9732075, Example 6.90::rac-(2-Cyclopropyl-5-m-tolyl-thiazol-4-yl)-[2-(5,6-dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335322 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335322&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128012 384987481 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658284 Cc1cccc(c1)-c1sc(nc1C(=O)N1CC(=C)CC1c1nc2cc(C)c(C)cc2[nH]1)C1CC1 335322 US11040966, Example 6.90::US9732075, Example 6.90::rac-(2-Cyclopropyl-5-m-tolyl-thiazol-4-yl)-[2-(5,6-dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335322 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335322&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128012 384987481 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658285 Cc1cccc(c1)-c1sc(nc1C(=O)N1CC(=C)CC1c1nc2c(C)cc(C)cc2[nH]1)C1CC1 335323 US11040966, Example 6.91::US9732075, Example 6.91::rac-(2-Cyclopropyl-5-m-tolyl-thiazol-4-yl)-[2-(4,6-dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335323 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335323&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127640 384987482 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658286 Cc1cccc(c1)-c1sc(nc1C(=O)N1CC(=C)CC1c1nc2c(C)cc(C)cc2[nH]1)C1CC1 335323 US11040966, Example 6.91::US9732075, Example 6.91::rac-(2-Cyclopropyl-5-m-tolyl-thiazol-4-yl)-[2-(4,6-dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335323 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335323&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127640 384987482 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658287 Cc1cccc(c1)-c1sc(nc1C(=O)N1CC(=C)CC1c1nc2c(C)c(C)ccc2[nH]1)C1CC1 335324 US11040966, Example 6.92::US9732075, Example 6.92::rac-(2-Cyclopropyl-5-m-tolyl-thiazol-4-yl)-[2-(4,5-dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335324 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335324&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127986 384987483 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658288 Cc1cccc(c1)-c1sc(nc1C(=O)N1CC(=C)CC1c1nc2c(C)c(C)ccc2[nH]1)C1CC1 335324 US11040966, Example 6.92::US9732075, Example 6.92::rac-(2-Cyclopropyl-5-m-tolyl-thiazol-4-yl)-[2-(4,5-dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335324 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335324&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127986 384987483 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658289 Cc1cccc(c1)-c1sc(nc1C(=O)N1CC(=C)CC1c1nc2c(Br)cccc2[nH]1)C1CC1 335325 US11040966, Example 6.93::US9732075, Example 6.93::rac-[2-(4-Bromo-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-cyclopropyl-5-m-tolyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 0.900 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335325 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335325&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127912 384987484 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658290 Cc1cccc(c1)-c1sc(nc1C(=O)N1CC(=C)CC1c1nc2c(Br)cccc2[nH]1)C1CC1 335325 US11040966, Example 6.93::US9732075, Example 6.93::rac-[2-(4-Bromo-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-cyclopropyl-5-m-tolyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335325 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335325&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127912 384987484 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658291 Cc1cccc(c1)-c1sc(nc1C(=O)N1CC(=C)CC1c1nc2c(C)cccc2[nH]1)C1CC1 335326 US11040966, Example 6.94::US9732075, Example 6.94::rac-(2-Cyclopropyl-5-m-tolyl-thiazol-4-yl)-[2-(4-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335326 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335326&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127280 384987485 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658292 Cc1cccc(c1)-c1sc(nc1C(=O)N1CC(=C)CC1c1nc2c(C)cccc2[nH]1)C1CC1 335326 US11040966, Example 6.94::US9732075, Example 6.94::rac-(2-Cyclopropyl-5-m-tolyl-thiazol-4-yl)-[2-(4-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335326 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335326&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127280 384987485 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658293 Cc1cccc(c1)-c1sc(nc1C(=O)N1CC(=C)CC1c1nc2cc(Cl)c(C)cc2[nH]1)C1CC1 335327 US11040966, Example 6.95::US9732075, Example 6.95::rac-[2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-cyclopropyl-5-m-tolyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335327 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335327&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127718 384987486 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658294 Cc1cccc(c1)-c1sc(nc1C(=O)N1CC(=C)CC1c1nc2cc(Cl)c(C)cc2[nH]1)C1CC1 335327 US11040966, Example 6.95::US9732075, Example 6.95::rac-[2-(5-Chloro-6-methyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-cyclopropyl-5-m-tolyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335327 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335327&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127718 384987486 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658295 Cc1cccc(c1)-c1sc(nc1C(=O)N1CC(=C)CC1c1nc2cc(ccc2[nH]1)C(C)(C)C)C1CC1 335328 US11040966, Example 6.96::US9732075, Example 6.96::rac-[2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-cyclopropyl-5-m-tolyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 234 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335328 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335328&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127759 384987487 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658296 Cc1cccc(c1)-c1sc(nc1C(=O)N1CC(=C)CC1c1nc2cc(ccc2[nH]1)C(C)(C)C)C1CC1 335328 US11040966, Example 6.96::US9732075, Example 6.96::rac-[2-(5-tert-Butyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-cyclopropyl-5-m-tolyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 68.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335328 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335328&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127759 384987487 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658297 Cc1cccc(c1)-c1sc(nc1C(=O)N1CC(=C)CC1c1nc2cc(Cl)c(cc2[nH]1)C(F)(F)F)C1CC1 335329 US11040966, Example 6.97::US9732075, Example 6.97::rac-[2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-(2-cyclopropyl-5-m-tolyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 14.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335329 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335329&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127227 384987488 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658298 Cc1cccc(c1)-c1sc(nc1C(=O)N1CC(=C)CC1c1nc2cc(Cl)c(cc2[nH]1)C(F)(F)F)C1CC1 335329 US11040966, Example 6.97::US9732075, Example 6.97::rac-[2-(5-Chloro-6-trifluoromethyl-1H-benzoimidazol-2-yl)4-methylene-pyrrolidin-1-yl]-(2-cyclopropyl-5-m-tolyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 10.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335329 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335329&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127227 384987488 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658299 COc1ccc(OC)c2[nH]c(nc12)C1CC(=C)CN1C(=O)c1nc(sc1-c1cccc(C)c1)C1CC1 335330 US11040966, Example 6.98::US9732075, Example 6.98::rac-(2-Cyclopropyl-5-m-tolyl-thiazol-4-yl)-[2-(4,7-dimethoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335330 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335330&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127661 384987489 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658300 COc1ccc(OC)c2[nH]c(nc12)C1CC(=C)CN1C(=O)c1nc(sc1-c1cccc(C)c1)C1CC1 335330 US11040966, Example 6.98::US9732075, Example 6.98::rac-(2-Cyclopropyl-5-m-tolyl-thiazol-4-yl)-[2-(4,7-dimethoxy-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone Orexin receptor type 2 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335330 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335330&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127661 384987489 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658301 Cc1cccc(c1)-c1sc(nc1C(=O)N1CC(=C)CC1c1nc2cccc(Cl)c2[nH]1)C1CC1 335331 US11040966, Example 6.99::US9732075, Example 6.99::rac-[2-(7-Chloro-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-cyclopropyl-5-m-tolyl-thiazol-4-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335331 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335331&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127389 384987490 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658302 Cc1cccc(c1)-c1sc(nc1C(=O)N1CC(=C)CC1c1nc2cccc(Cl)c2[nH]1)C1CC1 335331 US11040966, Example 6.99::US9732075, Example 6.99::rac-[2-(7-Chloro-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-cyclopropyl-5-m-tolyl-thiazol-4-yl)-methanone Orexin receptor type 2 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335331 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335331&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127389 384987490 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658303 Cc1ccc(C(=O)N2CC(=C)C[C@H]2c2nc3cc(C)c(C)cc3[nH]2)c(c1)-n1nccn1 InChI=1S/C24H24N6O/c1-14-5-6-18(21(9-14)30-25-7-8-26-30)24(31)29-13-15(2)10-22(29)23-27-19-11-16(3)17(4)12-20(19)28-23/h5-9,11-12,22H,2,10,13H2,1,3-4H3,(H,27,28)/t22-/m0/s1 QACQHWVHRNFOFN-QFIPXVFZSA-N 335332 US11040966, Example 6.198::US9732075, Example 6.198::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 12.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335332 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335332&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128161 384987491 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658304 Cc1ccc(C(=O)N2CC(=C)C[C@H]2c2nc3cc(C)c(C)cc3[nH]2)c(c1)-n1nccn1 InChI=1S/C24H24N6O/c1-14-5-6-18(21(9-14)30-25-7-8-26-30)24(31)29-13-15(2)10-22(29)23-27-19-11-16(3)17(4)12-20(19)28-23/h5-9,11-12,22H,2,10,13H2,1,3-4H3,(H,27,28)/t22-/m0/s1 QACQHWVHRNFOFN-QFIPXVFZSA-N 335332 US11040966, Example 6.198::US9732075, Example 6.198::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335332 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335332&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128161 384987491 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658305 Cc1cc2nc([nH]c2cc1C)[C@@H]1CC(=C)CN1C(=O)c1c(C)cccc1-n1nccn1 InChI=1S/C24H24N6O/c1-14-10-21(23-27-18-11-16(3)17(4)12-19(18)28-23)29(13-14)24(31)22-15(2)6-5-7-20(22)30-25-8-9-26-30/h5-9,11-12,21H,1,10,13H2,2-4H3,(H,27,28)/t21-/m0/s1 YPVNQWNPWXKEMQ-NRFANRHFSA-N 335333 US11040966, Example 6.199::US9732075, Example 6.199::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 143 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335333 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335333&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128151 384987492 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658306 Cc1cc2nc([nH]c2cc1C)[C@@H]1CC(=C)CN1C(=O)c1c(C)cccc1-n1nccn1 InChI=1S/C24H24N6O/c1-14-10-21(23-27-18-11-16(3)17(4)12-19(18)28-23)29(13-14)24(31)22-15(2)6-5-7-20(22)30-25-8-9-26-30/h5-9,11-12,21H,1,10,13H2,2-4H3,(H,27,28)/t21-/m0/s1 YPVNQWNPWXKEMQ-NRFANRHFSA-N 335333 US11040966, Example 6.199::US9732075, Example 6.199::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(2-methyl-6-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335333 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335333&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128151 384987492 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658307 COc1cc(C(=O)N2CC(=C)C[C@H]2c2nc3cc(C)c(C)cc3[nH]2)c(cc1OC)-n1nccn1 InChI=1S/C25H26N6O3/c1-14-8-21(24-28-18-9-15(2)16(3)10-19(18)29-24)30(13-14)25(32)17-11-22(33-4)23(34-5)12-20(17)31-26-6-7-27-31/h6-7,9-12,21H,1,8,13H2,2-5H3,(H,28,29)/t21-/m0/s1 HHARXBHQEJEKNO-NRFANRHFSA-N 335334 (4,5-Dimethoxy-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(5,6-dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone::US11040966, Example 6.200::US9732075, Example 6.200 Orexin/Hypocretin receptor type 1 Homo sapiens 58.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335334 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335334&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127580 384987493 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658308 COc1cc(C(=O)N2CC(=C)C[C@H]2c2nc3cc(C)c(C)cc3[nH]2)c(cc1OC)-n1nccn1 InChI=1S/C25H26N6O3/c1-14-8-21(24-28-18-9-15(2)16(3)10-19(18)29-24)30(13-14)25(32)17-11-22(33-4)23(34-5)12-20(17)31-26-6-7-27-31/h6-7,9-12,21H,1,8,13H2,2-5H3,(H,28,29)/t21-/m0/s1 HHARXBHQEJEKNO-NRFANRHFSA-N 335334 (4,5-Dimethoxy-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(5,6-dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-methanone::US11040966, Example 6.200::US9732075, Example 6.200 Orexin receptor type 2 Homo sapiens 10.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335334 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335334&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127580 384987493 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658309 Cc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2cc(C)c(C)cc2[nH]1)-n1cccn1 InChI=1S/C25H25N5O/c1-15-6-7-22(30-9-5-8-26-30)19(10-15)25(31)29-14-16(2)11-23(29)24-27-20-12-17(3)18(4)13-21(20)28-24/h5-10,12-13,23H,2,11,14H2,1,3-4H3,(H,27,28)/t23-/m0/s1 YKKUEQJPYWSGKF-QHCPKHFHSA-N 335335 US11040966, Example 6.201::US9732075, Example 6.201::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 148 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335335 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335335&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128327 384987494 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658310 Cc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2cc(C)c(C)cc2[nH]1)-n1cccn1 InChI=1S/C25H25N5O/c1-15-6-7-22(30-9-5-8-26-30)19(10-15)25(31)29-14-16(2)11-23(29)24-27-20-12-17(3)18(4)13-21(20)28-24/h5-10,12-13,23H,2,11,14H2,1,3-4H3,(H,27,28)/t23-/m0/s1 YKKUEQJPYWSGKF-QHCPKHFHSA-N 335335 US11040966, Example 6.201::US9732075, Example 6.201::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(5-methyl-2-pyrazol-1-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 25.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335335 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335335&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128327 384987494 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658311 Cc1ccc(c(n1)C(=O)N1CC(=C)C[C@H]1c1nc2cc(C)c(C)cc2[nH]1)-n1nccn1 InChI=1S/C23H23N7O/c1-13-9-20(22-27-17-10-14(2)15(3)11-18(17)28-22)29(12-13)23(31)21-19(6-5-16(4)26-21)30-24-7-8-25-30/h5-8,10-11,20H,1,9,12H2,2-4H3,(H,27,28)/t20-/m0/s1 AFRHJTNPBOUZNM-FQEVSTJZSA-N 335336 US11040966, Example 6.202::US9732075, Example 6.202::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 89.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335336 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335336&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128018 384987495 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658312 Cc1ccc(c(n1)C(=O)N1CC(=C)C[C@H]1c1nc2cc(C)c(C)cc2[nH]1)-n1nccn1 InChI=1S/C23H23N7O/c1-13-9-20(22-27-17-10-14(2)15(3)11-18(17)28-22)29(12-13)23(31)21-19(6-5-16(4)26-21)30-24-7-8-25-30/h5-8,10-11,20H,1,9,12H2,2-4H3,(H,27,28)/t20-/m0/s1 AFRHJTNPBOUZNM-FQEVSTJZSA-N 335336 US11040966, Example 6.202::US9732075, Example 6.202::[(S)-2-(5,6-Dimethyl-1H-benzoimidazol-2-yl)-4-methylene-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone Orexin receptor type 2 Homo sapiens 13.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335336 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335336&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128018 384987495 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658313 CO[C@@H]1C[C@H](N(C1)C(=O)c1cc(OC)ccc1-n1nccn1)c1nc2ccc(Cl)c(C)c2n1C InChI=1S/C24H25ClN6O3/c1-14-18(25)6-7-19-22(14)29(2)23(28-19)21-12-16(34-4)13-30(21)24(32)17-11-15(33-3)5-8-20(17)31-26-9-10-27-31/h5-11,16,21H,12-13H2,1-4H3/t16-,21+/m1/s1 QCFKJASFTGCJAY-IERDGZPVSA-N 335337 US11040966, Example 7.1::US9732075, Example 7.1::[(2S,4R)-2-(6-Chloro-1,7-dimethyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone and/or [(2S,4R)-2-(5-Chloro-1,4-dimethyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 16.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335337 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335337&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127696 384987496 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658314 CO[C@@H]1C[C@H](N(C1)C(=O)c1cc(OC)ccc1-n1nccn1)c1nc2ccc(Cl)c(C)c2n1C InChI=1S/C24H25ClN6O3/c1-14-18(25)6-7-19-22(14)29(2)23(28-19)21-12-16(34-4)13-30(21)24(32)17-11-15(33-3)5-8-20(17)31-26-9-10-27-31/h5-11,16,21H,12-13H2,1-4H3/t16-,21+/m1/s1 QCFKJASFTGCJAY-IERDGZPVSA-N 335337 US11040966, Example 7.1::US9732075, Example 7.1::[(2S,4R)-2-(6-Chloro-1,7-dimethyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone and/or [(2S,4R)-2-(5-Chloro-1,4-dimethyl-1H-benzoimidazol-2-yl)-4-methoxy-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 162 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335337 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335337&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127696 384987496 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658315 Cc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2cc(C)c(C)cc2n1C)-n1nccn1 InChI=1S/C25H26N6O/c1-15-6-7-21(31-26-8-9-27-31)19(10-15)25(32)30-14-16(2)11-23(30)24-28-20-12-17(3)18(4)13-22(20)29(24)5/h6-10,12-13,23H,2,11,14H2,1,3-5H3/t23-/m0/s1 MZQFVQWLLHBODC-QHCPKHFHSA-N 335338 US11040966, Example 7.2::US9732075, Example 7.2::[(S)-4-Methylene-2-(1,5,6-trimethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 420 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335338 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335338&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127415 384987497 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658316 Cc1ccc(c(c1)C(=O)N1CC(=C)C[C@H]1c1nc2cc(C)c(C)cc2n1C)-n1nccn1 InChI=1S/C25H26N6O/c1-15-6-7-21(31-26-8-9-27-31)19(10-15)25(32)30-14-16(2)11-23(30)24-28-20-12-17(3)18(4)13-22(20)29(24)5/h6-10,12-13,23H,2,11,14H2,1,3-5H3/t23-/m0/s1 MZQFVQWLLHBODC-QHCPKHFHSA-N 335338 US11040966, Example 7.2::US9732075, Example 7.2::[(S)-4-Methylene-2-(1,5,6-trimethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 69.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335338 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335338&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127415 384987497 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658317 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(Cl)ccc2n1C)-n1nccn1 InChI=1S/C24H25ClN6O/c1-15-6-8-19(31-26-11-12-27-31)17(14-15)22(32)30-13-5-10-24(30,3)23-28-21-16(2)18(25)7-9-20(21)29(23)4/h6-9,11-12,14H,5,10,13H2,1-4H3/t24-/m0/s1 MDIAYXGXQBIAME-DEOSSOPVSA-N 335339 US11040966, Example 7.3::US9732075, Example 7.3::[(S)-2-(5-Chloro-1,4-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone and/or [(S)-2-(6-Chloro-1,7-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone (mixture of isomers) Orexin/Hypocretin receptor type 1 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335339 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335339&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127999 384987498 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658318 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(Cl)ccc2n1C)-n1nccn1 InChI=1S/C24H25ClN6O/c1-15-6-8-19(31-26-11-12-27-31)17(14-15)22(32)30-13-5-10-24(30,3)23-28-21-16(2)18(25)7-9-20(21)29(23)4/h6-9,11-12,14H,5,10,13H2,1-4H3/t24-/m0/s1 MDIAYXGXQBIAME-DEOSSOPVSA-N 335339 US11040966, Example 7.3::US9732075, Example 7.3::[(S)-2-(5-Chloro-1,4-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone and/or [(S)-2-(6-Chloro-1,7-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone (mixture of isomers) Orexin receptor type 2 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335339 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335339&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127999 384987498 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658319 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(Br)cc(C)c2n1C)-n1nccn1 InChI=1S/C24H25BrN6O/c1-15-6-7-20(31-26-9-10-27-31)18(12-15)22(32)30-11-5-8-24(30,3)23-28-19-14-17(25)13-16(2)21(19)29(23)4/h6-7,9-10,12-14H,5,8,11H2,1-4H3/t24-/m0/s1 NEXMTSRENVSSOM-DEOSSOPVSA-N 335340 US11040966, Example 7.4::US9732075, Example 7.4::[(S)-2-(5-Bromo-1,7-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone and/or [(S)-2-(6-Bromo-1,4-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone (mixture of isomers) Orexin/Hypocretin receptor type 1 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335340 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335340&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127380 384987499 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658320 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(Br)cc(C)c2n1C)-n1nccn1 InChI=1S/C24H25BrN6O/c1-15-6-7-20(31-26-9-10-27-31)18(12-15)22(32)30-11-5-8-24(30,3)23-28-19-14-17(25)13-16(2)21(19)29(23)4/h6-7,9-10,12-14H,5,8,11H2,1-4H3/t24-/m0/s1 NEXMTSRENVSSOM-DEOSSOPVSA-N 335340 US11040966, Example 7.4::US9732075, Example 7.4::[(S)-2-(5-Bromo-1,7-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone and/or [(S)-2-(6-Bromo-1,4-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone (mixture of isomers) Orexin receptor type 2 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335340 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335340&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127380 384987499 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658321 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)cccc3n2C)c(s1)-c1cccc(Cl)c1 InChI=1S/C25H25ClN4OS/c1-15-8-5-11-19-20(15)28-24(29(19)4)25(3)12-7-13-30(25)23(31)21-22(32-16(2)27-21)17-9-6-10-18(26)14-17/h5-6,8-11,14H,7,12-13H2,1-4H3/t25-/m0/s1 XBQYXXMJHBIJHN-VWLOTQADSA-N 335341 (S)-(5-(3-chlorophenyl)-2-methylthiazol-4-yl)(2-(1,4-dimethyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)methanoneand/or (S)-(5-(3-chlorophenyl)-2-methylthiazol-4-yl)(2-(1,7-dimethyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)methanone (mixture of isomers)::US11040966, Example 7.5::US9732075, Example 7.5 Orexin/Hypocretin receptor type 1 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335341 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335341&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127851 384987500 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658322 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)cccc3n2C)c(s1)-c1cccc(Cl)c1 InChI=1S/C25H25ClN4OS/c1-15-8-5-11-19-20(15)28-24(29(19)4)25(3)12-7-13-30(25)23(31)21-22(32-16(2)27-21)17-9-6-10-18(26)14-17/h5-6,8-11,14H,7,12-13H2,1-4H3/t25-/m0/s1 XBQYXXMJHBIJHN-VWLOTQADSA-N 335341 (S)-(5-(3-chlorophenyl)-2-methylthiazol-4-yl)(2-(1,4-dimethyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)methanoneand/or (S)-(5-(3-chlorophenyl)-2-methylthiazol-4-yl)(2-(1,7-dimethyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)methanone (mixture of isomers)::US11040966, Example 7.5::US9732075, Example 7.5 Orexin receptor type 2 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335341 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335341&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127851 384987500 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658323 CCn1c(nc2c(C)cccc12)[C@]1(C)CCCN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C26H27ClN4OS/c1-5-30-20-12-6-9-16(2)21(20)29-25(30)26(4)13-8-14-31(26)24(32)22-23(33-17(3)28-22)18-10-7-11-19(27)15-18/h6-7,9-12,15H,5,8,13-14H2,1-4H3/t26-/m0/s1 SNNQMRHXRPRSPF-SANMLTNESA-N 335342 (S)-(5-(3-chlorophenyl)-2-methylthiazol-4-yl)(2-(1-ethyl-4-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)methanone and/or (S)-(5-(3-chlorophenyl)-2-methylthiazol-4-yl)(2-(1-ethyl-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)methanone (mixture of isomers)::US11040966, Example 7.6::US9732075, Example 7.6 Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335342 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335342&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127966 384987501 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658324 CCn1c(nc2c(C)cccc12)[C@]1(C)CCCN1C(=O)c1nc(C)sc1-c1cccc(Cl)c1 InChI=1S/C26H27ClN4OS/c1-5-30-20-12-6-9-16(2)21(20)29-25(30)26(4)13-8-14-31(26)24(32)22-23(33-17(3)28-22)18-10-7-11-19(27)15-18/h6-7,9-12,15H,5,8,13-14H2,1-4H3/t26-/m0/s1 SNNQMRHXRPRSPF-SANMLTNESA-N 335342 (S)-(5-(3-chlorophenyl)-2-methylthiazol-4-yl)(2-(1-ethyl-4-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)methanone and/or (S)-(5-(3-chlorophenyl)-2-methylthiazol-4-yl)(2-(1-ethyl-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)methanone (mixture of isomers)::US11040966, Example 7.6::US9732075, Example 7.6 Orexin receptor type 2 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335342 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335342&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127966 384987501 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658325 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3n2C)c(s1)-c1ccccc1 InChI=1S/C25H25ClN4OS/c1-15-18(26)11-12-19-20(15)28-24(29(19)4)25(3)13-8-14-30(25)23(31)21-22(32-16(2)27-21)17-9-6-5-7-10-17/h5-7,9-12H,8,13-14H2,1-4H3/t25-/m0/s1 UNRBBSQFBPJIAV-VWLOTQADSA-N 335343 (S)-(2-(5-chloro-1,4-dimethyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(2-methyl-5-phenylthiazol-4-yl)methanone and/or (S)-(2-(6-chloro-1,7-dimethyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(2-methyl-5-phenylthiazol-4-yl)methanone (mixture of isomers)::US11040966, Example 7.7::US9732075, Example 7.7 Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335343 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335343&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127968 384987502 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658326 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3n2C)c(s1)-c1ccccc1 InChI=1S/C25H25ClN4OS/c1-15-18(26)11-12-19-20(15)28-24(29(19)4)25(3)13-8-14-30(25)23(31)21-22(32-16(2)27-21)17-9-6-5-7-10-17/h5-7,9-12H,8,13-14H2,1-4H3/t25-/m0/s1 UNRBBSQFBPJIAV-VWLOTQADSA-N 335343 (S)-(2-(5-chloro-1,4-dimethyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(2-methyl-5-phenylthiazol-4-yl)methanone and/or (S)-(2-(6-chloro-1,7-dimethyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(2-methyl-5-phenylthiazol-4-yl)methanone (mixture of isomers)::US11040966, Example 7.7::US9732075, Example 7.7 Orexin receptor type 2 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335343 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335343&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127968 384987502 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658327 CCn1c(nc2c(C)c(Cl)ccc12)[C@]1(C)CCCN1C(=O)c1nc(C)sc1-c1ccccc1 InChI=1S/C26H27ClN4OS/c1-5-30-20-13-12-19(27)16(2)21(20)29-25(30)26(4)14-9-15-31(26)24(32)22-23(33-17(3)28-22)18-10-7-6-8-11-18/h6-8,10-13H,5,9,14-15H2,1-4H3/t26-/m0/s1 WKXGFOWQJLVKST-SANMLTNESA-N 335344 (S)-(2-(5-chloro-1-ethyl-4-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(2-methyl-5-phenylthiazol-4-yl)methanone and/or (S)-(2-(6-chloro-1-ethyl-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(2-methyl-5-phenylthiazol-4-yl)methanone (mixture of isomers)::US11040966, Example 7.8::US9732075, Example 7.8 Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335344 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335344&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128316 384987503 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658328 CCn1c(nc2c(C)c(Cl)ccc12)[C@]1(C)CCCN1C(=O)c1nc(C)sc1-c1ccccc1 InChI=1S/C26H27ClN4OS/c1-5-30-20-13-12-19(27)16(2)21(20)29-25(30)26(4)14-9-15-31(26)24(32)22-23(33-17(3)28-22)18-10-7-6-8-11-18/h6-8,10-13H,5,9,14-15H2,1-4H3/t26-/m0/s1 WKXGFOWQJLVKST-SANMLTNESA-N 335344 (S)-(2-(5-chloro-1-ethyl-4-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(2-methyl-5-phenylthiazol-4-yl)methanone and/or (S)-(2-(6-chloro-1-ethyl-7-methyl-1H-benzo[d]imidazol-2-yl)-2-methylpyrrolidin-1-yl)(2-methyl-5-phenylthiazol-4-yl)methanone (mixture of isomers)::US11040966, Example 7.8::US9732075, Example 7.8 Orexin receptor type 2 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335344 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335344&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128316 384987503 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658329 COc1cc2nc(n(C)c2cc1OC)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C25H28N6O3/c1-16-7-8-19(31-26-10-11-27-31)17(13-16)23(32)30-12-6-9-25(30,2)24-28-18-14-21(33-4)22(34-5)15-20(18)29(24)3/h7-8,10-11,13-15H,6,9,12H2,1-5H3/t25-/m0/s1 LFMHIWJWKKZZBF-VWLOTQADSA-N 335345 US11040966, Example 7.9::US9732075, Example 7.9::[(S)-2-(5,6-Dimethoxy-1-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 28.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335345 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335345&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127186 384987504 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658330 COc1cc2nc(n(C)c2cc1OC)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C25H28N6O3/c1-16-7-8-19(31-26-10-11-27-31)17(13-16)23(32)30-12-6-9-25(30,2)24-28-18-14-21(33-4)22(34-5)15-20(18)29(24)3/h7-8,10-11,13-15H,6,9,12H2,1-5H3/t25-/m0/s1 LFMHIWJWKKZZBF-VWLOTQADSA-N 335345 US11040966, Example 7.9::US9732075, Example 7.9::[(S)-2-(5,6-Dimethoxy-1-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 28.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335345 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335345&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127186 384987504 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658331 CCn1c(nc2cc(OC)c(OC)cc12)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C26H30N6O3/c1-6-30-21-16-23(35-5)22(34-4)15-19(21)29-25(30)26(3)10-7-13-31(26)24(33)18-14-17(2)8-9-20(18)32-27-11-12-28-32/h8-9,11-12,14-16H,6-7,10,13H2,1-5H3/t26-/m0/s1 MCJXSALINKTKNY-SANMLTNESA-N 335346 US11040966, Example 7.10::US9732075, Example 7.10::[(S)-2-(1-Ethyl-5,6-dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 33.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335346 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335346&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128250 384987505 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658332 CCn1c(nc2cc(OC)c(OC)cc12)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C26H30N6O3/c1-6-30-21-16-23(35-5)22(34-4)15-19(21)29-25(30)26(3)10-7-13-31(26)24(33)18-14-17(2)8-9-20(18)32-27-11-12-28-32/h8-9,11-12,14-16H,6-7,10,13H2,1-5H3/t26-/m0/s1 MCJXSALINKTKNY-SANMLTNESA-N 335346 US11040966, Example 7.10::US9732075, Example 7.10::[(S)-2-(1-Ethyl-5,6-dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 42.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335346 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335346&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128250 384987505 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658333 Cc1ccc(C(=O)N2CCC[C@@]2(C)c2nc3cc(C)c(C)cc3n2C)c(c1)-n1nccn1 InChI=1S/C25H28N6O/c1-16-7-8-19(21(13-16)31-26-10-11-27-31)23(32)30-12-6-9-25(30,4)24-28-20-14-17(2)18(3)15-22(20)29(24)5/h7-8,10-11,13-15H,6,9,12H2,1-5H3/t25-/m0/s1 QSHALKLBYOXRNE-VWLOTQADSA-N 335347 (4-Methyl-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(1,5,6-trimethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 7.11::US9732075, Example 7.11 Orexin/Hypocretin receptor type 1 Homo sapiens 17.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335347 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335347&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127196 384987506 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658334 Cc1ccc(C(=O)N2CCC[C@@]2(C)c2nc3cc(C)c(C)cc3n2C)c(c1)-n1nccn1 InChI=1S/C25H28N6O/c1-16-7-8-19(21(13-16)31-26-10-11-27-31)23(32)30-12-6-9-25(30,4)24-28-20-14-17(2)18(3)15-22(20)29(24)5/h7-8,10-11,13-15H,6,9,12H2,1-5H3/t25-/m0/s1 QSHALKLBYOXRNE-VWLOTQADSA-N 335347 (4-Methyl-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(1,5,6-trimethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 7.11::US9732075, Example 7.11 Orexin receptor type 2 Homo sapiens 720 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335347 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335347&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127196 384987506 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658335 CCn1c(nc2cc(C)c(C)cc12)[C@]1(C)CCCN1C(=O)c1ccc(C)cc1-n1nccn1 InChI=1S/C26H30N6O/c1-6-30-23-16-19(4)18(3)15-21(23)29-25(30)26(5)10-7-13-31(26)24(33)20-9-8-17(2)14-22(20)32-27-11-12-28-32/h8-9,11-12,14-16H,6-7,10,13H2,1-5H3/t26-/m0/s1 UUEAMENKRDDBFF-SANMLTNESA-N 335348 US11040966, Example 7.12::US9732075, Example 7.12::[(S)-2-(1-Ethyl-5,6-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 15.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335348 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335348&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127087 384987507 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658336 CCn1c(nc2cc(C)c(C)cc12)[C@]1(C)CCCN1C(=O)c1ccc(C)cc1-n1nccn1 InChI=1S/C26H30N6O/c1-6-30-23-16-19(4)18(3)15-21(23)29-25(30)26(5)10-7-13-31(26)24(33)20-9-8-17(2)14-22(20)32-27-11-12-28-32/h8-9,11-12,14-16H,6-7,10,13H2,1-5H3/t26-/m0/s1 UUEAMENKRDDBFF-SANMLTNESA-N 335348 US11040966, Example 7.12::US9732075, Example 7.12::[(S)-2-(1-Ethyl-5,6-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 52.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335348 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335348&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127087 384987507 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658337 COc1cc2nc(n(C)c2cc1OC)[C@]1(C)CCCN1C(=O)c1cc(C)c(C)cc1-n1nccn1 InChI=1S/C26H30N6O3/c1-16-12-18(20(13-17(16)2)32-27-9-10-28-32)24(33)31-11-7-8-26(31,3)25-29-19-14-22(34-5)23(35-6)15-21(19)30(25)4/h9-10,12-15H,7-8,11H2,1-6H3/t26-/m0/s1 SEMGRFYXHCNTNR-SANMLTNESA-N 335349 US11040966, Example 7.13::US9732075, Example 7.13::[(S)-2-(5,6-Dimethoxy-1-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,5-dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 21.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335349 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335349&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127074 384987508 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658338 COc1cc2nc(n(C)c2cc1OC)[C@]1(C)CCCN1C(=O)c1cc(C)c(C)cc1-n1nccn1 InChI=1S/C26H30N6O3/c1-16-12-18(20(13-17(16)2)32-27-9-10-28-32)24(33)31-11-7-8-26(31,3)25-29-19-14-22(34-5)23(35-6)15-21(19)30(25)4/h9-10,12-15H,7-8,11H2,1-6H3/t26-/m0/s1 SEMGRFYXHCNTNR-SANMLTNESA-N 335349 US11040966, Example 7.13::US9732075, Example 7.13::[(S)-2-(5,6-Dimethoxy-1-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,5-dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 49.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335349 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335349&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127074 384987508 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658339 CCn1c(nc2cc(OC)c(OC)cc12)[C@]1(C)CCCN1C(=O)c1cc(C)c(C)cc1-n1nccn1 InChI=1S/C27H32N6O3/c1-7-31-22-16-24(36-6)23(35-5)15-20(22)30-26(31)27(4)9-8-12-32(27)25(34)19-13-17(2)18(3)14-21(19)33-28-10-11-29-33/h10-11,13-16H,7-9,12H2,1-6H3/t27-/m0/s1 CEULBPMKDYHHHA-MHZLTWQESA-N 335350 (4,5-Dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(1-ethyl-5,6-dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone::US11040966, Example 7.14::US9732075, Example 7.14 Orexin/Hypocretin receptor type 1 Homo sapiens 23.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335350 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335350&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127097 384987509 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658340 CCn1c(nc2cc(OC)c(OC)cc12)[C@]1(C)CCCN1C(=O)c1cc(C)c(C)cc1-n1nccn1 InChI=1S/C27H32N6O3/c1-7-31-22-16-24(36-6)23(35-5)15-20(22)30-26(31)27(4)9-8-12-32(27)25(34)19-13-17(2)18(3)14-21(19)33-28-10-11-29-33/h10-11,13-16H,7-9,12H2,1-6H3/t27-/m0/s1 CEULBPMKDYHHHA-MHZLTWQESA-N 335350 (4,5-Dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(1-ethyl-5,6-dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone::US11040966, Example 7.14::US9732075, Example 7.14 Orexin receptor type 2 Homo sapiens 50.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335350 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335350&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127097 384987509 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658341 Cc1ccc(-c2ccc(F)cc2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2n1C InChI=1S/C29H30FN3O/c1-18-7-12-23(21-8-10-22(30)11-9-21)24(15-18)27(34)33-14-6-13-29(33,4)28-31-25-16-19(2)20(3)17-26(25)32(28)5/h7-12,15-17H,6,13-14H2,1-5H3/t29-/m0/s1 XUMUDHLYUYGOGN-LJAQVGFWSA-N 335351 (4'-Fluoro-4-methyl-biphenyl-2-yl)-[(S)-2-methyl-2-(1,5,6-trimethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 7.15::US9732075, Example 7.15 Orexin/Hypocretin receptor type 1 Homo sapiens 11.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335351 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335351&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127673 384987510 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658342 Cc1ccc(-c2ccc(F)cc2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2n1C InChI=1S/C29H30FN3O/c1-18-7-12-23(21-8-10-22(30)11-9-21)24(15-18)27(34)33-14-6-13-29(33,4)28-31-25-16-19(2)20(3)17-26(25)32(28)5/h7-12,15-17H,6,13-14H2,1-5H3/t29-/m0/s1 XUMUDHLYUYGOGN-LJAQVGFWSA-N 335351 (4'-Fluoro-4-methyl-biphenyl-2-yl)-[(S)-2-methyl-2-(1,5,6-trimethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 7.15::US9732075, Example 7.15 Orexin receptor type 2 Homo sapiens 65.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335351 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335351&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127673 384987510 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658343 CCn1c(nc2cc(C)c(C)cc12)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-c1ccc(F)cc1 InChI=1S/C30H32FN3O/c1-6-33-27-18-21(4)20(3)17-26(27)32-29(33)30(5)14-7-15-34(30)28(35)25-16-19(2)8-13-24(25)22-9-11-23(31)12-10-22/h8-13,16-18H,6-7,14-15H2,1-5H3/t30-/m0/s1 RUSVEXUMLMBODZ-PMERELPUSA-N 335352 US11040966, Example 7.16::US9732075, Example 7.16::[(S)-2-(1-Ethyl-5,6-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335352 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335352&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127547 384987511 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658344 CCn1c(nc2cc(C)c(C)cc12)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-c1ccc(F)cc1 InChI=1S/C30H32FN3O/c1-6-33-27-18-21(4)20(3)17-26(27)32-29(33)30(5)14-7-15-34(30)28(35)25-16-19(2)8-13-24(25)22-9-11-23(31)12-10-22/h8-13,16-18H,6-7,14-15H2,1-5H3/t30-/m0/s1 RUSVEXUMLMBODZ-PMERELPUSA-N 335352 US11040966, Example 7.16::US9732075, Example 7.16::[(S)-2-(1-Ethyl-5,6-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4'-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 21.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335352 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335352&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127547 384987511 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658345 Cc1cc(C(=O)N2CCC[C@@]2(C)c2nc3cc(C)c(C)cc3n2C)c(cc1C)-n1nccn1 InChI=1S/C26H30N6O/c1-16-12-20(22(14-18(16)3)32-27-9-10-28-32)24(33)31-11-7-8-26(31,5)25-29-21-13-17(2)19(4)15-23(21)30(25)6/h9-10,12-15H,7-8,11H2,1-6H3/t26-/m0/s1 MEVYEKMBSZIAIZ-SANMLTNESA-N 335353 (4,5-Dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(1,5,6-trimethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 7.17::US9732075, Example 7.17 Orexin/Hypocretin receptor type 1 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335353 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335353&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128029 384987512 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658346 Cc1cc(C(=O)N2CCC[C@@]2(C)c2nc3cc(C)c(C)cc3n2C)c(cc1C)-n1nccn1 InChI=1S/C26H30N6O/c1-16-12-20(22(14-18(16)3)32-27-9-10-28-32)24(33)31-11-7-8-26(31,5)25-29-21-13-17(2)19(4)15-23(21)30(25)6/h9-10,12-15H,7-8,11H2,1-6H3/t26-/m0/s1 MEVYEKMBSZIAIZ-SANMLTNESA-N 335353 (4,5-Dimethyl-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-methyl-2-(1,5,6-trimethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 7.17::US9732075, Example 7.17 Orexin receptor type 2 Homo sapiens 19.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335353 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335353&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128029 384987512 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658347 Cc1ccc(c(n1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(Cl)ccc2n1C)-n1nccn1 InChI=1S/C23H24ClN7O/c1-14-6-8-18(31-25-11-12-26-31)20(27-14)21(32)30-13-5-10-23(30,3)22-28-19-15(2)16(24)7-9-17(19)29(22)4/h6-9,11-12H,5,10,13H2,1-4H3/t23-/m0/s1 AZKADNWHMIVDCE-QHCPKHFHSA-N 335354 US11040966, Example 7.18::US9732075, Example 7.18::[(S)-2-(5-Chloro-1,4-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone and/or [(S)-2-(3-Chloro-1,2-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335354 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335354&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127195 384987513 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658348 Cc1ccc(c(n1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(Cl)ccc2n1C)-n1nccn1 InChI=1S/C23H24ClN7O/c1-14-6-8-18(31-25-11-12-26-31)20(27-14)21(32)30-13-5-10-23(30,3)22-28-19-15(2)16(24)7-9-17(19)29(22)4/h6-9,11-12H,5,10,13H2,1-4H3/t23-/m0/s1 AZKADNWHMIVDCE-QHCPKHFHSA-N 335354 US11040966, Example 7.18::US9732075, Example 7.18::[(S)-2-(5-Chloro-1,4-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone and/or [(S)-2-(3-Chloro-1,2-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(6-methyl-3-[1,2,3]triazol-2-yl-pyridin-2-yl)-methanone Orexin receptor type 2 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335354 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335354&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127195 384987513 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658349 Cc1c(Cl)ccc2n(C)c(nc12)[C@]1(C)CCCN1C(=O)c1ccccc1-n1nccn1 InChI=1S/C23H23ClN6O/c1-15-17(24)9-10-19-20(15)27-22(28(19)3)23(2)11-6-14-29(23)21(31)16-7-4-5-8-18(16)30-25-12-13-26-30/h4-5,7-10,12-13H,6,11,14H2,1-3H3/t23-/m0/s1 FDUYQPMXRKBPIM-QHCPKHFHSA-N 335355 US11040966, Example 7.19::US9732075, Example 7.19::[(S)-2-(5-Chloro-1,4-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanoneand/or [(S)-2-(3-Chloro-1,2-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone(mixtures of isomers) Orexin/Hypocretin receptor type 1 Homo sapiens 5.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335355 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335355&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128118 384987514 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658350 Cc1c(Cl)ccc2n(C)c(nc12)[C@]1(C)CCCN1C(=O)c1ccccc1-n1nccn1 InChI=1S/C23H23ClN6O/c1-15-17(24)9-10-19-20(15)27-22(28(19)3)23(2)11-6-14-29(23)21(31)16-7-4-5-8-18(16)30-25-12-13-26-30/h4-5,7-10,12-13H,6,11,14H2,1-3H3/t23-/m0/s1 FDUYQPMXRKBPIM-QHCPKHFHSA-N 335355 US11040966, Example 7.19::US9732075, Example 7.19::[(S)-2-(5-Chloro-1,4-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanoneand/or [(S)-2-(3-Chloro-1,2-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2-[1,2,3]triazol-2-yl-phenyl)-methanone(mixtures of isomers) Orexin receptor type 2 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335355 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335355&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128118 384987514 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658351 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2n1C)C(F)(F)F)-n1nccn1 InChI=1S/C24H22ClF3N6O/c1-14-5-6-19(34-29-8-9-30-34)15(11-14)21(35)33-10-4-7-23(33,2)22-31-18-12-16(24(26,27)28)17(25)13-20(18)32(22)3/h5-6,8-9,11-13H,4,7,10H2,1-3H3/t23-/m0/s1 QYGMQJCKFLXWAX-QHCPKHFHSA-N 335356 US11040966, Example 7.20::US9732075, Example 7.20::[(S)-2-(6-Chloro-1-methyl-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone and or [(S)-2-(5-Chloro-1-methyl-6-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone(mixtures of isomers) Orexin/Hypocretin receptor type 1 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335356 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335356&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128008 384987515 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658352 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(c(Cl)cc2n1C)C(F)(F)F)-n1nccn1 InChI=1S/C24H22ClF3N6O/c1-14-5-6-19(34-29-8-9-30-34)15(11-14)21(35)33-10-4-7-23(33,2)22-31-18-12-16(24(26,27)28)17(25)13-20(18)32(22)3/h5-6,8-9,11-13H,4,7,10H2,1-3H3/t23-/m0/s1 QYGMQJCKFLXWAX-QHCPKHFHSA-N 335356 US11040966, Example 7.20::US9732075, Example 7.20::[(S)-2-(6-Chloro-1-methyl-5-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone and or [(S)-2-(5-Chloro-1-methyl-6-trifluoromethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone(mixtures of isomers) Orexin receptor type 2 Homo sapiens 14.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335356 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335356&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128008 384987515 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658353 CCn1c(nc2c(C)c(Cl)ccc12)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C25H27ClN6O/c1-5-30-21-10-8-19(26)17(3)22(21)29-24(30)25(4)11-6-14-31(25)23(33)18-15-16(2)7-9-20(18)32-27-12-13-28-32/h7-10,12-13,15H,5-6,11,14H2,1-4H3/t25-/m0/s1 KANLBBSZECYCLU-VWLOTQADSA-N 335357 US11040966, Example 7.21::US9732075, Example 7.21::[(S)-2-(5-Chloro-1-ethyl-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone and/or [(S)-2-(3-Chloro-1-ethyl-2-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone (mixtures of isomers) Orexin/Hypocretin receptor type 1 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335357 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335357&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127515 384987516 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658354 CCn1c(nc2c(C)c(Cl)ccc12)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C25H27ClN6O/c1-5-30-21-10-8-19(26)17(3)22(21)29-24(30)25(4)11-6-14-31(25)23(33)18-15-16(2)7-9-20(18)32-27-12-13-28-32/h7-10,12-13,15H,5-6,11,14H2,1-4H3/t25-/m0/s1 KANLBBSZECYCLU-VWLOTQADSA-N 335357 US11040966, Example 7.21::US9732075, Example 7.21::[(S)-2-(5-Chloro-1-ethyl-4-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone and/or [(S)-2-(3-Chloro-1-ethyl-2-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone (mixtures of isomers) Orexin receptor type 2 Homo sapiens 2.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335357 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335357&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127515 384987516 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658355 Cc1c(Cl)ccc2n(C)c(nc12)[C@]1(C)CCCN1C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C23H22Cl2N6O/c1-14-17(25)6-8-19-20(14)28-22(29(19)3)23(2)9-4-12-30(23)21(32)16-13-15(24)5-7-18(16)31-26-10-11-27-31/h5-8,10-11,13H,4,9,12H2,1-3H3/t23-/m0/s1 PYTQJNRFZSSECU-QHCPKHFHSA-N 335358 US11040966, Example 7.22::US9732075, Example 7.22::[(S)-2-(5-Chloro-1,4-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-chloro-2-[1,2,3]triazol-2-yl-phenyl)-methanone and/or [(S)-2-(3-Chloro-1,2-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-chloro-2-[1,2,3]triazol-2-yl-phenyl)-methanone (mixtures of isomers) Orexin/Hypocretin receptor type 1 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335358 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335358&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128019 384987517 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658356 Cc1c(Cl)ccc2n(C)c(nc12)[C@]1(C)CCCN1C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C23H22Cl2N6O/c1-14-17(25)6-8-19-20(14)28-22(29(19)3)23(2)9-4-12-30(23)21(32)16-13-15(24)5-7-18(16)31-26-10-11-27-31/h5-8,10-11,13H,4,9,12H2,1-3H3/t23-/m0/s1 PYTQJNRFZSSECU-QHCPKHFHSA-N 335358 US11040966, Example 7.22::US9732075, Example 7.22::[(S)-2-(5-Chloro-1,4-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-chloro-2-[1,2,3]triazol-2-yl-phenyl)-methanone and/or [(S)-2-(3-Chloro-1,2-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-chloro-2-[1,2,3]triazol-2-yl-phenyl)-methanone (mixtures of isomers) Orexin receptor type 2 Homo sapiens 4.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335358 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335358&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128019 384987517 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658357 COc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(Cl)ccc2n1C)-n1nccn1 InChI=1S/C24H25ClN6O2/c1-15-18(25)7-9-20-21(15)28-23(29(20)3)24(2)10-5-13-30(24)22(32)17-14-16(33-4)6-8-19(17)31-26-11-12-27-31/h6-9,11-12,14H,5,10,13H2,1-4H3/t24-/m0/s1 SABPYUNGMHYDLK-DEOSSOPVSA-N 335359 US11040966, Example 7.23::US9732075, Example 7.23::[(S)-2-(5-Chloro-1,4-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone and/or [(S)-2-(3-Chloro-1,2-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone (mixtures of isomers) Orexin/Hypocretin receptor type 1 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335359 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335359&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128237 384987518 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658358 COc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2c(C)c(Cl)ccc2n1C)-n1nccn1 InChI=1S/C24H25ClN6O2/c1-15-18(25)7-9-20-21(15)28-23(29(20)3)24(2)10-5-13-30(24)22(32)17-14-16(33-4)6-8-19(17)31-26-11-12-27-31/h6-9,11-12,14H,5,10,13H2,1-4H3/t24-/m0/s1 SABPYUNGMHYDLK-DEOSSOPVSA-N 335359 US11040966, Example 7.23::US9732075, Example 7.23::[(S)-2-(5-Chloro-1,4-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone and/or [(S)-2-(3-Chloro-1,2-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methoxy-2-[1,2,3]triazol-2-yl-phenyl)-methanone (mixtures of isomers) Orexin receptor type 2 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335359 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335359&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128237 384987518 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658359 COc1cc2nc(n(C)c2cc1OC)[C@]1(C)CCCN1C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C24H25ClN6O3/c1-24(23-28-17-13-20(33-3)21(34-4)14-19(17)29(23)2)8-5-11-30(24)22(32)16-12-15(25)6-7-18(16)31-26-9-10-27-31/h6-7,9-10,12-14H,5,8,11H2,1-4H3/t24-/m0/s1 DUZLFGSTZKAOAD-DEOSSOPVSA-N 335360 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(5,6-dimethoxy-1-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone::US11040966, Example 7.24::US9732075, Example 7.24 Orexin/Hypocretin receptor type 1 Homo sapiens 33.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335360 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335360&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128120 384987519 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658360 COc1cc2nc(n(C)c2cc1OC)[C@]1(C)CCCN1C(=O)c1cc(Cl)ccc1-n1nccn1 InChI=1S/C24H25ClN6O3/c1-24(23-28-17-13-20(33-3)21(34-4)14-19(17)29(23)2)8-5-11-30(24)22(32)16-12-15(25)6-7-18(16)31-26-9-10-27-31/h6-7,9-10,12-14H,5,8,11H2,1-4H3/t24-/m0/s1 DUZLFGSTZKAOAD-DEOSSOPVSA-N 335360 (5-Chloro-2-[1,2,3]triazol-2-yl-phenyl)-[(S)-2-(5,6-dimethoxy-1-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone::US11040966, Example 7.24::US9732075, Example 7.24 Orexin receptor type 2 Homo sapiens 33.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335360 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335360&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128120 384987519 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658361 Cc1cccc(c1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2n1C InChI=1S/C30H33N3O/c1-19-9-7-10-23(15-19)24-12-11-20(2)16-25(24)28(34)33-14-8-13-30(33,5)29-31-26-17-21(3)22(4)18-27(26)32(29)6/h7,9-12,15-18H,8,13-14H2,1-6H3/t30-/m0/s1 SRYXXVHHNJEEGW-PMERELPUSA-N 335361 (4,3'-Dimethyl-biphenyl-2-yl)-[(S)-2-methyl-2-(1,5,6-trimethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 7.25::US9732075, Example 7.25 Orexin/Hypocretin receptor type 1 Homo sapiens 15.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335361 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335361&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128293 384987520 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658362 Cc1cccc(c1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2n1C InChI=1S/C30H33N3O/c1-19-9-7-10-23(15-19)24-12-11-20(2)16-25(24)28(34)33-14-8-13-30(33,5)29-31-26-17-21(3)22(4)18-27(26)32(29)6/h7,9-12,15-18H,8,13-14H2,1-6H3/t30-/m0/s1 SRYXXVHHNJEEGW-PMERELPUSA-N 335361 (4,3'-Dimethyl-biphenyl-2-yl)-[(S)-2-methyl-2-(1,5,6-trimethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 7.25::US9732075, Example 7.25 Orexin receptor type 2 Homo sapiens 18.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335361 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335361&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128293 384987520 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658363 Cc1cccc(c1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2n1CC1CC1 InChI=1S/C33H37N3O/c1-21-8-6-9-26(16-21)27-13-10-22(2)17-28(27)31(37)36-15-7-14-33(36,5)32-34-29-18-23(3)24(4)19-30(29)35(32)20-25-11-12-25/h6,8-10,13,16-19,25H,7,11-12,14-15,20H2,1-5H3/t33-/m0/s1 YENKJLHNIDTAKF-XIFFEERXSA-N 335362 US11040966, Example 7.26::US9732075, Example 7.26::[(S)-2-(1-Cyclopropylmethyl-5,6-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,3'-dimethyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 42.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335362 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335362&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127474 384987521 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658364 Cc1cccc(c1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2n1CC1CC1 InChI=1S/C33H37N3O/c1-21-8-6-9-26(16-21)27-13-10-22(2)17-28(27)31(37)36-15-7-14-33(36,5)32-34-29-18-23(3)24(4)19-30(29)35(32)20-25-11-12-25/h6,8-10,13,16-19,25H,7,11-12,14-15,20H2,1-5H3/t33-/m0/s1 YENKJLHNIDTAKF-XIFFEERXSA-N 335362 US11040966, Example 7.26::US9732075, Example 7.26::[(S)-2-(1-Cyclopropylmethyl-5,6-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,3'-dimethyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 54.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335362 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335362&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127474 384987521 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658365 CCn1c(nc2cc(C)c(C)cc12)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-c1cccc(C)c1 InChI=1S/C31H35N3O/c1-7-33-28-19-23(5)22(4)18-27(28)32-30(33)31(6)14-9-15-34(31)29(35)26-17-21(3)12-13-25(26)24-11-8-10-20(2)16-24/h8,10-13,16-19H,7,9,14-15H2,1-6H3/t31-/m0/s1 MZIISHMOBROYPU-HKBQPEDESA-N 335363 (4,3'-Dimethyl-biphenyl-2-yl)-[(S)-2-(1-ethyl-5,6-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone::US11040966, Example 7.27::US9732075, Example 7.27 Orexin/Hypocretin receptor type 1 Homo sapiens 23.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335363 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335363&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127099 384987522 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658366 CCn1c(nc2cc(C)c(C)cc12)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-c1cccc(C)c1 InChI=1S/C31H35N3O/c1-7-33-28-19-23(5)22(4)18-27(28)32-30(33)31(6)14-9-15-34(31)29(35)26-17-21(3)12-13-25(26)24-11-8-10-20(2)16-24/h8,10-13,16-19H,7,9,14-15H2,1-6H3/t31-/m0/s1 MZIISHMOBROYPU-HKBQPEDESA-N 335363 (4,3'-Dimethyl-biphenyl-2-yl)-[(S)-2-(1-ethyl-5,6-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone::US11040966, Example 7.27::US9732075, Example 7.27 Orexin receptor type 2 Homo sapiens 17.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335363 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335363&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127099 384987522 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658367 Cc1cccc(c1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2n1CCF InChI=1S/C31H34FN3O/c1-20-8-6-9-24(16-20)25-11-10-21(2)17-26(25)29(36)35-14-7-12-31(35,5)30-33-27-18-22(3)23(4)19-28(27)34(30)15-13-32/h6,8-11,16-19H,7,12-15H2,1-5H3/t31-/m0/s1 GNQBXDHQOPMQJM-HKBQPEDESA-N 335364 (4,3'-Dimethyl-biphenyl-2-yl)-{(S)-2-[1-(2-fluoro-ethyl)-5,6-dimethyl-1H-benzoimidazol-2-yl]-2-methyl-pyrrolidin-1-yl}-methanone::US11040966, Example 7.28::US9732075, Example 7.28 Orexin/Hypocretin receptor type 1 Homo sapiens 14.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335364 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335364&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127485 384987523 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658368 Cc1cccc(c1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2n1CCF InChI=1S/C31H34FN3O/c1-20-8-6-9-24(16-20)25-11-10-21(2)17-26(25)29(36)35-14-7-12-31(35,5)30-33-27-18-22(3)23(4)19-28(27)34(30)15-13-32/h6,8-11,16-19H,7,12-15H2,1-5H3/t31-/m0/s1 GNQBXDHQOPMQJM-HKBQPEDESA-N 335364 (4,3'-Dimethyl-biphenyl-2-yl)-{(S)-2-[1-(2-fluoro-ethyl)-5,6-dimethyl-1H-benzoimidazol-2-yl]-2-methyl-pyrrolidin-1-yl}-methanone::US11040966, Example 7.28::US9732075, Example 7.28 Orexin receptor type 2 Homo sapiens 19.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335364 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335364&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127485 384987523 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658369 COCCn1c(nc2cc(C)c(C)cc12)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-c1cccc(C)c1 InChI=1S/C32H37N3O2/c1-21-9-7-10-25(17-21)26-12-11-22(2)18-27(26)30(36)35-14-8-13-32(35,5)31-33-28-19-23(3)24(4)20-29(28)34(31)15-16-37-6/h7,9-12,17-20H,8,13-16H2,1-6H3/t32-/m0/s1 OWINHUHRSOSKLU-YTTGMZPUSA-N 335365 (4,3'-Dimethyl-biphenyl-2-yl)-{(S)-2-[1-(2-methoxy-ethyl)-5,6-dimethyl-1H-benzoimidazol-2-yl]-2-methyl-pyrrolidin-1-yl}-methanone::US11040966, Example 7.29::US9732075, Example 7.29 Orexin/Hypocretin receptor type 1 Homo sapiens 23.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335365 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335365&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127108 384987524 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658370 COCCn1c(nc2cc(C)c(C)cc12)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-c1cccc(C)c1 InChI=1S/C32H37N3O2/c1-21-9-7-10-25(17-21)26-12-11-22(2)18-27(26)30(36)35-14-8-13-32(35,5)31-33-28-19-23(3)24(4)20-29(28)34(31)15-16-37-6/h7,9-12,17-20H,8,13-16H2,1-6H3/t32-/m0/s1 OWINHUHRSOSKLU-YTTGMZPUSA-N 335365 (4,3'-Dimethyl-biphenyl-2-yl)-{(S)-2-[1-(2-methoxy-ethyl)-5,6-dimethyl-1H-benzoimidazol-2-yl]-2-methyl-pyrrolidin-1-yl}-methanone::US11040966, Example 7.29::US9732075, Example 7.29 Orexin receptor type 2 Homo sapiens 70.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335365 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335365&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127108 384987524 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658371 Cc1ccc(-c2cccc(F)c2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2n1C InChI=1S/C29H30FN3O/c1-18-10-11-23(21-8-6-9-22(30)17-21)24(14-18)27(34)33-13-7-12-29(33,4)28-31-25-15-19(2)20(3)16-26(25)32(28)5/h6,8-11,14-17H,7,12-13H2,1-5H3/t29-/m0/s1 UQYAZUFEYPVQGW-LJAQVGFWSA-N 335366 (3'-Fluoro-4-methyl-biphenyl-2-yl)-[(S)-2-methyl-2-(1,5,6-trimethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 7.30::US9732075, Example 7.30 Orexin/Hypocretin receptor type 1 Homo sapiens 9.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335366 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335366&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127633 384987525 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658372 Cc1ccc(-c2cccc(F)c2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2n1C InChI=1S/C29H30FN3O/c1-18-10-11-23(21-8-6-9-22(30)17-21)24(14-18)27(34)33-13-7-12-29(33,4)28-31-25-15-19(2)20(3)16-26(25)32(28)5/h6,8-11,14-17H,7,12-13H2,1-5H3/t29-/m0/s1 UQYAZUFEYPVQGW-LJAQVGFWSA-N 335366 (3'-Fluoro-4-methyl-biphenyl-2-yl)-[(S)-2-methyl-2-(1,5,6-trimethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 7.30::US9732075, Example 7.30 Orexin receptor type 2 Homo sapiens 12.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335366 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335366&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127633 384987525 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658373 CCn1c(nc2cc(C)c(C)cc12)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-c1cccc(F)c1 InChI=1S/C30H32FN3O/c1-6-33-27-17-21(4)20(3)16-26(27)32-29(33)30(5)13-8-14-34(30)28(35)25-15-19(2)11-12-24(25)22-9-7-10-23(31)18-22/h7,9-12,15-18H,6,8,13-14H2,1-5H3/t30-/m0/s1 YWNGORXGUYZZDF-PMERELPUSA-N 335367 US11040966, Example 7.31::US9732075, Example 7.31::[(S)-2-(1-Ethyl-5,6-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335367 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335367&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127035 384987526 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658374 CCn1c(nc2cc(C)c(C)cc12)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-c1cccc(F)c1 InChI=1S/C30H32FN3O/c1-6-33-27-17-21(4)20(3)16-26(27)32-29(33)30(5)13-8-14-34(30)28(35)25-15-19(2)11-12-24(25)22-9-7-10-23(31)18-22/h7,9-12,15-18H,6,8,13-14H2,1-5H3/t30-/m0/s1 YWNGORXGUYZZDF-PMERELPUSA-N 335367 US11040966, Example 7.31::US9732075, Example 7.31::[(S)-2-(1-Ethyl-5,6-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 19.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335367 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335367&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127035 384987526 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658375 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(F)c(Br)cc2n1C)-n1nccn1 InChI=1S/C23H22BrFN6O/c1-14-5-6-19(31-26-8-9-27-31)15(11-14)21(32)30-10-4-7-23(30,2)22-28-18-13-17(25)16(24)12-20(18)29(22)3/h5-6,8-9,11-13H,4,7,10H2,1-3H3/t23-/m0/s1 ZZBUNILRIYPXRI-QHCPKHFHSA-N 335368 US11040966, Example 7.32::US9732075, Example 7.32::[(S)-2-(6-Bromo-5-fluoro-1-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone and/or [(S)-2-(4-Bromo-3-fluoro-1-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone (mixtures of isomers) Orexin/Hypocretin receptor type 1 Homo sapiens 7.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335368 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335368&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127801 384987527 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658376 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(F)c(Br)cc2n1C)-n1nccn1 InChI=1S/C23H22BrFN6O/c1-14-5-6-19(31-26-8-9-27-31)15(11-14)21(32)30-10-4-7-23(30,2)22-28-18-13-17(25)16(24)12-20(18)29(22)3/h5-6,8-9,11-13H,4,7,10H2,1-3H3/t23-/m0/s1 ZZBUNILRIYPXRI-QHCPKHFHSA-N 335368 US11040966, Example 7.32::US9732075, Example 7.32::[(S)-2-(6-Bromo-5-fluoro-1-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone and/or [(S)-2-(4-Bromo-3-fluoro-1-methyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone (mixtures of isomers) Orexin receptor type 2 Homo sapiens 124 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335368 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335368&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127801 384987527 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658377 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3n2C)c(s1)-c1cccc(Cl)c1 InChI=1S/C25H24Cl2N4OS/c1-14-18(27)9-10-19-20(14)29-24(30(19)4)25(3)11-6-12-31(25)23(32)21-22(33-15(2)28-21)16-7-5-8-17(26)13-16/h5,7-10,13H,6,11-12H2,1-4H3/t25-/m0/s1 JHGRYXUHXJQVFP-VWLOTQADSA-N 335369 US11040966, Example 7.33::US9732075, Example 7.33::[(S)-2-(5-Chloro-1,4-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone and/or [(S)-2-(3-Chloro-1,2-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone (mixtures of isomers) Orexin/Hypocretin receptor type 1 Homo sapiens 1.000 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335369 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335369&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128351 384987528 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658378 Cc1nc(C(=O)N2CCC[C@@]2(C)c2nc3c(C)c(Cl)ccc3n2C)c(s1)-c1cccc(Cl)c1 InChI=1S/C25H24Cl2N4OS/c1-14-18(27)9-10-19-20(14)29-24(30(19)4)25(3)11-6-12-31(25)23(32)21-22(33-15(2)28-21)16-7-5-8-17(26)13-16/h5,7-10,13H,6,11-12H2,1-4H3/t25-/m0/s1 JHGRYXUHXJQVFP-VWLOTQADSA-N 335369 US11040966, Example 7.33::US9732075, Example 7.33::[(S)-2-(5-Chloro-1,4-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone and/or [(S)-2-(3-Chloro-1,2-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-[5-(3-chloro-phenyl)-2-methyl-thiazol-4-yl]-methanone (mixtures of isomers) Orexin receptor type 2 Homo sapiens 3.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335369 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335369&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128351 384987528 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658379 Cc1ccc(-c2cccc(F)c2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2n1CC1CC1 InChI=1S/C32H34FN3O/c1-20-9-12-26(24-7-5-8-25(33)18-24)27(15-20)30(37)36-14-6-13-32(36,4)31-34-28-16-21(2)22(3)17-29(28)35(31)19-23-10-11-23/h5,7-9,12,15-18,23H,6,10-11,13-14,19H2,1-4H3/t32-/m0/s1 PBNXJCYPBKTIRD-YTTGMZPUSA-N 335370 US11040966, Example 7.34::US9732075, Example 7.34::[(S)-2-(1-Cyclopropylmethyl-5,6-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 16.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335370 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335370&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127572 384987529 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658380 Cc1ccc(-c2cccc(F)c2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2n1CC1CC1 InChI=1S/C32H34FN3O/c1-20-9-12-26(24-7-5-8-25(33)18-24)27(15-20)30(37)36-14-6-13-32(36,4)31-34-28-16-21(2)22(3)17-29(28)35(31)19-23-10-11-23/h5,7-9,12,15-18,23H,6,10-11,13-14,19H2,1-4H3/t32-/m0/s1 PBNXJCYPBKTIRD-YTTGMZPUSA-N 335370 US11040966, Example 7.34::US9732075, Example 7.34::[(S)-2-(1-Cyclopropylmethyl-5,6-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 84.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335370 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335370&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127572 384987529 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658381 Cc1ccc(-c2cccc(F)c2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2n1CCF InChI=1S/C30H31F2N3O/c1-19-9-10-24(22-7-5-8-23(32)18-22)25(15-19)28(36)35-13-6-11-30(35,4)29-33-26-16-20(2)21(3)17-27(26)34(29)14-12-31/h5,7-10,15-18H,6,11-14H2,1-4H3/t30-/m0/s1 YBMJRJSPVBHBIV-PMERELPUSA-N 335371 US11040966, Example 7.35::US9732075, Example 7.35::{(S)-2-[1-(2-Fluoro-ethyl)-5,6-dimethyl-1H-benzoimidazol-2-yl]-2-methyl-pyrrolidin-1-yl}-(3'-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 6.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335371 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335371&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128155 384987530 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658382 Cc1ccc(-c2cccc(F)c2)c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2n1CCF InChI=1S/C30H31F2N3O/c1-19-9-10-24(22-7-5-8-23(32)18-22)25(15-19)28(36)35-13-6-11-30(35,4)29-33-26-16-20(2)21(3)17-27(26)34(29)14-12-31/h5,7-10,15-18H,6,11-14H2,1-4H3/t30-/m0/s1 YBMJRJSPVBHBIV-PMERELPUSA-N 335371 US11040966, Example 7.35::US9732075, Example 7.35::{(S)-2-[1-(2-Fluoro-ethyl)-5,6-dimethyl-1H-benzoimidazol-2-yl]-2-methyl-pyrrolidin-1-yl}-(3'-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 20.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335371 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335371&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128155 384987530 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658383 COCCn1c(nc2cc(C)c(C)cc12)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-c1cccc(F)c1 InChI=1S/C31H34FN3O2/c1-20-10-11-25(23-8-6-9-24(32)19-23)26(16-20)29(36)35-13-7-12-31(35,4)30-33-27-17-21(2)22(3)18-28(27)34(30)14-15-37-5/h6,8-11,16-19H,7,12-15H2,1-5H3/t31-/m0/s1 GNEHKJMUIPDIAZ-HKBQPEDESA-N 335372 (3'-Fluoro-4-methyl-biphenyl-2-yl)-{(S)-2-[1-(2-methoxy-ethyl)-5,6-dimethyl-1H-benzoimidazol-2-yl]-2-methyl-pyrrolidin-1-yl}-methanone::US11040966, Example 7.36::US9732075, Example 7.36 Orexin/Hypocretin receptor type 1 Homo sapiens 16.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335372 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335372&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128084 384987531 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658384 COCCn1c(nc2cc(C)c(C)cc12)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-c1cccc(F)c1 InChI=1S/C31H34FN3O2/c1-20-10-11-25(23-8-6-9-24(32)19-23)26(16-20)29(36)35-13-7-12-31(35,4)30-33-27-17-21(2)22(3)18-28(27)34(30)14-15-37-5/h6,8-11,16-19H,7,12-15H2,1-5H3/t31-/m0/s1 GNEHKJMUIPDIAZ-HKBQPEDESA-N 335372 (3'-Fluoro-4-methyl-biphenyl-2-yl)-{(S)-2-[1-(2-methoxy-ethyl)-5,6-dimethyl-1H-benzoimidazol-2-yl]-2-methyl-pyrrolidin-1-yl}-methanone::US11040966, Example 7.36::US9732075, Example 7.36 Orexin receptor type 2 Homo sapiens 115 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335372 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335372&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128084 384987531 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658385 Cc1ccc(cc1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2n1C InChI=1S/C30H33N3O/c1-19-8-11-23(12-9-19)24-13-10-20(2)16-25(24)28(34)33-15-7-14-30(33,5)29-31-26-17-21(3)22(4)18-27(26)32(29)6/h8-13,16-18H,7,14-15H2,1-6H3/t30-/m0/s1 RZNCXGFZWQJORF-PMERELPUSA-N 335373 (4,4'-Dimethyl-biphenyl-2-yl)-[(S)-2-methyl-2-(1,5,6-trimethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 7.37::US9732075, Example 7.37 Orexin/Hypocretin receptor type 1 Homo sapiens 11.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335373 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335373&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127552 384987532 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658386 Cc1ccc(cc1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2n1C InChI=1S/C30H33N3O/c1-19-8-11-23(12-9-19)24-13-10-20(2)16-25(24)28(34)33-15-7-14-30(33,5)29-31-26-17-21(3)22(4)18-27(26)32(29)6/h8-13,16-18H,7,14-15H2,1-6H3/t30-/m0/s1 RZNCXGFZWQJORF-PMERELPUSA-N 335373 (4,4'-Dimethyl-biphenyl-2-yl)-[(S)-2-methyl-2-(1,5,6-trimethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 7.37::US9732075, Example 7.37 Orexin receptor type 2 Homo sapiens 20.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335373 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335373&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127552 384987532 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658387 CCn1c(nc2cc(C)c(C)cc12)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-c1ccc(C)cc1 InChI=1S/C31H35N3O/c1-7-33-28-19-23(5)22(4)18-27(28)32-30(33)31(6)15-8-16-34(31)29(35)26-17-21(3)11-14-25(26)24-12-9-20(2)10-13-24/h9-14,17-19H,7-8,15-16H2,1-6H3/t31-/m0/s1 FTNDSQWTMFXGKC-HKBQPEDESA-N 335374 (4,4'-Dimethyl-biphenyl-2-yl)-[(S)-2-(1-ethyl-5,6-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone::US11040966, Example 7.38::US9732075, Example 7.38 Orexin/Hypocretin receptor type 1 Homo sapiens 8.00 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335374 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335374&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127192 384987533 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658388 CCn1c(nc2cc(C)c(C)cc12)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-c1ccc(C)cc1 InChI=1S/C31H35N3O/c1-7-33-28-19-23(5)22(4)18-27(28)32-30(33)31(6)15-8-16-34(31)29(35)26-17-21(3)11-14-25(26)24-12-9-20(2)10-13-24/h9-14,17-19H,7-8,15-16H2,1-6H3/t31-/m0/s1 FTNDSQWTMFXGKC-HKBQPEDESA-N 335374 (4,4'-Dimethyl-biphenyl-2-yl)-[(S)-2-(1-ethyl-5,6-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-methanone::US11040966, Example 7.38::US9732075, Example 7.38 Orexin receptor type 2 Homo sapiens 30.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335374 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335374&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127192 384987533 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658389 Cc1ccc(cc1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2n1CC1CC1 InChI=1S/C33H37N3O/c1-21-7-12-26(13-8-21)27-14-9-22(2)17-28(27)31(37)36-16-6-15-33(36,5)32-34-29-18-23(3)24(4)19-30(29)35(32)20-25-10-11-25/h7-9,12-14,17-19,25H,6,10-11,15-16,20H2,1-5H3/t33-/m0/s1 CVOGJGIWACLEIA-XIFFEERXSA-N 335375 US11040966, Example 7.39::US9732075, Example 7.39::[(S)-2-(1-Cyclopropylmethyl-5,6-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,4'-dimethyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 43.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335375 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335375&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127313 384987534 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658390 Cc1ccc(cc1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2n1CC1CC1 InChI=1S/C33H37N3O/c1-21-7-12-26(13-8-21)27-14-9-22(2)17-28(27)31(37)36-16-6-15-33(36,5)32-34-29-18-23(3)24(4)19-30(29)35(32)20-25-10-11-25/h7-9,12-14,17-19,25H,6,10-11,15-16,20H2,1-5H3/t33-/m0/s1 CVOGJGIWACLEIA-XIFFEERXSA-N 335375 US11040966, Example 7.39::US9732075, Example 7.39::[(S)-2-(1-Cyclopropylmethyl-5,6-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(4,4'-dimethyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 61.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335375 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335375&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127313 384987534 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658391 Cc1ccc(cc1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2n1CCF InChI=1S/C31H34FN3O/c1-20-7-10-24(11-8-20)25-12-9-21(2)17-26(25)29(36)35-15-6-13-31(35,5)30-33-27-18-22(3)23(4)19-28(27)34(30)16-14-32/h7-12,17-19H,6,13-16H2,1-5H3/t31-/m0/s1 BOXBCJUPUOXXMK-HKBQPEDESA-N 335376 (4,4'-Dimethyl-biphenyl-2-yl)-{(S)-2-[1-(2-fluoro-ethyl)-5,6-dimethyl-1H-benzoimidazol-2-yl]-2-methyl-pyrrolidin-1-yl}-methanone::US11040966, Example 7.40::US9732075, Example 7.40 Orexin/Hypocretin receptor type 1 Homo sapiens 23.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335376 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335376&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127259 384987535 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658392 Cc1ccc(cc1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2n1CCF InChI=1S/C31H34FN3O/c1-20-7-10-24(11-8-20)25-12-9-21(2)17-26(25)29(36)35-15-6-13-31(35,5)30-33-27-18-22(3)23(4)19-28(27)34(30)16-14-32/h7-12,17-19H,6,13-16H2,1-5H3/t31-/m0/s1 BOXBCJUPUOXXMK-HKBQPEDESA-N 335376 (4,4'-Dimethyl-biphenyl-2-yl)-{(S)-2-[1-(2-fluoro-ethyl)-5,6-dimethyl-1H-benzoimidazol-2-yl]-2-methyl-pyrrolidin-1-yl}-methanone::US11040966, Example 7.40::US9732075, Example 7.40 Orexin receptor type 2 Homo sapiens 39.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335376 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335376&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127259 384987535 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658393 COCCn1c(nc2cc(C)c(C)cc12)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-c1ccc(C)cc1 InChI=1S/C32H37N3O2/c1-21-8-11-25(12-9-21)26-13-10-22(2)18-27(26)30(36)35-15-7-14-32(35,5)31-33-28-19-23(3)24(4)20-29(28)34(31)16-17-37-6/h8-13,18-20H,7,14-17H2,1-6H3/t32-/m0/s1 ZUHCBZPZFOUAJF-YTTGMZPUSA-N 335377 (4,4'-Dimethyl-biphenyl-2-yl)-{(S)-2-[1-(2-methoxy-ethyl)-5,6-dimethyl-1H-benzoimidazol-2-yl]-2-methyl-pyrrolidin-1-yl}-methanone::US11040966, Example 7.41::US9732075, Example 7.41 Orexin/Hypocretin receptor type 1 Homo sapiens 44.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335377 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335377&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127579 384987536 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658394 COCCn1c(nc2cc(C)c(C)cc12)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-c1ccc(C)cc1 InChI=1S/C32H37N3O2/c1-21-8-11-25(12-9-21)26-13-10-22(2)18-27(26)30(36)35-15-7-14-32(35,5)31-33-28-19-23(3)24(4)20-29(28)34(31)16-17-37-6/h8-13,18-20H,7,14-17H2,1-6H3/t32-/m0/s1 ZUHCBZPZFOUAJF-YTTGMZPUSA-N 335377 (4,4'-Dimethyl-biphenyl-2-yl)-{(S)-2-[1-(2-methoxy-ethyl)-5,6-dimethyl-1H-benzoimidazol-2-yl]-2-methyl-pyrrolidin-1-yl}-methanone::US11040966, Example 7.41::US9732075, Example 7.41 Orexin receptor type 2 Homo sapiens 106 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335377 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335377&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127579 384987536 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658395 COc1cccc(c1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2n1C InChI=1S/C30H33N3O2/c1-19-11-12-24(22-9-7-10-23(18-22)35-6)25(15-19)28(34)33-14-8-13-30(33,4)29-31-26-16-20(2)21(3)17-27(26)32(29)5/h7,9-12,15-18H,8,13-14H2,1-6H3/t30-/m0/s1 IKJOUBXNNPJOFV-PMERELPUSA-N 335378 (3'-Methoxy-4-methyl-biphenyl-2-yl)-[(S)-2-methyl-2-(1,5,6-trimethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 7.42::US9732075, Example 7.42 Orexin/Hypocretin receptor type 1 Homo sapiens 38.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335378 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335378&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127508 384987537 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658396 COc1cccc(c1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2n1C InChI=1S/C30H33N3O2/c1-19-11-12-24(22-9-7-10-23(18-22)35-6)25(15-19)28(34)33-14-8-13-30(33,4)29-31-26-16-20(2)21(3)17-27(26)32(29)5/h7,9-12,15-18H,8,13-14H2,1-6H3/t30-/m0/s1 IKJOUBXNNPJOFV-PMERELPUSA-N 335378 (3'-Methoxy-4-methyl-biphenyl-2-yl)-[(S)-2-methyl-2-(1,5,6-trimethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 7.42::US9732075, Example 7.42 Orexin receptor type 2 Homo sapiens 28.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335378 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335378&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127508 384987537 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658397 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2n1C)-c1ccccc1F InChI=1S/C29H30FN3O/c1-18-11-12-21(22-9-6-7-10-24(22)30)23(15-18)27(34)33-14-8-13-29(33,4)28-31-25-16-19(2)20(3)17-26(25)32(28)5/h6-7,9-12,15-17H,8,13-14H2,1-5H3/t29-/m0/s1 PWESHWNSNAMDET-LJAQVGFWSA-N 335379 (2'-Fluoro-4-methyl-biphenyl-2-yl)-[(S)-2-methyl-2-(1,5,6-trimethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 7.43::US9732075, Example 7.43 Orexin/Hypocretin receptor type 1 Homo sapiens 24.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335379 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335379&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127100 384987538 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658398 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2n1C)-c1ccccc1F InChI=1S/C29H30FN3O/c1-18-11-12-21(22-9-6-7-10-24(22)30)23(15-18)27(34)33-14-8-13-29(33,4)28-31-25-16-19(2)20(3)17-26(25)32(28)5/h6-7,9-12,15-17H,8,13-14H2,1-5H3/t29-/m0/s1 PWESHWNSNAMDET-LJAQVGFWSA-N 335379 (2'-Fluoro-4-methyl-biphenyl-2-yl)-[(S)-2-methyl-2-(1,5,6-trimethyl-1H-benzoimidazol-2-yl)-pyrrolidin-1-yl]-methanone::US11040966, Example 7.43::US9732075, Example 7.43 Orexin receptor type 2 Homo sapiens 42.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335379 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335379&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127100 384987538 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658399 CCn1c(nc2cc(C)c(C)cc12)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-c1cccc(OC)c1 InChI=1S/C31H35N3O2/c1-7-33-28-18-22(4)21(3)17-27(28)32-30(33)31(5)14-9-15-34(31)29(35)26-16-20(2)12-13-25(26)23-10-8-11-24(19-23)36-6/h8,10-13,16-19H,7,9,14-15H2,1-6H3/t31-/m0/s1 LSMYNAIPGSYMGF-HKBQPEDESA-N 335380 US11040966, Example 7.44::US9732075, Example 7.44::[(S)-2-(1-Ethyl-5,6-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-methoxy-4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 21.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335380 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335380&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127773 384987539 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658400 CCn1c(nc2cc(C)c(C)cc12)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-c1cccc(OC)c1 InChI=1S/C31H35N3O2/c1-7-33-28-18-22(4)21(3)17-27(28)32-30(33)31(5)14-9-15-34(31)29(35)26-16-20(2)12-13-25(26)23-10-8-11-24(19-23)36-6/h8,10-13,16-19H,7,9,14-15H2,1-6H3/t31-/m0/s1 LSMYNAIPGSYMGF-HKBQPEDESA-N 335380 US11040966, Example 7.44::US9732075, Example 7.44::[(S)-2-(1-Ethyl-5,6-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-methoxy-4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 35.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335380 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335380&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127773 384987539 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658401 CCn1c(nc2cc(C)c(C)cc12)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-c1ccccc1F InChI=1S/C30H32FN3O/c1-6-33-27-18-21(4)20(3)17-26(27)32-29(33)30(5)14-9-15-34(30)28(35)24-16-19(2)12-13-22(24)23-10-7-8-11-25(23)31/h7-8,10-13,16-18H,6,9,14-15H2,1-5H3/t30-/m0/s1 ZKBDDMOPGKHYRL-PMERELPUSA-N 335381 US11040966, Example 7.45::US9732075, Example 7.45::[(S)-2-(1-Ethyl-5,6-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2'-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 31.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335381 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335381&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127980 384987540 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658402 CCn1c(nc2cc(C)c(C)cc12)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-c1ccccc1F InChI=1S/C30H32FN3O/c1-6-33-27-18-21(4)20(3)17-26(27)32-29(33)30(5)14-9-15-34(30)28(35)24-16-19(2)12-13-22(24)23-10-7-8-11-25(23)31/h7-8,10-13,16-18H,6,9,14-15H2,1-5H3/t30-/m0/s1 ZKBDDMOPGKHYRL-PMERELPUSA-N 335381 US11040966, Example 7.45::US9732075, Example 7.45::[(S)-2-(1-Ethyl-5,6-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2'-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 60.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335381 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335381&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127980 384987540 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658403 COCCn1c(nc2cc(OC)c(OC)cc12)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C27H32N6O4/c1-18-7-8-21(33-28-10-11-29-33)19(15-18)25(34)32-12-6-9-27(32,2)26-30-20-16-23(36-4)24(37-5)17-22(20)31(26)13-14-35-3/h7-8,10-11,15-17H,6,9,12-14H2,1-5H3/t27-/m0/s1 HZVGNXLQYIOJRS-MHZLTWQESA-N 335382 US11040966, Example 7.46::US9732075, Example 7.46::{(S)-2-[5,6-Dimethoxy-1-(2-methoxy-ethyl)-1H-benzoimidazol-2-yl]-2-methyl-pyrrolidin-1-yl}-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 78.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335382 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335382&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127165 384987541 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658404 COCCn1c(nc2cc(OC)c(OC)cc12)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C27H32N6O4/c1-18-7-8-21(33-28-10-11-29-33)19(15-18)25(34)32-12-6-9-27(32,2)26-30-20-16-23(36-4)24(37-5)17-22(20)31(26)13-14-35-3/h7-8,10-11,15-17H,6,9,12-14H2,1-5H3/t27-/m0/s1 HZVGNXLQYIOJRS-MHZLTWQESA-N 335382 US11040966, Example 7.46::US9732075, Example 7.46::{(S)-2-[5,6-Dimethoxy-1-(2-methoxy-ethyl)-1H-benzoimidazol-2-yl]-2-methyl-pyrrolidin-1-yl}-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 77.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335382 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335382&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127165 384987541 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658405 COc1cc2nc(n(CC3CC3)c2cc1OC)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C28H32N6O3/c1-18-6-9-22(34-29-11-12-30-34)20(14-18)26(35)33-13-5-10-28(33,2)27-31-21-15-24(36-3)25(37-4)16-23(21)32(27)17-19-7-8-19/h6,9,11-12,14-16,19H,5,7-8,10,13,17H2,1-4H3/t28-/m0/s1 ICBQNVKSWWAOBL-NDEPHWFRSA-N 335383 US11040966, Example 7.47::US9732075, Example 7.47::[(S)-2-(1-Cyclopropylmethyl-5,6-dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 39.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335383 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335383&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127892 384987542 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658406 COc1cc2nc(n(CC3CC3)c2cc1OC)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C28H32N6O3/c1-18-6-9-22(34-29-11-12-30-34)20(14-18)26(35)33-13-5-10-28(33,2)27-31-21-15-24(36-3)25(37-4)16-23(21)32(27)17-19-7-8-19/h6,9,11-12,14-16,19H,5,7-8,10,13,17H2,1-4H3/t28-/m0/s1 ICBQNVKSWWAOBL-NDEPHWFRSA-N 335383 US11040966, Example 7.47::US9732075, Example 7.47::[(S)-2-(1-Cyclopropylmethyl-5,6-dimethoxy-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 60.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335383 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335383&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127892 384987542 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658407 COc1cc2nc(n(CCF)c2cc1OC)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C26H29FN6O3/c1-17-6-7-20(33-28-10-11-29-33)18(14-17)24(34)32-12-5-8-26(32,2)25-30-19-15-22(35-3)23(36-4)16-21(19)31(25)13-9-27/h6-7,10-11,14-16H,5,8-9,12-13H2,1-4H3/t26-/m0/s1 IVIIHHTVNJCLFG-SANMLTNESA-N 335384 US11040966, Example 7.48::US9732075, Example 7.48::{(S)-2-[1-(2-Fluoro-ethyl)-5,6-dimethoxy-1H-benzoimidazol-2-yl]-2-methyl-pyrrolidin-1-yl}-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 33.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335384 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335384&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127994 384987543 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658408 COc1cc2nc(n(CCF)c2cc1OC)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-n1nccn1 InChI=1S/C26H29FN6O3/c1-17-6-7-20(33-28-10-11-29-33)18(14-17)24(34)32-12-5-8-26(32,2)25-30-19-15-22(35-3)23(36-4)16-21(19)31(25)13-9-27/h6-7,10-11,14-16H,5,8-9,12-13H2,1-4H3/t26-/m0/s1 IVIIHHTVNJCLFG-SANMLTNESA-N 335384 US11040966, Example 7.48::US9732075, Example 7.48::{(S)-2-[1-(2-Fluoro-ethyl)-5,6-dimethoxy-1H-benzoimidazol-2-yl]-2-methyl-pyrrolidin-1-yl}-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone Orexin receptor type 2 Homo sapiens 40.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335384 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335384&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127994 384987543 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658409 COc1cccc(c1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2n1CC1CC1 InChI=1S/C33H37N3O2/c1-21-10-13-27(25-8-6-9-26(19-25)38-5)28(16-21)31(37)36-15-7-14-33(36,4)32-34-29-17-22(2)23(3)18-30(29)35(32)20-24-11-12-24/h6,8-10,13,16-19,24H,7,11-12,14-15,20H2,1-5H3/t33-/m0/s1 RYBVNICKNHPDEK-XIFFEERXSA-N 335385 US11040966, Example 7.49::US9732075, Example 7.49::[(S)-2-(1-Cyclopropylmethyl-5,6-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-methoxy-4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 96.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335385 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335385&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128055 384987544 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658410 COc1cccc(c1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2n1CC1CC1 InChI=1S/C33H37N3O2/c1-21-10-13-27(25-8-6-9-26(19-25)38-5)28(16-21)31(37)36-15-7-14-33(36,4)32-34-29-17-22(2)23(3)18-30(29)35(32)20-24-11-12-24/h6,8-10,13,16-19,24H,7,11-12,14-15,20H2,1-5H3/t33-/m0/s1 RYBVNICKNHPDEK-XIFFEERXSA-N 335385 US11040966, Example 7.49::US9732075, Example 7.49::[(S)-2-(1-Cyclopropylmethyl-5,6-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(3'-methoxy-4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 173 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335385 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335385&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128055 384987544 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658411 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2n1CC1CC1)-c1ccccc1F InChI=1S/C32H34FN3O/c1-20-10-13-24(25-8-5-6-9-27(25)33)26(16-20)30(37)36-15-7-14-32(36,4)31-34-28-17-21(2)22(3)18-29(28)35(31)19-23-11-12-23/h5-6,8-10,13,16-18,23H,7,11-12,14-15,19H2,1-4H3/t32-/m0/s1 RSIMNJBBBVSQIY-YTTGMZPUSA-N 335386 US11040966, Example 7.50::US9732075, Example 7.50::[(S)-2-(1-Cyclopropylmethyl-5,6-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2'-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 66.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335386 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335386&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128310 384987545 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658412 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2n1CC1CC1)-c1ccccc1F InChI=1S/C32H34FN3O/c1-20-10-13-24(25-8-5-6-9-27(25)33)26(16-20)30(37)36-15-7-14-32(36,4)31-34-28-17-21(2)22(3)18-29(28)35(31)19-23-11-12-23/h5-6,8-10,13,16-18,23H,7,11-12,14-15,19H2,1-4H3/t32-/m0/s1 RSIMNJBBBVSQIY-YTTGMZPUSA-N 335386 US11040966, Example 7.50::US9732075, Example 7.50::[(S)-2-(1-Cyclopropylmethyl-5,6-dimethyl-1H-benzoimidazol-2-yl)-2-methyl-pyrrolidin-1-yl]-(2'-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 171 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335386 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335386&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128310 384987545 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658413 COc1cccc(c1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2n1CCF InChI=1S/C31H34FN3O2/c1-20-10-11-25(23-8-6-9-24(19-23)37-5)26(16-20)29(36)35-14-7-12-31(35,4)30-33-27-17-21(2)22(3)18-28(27)34(30)15-13-32/h6,8-11,16-19H,7,12-15H2,1-5H3/t31-/m0/s1 GMGQBQVXQMNYFZ-HKBQPEDESA-N 335387 US11040966, Example 7.51::US9732075, Example 7.51::{(S)-2-[1-(2-Fluoro-ethyl)-5,6-dimethyl-1H-benzoimidazol-2-yl]-2-methyl-pyrrolidin-1-yl}-(3'-methoxy-4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 19.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335387 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335387&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127083 384987546 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658414 COc1cccc(c1)-c1ccc(C)cc1C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2n1CCF InChI=1S/C31H34FN3O2/c1-20-10-11-25(23-8-6-9-24(19-23)37-5)26(16-20)29(36)35-14-7-12-31(35,4)30-33-27-17-21(2)22(3)18-28(27)34(30)15-13-32/h6,8-11,16-19H,7,12-15H2,1-5H3/t31-/m0/s1 GMGQBQVXQMNYFZ-HKBQPEDESA-N 335387 US11040966, Example 7.51::US9732075, Example 7.51::{(S)-2-[1-(2-Fluoro-ethyl)-5,6-dimethyl-1H-benzoimidazol-2-yl]-2-methyl-pyrrolidin-1-yl}-(3'-methoxy-4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 27.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335387 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335387&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127083 384987546 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658415 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2n1CCF)-c1ccccc1F InChI=1S/C30H31F2N3O/c1-19-10-11-22(23-8-5-6-9-25(23)32)24(16-19)28(36)35-14-7-12-30(35,4)29-33-26-17-20(2)21(3)18-27(26)34(29)15-13-31/h5-6,8-11,16-18H,7,12-15H2,1-4H3/t30-/m0/s1 HFBXMBNFSBUUTI-PMERELPUSA-N 335388 US11040966, Example 7.52::US9732075, Example 7.52::{(S)-2-[1-(2-Fluoro-ethyl)-5,6-dimethyl-1H-benzoimidazol-2-yl]-2-methyl-pyrrolidin-1-yl}-(2'-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 27.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335388 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335388&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127905 384987547 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658416 Cc1ccc(c(c1)C(=O)N1CCC[C@@]1(C)c1nc2cc(C)c(C)cc2n1CCF)-c1ccccc1F InChI=1S/C30H31F2N3O/c1-19-10-11-22(23-8-5-6-9-25(23)32)24(16-19)28(36)35-14-7-12-30(35,4)29-33-26-17-20(2)21(3)18-27(26)34(29)15-13-31/h5-6,8-11,16-18H,7,12-15H2,1-4H3/t30-/m0/s1 HFBXMBNFSBUUTI-PMERELPUSA-N 335388 US11040966, Example 7.52::US9732075, Example 7.52::{(S)-2-[1-(2-Fluoro-ethyl)-5,6-dimethyl-1H-benzoimidazol-2-yl]-2-methyl-pyrrolidin-1-yl}-(2'-fluoro-4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 60.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335388 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335388&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127905 384987547 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658417 COCCn1c(nc2cc(C)c(C)cc12)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-c1cccc(OC)c1 InChI=1S/C32H37N3O3/c1-21-11-12-26(24-9-7-10-25(20-24)38-6)27(17-21)30(36)35-14-8-13-32(35,4)31-33-28-18-22(2)23(3)19-29(28)34(31)15-16-37-5/h7,9-12,17-20H,8,13-16H2,1-6H3/t32-/m0/s1 SVKARPSPRZNZNP-YTTGMZPUSA-N 335389 US9732075, Example 7.53::{(S)-2-[1-(2-Methoxy-ethyl)-5,6-dimethyl-1H-benzoimidazol-2-yl]-2-methyl-pyrrolidin-1-yl}-(3'-methoxy-4-methyl-biphenyl-2-yl)-methanone Orexin/Hypocretin receptor type 1 Homo sapiens 46.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335389 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335389&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118127527 384987548 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658418 COCCn1c(nc2cc(C)c(C)cc12)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-c1cccc(OC)c1 InChI=1S/C32H37N3O3/c1-21-11-12-26(24-9-7-10-25(20-24)38-6)27(17-21)30(36)35-14-8-13-32(35,4)31-33-28-18-22(2)23(3)19-29(28)34(31)15-16-37-5/h7,9-12,17-20H,8,13-16H2,1-6H3/t32-/m0/s1 SVKARPSPRZNZNP-YTTGMZPUSA-N 335389 US9732075, Example 7.53::{(S)-2-[1-(2-Methoxy-ethyl)-5,6-dimethyl-1H-benzoimidazol-2-yl]-2-methyl-pyrrolidin-1-yl}-(3'-methoxy-4-methyl-biphenyl-2-yl)-methanone Orexin receptor type 2 Homo sapiens 190 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335389 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335389&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118127527 384987548 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0 658419 COCCn1c(nc2cc(C)c(C)cc12)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-c1ccccc1F InChI=1S/C31H34FN3O2/c1-20-11-12-23(24-9-6-7-10-26(24)32)25(17-20)29(36)35-14-8-13-31(35,4)30-33-27-18-21(2)22(3)19-28(27)34(30)15-16-37-5/h6-7,9-12,17-19H,8,13-16H2,1-5H3/t31-/m0/s1 ZOFFFVKQLLHRKP-HKBQPEDESA-N 335390 (2'-Fluoro-4-methyl-biphenyl-2-yl)-{(S)-2-[1-(2-methoxy-ethyl)-5,6-dimethyl-1H-benzoimidazol-2-yl]-2-methyl-pyrrolidin-1-yl}-methanone::US11040966, Example 7.54::US9732075, Example 7.54 Orexin/Hypocretin receptor type 1 Homo sapiens 87.0 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335390 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5448&target=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335390&enzyme=Orexin%2FHypocretin+receptor+type+1&column=ki&startPg=0&Increment=50&submit=Search 118128071 384987549 1 MEPSATPGAQMGVPPGSREPSPVPPDYEDEFLRYLWRDYLYPKQYEWVLIAAYVAVFVVALVGNTLVCLAVWRNHHMRTVTNYFIVNLSLADVLVTAICLPASLLVDITESWLFGHALCKVIPYLQAVSVSVAVLTLSFIALDRWYAICHPLLFKSTARRARGSILGIWAVSLAIMVPQAAVMECSSVLPELANRTRLFSVCDERWADDLYPKIYHSCFFIVTYLAPLGLMAMAYFQIFRKLWGRQIPGTTSALVRNWKRPSDQLGDLEQGLSGEPQPRARAFLAEVKQMRARRKTAKMLMVVLLVFALCYLPISVLNVLKRVFGMFRQASDREAVYACFTFSHWLVYANSAANPIIYNFLSGKFREQFKAAFSCCLPGLGPCGSLKAPSPRSSASHKSLSLQSRCSISKISEHVVLTSVTTVLP 4ZJ8,4ZJC Orexin/Hypocretin receptor type 1 OX1R_HUMAN O43613 A8K3A6 Q9HBV6 658420 COCCn1c(nc2cc(C)c(C)cc12)[C@]1(C)CCCN1C(=O)c1cc(C)ccc1-c1ccccc1F InChI=1S/C31H34FN3O2/c1-20-11-12-23(24-9-6-7-10-26(24)32)25(17-20)29(36)35-14-8-13-31(35,4)30-33-27-18-21(2)22(3)19-28(27)34(30)15-16-37-5/h6-7,9-12,17-19H,8,13-16H2,1-5H3/t31-/m0/s1 ZOFFFVKQLLHRKP-HKBQPEDESA-N 335390 (2'-Fluoro-4-methyl-biphenyl-2-yl)-{(S)-2-[1-(2-methoxy-ethyl)-5,6-dimethyl-1H-benzoimidazol-2-yl]-2-methyl-pyrrolidin-1-yl}-methanone::US11040966, Example 7.54::US9732075, Example 7.54 Orexin receptor type 2 Homo sapiens 270 US Patent 10.7270/Q29P33S0 aid1796974 US9732075 Boss, C; Brotschi, C; Gude, M; Heidmann, B; Sifferlen, T; Williams, J 8/15/2017 6/23/2019 IDORSIA PHARMACEUTICALS Ltd http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=335390 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=5447&target=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=335390&enzyme=Orexin+receptor+type+2&column=ki&startPg=0&Increment=50&submit=Search 118128071 384987549 1 MSGTKLEDSPPCRNWSSASELNETQEPFLNPTDYDDEEFLRYLWREYLHPKEYEWVLIAGYIIVFVVALIGNVLVCVAVWKNHHMRTVTNYFIVNLSLADVLVTITCLPATLVVDITETWFFGQSLCKVIPYLQTVSVSVSVLTLSCIALDRWYAICHPLMFKSTAKRARNSIVIIWIVSCIIMIPQAIVMECSTVFPGLANKTTLFTVCDERWGGEIYPKMYHICFFLVTYMAPLCLMVLAYLQIFRKLWCRQIPGTSSVVQRKWKPLQPVSQPRGPGQPTKSRMSAVAAEIKQIRARRKTARMLMIVLLVFAICYLPISILNVLKRVFGMFAHTEDRETVYAWFTFSHWLVYANSAANPIIYNFLSGKFREEFKAAFSCCCLGVHHRQEDRLTRGRTSTESRKSLTTQISNFDNISKLSEQVVLTSISTLPAANGAGPLQNW 4S0V,5WQC,5WS3 Orexin receptor type 2 OX2R_HUMAN O43614 Q5VTM0